data_2ncl_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ncl _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.469 0.484 0 CA-C-O 120.914 0.387 . . . . 2.66 111.897 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 80.0 p -107.11 164.5 12.11 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.008 0.923 . . . . 2.13 109.414 156.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 21.9 mp0 -64.32 -22.13 66.85 Favored 'General case' 0 CA--C 1.549 0.941 0 O-C-N 121.454 -0.778 . . . . 3.72 111.716 162.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.45 -39.61 95.81 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 126.72 2.105 . . . . 0.48 114.08 170.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.87 -43.99 73.64 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.486 1.643 . . . . 2.1 111.29 174.078 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 11.7 mt -66.28 -55.37 16.38 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 125.399 1.48 . . . . 1.64 109.867 178.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.3 tpm_? -49.69 -51.46 38.16 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.632 1.573 . . . . 8.63 113.351 176.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 26.0 t -65.21 -43.33 95.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 106.945 -1.502 . . . . 1.78 106.945 -175.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 36.1 m -58.7 -38.21 77.78 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 118.525 -0.75 . . . . 1.51 112.056 175.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 14.3 mm-40 -60.97 -49.67 76.49 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 119.448 1.022 . . . . 1.73 112.219 -179.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 18.3 mt -75.34 -30.96 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 CA-C-N 118.343 0.519 . . . . 1.87 110.027 -175.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 29.9 mt -56.49 -38.33 71.61 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 114.459 1.281 . . . . 1.92 114.459 171.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 31.2 mttt -58.94 -36.76 75.32 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 119.122 0.874 . . . . 3.98 112.347 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.03 -36.31 15.87 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 128.651 2.78 . . . . 4.92 114.493 -173.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 48.6 mmtt -71.27 -20.84 62.17 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 118.262 -0.875 . . . . 2.13 112.397 167.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -134.09 59.12 35.8 Favored Pre-proline 0 CA--C 1.558 1.275 0 N-CA-C 117.756 2.502 . . . . 3.64 117.756 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.35 -19.81 32.86 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 124.62 3.547 . . . . 0.94 114.983 171.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 40.8 mmt180 -78.79 -0.12 29.19 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 120.836 -1.165 . . . . 5.72 113.775 170.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.26 149.1 50.86 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 115.675 1.731 . . . . 1.66 115.675 -176.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 16.3 p -108.15 -27.97 9.77 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 127.048 2.139 . . . . 1.44 112.842 170.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -119.57 138.63 53.08 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.376 1.071 . . . . 1.89 110.881 163.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.2 pt -153.92 118.87 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 124.788 1.235 . . . . 1.75 111.663 166.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.4 ptpt -158.11 154.39 27.43 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 126.032 1.733 . . . . 2.17 112.3 173.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.4 t -132.66 149.98 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 126.465 1.906 . . . . 1.8 109.712 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 92.5 m -140.0 131.18 26.51 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.613 0.765 . . . . 1.78 111.427 169.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -73.91 121.96 21.78 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.513 0.725 . . . . 1.8 109.978 163.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . 0.255 5.5 pt -117.11 25.52 4.35 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 C-N-CA 125.495 1.518 . . . . 1.69 111.039 179.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 31.9 t -137.91 58.99 1.67 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 128.564 2.746 . . . . 1.98 111.223 -173.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -55.53 -6.53 1.1 Allowed Glycine 0 CA--C 1.544 1.878 0 N-CA-C 119.003 2.361 . . . . 1.3 119.003 -173.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -133.04 16.39 4.7 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 126.247 1.879 . . . . 1.33 114.653 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 15.4 t -153.17 -39.7 0.1 Allowed 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.778 1.231 . . . . 2.54 111.776 170.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 64.67 44.18 95.31 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 125.699 1.618 . . . . 0.88 112.707 -167.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -90.08 -31.39 17.16 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.911 1.284 . . . . 2.33 113.667 173.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 9.0 mtm -104.43 138.01 41.46 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.866 1.266 . . . . 1.98 112.576 174.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -137.46 147.34 45.25 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.995 0.918 . . . . 3.32 111.225 169.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -83.32 138.49 33.53 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 124.904 1.282 . . . . 2.44 109.531 161.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 97.5 mt -134.48 129.0 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 CA-C-N 119.344 0.975 . . . . 1.76 109.474 168.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 71.6 mttt -126.06 115.99 20.71 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.688 1.195 . . . . 3.5 110.347 178.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.1 mt -127.02 156.62 38.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 126.442 1.897 . . . . 1.52 109.423 -177.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -152.87 133.3 13.67 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.252 1.821 . . . . 2.02 106.584 162.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 28.0 t -155.91 143.37 19.39 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 120.132 1.333 . . . . 0.44 112.883 -173.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -57.51 -20.62 32.62 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.923 1.289 . . . . 3.25 114.149 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -75.69 -15.12 60.34 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 114.27 1.211 . . . . 1.86 114.27 177.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -83.5 16.72 2.46 Favored 'General case' 0 CA--C 1.55 0.964 0 N-CA-C 113.689 0.996 . . . . 2.83 113.689 -174.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -71.05 -44.35 65.94 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.677 1.591 . . . . 4.25 112.654 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -91.85 35.85 0.97 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.206 1.402 . . . . 4.11 113.115 -174.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 62.6 mmtt -144.78 141.32 29.11 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.684 1.594 . . . . 2.39 113.115 -167.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 22.6 mmt180 -73.03 170.62 14.48 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 126.596 1.959 . . . . 5.39 112.223 162.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 84.2 m -50.95 -54.71 21.9 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.816 1.043 . . . . 2.21 113.816 168.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.1 p -59.9 -35.88 63.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 123.776 0.83 . . . . 2.07 112.974 178.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -76.4 -37.07 57.65 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.722 0.809 . . . . 1.5 112.029 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -59.83 -54.07 50.52 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.962 0.905 . . . . 0.95 109.889 168.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 47.8 m170 -50.13 -52.76 32.45 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.256 1.022 . . . . 0.66 111.878 177.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 39.9 tp60 -47.07 -44.28 20.82 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.592 1.557 . . . . 1.3 112.847 179.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 81.2 mtp -62.97 -43.43 98.81 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 121.166 -0.959 . . . . 1.95 112.255 178.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.2 t -71.22 -25.83 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 125.657 1.583 . . . . 1.49 111.735 177.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -76.8 -44.41 32.74 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.621 1.568 . . . . 0.51 109.69 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -64.76 -27.39 68.86 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 125.104 1.362 . . . . 3.44 113.99 175.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.94 -29.99 71.22 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.501 1.52 . . . . 1.49 112.916 -175.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.0 -8.19 8.85 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 115.124 1.527 . . . . 1.44 115.124 176.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -44.37 -43.58 7.68 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.081 1.352 . . . . 2.88 112.847 176.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -85.78 6.01 29.88 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-O 122.505 1.145 . . . . 2.45 111.759 -165.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -124.54 -56.27 1.61 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 129.946 3.299 . . . . 2.98 108.377 -177.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.0 mm -126.38 132.9 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 127.573 2.349 . . . . 3.17 108.923 169.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -92.77 -10.89 35.34 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 116.274 1.953 . . . . 3.48 116.274 -174.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -78.66 36.65 0.27 Allowed 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 117.702 2.482 . . . . 3.05 117.702 -153.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 4.6 mpp? -64.06 9.42 0.07 Allowed 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 116.259 1.948 . . . . 2.4 116.259 -175.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 49.3 t60 -65.07 -38.82 92.05 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 120.946 -1.096 . . . . 5.74 111.81 160.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -84.61 -17.79 63.23 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 126.355 1.931 . . . . 0.58 114.045 -178.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.5 mp -87.61 118.77 27.31 Favored 'General case' 0 C--N 1.332 -0.179 0 O-C-N 121.674 -0.898 . . . . 2.84 112.265 -170.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 28.7 ttm180 -98.02 102.06 13.71 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 127.453 2.301 . . . . 5.7 109.885 -177.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 4.1 mt -111.7 143.91 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-O 123.903 1.811 . . . . 1.55 113.14 -169.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -136.0 125.6 25.32 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 111.543 -2.571 . . . . 3.17 108.005 -171.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 28.3 p -144.86 153.55 41.72 Favored 'General case' 0 CA--C 1.509 -0.607 0 C-N-CA 125.837 1.655 . . . . 1.84 109.791 -171.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -163.35 175.55 10.73 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.239 -1.346 . . . . 1.34 109.379 176.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.4 p -122.97 139.65 31.87 Favored Pre-proline 0 C--N 1.325 -0.488 0 O-C-N 121.289 -0.882 . . . . 1.79 109.531 170.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo . . . . . 0 N--CA 1.45 -1.062 0 C-N-CA 123.207 2.605 . . . . 1.07 108.463 172.847 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 . . . . . 0 N--CA 1.47 0.565 0 N-CA-C 115.443 1.646 . . . . 3.06 115.443 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 38.9 p -117.0 179.9 3.89 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.877 1.671 . . . . 1.96 111.041 169.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -70.45 -35.25 73.23 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 120.633 -1.292 . . . . 3.05 111.959 168.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -67.42 -37.59 90.33 Favored Glycine 0 CA--C 1.529 0.948 0 CA-C-O 118.572 -1.127 . . . . 0.48 112.901 178.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -46.08 -50.24 15.49 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.51 1.524 . . . . 1.38 112.713 173.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 15.1 mt -69.95 -50.73 39.03 Favored 'General case' 0 CA--C 1.528 0.098 0 C-N-CA 124.957 1.303 . . . . 1.8 111.132 -178.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.54 -48.36 77.43 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.578 1.151 . . . . 3.92 110.85 -179.027 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.0 t -63.12 -41.93 94.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 108.496 -0.927 . . . . 1.6 108.496 177.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 74.2 m -59.09 -42.08 89.61 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 118.761 0.709 . . . . 1.86 111.28 178.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -69.48 -33.37 72.79 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 114.011 1.115 . . . . 3.58 114.011 -175.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 30.5 mt -79.53 -30.69 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 CA-C-N 119.099 0.863 . . . . 1.67 110.694 173.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 33.1 mt -58.19 -36.74 73.54 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 120.74 -1.225 . . . . 1.83 113.233 171.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 38.0 mttt -59.78 -24.6 64.23 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 114.21 1.189 . . . . 1.97 114.21 173.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -101.25 -34.73 9.54 Favored 'General case' 0 N--CA 1.427 -1.575 0 C-N-CA 125.494 1.518 . . . . 2.08 113.87 -175.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -75.26 -24.66 57.63 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 118.646 -1.221 . . . . 1.95 111.79 169.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -130.6 54.55 14.99 Favored Pre-proline 0 CA--C 1.548 0.865 0 N-CA-C 117.049 2.24 . . . . 3.76 117.049 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -62.49 -30.79 80.26 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 123.573 2.849 . . . . 0.74 113.688 174.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 28.0 mmt85 -75.95 -11.89 60.04 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 120.352 1.433 . . . . 5.52 114.519 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -55.21 146.67 18.26 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.157 1.783 . . . . 1.41 114.524 -174.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 66.7 p -88.09 -30.74 19.65 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.905 0.882 . . . . 1.74 111.111 170.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -129.77 138.67 51.19 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.005 0.922 . . . . 1.52 111.734 170.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.6 pt -150.46 117.74 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 125.572 1.549 . . . . 2.18 111.419 165.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.79 157.79 37.06 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.705 1.202 . . . . 3.45 113.46 169.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.0 t -125.08 144.13 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 128.215 2.606 . . . . 1.86 110.492 -173.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 80.7 m -128.86 126.37 39.64 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.388 1.475 . . . . 1.77 109.518 166.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -73.41 139.2 45.72 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 122.023 0.916 . . . . 2.47 110.344 165.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.7 pt -134.31 32.8 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 C-N-CA 126.411 1.884 . . . . 1.93 110.397 177.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 23.2 t -141.01 62.31 1.48 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 128.13 2.572 . . . . 1.99 112.779 -171.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.08 -30.11 60.27 Favored Glycine 0 CA--C 1.54 1.619 0 O-C-N 119.989 -1.694 . . . . 1.8 114.649 179.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -85.81 -9.46 77.86 Favored Glycine 0 CA--C 1.539 1.549 0 N-CA-C 116.421 1.328 . . . . 1.62 116.421 -179.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 19.6 t -148.52 -38.83 0.17 Allowed 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 119.493 1.646 . . . . 3.27 114.319 -175.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 66.82 43.52 91.41 Favored Glycine 0 CA--C 1.536 1.375 0 C-N-CA 126.854 2.168 . . . . 1.16 112.581 -165.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -94.06 -37.98 11.36 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.13 1.372 . . . . 2.57 113.594 172.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' MET . . . . . 0.421 ' HG3' ' CA ' ' A' ' 97' ' ' GLY . 4.0 mpp? -94.99 140.29 30.16 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 124.373 1.069 . . . . 2.82 112.962 -175.252 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -145.38 143.5 30.15 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 122.393 1.092 . . . . 3.24 113.805 175.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -100.07 119.51 38.41 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.364 1.866 . . . . 2.67 109.911 170.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 61.6 mt -132.48 130.54 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.784 1.234 . . . . 1.96 110.747 -161.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -117.67 125.95 51.63 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.304 1.442 . . . . 3.83 110.683 177.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.2 mt -129.35 156.37 41.79 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 C-N-CA 127.347 2.259 . . . . 1.67 109.703 174.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -155.37 133.67 11.67 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.678 1.591 . . . . 1.82 108.704 164.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 16.9 t -159.55 140.49 12.51 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 119.811 1.187 . . . . 0.33 112.865 -175.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -61.48 -3.6 1.05 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 127.609 2.364 . . . . 3.73 115.084 179.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -84.8 -23.6 29.07 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.901 1.68 . . . . 1.66 113.725 173.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -79.92 9.93 4.79 Favored 'General case' 0 CA--C 1.555 1.16 0 N-CA-C 116.052 1.871 . . . . 2.91 116.052 -165.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.89 -37.17 35.35 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 117.613 2.449 . . . . 4.01 117.613 -163.033 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -88.63 40.53 0.97 Allowed 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 121.046 1.748 . . . . 4.33 111.993 178.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.9 mmtp -139.71 137.16 34.93 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 125.437 1.495 . . . . 2.97 111.823 -168.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 46.2 mtt180 -68.75 172.03 6.97 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.856 1.662 . . . . 4.51 111.741 164.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 87.0 m -47.6 -58.34 4.37 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 125.357 1.463 . . . . 1.78 113.425 170.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.2 p -59.48 -36.13 62.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.351 1.061 . . . . 1.77 112.775 176.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 11.1 mt-30 -77.08 -27.34 54.22 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 113.446 0.906 . . . . 1.61 113.446 -177.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -71.42 -54.1 11.81 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.012 0.925 . . . . 0.89 110.33 166.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 52.6 m170 -55.08 -42.58 73.0 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.543 0.737 . . . . 0.57 112.414 -177.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 31.0 tp60 -47.43 -42.0 21.44 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 126.201 1.801 . . . . 1.15 113.032 177.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 63.8 mtp -66.36 -43.47 85.9 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 123.568 0.747 . . . . 1.62 111.234 -177.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.5 t -72.27 -34.31 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 127.058 2.143 . . . . 1.8 111.654 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -63.16 -53.15 57.76 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 127.169 2.188 . . . . 0.56 109.524 173.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.8 tm0? -65.27 -30.19 71.04 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.234 -0.916 . . . . 3.21 112.235 -177.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -55.89 -34.22 65.34 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 125.631 1.573 . . . . 1.69 112.72 -172.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.41 -2.81 9.45 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 115.053 1.501 . . . . 1.73 115.053 177.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 26.8 ttpt -51.15 -36.3 40.17 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.957 0.903 . . . . 2.72 112.475 178.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -74.92 -13.73 60.57 Favored 'General case' 0 N--CA 1.439 -1.022 0 O-C-N 121.578 -0.701 . . . . 2.24 112.269 -176.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -94.86 -49.49 5.56 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 128.466 2.706 . . . . 3.0 113.448 172.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 30.6 mt -141.02 129.35 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 127.738 2.415 . . . . 2.12 107.938 177.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 45.7 mttp -97.66 -14.66 20.8 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 116.21 1.93 . . . . 4.27 116.21 -170.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -79.35 68.41 5.34 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 115.354 1.613 . . . . 4.96 115.354 -160.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -70.39 1.58 4.84 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 116.471 2.026 . . . . 2.97 116.471 -178.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 22.4 t60 -54.57 -32.66 58.91 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.924 0.868 . . . . 5.71 112.064 153.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.421 ' CA ' ' HG3' ' A' ' 62' ' ' MET . . . -83.39 -18.01 65.28 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 126.175 1.845 . . . . 0.62 116.544 -176.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 10.1 mt -93.62 139.56 30.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 118.517 1.158 . . . . 3.45 110.746 -168.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 35.5 ttt180 -123.55 95.76 4.71 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.552 1.541 . . . . 4.03 107.91 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -114.32 135.34 54.39 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.475 0 CA-C-O 123.115 1.436 . . . . 1.87 112.444 -161.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -127.83 114.24 16.97 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 112.178 -2.283 . . . . 3.42 107.764 -168.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 23.4 p -127.13 150.31 49.55 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.293 1.437 . . . . 1.5 110.566 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 2.2 p -150.7 172.73 15.11 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.222 -1.354 . . . . 0.79 111.123 173.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.9 p -140.24 129.58 13.42 Favored Pre-proline 0 N--CA 1.472 0.628 0 C-N-CA 123.172 0.589 . . . . 1.75 111.6 178.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo . . . . . 0 CA--C 1.538 0.714 0 C-N-CA 123.751 2.967 . . . . 0.68 111.418 -177.441 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 96.7 mm-40 . . . . . 0 C--O 1.238 0.463 0 CA-C-O 122.638 1.208 . . . . 3.2 113.018 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 62.6 p -121.06 161.63 21.38 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 112.532 -2.122 . . . . 1.72 108.46 149.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -63.88 -21.15 66.32 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 120.586 -1.321 . . . . 2.7 112.044 164.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -67.38 -39.24 91.61 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 126.875 2.179 . . . . 0.66 113.572 173.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.25 -44.31 68.04 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.512 1.525 . . . . 1.29 111.233 173.03 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.4 mt -68.79 -53.92 18.87 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 125.801 1.64 . . . . 1.82 110.935 176.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.5 ttp-105 -49.8 -50.06 46.41 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 126.617 1.967 . . . . 4.38 111.162 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 52.0 t -68.27 -46.94 80.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 123.992 0.917 . . . . 1.6 108.538 -178.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 98.3 m -57.93 -42.63 85.23 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 118.497 0.589 . . . . 1.72 111.903 178.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -62.39 -35.9 80.62 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.888 0.875 . . . . 2.93 112.449 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 62.4 mt -80.86 -31.81 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-N 118.845 0.748 . . . . 1.8 111.019 175.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 29.6 mt -58.09 -37.58 74.78 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 120.945 -1.097 . . . . 1.42 112.34 171.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 23.9 mttt -63.38 -22.36 66.83 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 113.539 0.94 . . . . 2.66 113.539 174.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -96.41 -36.15 10.93 Favored 'General case' 0 N--CA 1.434 -1.255 0 C-N-CA 125.994 1.717 . . . . 2.13 114.694 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 64.9 mmtt -74.84 -28.01 60.51 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 119.668 -0.813 . . . . 2.68 111.8 171.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -130.33 50.29 5.83 Favored Pre-proline 0 CA--C 1.55 0.952 0 N-CA-C 117.65 2.463 . . . . 3.61 117.65 -178.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -61.51 -25.47 79.63 Favored 'Trans proline' 0 C--O 1.237 0.468 0 C-N-CA 123.949 3.099 . . . . 0.95 114.428 177.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 12.5 mmt85 -80.78 -11.35 59.62 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 114.148 1.166 . . . . 5.84 114.148 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -51.85 151.33 3.55 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 126.245 1.818 . . . . 1.52 114.725 -173.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 68.9 p -93.04 -32.21 14.57 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.976 1.31 . . . . 1.57 111.033 169.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -124.82 139.01 54.23 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.212 1.005 . . . . 1.6 111.992 170.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.4 pt -156.16 112.49 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 126.433 1.893 . . . . 1.76 111.316 166.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.5 ptpt -151.88 148.3 27.64 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.916 1.286 . . . . 1.82 112.888 172.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 29.0 t -124.39 144.2 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 127.1 2.16 . . . . 1.65 108.872 -178.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 98.9 m -132.07 127.34 35.9 Favored 'General case' 0 CA--C 1.512 -0.507 0 C-N-CA 124.732 1.213 . . . . 1.95 109.931 172.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.82 130.44 41.07 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 124.25 1.02 . . . . 2.58 111.009 174.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.3 pt -132.64 26.61 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 C-N-CA 126.234 1.814 . . . . 1.6 110.77 174.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.5 t -138.14 107.97 6.3 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.931 1.293 . . . . 2.04 113.519 164.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -83.43 -18.06 65.12 Favored Glycine 0 N--CA 1.474 1.203 0 C-N-CA 124.228 0.918 . . . . 2.4 113.821 162.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -77.36 -39.69 25.71 Favored Glycine 0 N--CA 1.467 0.746 0 C-N-CA 124.548 1.071 . . . . 2.28 113.368 -175.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 20.8 m -145.9 -17.89 0.46 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.755 1.222 . . . . 2.55 113.284 -170.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 63.06 37.8 95.54 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 126.374 1.94 . . . . 1.03 113.948 -178.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -101.61 -8.96 21.37 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.67 1.188 . . . . 2.94 113.074 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 7.8 ttm -119.35 122.12 41.11 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 125.824 1.65 . . . . 1.9 109.803 -162.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -146.06 147.26 31.43 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 121.859 0.838 . . . . 3.4 112.989 -177.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -101.52 124.29 46.95 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.705 1.602 . . . . 2.48 109.692 173.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 95.5 mt -134.54 130.84 53.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 O-C-N 120.866 -1.146 . . . . 1.94 111.44 -165.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.5 mptt -119.8 130.45 54.93 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.529 0.732 . . . . 4.22 111.618 171.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.3 mt -129.67 159.46 41.69 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 C-N-CA 126.566 1.947 . . . . 1.58 109.279 176.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -159.42 135.4 8.78 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 126.347 1.859 . . . . 1.86 108.628 165.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.3 t -162.98 146.7 11.03 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 118.494 0.588 . . . . 0.46 111.491 -176.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -51.38 -32.53 26.29 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.858 1.663 . . . . 3.66 113.759 178.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -63.39 -20.08 65.22 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 114.838 1.422 . . . . 1.68 114.838 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -81.45 10.96 4.96 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 114.984 1.476 . . . . 2.85 114.984 -169.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.5 pttt -74.63 -43.84 53.45 Favored 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 115.002 1.482 . . . . 3.03 115.002 -172.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -91.15 27.64 1.83 Allowed 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 124.894 1.278 . . . . 4.23 111.803 -174.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -123.09 140.14 53.34 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 127.47 2.308 . . . . 2.27 111.451 -171.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 13.1 mmt85 -69.37 165.94 19.67 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.057 1.343 . . . . 3.55 110.629 161.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 28.2 m -52.09 -53.55 41.06 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.718 1.207 . . . . 1.75 112.986 171.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.1 p -59.55 -35.64 60.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 124.252 1.021 . . . . 2.08 113.161 175.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -74.79 -35.89 62.51 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.676 0.621 . . . . 1.21 112.676 177.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -60.26 -51.6 68.86 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 119.462 1.028 . . . . 0.87 109.192 169.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 36.7 m170 -55.62 -46.08 77.44 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.603 0.761 . . . . 0.84 112.982 177.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 40.1 tp60 -48.43 -45.5 36.4 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.511 1.525 . . . . 1.31 112.625 176.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 67.0 mtp -63.71 -34.73 78.53 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 119.407 1.003 . . . . 1.91 112.792 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.8 t -78.24 -30.34 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 125.689 1.596 . . . . 1.82 111.752 177.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -71.27 -50.9 27.95 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.266 1.826 . . . . 0.72 110.965 174.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 27.3 tp60 -69.78 -15.01 63.05 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 125.327 1.451 . . . . 3.15 113.784 -178.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.15 -39.93 88.05 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.575 1.15 . . . . 1.8 112.539 173.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.86 -0.07 8.54 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 115.764 1.764 . . . . 1.69 115.764 -177.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 27.0 ttmt -43.57 -45.24 6.59 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 125.631 1.572 . . . . 2.96 113.147 177.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -83.19 -7.02 59.68 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-O 121.294 0.569 . . . . 2.09 112.201 -169.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 23.6 tp10 -103.59 -41.49 5.95 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 129.55 3.14 . . . . 2.21 111.011 -176.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 44.6 mt -150.61 115.21 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 129.806 3.242 . . . . 2.33 107.029 175.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -92.26 -4.62 53.79 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 117.336 2.347 . . . . 4.17 117.336 -169.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -82.13 33.55 0.4 Allowed 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 127.97 2.508 . . . . 2.99 115.503 -161.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 4.4 mpp? -68.53 6.16 0.88 Allowed 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 117.639 2.459 . . . . 2.32 117.639 -165.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 34.2 t60 -42.62 -38.67 2.09 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 121.218 -0.926 . . . . 5.61 112.113 152.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -69.14 -16.15 70.57 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 126.294 1.902 . . . . 0.7 117.03 -179.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 12.4 mt -96.7 129.47 44.1 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 119.057 1.428 . . . . 3.43 112.715 -163.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 35.9 ttt180 -111.03 87.64 2.59 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 126.912 2.085 . . . . 4.3 107.906 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 1.7 mt -106.23 144.61 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-O 122.879 1.323 . . . . 1.84 112.31 -166.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -137.11 132.02 33.48 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 111.748 -2.478 . . . . 3.63 108.756 -173.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 21.1 p -146.24 152.78 39.74 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 126.449 1.899 . . . . 1.55 110.198 -173.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 2.6 p -159.51 177.92 10.43 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 124.405 1.082 . . . . 0.8 110.97 176.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.2 p -136.86 138.8 27.04 Favored Pre-proline 0 N--CA 1.47 0.567 0 C-N-CA 124.089 0.956 . . . . 1.82 110.412 175.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo . . . . . 0 CA--C 1.533 0.47 0 C-N-CA 122.828 2.352 . . . . 0.7 110.723 174.352 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 . . . . . 0 C--O 1.236 0.385 0 N-CA-C 112.924 0.713 . . . . 7.5 112.924 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 79.2 p -110.38 -179.44 3.77 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.203 -1.036 . . . . 1.81 108.203 140.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -71.63 -30.94 66.33 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 119.797 -1.815 . . . . 3.5 112.396 162.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.73 -41.21 99.57 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 124.279 0.943 . . . . 0.77 113.281 173.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -54.14 -42.07 69.12 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.176 1.39 . . . . 1.52 112.919 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 22.5 mt -69.16 -50.67 45.59 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 125.519 1.527 . . . . 2.08 111.323 177.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.98 -50.3 73.1 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 126.004 1.722 . . . . 3.71 110.61 -179.148 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 56.2 t -60.42 -47.4 92.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 108.292 -1.003 . . . . 1.54 108.292 177.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 93.0 m -58.53 -38.63 78.17 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.646 0.61 . . . . 1.66 112.646 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.3 mm-40 -63.54 -40.23 96.49 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 118.412 0.551 . . . . 1.7 112.313 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 35.7 mt -82.02 -28.4 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 122.759 0.424 . . . . 1.91 110.77 -175.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 11.8 mt -54.23 -37.75 64.96 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.473 -0.767 . . . . 1.69 112.832 168.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.7 mttt -62.49 -25.27 67.92 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 114.237 1.199 . . . . 3.04 114.237 178.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -106.14 -31.83 8.51 Favored 'General case' 0 N--CA 1.435 -1.22 0 C-N-CA 126.775 2.03 . . . . 2.49 113.728 -167.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 53.1 mmtt -77.57 -24.84 49.71 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 118.729 -0.653 . . . . 2.47 111.713 164.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -131.71 49.54 4.77 Favored Pre-proline 0 CA--C 1.556 1.191 0 N-CA-C 118.435 2.754 . . . . 2.69 118.435 -178.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -68.07 -12.97 36.84 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 125.056 3.837 . . . . 0.85 114.948 176.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 38.8 mtt180 -99.58 -6.73 26.88 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.195 0.998 . . . . 6.05 113.444 175.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.41 139.91 58.56 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 125.025 1.33 . . . . 1.67 113.141 176.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 44.2 p -75.46 -35.52 60.86 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.249 1.42 . . . . 1.9 109.395 176.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -124.29 138.26 54.41 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.562 1.145 . . . . 1.66 111.736 171.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.8 pt -150.22 118.46 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 125.577 1.551 . . . . 1.97 112.522 163.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 7.8 ptpt -158.88 158.26 33.06 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.744 1.218 . . . . 2.69 114.016 177.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.7 t -126.11 155.93 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 127.766 2.426 . . . . 1.76 111.028 -174.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 88.4 m -147.14 127.35 13.83 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 120.996 -1.065 . . . . 1.54 111.817 162.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -69.63 126.91 31.16 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.889 0.852 . . . . 1.86 110.568 165.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.5 pt -126.08 25.14 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 C-N-CA 126.047 1.739 . . . . 1.52 111.387 -178.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 34.9 t -132.5 62.74 1.64 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 128.308 2.643 . . . . 2.22 109.032 176.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -54.29 -13.3 3.7 Favored Glycine 0 CA--C 1.54 1.643 0 N-CA-C 117.642 1.817 . . . . 1.73 117.642 -169.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -123.55 -6.71 7.2 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 126.31 1.91 . . . . 1.75 115.828 -179.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -138.74 -21.75 0.99 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.212 1.405 . . . . 3.21 114.399 -176.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 55.0 39.06 67.3 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 128.054 2.74 . . . . 0.95 115.477 -178.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -88.05 -32.47 18.74 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.131 1.372 . . . . 2.17 114.094 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 8.5 mtm -106.9 142.25 36.82 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.648 1.579 . . . . 2.35 112.842 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -142.46 144.09 32.88 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 122.181 0.991 . . . . 3.36 112.539 172.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -83.05 139.46 33.24 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 126.604 1.961 . . . . 2.07 110.076 165.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 90.6 mt -138.01 128.45 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 CA-C-N 119.39 0.996 . . . . 1.79 110.606 170.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 77.9 mttt -113.73 126.78 55.61 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.118 1.367 . . . . 3.85 110.943 171.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.3 mt -130.55 156.95 42.89 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 126.863 2.065 . . . . 1.56 109.938 174.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -156.8 130.86 8.43 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.332 1.453 . . . . 1.65 109.583 166.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 32.6 t -158.26 143.6 16.66 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 119.994 1.27 . . . . 0.57 112.019 -176.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -51.77 -24.86 6.49 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.206 1.402 . . . . 3.1 113.52 173.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -69.51 -14.59 62.94 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 114.182 1.179 . . . . 1.73 114.182 -178.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -92.33 13.85 18.17 Favored 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 125.163 1.385 . . . . 2.92 114.266 -175.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -79.27 -15.05 58.58 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 115.769 1.766 . . . . 4.18 115.769 -167.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -123.17 29.95 6.53 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.082 1.753 . . . . 4.54 110.867 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -122.35 129.85 52.54 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 126.299 1.84 . . . . 2.24 111.053 -172.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 38.3 mtt-85 -63.52 164.41 9.47 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.852 1.261 . . . . 4.29 111.064 168.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 86.7 m -44.53 -55.89 4.76 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.933 0.893 . . . . 1.71 112.985 170.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.2 p -61.57 -37.25 77.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 124.987 1.315 . . . . 1.7 113.164 178.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -75.66 -29.85 59.22 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 112.917 0.71 . . . . 1.12 112.917 179.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 60.5 mt-30 -65.09 -54.8 24.44 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 119.007 0.821 . . . . 1.96 109.03 168.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 45.1 m170 -54.46 -45.31 73.09 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.952 0.901 . . . . 0.61 112.859 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 50.5 tp60 -48.36 -43.46 33.58 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.363 1.465 . . . . 1.39 112.912 178.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 45.5 mtp -66.32 -42.03 88.81 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 121.43 -0.794 . . . . 1.82 111.717 -178.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.1 t -72.22 -29.7 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 125.267 1.427 . . . . 1.58 111.773 176.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -69.23 -51.72 34.9 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 126.185 1.794 . . . . 0.89 108.276 179.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -69.0 -19.89 64.15 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 113.748 1.018 . . . . 2.61 113.748 -176.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.4 -41.77 80.94 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.031 0.932 . . . . 1.49 111.652 178.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.86 -4.16 9.67 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 115.386 1.625 . . . . 1.68 115.386 -176.282 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 21.9 tttt -53.32 -34.68 58.43 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 125.048 1.339 . . . . 2.96 113.45 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 67.2 mt-10 -87.27 -2.58 58.72 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 123.166 0.587 . . . . 2.32 111.638 -174.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -100.98 -45.55 5.38 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 128.147 2.579 . . . . 3.09 112.17 167.225 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 30.2 mt -145.78 110.6 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 128.003 2.521 . . . . 2.08 107.676 178.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -86.17 -1.43 57.43 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 116.185 1.92 . . . . 3.07 116.185 -173.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -77.19 43.39 0.37 Allowed 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 128.728 2.811 . . . . 3.59 115.948 -164.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 4.7 mpp? -62.95 1.89 0.37 Allowed 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 114.952 1.464 . . . . 2.47 114.952 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 22.0 t60 -59.78 -26.51 65.77 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.513 1.125 . . . . 5.39 113.21 163.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -106.37 -8.15 33.67 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 126.893 2.187 . . . . 0.52 114.855 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.7 mp -96.38 123.52 40.05 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 118.374 1.087 . . . . 2.7 111.55 -173.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 54.0 ttt180 -105.68 100.01 9.59 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 126.956 2.102 . . . . 3.53 109.08 -174.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 3.6 mt -108.28 141.17 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-O 122.969 1.366 . . . . 1.59 111.795 -169.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -130.91 123.27 28.56 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 111.695 -2.502 . . . . 3.17 107.363 -173.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 16.2 p -136.94 140.45 42.26 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.058 1.343 . . . . 1.65 109.697 -176.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.6 t -138.01 -177.6 4.89 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 122.585 1.183 . . . . 2.24 110.922 167.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.2 p -147.65 135.78 10.96 Favored Pre-proline 0 C--N 1.317 -0.827 0 C-N-CA 126.085 1.754 . . . . 1.76 108.662 177.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo . . . . . 0 CA--C 1.538 0.676 0 C-N-CA 123.018 2.478 . . . . 1.17 110.646 175.102 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 . . . . . 0 N--CA 1.469 0.517 0 N-CA-C 115.534 1.679 . . . . 3.42 115.534 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 72.3 p -128.19 169.28 14.32 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 126.751 2.02 . . . . 1.76 108.614 160.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -68.37 -16.93 64.11 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 121.027 -1.046 . . . . 2.79 113.004 165.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.99 -42.88 67.32 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 124.62 1.105 . . . . 0.55 113.295 169.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.08 -48.88 43.91 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.488 1.915 . . . . 1.36 111.892 173.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 24.0 mt -67.04 -51.85 49.55 Favored 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 125.755 1.622 . . . . 1.84 111.353 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.5 ttp180 -50.45 -49.93 53.74 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 126.936 2.094 . . . . 5.82 110.667 178.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.7 t -67.92 -46.98 80.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 108.874 -0.787 . . . . 1.68 108.874 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 57.5 m -55.48 -40.35 71.56 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 118.324 0.511 . . . . 1.39 112.326 178.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -61.71 -42.47 98.98 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 112.349 0.499 . . . . 1.63 112.349 -177.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 18.5 mt -79.65 -29.37 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 CA-C-N 118.345 0.52 . . . . 1.95 111.514 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 22.9 mt -55.55 -40.4 71.86 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 120.98 -1.075 . . . . 1.76 113.759 172.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 42.4 mttt -59.45 -27.82 66.43 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 113.832 1.049 . . . . 2.23 113.832 178.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -97.4 -34.22 11.12 Favored 'General case' 0 N--CA 1.431 -1.382 0 C-N-CA 127.423 2.289 . . . . 2.22 114.233 -172.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 63.1 mmtt -74.27 -23.52 59.13 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 119.089 -1.044 . . . . 2.28 111.919 167.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -127.84 54.97 14.4 Favored Pre-proline 0 CA--C 1.554 1.101 0 N-CA-C 117.874 2.546 . . . . 2.65 117.874 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -66.87 -17.99 52.25 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 124.935 3.757 . . . . 0.82 114.99 173.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 25.1 mmt85 -85.29 -1.18 56.69 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 113.89 1.07 . . . . 5.58 113.89 171.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.19 149.36 50.05 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 114.3 1.222 . . . . 1.61 114.3 -176.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 72.4 p -114.98 -4.15 12.59 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.94 1.696 . . . . 1.72 113.418 173.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -140.73 146.31 37.59 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.422 1.089 . . . . 1.74 111.391 147.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.3 pt -154.58 117.54 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 126.381 1.872 . . . . 1.71 111.918 169.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.4 ptpt -158.66 148.43 19.41 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.918 1.287 . . . . 1.81 114.041 178.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.2 t -126.52 150.48 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 C-N-CA 126.834 2.053 . . . . 1.74 111.287 -173.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 98.1 m -143.57 135.41 26.51 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.502 0.721 . . . . 1.69 112.371 171.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -77.62 126.0 30.2 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 122.131 0.967 . . . . 1.92 111.012 168.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.0 pt -124.05 29.47 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 C-N-CA 126.151 1.781 . . . . 1.6 110.978 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.476 ' CB ' ' H ' ' A' ' 62' ' ' MET . 29.8 t -135.69 58.53 1.75 Allowed 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 128.214 2.606 . . . . 1.94 111.453 -174.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -65.27 14.77 0.21 Allowed Glycine 0 CA--C 1.537 1.444 0 N-CA-C 117.794 1.877 . . . . 2.12 117.794 -174.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -135.81 0.3 3.33 Favored Glycine 0 CA--C 1.537 1.407 0 C-N-CA 125.803 1.668 . . . . 1.27 114.085 175.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 36.7 t -151.61 -38.62 0.12 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.958 1.303 . . . . 3.12 113.568 -177.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 67.19 38.5 92.02 Favored Glycine 0 CA--C 1.541 1.678 0 C-N-CA 126.37 1.938 . . . . 0.77 114.67 -165.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -93.71 -20.32 20.25 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 127.242 2.217 . . . . 2.31 115.382 176.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' MET . . . . . 0.476 ' H ' ' CB ' ' A' ' 56' ' ' SER . 6.1 mtm -111.38 139.91 46.4 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.643 1.577 . . . . 2.41 112.862 172.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -139.96 150.0 43.97 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.875 0.87 . . . . 3.21 112.376 172.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -86.74 139.87 30.3 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 125.363 1.465 . . . . 2.31 110.126 163.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 90.1 mt -134.34 127.34 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 124.242 1.017 . . . . 1.85 109.606 168.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -117.34 122.74 44.72 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.522 1.129 . . . . 3.0 109.259 171.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.2 mt -126.81 157.63 37.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 127.089 2.155 . . . . 1.73 109.196 177.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -155.27 131.42 10.2 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 125.706 1.602 . . . . 1.93 107.69 168.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 28.7 t -156.82 143.05 18.12 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 120.304 1.411 . . . . 0.42 112.327 -173.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -63.91 -10.43 20.89 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 114.767 1.395 . . . . 3.18 114.767 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -79.51 -17.52 53.91 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 113.953 1.094 . . . . 1.83 113.953 174.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -84.19 1.23 45.48 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 114.556 1.317 . . . . 3.44 114.556 -167.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 30.1 pttt -79.77 -22.97 42.53 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 115.306 1.595 . . . . 4.76 115.306 -171.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -97.89 19.25 14.15 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-O 121.987 0.899 . . . . 4.0 111.794 178.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 44.1 mmtt -120.48 139.66 52.55 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 128.079 2.552 . . . . 2.42 111.16 -175.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 17.0 mtm180 -66.15 164.48 15.53 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.335 1.054 . . . . 5.96 111.197 161.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.1 m -46.66 -54.19 10.08 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 113.781 1.03 . . . . 1.75 113.781 170.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 9.4 p -59.5 -37.01 67.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 123.685 0.794 . . . . 1.73 112.053 176.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -77.65 -16.81 58.28 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 114.104 1.15 . . . . 1.03 114.104 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -77.87 -55.12 5.58 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 119.45 1.023 . . . . 0.81 109.658 166.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 44.7 m170 -54.12 -46.62 72.22 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.328 1.051 . . . . 0.64 113.178 -177.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 53.2 tp60 -47.79 -40.61 21.36 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.426 1.89 . . . . 1.36 113.165 177.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 64.5 mtp -66.78 -44.27 81.79 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.468 1.107 . . . . 1.82 111.596 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.9 t -69.49 -31.0 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 126.162 1.785 . . . . 1.7 110.955 178.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -68.87 -52.27 31.48 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.058 1.743 . . . . 0.5 110.176 174.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.04 -28.37 62.48 Favored 'General case' 0 CA--C 1.546 0.808 0 O-C-N 120.679 -1.263 . . . . 2.95 111.848 178.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.66 -33.83 76.5 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.741 1.216 . . . . 1.47 112.892 -173.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.46 -7.88 8.63 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 114.473 1.286 . . . . 1.73 114.473 177.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 32.0 ttpt -46.47 -43.51 16.73 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 124.454 1.102 . . . . 3.45 112.369 176.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -77.96 -4.05 45.03 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-O 121.645 0.736 . . . . 2.38 112.055 -169.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -111.79 -45.41 3.35 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 129.991 3.317 . . . . 2.26 111.154 -176.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 40.3 mt -144.85 124.95 7.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 129.001 2.92 . . . . 2.33 107.283 177.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -96.09 -10.93 27.15 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 115.317 1.599 . . . . 4.32 115.317 -174.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . 0.27 19.0 pt-20 -77.12 43.31 0.36 Allowed 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 116.38 1.993 . . . . 4.64 116.38 -162.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 59.1 mtm -71.32 -1.61 13.44 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.65 1.98 . . . . 2.53 115.948 -167.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 6.9 p-80 -60.19 -20.36 58.3 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 121.335 -0.853 . . . . 6.43 112.904 159.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -87.63 -12.94 65.98 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 125.43 1.491 . . . . 0.6 115.176 169.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.6 mp -100.08 116.47 32.18 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 118.381 1.091 . . . . 2.74 112.268 -168.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 17.6 ttm180 -98.13 103.55 15.51 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 126.505 1.922 . . . . 5.83 110.081 -175.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 2.9 mt -108.56 145.48 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 123.548 1.642 . . . . 1.73 112.933 -171.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -139.43 120.97 15.15 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 111.048 -2.796 . . . . 3.26 107.825 -171.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 21.2 p -133.6 152.03 51.81 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 126.242 1.817 . . . . 1.51 110.025 -177.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 10.4 p -157.41 179.3 9.38 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.931 -1.031 . . . . 0.68 111.187 173.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.4 p -144.21 133.73 11.56 Favored Pre-proline 0 N--CA 1.47 0.572 0 N-CA-C 113.197 0.814 . . . . 1.75 113.197 -177.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo . . . . . 0 N--CA 1.455 -0.774 0 C-N-CA 122.773 2.315 . . . . 0.67 109.456 173.011 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 . . . . . 0 CA--C 1.537 0.455 0 N-CA-C 109.759 -0.46 . . . . 2.66 109.759 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 23.1 p -115.55 164.24 14.6 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.517 1.127 . . . . 1.86 110.662 170.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -65.42 -32.77 74.58 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 120.77 -1.206 . . . . 2.89 111.377 174.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.02 -35.12 90.97 Favored Glycine 0 C--O 1.218 -0.875 0 CA-C-O 118.578 -1.123 . . . . 0.48 112.251 172.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.38 -50.93 64.07 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 119.94 1.87 . . . . 1.26 111.825 174.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 15.2 mt -69.8 -50.37 43.66 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 125.657 1.583 . . . . 1.84 110.615 -176.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.38 -48.35 79.28 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 126.135 1.774 . . . . 4.15 111.533 177.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 29.6 t -62.84 -44.03 99.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 107.875 -1.157 . . . . 1.57 107.875 178.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 47.2 m -58.05 -40.38 80.8 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 118.575 0.625 . . . . 1.8 112.084 177.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 9.9 mm-40 -64.42 -45.2 88.59 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.634 0.605 . . . . 1.9 112.634 -179.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 41.1 mt -72.04 -30.95 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-N 118.143 0.429 . . . . 2.05 109.866 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 37.5 mt -60.48 -37.73 81.98 Favored 'General case' 0 CA--C 1.531 0.237 0 O-C-N 120.925 -1.109 . . . . 1.48 113.487 173.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 34.3 mttt -64.68 -25.88 68.14 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 113.596 0.961 . . . . 2.32 113.596 175.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -87.08 -39.91 15.16 Favored 'General case' 0 N--CA 1.433 -1.325 0 C-N-CA 125.769 1.627 . . . . 2.21 113.404 176.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 62.4 mmtt -74.95 -25.51 58.93 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 119.342 -0.943 . . . . 2.38 112.067 175.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -128.11 49.69 4.71 Favored Pre-proline 0 CA--C 1.55 0.975 0 N-CA-C 119.112 3.004 . . . . 3.66 119.112 -179.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -67.72 -12.84 36.86 Favored 'Trans proline' 0 CA--C 1.534 0.489 0 C-N-CA 124.718 3.612 . . . . 0.73 115.268 175.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 12.3 mmm180 -76.18 -16.49 59.84 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 114.124 1.157 . . . . 8.34 114.124 169.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.94 152.48 43.1 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 115.892 1.812 . . . . 1.65 115.892 -166.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 30.9 p -100.24 -22.95 14.95 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 118.019 -0.991 . . . . 1.59 112.374 168.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -126.11 141.41 51.95 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 119.932 1.242 . . . . 1.39 111.53 161.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.4 pt -157.6 103.31 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 127.23 2.212 . . . . 1.61 110.337 171.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.5 ptpt -152.3 157.21 41.04 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.163 1.385 . . . . 2.07 113.097 -175.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 23.7 t -137.72 144.57 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 126.639 1.976 . . . . 1.62 110.548 -169.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 88.6 m -134.67 126.29 28.81 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 108.989 -0.745 . . . . 1.61 108.989 165.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -70.67 133.83 46.99 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.474 0.654 . . . . 2.15 109.755 167.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . 0.261 2.9 pt -127.7 34.9 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 C-N-CA 126.373 1.869 . . . . 1.77 109.188 173.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 36.4 p -144.72 42.57 1.35 Allowed 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 128.281 2.632 . . . . 4.06 116.766 -174.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -51.26 -22.42 7.06 Favored Glycine 0 CA--C 1.546 2.02 0 N-CA-C 118.399 2.119 . . . . 2.03 118.399 -176.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -110.28 -0.02 29.68 Favored Glycine 0 CA--C 1.541 1.7 0 C-N-CA 126.406 1.955 . . . . 1.54 115.37 177.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 7.8 t -132.99 -40.79 0.92 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.544 1.138 . . . . 3.14 113.756 -176.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 57.88 47.83 86.29 Favored Glycine 0 CA--C 1.536 1.396 0 C-N-CA 128.348 2.88 . . . . 1.22 113.535 -167.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -124.41 18.02 8.95 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.794 1.238 . . . . 1.76 114.024 -179.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 8.5 ttm -153.07 122.77 6.83 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.757 1.223 . . . . 2.06 112.097 -170.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -141.97 148.21 38.21 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.989 0.899 . . . . 3.22 113.413 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -93.18 114.3 26.75 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.627 1.971 . . . . 2.38 109.732 168.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 83.0 mt -125.46 123.78 65.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 CA-C-N 120.125 1.33 . . . . 1.96 110.625 -170.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 71.7 mttt -125.26 119.52 28.67 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.871 1.269 . . . . 3.37 111.011 -172.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.3 mt -130.02 153.33 38.74 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 127.158 2.183 . . . . 1.58 109.93 -176.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -154.22 127.96 8.75 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.125 1.37 . . . . 1.85 108.733 166.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 23.0 t -159.33 142.26 14.21 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 120.383 1.447 . . . . 0.3 112.657 -172.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -50.65 -31.41 16.12 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.544 1.137 . . . . 2.73 112.522 178.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -66.98 -10.73 52.63 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 114.644 1.35 . . . . 1.66 114.644 -175.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -95.71 10.28 37.47 Favored 'General case' 0 CA--C 1.557 1.217 0 N-CA-C 116.194 1.924 . . . . 3.57 116.194 -175.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.8 -37.15 70.45 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-N 120.775 1.625 . . . . 3.72 115.139 -172.073 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -86.19 13.29 8.14 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.575 1.55 . . . . 3.36 112.266 -174.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 51.4 mmtt -127.67 131.21 49.84 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.586 1.554 . . . . 3.35 112.951 -159.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 19.1 mmt180 -63.53 163.33 11.27 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.351 1.46 . . . . 6.48 111.561 166.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 41.3 m -43.5 -55.52 4.17 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 125.498 1.519 . . . . 1.81 114.167 168.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 9.9 p -59.85 -38.35 75.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 N-CA-C 113.579 0.955 . . . . 1.68 113.579 175.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -74.83 -32.45 61.94 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.308 0.643 . . . . 1.12 112.277 -177.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -66.44 -54.29 25.9 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.314 1.046 . . . . 0.88 109.81 168.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 46.6 m170 -52.83 -44.77 66.95 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.886 1.274 . . . . 0.61 112.951 -178.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 41.3 tp60 -53.34 -39.76 64.37 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.801 1.24 . . . . 1.2 112.821 178.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 4.7 mtm -66.38 -41.44 89.38 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 121.262 -0.899 . . . . 1.74 111.302 179.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.3 t -72.39 -26.45 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 125.243 1.417 . . . . 1.55 111.914 178.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -70.1 -56.16 7.61 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 126.046 1.739 . . . . 0.83 109.148 175.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.98 -6.42 42.0 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.101 1.149 . . . . 2.79 114.101 -178.246 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.02 -33.83 76.99 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 120.945 -1.097 . . . . 1.73 112.738 169.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.24 -0.64 2.01 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 115.489 1.663 . . . . 1.67 115.489 -176.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 34.9 tttt -50.26 -38.36 40.45 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 125.175 1.39 . . . . 3.23 113.016 177.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -75.31 -18.44 60.03 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-O 121.514 0.673 . . . . 1.89 111.413 -177.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -88.72 -51.98 5.38 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 129.126 2.971 . . . . 2.43 110.991 177.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 32.9 mt -147.61 114.48 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 128.467 2.707 . . . . 2.17 108.327 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.4 tmtp? -92.28 -7.62 47.55 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 114.87 1.433 . . . . 4.91 114.87 -163.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -70.43 57.42 0.17 Allowed 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 129.681 3.192 . . . . 3.13 115.477 -164.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . 0.273 1.3 mpt? -75.84 3.63 9.62 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 119.311 -2.118 . . . . 3.07 116.483 -178.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 73.2 t60 -59.21 -30.28 68.11 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 121.235 -0.916 . . . . 6.01 112.371 151.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -83.56 -30.44 29.97 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 127.886 2.66 . . . . 0.66 116.457 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.0 mt -89.31 120.62 30.82 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 122.856 1.312 . . . . 3.32 111.415 -164.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 14.6 ttm180 -106.82 99.23 8.82 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 112.797 -2.001 . . . . 6.17 106.502 -179.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 1.4 mt -113.3 140.41 33.59 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.457 0 CA-C-O 122.845 1.307 . . . . 1.66 111.105 -165.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -135.14 117.21 15.37 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 111.907 -2.406 . . . . 3.37 107.445 -166.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 18.5 p -134.89 147.52 49.87 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.221 1.808 . . . . 1.54 110.145 -175.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.9 p -153.42 179.02 9.16 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.052 -1.431 . . . . 0.64 110.319 174.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 6.5 p -145.82 133.26 10.26 Favored Pre-proline 0 N--CA 1.469 0.481 0 O-C-N 121.572 -0.705 . . . . 1.67 111.801 -178.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo . . . . . 0 N--CA 1.448 -1.205 0 C-N-CA 122.721 2.281 . . . . 1.01 108.911 166.173 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.8 mp0 . . . . . 0 C--O 1.238 0.478 0 N-CA-C 115.228 1.566 . . . . 3.02 115.228 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 59.2 p -87.13 165.35 15.81 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 114.863 -1.062 . . . . 1.76 110.492 156.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -64.54 -27.68 69.13 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 120.936 -1.103 . . . . 4.29 111.875 168.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.54 -38.68 96.04 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 126.119 1.818 . . . . 0.5 113.379 170.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.79 -43.18 72.62 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.291 1.546 . . . . 2.13 112.014 174.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 11.7 mt -69.17 -52.04 31.97 Favored 'General case' 0 N--CA 1.462 0.129 0 C-N-CA 125.573 1.549 . . . . 1.77 111.005 178.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -53.48 -49.75 66.82 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 126.923 2.089 . . . . 4.33 110.874 178.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 38.1 t -67.4 -45.04 86.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 108.75 -0.833 . . . . 1.83 108.75 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 68.4 m -53.98 -43.55 70.05 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 118.511 0.596 . . . . 1.77 112.392 175.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -62.89 -43.65 98.21 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 118.593 0.633 . . . . 1.8 111.734 -176.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 53.2 mt -71.6 -29.86 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 123.312 0.645 . . . . 2.01 110.323 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 53.2 mt -64.93 -41.44 95.52 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 120.655 -1.278 . . . . 2.11 113.269 171.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 38.7 mttt -62.19 -19.43 63.11 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-N 119.544 1.066 . . . . 2.75 113.852 174.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -95.91 -37.95 10.48 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 126.315 1.846 . . . . 2.31 114.832 -178.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -78.38 -22.1 48.38 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 118.675 -0.678 . . . . 2.03 112.492 170.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -133.07 50.07 5.13 Favored Pre-proline 0 CA--C 1.548 0.902 0 N-CA-C 118.854 2.909 . . . . 2.67 118.854 -179.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -62.98 -26.42 74.08 Favored 'Trans proline' 0 CA--C 1.534 0.516 0 C-N-CA 123.48 2.786 . . . . 1.0 115.842 177.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 27.0 mmm180 -76.97 -12.85 60.0 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 120.387 1.449 . . . . 8.59 114.61 176.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -53.8 144.92 17.08 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.925 1.29 . . . . 1.53 114.159 -175.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 44.3 p -97.4 -22.5 16.57 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.473 1.109 . . . . 1.52 111.984 176.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -123.4 138.39 54.61 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.942 0.897 . . . . 1.65 110.321 157.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -154.35 105.97 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 124.841 1.256 . . . . 1.89 110.361 169.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.9 ptpt -150.05 154.75 38.68 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.025 1.33 . . . . 2.32 112.814 -179.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.9 t -129.95 148.27 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 126.785 2.034 . . . . 1.59 109.632 -178.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 55.2 m -135.42 132.91 38.06 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 118.465 0.575 . . . . 1.58 110.244 161.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -72.51 134.34 45.24 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 122.037 0.922 . . . . 1.79 109.767 167.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . 0.257 1.8 pt -127.7 33.39 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 125.57 1.548 . . . . 1.87 109.787 174.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.2 p -141.55 63.93 1.42 Allowed 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 127.087 2.155 . . . . 3.76 114.362 -177.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -58.03 -19.05 36.32 Favored Glycine 0 CA--C 1.543 1.819 0 N-CA-C 116.326 1.29 . . . . 1.25 116.326 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -108.86 -5.55 31.03 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 125.74 1.638 . . . . 1.01 116.63 -178.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 1.3 m -152.11 -15.86 0.18 Allowed 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 115.2 1.555 . . . . 2.91 115.2 -177.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 51.75 38.93 45.88 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 127.246 2.355 . . . . 0.81 114.995 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -110.76 6.5 21.53 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.116 1.366 . . . . 2.43 113.236 -175.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 15.0 ttm -140.48 121.07 14.22 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.714 2.006 . . . . 1.93 110.497 -161.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -143.36 146.33 33.43 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 113.815 1.043 . . . . 3.26 113.815 -174.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -90.88 114.15 26.52 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.901 1.68 . . . . 2.63 109.417 167.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 95.9 mt -120.55 123.66 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 O-C-N 120.762 -1.211 . . . . 1.77 109.565 -175.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 75.7 mttt -124.28 111.23 15.58 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.78 1.232 . . . . 3.47 110.254 -174.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.3 mt -120.46 155.26 23.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 127.445 2.298 . . . . 1.52 109.052 -178.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -153.66 130.49 10.89 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.186 1.394 . . . . 1.85 107.291 162.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.6 t -155.3 140.75 17.78 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 120.107 1.321 . . . . 0.37 112.352 -173.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -61.91 -6.6 2.91 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.621 1.568 . . . . 3.89 115.111 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -84.68 -14.58 48.06 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.733 1.613 . . . . 1.77 114.207 175.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -87.13 12.03 12.51 Favored 'General case' 0 CA--C 1.559 1.302 0 N-CA-C 114.37 1.248 . . . . 3.54 114.37 -175.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.252 0.0 OUTLIER -76.83 -14.62 59.89 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 117.225 2.305 . . . . 3.73 117.225 -166.476 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -118.29 25.33 10.38 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.341 1.456 . . . . 4.88 111.253 169.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 52.3 mmtt -112.61 131.36 55.66 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.544 1.538 . . . . 2.39 111.868 177.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 36.1 mtt180 -65.71 161.69 20.16 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.667 1.187 . . . . 4.48 111.071 163.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 54.1 m -38.04 -55.56 1.24 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 126.356 1.862 . . . . 1.84 113.799 168.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.5 p -63.86 -40.34 88.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 125.212 1.405 . . . . 2.29 113.598 178.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -71.92 -32.3 67.22 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 121.619 -0.675 . . . . 1.01 111.573 178.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -63.79 -53.45 50.62 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.568 0.747 . . . . 0.99 109.885 169.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 62.8 m170 -49.94 -52.35 34.06 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.796 0.838 . . . . 0.95 111.968 178.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 23.4 tp60 -46.9 -44.33 19.62 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.037 1.735 . . . . 1.32 113.134 178.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 85.0 mtp -62.33 -43.51 98.66 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 119.159 0.89 . . . . 1.86 112.516 178.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.6 t -71.7 -27.41 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 C-N-CA 125.647 1.579 . . . . 1.52 112.146 178.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -74.31 -50.67 17.87 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.525 1.93 . . . . 0.47 109.381 177.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 12.5 mm-40 -65.56 -18.66 65.49 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.378 1.471 . . . . 3.74 113.635 178.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.69 -44.67 85.99 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 119.337 0.971 . . . . 1.43 111.056 179.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.11 5.66 9.22 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 115.513 1.672 . . . . 1.76 115.513 -174.204 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.5 ttmt -51.67 -40.23 59.66 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 125.037 1.335 . . . . 4.29 113.136 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -81.68 10.32 6.31 Favored 'General case' 0 CA--C 1.554 1.126 0 CA-C-O 122.121 0.962 . . . . 2.4 113.347 -174.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -126.84 -56.26 1.37 Allowed 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 129.443 3.097 . . . . 3.12 108.652 -176.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -128.57 120.97 53.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 126.872 2.069 . . . . 2.99 108.371 165.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -105.75 1.69 27.28 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 119.919 -1.738 . . . . 3.44 114.812 -179.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.3 mp0 -71.88 47.01 0.14 Allowed 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 130.573 3.549 . . . . 3.25 115.332 -173.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . 0.254 2.1 mpt? -72.35 12.75 0.41 Allowed 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 116.703 2.112 . . . . 3.02 116.703 -173.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 39.8 p-80 -63.39 -28.4 69.96 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.366 -0.834 . . . . 5.63 112.083 154.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -77.94 -22.61 68.44 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 115.916 1.126 . . . . 0.65 115.916 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 10.1 mt -92.06 136.02 33.51 Favored 'General case' 0 C--O 1.238 0.463 0 O-C-N 120.813 -1.404 . . . . 3.29 111.222 -164.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 15.3 ttt180 -114.63 105.49 13.12 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.686 1.594 . . . . 4.44 106.896 169.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 1.5 mt -114.41 137.47 47.64 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.648 0 CA-C-O 123.098 1.427 . . . . 1.93 111.005 -169.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -130.54 123.72 30.24 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-N 111.769 -2.468 . . . . 3.26 106.628 -169.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 17.3 p -140.86 152.68 45.29 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 126.237 1.815 . . . . 1.52 109.217 -175.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -161.05 173.88 14.56 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.296 -0.866 . . . . 0.7 110.481 176.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 12.5 p -141.84 133.71 13.54 Favored Pre-proline 0 N--CA 1.468 0.467 0 O-C-N 121.329 -0.857 . . . . 1.69 111.962 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo . . . . . 0 N--CA 1.453 -0.874 0 C-N-CA 122.081 1.854 . . . . 1.0 110.615 174.698 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 . . . . . 0 CA--C 1.544 0.743 0 N-CA-C 115.128 1.529 . . . . 2.97 115.128 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 66.9 p -100.93 170.18 8.47 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 121.128 -0.982 . . . . 1.88 109.897 159.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 -70.07 -29.48 66.49 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 120.436 -1.415 . . . . 3.86 111.902 163.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -66.54 -38.14 93.15 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 124.282 0.944 . . . . 0.4 113.139 177.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.94 -44.27 50.39 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.449 1.499 . . . . 1.98 111.539 172.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.4 mt -70.26 -51.87 27.32 Favored 'General case' 0 C--N 1.337 0.046 0 C-N-CA 125.479 1.512 . . . . 1.63 110.747 -178.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.87 -48.93 76.97 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.904 1.682 . . . . 3.91 110.865 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.8 t -65.54 -45.25 93.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 108.435 -0.95 . . . . 1.56 108.435 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 98.7 m -56.92 -41.32 77.96 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 118.687 0.676 . . . . 1.42 112.411 176.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -63.86 -42.52 97.52 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 112.753 0.649 . . . . 2.04 112.753 -178.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 32.2 mt -75.45 -30.25 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 CA-C-N 118.629 0.649 . . . . 1.78 110.462 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 44.0 mt -60.14 -40.35 89.48 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 120.779 -1.2 . . . . 2.04 113.34 171.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 27.2 mttt -60.73 -24.95 66.09 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 119.338 0.972 . . . . 3.01 113.391 176.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -94.62 -35.38 12.24 Favored 'General case' 0 N--CA 1.434 -1.236 0 C-N-CA 126.895 2.078 . . . . 1.96 115.066 -178.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 56.8 mmtt -75.89 -22.77 55.79 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 119.735 -0.786 . . . . 2.46 111.856 170.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -130.19 51.39 7.45 Favored Pre-proline 0 CA--C 1.551 1.002 0 N-CA-C 118.428 2.751 . . . . 2.75 118.428 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -67.66 -18.88 48.28 Favored 'Trans proline' 0 CA--C 1.534 0.507 0 C-N-CA 124.457 3.438 . . . . 0.62 115.099 176.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.96 -5.01 58.9 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 114.861 1.43 . . . . 6.65 114.861 172.029 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.09 146.73 52.63 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 113.615 0.968 . . . . 1.53 113.615 -178.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 60.9 p -93.34 -32.76 14.16 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.331 -0.849 . . . . 1.75 111.06 172.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -117.63 137.88 52.34 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.046 0.938 . . . . 1.69 111.527 165.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -156.03 108.16 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 126.685 1.994 . . . . 1.78 109.919 171.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.1 ptpt -152.37 157.83 41.84 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.813 1.645 . . . . 1.93 113.618 178.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.3 t -132.67 151.68 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 126.051 1.74 . . . . 1.64 110.763 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 89.8 m -141.1 125.22 17.3 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 120.31 -1.493 . . . . 1.68 110.846 169.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -67.44 135.3 52.91 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.809 0.814 . . . . 1.77 109.838 168.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.3 pt -134.34 19.93 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 124.909 1.284 . . . . 1.77 111.76 178.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.3 t -123.05 83.42 2.12 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 127.316 2.246 . . . . 2.03 111.399 176.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -73.2 9.22 7.39 Favored Glycine 0 N--CA 1.476 1.363 0 O-C-N 120.325 -1.484 . . . . 1.85 115.212 -177.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -129.12 -12.98 2.48 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 126.452 1.977 . . . . 1.52 114.046 -175.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 7.2 t -151.41 -18.04 0.2 Allowed 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 118.575 1.187 . . . . 2.7 114.055 175.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 54.93 37.55 62.76 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 124.686 1.136 . . . . 0.9 111.984 -163.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -91.97 1.83 56.94 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.295 1.438 . . . . 1.8 113.184 178.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 1.4 mtp -134.31 141.46 46.94 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 126.179 1.792 . . . . 3.1 112.396 175.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -142.62 145.37 33.43 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 122.021 0.915 . . . . 3.35 112.363 173.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -80.86 133.74 35.64 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 125.897 1.679 . . . . 1.82 108.573 161.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.5 mt -137.34 122.7 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 CA-C-N 119.464 1.029 . . . . 1.83 108.911 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 70.3 mttt -124.73 112.05 16.28 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.29 1.036 . . . . 3.4 110.183 -175.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.3 mt -121.96 155.93 26.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 126.858 2.063 . . . . 1.53 109.061 -177.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -156.06 126.72 6.8 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.453 1.501 . . . . 2.06 107.598 165.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.4 t -156.84 147.93 22.0 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 119.932 1.242 . . . . 0.38 112.417 -173.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -57.48 -28.11 63.1 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.245 1.418 . . . . 4.02 113.019 -174.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -69.78 -18.22 63.47 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 115.039 1.496 . . . . 1.75 115.039 177.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -80.94 13.84 2.5 Favored 'General case' 0 CA--C 1.545 0.759 0 O-C-N 121.102 -0.999 . . . . 2.86 113.215 -176.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 50.7 pttt -78.74 -27.68 44.79 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.157 1.383 . . . . 3.76 113.348 176.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -109.11 33.7 4.13 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.12 1.768 . . . . 4.83 111.875 -167.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 65.4 mmtt -139.56 141.64 37.2 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 126.897 2.079 . . . . 2.75 111.407 -169.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 6.6 mmt180 -65.88 168.78 7.49 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.668 1.187 . . . . 4.31 110.872 162.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 94.7 m -54.97 -53.91 49.62 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 113.036 0.754 . . . . 1.83 113.036 170.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 10.1 p -57.4 -40.46 74.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 123.216 0.606 . . . . 2.14 111.681 176.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -68.64 -32.36 72.16 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.2 0.815 . . . . 2.47 113.2 178.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 -62.41 -52.08 65.0 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.556 1.071 . . . . 2.5 109.924 170.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 33.1 m170 -58.21 -50.08 74.8 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 118.944 0.793 . . . . 0.93 112.64 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -54.15 -40.95 67.9 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 124.706 1.202 . . . . 4.25 113.937 178.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 1.1 mmm -61.97 -34.6 76.44 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 120.403 1.456 . . . . 1.55 111.657 -178.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.1 t -79.32 -32.04 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 127.122 2.169 . . . . 1.75 111.347 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -67.7 -46.51 72.03 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.347 1.459 . . . . 0.89 111.312 170.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 55.0 tp60 -65.73 -25.76 67.44 Favored 'General case' 0 N--CA 1.445 -0.687 0 O-C-N 120.373 -1.454 . . . . 2.61 113.847 -177.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.87 -30.99 69.36 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.451 1.5 . . . . 1.63 112.521 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -127.13 1.14 6.48 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 115.492 1.664 . . . . 1.87 115.492 177.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 31.2 ttmt -46.54 -43.3 16.93 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.443 1.497 . . . . 2.81 112.413 175.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -81.74 -18.86 42.79 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-O 121.362 0.601 . . . . 2.17 111.509 -171.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -88.9 -49.52 6.75 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 127.995 2.518 . . . . 2.34 111.197 -178.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 51.0 mt -147.36 101.06 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 127.544 2.338 . . . . 2.43 108.115 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.3 ptmm? -79.21 -7.57 58.34 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 116.551 2.056 . . . . 3.39 116.551 -166.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -79.19 44.03 0.56 Allowed 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 130.074 3.35 . . . . 3.53 115.594 -165.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 4.2 mpp? -73.86 12.45 0.67 Allowed 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 117.651 2.463 . . . . 2.38 117.651 -168.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 68.6 t60 -53.78 -32.6 53.1 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 120.516 1.507 . . . . 5.77 112.337 168.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -75.65 -12.23 83.93 Favored Glycine 0 CA--C 1.522 0.475 0 N-CA-C 117.364 1.706 . . . . 0.7 117.364 -178.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 13.2 mt -88.25 133.71 33.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 122.787 1.279 . . . . 3.14 111.369 -162.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 19.9 ttm180 -120.0 85.49 2.39 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 126.901 2.081 . . . . 6.49 106.9 -172.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 1.6 mt -106.67 141.39 22.01 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 CA-C-O 123.905 1.812 . . . . 1.82 112.038 -163.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -135.87 125.43 25.21 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 111.515 -2.584 . . . . 3.46 107.513 -170.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 26.2 p -140.99 157.74 44.91 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 125.834 1.654 . . . . 1.6 109.077 -176.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 2.5 p -168.55 178.58 4.7 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.583 -1.189 . . . . 0.68 109.837 176.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.3 p -138.65 129.4 15.17 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 124.106 0.962 . . . . 1.56 112.022 -178.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo . . . . . 0 C--N 1.348 0.529 0 C-N-CA 124.079 3.186 . . . . 0.84 111.957 -175.617 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 12.0 mp0 . . . . . 0 CA--C 1.536 0.424 0 CA-C-O 121.551 0.691 . . . . 3.18 111.305 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 80.4 p -120.49 170.59 9.25 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 107.947 -1.131 . . . . 1.69 107.947 144.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -69.5 -22.6 63.59 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 120.919 -1.113 . . . . 2.87 112.068 166.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.36 -41.38 98.15 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 124.309 0.956 . . . . 0.41 112.574 169.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.72 -46.22 40.47 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.681 1.593 . . . . 1.32 111.681 171.099 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.6 mt -68.6 -52.47 31.26 Favored 'General case' 0 C--N 1.339 0.113 0 C-N-CA 125.085 1.354 . . . . 1.62 111.225 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -56.59 -50.18 72.71 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.375 1.47 . . . . 4.1 110.824 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.7 t -60.3 -46.74 94.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 107.757 -1.201 . . . . 1.6 107.757 179.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 63.3 m -57.92 -41.22 82.24 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 118.417 0.553 . . . . 1.72 112.358 177.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 -60.55 -45.62 93.23 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 123.28 0.632 . . . . 1.77 111.396 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 42.9 mt -76.87 -27.29 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 117.871 0.305 . . . . 2.07 110.433 -175.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 19.0 mt -58.73 -39.0 79.6 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.077 -1.014 . . . . 1.48 112.831 168.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 37.6 mttt -65.35 -19.9 66.15 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 113.794 1.035 . . . . 2.27 113.794 175.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -102.39 -34.83 9.03 Favored 'General case' 0 N--CA 1.436 -1.166 0 C-N-CA 126.776 2.03 . . . . 2.24 114.532 -174.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 26.6 mmtp -75.97 -30.79 58.73 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 120.038 -0.665 . . . . 4.14 111.039 167.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -128.14 50.57 5.74 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 118.351 2.722 . . . . 2.68 118.351 -176.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -60.47 -27.61 85.16 Favored 'Trans proline' 0 C--O 1.236 0.409 0 C-N-CA 123.134 2.556 . . . . 0.84 114.297 174.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 31.7 mmt180 -74.86 -9.24 58.36 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 114.079 1.14 . . . . 5.89 114.079 179.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.59 152.37 15.19 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 115.579 1.696 . . . . 1.74 115.579 -173.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 42.8 p -104.27 -5.68 21.63 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 127.259 2.223 . . . . 1.66 113.148 168.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -143.16 143.88 31.98 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 119.932 1.242 . . . . 1.8 111.814 153.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.9 pt -155.15 116.14 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 126.753 2.021 . . . . 1.79 111.069 169.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 7.9 ptpt -161.03 153.5 20.49 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.481 1.512 . . . . 2.07 112.782 179.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.5 t -134.54 143.49 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 126.218 1.807 . . . . 1.56 110.483 -175.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 64.2 m -133.76 125.14 27.9 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.839 1.656 . . . . 1.87 110.805 173.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -75.27 132.86 41.33 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 122.304 1.05 . . . . 1.82 111.526 171.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.4 pt -133.84 26.8 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 C-N-CA 126.295 1.838 . . . . 1.5 110.898 178.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 46.8 t -134.2 69.91 1.46 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 126.879 2.072 . . . . 1.95 112.696 176.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -54.06 -25.13 30.53 Favored Glycine 0 CA--C 1.54 1.609 0 N-CA-C 116.074 1.19 . . . . 1.5 116.074 -179.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -88.35 -17.67 56.79 Favored Glycine 0 CA--C 1.534 1.28 0 CA-C-N 119.118 1.459 . . . . 1.54 116.194 -176.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 9.8 m -154.86 -32.46 0.1 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.792 1.237 . . . . 2.23 114.127 -164.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 64.99 47.1 86.35 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 125.426 1.489 . . . . 0.87 112.987 -166.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -98.15 -1.6 41.87 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 126.402 1.881 . . . . 1.46 114.098 176.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 15.6 mtm -136.96 138.8 40.97 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 126.151 1.781 . . . . 2.75 110.88 177.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -143.75 146.51 33.19 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.701 0.8 . . . . 3.24 111.781 172.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -94.91 130.08 41.68 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.61 1.564 . . . . 2.39 109.561 169.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 80.4 mt -137.65 129.33 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.879 0.872 . . . . 1.92 110.636 -167.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 60.0 mttt -115.75 125.12 52.37 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.94 0.896 . . . . 4.87 110.272 173.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.2 mt -129.21 155.18 41.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 C-N-CA 125.482 1.513 . . . . 1.61 109.877 173.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -158.35 133.23 8.4 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 120.059 -1.651 . . . . 2.01 109.31 171.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 19.6 t -162.4 147.1 12.26 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 119.911 1.232 . . . . 0.45 112.21 -174.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -53.91 -28.83 39.21 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.382 1.473 . . . . 4.77 113.014 -179.018 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -65.7 -20.32 66.24 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 115.237 1.569 . . . . 1.82 115.237 177.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -84.43 2.1 42.32 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 115.104 1.52 . . . . 3.48 115.104 -168.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 16.4 pttm -69.34 -47.35 64.63 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-O 121.819 0.819 . . . . 3.99 112.079 -176.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -84.2 35.29 0.53 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 128.842 2.857 . . . . 4.18 111.455 -170.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 49.0 mmtt -140.11 140.35 36.02 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 127.892 2.477 . . . . 2.4 110.754 -172.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 49.5 mtt180 -68.13 172.42 5.74 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.537 0.735 . . . . 4.57 111.404 163.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 37.3 m -51.41 -54.41 26.93 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.671 0.789 . . . . 2.02 112.852 168.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 10.9 p -57.23 -37.68 57.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 124.312 1.045 . . . . 1.74 112.701 176.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -80.59 -32.3 36.52 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 113.128 0.788 . . . . 1.19 113.128 -177.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -61.94 -50.26 72.84 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 119.904 1.229 . . . . 0.84 109.846 168.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 50.8 m170 -55.75 -49.73 72.32 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 122.912 0.485 . . . . 0.86 111.629 177.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 47.4 tp60 -46.88 -45.1 20.2 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.706 2.002 . . . . 1.37 112.937 -178.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 71.9 mtp -62.34 -43.26 99.24 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.998 0.919 . . . . 1.64 112.189 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.0 t -74.03 -27.23 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 126.612 1.965 . . . . 1.47 112.097 178.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -71.98 -50.04 32.08 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 126.003 1.721 . . . . 0.56 108.751 176.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 15.3 mm-40 -65.88 -24.38 66.84 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.621 1.168 . . . . 3.58 112.806 179.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -56.44 -37.17 69.87 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.398 1.079 . . . . 1.67 112.568 -176.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -127.79 4.62 6.04 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 115.236 1.569 . . . . 1.61 115.236 -179.054 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 16.4 ttmt -50.73 -34.9 28.84 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.827 1.251 . . . . 4.05 113.309 -178.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -74.05 -29.92 62.14 Favored 'General case' 0 N--CA 1.439 -1.025 0 O-C-N 121.484 -0.76 . . . . 2.58 111.78 -177.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.23 -58.42 3.29 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 127.944 2.498 . . . . 2.71 111.995 175.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 34.7 mt -136.97 123.88 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 125.778 1.631 . . . . 2.17 107.868 178.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -90.75 -12.04 37.73 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 115.005 1.483 . . . . 3.6 115.005 -166.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -85.77 67.19 9.96 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 126.182 1.793 . . . . 3.53 113.752 -156.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . 0.272 0.8 OUTLIER -74.35 -4.0 33.7 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 115.71 1.745 . . . . 3.03 115.71 176.844 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 67.2 t60 -55.76 -24.52 35.86 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 121.61 -0.681 . . . . 5.62 112.786 153.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -88.2 -27.0 26.84 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 127.424 2.44 . . . . 0.83 116.146 177.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.0 mt -90.5 134.5 34.32 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 121.895 -0.768 . . . . 3.47 111.622 -166.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 27.0 ttt180 -117.08 92.68 3.92 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.837 1.655 . . . . 3.97 108.527 -176.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -114.03 135.12 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-O 123.094 1.426 . . . . 1.79 113.198 -159.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -131.36 91.22 2.98 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 112.897 -1.956 . . . . 3.38 109.917 -164.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.1 p -99.64 152.34 20.16 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.988 1.715 . . . . 1.7 111.895 178.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.2 p -156.39 -179.42 8.15 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 125.716 1.606 . . . . 0.75 110.614 174.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.5 p -143.27 132.04 11.43 Favored Pre-proline 0 N--CA 1.476 0.834 0 O-C-N 121.5 -0.75 . . . . 1.74 112.725 -179.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo . . . . . 0 C--N 1.351 0.685 0 C-N-CA 124.327 3.351 . . . . 0.87 112.294 -176.511 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 . . . . . 0 N--CA 1.469 0.501 0 CA-C-O 120.794 0.331 . . . . 2.96 111.255 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 69.3 p -110.7 179.05 4.17 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.764 1.226 . . . . 1.67 109.957 160.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -71.02 -30.27 66.43 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 120.86 -1.15 . . . . 3.37 111.951 161.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.21 -38.14 82.0 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 124.8 1.191 . . . . 0.44 114.119 -178.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.53 -45.28 37.19 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.638 1.575 . . . . 1.22 111.575 174.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 15.0 mt -69.42 -52.82 23.25 Favored 'General case' 0 CA--C 1.522 -0.125 0 C-N-CA 125.68 1.592 . . . . 1.7 110.945 -178.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.9 tpt180 -56.38 -49.64 73.88 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 125.419 1.487 . . . . 6.29 111.585 -178.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 37.1 t -65.57 -42.17 92.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 107.827 -1.175 . . . . 1.89 107.827 -179.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 87.1 m -57.99 -38.49 76.2 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 118.547 0.612 . . . . 1.48 112.318 174.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 -63.06 -40.86 98.95 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 113.498 0.925 . . . . 1.74 113.498 -177.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 16.4 mt -81.32 -30.79 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 118.363 0.529 . . . . 2.14 110.34 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 45.5 mt -51.95 -38.33 56.08 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 114.372 1.249 . . . . 2.1 114.372 169.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 57.0 mttt -59.65 -31.05 69.17 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 124.962 1.305 . . . . 3.84 113.912 178.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -93.69 -32.02 14.21 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 127.616 2.366 . . . . 2.4 113.794 -174.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 59.9 mmtt -75.32 -26.55 58.74 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 119.805 -0.758 . . . . 2.87 111.086 168.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -128.45 55.47 17.52 Favored Pre-proline 0 CA--C 1.55 0.959 0 N-CA-C 117.897 2.554 . . . . 2.76 117.897 -177.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -68.83 -19.28 41.0 Favored 'Trans proline' 0 CA--C 1.534 0.489 0 C-N-CA 123.947 3.098 . . . . 0.81 113.993 168.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 76.4 mtt180 -79.46 -2.61 42.75 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 114.601 1.334 . . . . 7.29 114.601 174.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.25 158.38 33.46 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 115.727 1.751 . . . . 1.89 115.727 -170.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 64.2 p -118.09 -15.77 9.85 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.97 1.308 . . . . 1.89 112.651 168.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -131.66 141.72 49.67 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.914 0.885 . . . . 1.72 111.727 152.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.0 pt -149.79 117.96 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 126.084 1.754 . . . . 1.92 110.661 161.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 11.4 ptpt -152.8 155.01 36.31 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.86 1.264 . . . . 2.48 112.285 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.7 t -135.78 144.88 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 126.281 1.833 . . . . 1.61 110.398 -176.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 94.4 m -136.77 128.61 29.1 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.317 0.647 . . . . 1.48 110.646 171.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -73.14 123.74 24.21 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.589 0.756 . . . . 2.01 109.604 165.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.3 pt -122.18 27.2 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 125.001 1.321 . . . . 1.76 110.574 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 36.6 t -136.32 65.55 1.52 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 127.189 2.196 . . . . 2.16 111.001 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.37 0.6 2.66 Favored Glycine 0 CA--C 1.54 1.607 0 N-CA-C 117.227 1.651 . . . . 1.6 117.227 -176.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -131.72 4.13 5.4 Favored Glycine 0 CA--C 1.538 1.521 0 C-N-CA 125.687 1.613 . . . . 1.54 115.131 176.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 4.4 t -147.97 -27.35 0.34 Allowed 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 118.614 1.207 . . . . 2.52 113.979 175.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 59.09 33.14 73.19 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 127.138 2.304 . . . . 1.0 114.316 -170.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -84.31 -28.27 27.23 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 118.291 1.046 . . . . 2.14 113.516 178.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -106.49 140.54 39.23 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 125.052 1.341 . . . . 2.29 113.017 -179.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -142.64 145.68 33.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.751 -1.113 . . . . 3.18 111.605 170.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -83.58 138.66 33.28 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 125.101 1.36 . . . . 1.78 109.288 162.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 93.9 mt -133.95 126.83 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.189 0.996 . . . . 1.7 108.939 169.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 67.8 mttt -124.59 122.22 36.94 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.555 1.142 . . . . 3.5 110.127 178.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.6 mt -126.25 158.66 35.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 125.869 1.668 . . . . 1.92 109.296 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -151.89 130.17 12.02 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 126.293 1.837 . . . . 1.86 106.257 160.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 21.2 t -154.35 139.55 17.51 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 118.745 0.702 . . . . 0.36 110.683 -176.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -58.32 -18.3 26.23 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.32 1.448 . . . . 3.23 114.525 -177.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -74.23 -19.72 60.42 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.311 1.444 . . . . 1.69 114.529 177.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -82.84 10.91 6.74 Favored 'General case' 0 CA--C 1.555 1.17 0 N-CA-C 116.123 1.898 . . . . 2.85 116.123 -169.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 22.6 pttt -65.26 -46.85 78.85 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 127.059 2.144 . . . . 2.86 115.754 -165.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -92.4 -20.7 20.76 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 126.799 2.04 . . . . 5.11 112.353 -175.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 66.7 mmtt -58.82 142.91 49.05 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.567 1.147 . . . . 2.03 113.083 177.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 9.8 mmp_? -69.12 168.82 13.16 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 125.52 1.528 . . . . 7.77 111.148 163.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.6 m -46.76 -56.86 5.52 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.424 0.69 . . . . 1.99 112.606 170.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.7 p -58.8 -41.73 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 125.235 1.414 . . . . 2.14 112.633 178.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -76.0 -23.08 55.22 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 118.703 -0.665 . . . . 1.28 112.496 -177.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -68.63 -58.05 4.83 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 119.634 1.107 . . . . 0.79 109.925 164.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 32.5 m170 -56.14 -43.87 78.66 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.618 0.767 . . . . 0.64 112.788 -177.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 50.9 tp60 -53.31 -40.6 64.9 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.325 1.45 . . . . 1.36 113.086 178.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 2.6 mtm -64.04 -39.57 94.38 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 119.649 1.113 . . . . 1.51 111.283 178.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.3 t -73.18 -28.42 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 125.497 1.519 . . . . 1.48 111.775 177.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -71.58 -48.2 49.93 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.644 1.578 . . . . 0.6 110.812 174.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.14 -22.32 66.89 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 120.736 -1.227 . . . . 3.53 112.384 177.03 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.28 -22.07 66.82 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 113.704 1.001 . . . . 1.42 113.704 -177.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -132.69 -1.95 3.39 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 114.604 1.335 . . . . 1.92 114.604 173.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 36.3 tttt -47.02 -41.74 17.02 Favored 'General case' 0 C--N 1.344 0.327 0 C-N-CA 124.682 1.193 . . . . 4.51 111.62 173.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -76.29 -3.15 35.12 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 123.913 0.885 . . . . 3.08 112.761 -173.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -105.89 -51.54 2.97 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 128.288 2.635 . . . . 3.27 111.677 170.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 5.6 mt -143.33 126.88 13.61 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.371 0 C-N-CA 128.575 2.75 . . . . 2.92 106.648 -178.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -94.63 -22.46 18.15 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.174 -0.954 . . . . 4.88 113.196 -175.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -74.61 78.56 1.99 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.463 1.505 . . . . 3.75 113.018 -174.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 4.2 mpp? -82.38 13.46 3.58 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.936 1.295 . . . . 2.09 114.368 177.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 80.8 t60 -63.8 -34.29 77.59 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 120.624 -1.297 . . . . 5.77 114.082 -177.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -84.5 -11.94 76.56 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 126.218 1.866 . . . . 0.89 113.901 174.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.3 mp -86.47 139.13 31.18 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.427 1.091 . . . . 2.96 111.917 -172.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 16.7 ttm180 -126.99 99.36 5.69 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 126.272 1.829 . . . . 6.31 109.85 -169.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 3.6 mt -108.94 145.62 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-O 122.945 1.355 . . . . 1.64 113.306 -167.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -144.39 134.6 24.27 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 127.93 2.492 . . . . 3.46 109.31 -170.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 16.4 p -150.8 153.14 34.88 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 127.847 2.459 . . . . 1.52 109.397 -170.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.67 172.34 18.69 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 124.922 1.289 . . . . 0.66 110.045 175.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 8.9 p -136.97 125.87 15.16 Favored Pre-proline 0 N--CA 1.473 0.679 0 N-CA-C 113.661 0.985 . . . . 1.59 113.661 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo . . . . . 0 N--CA 1.449 -1.101 0 C-N-CA 123.211 2.607 . . . . 0.77 110.763 170.962 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 . . . . . 0 N--CA 1.471 0.595 0 N-CA-C 112.09 0.404 . . . . 3.09 112.09 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 80.8 p -120.92 176.14 5.7 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.526 1.53 . . . . 2.03 111.324 165.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 -66.04 -31.12 71.82 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 120.169 -1.582 . . . . 4.17 112.048 160.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.14 -46.13 95.13 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 125.565 1.555 . . . . 0.55 112.603 177.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.34 -47.24 47.42 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.469 1.507 . . . . 1.28 112.179 177.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 11.7 mt -72.24 -47.65 48.7 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.075 1.35 . . . . 1.75 111.716 -179.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -56.03 -50.44 70.9 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 126.381 1.873 . . . . 3.8 111.117 177.439 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 50.2 t -60.1 -46.21 94.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 107.945 -1.132 . . . . 1.5 107.945 178.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 37.6 m -59.41 -39.14 82.5 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 118.974 -0.536 . . . . 1.45 112.438 179.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 7.9 mm-40 -60.48 -40.96 93.19 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 118.88 0.764 . . . . 2.0 112.43 178.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 49.0 mt -81.63 -28.16 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 123.129 0.572 . . . . 1.63 110.63 -177.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 18.0 mt -59.66 -40.31 87.32 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 120.722 -1.236 . . . . 1.66 112.83 168.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 46.5 mttt -63.55 -23.31 67.33 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 119.423 1.01 . . . . 2.09 113.383 177.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -96.4 -35.51 11.15 Favored 'General case' 0 N--CA 1.434 -1.265 0 C-N-CA 126.937 2.095 . . . . 2.09 114.803 -177.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 64.3 mmtt -74.17 -27.75 60.97 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 118.176 -0.916 . . . . 2.19 111.125 167.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -127.29 51.44 6.63 Favored Pre-proline 0 CA--C 1.551 0.995 0 N-CA-C 117.347 2.351 . . . . 2.66 117.347 -178.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -64.75 -14.0 42.39 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 125.171 3.914 . . . . 0.76 115.04 176.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 32.5 mmt180 -83.31 -14.98 51.83 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.955 1.465 . . . . 5.72 114.955 170.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.62 143.14 47.32 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 116.728 2.122 . . . . 1.52 116.728 -166.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 77.8 p -96.89 -24.85 15.67 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.922 0.889 . . . . 1.54 112.64 175.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -126.28 140.42 52.54 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.838 0.855 . . . . 1.57 111.743 161.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.3 pt -155.77 117.8 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 126.292 1.837 . . . . 1.8 110.582 173.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.2 ptpt -152.44 155.84 38.32 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.459 1.504 . . . . 2.45 112.408 173.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.1 t -132.15 143.24 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 125.98 1.712 . . . . 1.62 109.9 177.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 74.6 m -136.53 123.64 21.65 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 118.46 0.573 . . . . 1.71 111.72 173.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -65.59 128.05 34.37 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 108.528 -0.916 . . . . 1.97 108.528 165.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.9 pt -127.53 33.1 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 125.859 1.663 . . . . 1.63 109.499 178.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.6 t -145.98 57.46 1.21 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 128.138 2.575 . . . . 1.9 110.828 -173.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.21 -0.85 0.33 Allowed Glycine 0 CA--C 1.541 1.711 0 C-N-CA 126.681 2.086 . . . . 1.31 117.889 -178.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -144.54 24.25 2.0 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 126.488 1.994 . . . . 1.43 113.505 -178.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -162.99 -27.77 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.565 1.546 . . . . 2.4 112.901 172.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 53.41 39.87 60.32 Favored Glycine 0 CA--C 1.536 1.362 0 C-N-CA 127.277 2.37 . . . . 0.63 114.707 -173.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -96.7 -34.79 11.23 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.976 1.31 . . . . 1.66 113.716 178.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 8.9 mtm -96.23 138.42 33.86 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 124.183 0.993 . . . . 2.41 111.525 177.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -142.63 144.88 32.99 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.019 0.928 . . . . 3.27 112.759 172.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -82.29 137.99 34.68 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 126.289 1.836 . . . . 2.34 109.215 165.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 92.2 mt -136.19 125.15 38.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.017 0.927 . . . . 1.75 109.507 169.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 64.4 mttt -123.89 114.62 20.07 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.47 1.108 . . . . 3.49 109.957 177.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.2 mt -122.92 157.56 28.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 126.535 1.934 . . . . 1.68 109.653 -177.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -154.93 132.91 11.57 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.756 1.623 . . . . 1.73 108.265 163.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 33.2 t -158.6 140.53 13.79 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 119.277 0.944 . . . . 0.39 110.515 -174.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -58.16 -19.81 35.88 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 114.311 1.226 . . . . 2.92 114.311 -177.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -72.01 -19.65 61.83 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.052 1.341 . . . . 1.75 114.387 179.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -79.44 13.28 2.04 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 114.165 1.172 . . . . 3.0 114.165 -171.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 42.6 pttt -77.69 -42.13 35.59 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 113.226 0.825 . . . . 3.22 113.226 -172.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -81.4 38.8 0.5 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.342 1.057 . . . . 3.78 112.739 -177.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 61.5 mmtt -138.44 144.75 40.28 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 126.164 1.786 . . . . 2.61 111.886 -171.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 55.4 mtt180 -71.98 167.24 20.55 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 124.226 1.01 . . . . 4.73 111.144 154.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 95.6 m -43.39 -56.03 3.8 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 126.136 1.774 . . . . 1.68 113.216 166.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.5 p -59.07 -42.63 87.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.92 1.288 . . . . 1.87 113.264 175.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -74.68 -23.31 58.61 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 118.578 -0.725 . . . . 1.31 112.381 -177.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -67.78 -54.69 17.14 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 119.728 1.149 . . . . 0.91 110.241 163.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 36.6 m170 -49.94 -51.29 42.32 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.068 0.947 . . . . 0.69 112.102 -179.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 15.5 tp60 -47.37 -44.17 23.9 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.082 1.353 . . . . 1.42 113.541 178.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 76.5 mtp -61.91 -43.92 97.85 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 119.334 0.97 . . . . 1.62 111.467 -177.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.1 t -72.62 -28.28 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 126.579 1.952 . . . . 1.45 111.226 179.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -72.5 -50.07 28.51 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.924 1.69 . . . . 0.48 109.679 176.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.8 mm-40 -65.01 -20.13 66.35 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.738 1.215 . . . . 3.16 113.355 178.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.94 -43.53 86.39 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 118.707 0.685 . . . . 1.69 111.398 178.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.55 5.65 9.54 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 115.132 1.53 . . . . 1.65 115.132 -174.245 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.9 ttmt -52.43 -38.18 58.53 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 125.034 1.333 . . . . 3.89 112.89 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -76.2 -26.08 55.79 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 112.92 0.711 . . . . 3.02 112.92 -178.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -78.9 -60.73 2.26 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.502 1.921 . . . . 3.39 110.647 175.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 42.5 mt -135.22 103.44 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 126.393 1.877 . . . . 2.14 108.361 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 14.1 ptpt -79.61 -17.38 53.97 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 115.428 1.64 . . . . 3.17 115.428 -169.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 19.7 mp0 -67.14 47.78 0.04 OUTLIER 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 130.227 3.411 . . . . 3.32 116.269 -171.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 4.2 mpp? -62.65 -2.1 1.02 Allowed 'General case' 0 N--CA 1.476 0.865 0 O-C-N 119.31 -2.118 . . . . 2.1 115.21 177.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 2.6 p80 -58.05 -29.82 65.69 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 119.419 1.009 . . . . 4.43 113.34 162.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -85.49 -23.39 47.44 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 124.862 1.22 . . . . 0.52 113.495 177.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.6 mp -83.19 143.3 30.57 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 122.401 1.096 . . . . 2.61 112.386 -169.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 24.1 ttt180 -118.88 95.93 5.03 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 127.258 2.223 . . . . 3.4 108.511 -175.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 2.7 mt -110.14 138.31 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 CA-C-O 123.66 1.695 . . . . 1.76 113.528 -168.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -137.76 127.09 24.71 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-N 111.116 -2.765 . . . . 3.33 108.494 -169.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 12.4 p -145.51 154.44 42.2 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.123 1.769 . . . . 1.61 108.955 -173.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.2 p -160.94 173.24 15.57 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.475 -1.238 . . . . 0.67 110.309 176.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.4 p -138.9 123.74 11.71 Favored Pre-proline 0 C--O 1.237 0.445 0 N-CA-C 112.649 0.611 . . . . 1.65 112.649 -177.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo . . . . . 0 N--CA 1.448 -1.205 0 C-N-CA 122.934 2.422 . . . . 0.88 108.431 169.569 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 . . . . . 0 CA--C 1.542 0.667 0 CA-C-O 122.583 1.182 . . . . 3.15 113.177 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 56.6 p -121.32 178.79 4.64 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.053 1.741 . . . . 1.79 110.022 169.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -70.08 -27.92 65.01 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.046 -1.033 . . . . 3.26 111.491 160.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -71.79 -39.8 59.17 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 125.622 1.582 . . . . 0.43 114.105 -178.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.29 -44.18 43.87 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 119.449 1.625 . . . . 2.0 111.334 174.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 8.9 mt -68.52 -56.18 9.21 Favored 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 125.987 1.715 . . . . 1.53 110.67 178.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.58 -46.65 77.22 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.235 1.014 . . . . 3.75 111.555 -178.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.8 t -61.65 -48.01 90.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 107.972 -1.122 . . . . 1.8 107.972 178.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 52.9 m -57.31 -43.97 83.73 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 118.645 0.657 . . . . 1.7 112.059 176.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -61.99 -28.81 69.83 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.339 1.456 . . . . 2.85 113.262 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 64.4 mt -90.49 -29.19 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 124.532 1.133 . . . . 1.75 111.702 173.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.6 mt -56.94 -36.69 70.54 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 120.321 -1.487 . . . . 2.09 112.754 172.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 38.0 mttt -63.67 -17.33 62.84 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 115.004 1.483 . . . . 2.52 115.004 177.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -106.56 -37.73 6.37 Favored 'General case' 0 N--CA 1.429 -1.508 0 C-N-CA 125.987 1.715 . . . . 1.94 113.576 -172.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -77.34 -23.62 50.9 Favored 'General case' 0 N--CA 1.453 -0.311 0 O-C-N 123.538 0.524 . . . . 2.13 111.99 166.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -133.99 52.4 8.01 Favored Pre-proline 0 CA--C 1.546 0.795 0 N-CA-C 117.702 2.482 . . . . 2.69 117.702 -179.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -61.73 -22.68 74.94 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 123.585 2.857 . . . . 0.74 113.547 166.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 19.1 mtm180 -67.91 -15.04 63.43 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 114.654 1.353 . . . . 8.6 114.654 174.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.84 144.74 47.36 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 114.45 1.278 . . . . 1.5 114.45 -164.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 65.3 p -96.27 -19.66 19.12 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.938 0.895 . . . . 1.96 112.551 174.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -130.77 142.23 50.4 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.202 1.001 . . . . 1.4 111.975 159.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.4 pt -155.5 111.4 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 126.662 1.985 . . . . 1.6 111.359 172.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.6 ptpt -154.22 150.14 27.75 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.006 1.322 . . . . 2.14 112.71 -178.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.4 t -131.88 143.25 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 C-N-CA 125.818 1.647 . . . . 1.66 110.512 -173.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 77.6 m -135.34 129.71 33.87 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.825 1.25 . . . . 1.52 112.1 172.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -78.94 132.68 36.81 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.11 0.964 . . . . 1.76 110.457 170.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.7 pt -130.58 28.24 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 125.843 1.657 . . . . 1.71 111.285 179.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 41.6 t -139.13 63.72 1.5 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 127.625 2.37 . . . . 1.96 110.981 -176.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.98 -9.06 12.19 Favored Glycine 0 CA--C 1.54 1.641 0 N-CA-C 117.086 1.594 . . . . 1.19 117.086 -176.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -115.9 3.67 20.98 Favored Glycine 0 CA--C 1.537 1.456 0 C-N-CA 126.363 1.935 . . . . 1.09 115.331 179.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 37.0 t -155.32 -38.37 0.09 Allowed 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 118.631 1.215 . . . . 2.67 113.087 -176.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 64.58 36.45 93.17 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 127.026 2.251 . . . . 0.69 113.754 -169.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -85.02 -23.05 28.81 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 114.007 1.114 . . . . 2.09 114.007 173.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 1.2 mpp? -112.82 140.41 47.63 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.176 0.99 . . . . 2.44 113.56 -176.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -143.52 144.99 32.21 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 122.154 0.978 . . . . 3.23 113.144 173.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -98.46 120.15 38.39 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.009 1.724 . . . . 2.52 109.653 169.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 68.2 mt -132.07 129.54 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 124.684 1.194 . . . . 2.05 109.833 -163.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 67.9 mttt -125.45 125.66 43.69 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.62 0.768 . . . . 3.15 110.628 179.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.2 mt -129.49 157.95 42.14 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 127.589 2.356 . . . . 1.77 108.774 178.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 71.5 tt0 -157.14 128.61 6.95 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.774 1.63 . . . . 1.65 108.325 168.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 9.1 t -162.54 147.74 12.31 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 120.301 1.41 . . . . 0.41 114.05 -169.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -59.07 -24.6 63.04 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 126.049 1.74 . . . . 4.55 113.929 -172.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -73.57 -16.18 61.26 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.56 1.544 . . . . 1.8 115.086 177.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -83.51 -2.59 56.31 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 114.509 1.3 . . . . 3.55 114.509 -171.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 21.2 pttm -69.75 -42.09 74.35 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 113.505 0.928 . . . . 4.06 113.505 -178.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -91.58 41.44 1.07 Allowed 'General case' 0 CA--C 1.547 0.847 0 CA-C-O 123.018 1.389 . . . . 4.09 111.143 -170.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.9 mmtp -146.31 142.49 28.35 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 128.225 2.61 . . . . 4.12 109.572 -166.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 10.7 mmt85 -64.39 166.91 7.54 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.697 1.199 . . . . 4.3 110.583 158.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 55.0 m -53.19 -51.09 63.2 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 113.801 1.038 . . . . 1.78 113.801 168.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 14.7 p -63.47 -34.67 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 112.616 0.598 . . . . 1.87 112.616 177.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -65.22 -44.98 86.53 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 118.117 -0.945 . . . . 2.61 111.667 173.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -58.04 -51.42 69.73 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 119.291 0.95 . . . . 0.78 110.202 174.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 40.0 m170 -56.08 -50.01 72.21 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 123.405 0.682 . . . . 0.55 111.371 178.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 32.6 tp60 -53.07 -39.84 63.59 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.771 1.228 . . . . 1.53 112.875 -177.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 85.4 mtp -59.36 -47.11 86.67 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 119.752 1.16 . . . . 1.78 111.973 177.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.7 t -70.21 -32.19 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 126.009 1.723 . . . . 1.83 111.41 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -65.55 -52.29 53.52 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.128 1.771 . . . . 0.58 109.942 173.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 8.2 tm0? -66.98 -26.44 66.81 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.328 1.051 . . . . 3.15 113.161 -176.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -56.73 -39.09 73.32 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.712 1.605 . . . . 1.55 112.27 -179.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.64 -0.57 10.21 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 114.315 1.228 . . . . 1.87 114.315 -178.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 25.6 ttpt -52.5 -33.26 44.19 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.549 1.139 . . . . 2.64 112.805 175.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -81.81 -3.14 53.21 Favored 'General case' 0 CA--C 1.553 1.067 0 O-C-N 121.335 -0.853 . . . . 1.9 112.564 -178.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -104.61 -54.76 2.46 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 127.496 2.318 . . . . 3.18 111.435 169.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 32.6 mt -138.31 119.9 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 126.775 2.03 . . . . 1.86 108.494 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 41.5 mtmt -90.97 -1.43 57.83 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 115.012 1.486 . . . . 3.81 115.012 -169.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -81.58 58.61 3.78 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.379 1.872 . . . . 3.04 114.676 -158.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . 0.3 1.3 mpt? -75.28 9.52 2.04 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 119.779 -1.826 . . . . 3.0 115.477 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 13.7 p80 -65.01 -26.4 68.27 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.46 0.541 . . . . 5.29 112.46 153.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -94.77 -17.98 36.49 Favored Glycine 0 C--N 1.333 0.414 0 C-N-CA 126.455 1.979 . . . . 0.6 115.986 -175.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.8 mt -93.33 124.1 37.08 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 117.732 0.766 . . . . 3.26 110.875 -165.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 22.0 ttt180 -110.14 89.13 2.93 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 126.363 1.865 . . . . 4.08 107.347 -177.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 1.1 mt -108.69 139.99 29.05 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.565 0 CA-C-O 123.037 1.399 . . . . 1.81 111.743 -163.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -131.5 121.08 23.89 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 111.777 -2.465 . . . . 3.34 108.115 -169.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 24.4 p -131.93 153.96 49.76 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 126.268 1.827 . . . . 1.64 110.196 -179.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -160.49 179.76 8.34 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 126.114 1.766 . . . . 1.05 109.135 171.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.7 p -136.73 135.91 20.91 Favored Pre-proline 0 N--CA 1.474 0.748 0 O-C-N 120.897 -1.127 . . . . 1.52 111.98 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo . . . . . 0 C--N 1.351 0.676 0 C-N-CA 124.52 3.48 . . . . 0.96 111.402 -179.262 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.8 mp0 . . . . . 0 N--CA 1.471 0.602 0 N-CA-C 114.439 1.274 . . . . 2.98 114.439 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 72.8 p -121.04 179.51 4.36 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 126.257 1.823 . . . . 1.77 110.278 157.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.41 -32.7 71.87 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 120.941 -1.1 . . . . 3.68 112.357 164.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.14 -38.4 96.47 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 125.183 1.373 . . . . 0.45 112.949 174.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.71 -45.66 63.64 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.879 1.272 . . . . 1.49 112.369 176.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 13.1 mt -71.21 -49.87 38.98 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 125.008 1.323 . . . . 1.55 111.491 -178.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -54.26 -50.65 66.72 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 127.358 2.263 . . . . 5.27 110.991 178.355 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.8 t -63.86 -45.68 96.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 108.312 -0.996 . . . . 1.57 108.312 178.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 51.6 m -55.7 -36.52 67.27 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.243 0.46 . . . . 1.42 112.243 177.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -69.21 -43.47 74.03 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 114.123 1.157 . . . . 2.04 114.123 -178.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 26.7 mt -75.67 -28.29 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-N 118.689 0.677 . . . . 1.86 110.403 -179.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 21.5 mt -55.75 -37.7 68.84 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.569 0.951 . . . . 1.45 113.569 169.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 38.3 mttt -62.84 -32.92 74.24 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 118.563 0.62 . . . . 2.08 112.561 179.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -90.57 -35.48 15.0 Favored 'General case' 0 N--CA 1.438 -1.054 0 C-N-CA 128.362 2.665 . . . . 2.25 114.779 -175.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -77.17 -17.43 58.56 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 120.159 -0.616 . . . . 2.42 112.525 169.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -132.16 60.96 54.8 Favored Pre-proline 0 CA--C 1.551 1.017 0 N-CA-C 116.914 2.19 . . . . 3.66 116.914 175.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -68.68 -24.09 35.49 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 124.658 3.572 . . . . 1.02 114.759 170.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -80.27 0.13 34.05 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 114.495 1.295 . . . . 7.62 114.495 171.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.53 147.99 52.51 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 114.654 1.353 . . . . 1.85 114.654 -175.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 25.8 p -103.82 -18.69 14.55 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.525 1.13 . . . . 1.46 112.671 167.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -133.41 144.2 49.38 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 119.568 1.076 . . . . 1.7 112.149 159.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.9 pt -157.04 110.51 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 127.425 2.29 . . . . 1.63 110.815 171.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.5 ptpt -151.61 155.99 39.53 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.602 1.561 . . . . 2.17 113.024 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.9 t -136.04 145.57 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 126.016 1.726 . . . . 1.58 111.628 -172.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 94.3 m -138.82 126.67 22.24 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.233 0.613 . . . . 1.55 111.695 172.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -71.51 126.82 30.66 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.787 0.803 . . . . 1.82 110.451 168.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.2 pt -125.84 22.06 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 C-N-CA 125.524 1.529 . . . . 1.65 111.147 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 38.1 t -131.65 62.37 1.63 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 128.709 2.803 . . . . 2.03 110.896 179.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.01 -10.1 18.16 Favored Glycine 0 CA--C 1.539 1.562 0 N-CA-C 117.261 1.664 . . . . 1.15 117.261 -174.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -103.38 -19.62 12.17 Favored Glycine 0 N--CA 1.471 1.019 0 C-N-CA 126.534 2.016 . . . . 1.05 115.28 179.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 33.1 m -145.34 -29.56 0.44 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.29 1.036 . . . . 3.25 113.345 -163.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 60.42 41.41 98.55 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 128.201 2.81 . . . . 0.73 113.735 -175.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -98.39 -16.86 19.12 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.265 1.826 . . . . 1.65 112.955 -178.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' MET . . . . . 0.401 ' HG3' ' CA ' ' A' ' 97' ' ' GLY . 4.3 mpp? -117.8 141.49 48.35 Favored 'General case' 0 CA--C 1.52 -0.175 0 C-N-CA 126.627 1.971 . . . . 1.99 112.809 175.24 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -144.39 147.02 32.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.863 -1.062 . . . . 3.2 111.241 171.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -83.7 137.24 33.86 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 125.185 1.394 . . . . 2.23 109.193 163.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 97.5 mt -133.72 129.16 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 123.869 0.868 . . . . 1.79 109.345 170.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 70.0 mttt -124.56 116.97 23.31 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.673 1.189 . . . . 3.4 110.624 177.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.3 mt -122.29 162.62 21.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 C-N-CA 126.361 1.865 . . . . 1.51 109.271 -177.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -156.67 131.32 8.83 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.696 1.999 . . . . 1.77 107.111 162.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.7 t -157.28 140.14 15.13 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 120.402 1.456 . . . . 0.37 111.767 -173.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -58.26 -21.64 49.36 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.241 1.016 . . . . 3.41 113.543 -178.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -71.01 -15.4 62.56 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 115.274 1.583 . . . . 1.8 115.274 179.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -88.0 10.26 19.58 Favored 'General case' 0 CA--C 1.553 1.068 0 N-CA-C 115.537 1.68 . . . . 2.84 115.537 -171.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 14.9 pttt -63.07 -46.35 87.87 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 126.251 1.82 . . . . 3.29 115.569 -165.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -100.69 -11.03 20.29 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.385 1.474 . . . . 4.41 111.692 -168.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 32.9 mmtt -64.76 142.88 58.28 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 126.81 2.044 . . . . 2.45 112.561 174.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 16.6 mtt-85 -67.58 166.49 14.82 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 122.9 0.48 . . . . 4.28 111.092 159.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.8 m -50.31 -50.56 50.32 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 113.873 1.064 . . . . 2.05 113.873 172.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 10.4 p -62.71 -38.44 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 123.474 0.71 . . . . 1.91 112.783 174.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -75.34 -19.79 59.41 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.736 0.643 . . . . 1.43 112.736 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -70.34 -53.94 14.63 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.397 -0.814 . . . . 0.85 109.807 163.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 49.7 m170 -53.05 -48.28 67.79 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.82 0.848 . . . . 0.8 113.062 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 47.0 tp60 -47.79 -43.28 27.52 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.796 1.638 . . . . 1.19 113.477 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 3.6 mtm -67.07 -39.82 86.91 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 118.93 0.786 . . . . 1.62 111.768 -178.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.2 t -73.14 -33.83 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 125.616 1.567 . . . . 1.82 110.644 179.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -63.42 -50.64 69.0 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.111 1.764 . . . . 0.45 110.536 173.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 35.5 tp60 -66.05 -21.7 66.39 Favored 'General case' 0 N--CA 1.45 -0.474 0 O-C-N 119.849 -1.782 . . . . 2.38 114.118 -178.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.17 -40.55 85.97 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.379 0.672 . . . . 1.81 111.589 177.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.66 3.78 9.54 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 115.372 1.619 . . . . 1.38 115.372 -176.02 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 26.3 ttmt -43.8 -45.55 7.36 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 125.405 1.482 . . . . 2.71 111.877 174.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -84.27 -6.0 59.34 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 113.225 0.824 . . . . 3.05 113.225 -172.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -98.51 -56.15 2.54 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 127.226 2.211 . . . . 2.21 111.867 174.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 23.3 mt -132.96 92.61 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.57 1.548 . . . . 2.05 107.76 176.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -69.8 -19.08 63.5 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 114.094 1.146 . . . . 3.57 114.094 -172.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . 0.295 16.3 pt-20 -73.97 43.75 0.17 Allowed 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 116.359 1.985 . . . . 3.97 116.359 -169.09 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 64.3 mtm -66.21 0.75 1.85 Allowed 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 126.52 1.928 . . . . 2.38 116.023 -172.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 21.0 p-80 -61.6 -5.52 1.91 Allowed 'General case' 0 CA--C 1.55 0.959 0 N-CA-C 113.836 1.05 . . . . 6.4 113.836 157.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.401 ' CA ' ' HG3' ' A' ' 62' ' ' MET . . . -104.17 -14.99 22.98 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 125.468 1.509 . . . . 0.52 115.807 167.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.9 mp -89.68 124.97 35.06 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 118.904 1.352 . . . . 2.6 111.753 -169.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 50.3 ttt180 -103.26 100.87 10.79 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 127.072 2.149 . . . . 3.76 110.063 -178.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 5.4 mt -108.97 144.39 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-O 123.822 1.772 . . . . 1.52 112.853 -170.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -136.89 135.93 38.25 Favored 'General case' 0 N--CA 1.433 -1.298 0 C-N-CA 128.944 2.897 . . . . 3.32 109.248 -175.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.4 p -145.66 157.7 43.93 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 126.792 2.037 . . . . 1.82 108.176 -175.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -155.81 175.25 14.18 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 124.77 1.228 . . . . 0.9 108.959 172.386 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.1 p -142.8 126.33 9.38 Favored Pre-proline 0 N--CA 1.467 0.395 0 O-C-N 121.386 -0.821 . . . . 1.63 112.198 -179.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo . . . . . 0 N--CA 1.449 -1.116 0 C-N-CA 122.953 2.435 . . . . 0.76 110.894 176.201 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 . . . . . 0 C--O 1.234 0.255 0 N-CA-C 113.103 0.779 . . . . 2.64 113.103 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 58.7 p -102.02 176.46 5.19 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 126.115 1.766 . . . . 1.76 111.674 177.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -67.72 -34.03 76.06 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 120.486 -1.384 . . . . 4.13 112.115 164.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.4 -38.34 80.3 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 125.044 1.307 . . . . 0.52 114.229 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.87 -48.66 66.96 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 118.926 1.363 . . . . 1.39 112.551 -179.082 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 16.2 mt -70.11 -48.48 57.4 Favored 'General case' 0 CA--C 1.527 0.082 0 C-N-CA 125.375 1.47 . . . . 1.7 110.822 -178.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -53.32 -51.18 63.2 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 127.584 2.354 . . . . 5.1 111.319 179.251 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 39.3 t -62.83 -48.37 88.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 124.584 1.154 . . . . 1.5 108.425 177.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 42.1 m -57.0 -38.78 73.56 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.303 0.483 . . . . 1.83 112.303 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 -62.87 -41.22 99.3 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 112.395 0.517 . . . . 1.85 112.395 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 69.5 mt -78.03 -30.23 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 123.377 0.671 . . . . 1.84 111.317 -179.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 18.0 mt -55.33 -39.48 70.04 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 121.075 -1.015 . . . . 1.65 113.287 172.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 44.5 mttt -64.44 -26.36 68.41 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 113.459 0.911 . . . . 1.95 113.459 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -90.46 -35.36 15.17 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 126.823 2.049 . . . . 2.25 114.926 -177.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -74.68 -22.7 58.72 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 119.05 -1.06 . . . . 3.43 111.788 168.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -130.95 55.54 19.65 Favored Pre-proline 0 CA--C 1.552 1.052 0 N-CA-C 116.817 2.154 . . . . 2.74 116.817 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -68.31 -18.94 44.43 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 124.675 3.583 . . . . 0.85 115.225 177.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -81.96 -9.93 59.42 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 121.069 -1.019 . . . . 5.74 113.514 170.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.26 144.44 46.23 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 114.637 1.347 . . . . 1.72 114.637 -173.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 74.1 p -95.42 -29.64 14.31 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.769 1.628 . . . . 1.68 111.05 175.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -126.71 141.74 51.75 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.711 1.205 . . . . 1.35 111.265 165.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.1 pt -158.69 104.01 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 127.546 2.338 . . . . 1.73 109.434 174.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.0 ptpt -149.67 148.6 29.47 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.67 1.188 . . . . 2.34 112.86 -177.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.2 t -133.26 147.08 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 126.285 1.834 . . . . 1.69 111.246 -170.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 93.7 m -141.77 127.85 19.62 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 118.406 0.548 . . . . 1.54 111.538 170.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -68.41 135.86 52.4 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 122.174 0.988 . . . . 1.81 110.062 165.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . 0.255 1.6 pt -127.33 25.2 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.887 0 C-N-CA 125.647 1.579 . . . . 1.67 111.082 177.506 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 11.3 p -143.34 53.75 1.35 Allowed 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 128.98 2.912 . . . . 3.42 114.38 -171.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -55.98 -18.41 18.99 Favored Glycine 0 CA--C 1.546 2.022 0 O-C-N 120.403 -1.435 . . . . 1.31 116.678 -177.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -96.29 -5.84 59.07 Favored Glycine 0 CA--C 1.541 1.693 0 CA-C-N 119.658 1.729 . . . . 1.07 116.132 176.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 11.9 t -147.27 -31.75 0.31 Allowed 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 119.275 1.538 . . . . 2.2 114.301 -173.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 58.68 34.82 78.54 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 129.093 3.235 . . . . 0.66 114.361 -171.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -100.09 3.51 44.04 Favored 'General case' 0 CA--C 1.552 1.021 0 N-CA-C 115.223 1.564 . . . . 1.59 115.223 -177.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 2.1 mtp -131.36 138.43 49.16 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 127.396 2.279 . . . . 2.73 112.865 175.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -145.13 143.11 30.19 Favored 'General case' 0 C--O 1.227 -0.092 0 CA-C-O 122.645 1.212 . . . . 3.21 113.933 174.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -82.09 133.0 35.25 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 125.09 1.356 . . . . 1.74 110.021 165.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 82.7 mt -133.65 127.08 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 CA-C-N 119.816 1.189 . . . . 1.82 110.116 175.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 74.1 mttt -123.16 117.94 26.52 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.811 1.244 . . . . 3.52 110.232 178.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.3 mt -122.71 160.77 24.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 126.305 1.842 . . . . 1.51 109.046 -179.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -155.41 131.6 10.19 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 126.266 1.826 . . . . 1.94 107.219 162.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.9 t -154.07 137.66 16.01 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 118.678 0.672 . . . . 0.32 111.704 -177.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -55.11 -16.0 2.66 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 127.223 2.209 . . . . 4.22 114.567 176.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -76.66 -21.81 54.92 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 114.021 1.119 . . . . 1.71 114.021 175.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -79.97 11.85 3.11 Favored 'General case' 0 CA--C 1.556 1.192 0 N-CA-C 115.446 1.647 . . . . 2.86 115.446 -166.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -75.74 -36.4 59.91 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 117.777 2.51 . . . . 3.08 117.777 -163.293 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -80.75 -25.85 37.72 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 120.723 1.601 . . . . 5.36 111.429 173.258 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 43.1 mmtt -65.95 133.89 51.81 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.67 1.188 . . . . 2.76 113.289 -173.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 46.2 mtt-85 -63.75 160.73 16.55 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 125.451 1.5 . . . . 4.64 110.928 163.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 41.3 m -35.69 -57.77 0.64 Allowed 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 125.377 1.471 . . . . 1.76 114.094 167.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.0 p -65.79 -39.54 85.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 125.29 1.436 . . . . 1.98 112.674 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -70.21 -26.82 64.05 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 118.487 -0.768 . . . . 1.03 112.907 177.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -70.25 -52.75 20.71 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 119.112 0.869 . . . . 0.93 110.359 167.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 39.2 m170 -53.35 -49.18 67.66 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 118.911 0.778 . . . . 0.58 112.553 -178.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 33.0 tp60 -48.99 -43.52 40.22 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.844 1.258 . . . . 1.36 113.097 177.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 86.3 mtp -59.89 -44.5 94.2 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 121.179 -0.951 . . . . 1.87 112.026 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.1 t -73.17 -31.51 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 125.753 1.621 . . . . 1.52 111.608 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -67.51 -49.81 61.71 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 126.644 1.978 . . . . 0.46 110.237 175.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 39.8 tp60 -69.27 -20.82 63.92 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 120.513 -1.367 . . . . 2.83 113.708 -176.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.26 -46.87 88.31 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.253 1.421 . . . . 1.56 111.658 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.28 -5.09 14.19 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.975 1.102 . . . . 1.71 113.975 -175.327 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 11.7 ttmt -47.72 -35.96 10.6 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.187 1.395 . . . . 3.89 113.103 169.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -76.31 -0.16 21.49 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 114.294 1.22 . . . . 2.48 114.294 -178.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -120.27 -49.18 2.29 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 127.94 2.496 . . . . 3.22 111.222 175.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 37.2 mt -138.76 118.9 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 127.136 2.174 . . . . 1.92 107.224 176.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 37.2 mtpt -86.57 -10.93 52.93 Favored 'General case' 0 N--CA 1.478 0.973 0 O-C-N 120.455 -1.403 . . . . 3.09 113.509 -175.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 -77.92 47.81 0.66 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 128.052 2.541 . . . . 3.48 115.688 -158.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 3.3 mpp? -65.24 1.97 0.93 Allowed 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 115.391 1.626 . . . . 2.18 115.391 -178.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -64.49 -23.52 67.31 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 114.214 1.19 . . . . 4.6 114.214 160.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -90.21 -22.46 35.06 Favored Glycine 0 N--CA 1.475 1.256 0 C-N-CA 126.082 1.801 . . . . 0.54 114.916 173.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.9 mp -85.51 145.45 27.39 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.165 0.986 . . . . 2.7 112.85 -169.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 -123.48 101.83 7.55 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 126.385 1.874 . . . . 4.29 109.73 176.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 2.3 mt -105.61 146.57 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 CA-C-O 123.515 1.626 . . . . 1.51 113.619 -173.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -140.36 131.6 26.57 Favored 'General case' 0 N--CA 1.439 -1.004 0 C-N-CA 128.814 2.845 . . . . 3.26 108.952 -172.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 19.6 p -146.55 148.71 32.43 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.756 2.022 . . . . 1.59 109.489 -177.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.7 p -147.77 171.47 15.63 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.566 -1.197 . . . . 0.72 111.027 173.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 13.4 p -136.37 128.61 17.34 Favored Pre-proline 0 N--CA 1.47 0.55 0 C-N-CA 123.799 0.84 . . . . 1.61 110.332 173.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo . . . . . 0 N--CA 1.457 -0.651 0 C-N-CA 121.966 1.777 . . . . 0.86 109.751 176.961 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.1 mp0 . . . . . 0 N--CA 1.468 0.466 0 CA-C-O 121.669 0.747 . . . . 3.12 111.39 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 30.6 p -129.14 173.06 10.81 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.98 1.712 . . . . 2.02 109.32 161.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -72.34 -26.88 62.1 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 120.286 -1.509 . . . . 4.65 111.19 177.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -66.51 -35.66 90.34 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 125.492 1.52 . . . . 0.45 113.282 170.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.69 -50.77 42.46 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.187 1.395 . . . . 1.37 111.563 173.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.8 mt -68.92 -48.81 62.38 Favored 'General case' 0 C--O 1.223 -0.292 0 C-N-CA 124.897 1.279 . . . . 1.55 110.973 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.39 -47.2 69.7 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.792 1.237 . . . . 4.6 111.416 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.3 t -67.74 -46.97 81.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 O-C-N 124.156 0.91 . . . . 1.85 108.716 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 89.6 m -52.82 -44.48 66.72 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.463 0.705 . . . . 1.63 112.005 175.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -62.42 -32.68 73.56 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.038 0.935 . . . . 2.93 113.126 -177.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 35.2 mt -82.27 -35.5 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 CA-C-N 118.798 0.727 . . . . 1.77 111.662 172.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 20.2 mt -53.74 -38.9 64.83 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 120.907 -1.121 . . . . 1.73 113.488 175.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 40.7 mttt -76.29 -9.64 58.8 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 114.8 1.407 . . . . 2.66 114.8 -178.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -90.26 -40.83 11.92 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 126.363 1.865 . . . . 3.02 113.214 167.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 65.0 mmtt -74.16 -30.12 62.1 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 119.1 -1.04 . . . . 2.16 111.777 177.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -132.98 53.15 10.13 Favored Pre-proline 0 CA--C 1.549 0.933 0 N-CA-C 117.285 2.328 . . . . 2.81 117.285 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -61.58 -26.38 80.44 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 123.975 3.117 . . . . 1.35 114.436 178.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 10.9 mmt180 -91.72 -3.79 55.83 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 114.344 1.238 . . . . 6.67 114.344 -176.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -55.07 149.5 11.95 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.03 1.732 . . . . 1.69 114.707 176.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 74.0 p -100.87 -9.88 21.2 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 126.172 1.789 . . . . 1.45 112.878 178.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -135.39 141.94 45.58 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.121 0.968 . . . . 1.41 110.52 150.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -154.19 108.14 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 C-N-CA 125.838 1.655 . . . . 1.95 110.799 171.517 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.4 ptpt -154.9 156.63 36.46 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.042 1.337 . . . . 2.09 113.11 176.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 25.3 t -122.34 151.65 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 127.37 2.268 . . . . 1.85 109.458 177.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 63.3 m -138.26 116.65 11.97 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 109.682 -0.488 . . . . 1.75 109.682 168.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -65.58 133.02 50.3 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 122.18 0.991 . . . . 2.12 109.11 166.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.1 pt -126.59 32.23 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 124.721 1.208 . . . . 1.71 109.533 178.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.6 t -146.6 45.83 1.2 Allowed 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 126.793 2.037 . . . . 1.87 113.257 -169.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -49.59 -31.89 15.56 Favored Glycine 0 CA--C 1.543 1.802 0 O-C-N 120.112 -1.618 . . . . 1.43 115.887 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -77.18 -12.81 84.26 Favored Glycine 0 CA--C 1.541 1.673 0 N-CA-C 116.248 1.259 . . . . 1.52 116.248 176.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 4.7 t -147.75 -44.14 0.17 Allowed 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 119.891 1.845 . . . . 2.63 114.384 -173.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 73.97 47.73 18.21 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 128.921 3.153 . . . . 0.93 112.434 -168.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -96.05 -29.64 14.0 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.545 1.538 . . . . 2.09 114.252 174.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -113.09 142.13 46.09 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 125.267 1.427 . . . . 2.3 113.811 -177.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -143.2 142.42 31.41 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 122.282 1.039 . . . . 3.24 112.824 172.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -83.58 139.98 32.52 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 125.862 1.665 . . . . 2.32 109.529 163.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 90.4 mt -135.94 129.59 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-N 119.335 0.97 . . . . 1.85 109.185 172.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 77.4 mttt -126.27 113.73 17.34 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.708 1.203 . . . . 3.45 109.768 -177.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.2 mt -125.11 157.82 33.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 126.333 1.853 . . . . 1.48 109.109 -178.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 48.2 tt0 -157.76 129.34 6.83 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 126.103 1.761 . . . . 1.84 107.415 167.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 18.2 t -160.14 145.28 14.97 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 120.131 1.332 . . . . 0.35 113.091 -171.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -59.42 -16.9 26.35 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.964 2.105 . . . . 3.69 114.583 -176.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -77.36 -20.21 55.14 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.733 1.613 . . . . 1.73 115.03 173.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -80.72 5.67 15.08 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 114.861 1.43 . . . . 2.89 114.861 -167.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 22.8 pttt -73.33 -49.64 26.34 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 114.7 1.37 . . . . 4.1 114.7 -171.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . 0.278 15.2 pm0 -80.89 25.35 0.45 Allowed 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 119.658 1.117 . . . . 4.08 113.855 -177.336 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 42.1 mmtt -119.03 141.39 48.75 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 127.393 2.277 . . . . 2.02 110.854 -177.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 40.1 mtt180 -67.82 166.15 16.05 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 123.003 0.521 . . . . 4.45 111.213 158.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 52.6 m -47.4 -53.35 14.18 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 114.384 1.253 . . . . 1.69 114.384 170.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 13.6 p -61.11 -37.81 78.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 123.215 0.606 . . . . 1.83 112.594 175.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -74.45 -27.59 60.66 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 118.53 -0.748 . . . . 1.14 112.553 179.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -64.28 -56.02 17.45 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.279 1.032 . . . . 0.85 109.872 166.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 35.7 m170 -53.0 -48.33 67.59 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.703 0.801 . . . . 0.58 112.255 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 30.8 tp60 -52.64 -40.54 62.9 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.471 1.108 . . . . 1.38 113.221 178.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -63.67 -37.65 88.15 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 120.3 1.409 . . . . 2.18 111.221 179.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.3 t -76.76 -31.08 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 125.192 1.397 . . . . 1.71 111.689 179.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -67.63 -48.07 67.77 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.597 1.559 . . . . 0.47 110.195 173.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -61.55 -27.53 68.68 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 120.713 -1.242 . . . . 3.62 113.202 178.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.64 -35.74 74.99 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.614 1.165 . . . . 1.48 112.399 -177.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.18 -3.03 8.53 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 113.927 1.084 . . . . 1.78 113.927 -178.177 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 26.1 ttpt -49.26 -37.63 24.14 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.141 1.376 . . . . 3.56 112.82 177.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -78.13 -12.64 60.01 Favored 'General case' 0 CA--C 1.552 1.043 0 CA-C-O 121.68 0.753 . . . . 2.62 111.863 -173.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -109.56 -51.04 2.92 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 128.98 2.912 . . . . 3.14 110.681 -171.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.3 mm -129.68 123.62 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 127.851 2.46 . . . . 2.82 106.579 164.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -97.01 -9.21 28.64 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 119.873 -1.767 . . . . 4.37 114.876 -178.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -81.94 50.77 1.61 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 127.631 2.372 . . . . 2.98 114.356 -166.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 5.2 mpp? -64.92 -2.21 2.49 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 114.998 1.481 . . . . 2.42 114.998 -175.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 19.4 p-80 -63.79 -14.87 56.51 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 114.28 1.215 . . . . 6.19 114.28 165.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -92.75 -17.55 44.26 Favored Glycine 0 CA--C 1.537 1.431 0 O-C-N 121.13 -0.981 . . . . 0.65 114.451 167.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.8 mp -89.07 146.49 24.8 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 121.283 -1.127 . . . . 2.68 112.685 -170.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 21.3 ttt85 -131.63 99.6 4.85 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.853 2.061 . . . . 3.92 110.049 -173.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 4.0 mt -107.96 145.82 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 CA-C-O 123.461 1.6 . . . . 1.76 113.943 -169.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -135.31 127.89 30.74 Favored 'General case' 0 N--CA 1.438 -1.051 0 C-N-CA 128.446 2.698 . . . . 3.18 107.975 -171.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 23.7 p -143.28 160.61 40.18 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 126.466 1.907 . . . . 1.51 110.207 -175.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -171.28 175.69 4.14 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 124.953 1.301 . . . . 1.26 109.735 179.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.5 p -136.68 135.66 20.67 Favored Pre-proline 0 N--CA 1.471 0.581 0 C-N-CA 123.855 0.862 . . . . 1.74 110.936 175.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo . . . . . 0 N--CA 1.458 -0.594 0 C-N-CA 123.561 2.84 . . . . 0.67 109.584 173.356 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 18.0 mp0 . . . . . 0 N--CA 1.476 0.843 0 N-CA-C 115.734 1.753 . . . . 2.95 115.734 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 80.9 p -103.42 169.98 8.22 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.054 0.942 . . . . 1.58 109.309 150.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -70.81 -21.74 62.43 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 120.844 -1.16 . . . . 2.9 112.662 169.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.21 -41.62 96.76 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 125.533 1.54 . . . . 0.49 113.264 169.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.68 -47.81 29.4 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.769 1.627 . . . . 1.27 111.708 172.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.4 mt -68.46 -50.68 50.71 Favored 'General case' 0 C--O 1.231 0.095 0 C-N-CA 125.456 1.502 . . . . 1.67 111.444 -178.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -57.83 -49.74 75.63 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 126.119 1.768 . . . . 5.12 111.145 -179.251 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 36.3 t -60.59 -47.54 92.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 108.223 -1.029 . . . . 1.56 108.223 176.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 88.8 m -57.1 -37.58 72.15 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 112.539 0.57 . . . . 1.86 112.539 178.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 7.9 mm-40 -64.47 -41.64 96.39 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 113.178 0.807 . . . . 2.08 113.178 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 27.7 mt -76.04 -29.83 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-N 118.195 0.452 . . . . 2.01 110.561 177.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 23.5 mt -57.42 -39.13 75.53 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 120.865 -1.147 . . . . 1.72 113.594 170.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 39.5 mttt -64.45 -17.96 64.31 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 113.935 1.087 . . . . 2.18 113.935 177.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -104.36 -35.56 7.9 Favored 'General case' 0 N--CA 1.433 -1.325 0 C-N-CA 126.894 2.078 . . . . 1.86 114.021 -177.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -74.15 -23.33 59.25 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 119.607 -0.837 . . . . 2.06 111.777 167.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -132.86 51.4 7.0 Favored Pre-proline 0 CA--C 1.548 0.871 0 N-CA-C 117.748 2.499 . . . . 3.62 117.748 -178.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -64.82 -24.76 61.03 Favored 'Trans proline' 0 C--O 1.238 0.489 0 C-N-CA 123.89 3.06 . . . . 0.76 114.352 174.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 15.5 mmp_? -76.94 -1.08 26.76 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.593 0.96 . . . . 6.74 113.593 173.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.15 154.55 30.81 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 115.176 1.547 . . . . 1.63 115.176 177.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 70.6 p -107.96 -27.81 9.96 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.022 1.329 . . . . 1.91 112.568 165.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -117.67 133.73 55.64 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.745 0.818 . . . . 1.46 111.14 163.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.3 pt -152.63 99.44 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 125.955 1.702 . . . . 1.73 109.689 169.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.2 ptpt -146.67 149.05 32.71 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.194 1.398 . . . . 2.02 111.809 -176.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.5 t -133.71 152.31 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 125.947 1.699 . . . . 1.66 110.221 -172.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 81.4 m -141.56 135.29 29.94 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.356 0.663 . . . . 1.65 110.607 167.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -75.86 130.28 38.31 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 122.108 0.956 . . . . 2.06 110.315 166.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . 0.273 3.7 pt -123.0 29.1 2.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 125.533 1.533 . . . . 1.62 110.33 177.067 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.1 p -135.17 62.85 1.63 Allowed 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 127.897 2.479 . . . . 3.52 114.005 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.36 2.27 1.71 Allowed Glycine 0 CA--C 1.539 1.562 0 N-CA-C 117.252 1.661 . . . . 1.3 117.252 178.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -122.73 -5.6 8.26 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-N 119.84 1.82 . . . . 0.99 115.943 172.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 1.7 m -151.79 -18.68 0.19 Allowed 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 115.066 1.506 . . . . 3.3 115.066 -175.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 52.53 43.96 59.08 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 126.254 1.883 . . . . 0.8 114.209 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -112.55 2.68 16.37 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 125.303 1.441 . . . . 1.91 114.097 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 13.9 ttm -132.85 120.92 22.18 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 128.93 2.892 . . . . 1.92 109.498 -166.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -140.95 143.95 34.85 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.709 0.766 . . . . 3.19 112.824 -175.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -82.75 135.59 34.95 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 125.217 1.407 . . . . 2.57 108.985 164.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 88.3 mt -135.93 127.71 44.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-N 119.457 1.026 . . . . 1.64 110.081 172.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -121.01 114.2 21.17 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.9 1.28 . . . . 3.24 109.923 176.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.2 mt -121.55 153.37 25.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 126.011 1.724 . . . . 1.79 108.99 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -157.58 124.13 4.92 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 125.132 1.373 . . . . 1.86 107.711 168.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 43.2 t -153.95 144.32 22.25 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.723 1.147 . . . . 0.44 113.02 -169.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -55.88 -21.88 22.54 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.78 1.632 . . . . 3.73 114.589 -178.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -75.52 -21.71 57.75 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 113.692 0.997 . . . . 1.78 113.692 177.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -77.67 13.29 1.34 Allowed 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 114.111 1.152 . . . . 3.52 114.111 -167.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -83.49 -43.1 16.14 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.888 0.699 . . . . 2.89 112.888 -176.581 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -83.12 46.24 1.1 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 125.332 1.453 . . . . 3.42 110.765 179.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 54.0 mmtt -148.04 144.17 27.72 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 128.316 2.647 . . . . 2.5 111.82 -176.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 17.6 mtt85 -70.05 171.12 10.08 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.17 0.988 . . . . 5.08 111.341 155.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 87.3 m -57.98 -48.26 80.51 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 113.758 1.021 . . . . 2.35 113.758 174.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 13.6 p -59.72 -37.3 70.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 O-C-N 121.805 -0.56 . . . . 1.71 112.186 172.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -74.55 -26.38 59.92 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 118.609 -0.71 . . . . 1.0 111.996 179.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -64.79 -54.09 36.78 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.712 1.142 . . . . 0.96 109.911 165.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 37.2 m170 -54.29 -49.14 70.3 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.256 1.023 . . . . 0.82 113.307 -178.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 56.5 tp60 -48.54 -43.3 35.3 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.667 1.987 . . . . 1.44 113.528 177.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 83.2 mtp -63.28 -46.39 86.99 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.681 0.792 . . . . 1.78 111.648 179.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.9 t -66.5 -30.99 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 125.191 1.396 . . . . 1.72 111.383 178.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -68.37 -54.45 17.19 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.161 1.785 . . . . 0.51 110.726 175.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.7 -22.12 66.59 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.678 0.791 . . . . 2.96 112.973 -178.077 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.06 -41.1 78.12 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 125.482 1.513 . . . . 1.75 112.608 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.22 2.24 9.18 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 114.646 1.35 . . . . 1.64 114.646 -176.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 11.7 ttpp -51.65 -37.61 51.17 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 124.819 1.248 . . . . 3.9 112.131 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -83.21 -7.11 59.66 Favored 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 113.392 0.886 . . . . 2.02 113.392 -175.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -98.21 -51.1 4.11 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 127.027 2.131 . . . . 3.41 110.917 174.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 21.4 mt -143.21 104.57 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 126.585 1.954 . . . . 1.87 107.642 176.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -79.01 -2.09 38.63 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 115.313 1.597 . . . . 3.08 115.313 -174.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -74.26 36.69 0.1 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 129.335 3.054 . . . . 3.95 116.046 -165.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 5.6 mpp? -63.13 1.89 0.41 Allowed 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 116.053 1.871 . . . . 2.43 116.053 -176.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 7.6 p80 -58.16 -29.46 65.62 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 120.602 -1.311 . . . . 4.89 112.036 156.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -78.58 -29.81 51.15 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 126.496 1.998 . . . . 0.55 115.595 176.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.2 mp -91.33 122.17 33.71 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.368 -1.077 . . . . 2.77 113.07 -158.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 47.1 ttt180 -99.1 100.73 11.91 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 127.386 2.274 . . . . 3.84 109.785 -179.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 2.1 mt -108.04 143.06 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 CA-C-O 123.18 1.467 . . . . 2.02 113.506 -170.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -133.97 123.27 24.34 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 128.277 2.631 . . . . 3.28 108.49 -173.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 33.3 p -137.68 156.29 48.19 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 125.62 1.568 . . . . 1.74 112.158 -176.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.1 p -167.09 177.31 6.32 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.651 1.58 . . . . 0.68 110.476 178.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.5 p -136.87 132.0 18.22 Favored Pre-proline 0 N--CA 1.479 1.01 0 O-C-N 121.033 -1.042 . . . . 1.78 111.328 175.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo . . . . . 0 N--CA 1.457 -0.62 0 C-N-CA 123.11 2.54 . . . . 1.25 111.379 -176.568 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 14.0 mp0 . . . . . 0 CA--C 1.542 0.65 0 N-CA-C 114.796 1.406 . . . . 4.28 114.796 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 33.8 p -118.83 171.88 7.91 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.688 1.595 . . . . 1.96 111.375 166.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -64.04 -32.96 74.69 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 121.474 -0.766 . . . . 2.98 111.106 169.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.92 -34.6 71.42 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 124.902 1.239 . . . . 0.61 113.821 179.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.19 -47.32 54.67 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.133 1.373 . . . . 1.26 111.634 173.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 12.3 mt -68.07 -49.99 57.87 Favored 'General case' 0 CA--C 1.523 -0.095 0 C-N-CA 124.94 1.296 . . . . 1.65 111.064 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -57.99 -46.74 84.71 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.218 1.407 . . . . 7.88 111.227 -179.487 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 39.5 t -61.91 -46.44 96.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 108.108 -1.071 . . . . 1.78 108.108 177.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 29.8 m -57.89 -35.92 71.68 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 112.693 0.627 . . . . 1.55 112.693 177.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -67.32 -44.57 78.81 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 113.112 0.782 . . . . 2.02 113.112 179.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 28.7 mt -74.89 -28.23 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-N 118.652 0.66 . . . . 1.76 110.555 -179.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 23.6 mt -58.52 -36.81 74.4 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 120.945 -1.097 . . . . 1.7 113.448 170.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 58.0 mttt -58.42 -31.96 68.22 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 113.055 0.761 . . . . 3.08 113.055 175.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -95.67 -34.59 11.9 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 127.069 2.148 . . . . 2.1 114.213 -172.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -77.73 -20.67 53.11 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 120.11 -0.636 . . . . 1.98 112.468 168.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -130.38 52.14 8.86 Favored Pre-proline 0 CA--C 1.55 0.972 0 N-CA-C 118.052 2.612 . . . . 2.68 118.052 178.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -63.51 -22.28 70.89 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.966 3.111 . . . . 0.82 114.409 174.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 21.8 mmt180 -87.48 -1.58 58.03 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 113.889 1.07 . . . . 5.92 113.889 177.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.37 151.82 46.34 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.897 1.279 . . . . 1.86 113.731 178.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 81.8 p -113.23 -9.0 13.5 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.594 1.558 . . . . 1.92 113.527 174.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -135.37 142.65 45.77 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 120.028 1.285 . . . . 1.86 111.107 153.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.4 pt -151.29 120.07 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 125.492 1.517 . . . . 1.9 111.959 170.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -159.2 158.6 32.99 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.386 1.475 . . . . 3.27 113.247 178.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.0 t -138.74 150.96 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 126.364 1.866 . . . . 1.61 109.952 -174.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 55.0 m -140.88 125.78 18.19 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 118.58 0.627 . . . . 1.61 109.865 168.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -69.68 130.17 41.62 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 121.53 -0.731 . . . . 2.53 109.273 167.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.9 pt -127.36 32.85 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 125.562 1.545 . . . . 1.6 110.485 178.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 44.8 t -138.91 69.67 1.37 Allowed 'General case' 0 C--N 1.343 0.307 0 C-N-CA 127.938 2.495 . . . . 1.91 111.209 -177.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -42.47 -36.67 2.32 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 126.16 1.838 . . . . 1.34 116.129 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -100.02 -14.27 34.29 Favored Glycine 0 CA--C 1.539 1.539 0 N-CA-C 115.981 1.153 . . . . 1.5 115.981 -173.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 8.2 t -138.12 -29.08 0.84 Allowed 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 119.18 1.49 . . . . 2.89 114.484 -174.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 55.86 47.68 77.49 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 124.263 0.935 . . . . 0.87 112.22 -161.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -93.39 -25.52 17.65 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.948 1.299 . . . . 1.56 113.175 173.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 23.0 mtm -106.02 135.16 47.97 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 125.268 1.427 . . . . 2.1 111.776 172.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -138.13 143.51 40.39 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 121.959 0.885 . . . . 3.25 112.179 169.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -81.08 139.08 35.89 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 125.931 1.692 . . . . 2.39 109.156 162.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 93.6 mt -137.39 129.05 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 CA-C-N 119.68 1.127 . . . . 1.74 110.018 171.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 79.7 mttt -123.08 117.38 25.28 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.814 1.246 . . . . 3.32 109.858 177.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.2 mt -126.1 157.06 36.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 126.371 1.868 . . . . 1.58 109.338 -179.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -154.6 126.11 7.45 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 120.441 -1.412 . . . . 2.17 108.326 170.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 17.8 t -157.31 146.41 19.96 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-N 119.637 1.108 . . . . 0.37 112.937 -172.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -57.7 -26.21 61.41 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 126.389 1.876 . . . . 4.04 112.653 -177.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -73.08 -11.95 60.73 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.714 1.606 . . . . 1.88 114.96 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -91.2 6.09 46.49 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 116.408 2.003 . . . . 3.45 116.408 -171.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.47 -37.3 63.26 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 115.84 1.793 . . . . 3.67 115.84 -172.52 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -87.36 28.36 0.97 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 124.739 1.216 . . . . 4.12 112.669 -177.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 55.6 mmtt -131.08 132.99 45.26 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.929 1.292 . . . . 3.15 113.335 -164.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 23.9 mtt85 -65.09 169.83 5.08 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.889 1.276 . . . . 4.87 110.971 164.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 27.5 m -51.53 -53.86 33.33 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 113.384 0.883 . . . . 1.75 113.384 174.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.4 p -61.61 -38.05 79.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 123.377 0.671 . . . . 1.74 111.569 175.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -75.04 -20.67 59.47 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 113.727 1.01 . . . . 1.39 113.727 -178.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -75.13 -55.35 5.82 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 119.054 0.843 . . . . 0.89 110.116 164.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 40.8 m170 -56.42 -46.45 80.22 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.912 0.885 . . . . 0.92 113.24 -175.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 29.7 tp60 -47.88 -41.79 25.17 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.287 1.435 . . . . 1.25 113.088 177.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 3.7 mtm -64.17 -40.68 96.63 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 121.491 -0.756 . . . . 2.2 111.668 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.8 t -75.78 -23.99 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 126.07 1.748 . . . . 1.51 111.235 179.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -76.16 -48.44 20.53 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.911 1.684 . . . . 0.45 109.273 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 19.5 mm-40 -65.74 -23.68 66.79 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.622 1.169 . . . . 3.71 114.081 178.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.49 -38.49 84.47 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.119 0.968 . . . . 1.45 112.688 -177.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.22 3.41 10.36 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 114.605 1.335 . . . . 1.88 114.605 -178.58 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.9 ttmt -53.25 -39.94 64.23 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.674 1.189 . . . . 3.93 112.576 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -82.47 -5.83 58.93 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 123.311 0.644 . . . . 2.14 112.629 -175.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -95.83 -49.16 5.44 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 127.412 2.285 . . . . 2.77 111.592 167.682 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 21.2 mt -148.38 110.36 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 128.133 2.573 . . . . 2.12 109.024 178.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt -85.52 0.38 52.58 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 117.852 2.538 . . . . 5.06 117.852 -173.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -77.19 48.42 0.62 Allowed 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 129.557 3.143 . . . . 2.86 115.845 -160.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . 0.267 1.4 mpt? -70.63 3.51 3.07 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 119.709 -1.869 . . . . 3.11 115.42 -177.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 17.5 p-80 -66.92 -13.62 61.94 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 114.491 1.293 . . . . 5.95 114.491 156.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -108.64 -25.39 5.74 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 125.914 1.721 . . . . 0.57 115.103 171.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.2 mp -78.27 141.25 38.67 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 121.009 -1.289 . . . . 2.67 113.577 -174.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 34.8 ttt180 -125.9 101.76 6.97 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 127.316 2.246 . . . . 3.76 109.933 -177.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 4.0 mt -108.21 149.77 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-O 123.59 1.662 . . . . 1.62 113.593 -171.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -139.77 119.56 13.35 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 111.356 -2.657 . . . . 3.2 108.631 -171.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.8 p -136.85 145.02 43.92 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 125.285 1.434 . . . . 1.73 111.253 -177.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.8 p -148.08 178.58 8.42 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.283 -1.326 . . . . 0.87 111.404 176.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 6.8 p -145.0 135.82 12.25 Favored Pre-proline 0 N--CA 1.47 0.575 0 O-C-N 121.759 -0.588 . . . . 1.62 112.385 -178.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo . . . . . 0 N--CA 1.454 -0.8 0 C-N-CA 123.298 2.665 . . . . 0.77 110.999 176.654 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 . . . . . 0 N--CA 1.469 0.504 0 CA-C-O 121.542 0.687 . . . . 3.0 111.304 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 70.1 p -100.4 -178.89 3.94 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 126.069 1.748 . . . . 2.16 110.13 160.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -73.24 -25.71 60.83 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 120.264 -1.522 . . . . 2.88 112.208 160.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.73 -40.27 98.56 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 125.453 1.501 . . . . 0.52 113.244 173.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -52.22 -42.19 63.37 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.588 1.555 . . . . 1.24 113.016 177.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 14.0 mt -75.06 -48.44 23.9 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 126.543 1.937 . . . . 1.89 110.549 -179.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -53.81 -49.09 69.12 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.333 1.453 . . . . 3.78 111.149 175.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 29.8 t -62.46 -52.04 64.79 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 C-N-CA 125.457 1.503 . . . . 1.55 107.576 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 99.3 m -52.24 -43.13 64.15 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.479 0.712 . . . . 1.5 111.848 178.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -65.33 -42.21 93.15 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 118.267 -0.873 . . . . 2.35 112.406 -178.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 38.6 mt -72.4 -32.0 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 CA-C-N 119.754 1.161 . . . . 1.68 110.494 178.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 20.6 mt -54.36 -44.06 71.87 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 121.344 -0.848 . . . . 1.7 112.904 173.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 34.9 mttt -65.91 -23.88 66.72 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 113.69 0.996 . . . . 3.14 113.69 -178.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -93.03 -33.83 13.95 Favored 'General case' 0 N--CA 1.435 -1.211 0 C-N-CA 126.694 1.998 . . . . 2.34 114.357 -177.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -75.64 -21.43 57.71 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 120.292 -0.563 . . . . 2.12 111.947 166.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -131.12 58.2 37.16 Favored Pre-proline 0 CA--C 1.549 0.927 0 N-CA-C 117.254 2.316 . . . . 2.76 117.254 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -67.18 -13.38 39.43 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 124.241 3.294 . . . . 1.11 114.428 168.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.97 -12.72 60.19 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 115.274 1.583 . . . . 8.7 115.274 171.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.94 153.79 42.69 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 116.37 1.989 . . . . 1.62 116.37 -162.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 39.8 p -107.83 -25.28 11.31 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.521 1.528 . . . . 1.71 112.466 166.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -125.9 141.24 52.07 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.297 0.953 . . . . 1.47 111.62 164.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.2 pt -157.4 112.06 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 126.589 1.956 . . . . 1.99 109.598 174.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.8 ptpt -153.38 149.9 28.3 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.239 1.416 . . . . 2.73 112.221 -177.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.5 t -133.63 151.58 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 126.081 1.753 . . . . 1.82 110.574 -176.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 88.0 m -146.6 122.73 10.82 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 121.046 -1.034 . . . . 1.65 111.903 167.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -65.94 129.04 38.42 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.634 0.731 . . . . 1.99 109.314 162.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.9 pt -129.26 28.62 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 C-N-CA 126.364 1.865 . . . . 1.75 110.009 179.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.5 t -132.99 59.25 1.74 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 127.547 2.339 . . . . 1.8 112.271 -165.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -66.5 14.33 0.36 Allowed Glycine 0 CA--C 1.539 1.562 0 C-N-CA 126.126 1.822 . . . . 1.82 117.295 -175.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -154.07 16.99 0.61 Allowed Glycine 0 CA--C 1.533 1.171 0 C-N-CA 125.568 1.556 . . . . 1.82 113.853 -177.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.6 t -161.52 -27.88 0.05 Allowed 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.363 1.465 . . . . 3.09 112.49 177.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 54.47 40.53 69.65 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 125.642 1.591 . . . . 0.78 113.898 -171.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -109.96 -37.07 5.71 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 127.372 2.269 . . . . 1.53 113.959 -176.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 30.0 mtm -84.03 130.94 34.86 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 124.283 1.033 . . . . 2.06 110.669 175.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -141.32 141.87 33.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 122.147 0.975 . . . . 3.2 112.313 172.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -81.23 137.22 35.87 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 124.905 1.282 . . . . 1.97 109.748 162.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.9 mt -136.76 131.94 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 108.213 -1.032 . . . . 1.87 108.213 171.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 8.0 tmtm? -128.42 128.61 44.78 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 118.992 0.815 . . . . 8.51 112.095 169.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.2 mt -124.51 162.44 26.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 125.772 1.629 . . . . 1.52 108.869 -179.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -156.7 131.14 8.69 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 126.652 1.981 . . . . 2.08 106.829 164.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 32.9 t -158.04 143.92 17.17 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 119.558 1.072 . . . . 0.36 111.776 -172.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -55.9 -23.56 32.12 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 113.821 1.045 . . . . 3.03 113.821 179.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -70.67 -19.14 62.82 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 114.9 1.444 . . . . 1.83 114.9 178.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -83.14 10.72 7.6 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 114.545 1.313 . . . . 2.85 114.545 -169.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.6 pttt -72.35 -44.92 61.91 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.979 1.711 . . . . 4.02 113.527 -175.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -83.9 20.36 1.52 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.997 1.719 . . . . 3.71 112.489 -175.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 64.4 mmtt -130.47 132.55 45.73 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 126.469 1.907 . . . . 2.62 111.984 -166.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 47.6 mtt180 -69.5 168.25 15.0 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.965 1.306 . . . . 4.16 111.694 163.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 56.6 m -46.2 -55.41 7.15 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.058 1.343 . . . . 1.68 113.533 170.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.7 p -57.55 -44.24 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 124.501 1.12 . . . . 1.93 112.464 174.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -72.04 -27.87 62.98 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 118.378 -0.82 . . . . 1.27 112.85 -178.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -69.97 -51.84 29.28 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 119.451 1.023 . . . . 0.86 109.921 169.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 44.1 m170 -52.17 -53.07 47.66 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.075 0.95 . . . . 0.69 112.24 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 28.0 tp60 -46.59 -43.67 17.5 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.1 1.36 . . . . 1.93 113.411 177.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 61.6 mtp -64.18 -36.22 83.36 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 120.998 -1.064 . . . . 1.66 113.069 -178.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.0 t -79.05 -36.07 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 125.613 1.565 . . . . 1.49 110.56 177.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -61.22 -50.29 73.68 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.986 1.314 . . . . 0.47 110.221 174.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 63.7 tp60 -57.45 -29.82 64.51 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 120.246 -1.534 . . . . 2.84 113.553 178.073 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.54 -37.22 82.98 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.119 0.968 . . . . 1.54 112.058 -177.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.59 0.88 8.84 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 115.06 1.504 . . . . 1.86 115.06 -179.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 30.2 ttpt -47.41 -36.76 10.27 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 125.85 1.66 . . . . 3.77 112.618 175.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -88.85 7.55 33.68 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 112.403 0.52 . . . . 2.07 112.403 -172.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -121.11 -61.13 1.58 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 128.625 2.77 . . . . 2.73 110.449 175.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 7.2 mm -115.77 90.33 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 125.046 1.338 . . . . 2.84 109.018 171.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 8.0 ptpp? -76.15 -18.56 59.06 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 114.348 1.24 . . . . 5.4 114.348 -173.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -67.08 46.19 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 131.258 3.823 . . . . 3.39 114.429 -178.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 61.2 mtm -71.58 10.25 0.68 Allowed 'General case' 0 CA--C 1.54 0.56 0 O-C-N 119.393 -2.067 . . . . 2.4 114.933 -172.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -69.59 -20.59 63.63 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.315 0.857 . . . . 4.38 113.315 161.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -84.45 -32.88 21.25 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 123.904 0.764 . . . . 0.62 112.212 174.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.0 mp -71.91 144.31 49.03 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 122.515 1.15 . . . . 2.69 112.795 -173.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 45.1 ttt180 -128.48 99.67 5.48 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 126.547 1.939 . . . . 3.47 109.126 -176.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 4.9 mt -108.78 141.75 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 123.697 1.713 . . . . 2.01 112.953 -170.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -130.51 132.79 45.8 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 111.495 -2.593 . . . . 3.18 107.542 -172.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 17.2 p -151.85 151.85 31.85 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.788 1.235 . . . . 1.55 109.945 -173.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.1 p -161.83 -179.53 7.27 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.506 -1.224 . . . . 0.71 110.243 178.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 6.3 p -135.15 136.14 24.15 Favored Pre-proline 0 C--N 1.325 -0.481 0 C-N-CA 124.267 1.027 . . . . 1.68 109.782 177.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo . . . . . 0 N--CA 1.457 -0.653 0 C-N-CA 123.377 2.718 . . . . 0.79 108.791 175.728 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 16.4 mp0 . . . . . 0 CA--C 1.537 0.444 0 N-CA-C 113.445 0.906 . . . . 3.05 113.445 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 80.9 p -127.06 166.87 16.79 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.774 2.03 . . . . 1.6 108.291 159.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -62.68 -26.66 68.77 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 119.986 1.267 . . . . 3.27 111.951 169.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.43 -43.47 94.82 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 126.01 1.767 . . . . 0.44 113.063 172.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.88 -45.6 60.14 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 119.321 1.56 . . . . 2.03 111.44 173.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.7 mt -69.52 -52.22 28.43 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 124.912 1.285 . . . . 1.6 111.264 178.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -53.62 -48.28 69.46 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.915 1.286 . . . . 3.72 110.695 179.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 67.6 t -63.99 -49.24 82.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 108.25 -1.019 . . . . 1.53 108.25 179.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 98.3 m -56.18 -43.01 77.99 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.15 0.58 . . . . 1.72 112.4 178.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.74 -37.02 85.78 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.479 1.112 . . . . 2.76 111.911 -179.089 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 64.1 mt -79.82 -30.63 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 CA-C-N 118.775 0.716 . . . . 1.94 110.855 176.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.2 mt -59.81 -36.09 76.05 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 120.694 -1.254 . . . . 1.62 112.687 170.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 27.2 mttt -65.84 -19.05 65.74 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 113.429 0.9 . . . . 2.06 113.429 175.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -98.43 -39.2 8.89 Favored 'General case' 0 N--CA 1.434 -1.254 0 C-N-CA 126.079 1.752 . . . . 2.17 113.946 179.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 29.5 mmtt -78.17 -21.69 49.81 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 112.675 0.62 . . . . 3.03 112.675 172.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -136.24 52.4 6.31 Favored Pre-proline 0 CA--C 1.55 0.98 0 N-CA-C 118.126 2.639 . . . . 3.66 118.126 178.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -69.47 -22.07 33.94 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 123.659 2.906 . . . . 1.09 114.395 173.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 13.4 mmp_? -82.7 -18.37 41.13 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 120.861 -1.149 . . . . 7.82 112.485 177.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -55.5 145.87 21.71 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 125.868 1.667 . . . . 1.92 113.559 176.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 81.9 p -86.44 -28.97 23.19 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.247 1.019 . . . . 1.88 110.938 176.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -121.69 143.73 49.18 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.001 0.921 . . . . 1.75 112.615 164.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.5 pt -155.41 111.53 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 128.123 2.569 . . . . 1.97 110.167 169.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 6.4 ptpt -153.28 156.0 37.59 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.885 1.274 . . . . 1.94 113.062 176.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.7 t -133.77 145.94 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 126.314 1.846 . . . . 1.66 110.281 -177.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 28.4 m -132.69 128.02 36.05 Favored 'General case' 0 CA--C 1.512 -0.482 0 C-N-CA 123.706 0.802 . . . . 1.63 111.521 171.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -74.04 125.3 27.99 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 122.209 1.004 . . . . 1.8 109.586 165.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.4 pt -124.72 30.5 2.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 125.273 1.429 . . . . 1.6 109.96 178.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 32.4 t -138.98 62.73 1.53 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 127.509 2.324 . . . . 1.88 111.998 -175.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -65.63 10.62 0.47 Allowed Glycine 0 CA--C 1.541 1.696 0 O-C-N 120.256 -1.528 . . . . 1.51 116.689 178.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -121.49 -4.28 9.92 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 125.749 1.642 . . . . 1.06 114.709 171.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 9.2 t -156.97 -31.59 0.08 Allowed 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 119.386 1.593 . . . . 3.45 114.832 -176.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 59.93 48.93 83.67 Favored Glycine 0 CA--C 1.538 1.516 0 C-N-CA 126.036 1.779 . . . . 0.62 113.051 -161.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -105.88 -17.47 14.35 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 126.299 1.839 . . . . 1.68 114.625 178.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 6.6 mtm -110.9 140.43 45.38 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 126.11 1.764 . . . . 2.48 111.954 168.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -142.99 148.93 37.62 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.725 0.81 . . . . 3.26 112.795 172.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -85.84 138.45 32.04 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.858 1.663 . . . . 1.96 109.356 163.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 84.2 mt -134.75 131.01 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 CA-C-N 120.057 1.299 . . . . 1.8 109.965 171.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 66.9 mttt -128.2 118.59 23.61 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.637 1.175 . . . . 3.61 111.329 179.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.2 mt -128.5 157.36 41.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 C-N-CA 126.586 1.954 . . . . 1.51 109.633 -178.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -157.39 126.9 6.03 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 120.353 -1.467 . . . . 1.84 109.248 170.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 16.4 t -160.1 144.29 14.43 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 120.599 1.545 . . . . 0.46 112.815 -169.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -55.32 -29.69 58.76 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.902 1.281 . . . . 4.87 112.562 -177.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -66.43 -19.25 65.75 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 115.166 1.543 . . . . 1.75 115.166 178.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -82.56 -2.78 54.66 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 120.824 -1.172 . . . . 3.5 114.106 -172.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 55.3 pttt -67.09 -25.45 66.23 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.752 1.621 . . . . 3.85 114.432 -176.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -109.05 26.61 10.41 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.976 1.71 . . . . 4.56 111.415 -169.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 38.9 mmtt -131.79 141.4 49.46 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 126.535 1.934 . . . . 2.36 111.319 -172.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 31.0 mtt180 -64.04 165.38 9.11 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 118.975 -0.535 . . . . 5.65 110.906 165.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 66.7 m -48.24 -54.53 13.27 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 113.154 0.798 . . . . 1.78 113.154 170.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.2 p -60.34 -39.38 80.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 124.656 1.182 . . . . 1.84 112.717 176.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -69.88 -35.37 74.6 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 112.841 0.682 . . . . 1.33 112.841 176.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -60.87 -52.33 65.52 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 119.507 1.049 . . . . 0.79 109.911 170.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 38.3 m170 -54.8 -51.6 65.27 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.292 0.637 . . . . 0.57 111.81 176.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 41.3 tp60 -48.76 -44.02 38.36 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.933 1.693 . . . . 1.4 113.161 178.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 1.4 mtm -63.46 -40.36 96.92 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 119.628 1.104 . . . . 2.14 111.868 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.2 t -74.83 -31.17 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 124.556 1.142 . . . . 1.6 111.145 178.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -66.88 -52.82 38.75 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.571 1.549 . . . . 0.45 110.697 176.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 43.7 tp60 -64.09 -23.91 67.5 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 119.993 -1.692 . . . . 2.63 113.15 -177.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -54.19 -45.82 72.25 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.9 1.28 . . . . 1.61 111.254 177.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -119.91 1.47 10.96 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 114.994 1.479 . . . . 1.49 114.994 -175.062 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 29.8 ttpt -51.28 -36.8 43.95 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 125.226 1.41 . . . . 3.16 112.13 -177.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -85.15 -9.09 58.25 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 112.781 0.66 . . . . 2.21 112.781 -174.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -94.91 -62.05 1.38 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 127.128 2.171 . . . . 3.01 110.428 174.418 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 8.6 mm -121.61 88.93 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 125.631 1.572 . . . . 2.52 109.044 176.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -72.76 -16.68 61.64 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 115.378 1.621 . . . . 3.36 115.378 -174.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.9 mp0 -63.18 39.08 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 130.946 3.699 . . . . 3.1 115.903 -177.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 64.2 mtm -69.46 2.55 2.98 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 119.669 -1.894 . . . . 2.52 115.412 -170.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 10.9 p-80 -65.85 -22.7 66.56 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.611 0.764 . . . . 5.98 112.668 160.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -84.57 -14.79 69.88 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 125.995 1.76 . . . . 0.52 114.27 171.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.6 mp -97.47 127.01 43.08 Favored 'General case' 0 C--O 1.236 0.37 0 O-C-N 121.553 -0.969 . . . . 2.75 111.877 -168.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 59.2 ttt180 -106.11 101.05 10.56 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.734 2.014 . . . . 4.61 109.735 178.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 4.8 mt -107.59 141.08 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-O 123.183 1.468 . . . . 1.8 112.02 -173.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -129.74 130.99 46.13 Favored 'General case' 0 N--CA 1.433 -1.31 0 C-N-CA 128.35 2.66 . . . . 3.43 108.628 -174.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 13.6 p -143.1 152.94 42.4 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 126.006 1.722 . . . . 1.55 109.036 -178.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 2.8 p -163.03 -179.48 6.75 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.617 -1.174 . . . . 0.63 109.671 177.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.2 p -144.19 135.26 12.46 Favored Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 112.909 0.707 . . . . 1.92 112.909 -175.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo . . . . . 0 C--N 1.35 0.654 0 C-N-CA 124.157 3.238 . . . . 0.73 112.024 179.72 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 . . . . . 0 CA--C 1.548 0.868 0 CA-C-O 121.112 0.482 . . . . 3.52 111.093 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 55.2 p -127.69 -175.87 3.6 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 126.257 1.823 . . . . 1.73 109.795 168.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -62.21 -39.55 93.14 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 120.646 1.566 . . . . 4.61 110.764 160.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.48 -43.78 96.16 Favored Glycine 0 C--N 1.34 0.789 0 C-N-CA 126.045 1.783 . . . . 0.73 113.21 -177.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.12 -48.35 73.77 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 118.974 1.387 . . . . 1.31 112.565 -178.317 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 46.0 mt -66.32 -50.31 64.07 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 125.807 1.643 . . . . 1.82 110.882 178.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -54.99 -50.03 70.0 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.779 2.032 . . . . 4.05 111.428 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.2 t -64.36 -47.12 90.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 124.418 1.087 . . . . 1.78 108.127 177.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 89.7 m -57.65 -38.3 74.83 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 118.035 0.38 . . . . 1.66 111.998 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -62.39 -40.67 97.24 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 112.629 0.603 . . . . 1.69 112.629 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 24.3 mt -79.4 -29.46 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 O-C-N 123.314 0.384 . . . . 2.02 111.013 179.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.1 mt -56.13 -41.54 75.48 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 120.833 -1.167 . . . . 1.81 113.534 169.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 38.5 mttt -60.89 -28.61 69.01 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 113.262 0.838 . . . . 2.97 113.262 178.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -93.48 -37.96 11.67 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 127.294 2.238 . . . . 2.04 114.497 -175.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -73.87 -26.91 60.8 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-O 117.999 -1.0 . . . . 2.03 111.489 171.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -132.06 52.01 8.33 Favored Pre-proline 0 CA--C 1.547 0.865 0 N-CA-C 117.811 2.523 . . . . 2.7 117.811 -177.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -62.48 -22.6 74.24 Favored 'Trans proline' 0 C--O 1.236 0.403 0 C-N-CA 123.758 2.972 . . . . 0.74 114.194 174.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.41 -18.44 64.45 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 113.953 1.094 . . . . 8.52 113.953 174.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -56.36 150.67 14.35 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 115.552 1.686 . . . . 1.55 115.552 -167.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 61.1 p -90.26 -35.66 15.17 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 114.702 -1.135 . . . . 1.76 111.672 166.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -125.09 136.13 53.36 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.53 1.132 . . . . 1.39 111.176 173.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.5 pt -153.89 114.08 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 124.381 1.073 . . . . 1.52 112.876 171.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -157.14 154.62 29.64 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.569 1.548 . . . . 2.42 113.297 -179.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.8 t -131.77 142.66 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 127.673 2.389 . . . . 1.88 108.604 177.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 59.2 m -135.77 120.72 18.67 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.948 1.299 . . . . 1.82 110.484 175.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -70.52 128.74 37.19 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.95 0.881 . . . . 1.91 109.839 168.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.7 pt -130.47 31.19 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 C-N-CA 126.566 1.946 . . . . 2.05 109.597 178.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.7 t -139.87 61.91 1.52 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 128.319 2.648 . . . . 2.06 110.436 -170.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.6 -3.47 5.63 Favored Glycine 0 CA--C 1.538 1.504 0 N-CA-C 118.128 2.011 . . . . 1.25 118.128 -168.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -140.37 12.41 3.01 Favored Glycine 0 N--CA 1.475 1.24 0 CA-C-N 119.632 1.716 . . . . 1.35 115.222 175.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 16.7 m -143.55 -34.15 0.41 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.746 1.618 . . . . 3.95 111.865 -176.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 52.84 42.96 60.41 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 126.69 2.091 . . . . 0.71 113.194 -177.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -107.34 -29.86 9.04 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.446 1.898 . . . . 2.31 112.357 -177.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 1.8 mtm -102.97 126.53 50.18 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 126.501 1.92 . . . . 2.54 109.96 -179.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -139.05 150.51 45.84 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.157 0.983 . . . . 3.27 110.487 178.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -104.72 124.28 49.11 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.856 1.662 . . . . 2.04 109.448 171.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 53.8 mt -124.61 135.5 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 125.314 1.446 . . . . 1.8 110.645 -176.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 62.0 tttt -126.74 120.71 30.07 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.177 0.991 . . . . 6.07 110.455 174.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.1 mt -125.31 154.0 33.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 126.453 1.901 . . . . 1.76 108.974 176.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -156.02 130.3 8.79 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 120.561 -1.337 . . . . 1.63 108.393 166.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.4 t -162.64 147.22 11.89 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 118.881 0.764 . . . . 0.76 112.369 -174.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -55.21 -24.15 25.83 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.303 1.841 . . . . 2.95 114.553 -175.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -70.07 -18.26 63.27 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 115.155 1.539 . . . . 2.51 115.155 175.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -78.56 15.86 0.94 Allowed 'General case' 0 CA--C 1.559 1.32 0 N-CA-C 114.854 1.427 . . . . 2.84 114.854 -173.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 38.4 pttt -79.1 -35.7 41.86 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 128.215 2.606 . . . . 3.25 117.275 -165.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -119.45 32.27 6.17 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.455 1.102 . . . . 3.69 112.301 -179.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 67.8 mmtt -112.13 142.21 44.86 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 128.043 2.537 . . . . 2.12 111.214 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 8.2 mmt180 -66.19 161.87 21.09 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.141 0.976 . . . . 4.12 111.002 163.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 96.4 m -47.42 -55.74 8.36 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.334 1.054 . . . . 1.92 113.616 169.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.6 p -56.9 -37.61 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 124.809 1.243 . . . . 1.82 112.644 178.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.4 mm100 -77.14 -32.33 56.28 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.444 1.098 . . . . 2.3 113.048 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -62.92 -53.57 51.97 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.156 0.889 . . . . 0.78 109.832 168.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 39.2 m170 -53.15 -50.87 63.68 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.914 0.886 . . . . 0.51 111.626 177.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 34.7 tp60 -48.28 -44.27 33.46 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.922 1.289 . . . . 1.29 112.875 178.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 4.1 mtm -61.59 -43.41 98.92 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 119.977 1.262 . . . . 2.24 111.297 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.8 t -71.83 -29.08 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.87 1.268 . . . . 1.5 111.471 178.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -71.91 -44.67 63.31 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.102 1.361 . . . . 0.62 110.481 175.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.7 -22.83 66.06 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 120.647 -1.283 . . . . 2.84 113.379 178.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.45 -38.98 78.64 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.784 1.234 . . . . 1.66 112.48 176.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.04 -2.31 9.2 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 114.772 1.397 . . . . 1.8 114.772 -173.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 11.0 ttpp -49.49 -35.73 20.77 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 126.086 1.754 . . . . 4.83 113.323 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -88.76 -11.19 45.7 Favored 'General case' 0 CA--C 1.552 1.044 0 N-CA-C 112.307 0.484 . . . . 2.09 112.307 -174.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -95.45 -49.79 5.27 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 127.338 2.255 . . . . 3.75 112.045 174.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 34.2 mt -135.41 113.07 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 127.525 2.33 . . . . 2.28 106.302 172.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.86 -17.78 34.65 Favored 'General case' 0 N--CA 1.48 1.075 0 O-C-N 120.703 -1.248 . . . . 4.21 114.22 -169.54 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -88.33 63.9 7.34 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.33 1.852 . . . . 4.21 112.798 -164.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 5.3 mpp? -69.14 8.04 0.63 Allowed 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 115.16 1.541 . . . . 2.31 115.16 -178.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 28.3 p80 -53.18 -36.42 60.92 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 120.978 -1.076 . . . . 5.22 113.377 171.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -85.43 -9.25 79.55 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 125.673 1.606 . . . . 0.62 114.635 -179.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.9 mp -96.68 107.36 19.8 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 121.311 -1.111 . . . . 2.77 112.44 -166.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 10.4 ttt180 -81.05 117.39 21.59 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 112.818 -1.992 . . . . 3.94 108.467 171.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 4.3 mt -125.29 135.07 65.18 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.679 0 CA-C-O 123.448 1.594 . . . . 1.75 112.491 -175.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -121.69 122.67 40.1 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 111.539 -2.573 . . . . 3.85 107.611 -175.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 15.6 p -132.92 152.5 51.89 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.103 1.361 . . . . 1.52 110.21 179.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.8 p -158.2 175.57 13.6 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 124.639 1.176 . . . . 0.64 110.367 176.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 9.0 p -141.94 127.82 10.86 Favored Pre-proline 0 N--CA 1.472 0.661 0 C-N-CA 123.132 0.573 . . . . 1.57 111.77 -177.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo . . . . . 0 CA--C 1.537 0.64 0 C-N-CA 123.447 2.765 . . . . 0.66 111.957 -176.367 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.856 0 CA-C-O 119.715 -0.183 . . . . 5.83 110.805 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.7 m -146.44 175.32 10.64 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 125.645 1.578 . . . . 4.21 110.289 177.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -127.51 154.91 44.55 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.658 1.183 . . . . 2.66 111.897 170.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 80.0 p -107.11 164.5 12.11 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.008 0.923 . . . . 2.13 109.414 156.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 21.9 mp0 -64.32 -22.13 66.85 Favored 'General case' 0 CA--C 1.549 0.941 0 O-C-N 121.454 -0.778 . . . . 3.72 111.716 162.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.45 -39.61 95.81 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 126.72 2.105 . . . . 0.48 114.08 170.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.87 -43.99 73.64 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.486 1.643 . . . . 2.1 111.29 174.078 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 11.7 mt -66.28 -55.37 16.38 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 125.399 1.48 . . . . 1.64 109.867 178.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.3 tpm_? -49.69 -51.46 38.16 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.632 1.573 . . . . 8.63 113.351 176.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 26.0 t -65.21 -43.33 95.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 106.945 -1.502 . . . . 1.78 106.945 -175.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 36.1 m -58.7 -38.21 77.78 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 118.525 -0.75 . . . . 1.51 112.056 175.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 14.3 mm-40 -60.97 -49.67 76.49 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 119.448 1.022 . . . . 1.73 112.219 -179.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 18.3 mt -75.34 -30.96 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 CA-C-N 118.343 0.519 . . . . 1.87 110.027 -175.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 29.9 mt -56.49 -38.33 71.61 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 114.459 1.281 . . . . 1.92 114.459 171.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 31.2 mttt -58.94 -36.76 75.32 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 119.122 0.874 . . . . 3.98 112.347 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.03 -36.31 15.87 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 128.651 2.78 . . . . 4.92 114.493 -173.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 48.6 mmtt -71.27 -20.84 62.17 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 118.262 -0.875 . . . . 2.13 112.397 167.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -134.09 59.12 35.8 Favored Pre-proline 0 CA--C 1.558 1.275 0 N-CA-C 117.756 2.502 . . . . 3.64 117.756 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.35 -19.81 32.86 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 124.62 3.547 . . . . 0.94 114.983 171.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 40.8 mmt180 -78.79 -0.12 29.19 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 120.836 -1.165 . . . . 5.72 113.775 170.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.26 149.1 50.86 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 115.675 1.731 . . . . 1.66 115.675 -176.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 16.3 p -108.15 -27.97 9.77 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 127.048 2.139 . . . . 1.44 112.842 170.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -119.57 138.63 53.08 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.376 1.071 . . . . 1.89 110.881 163.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.2 pt -153.92 118.87 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 124.788 1.235 . . . . 1.75 111.663 166.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.4 ptpt -158.11 154.39 27.43 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 126.032 1.733 . . . . 2.17 112.3 173.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.4 t -132.66 149.98 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 126.465 1.906 . . . . 1.8 109.712 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 92.5 m -140.0 131.18 26.51 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.613 0.765 . . . . 1.78 111.427 169.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -73.91 121.96 21.78 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.513 0.725 . . . . 1.8 109.978 163.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . 0.255 5.5 pt -117.11 25.52 4.35 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 C-N-CA 125.495 1.518 . . . . 1.69 111.039 179.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 31.9 t -137.91 58.99 1.67 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 128.564 2.746 . . . . 1.98 111.223 -173.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -55.53 -6.53 1.1 Allowed Glycine 0 CA--C 1.544 1.878 0 N-CA-C 119.003 2.361 . . . . 1.3 119.003 -173.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -133.04 16.39 4.7 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 126.247 1.879 . . . . 1.33 114.653 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 15.4 t -153.17 -39.7 0.1 Allowed 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.778 1.231 . . . . 2.54 111.776 170.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 64.67 44.18 95.31 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 125.699 1.618 . . . . 0.88 112.707 -167.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -90.08 -31.39 17.16 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.911 1.284 . . . . 2.33 113.667 173.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 9.0 mtm -104.43 138.01 41.46 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.866 1.266 . . . . 1.98 112.576 174.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -137.46 147.34 45.25 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.995 0.918 . . . . 3.32 111.225 169.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -83.32 138.49 33.53 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 124.904 1.282 . . . . 2.44 109.531 161.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 97.5 mt -134.48 129.0 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 CA-C-N 119.344 0.975 . . . . 1.76 109.474 168.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 71.6 mttt -126.06 115.99 20.71 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.688 1.195 . . . . 3.5 110.347 178.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.1 mt -127.02 156.62 38.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 126.442 1.897 . . . . 1.52 109.423 -177.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -152.87 133.3 13.67 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.252 1.821 . . . . 2.02 106.584 162.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 28.0 t -155.91 143.37 19.39 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 120.132 1.333 . . . . 0.44 112.883 -173.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -57.51 -20.62 32.62 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.923 1.289 . . . . 3.25 114.149 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -75.69 -15.12 60.34 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 114.27 1.211 . . . . 1.86 114.27 177.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -83.5 16.72 2.46 Favored 'General case' 0 CA--C 1.55 0.964 0 N-CA-C 113.689 0.996 . . . . 2.83 113.689 -174.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -71.05 -44.35 65.94 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.677 1.591 . . . . 4.25 112.654 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -91.85 35.85 0.97 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.206 1.402 . . . . 4.11 113.115 -174.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 62.6 mmtt -144.78 141.32 29.11 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.684 1.594 . . . . 2.39 113.115 -167.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 22.6 mmt180 -73.03 170.62 14.48 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 126.596 1.959 . . . . 5.39 112.223 162.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 84.2 m -50.95 -54.71 21.9 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.816 1.043 . . . . 2.21 113.816 168.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.1 p -59.9 -35.88 63.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 123.776 0.83 . . . . 2.07 112.974 178.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -76.4 -37.07 57.65 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.722 0.809 . . . . 1.5 112.029 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -59.83 -54.07 50.52 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.962 0.905 . . . . 0.95 109.889 168.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 47.8 m170 -50.13 -52.76 32.45 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.256 1.022 . . . . 0.66 111.878 177.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 39.9 tp60 -47.07 -44.28 20.82 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.592 1.557 . . . . 1.3 112.847 179.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 81.2 mtp -62.97 -43.43 98.81 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 121.166 -0.959 . . . . 1.95 112.255 178.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.2 t -71.22 -25.83 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 125.657 1.583 . . . . 1.49 111.735 177.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -76.8 -44.41 32.74 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.621 1.568 . . . . 0.51 109.69 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -64.76 -27.39 68.86 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 125.104 1.362 . . . . 3.44 113.99 175.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.94 -29.99 71.22 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.501 1.52 . . . . 1.49 112.916 -175.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.0 -8.19 8.85 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 115.124 1.527 . . . . 1.44 115.124 176.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -44.37 -43.58 7.68 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.081 1.352 . . . . 2.88 112.847 176.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -85.78 6.01 29.88 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-O 122.505 1.145 . . . . 2.45 111.759 -165.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -124.54 -56.27 1.61 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 129.946 3.299 . . . . 2.98 108.377 -177.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.0 mm -126.38 132.9 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 127.573 2.349 . . . . 3.17 108.923 169.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -92.77 -10.89 35.34 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 116.274 1.953 . . . . 3.48 116.274 -174.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -78.66 36.65 0.27 Allowed 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 117.702 2.482 . . . . 3.05 117.702 -153.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 4.6 mpp? -64.06 9.42 0.07 Allowed 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 116.259 1.948 . . . . 2.4 116.259 -175.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 49.3 t60 -65.07 -38.82 92.05 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 120.946 -1.096 . . . . 5.74 111.81 160.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -84.61 -17.79 63.23 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 126.355 1.931 . . . . 0.58 114.045 -178.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.5 mp -87.61 118.77 27.31 Favored 'General case' 0 C--N 1.332 -0.179 0 O-C-N 121.674 -0.898 . . . . 2.84 112.265 -170.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 28.7 ttm180 -98.02 102.06 13.71 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 127.453 2.301 . . . . 5.7 109.885 -177.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 4.1 mt -111.7 143.91 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-O 123.903 1.811 . . . . 1.55 113.14 -169.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -136.0 125.6 25.32 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 111.543 -2.571 . . . . 3.17 108.005 -171.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 28.3 p -144.86 153.55 41.72 Favored 'General case' 0 CA--C 1.509 -0.607 0 C-N-CA 125.837 1.655 . . . . 1.84 109.791 -171.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -163.35 175.55 10.73 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.239 -1.346 . . . . 1.34 109.379 176.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.4 p -122.97 139.65 31.87 Favored Pre-proline 0 C--N 1.325 -0.488 0 O-C-N 121.289 -0.882 . . . . 1.79 109.531 170.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -80.94 121.54 4.06 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 123.207 2.605 . . . . 1.07 108.463 172.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 10.2 mmtt -149.5 26.55 0.84 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.067 1.347 . . . . 4.26 111.083 -160.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 63.6 mtm-85 . . . . . 0 C--O 1.257 1.475 0 C-N-CA 126.687 1.995 . . . . 11.53 113.788 -157.002 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.736 0 N-CA-C 109.588 -0.523 . . . . 7.34 109.588 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 13.9 m -65.86 138.77 58.1 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.908 0.883 . . . . 4.72 111.777 -177.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -44.61 147.85 0.56 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.828 1.651 . . . . 3.06 115.443 -178.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 38.9 p -117.0 179.9 3.89 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.877 1.671 . . . . 1.96 111.041 169.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -70.45 -35.25 73.23 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 120.633 -1.292 . . . . 3.05 111.959 168.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -67.42 -37.59 90.33 Favored Glycine 0 CA--C 1.529 0.948 0 CA-C-O 118.572 -1.127 . . . . 0.48 112.901 178.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -46.08 -50.24 15.49 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.51 1.524 . . . . 1.38 112.713 173.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 15.1 mt -69.95 -50.73 39.03 Favored 'General case' 0 CA--C 1.528 0.098 0 C-N-CA 124.957 1.303 . . . . 1.8 111.132 -178.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.54 -48.36 77.43 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.578 1.151 . . . . 3.92 110.85 -179.027 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.0 t -63.12 -41.93 94.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 108.496 -0.927 . . . . 1.6 108.496 177.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 74.2 m -59.09 -42.08 89.61 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 118.761 0.709 . . . . 1.86 111.28 178.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -69.48 -33.37 72.79 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 114.011 1.115 . . . . 3.58 114.011 -175.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 30.5 mt -79.53 -30.69 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 CA-C-N 119.099 0.863 . . . . 1.67 110.694 173.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 33.1 mt -58.19 -36.74 73.54 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 120.74 -1.225 . . . . 1.83 113.233 171.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 38.0 mttt -59.78 -24.6 64.23 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 114.21 1.189 . . . . 1.97 114.21 173.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -101.25 -34.73 9.54 Favored 'General case' 0 N--CA 1.427 -1.575 0 C-N-CA 125.494 1.518 . . . . 2.08 113.87 -175.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -75.26 -24.66 57.63 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 118.646 -1.221 . . . . 1.95 111.79 169.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -130.6 54.55 14.99 Favored Pre-proline 0 CA--C 1.548 0.865 0 N-CA-C 117.049 2.24 . . . . 3.76 117.049 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -62.49 -30.79 80.26 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 123.573 2.849 . . . . 0.74 113.688 174.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 28.0 mmt85 -75.95 -11.89 60.04 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 120.352 1.433 . . . . 5.52 114.519 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -55.21 146.67 18.26 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.157 1.783 . . . . 1.41 114.524 -174.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 66.7 p -88.09 -30.74 19.65 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.905 0.882 . . . . 1.74 111.111 170.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -129.77 138.67 51.19 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.005 0.922 . . . . 1.52 111.734 170.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.6 pt -150.46 117.74 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 125.572 1.549 . . . . 2.18 111.419 165.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.79 157.79 37.06 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.705 1.202 . . . . 3.45 113.46 169.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.0 t -125.08 144.13 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 128.215 2.606 . . . . 1.86 110.492 -173.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 80.7 m -128.86 126.37 39.64 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.388 1.475 . . . . 1.77 109.518 166.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -73.41 139.2 45.72 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 122.023 0.916 . . . . 2.47 110.344 165.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.7 pt -134.31 32.8 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 C-N-CA 126.411 1.884 . . . . 1.93 110.397 177.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 23.2 t -141.01 62.31 1.48 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 128.13 2.572 . . . . 1.99 112.779 -171.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.08 -30.11 60.27 Favored Glycine 0 CA--C 1.54 1.619 0 O-C-N 119.989 -1.694 . . . . 1.8 114.649 179.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -85.81 -9.46 77.86 Favored Glycine 0 CA--C 1.539 1.549 0 N-CA-C 116.421 1.328 . . . . 1.62 116.421 -179.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 19.6 t -148.52 -38.83 0.17 Allowed 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 119.493 1.646 . . . . 3.27 114.319 -175.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 66.82 43.52 91.41 Favored Glycine 0 CA--C 1.536 1.375 0 C-N-CA 126.854 2.168 . . . . 1.16 112.581 -165.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -94.06 -37.98 11.36 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.13 1.372 . . . . 2.57 113.594 172.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' MET . . . . . 0.421 ' HG3' ' CA ' ' A' ' 97' ' ' GLY . 4.0 mpp? -94.99 140.29 30.16 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 124.373 1.069 . . . . 2.82 112.962 -175.252 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -145.38 143.5 30.15 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 122.393 1.092 . . . . 3.24 113.805 175.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -100.07 119.51 38.41 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.364 1.866 . . . . 2.67 109.911 170.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 61.6 mt -132.48 130.54 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.784 1.234 . . . . 1.96 110.747 -161.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -117.67 125.95 51.63 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.304 1.442 . . . . 3.83 110.683 177.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.2 mt -129.35 156.37 41.79 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 C-N-CA 127.347 2.259 . . . . 1.67 109.703 174.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -155.37 133.67 11.67 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.678 1.591 . . . . 1.82 108.704 164.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 16.9 t -159.55 140.49 12.51 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 119.811 1.187 . . . . 0.33 112.865 -175.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -61.48 -3.6 1.05 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 127.609 2.364 . . . . 3.73 115.084 179.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -84.8 -23.6 29.07 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.901 1.68 . . . . 1.66 113.725 173.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -79.92 9.93 4.79 Favored 'General case' 0 CA--C 1.555 1.16 0 N-CA-C 116.052 1.871 . . . . 2.91 116.052 -165.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.89 -37.17 35.35 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 117.613 2.449 . . . . 4.01 117.613 -163.033 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -88.63 40.53 0.97 Allowed 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 121.046 1.748 . . . . 4.33 111.993 178.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.9 mmtp -139.71 137.16 34.93 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 125.437 1.495 . . . . 2.97 111.823 -168.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 46.2 mtt180 -68.75 172.03 6.97 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.856 1.662 . . . . 4.51 111.741 164.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 87.0 m -47.6 -58.34 4.37 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 125.357 1.463 . . . . 1.78 113.425 170.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.2 p -59.48 -36.13 62.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.351 1.061 . . . . 1.77 112.775 176.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 11.1 mt-30 -77.08 -27.34 54.22 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 113.446 0.906 . . . . 1.61 113.446 -177.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -71.42 -54.1 11.81 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.012 0.925 . . . . 0.89 110.33 166.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 52.6 m170 -55.08 -42.58 73.0 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.543 0.737 . . . . 0.57 112.414 -177.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 31.0 tp60 -47.43 -42.0 21.44 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 126.201 1.801 . . . . 1.15 113.032 177.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 63.8 mtp -66.36 -43.47 85.9 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 123.568 0.747 . . . . 1.62 111.234 -177.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.5 t -72.27 -34.31 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 127.058 2.143 . . . . 1.8 111.654 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -63.16 -53.15 57.76 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 127.169 2.188 . . . . 0.56 109.524 173.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.8 tm0? -65.27 -30.19 71.04 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.234 -0.916 . . . . 3.21 112.235 -177.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -55.89 -34.22 65.34 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 125.631 1.573 . . . . 1.69 112.72 -172.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.41 -2.81 9.45 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 115.053 1.501 . . . . 1.73 115.053 177.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 26.8 ttpt -51.15 -36.3 40.17 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.957 0.903 . . . . 2.72 112.475 178.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -74.92 -13.73 60.57 Favored 'General case' 0 N--CA 1.439 -1.022 0 O-C-N 121.578 -0.701 . . . . 2.24 112.269 -176.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -94.86 -49.49 5.56 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 128.466 2.706 . . . . 3.0 113.448 172.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 30.6 mt -141.02 129.35 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 127.738 2.415 . . . . 2.12 107.938 177.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 45.7 mttp -97.66 -14.66 20.8 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 116.21 1.93 . . . . 4.27 116.21 -170.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -79.35 68.41 5.34 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 115.354 1.613 . . . . 4.96 115.354 -160.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -70.39 1.58 4.84 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 116.471 2.026 . . . . 2.97 116.471 -178.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 22.4 t60 -54.57 -32.66 58.91 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.924 0.868 . . . . 5.71 112.064 153.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.421 ' CA ' ' HG3' ' A' ' 62' ' ' MET . . . -83.39 -18.01 65.28 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 126.175 1.845 . . . . 0.62 116.544 -176.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 10.1 mt -93.62 139.56 30.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 118.517 1.158 . . . . 3.45 110.746 -168.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 35.5 ttt180 -123.55 95.76 4.71 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.552 1.541 . . . . 4.03 107.91 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -114.32 135.34 54.39 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.475 0 CA-C-O 123.115 1.436 . . . . 1.87 112.444 -161.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -127.83 114.24 16.97 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 112.178 -2.283 . . . . 3.42 107.764 -168.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 23.4 p -127.13 150.31 49.55 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.293 1.437 . . . . 1.5 110.566 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 2.2 p -150.7 172.73 15.11 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.222 -1.354 . . . . 0.79 111.123 173.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.9 p -140.24 129.58 13.42 Favored Pre-proline 0 N--CA 1.472 0.628 0 C-N-CA 123.172 0.589 . . . . 1.75 111.6 178.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -78.66 109.67 2.66 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 123.751 2.967 . . . . 0.68 111.418 -177.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 71.7 tttt -140.98 46.7 1.75 Allowed 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.313 1.445 . . . . 4.55 111.853 -157.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 48.0 ttp180 . . . . . 0 C--O 1.254 1.307 0 C-N-CA 127.064 2.145 . . . . 7.54 113.331 -172.282 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.943 0 N-CA-C 110.12 -0.326 . . . . 5.72 110.12 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.0 t -145.64 153.23 40.8 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.268 1.027 . . . . 4.36 111.227 -177.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 96.7 mm-40 -129.96 152.99 48.82 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 122.638 1.208 . . . . 3.2 113.018 171.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 62.6 p -121.06 161.63 21.38 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 112.532 -2.122 . . . . 1.72 108.46 149.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -63.88 -21.15 66.32 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 120.586 -1.321 . . . . 2.7 112.044 164.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -67.38 -39.24 91.61 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 126.875 2.179 . . . . 0.66 113.572 173.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.25 -44.31 68.04 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.512 1.525 . . . . 1.29 111.233 173.03 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.4 mt -68.79 -53.92 18.87 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 125.801 1.64 . . . . 1.82 110.935 176.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.5 ttp-105 -49.8 -50.06 46.41 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 126.617 1.967 . . . . 4.38 111.162 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 52.0 t -68.27 -46.94 80.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 123.992 0.917 . . . . 1.6 108.538 -178.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 98.3 m -57.93 -42.63 85.23 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 118.497 0.589 . . . . 1.72 111.903 178.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -62.39 -35.9 80.62 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.888 0.875 . . . . 2.93 112.449 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 62.4 mt -80.86 -31.81 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-N 118.845 0.748 . . . . 1.8 111.019 175.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 29.6 mt -58.09 -37.58 74.78 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 120.945 -1.097 . . . . 1.42 112.34 171.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 23.9 mttt -63.38 -22.36 66.83 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 113.539 0.94 . . . . 2.66 113.539 174.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -96.41 -36.15 10.93 Favored 'General case' 0 N--CA 1.434 -1.255 0 C-N-CA 125.994 1.717 . . . . 2.13 114.694 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 64.9 mmtt -74.84 -28.01 60.51 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 119.668 -0.813 . . . . 2.68 111.8 171.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -130.33 50.29 5.83 Favored Pre-proline 0 CA--C 1.55 0.952 0 N-CA-C 117.65 2.463 . . . . 3.61 117.65 -178.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -61.51 -25.47 79.63 Favored 'Trans proline' 0 C--O 1.237 0.468 0 C-N-CA 123.949 3.099 . . . . 0.95 114.428 177.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 12.5 mmt85 -80.78 -11.35 59.62 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 114.148 1.166 . . . . 5.84 114.148 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -51.85 151.33 3.55 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 126.245 1.818 . . . . 1.52 114.725 -173.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 68.9 p -93.04 -32.21 14.57 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.976 1.31 . . . . 1.57 111.033 169.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -124.82 139.01 54.23 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.212 1.005 . . . . 1.6 111.992 170.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.4 pt -156.16 112.49 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 126.433 1.893 . . . . 1.76 111.316 166.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.5 ptpt -151.88 148.3 27.64 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.916 1.286 . . . . 1.82 112.888 172.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 29.0 t -124.39 144.2 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 127.1 2.16 . . . . 1.65 108.872 -178.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 98.9 m -132.07 127.34 35.9 Favored 'General case' 0 CA--C 1.512 -0.507 0 C-N-CA 124.732 1.213 . . . . 1.95 109.931 172.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.82 130.44 41.07 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 124.25 1.02 . . . . 2.58 111.009 174.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.3 pt -132.64 26.61 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 C-N-CA 126.234 1.814 . . . . 1.6 110.77 174.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.5 t -138.14 107.97 6.3 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.931 1.293 . . . . 2.04 113.519 164.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -83.43 -18.06 65.12 Favored Glycine 0 N--CA 1.474 1.203 0 C-N-CA 124.228 0.918 . . . . 2.4 113.821 162.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -77.36 -39.69 25.71 Favored Glycine 0 N--CA 1.467 0.746 0 C-N-CA 124.548 1.071 . . . . 2.28 113.368 -175.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 20.8 m -145.9 -17.89 0.46 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.755 1.222 . . . . 2.55 113.284 -170.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 63.06 37.8 95.54 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 126.374 1.94 . . . . 1.03 113.948 -178.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -101.61 -8.96 21.37 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.67 1.188 . . . . 2.94 113.074 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 7.8 ttm -119.35 122.12 41.11 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 125.824 1.65 . . . . 1.9 109.803 -162.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -146.06 147.26 31.43 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 121.859 0.838 . . . . 3.4 112.989 -177.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -101.52 124.29 46.95 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.705 1.602 . . . . 2.48 109.692 173.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 95.5 mt -134.54 130.84 53.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 O-C-N 120.866 -1.146 . . . . 1.94 111.44 -165.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.5 mptt -119.8 130.45 54.93 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.529 0.732 . . . . 4.22 111.618 171.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.3 mt -129.67 159.46 41.69 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 C-N-CA 126.566 1.947 . . . . 1.58 109.279 176.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -159.42 135.4 8.78 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 126.347 1.859 . . . . 1.86 108.628 165.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.3 t -162.98 146.7 11.03 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 118.494 0.588 . . . . 0.46 111.491 -176.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -51.38 -32.53 26.29 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.858 1.663 . . . . 3.66 113.759 178.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -63.39 -20.08 65.22 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 114.838 1.422 . . . . 1.68 114.838 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -81.45 10.96 4.96 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 114.984 1.476 . . . . 2.85 114.984 -169.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.5 pttt -74.63 -43.84 53.45 Favored 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 115.002 1.482 . . . . 3.03 115.002 -172.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -91.15 27.64 1.83 Allowed 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 124.894 1.278 . . . . 4.23 111.803 -174.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -123.09 140.14 53.34 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 127.47 2.308 . . . . 2.27 111.451 -171.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 13.1 mmt85 -69.37 165.94 19.67 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.057 1.343 . . . . 3.55 110.629 161.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 28.2 m -52.09 -53.55 41.06 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.718 1.207 . . . . 1.75 112.986 171.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.1 p -59.55 -35.64 60.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 124.252 1.021 . . . . 2.08 113.161 175.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -74.79 -35.89 62.51 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.676 0.621 . . . . 1.21 112.676 177.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -60.26 -51.6 68.86 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 119.462 1.028 . . . . 0.87 109.192 169.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 36.7 m170 -55.62 -46.08 77.44 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.603 0.761 . . . . 0.84 112.982 177.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 40.1 tp60 -48.43 -45.5 36.4 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.511 1.525 . . . . 1.31 112.625 176.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 67.0 mtp -63.71 -34.73 78.53 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 119.407 1.003 . . . . 1.91 112.792 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.8 t -78.24 -30.34 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 125.689 1.596 . . . . 1.82 111.752 177.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -71.27 -50.9 27.95 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.266 1.826 . . . . 0.72 110.965 174.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 27.3 tp60 -69.78 -15.01 63.05 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 125.327 1.451 . . . . 3.15 113.784 -178.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.15 -39.93 88.05 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.575 1.15 . . . . 1.8 112.539 173.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.86 -0.07 8.54 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 115.764 1.764 . . . . 1.69 115.764 -177.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 27.0 ttmt -43.57 -45.24 6.59 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 125.631 1.572 . . . . 2.96 113.147 177.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -83.19 -7.02 59.68 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-O 121.294 0.569 . . . . 2.09 112.201 -169.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 23.6 tp10 -103.59 -41.49 5.95 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 129.55 3.14 . . . . 2.21 111.011 -176.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 44.6 mt -150.61 115.21 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 129.806 3.242 . . . . 2.33 107.029 175.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -92.26 -4.62 53.79 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 117.336 2.347 . . . . 4.17 117.336 -169.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -82.13 33.55 0.4 Allowed 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 127.97 2.508 . . . . 2.99 115.503 -161.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 4.4 mpp? -68.53 6.16 0.88 Allowed 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 117.639 2.459 . . . . 2.32 117.639 -165.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 34.2 t60 -42.62 -38.67 2.09 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 121.218 -0.926 . . . . 5.61 112.113 152.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -69.14 -16.15 70.57 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 126.294 1.902 . . . . 0.7 117.03 -179.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 12.4 mt -96.7 129.47 44.1 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 119.057 1.428 . . . . 3.43 112.715 -163.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 35.9 ttt180 -111.03 87.64 2.59 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 126.912 2.085 . . . . 4.3 107.906 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 1.7 mt -106.23 144.61 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-O 122.879 1.323 . . . . 1.84 112.31 -166.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -137.11 132.02 33.48 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 111.748 -2.478 . . . . 3.63 108.756 -173.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 21.1 p -146.24 152.78 39.74 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 126.449 1.899 . . . . 1.55 110.198 -173.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 2.6 p -159.51 177.92 10.43 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 124.405 1.082 . . . . 0.8 110.97 176.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.2 p -136.86 138.8 27.04 Favored Pre-proline 0 N--CA 1.47 0.567 0 C-N-CA 124.089 0.956 . . . . 1.82 110.412 175.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -79.04 118.02 3.98 Favored 'Trans proline' 0 CA--C 1.533 0.47 0 C-N-CA 122.828 2.352 . . . . 0.7 110.723 174.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -153.04 31.15 0.49 Allowed 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 114.127 1.158 . . . . 3.4 114.127 -159.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.318 0 C-N-CA 125.268 1.427 . . . . 9.46 113.493 -178.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.734 0 N-CA-C 109.768 -0.456 . . . . 8.76 109.768 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.1 m 54.0 48.92 20.06 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.13 1.372 . . . . 5.51 112.901 -176.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -107.1 139.98 40.67 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 125.824 1.649 . . . . 7.5 112.924 -175.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 79.2 p -110.38 -179.44 3.77 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.203 -1.036 . . . . 1.81 108.203 140.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -71.63 -30.94 66.33 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 119.797 -1.815 . . . . 3.5 112.396 162.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.73 -41.21 99.57 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 124.279 0.943 . . . . 0.77 113.281 173.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -54.14 -42.07 69.12 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.176 1.39 . . . . 1.52 112.919 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 22.5 mt -69.16 -50.67 45.59 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 125.519 1.527 . . . . 2.08 111.323 177.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.98 -50.3 73.1 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 126.004 1.722 . . . . 3.71 110.61 -179.148 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 56.2 t -60.42 -47.4 92.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 108.292 -1.003 . . . . 1.54 108.292 177.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 93.0 m -58.53 -38.63 78.17 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.646 0.61 . . . . 1.66 112.646 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.3 mm-40 -63.54 -40.23 96.49 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 118.412 0.551 . . . . 1.7 112.313 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 35.7 mt -82.02 -28.4 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 122.759 0.424 . . . . 1.91 110.77 -175.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 11.8 mt -54.23 -37.75 64.96 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.473 -0.767 . . . . 1.69 112.832 168.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.7 mttt -62.49 -25.27 67.92 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 114.237 1.199 . . . . 3.04 114.237 178.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -106.14 -31.83 8.51 Favored 'General case' 0 N--CA 1.435 -1.22 0 C-N-CA 126.775 2.03 . . . . 2.49 113.728 -167.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 53.1 mmtt -77.57 -24.84 49.71 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 118.729 -0.653 . . . . 2.47 111.713 164.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -131.71 49.54 4.77 Favored Pre-proline 0 CA--C 1.556 1.191 0 N-CA-C 118.435 2.754 . . . . 2.69 118.435 -178.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -68.07 -12.97 36.84 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 125.056 3.837 . . . . 0.85 114.948 176.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 38.8 mtt180 -99.58 -6.73 26.88 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.195 0.998 . . . . 6.05 113.444 175.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.41 139.91 58.56 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 125.025 1.33 . . . . 1.67 113.141 176.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 44.2 p -75.46 -35.52 60.86 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.249 1.42 . . . . 1.9 109.395 176.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -124.29 138.26 54.41 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.562 1.145 . . . . 1.66 111.736 171.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.8 pt -150.22 118.46 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 125.577 1.551 . . . . 1.97 112.522 163.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 7.8 ptpt -158.88 158.26 33.06 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.744 1.218 . . . . 2.69 114.016 177.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.7 t -126.11 155.93 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 127.766 2.426 . . . . 1.76 111.028 -174.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 88.4 m -147.14 127.35 13.83 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 120.996 -1.065 . . . . 1.54 111.817 162.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -69.63 126.91 31.16 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.889 0.852 . . . . 1.86 110.568 165.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.5 pt -126.08 25.14 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 C-N-CA 126.047 1.739 . . . . 1.52 111.387 -178.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 34.9 t -132.5 62.74 1.64 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 128.308 2.643 . . . . 2.22 109.032 176.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -54.29 -13.3 3.7 Favored Glycine 0 CA--C 1.54 1.643 0 N-CA-C 117.642 1.817 . . . . 1.73 117.642 -169.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -123.55 -6.71 7.2 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 126.31 1.91 . . . . 1.75 115.828 -179.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -138.74 -21.75 0.99 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.212 1.405 . . . . 3.21 114.399 -176.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 55.0 39.06 67.3 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 128.054 2.74 . . . . 0.95 115.477 -178.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -88.05 -32.47 18.74 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.131 1.372 . . . . 2.17 114.094 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 8.5 mtm -106.9 142.25 36.82 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.648 1.579 . . . . 2.35 112.842 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -142.46 144.09 32.88 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 122.181 0.991 . . . . 3.36 112.539 172.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -83.05 139.46 33.24 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 126.604 1.961 . . . . 2.07 110.076 165.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 90.6 mt -138.01 128.45 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 CA-C-N 119.39 0.996 . . . . 1.79 110.606 170.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 77.9 mttt -113.73 126.78 55.61 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.118 1.367 . . . . 3.85 110.943 171.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.3 mt -130.55 156.95 42.89 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 126.863 2.065 . . . . 1.56 109.938 174.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -156.8 130.86 8.43 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.332 1.453 . . . . 1.65 109.583 166.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 32.6 t -158.26 143.6 16.66 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 119.994 1.27 . . . . 0.57 112.019 -176.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -51.77 -24.86 6.49 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.206 1.402 . . . . 3.1 113.52 173.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -69.51 -14.59 62.94 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 114.182 1.179 . . . . 1.73 114.182 -178.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -92.33 13.85 18.17 Favored 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 125.163 1.385 . . . . 2.92 114.266 -175.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -79.27 -15.05 58.58 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 115.769 1.766 . . . . 4.18 115.769 -167.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -123.17 29.95 6.53 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.082 1.753 . . . . 4.54 110.867 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -122.35 129.85 52.54 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 126.299 1.84 . . . . 2.24 111.053 -172.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 38.3 mtt-85 -63.52 164.41 9.47 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.852 1.261 . . . . 4.29 111.064 168.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 86.7 m -44.53 -55.89 4.76 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.933 0.893 . . . . 1.71 112.985 170.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.2 p -61.57 -37.25 77.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 124.987 1.315 . . . . 1.7 113.164 178.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -75.66 -29.85 59.22 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 112.917 0.71 . . . . 1.12 112.917 179.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 60.5 mt-30 -65.09 -54.8 24.44 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 119.007 0.821 . . . . 1.96 109.03 168.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 45.1 m170 -54.46 -45.31 73.09 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.952 0.901 . . . . 0.61 112.859 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 50.5 tp60 -48.36 -43.46 33.58 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.363 1.465 . . . . 1.39 112.912 178.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 45.5 mtp -66.32 -42.03 88.81 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 121.43 -0.794 . . . . 1.82 111.717 -178.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.1 t -72.22 -29.7 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 125.267 1.427 . . . . 1.58 111.773 176.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -69.23 -51.72 34.9 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 126.185 1.794 . . . . 0.89 108.276 179.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -69.0 -19.89 64.15 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 113.748 1.018 . . . . 2.61 113.748 -176.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.4 -41.77 80.94 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.031 0.932 . . . . 1.49 111.652 178.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.86 -4.16 9.67 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 115.386 1.625 . . . . 1.68 115.386 -176.282 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 21.9 tttt -53.32 -34.68 58.43 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 125.048 1.339 . . . . 2.96 113.45 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 67.2 mt-10 -87.27 -2.58 58.72 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 123.166 0.587 . . . . 2.32 111.638 -174.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -100.98 -45.55 5.38 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 128.147 2.579 . . . . 3.09 112.17 167.225 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 30.2 mt -145.78 110.6 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 128.003 2.521 . . . . 2.08 107.676 178.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -86.17 -1.43 57.43 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 116.185 1.92 . . . . 3.07 116.185 -173.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -77.19 43.39 0.37 Allowed 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 128.728 2.811 . . . . 3.59 115.948 -164.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 4.7 mpp? -62.95 1.89 0.37 Allowed 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 114.952 1.464 . . . . 2.47 114.952 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 22.0 t60 -59.78 -26.51 65.77 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.513 1.125 . . . . 5.39 113.21 163.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -106.37 -8.15 33.67 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 126.893 2.187 . . . . 0.52 114.855 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.7 mp -96.38 123.52 40.05 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 118.374 1.087 . . . . 2.7 111.55 -173.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 54.0 ttt180 -105.68 100.01 9.59 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 126.956 2.102 . . . . 3.53 109.08 -174.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 3.6 mt -108.28 141.17 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-O 122.969 1.366 . . . . 1.59 111.795 -169.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -130.91 123.27 28.56 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 111.695 -2.502 . . . . 3.17 107.363 -173.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 16.2 p -136.94 140.45 42.26 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.058 1.343 . . . . 1.65 109.697 -176.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.6 t -138.01 -177.6 4.89 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 122.585 1.183 . . . . 2.24 110.922 167.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.2 p -147.65 135.78 10.96 Favored Pre-proline 0 C--N 1.317 -0.827 0 C-N-CA 126.085 1.754 . . . . 1.76 108.662 177.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -71.96 93.64 0.71 Allowed 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 123.018 2.478 . . . . 1.17 110.646 175.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 56.2 tttt -150.49 79.42 1.34 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 128.564 2.746 . . . . 5.13 107.941 -168.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 9.8 mmt180 . . . . . 0 C--O 1.254 1.312 0 C-N-CA 127.484 2.313 . . . . 13.85 111.74 -178.653 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.616 0 CA-C-O 118.515 -0.755 . . . . 6.99 112.177 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.5 m -62.61 128.7 37.18 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-N 120.345 1.43 . . . . 4.5 110.939 178.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -142.16 156.58 45.35 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 115.534 1.679 . . . . 3.42 115.534 -163.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 72.3 p -128.19 169.28 14.32 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 126.751 2.02 . . . . 1.76 108.614 160.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -68.37 -16.93 64.11 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 121.027 -1.046 . . . . 2.79 113.004 165.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.99 -42.88 67.32 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 124.62 1.105 . . . . 0.55 113.295 169.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.08 -48.88 43.91 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.488 1.915 . . . . 1.36 111.892 173.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 24.0 mt -67.04 -51.85 49.55 Favored 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 125.755 1.622 . . . . 1.84 111.353 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.5 ttp180 -50.45 -49.93 53.74 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 126.936 2.094 . . . . 5.82 110.667 178.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.7 t -67.92 -46.98 80.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 108.874 -0.787 . . . . 1.68 108.874 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 57.5 m -55.48 -40.35 71.56 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 118.324 0.511 . . . . 1.39 112.326 178.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -61.71 -42.47 98.98 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 112.349 0.499 . . . . 1.63 112.349 -177.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 18.5 mt -79.65 -29.37 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 CA-C-N 118.345 0.52 . . . . 1.95 111.514 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 22.9 mt -55.55 -40.4 71.86 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 120.98 -1.075 . . . . 1.76 113.759 172.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 42.4 mttt -59.45 -27.82 66.43 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 113.832 1.049 . . . . 2.23 113.832 178.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -97.4 -34.22 11.12 Favored 'General case' 0 N--CA 1.431 -1.382 0 C-N-CA 127.423 2.289 . . . . 2.22 114.233 -172.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 63.1 mmtt -74.27 -23.52 59.13 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 119.089 -1.044 . . . . 2.28 111.919 167.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -127.84 54.97 14.4 Favored Pre-proline 0 CA--C 1.554 1.101 0 N-CA-C 117.874 2.546 . . . . 2.65 117.874 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -66.87 -17.99 52.25 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 124.935 3.757 . . . . 0.82 114.99 173.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 25.1 mmt85 -85.29 -1.18 56.69 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 113.89 1.07 . . . . 5.58 113.89 171.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.19 149.36 50.05 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 114.3 1.222 . . . . 1.61 114.3 -176.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 72.4 p -114.98 -4.15 12.59 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.94 1.696 . . . . 1.72 113.418 173.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -140.73 146.31 37.59 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.422 1.089 . . . . 1.74 111.391 147.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.3 pt -154.58 117.54 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 126.381 1.872 . . . . 1.71 111.918 169.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.4 ptpt -158.66 148.43 19.41 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.918 1.287 . . . . 1.81 114.041 178.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.2 t -126.52 150.48 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 C-N-CA 126.834 2.053 . . . . 1.74 111.287 -173.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 98.1 m -143.57 135.41 26.51 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.502 0.721 . . . . 1.69 112.371 171.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -77.62 126.0 30.2 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 122.131 0.967 . . . . 1.92 111.012 168.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.0 pt -124.05 29.47 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 C-N-CA 126.151 1.781 . . . . 1.6 110.978 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.476 ' CB ' ' H ' ' A' ' 62' ' ' MET . 29.8 t -135.69 58.53 1.75 Allowed 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 128.214 2.606 . . . . 1.94 111.453 -174.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -65.27 14.77 0.21 Allowed Glycine 0 CA--C 1.537 1.444 0 N-CA-C 117.794 1.877 . . . . 2.12 117.794 -174.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -135.81 0.3 3.33 Favored Glycine 0 CA--C 1.537 1.407 0 C-N-CA 125.803 1.668 . . . . 1.27 114.085 175.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 36.7 t -151.61 -38.62 0.12 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.958 1.303 . . . . 3.12 113.568 -177.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 67.19 38.5 92.02 Favored Glycine 0 CA--C 1.541 1.678 0 C-N-CA 126.37 1.938 . . . . 0.77 114.67 -165.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -93.71 -20.32 20.25 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 127.242 2.217 . . . . 2.31 115.382 176.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' MET . . . . . 0.476 ' H ' ' CB ' ' A' ' 56' ' ' SER . 6.1 mtm -111.38 139.91 46.4 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.643 1.577 . . . . 2.41 112.862 172.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -139.96 150.0 43.97 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.875 0.87 . . . . 3.21 112.376 172.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -86.74 139.87 30.3 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 125.363 1.465 . . . . 2.31 110.126 163.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 90.1 mt -134.34 127.34 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 124.242 1.017 . . . . 1.85 109.606 168.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -117.34 122.74 44.72 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.522 1.129 . . . . 3.0 109.259 171.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.2 mt -126.81 157.63 37.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 127.089 2.155 . . . . 1.73 109.196 177.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -155.27 131.42 10.2 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 125.706 1.602 . . . . 1.93 107.69 168.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 28.7 t -156.82 143.05 18.12 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 120.304 1.411 . . . . 0.42 112.327 -173.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -63.91 -10.43 20.89 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 114.767 1.395 . . . . 3.18 114.767 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -79.51 -17.52 53.91 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 113.953 1.094 . . . . 1.83 113.953 174.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -84.19 1.23 45.48 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 114.556 1.317 . . . . 3.44 114.556 -167.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 30.1 pttt -79.77 -22.97 42.53 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 115.306 1.595 . . . . 4.76 115.306 -171.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -97.89 19.25 14.15 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-O 121.987 0.899 . . . . 4.0 111.794 178.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 44.1 mmtt -120.48 139.66 52.55 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 128.079 2.552 . . . . 2.42 111.16 -175.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 17.0 mtm180 -66.15 164.48 15.53 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.335 1.054 . . . . 5.96 111.197 161.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.1 m -46.66 -54.19 10.08 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 113.781 1.03 . . . . 1.75 113.781 170.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 9.4 p -59.5 -37.01 67.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 123.685 0.794 . . . . 1.73 112.053 176.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -77.65 -16.81 58.28 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 114.104 1.15 . . . . 1.03 114.104 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -77.87 -55.12 5.58 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 119.45 1.023 . . . . 0.81 109.658 166.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 44.7 m170 -54.12 -46.62 72.22 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.328 1.051 . . . . 0.64 113.178 -177.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 53.2 tp60 -47.79 -40.61 21.36 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.426 1.89 . . . . 1.36 113.165 177.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 64.5 mtp -66.78 -44.27 81.79 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.468 1.107 . . . . 1.82 111.596 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.9 t -69.49 -31.0 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 126.162 1.785 . . . . 1.7 110.955 178.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -68.87 -52.27 31.48 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.058 1.743 . . . . 0.5 110.176 174.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.04 -28.37 62.48 Favored 'General case' 0 CA--C 1.546 0.808 0 O-C-N 120.679 -1.263 . . . . 2.95 111.848 178.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.66 -33.83 76.5 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.741 1.216 . . . . 1.47 112.892 -173.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.46 -7.88 8.63 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 114.473 1.286 . . . . 1.73 114.473 177.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 32.0 ttpt -46.47 -43.51 16.73 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 124.454 1.102 . . . . 3.45 112.369 176.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -77.96 -4.05 45.03 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-O 121.645 0.736 . . . . 2.38 112.055 -169.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -111.79 -45.41 3.35 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 129.991 3.317 . . . . 2.26 111.154 -176.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 40.3 mt -144.85 124.95 7.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 129.001 2.92 . . . . 2.33 107.283 177.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -96.09 -10.93 27.15 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 115.317 1.599 . . . . 4.32 115.317 -174.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . 0.27 19.0 pt-20 -77.12 43.31 0.36 Allowed 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 116.38 1.993 . . . . 4.64 116.38 -162.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 59.1 mtm -71.32 -1.61 13.44 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.65 1.98 . . . . 2.53 115.948 -167.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 6.9 p-80 -60.19 -20.36 58.3 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 121.335 -0.853 . . . . 6.43 112.904 159.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -87.63 -12.94 65.98 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 125.43 1.491 . . . . 0.6 115.176 169.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.6 mp -100.08 116.47 32.18 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 118.381 1.091 . . . . 2.74 112.268 -168.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 17.6 ttm180 -98.13 103.55 15.51 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 126.505 1.922 . . . . 5.83 110.081 -175.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 2.9 mt -108.56 145.48 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 123.548 1.642 . . . . 1.73 112.933 -171.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -139.43 120.97 15.15 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 111.048 -2.796 . . . . 3.26 107.825 -171.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 21.2 p -133.6 152.03 51.81 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 126.242 1.817 . . . . 1.51 110.025 -177.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 10.4 p -157.41 179.3 9.38 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.931 -1.031 . . . . 0.68 111.187 173.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.4 p -144.21 133.73 11.56 Favored Pre-proline 0 N--CA 1.47 0.572 0 N-CA-C 113.197 0.814 . . . . 1.75 113.197 -177.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.98 112.28 3.48 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.773 2.315 . . . . 0.67 109.456 173.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -135.98 97.29 3.59 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.935 1.694 . . . . 5.29 109.098 -164.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 . . . . . 0 C--O 1.252 1.214 0 CA-C-O 115.888 -2.006 . . . . 12.02 115.7 -171.928 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.85 0 CA-C-O 118.054 -0.974 . . . . 5.55 112.708 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . 0.299 3.2 t 54.29 175.77 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 127.147 2.179 . . . . 4.42 115.829 -174.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -151.9 150.63 30.29 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 127.088 2.155 . . . . 2.66 109.759 -177.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 23.1 p -115.55 164.24 14.6 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.517 1.127 . . . . 1.86 110.662 170.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -65.42 -32.77 74.58 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 120.77 -1.206 . . . . 2.89 111.377 174.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.02 -35.12 90.97 Favored Glycine 0 C--O 1.218 -0.875 0 CA-C-O 118.578 -1.123 . . . . 0.48 112.251 172.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.38 -50.93 64.07 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 119.94 1.87 . . . . 1.26 111.825 174.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 15.2 mt -69.8 -50.37 43.66 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 125.657 1.583 . . . . 1.84 110.615 -176.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.38 -48.35 79.28 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 126.135 1.774 . . . . 4.15 111.533 177.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 29.6 t -62.84 -44.03 99.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 107.875 -1.157 . . . . 1.57 107.875 178.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 47.2 m -58.05 -40.38 80.8 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 118.575 0.625 . . . . 1.8 112.084 177.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 9.9 mm-40 -64.42 -45.2 88.59 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.634 0.605 . . . . 1.9 112.634 -179.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 41.1 mt -72.04 -30.95 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-N 118.143 0.429 . . . . 2.05 109.866 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 37.5 mt -60.48 -37.73 81.98 Favored 'General case' 0 CA--C 1.531 0.237 0 O-C-N 120.925 -1.109 . . . . 1.48 113.487 173.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 34.3 mttt -64.68 -25.88 68.14 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 113.596 0.961 . . . . 2.32 113.596 175.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -87.08 -39.91 15.16 Favored 'General case' 0 N--CA 1.433 -1.325 0 C-N-CA 125.769 1.627 . . . . 2.21 113.404 176.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 62.4 mmtt -74.95 -25.51 58.93 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 119.342 -0.943 . . . . 2.38 112.067 175.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -128.11 49.69 4.71 Favored Pre-proline 0 CA--C 1.55 0.975 0 N-CA-C 119.112 3.004 . . . . 3.66 119.112 -179.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -67.72 -12.84 36.86 Favored 'Trans proline' 0 CA--C 1.534 0.489 0 C-N-CA 124.718 3.612 . . . . 0.73 115.268 175.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 12.3 mmm180 -76.18 -16.49 59.84 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 114.124 1.157 . . . . 8.34 114.124 169.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.94 152.48 43.1 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 115.892 1.812 . . . . 1.65 115.892 -166.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 30.9 p -100.24 -22.95 14.95 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 118.019 -0.991 . . . . 1.59 112.374 168.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -126.11 141.41 51.95 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 119.932 1.242 . . . . 1.39 111.53 161.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.4 pt -157.6 103.31 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 127.23 2.212 . . . . 1.61 110.337 171.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.5 ptpt -152.3 157.21 41.04 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.163 1.385 . . . . 2.07 113.097 -175.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 23.7 t -137.72 144.57 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 126.639 1.976 . . . . 1.62 110.548 -169.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 88.6 m -134.67 126.29 28.81 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 108.989 -0.745 . . . . 1.61 108.989 165.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -70.67 133.83 46.99 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.474 0.654 . . . . 2.15 109.755 167.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . 0.261 2.9 pt -127.7 34.9 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 C-N-CA 126.373 1.869 . . . . 1.77 109.188 173.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 36.4 p -144.72 42.57 1.35 Allowed 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 128.281 2.632 . . . . 4.06 116.766 -174.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -51.26 -22.42 7.06 Favored Glycine 0 CA--C 1.546 2.02 0 N-CA-C 118.399 2.119 . . . . 2.03 118.399 -176.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -110.28 -0.02 29.68 Favored Glycine 0 CA--C 1.541 1.7 0 C-N-CA 126.406 1.955 . . . . 1.54 115.37 177.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 7.8 t -132.99 -40.79 0.92 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.544 1.138 . . . . 3.14 113.756 -176.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 57.88 47.83 86.29 Favored Glycine 0 CA--C 1.536 1.396 0 C-N-CA 128.348 2.88 . . . . 1.22 113.535 -167.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -124.41 18.02 8.95 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.794 1.238 . . . . 1.76 114.024 -179.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 8.5 ttm -153.07 122.77 6.83 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.757 1.223 . . . . 2.06 112.097 -170.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -141.97 148.21 38.21 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.989 0.899 . . . . 3.22 113.413 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -93.18 114.3 26.75 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.627 1.971 . . . . 2.38 109.732 168.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 83.0 mt -125.46 123.78 65.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 CA-C-N 120.125 1.33 . . . . 1.96 110.625 -170.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 71.7 mttt -125.26 119.52 28.67 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.871 1.269 . . . . 3.37 111.011 -172.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.3 mt -130.02 153.33 38.74 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 127.158 2.183 . . . . 1.58 109.93 -176.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -154.22 127.96 8.75 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.125 1.37 . . . . 1.85 108.733 166.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 23.0 t -159.33 142.26 14.21 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 120.383 1.447 . . . . 0.3 112.657 -172.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -50.65 -31.41 16.12 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.544 1.137 . . . . 2.73 112.522 178.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -66.98 -10.73 52.63 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 114.644 1.35 . . . . 1.66 114.644 -175.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -95.71 10.28 37.47 Favored 'General case' 0 CA--C 1.557 1.217 0 N-CA-C 116.194 1.924 . . . . 3.57 116.194 -175.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.8 -37.15 70.45 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-N 120.775 1.625 . . . . 3.72 115.139 -172.073 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -86.19 13.29 8.14 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.575 1.55 . . . . 3.36 112.266 -174.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 51.4 mmtt -127.67 131.21 49.84 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.586 1.554 . . . . 3.35 112.951 -159.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 19.1 mmt180 -63.53 163.33 11.27 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.351 1.46 . . . . 6.48 111.561 166.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 41.3 m -43.5 -55.52 4.17 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 125.498 1.519 . . . . 1.81 114.167 168.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 9.9 p -59.85 -38.35 75.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 N-CA-C 113.579 0.955 . . . . 1.68 113.579 175.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -74.83 -32.45 61.94 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.308 0.643 . . . . 1.12 112.277 -177.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -66.44 -54.29 25.9 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.314 1.046 . . . . 0.88 109.81 168.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 46.6 m170 -52.83 -44.77 66.95 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.886 1.274 . . . . 0.61 112.951 -178.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 41.3 tp60 -53.34 -39.76 64.37 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.801 1.24 . . . . 1.2 112.821 178.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 4.7 mtm -66.38 -41.44 89.38 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 121.262 -0.899 . . . . 1.74 111.302 179.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.3 t -72.39 -26.45 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 125.243 1.417 . . . . 1.55 111.914 178.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -70.1 -56.16 7.61 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 126.046 1.739 . . . . 0.83 109.148 175.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.98 -6.42 42.0 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.101 1.149 . . . . 2.79 114.101 -178.246 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.02 -33.83 76.99 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 120.945 -1.097 . . . . 1.73 112.738 169.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.24 -0.64 2.01 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 115.489 1.663 . . . . 1.67 115.489 -176.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 34.9 tttt -50.26 -38.36 40.45 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 125.175 1.39 . . . . 3.23 113.016 177.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -75.31 -18.44 60.03 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-O 121.514 0.673 . . . . 1.89 111.413 -177.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -88.72 -51.98 5.38 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 129.126 2.971 . . . . 2.43 110.991 177.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 32.9 mt -147.61 114.48 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 128.467 2.707 . . . . 2.17 108.327 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.4 tmtp? -92.28 -7.62 47.55 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 114.87 1.433 . . . . 4.91 114.87 -163.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -70.43 57.42 0.17 Allowed 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 129.681 3.192 . . . . 3.13 115.477 -164.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . 0.273 1.3 mpt? -75.84 3.63 9.62 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 119.311 -2.118 . . . . 3.07 116.483 -178.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 73.2 t60 -59.21 -30.28 68.11 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 121.235 -0.916 . . . . 6.01 112.371 151.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -83.56 -30.44 29.97 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 127.886 2.66 . . . . 0.66 116.457 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.0 mt -89.31 120.62 30.82 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 122.856 1.312 . . . . 3.32 111.415 -164.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 14.6 ttm180 -106.82 99.23 8.82 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 112.797 -2.001 . . . . 6.17 106.502 -179.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 1.4 mt -113.3 140.41 33.59 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.457 0 CA-C-O 122.845 1.307 . . . . 1.66 111.105 -165.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -135.14 117.21 15.37 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 111.907 -2.406 . . . . 3.37 107.445 -166.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 18.5 p -134.89 147.52 49.87 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.221 1.808 . . . . 1.54 110.145 -175.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.9 p -153.42 179.02 9.16 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.052 -1.431 . . . . 0.64 110.319 174.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 6.5 p -145.82 133.26 10.26 Favored Pre-proline 0 N--CA 1.469 0.481 0 O-C-N 121.572 -0.705 . . . . 1.67 111.801 -178.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -77.71 123.98 6.67 Favored 'Trans proline' 0 N--CA 1.448 -1.205 0 C-N-CA 122.721 2.281 . . . . 1.01 108.911 166.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -141.88 64.93 1.38 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.673 1.589 . . . . 4.2 108.693 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 63.1 ttt-85 . . . . . 0 C--O 1.254 1.297 0 C-N-CA 125.785 1.634 . . . . 7.9 111.966 177.305 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.78 0 N-CA-C 111.935 0.346 . . . . 7.18 111.935 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . 0.32 1.0 OUTLIER 51.79 11.22 0.13 Allowed 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 128.797 2.839 . . . . 5.04 117.593 179.647 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.8 mp0 -54.34 131.52 42.14 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 126.067 1.747 . . . . 3.02 115.228 -177.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 59.2 p -87.13 165.35 15.81 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 114.863 -1.062 . . . . 1.76 110.492 156.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -64.54 -27.68 69.13 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 120.936 -1.103 . . . . 4.29 111.875 168.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.54 -38.68 96.04 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 126.119 1.818 . . . . 0.5 113.379 170.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.79 -43.18 72.62 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.291 1.546 . . . . 2.13 112.014 174.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 11.7 mt -69.17 -52.04 31.97 Favored 'General case' 0 N--CA 1.462 0.129 0 C-N-CA 125.573 1.549 . . . . 1.77 111.005 178.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -53.48 -49.75 66.82 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 126.923 2.089 . . . . 4.33 110.874 178.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 38.1 t -67.4 -45.04 86.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 108.75 -0.833 . . . . 1.83 108.75 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 68.4 m -53.98 -43.55 70.05 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 118.511 0.596 . . . . 1.77 112.392 175.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -62.89 -43.65 98.21 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 118.593 0.633 . . . . 1.8 111.734 -176.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 53.2 mt -71.6 -29.86 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 123.312 0.645 . . . . 2.01 110.323 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 53.2 mt -64.93 -41.44 95.52 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 120.655 -1.278 . . . . 2.11 113.269 171.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 38.7 mttt -62.19 -19.43 63.11 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-N 119.544 1.066 . . . . 2.75 113.852 174.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -95.91 -37.95 10.48 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 126.315 1.846 . . . . 2.31 114.832 -178.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -78.38 -22.1 48.38 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 118.675 -0.678 . . . . 2.03 112.492 170.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -133.07 50.07 5.13 Favored Pre-proline 0 CA--C 1.548 0.902 0 N-CA-C 118.854 2.909 . . . . 2.67 118.854 -179.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -62.98 -26.42 74.08 Favored 'Trans proline' 0 CA--C 1.534 0.516 0 C-N-CA 123.48 2.786 . . . . 1.0 115.842 177.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 27.0 mmm180 -76.97 -12.85 60.0 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 120.387 1.449 . . . . 8.59 114.61 176.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -53.8 144.92 17.08 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.925 1.29 . . . . 1.53 114.159 -175.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 44.3 p -97.4 -22.5 16.57 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.473 1.109 . . . . 1.52 111.984 176.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -123.4 138.39 54.61 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.942 0.897 . . . . 1.65 110.321 157.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -154.35 105.97 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 124.841 1.256 . . . . 1.89 110.361 169.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.9 ptpt -150.05 154.75 38.68 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.025 1.33 . . . . 2.32 112.814 -179.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.9 t -129.95 148.27 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 126.785 2.034 . . . . 1.59 109.632 -178.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 55.2 m -135.42 132.91 38.06 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 118.465 0.575 . . . . 1.58 110.244 161.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -72.51 134.34 45.24 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 122.037 0.922 . . . . 1.79 109.767 167.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . 0.257 1.8 pt -127.7 33.39 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 125.57 1.548 . . . . 1.87 109.787 174.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.2 p -141.55 63.93 1.42 Allowed 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 127.087 2.155 . . . . 3.76 114.362 -177.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -58.03 -19.05 36.32 Favored Glycine 0 CA--C 1.543 1.819 0 N-CA-C 116.326 1.29 . . . . 1.25 116.326 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -108.86 -5.55 31.03 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 125.74 1.638 . . . . 1.01 116.63 -178.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 1.3 m -152.11 -15.86 0.18 Allowed 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 115.2 1.555 . . . . 2.91 115.2 -177.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 51.75 38.93 45.88 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 127.246 2.355 . . . . 0.81 114.995 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -110.76 6.5 21.53 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.116 1.366 . . . . 2.43 113.236 -175.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 15.0 ttm -140.48 121.07 14.22 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.714 2.006 . . . . 1.93 110.497 -161.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -143.36 146.33 33.43 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 113.815 1.043 . . . . 3.26 113.815 -174.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -90.88 114.15 26.52 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.901 1.68 . . . . 2.63 109.417 167.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 95.9 mt -120.55 123.66 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 O-C-N 120.762 -1.211 . . . . 1.77 109.565 -175.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 75.7 mttt -124.28 111.23 15.58 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.78 1.232 . . . . 3.47 110.254 -174.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.3 mt -120.46 155.26 23.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 127.445 2.298 . . . . 1.52 109.052 -178.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -153.66 130.49 10.89 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.186 1.394 . . . . 1.85 107.291 162.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.6 t -155.3 140.75 17.78 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 120.107 1.321 . . . . 0.37 112.352 -173.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -61.91 -6.6 2.91 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.621 1.568 . . . . 3.89 115.111 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -84.68 -14.58 48.06 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.733 1.613 . . . . 1.77 114.207 175.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -87.13 12.03 12.51 Favored 'General case' 0 CA--C 1.559 1.302 0 N-CA-C 114.37 1.248 . . . . 3.54 114.37 -175.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.252 0.0 OUTLIER -76.83 -14.62 59.89 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 117.225 2.305 . . . . 3.73 117.225 -166.476 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -118.29 25.33 10.38 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.341 1.456 . . . . 4.88 111.253 169.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 52.3 mmtt -112.61 131.36 55.66 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.544 1.538 . . . . 2.39 111.868 177.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 36.1 mtt180 -65.71 161.69 20.16 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.667 1.187 . . . . 4.48 111.071 163.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 54.1 m -38.04 -55.56 1.24 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 126.356 1.862 . . . . 1.84 113.799 168.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.5 p -63.86 -40.34 88.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 125.212 1.405 . . . . 2.29 113.598 178.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -71.92 -32.3 67.22 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 121.619 -0.675 . . . . 1.01 111.573 178.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -63.79 -53.45 50.62 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.568 0.747 . . . . 0.99 109.885 169.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 62.8 m170 -49.94 -52.35 34.06 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.796 0.838 . . . . 0.95 111.968 178.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 23.4 tp60 -46.9 -44.33 19.62 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.037 1.735 . . . . 1.32 113.134 178.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 85.0 mtp -62.33 -43.51 98.66 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 119.159 0.89 . . . . 1.86 112.516 178.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.6 t -71.7 -27.41 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 C-N-CA 125.647 1.579 . . . . 1.52 112.146 178.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -74.31 -50.67 17.87 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.525 1.93 . . . . 0.47 109.381 177.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 12.5 mm-40 -65.56 -18.66 65.49 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.378 1.471 . . . . 3.74 113.635 178.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.69 -44.67 85.99 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 119.337 0.971 . . . . 1.43 111.056 179.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.11 5.66 9.22 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 115.513 1.672 . . . . 1.76 115.513 -174.204 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.5 ttmt -51.67 -40.23 59.66 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 125.037 1.335 . . . . 4.29 113.136 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -81.68 10.32 6.31 Favored 'General case' 0 CA--C 1.554 1.126 0 CA-C-O 122.121 0.962 . . . . 2.4 113.347 -174.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -126.84 -56.26 1.37 Allowed 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 129.443 3.097 . . . . 3.12 108.652 -176.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -128.57 120.97 53.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 126.872 2.069 . . . . 2.99 108.371 165.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -105.75 1.69 27.28 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 119.919 -1.738 . . . . 3.44 114.812 -179.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.3 mp0 -71.88 47.01 0.14 Allowed 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 130.573 3.549 . . . . 3.25 115.332 -173.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . 0.254 2.1 mpt? -72.35 12.75 0.41 Allowed 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 116.703 2.112 . . . . 3.02 116.703 -173.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 39.8 p-80 -63.39 -28.4 69.96 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.366 -0.834 . . . . 5.63 112.083 154.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -77.94 -22.61 68.44 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 115.916 1.126 . . . . 0.65 115.916 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 10.1 mt -92.06 136.02 33.51 Favored 'General case' 0 C--O 1.238 0.463 0 O-C-N 120.813 -1.404 . . . . 3.29 111.222 -164.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 15.3 ttt180 -114.63 105.49 13.12 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.686 1.594 . . . . 4.44 106.896 169.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 1.5 mt -114.41 137.47 47.64 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.648 0 CA-C-O 123.098 1.427 . . . . 1.93 111.005 -169.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -130.54 123.72 30.24 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-N 111.769 -2.468 . . . . 3.26 106.628 -169.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 17.3 p -140.86 152.68 45.29 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 126.237 1.815 . . . . 1.52 109.217 -175.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -161.05 173.88 14.56 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.296 -0.866 . . . . 0.7 110.481 176.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 12.5 p -141.84 133.71 13.54 Favored Pre-proline 0 N--CA 1.468 0.467 0 O-C-N 121.329 -0.857 . . . . 1.69 111.962 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -77.45 103.45 1.73 Allowed 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.081 1.854 . . . . 1.0 110.615 174.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 71.4 tttt -146.87 93.81 2.33 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.428 1.891 . . . . 4.5 110.515 -169.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 4.0 ptp180 . . . . . 0 C--O 1.253 1.251 0 C-N-CA 126.573 1.949 . . . . 7.63 114.856 176.498 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.723 0 N-CA-C 110.194 -0.299 . . . . 5.13 110.194 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . 0.317 1.5 t 54.93 -4.62 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 117.924 2.565 . . . . 6.24 117.924 -172.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 62.69 153.12 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 127.251 2.22 . . . . 2.97 115.128 176.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 66.9 p -100.93 170.18 8.47 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 121.128 -0.982 . . . . 1.88 109.897 159.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 -70.07 -29.48 66.49 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 120.436 -1.415 . . . . 3.86 111.902 163.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -66.54 -38.14 93.15 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 124.282 0.944 . . . . 0.4 113.139 177.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.94 -44.27 50.39 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.449 1.499 . . . . 1.98 111.539 172.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.4 mt -70.26 -51.87 27.32 Favored 'General case' 0 C--N 1.337 0.046 0 C-N-CA 125.479 1.512 . . . . 1.63 110.747 -178.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.87 -48.93 76.97 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.904 1.682 . . . . 3.91 110.865 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.8 t -65.54 -45.25 93.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 108.435 -0.95 . . . . 1.56 108.435 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 98.7 m -56.92 -41.32 77.96 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 118.687 0.676 . . . . 1.42 112.411 176.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -63.86 -42.52 97.52 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 112.753 0.649 . . . . 2.04 112.753 -178.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 32.2 mt -75.45 -30.25 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 CA-C-N 118.629 0.649 . . . . 1.78 110.462 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 44.0 mt -60.14 -40.35 89.48 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 120.779 -1.2 . . . . 2.04 113.34 171.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 27.2 mttt -60.73 -24.95 66.09 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 119.338 0.972 . . . . 3.01 113.391 176.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -94.62 -35.38 12.24 Favored 'General case' 0 N--CA 1.434 -1.236 0 C-N-CA 126.895 2.078 . . . . 1.96 115.066 -178.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 56.8 mmtt -75.89 -22.77 55.79 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 119.735 -0.786 . . . . 2.46 111.856 170.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -130.19 51.39 7.45 Favored Pre-proline 0 CA--C 1.551 1.002 0 N-CA-C 118.428 2.751 . . . . 2.75 118.428 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -67.66 -18.88 48.28 Favored 'Trans proline' 0 CA--C 1.534 0.507 0 C-N-CA 124.457 3.438 . . . . 0.62 115.099 176.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.96 -5.01 58.9 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 114.861 1.43 . . . . 6.65 114.861 172.029 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.09 146.73 52.63 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 113.615 0.968 . . . . 1.53 113.615 -178.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 60.9 p -93.34 -32.76 14.16 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.331 -0.849 . . . . 1.75 111.06 172.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -117.63 137.88 52.34 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.046 0.938 . . . . 1.69 111.527 165.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -156.03 108.16 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 126.685 1.994 . . . . 1.78 109.919 171.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.1 ptpt -152.37 157.83 41.84 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.813 1.645 . . . . 1.93 113.618 178.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.3 t -132.67 151.68 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 126.051 1.74 . . . . 1.64 110.763 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 89.8 m -141.1 125.22 17.3 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 120.31 -1.493 . . . . 1.68 110.846 169.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -67.44 135.3 52.91 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.809 0.814 . . . . 1.77 109.838 168.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.3 pt -134.34 19.93 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 124.909 1.284 . . . . 1.77 111.76 178.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.3 t -123.05 83.42 2.12 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 127.316 2.246 . . . . 2.03 111.399 176.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -73.2 9.22 7.39 Favored Glycine 0 N--CA 1.476 1.363 0 O-C-N 120.325 -1.484 . . . . 1.85 115.212 -177.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -129.12 -12.98 2.48 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 126.452 1.977 . . . . 1.52 114.046 -175.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 7.2 t -151.41 -18.04 0.2 Allowed 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 118.575 1.187 . . . . 2.7 114.055 175.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 54.93 37.55 62.76 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 124.686 1.136 . . . . 0.9 111.984 -163.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -91.97 1.83 56.94 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.295 1.438 . . . . 1.8 113.184 178.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 1.4 mtp -134.31 141.46 46.94 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 126.179 1.792 . . . . 3.1 112.396 175.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -142.62 145.37 33.43 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 122.021 0.915 . . . . 3.35 112.363 173.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -80.86 133.74 35.64 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 125.897 1.679 . . . . 1.82 108.573 161.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.5 mt -137.34 122.7 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 CA-C-N 119.464 1.029 . . . . 1.83 108.911 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 70.3 mttt -124.73 112.05 16.28 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.29 1.036 . . . . 3.4 110.183 -175.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.3 mt -121.96 155.93 26.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 126.858 2.063 . . . . 1.53 109.061 -177.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -156.06 126.72 6.8 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.453 1.501 . . . . 2.06 107.598 165.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.4 t -156.84 147.93 22.0 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 119.932 1.242 . . . . 0.38 112.417 -173.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -57.48 -28.11 63.1 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.245 1.418 . . . . 4.02 113.019 -174.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -69.78 -18.22 63.47 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 115.039 1.496 . . . . 1.75 115.039 177.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -80.94 13.84 2.5 Favored 'General case' 0 CA--C 1.545 0.759 0 O-C-N 121.102 -0.999 . . . . 2.86 113.215 -176.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 50.7 pttt -78.74 -27.68 44.79 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.157 1.383 . . . . 3.76 113.348 176.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -109.11 33.7 4.13 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.12 1.768 . . . . 4.83 111.875 -167.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 65.4 mmtt -139.56 141.64 37.2 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 126.897 2.079 . . . . 2.75 111.407 -169.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 6.6 mmt180 -65.88 168.78 7.49 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.668 1.187 . . . . 4.31 110.872 162.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 94.7 m -54.97 -53.91 49.62 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 113.036 0.754 . . . . 1.83 113.036 170.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 10.1 p -57.4 -40.46 74.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 123.216 0.606 . . . . 2.14 111.681 176.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -68.64 -32.36 72.16 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.2 0.815 . . . . 2.47 113.2 178.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 -62.41 -52.08 65.0 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.556 1.071 . . . . 2.5 109.924 170.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 33.1 m170 -58.21 -50.08 74.8 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 118.944 0.793 . . . . 0.93 112.64 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -54.15 -40.95 67.9 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 124.706 1.202 . . . . 4.25 113.937 178.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 1.1 mmm -61.97 -34.6 76.44 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 120.403 1.456 . . . . 1.55 111.657 -178.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.1 t -79.32 -32.04 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 127.122 2.169 . . . . 1.75 111.347 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -67.7 -46.51 72.03 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.347 1.459 . . . . 0.89 111.312 170.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 55.0 tp60 -65.73 -25.76 67.44 Favored 'General case' 0 N--CA 1.445 -0.687 0 O-C-N 120.373 -1.454 . . . . 2.61 113.847 -177.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.87 -30.99 69.36 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.451 1.5 . . . . 1.63 112.521 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -127.13 1.14 6.48 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 115.492 1.664 . . . . 1.87 115.492 177.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 31.2 ttmt -46.54 -43.3 16.93 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.443 1.497 . . . . 2.81 112.413 175.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -81.74 -18.86 42.79 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-O 121.362 0.601 . . . . 2.17 111.509 -171.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -88.9 -49.52 6.75 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 127.995 2.518 . . . . 2.34 111.197 -178.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 51.0 mt -147.36 101.06 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 127.544 2.338 . . . . 2.43 108.115 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.3 ptmm? -79.21 -7.57 58.34 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 116.551 2.056 . . . . 3.39 116.551 -166.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -79.19 44.03 0.56 Allowed 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 130.074 3.35 . . . . 3.53 115.594 -165.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 4.2 mpp? -73.86 12.45 0.67 Allowed 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 117.651 2.463 . . . . 2.38 117.651 -168.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 68.6 t60 -53.78 -32.6 53.1 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 120.516 1.507 . . . . 5.77 112.337 168.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -75.65 -12.23 83.93 Favored Glycine 0 CA--C 1.522 0.475 0 N-CA-C 117.364 1.706 . . . . 0.7 117.364 -178.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 13.2 mt -88.25 133.71 33.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 122.787 1.279 . . . . 3.14 111.369 -162.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 19.9 ttm180 -120.0 85.49 2.39 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 126.901 2.081 . . . . 6.49 106.9 -172.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 1.6 mt -106.67 141.39 22.01 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 CA-C-O 123.905 1.812 . . . . 1.82 112.038 -163.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -135.87 125.43 25.21 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 111.515 -2.584 . . . . 3.46 107.513 -170.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 26.2 p -140.99 157.74 44.91 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 125.834 1.654 . . . . 1.6 109.077 -176.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 2.5 p -168.55 178.58 4.7 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.583 -1.189 . . . . 0.68 109.837 176.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.3 p -138.65 129.4 15.17 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 124.106 0.962 . . . . 1.56 112.022 -178.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -82.06 125.39 4.67 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 124.079 3.186 . . . . 0.84 111.957 -175.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 2.7 mmtm -148.28 55.7 1.04 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.106 -0.952 . . . . 6.49 112.728 -152.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 24.9 mmt180 . . . . . 0 C--O 1.257 1.481 0 C-N-CA 124.906 1.282 . . . . 8.61 112.982 173.536 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.761 0 N-CA-C 110.025 -0.361 . . . . 6.2 110.025 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 80.1 m -127.6 140.82 51.87 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.463 0.705 . . . . 3.66 111.704 -176.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 12.0 mp0 -114.22 166.57 11.51 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.187 1.795 . . . . 3.18 111.305 178.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 80.4 p -120.49 170.59 9.25 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 107.947 -1.131 . . . . 1.69 107.947 144.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -69.5 -22.6 63.59 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 120.919 -1.113 . . . . 2.87 112.068 166.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.36 -41.38 98.15 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 124.309 0.956 . . . . 0.41 112.574 169.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.72 -46.22 40.47 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.681 1.593 . . . . 1.32 111.681 171.099 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.6 mt -68.6 -52.47 31.26 Favored 'General case' 0 C--N 1.339 0.113 0 C-N-CA 125.085 1.354 . . . . 1.62 111.225 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -56.59 -50.18 72.71 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.375 1.47 . . . . 4.1 110.824 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.7 t -60.3 -46.74 94.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 107.757 -1.201 . . . . 1.6 107.757 179.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 63.3 m -57.92 -41.22 82.24 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 118.417 0.553 . . . . 1.72 112.358 177.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 -60.55 -45.62 93.23 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 123.28 0.632 . . . . 1.77 111.396 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 42.9 mt -76.87 -27.29 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 117.871 0.305 . . . . 2.07 110.433 -175.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 19.0 mt -58.73 -39.0 79.6 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.077 -1.014 . . . . 1.48 112.831 168.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 37.6 mttt -65.35 -19.9 66.15 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 113.794 1.035 . . . . 2.27 113.794 175.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -102.39 -34.83 9.03 Favored 'General case' 0 N--CA 1.436 -1.166 0 C-N-CA 126.776 2.03 . . . . 2.24 114.532 -174.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 26.6 mmtp -75.97 -30.79 58.73 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 120.038 -0.665 . . . . 4.14 111.039 167.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -128.14 50.57 5.74 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 118.351 2.722 . . . . 2.68 118.351 -176.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -60.47 -27.61 85.16 Favored 'Trans proline' 0 C--O 1.236 0.409 0 C-N-CA 123.134 2.556 . . . . 0.84 114.297 174.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 31.7 mmt180 -74.86 -9.24 58.36 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 114.079 1.14 . . . . 5.89 114.079 179.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.59 152.37 15.19 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 115.579 1.696 . . . . 1.74 115.579 -173.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 42.8 p -104.27 -5.68 21.63 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 127.259 2.223 . . . . 1.66 113.148 168.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -143.16 143.88 31.98 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 119.932 1.242 . . . . 1.8 111.814 153.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.9 pt -155.15 116.14 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 126.753 2.021 . . . . 1.79 111.069 169.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 7.9 ptpt -161.03 153.5 20.49 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.481 1.512 . . . . 2.07 112.782 179.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.5 t -134.54 143.49 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 126.218 1.807 . . . . 1.56 110.483 -175.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 64.2 m -133.76 125.14 27.9 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.839 1.656 . . . . 1.87 110.805 173.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -75.27 132.86 41.33 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 122.304 1.05 . . . . 1.82 111.526 171.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.4 pt -133.84 26.8 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 C-N-CA 126.295 1.838 . . . . 1.5 110.898 178.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 46.8 t -134.2 69.91 1.46 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 126.879 2.072 . . . . 1.95 112.696 176.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -54.06 -25.13 30.53 Favored Glycine 0 CA--C 1.54 1.609 0 N-CA-C 116.074 1.19 . . . . 1.5 116.074 -179.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -88.35 -17.67 56.79 Favored Glycine 0 CA--C 1.534 1.28 0 CA-C-N 119.118 1.459 . . . . 1.54 116.194 -176.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 9.8 m -154.86 -32.46 0.1 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.792 1.237 . . . . 2.23 114.127 -164.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 64.99 47.1 86.35 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 125.426 1.489 . . . . 0.87 112.987 -166.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -98.15 -1.6 41.87 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 126.402 1.881 . . . . 1.46 114.098 176.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 15.6 mtm -136.96 138.8 40.97 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 126.151 1.781 . . . . 2.75 110.88 177.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -143.75 146.51 33.19 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.701 0.8 . . . . 3.24 111.781 172.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -94.91 130.08 41.68 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.61 1.564 . . . . 2.39 109.561 169.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 80.4 mt -137.65 129.33 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.879 0.872 . . . . 1.92 110.636 -167.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 60.0 mttt -115.75 125.12 52.37 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.94 0.896 . . . . 4.87 110.272 173.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.2 mt -129.21 155.18 41.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 C-N-CA 125.482 1.513 . . . . 1.61 109.877 173.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -158.35 133.23 8.4 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 120.059 -1.651 . . . . 2.01 109.31 171.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 19.6 t -162.4 147.1 12.26 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 119.911 1.232 . . . . 0.45 112.21 -174.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -53.91 -28.83 39.21 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.382 1.473 . . . . 4.77 113.014 -179.018 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -65.7 -20.32 66.24 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 115.237 1.569 . . . . 1.82 115.237 177.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -84.43 2.1 42.32 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 115.104 1.52 . . . . 3.48 115.104 -168.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 16.4 pttm -69.34 -47.35 64.63 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-O 121.819 0.819 . . . . 3.99 112.079 -176.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -84.2 35.29 0.53 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 128.842 2.857 . . . . 4.18 111.455 -170.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 49.0 mmtt -140.11 140.35 36.02 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 127.892 2.477 . . . . 2.4 110.754 -172.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 49.5 mtt180 -68.13 172.42 5.74 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.537 0.735 . . . . 4.57 111.404 163.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 37.3 m -51.41 -54.41 26.93 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.671 0.789 . . . . 2.02 112.852 168.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 10.9 p -57.23 -37.68 57.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 124.312 1.045 . . . . 1.74 112.701 176.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -80.59 -32.3 36.52 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 113.128 0.788 . . . . 1.19 113.128 -177.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -61.94 -50.26 72.84 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 119.904 1.229 . . . . 0.84 109.846 168.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 50.8 m170 -55.75 -49.73 72.32 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 122.912 0.485 . . . . 0.86 111.629 177.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 47.4 tp60 -46.88 -45.1 20.2 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.706 2.002 . . . . 1.37 112.937 -178.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 71.9 mtp -62.34 -43.26 99.24 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.998 0.919 . . . . 1.64 112.189 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.0 t -74.03 -27.23 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 126.612 1.965 . . . . 1.47 112.097 178.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -71.98 -50.04 32.08 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 126.003 1.721 . . . . 0.56 108.751 176.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 15.3 mm-40 -65.88 -24.38 66.84 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.621 1.168 . . . . 3.58 112.806 179.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -56.44 -37.17 69.87 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.398 1.079 . . . . 1.67 112.568 -176.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -127.79 4.62 6.04 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 115.236 1.569 . . . . 1.61 115.236 -179.054 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 16.4 ttmt -50.73 -34.9 28.84 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.827 1.251 . . . . 4.05 113.309 -178.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -74.05 -29.92 62.14 Favored 'General case' 0 N--CA 1.439 -1.025 0 O-C-N 121.484 -0.76 . . . . 2.58 111.78 -177.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.23 -58.42 3.29 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 127.944 2.498 . . . . 2.71 111.995 175.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 34.7 mt -136.97 123.88 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 125.778 1.631 . . . . 2.17 107.868 178.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -90.75 -12.04 37.73 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 115.005 1.483 . . . . 3.6 115.005 -166.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -85.77 67.19 9.96 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 126.182 1.793 . . . . 3.53 113.752 -156.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . 0.272 0.8 OUTLIER -74.35 -4.0 33.7 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 115.71 1.745 . . . . 3.03 115.71 176.844 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 67.2 t60 -55.76 -24.52 35.86 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 121.61 -0.681 . . . . 5.62 112.786 153.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -88.2 -27.0 26.84 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 127.424 2.44 . . . . 0.83 116.146 177.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.0 mt -90.5 134.5 34.32 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 121.895 -0.768 . . . . 3.47 111.622 -166.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 27.0 ttt180 -117.08 92.68 3.92 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.837 1.655 . . . . 3.97 108.527 -176.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -114.03 135.12 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-O 123.094 1.426 . . . . 1.79 113.198 -159.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -131.36 91.22 2.98 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 112.897 -1.956 . . . . 3.38 109.917 -164.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.1 p -99.64 152.34 20.16 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.988 1.715 . . . . 1.7 111.895 178.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.2 p -156.39 -179.42 8.15 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 125.716 1.606 . . . . 0.75 110.614 174.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.5 p -143.27 132.04 11.43 Favored Pre-proline 0 N--CA 1.476 0.834 0 O-C-N 121.5 -0.75 . . . . 1.74 112.725 -179.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -77.02 125.11 7.75 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 124.327 3.351 . . . . 0.87 112.294 -176.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 38.2 mttt -149.7 100.68 3.0 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 113.017 -1.901 . . . . 5.19 111.52 -156.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 70.7 ttt-85 . . . . . 0 C--O 1.251 1.157 0 C-N-CA 127.849 2.46 . . . . 11.11 114.307 164.637 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.883 0 CA-C-O 121.211 0.529 . . . . 6.42 111.054 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.22 159.81 21.31 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 126.493 1.917 . . . . 3.8 111.272 -174.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -153.05 163.18 40.33 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 121.234 -0.916 . . . . 2.96 111.255 164.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 69.3 p -110.7 179.05 4.17 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.764 1.226 . . . . 1.67 109.957 160.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -71.02 -30.27 66.43 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 120.86 -1.15 . . . . 3.37 111.951 161.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.21 -38.14 82.0 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 124.8 1.191 . . . . 0.44 114.119 -178.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.53 -45.28 37.19 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.638 1.575 . . . . 1.22 111.575 174.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 15.0 mt -69.42 -52.82 23.25 Favored 'General case' 0 CA--C 1.522 -0.125 0 C-N-CA 125.68 1.592 . . . . 1.7 110.945 -178.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.9 tpt180 -56.38 -49.64 73.88 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 125.419 1.487 . . . . 6.29 111.585 -178.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 37.1 t -65.57 -42.17 92.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 107.827 -1.175 . . . . 1.89 107.827 -179.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 87.1 m -57.99 -38.49 76.2 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 118.547 0.612 . . . . 1.48 112.318 174.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 -63.06 -40.86 98.95 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 113.498 0.925 . . . . 1.74 113.498 -177.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 16.4 mt -81.32 -30.79 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 118.363 0.529 . . . . 2.14 110.34 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 45.5 mt -51.95 -38.33 56.08 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 114.372 1.249 . . . . 2.1 114.372 169.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 57.0 mttt -59.65 -31.05 69.17 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 124.962 1.305 . . . . 3.84 113.912 178.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -93.69 -32.02 14.21 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 127.616 2.366 . . . . 2.4 113.794 -174.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 59.9 mmtt -75.32 -26.55 58.74 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 119.805 -0.758 . . . . 2.87 111.086 168.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -128.45 55.47 17.52 Favored Pre-proline 0 CA--C 1.55 0.959 0 N-CA-C 117.897 2.554 . . . . 2.76 117.897 -177.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -68.83 -19.28 41.0 Favored 'Trans proline' 0 CA--C 1.534 0.489 0 C-N-CA 123.947 3.098 . . . . 0.81 113.993 168.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 76.4 mtt180 -79.46 -2.61 42.75 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 114.601 1.334 . . . . 7.29 114.601 174.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.25 158.38 33.46 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 115.727 1.751 . . . . 1.89 115.727 -170.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 64.2 p -118.09 -15.77 9.85 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.97 1.308 . . . . 1.89 112.651 168.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -131.66 141.72 49.67 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.914 0.885 . . . . 1.72 111.727 152.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.0 pt -149.79 117.96 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 126.084 1.754 . . . . 1.92 110.661 161.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 11.4 ptpt -152.8 155.01 36.31 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.86 1.264 . . . . 2.48 112.285 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.7 t -135.78 144.88 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 126.281 1.833 . . . . 1.61 110.398 -176.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 94.4 m -136.77 128.61 29.1 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.317 0.647 . . . . 1.48 110.646 171.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -73.14 123.74 24.21 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.589 0.756 . . . . 2.01 109.604 165.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.3 pt -122.18 27.2 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 125.001 1.321 . . . . 1.76 110.574 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 36.6 t -136.32 65.55 1.52 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 127.189 2.196 . . . . 2.16 111.001 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.37 0.6 2.66 Favored Glycine 0 CA--C 1.54 1.607 0 N-CA-C 117.227 1.651 . . . . 1.6 117.227 -176.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -131.72 4.13 5.4 Favored Glycine 0 CA--C 1.538 1.521 0 C-N-CA 125.687 1.613 . . . . 1.54 115.131 176.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 4.4 t -147.97 -27.35 0.34 Allowed 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 118.614 1.207 . . . . 2.52 113.979 175.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 59.09 33.14 73.19 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 127.138 2.304 . . . . 1.0 114.316 -170.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -84.31 -28.27 27.23 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 118.291 1.046 . . . . 2.14 113.516 178.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -106.49 140.54 39.23 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 125.052 1.341 . . . . 2.29 113.017 -179.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -142.64 145.68 33.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.751 -1.113 . . . . 3.18 111.605 170.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -83.58 138.66 33.28 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 125.101 1.36 . . . . 1.78 109.288 162.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 93.9 mt -133.95 126.83 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.189 0.996 . . . . 1.7 108.939 169.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 67.8 mttt -124.59 122.22 36.94 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.555 1.142 . . . . 3.5 110.127 178.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.6 mt -126.25 158.66 35.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 125.869 1.668 . . . . 1.92 109.296 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -151.89 130.17 12.02 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 126.293 1.837 . . . . 1.86 106.257 160.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 21.2 t -154.35 139.55 17.51 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 118.745 0.702 . . . . 0.36 110.683 -176.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -58.32 -18.3 26.23 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.32 1.448 . . . . 3.23 114.525 -177.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -74.23 -19.72 60.42 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.311 1.444 . . . . 1.69 114.529 177.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -82.84 10.91 6.74 Favored 'General case' 0 CA--C 1.555 1.17 0 N-CA-C 116.123 1.898 . . . . 2.85 116.123 -169.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 22.6 pttt -65.26 -46.85 78.85 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 127.059 2.144 . . . . 2.86 115.754 -165.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -92.4 -20.7 20.76 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 126.799 2.04 . . . . 5.11 112.353 -175.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 66.7 mmtt -58.82 142.91 49.05 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.567 1.147 . . . . 2.03 113.083 177.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 9.8 mmp_? -69.12 168.82 13.16 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 125.52 1.528 . . . . 7.77 111.148 163.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.6 m -46.76 -56.86 5.52 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.424 0.69 . . . . 1.99 112.606 170.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.7 p -58.8 -41.73 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 125.235 1.414 . . . . 2.14 112.633 178.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -76.0 -23.08 55.22 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 118.703 -0.665 . . . . 1.28 112.496 -177.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -68.63 -58.05 4.83 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 119.634 1.107 . . . . 0.79 109.925 164.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 32.5 m170 -56.14 -43.87 78.66 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.618 0.767 . . . . 0.64 112.788 -177.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 50.9 tp60 -53.31 -40.6 64.9 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.325 1.45 . . . . 1.36 113.086 178.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 2.6 mtm -64.04 -39.57 94.38 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 119.649 1.113 . . . . 1.51 111.283 178.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.3 t -73.18 -28.42 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 125.497 1.519 . . . . 1.48 111.775 177.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -71.58 -48.2 49.93 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.644 1.578 . . . . 0.6 110.812 174.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.14 -22.32 66.89 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 120.736 -1.227 . . . . 3.53 112.384 177.03 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.28 -22.07 66.82 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 113.704 1.001 . . . . 1.42 113.704 -177.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -132.69 -1.95 3.39 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 114.604 1.335 . . . . 1.92 114.604 173.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 36.3 tttt -47.02 -41.74 17.02 Favored 'General case' 0 C--N 1.344 0.327 0 C-N-CA 124.682 1.193 . . . . 4.51 111.62 173.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -76.29 -3.15 35.12 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 123.913 0.885 . . . . 3.08 112.761 -173.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -105.89 -51.54 2.97 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 128.288 2.635 . . . . 3.27 111.677 170.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 5.6 mt -143.33 126.88 13.61 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.371 0 C-N-CA 128.575 2.75 . . . . 2.92 106.648 -178.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -94.63 -22.46 18.15 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.174 -0.954 . . . . 4.88 113.196 -175.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -74.61 78.56 1.99 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.463 1.505 . . . . 3.75 113.018 -174.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 4.2 mpp? -82.38 13.46 3.58 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.936 1.295 . . . . 2.09 114.368 177.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 80.8 t60 -63.8 -34.29 77.59 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 120.624 -1.297 . . . . 5.77 114.082 -177.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -84.5 -11.94 76.56 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 126.218 1.866 . . . . 0.89 113.901 174.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.3 mp -86.47 139.13 31.18 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.427 1.091 . . . . 2.96 111.917 -172.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 16.7 ttm180 -126.99 99.36 5.69 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 126.272 1.829 . . . . 6.31 109.85 -169.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 3.6 mt -108.94 145.62 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-O 122.945 1.355 . . . . 1.64 113.306 -167.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -144.39 134.6 24.27 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 127.93 2.492 . . . . 3.46 109.31 -170.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 16.4 p -150.8 153.14 34.88 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 127.847 2.459 . . . . 1.52 109.397 -170.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.67 172.34 18.69 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 124.922 1.289 . . . . 0.66 110.045 175.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 8.9 p -136.97 125.87 15.16 Favored Pre-proline 0 N--CA 1.473 0.679 0 N-CA-C 113.661 0.985 . . . . 1.59 113.661 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -78.24 134.39 12.79 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 123.211 2.607 . . . . 0.77 110.763 170.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 25.1 ttmt -133.08 96.73 3.83 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.101 1.36 . . . . 3.46 108.335 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 . . . . . 0 C--O 1.25 1.099 0 C-N-CA 127.319 2.248 . . . . 11.44 113.555 -171.206 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.779 0 N-CA-C 111.414 0.153 . . . . 5.76 111.414 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.2 t -154.96 163.44 40.3 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.919 1.287 . . . . 4.7 112.272 -177.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -137.03 151.58 49.1 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 126.072 1.749 . . . . 3.09 112.09 173.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 80.8 p -120.92 176.14 5.7 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.526 1.53 . . . . 2.03 111.324 165.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 -66.04 -31.12 71.82 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 120.169 -1.582 . . . . 4.17 112.048 160.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.14 -46.13 95.13 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 125.565 1.555 . . . . 0.55 112.603 177.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.34 -47.24 47.42 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.469 1.507 . . . . 1.28 112.179 177.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 11.7 mt -72.24 -47.65 48.7 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.075 1.35 . . . . 1.75 111.716 -179.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -56.03 -50.44 70.9 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 126.381 1.873 . . . . 3.8 111.117 177.439 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 50.2 t -60.1 -46.21 94.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 107.945 -1.132 . . . . 1.5 107.945 178.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 37.6 m -59.41 -39.14 82.5 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 118.974 -0.536 . . . . 1.45 112.438 179.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 7.9 mm-40 -60.48 -40.96 93.19 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 118.88 0.764 . . . . 2.0 112.43 178.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 49.0 mt -81.63 -28.16 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 123.129 0.572 . . . . 1.63 110.63 -177.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 18.0 mt -59.66 -40.31 87.32 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 120.722 -1.236 . . . . 1.66 112.83 168.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 46.5 mttt -63.55 -23.31 67.33 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 119.423 1.01 . . . . 2.09 113.383 177.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -96.4 -35.51 11.15 Favored 'General case' 0 N--CA 1.434 -1.265 0 C-N-CA 126.937 2.095 . . . . 2.09 114.803 -177.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 64.3 mmtt -74.17 -27.75 60.97 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 118.176 -0.916 . . . . 2.19 111.125 167.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -127.29 51.44 6.63 Favored Pre-proline 0 CA--C 1.551 0.995 0 N-CA-C 117.347 2.351 . . . . 2.66 117.347 -178.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -64.75 -14.0 42.39 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 125.171 3.914 . . . . 0.76 115.04 176.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 32.5 mmt180 -83.31 -14.98 51.83 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.955 1.465 . . . . 5.72 114.955 170.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.62 143.14 47.32 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 116.728 2.122 . . . . 1.52 116.728 -166.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 77.8 p -96.89 -24.85 15.67 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.922 0.889 . . . . 1.54 112.64 175.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -126.28 140.42 52.54 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.838 0.855 . . . . 1.57 111.743 161.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.3 pt -155.77 117.8 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 126.292 1.837 . . . . 1.8 110.582 173.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.2 ptpt -152.44 155.84 38.32 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.459 1.504 . . . . 2.45 112.408 173.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.1 t -132.15 143.24 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 125.98 1.712 . . . . 1.62 109.9 177.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 74.6 m -136.53 123.64 21.65 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 118.46 0.573 . . . . 1.71 111.72 173.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -65.59 128.05 34.37 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 108.528 -0.916 . . . . 1.97 108.528 165.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.9 pt -127.53 33.1 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 125.859 1.663 . . . . 1.63 109.499 178.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.6 t -145.98 57.46 1.21 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 128.138 2.575 . . . . 1.9 110.828 -173.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.21 -0.85 0.33 Allowed Glycine 0 CA--C 1.541 1.711 0 C-N-CA 126.681 2.086 . . . . 1.31 117.889 -178.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -144.54 24.25 2.0 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 126.488 1.994 . . . . 1.43 113.505 -178.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -162.99 -27.77 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.565 1.546 . . . . 2.4 112.901 172.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 53.41 39.87 60.32 Favored Glycine 0 CA--C 1.536 1.362 0 C-N-CA 127.277 2.37 . . . . 0.63 114.707 -173.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -96.7 -34.79 11.23 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.976 1.31 . . . . 1.66 113.716 178.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 8.9 mtm -96.23 138.42 33.86 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 124.183 0.993 . . . . 2.41 111.525 177.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -142.63 144.88 32.99 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.019 0.928 . . . . 3.27 112.759 172.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -82.29 137.99 34.68 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 126.289 1.836 . . . . 2.34 109.215 165.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 92.2 mt -136.19 125.15 38.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.017 0.927 . . . . 1.75 109.507 169.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 64.4 mttt -123.89 114.62 20.07 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.47 1.108 . . . . 3.49 109.957 177.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.2 mt -122.92 157.56 28.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 126.535 1.934 . . . . 1.68 109.653 -177.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -154.93 132.91 11.57 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.756 1.623 . . . . 1.73 108.265 163.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 33.2 t -158.6 140.53 13.79 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 119.277 0.944 . . . . 0.39 110.515 -174.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -58.16 -19.81 35.88 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 114.311 1.226 . . . . 2.92 114.311 -177.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -72.01 -19.65 61.83 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.052 1.341 . . . . 1.75 114.387 179.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -79.44 13.28 2.04 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 114.165 1.172 . . . . 3.0 114.165 -171.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 42.6 pttt -77.69 -42.13 35.59 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 113.226 0.825 . . . . 3.22 113.226 -172.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -81.4 38.8 0.5 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.342 1.057 . . . . 3.78 112.739 -177.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 61.5 mmtt -138.44 144.75 40.28 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 126.164 1.786 . . . . 2.61 111.886 -171.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 55.4 mtt180 -71.98 167.24 20.55 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 124.226 1.01 . . . . 4.73 111.144 154.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 95.6 m -43.39 -56.03 3.8 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 126.136 1.774 . . . . 1.68 113.216 166.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.5 p -59.07 -42.63 87.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.92 1.288 . . . . 1.87 113.264 175.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -74.68 -23.31 58.61 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 118.578 -0.725 . . . . 1.31 112.381 -177.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -67.78 -54.69 17.14 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 119.728 1.149 . . . . 0.91 110.241 163.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 36.6 m170 -49.94 -51.29 42.32 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.068 0.947 . . . . 0.69 112.102 -179.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 15.5 tp60 -47.37 -44.17 23.9 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.082 1.353 . . . . 1.42 113.541 178.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 76.5 mtp -61.91 -43.92 97.85 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 119.334 0.97 . . . . 1.62 111.467 -177.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.1 t -72.62 -28.28 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 126.579 1.952 . . . . 1.45 111.226 179.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -72.5 -50.07 28.51 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.924 1.69 . . . . 0.48 109.679 176.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.8 mm-40 -65.01 -20.13 66.35 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.738 1.215 . . . . 3.16 113.355 178.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.94 -43.53 86.39 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 118.707 0.685 . . . . 1.69 111.398 178.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.55 5.65 9.54 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 115.132 1.53 . . . . 1.65 115.132 -174.245 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.9 ttmt -52.43 -38.18 58.53 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 125.034 1.333 . . . . 3.89 112.89 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -76.2 -26.08 55.79 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 112.92 0.711 . . . . 3.02 112.92 -178.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -78.9 -60.73 2.26 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.502 1.921 . . . . 3.39 110.647 175.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 42.5 mt -135.22 103.44 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 126.393 1.877 . . . . 2.14 108.361 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 14.1 ptpt -79.61 -17.38 53.97 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 115.428 1.64 . . . . 3.17 115.428 -169.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 19.7 mp0 -67.14 47.78 0.04 OUTLIER 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 130.227 3.411 . . . . 3.32 116.269 -171.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 4.2 mpp? -62.65 -2.1 1.02 Allowed 'General case' 0 N--CA 1.476 0.865 0 O-C-N 119.31 -2.118 . . . . 2.1 115.21 177.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 2.6 p80 -58.05 -29.82 65.69 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 119.419 1.009 . . . . 4.43 113.34 162.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -85.49 -23.39 47.44 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 124.862 1.22 . . . . 0.52 113.495 177.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.6 mp -83.19 143.3 30.57 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 122.401 1.096 . . . . 2.61 112.386 -169.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 24.1 ttt180 -118.88 95.93 5.03 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 127.258 2.223 . . . . 3.4 108.511 -175.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 2.7 mt -110.14 138.31 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 CA-C-O 123.66 1.695 . . . . 1.76 113.528 -168.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -137.76 127.09 24.71 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-N 111.116 -2.765 . . . . 3.33 108.494 -169.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 12.4 p -145.51 154.44 42.2 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.123 1.769 . . . . 1.61 108.955 -173.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.2 p -160.94 173.24 15.57 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.475 -1.238 . . . . 0.67 110.309 176.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.4 p -138.9 123.74 11.71 Favored Pre-proline 0 C--O 1.237 0.445 0 N-CA-C 112.649 0.611 . . . . 1.65 112.649 -177.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -74.73 126.63 10.27 Favored 'Trans proline' 0 N--CA 1.448 -1.205 0 C-N-CA 122.934 2.422 . . . . 0.88 108.431 169.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -124.14 74.79 1.32 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.721 1.608 . . . . 4.38 109.109 -174.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 58.2 ttt-85 . . . . . 0 C--O 1.252 1.216 0 C-N-CA 127.563 2.345 . . . . 10.42 112.851 -176.468 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.848 0 CA-C-O 120.474 0.178 . . . . 4.99 111.232 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.6 m 65.98 144.54 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 127.614 2.365 . . . . 3.92 114.869 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -143.14 162.36 35.77 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 120.656 -1.278 . . . . 3.15 113.177 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 56.6 p -121.32 178.79 4.64 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.053 1.741 . . . . 1.79 110.022 169.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -70.08 -27.92 65.01 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.046 -1.033 . . . . 3.26 111.491 160.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -71.79 -39.8 59.17 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 125.622 1.582 . . . . 0.43 114.105 -178.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.29 -44.18 43.87 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 119.449 1.625 . . . . 2.0 111.334 174.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 8.9 mt -68.52 -56.18 9.21 Favored 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 125.987 1.715 . . . . 1.53 110.67 178.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.58 -46.65 77.22 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.235 1.014 . . . . 3.75 111.555 -178.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.8 t -61.65 -48.01 90.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 107.972 -1.122 . . . . 1.8 107.972 178.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 52.9 m -57.31 -43.97 83.73 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 118.645 0.657 . . . . 1.7 112.059 176.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -61.99 -28.81 69.83 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.339 1.456 . . . . 2.85 113.262 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 64.4 mt -90.49 -29.19 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 124.532 1.133 . . . . 1.75 111.702 173.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.6 mt -56.94 -36.69 70.54 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 120.321 -1.487 . . . . 2.09 112.754 172.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 38.0 mttt -63.67 -17.33 62.84 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 115.004 1.483 . . . . 2.52 115.004 177.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -106.56 -37.73 6.37 Favored 'General case' 0 N--CA 1.429 -1.508 0 C-N-CA 125.987 1.715 . . . . 1.94 113.576 -172.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -77.34 -23.62 50.9 Favored 'General case' 0 N--CA 1.453 -0.311 0 O-C-N 123.538 0.524 . . . . 2.13 111.99 166.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -133.99 52.4 8.01 Favored Pre-proline 0 CA--C 1.546 0.795 0 N-CA-C 117.702 2.482 . . . . 2.69 117.702 -179.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -61.73 -22.68 74.94 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 123.585 2.857 . . . . 0.74 113.547 166.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 19.1 mtm180 -67.91 -15.04 63.43 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 114.654 1.353 . . . . 8.6 114.654 174.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.84 144.74 47.36 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 114.45 1.278 . . . . 1.5 114.45 -164.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 65.3 p -96.27 -19.66 19.12 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.938 0.895 . . . . 1.96 112.551 174.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -130.77 142.23 50.4 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.202 1.001 . . . . 1.4 111.975 159.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.4 pt -155.5 111.4 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 126.662 1.985 . . . . 1.6 111.359 172.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.6 ptpt -154.22 150.14 27.75 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.006 1.322 . . . . 2.14 112.71 -178.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.4 t -131.88 143.25 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 C-N-CA 125.818 1.647 . . . . 1.66 110.512 -173.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 77.6 m -135.34 129.71 33.87 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.825 1.25 . . . . 1.52 112.1 172.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -78.94 132.68 36.81 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.11 0.964 . . . . 1.76 110.457 170.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.7 pt -130.58 28.24 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 125.843 1.657 . . . . 1.71 111.285 179.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 41.6 t -139.13 63.72 1.5 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 127.625 2.37 . . . . 1.96 110.981 -176.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.98 -9.06 12.19 Favored Glycine 0 CA--C 1.54 1.641 0 N-CA-C 117.086 1.594 . . . . 1.19 117.086 -176.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -115.9 3.67 20.98 Favored Glycine 0 CA--C 1.537 1.456 0 C-N-CA 126.363 1.935 . . . . 1.09 115.331 179.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 37.0 t -155.32 -38.37 0.09 Allowed 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 118.631 1.215 . . . . 2.67 113.087 -176.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 64.58 36.45 93.17 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 127.026 2.251 . . . . 0.69 113.754 -169.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -85.02 -23.05 28.81 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 114.007 1.114 . . . . 2.09 114.007 173.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 1.2 mpp? -112.82 140.41 47.63 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.176 0.99 . . . . 2.44 113.56 -176.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -143.52 144.99 32.21 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 122.154 0.978 . . . . 3.23 113.144 173.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -98.46 120.15 38.39 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.009 1.724 . . . . 2.52 109.653 169.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 68.2 mt -132.07 129.54 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 124.684 1.194 . . . . 2.05 109.833 -163.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 67.9 mttt -125.45 125.66 43.69 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.62 0.768 . . . . 3.15 110.628 179.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.2 mt -129.49 157.95 42.14 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 127.589 2.356 . . . . 1.77 108.774 178.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 71.5 tt0 -157.14 128.61 6.95 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.774 1.63 . . . . 1.65 108.325 168.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 9.1 t -162.54 147.74 12.31 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 120.301 1.41 . . . . 0.41 114.05 -169.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -59.07 -24.6 63.04 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 126.049 1.74 . . . . 4.55 113.929 -172.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -73.57 -16.18 61.26 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.56 1.544 . . . . 1.8 115.086 177.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -83.51 -2.59 56.31 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 114.509 1.3 . . . . 3.55 114.509 -171.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 21.2 pttm -69.75 -42.09 74.35 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 113.505 0.928 . . . . 4.06 113.505 -178.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -91.58 41.44 1.07 Allowed 'General case' 0 CA--C 1.547 0.847 0 CA-C-O 123.018 1.389 . . . . 4.09 111.143 -170.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.9 mmtp -146.31 142.49 28.35 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 128.225 2.61 . . . . 4.12 109.572 -166.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 10.7 mmt85 -64.39 166.91 7.54 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.697 1.199 . . . . 4.3 110.583 158.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 55.0 m -53.19 -51.09 63.2 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 113.801 1.038 . . . . 1.78 113.801 168.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 14.7 p -63.47 -34.67 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 112.616 0.598 . . . . 1.87 112.616 177.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -65.22 -44.98 86.53 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 118.117 -0.945 . . . . 2.61 111.667 173.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -58.04 -51.42 69.73 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 119.291 0.95 . . . . 0.78 110.202 174.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 40.0 m170 -56.08 -50.01 72.21 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 123.405 0.682 . . . . 0.55 111.371 178.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 32.6 tp60 -53.07 -39.84 63.59 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.771 1.228 . . . . 1.53 112.875 -177.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 85.4 mtp -59.36 -47.11 86.67 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 119.752 1.16 . . . . 1.78 111.973 177.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.7 t -70.21 -32.19 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 126.009 1.723 . . . . 1.83 111.41 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -65.55 -52.29 53.52 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.128 1.771 . . . . 0.58 109.942 173.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 8.2 tm0? -66.98 -26.44 66.81 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.328 1.051 . . . . 3.15 113.161 -176.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -56.73 -39.09 73.32 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.712 1.605 . . . . 1.55 112.27 -179.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.64 -0.57 10.21 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 114.315 1.228 . . . . 1.87 114.315 -178.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 25.6 ttpt -52.5 -33.26 44.19 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.549 1.139 . . . . 2.64 112.805 175.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -81.81 -3.14 53.21 Favored 'General case' 0 CA--C 1.553 1.067 0 O-C-N 121.335 -0.853 . . . . 1.9 112.564 -178.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -104.61 -54.76 2.46 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 127.496 2.318 . . . . 3.18 111.435 169.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 32.6 mt -138.31 119.9 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 126.775 2.03 . . . . 1.86 108.494 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 41.5 mtmt -90.97 -1.43 57.83 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 115.012 1.486 . . . . 3.81 115.012 -169.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -81.58 58.61 3.78 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.379 1.872 . . . . 3.04 114.676 -158.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . 0.3 1.3 mpt? -75.28 9.52 2.04 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 119.779 -1.826 . . . . 3.0 115.477 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 13.7 p80 -65.01 -26.4 68.27 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.46 0.541 . . . . 5.29 112.46 153.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -94.77 -17.98 36.49 Favored Glycine 0 C--N 1.333 0.414 0 C-N-CA 126.455 1.979 . . . . 0.6 115.986 -175.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.8 mt -93.33 124.1 37.08 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 117.732 0.766 . . . . 3.26 110.875 -165.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 22.0 ttt180 -110.14 89.13 2.93 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 126.363 1.865 . . . . 4.08 107.347 -177.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 1.1 mt -108.69 139.99 29.05 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.565 0 CA-C-O 123.037 1.399 . . . . 1.81 111.743 -163.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -131.5 121.08 23.89 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 111.777 -2.465 . . . . 3.34 108.115 -169.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 24.4 p -131.93 153.96 49.76 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 126.268 1.827 . . . . 1.64 110.196 -179.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -160.49 179.76 8.34 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 126.114 1.766 . . . . 1.05 109.135 171.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.7 p -136.73 135.91 20.91 Favored Pre-proline 0 N--CA 1.474 0.748 0 O-C-N 120.897 -1.127 . . . . 1.52 111.98 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -84.46 135.79 6.22 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 124.52 3.48 . . . . 0.96 111.402 -179.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 7.0 mmtt -143.53 27.04 1.56 Allowed 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 114.182 1.179 . . . . 4.81 114.182 -161.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 71.1 mtm180 . . . . . 0 C--O 1.25 1.106 0 C-N-CA 126.182 1.793 . . . . 9.71 114.212 -168.572 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.003 0 CA-C-O 120.289 0.09 . . . . 6.03 111.203 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . 0.265 92.2 m 63.82 139.13 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 127.379 2.272 . . . . 3.7 113.283 -167.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.8 mp0 -130.21 157.93 41.12 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 114.439 1.274 . . . . 2.98 114.439 -168.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 72.8 p -121.04 179.51 4.36 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 126.257 1.823 . . . . 1.77 110.278 157.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.41 -32.7 71.87 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 120.941 -1.1 . . . . 3.68 112.357 164.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.14 -38.4 96.47 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 125.183 1.373 . . . . 0.45 112.949 174.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.71 -45.66 63.64 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.879 1.272 . . . . 1.49 112.369 176.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 13.1 mt -71.21 -49.87 38.98 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 125.008 1.323 . . . . 1.55 111.491 -178.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -54.26 -50.65 66.72 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 127.358 2.263 . . . . 5.27 110.991 178.355 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.8 t -63.86 -45.68 96.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 108.312 -0.996 . . . . 1.57 108.312 178.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 51.6 m -55.7 -36.52 67.27 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.243 0.46 . . . . 1.42 112.243 177.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -69.21 -43.47 74.03 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 114.123 1.157 . . . . 2.04 114.123 -178.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 26.7 mt -75.67 -28.29 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-N 118.689 0.677 . . . . 1.86 110.403 -179.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 21.5 mt -55.75 -37.7 68.84 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.569 0.951 . . . . 1.45 113.569 169.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 38.3 mttt -62.84 -32.92 74.24 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 118.563 0.62 . . . . 2.08 112.561 179.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -90.57 -35.48 15.0 Favored 'General case' 0 N--CA 1.438 -1.054 0 C-N-CA 128.362 2.665 . . . . 2.25 114.779 -175.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -77.17 -17.43 58.56 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 120.159 -0.616 . . . . 2.42 112.525 169.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -132.16 60.96 54.8 Favored Pre-proline 0 CA--C 1.551 1.017 0 N-CA-C 116.914 2.19 . . . . 3.66 116.914 175.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -68.68 -24.09 35.49 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 124.658 3.572 . . . . 1.02 114.759 170.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -80.27 0.13 34.05 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 114.495 1.295 . . . . 7.62 114.495 171.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.53 147.99 52.51 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 114.654 1.353 . . . . 1.85 114.654 -175.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 25.8 p -103.82 -18.69 14.55 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.525 1.13 . . . . 1.46 112.671 167.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -133.41 144.2 49.38 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 119.568 1.076 . . . . 1.7 112.149 159.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.9 pt -157.04 110.51 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 127.425 2.29 . . . . 1.63 110.815 171.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.5 ptpt -151.61 155.99 39.53 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.602 1.561 . . . . 2.17 113.024 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.9 t -136.04 145.57 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 126.016 1.726 . . . . 1.58 111.628 -172.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 94.3 m -138.82 126.67 22.24 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.233 0.613 . . . . 1.55 111.695 172.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -71.51 126.82 30.66 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.787 0.803 . . . . 1.82 110.451 168.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.2 pt -125.84 22.06 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 C-N-CA 125.524 1.529 . . . . 1.65 111.147 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 38.1 t -131.65 62.37 1.63 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 128.709 2.803 . . . . 2.03 110.896 179.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.01 -10.1 18.16 Favored Glycine 0 CA--C 1.539 1.562 0 N-CA-C 117.261 1.664 . . . . 1.15 117.261 -174.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -103.38 -19.62 12.17 Favored Glycine 0 N--CA 1.471 1.019 0 C-N-CA 126.534 2.016 . . . . 1.05 115.28 179.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 33.1 m -145.34 -29.56 0.44 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.29 1.036 . . . . 3.25 113.345 -163.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 60.42 41.41 98.55 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 128.201 2.81 . . . . 0.73 113.735 -175.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -98.39 -16.86 19.12 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.265 1.826 . . . . 1.65 112.955 -178.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' MET . . . . . 0.401 ' HG3' ' CA ' ' A' ' 97' ' ' GLY . 4.3 mpp? -117.8 141.49 48.35 Favored 'General case' 0 CA--C 1.52 -0.175 0 C-N-CA 126.627 1.971 . . . . 1.99 112.809 175.24 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -144.39 147.02 32.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.863 -1.062 . . . . 3.2 111.241 171.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -83.7 137.24 33.86 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 125.185 1.394 . . . . 2.23 109.193 163.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 97.5 mt -133.72 129.16 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 123.869 0.868 . . . . 1.79 109.345 170.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 70.0 mttt -124.56 116.97 23.31 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.673 1.189 . . . . 3.4 110.624 177.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.3 mt -122.29 162.62 21.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 C-N-CA 126.361 1.865 . . . . 1.51 109.271 -177.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -156.67 131.32 8.83 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.696 1.999 . . . . 1.77 107.111 162.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.7 t -157.28 140.14 15.13 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 120.402 1.456 . . . . 0.37 111.767 -173.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -58.26 -21.64 49.36 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.241 1.016 . . . . 3.41 113.543 -178.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -71.01 -15.4 62.56 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 115.274 1.583 . . . . 1.8 115.274 179.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -88.0 10.26 19.58 Favored 'General case' 0 CA--C 1.553 1.068 0 N-CA-C 115.537 1.68 . . . . 2.84 115.537 -171.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 14.9 pttt -63.07 -46.35 87.87 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 126.251 1.82 . . . . 3.29 115.569 -165.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -100.69 -11.03 20.29 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.385 1.474 . . . . 4.41 111.692 -168.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 32.9 mmtt -64.76 142.88 58.28 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 126.81 2.044 . . . . 2.45 112.561 174.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 16.6 mtt-85 -67.58 166.49 14.82 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 122.9 0.48 . . . . 4.28 111.092 159.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.8 m -50.31 -50.56 50.32 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 113.873 1.064 . . . . 2.05 113.873 172.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 10.4 p -62.71 -38.44 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 123.474 0.71 . . . . 1.91 112.783 174.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -75.34 -19.79 59.41 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.736 0.643 . . . . 1.43 112.736 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -70.34 -53.94 14.63 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.397 -0.814 . . . . 0.85 109.807 163.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 49.7 m170 -53.05 -48.28 67.79 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.82 0.848 . . . . 0.8 113.062 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 47.0 tp60 -47.79 -43.28 27.52 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.796 1.638 . . . . 1.19 113.477 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 3.6 mtm -67.07 -39.82 86.91 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 118.93 0.786 . . . . 1.62 111.768 -178.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.2 t -73.14 -33.83 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 125.616 1.567 . . . . 1.82 110.644 179.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -63.42 -50.64 69.0 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.111 1.764 . . . . 0.45 110.536 173.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 35.5 tp60 -66.05 -21.7 66.39 Favored 'General case' 0 N--CA 1.45 -0.474 0 O-C-N 119.849 -1.782 . . . . 2.38 114.118 -178.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.17 -40.55 85.97 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.379 0.672 . . . . 1.81 111.589 177.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.66 3.78 9.54 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 115.372 1.619 . . . . 1.38 115.372 -176.02 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 26.3 ttmt -43.8 -45.55 7.36 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 125.405 1.482 . . . . 2.71 111.877 174.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -84.27 -6.0 59.34 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 113.225 0.824 . . . . 3.05 113.225 -172.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -98.51 -56.15 2.54 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 127.226 2.211 . . . . 2.21 111.867 174.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 23.3 mt -132.96 92.61 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.57 1.548 . . . . 2.05 107.76 176.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -69.8 -19.08 63.5 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 114.094 1.146 . . . . 3.57 114.094 -172.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . 0.295 16.3 pt-20 -73.97 43.75 0.17 Allowed 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 116.359 1.985 . . . . 3.97 116.359 -169.09 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 64.3 mtm -66.21 0.75 1.85 Allowed 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 126.52 1.928 . . . . 2.38 116.023 -172.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 21.0 p-80 -61.6 -5.52 1.91 Allowed 'General case' 0 CA--C 1.55 0.959 0 N-CA-C 113.836 1.05 . . . . 6.4 113.836 157.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.401 ' CA ' ' HG3' ' A' ' 62' ' ' MET . . . -104.17 -14.99 22.98 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 125.468 1.509 . . . . 0.52 115.807 167.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.9 mp -89.68 124.97 35.06 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 118.904 1.352 . . . . 2.6 111.753 -169.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 50.3 ttt180 -103.26 100.87 10.79 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 127.072 2.149 . . . . 3.76 110.063 -178.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 5.4 mt -108.97 144.39 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-O 123.822 1.772 . . . . 1.52 112.853 -170.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -136.89 135.93 38.25 Favored 'General case' 0 N--CA 1.433 -1.298 0 C-N-CA 128.944 2.897 . . . . 3.32 109.248 -175.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.4 p -145.66 157.7 43.93 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 126.792 2.037 . . . . 1.82 108.176 -175.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -155.81 175.25 14.18 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 124.77 1.228 . . . . 0.9 108.959 172.386 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.1 p -142.8 126.33 9.38 Favored Pre-proline 0 N--CA 1.467 0.395 0 O-C-N 121.386 -0.821 . . . . 1.63 112.198 -179.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -73.82 102.41 1.5 Allowed 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 122.953 2.435 . . . . 0.76 110.894 176.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 19.4 ttpp -139.58 70.5 1.37 Allowed 'General case' 0 C--O 1.236 0.347 0 C-N-CA 127.172 2.189 . . . . 3.89 106.754 168.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 . . . . . 0 C--O 1.25 1.114 0 C-N-CA 127.293 2.237 . . . . 8.38 110.798 -179.124 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.649 0 CA-C-O 119.858 -0.115 . . . . 9.07 111.015 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 14.7 t -154.7 -22.03 0.12 Allowed 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 115.267 1.58 . . . . 6.26 115.267 178.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -154.43 138.53 16.47 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 123.993 0.917 . . . . 2.64 113.103 -175.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 58.7 p -102.02 176.46 5.19 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 126.115 1.766 . . . . 1.76 111.674 177.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -67.72 -34.03 76.06 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 120.486 -1.384 . . . . 4.13 112.115 164.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.4 -38.34 80.3 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 125.044 1.307 . . . . 0.52 114.229 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.87 -48.66 66.96 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 118.926 1.363 . . . . 1.39 112.551 -179.082 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 16.2 mt -70.11 -48.48 57.4 Favored 'General case' 0 CA--C 1.527 0.082 0 C-N-CA 125.375 1.47 . . . . 1.7 110.822 -178.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -53.32 -51.18 63.2 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 127.584 2.354 . . . . 5.1 111.319 179.251 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 39.3 t -62.83 -48.37 88.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 124.584 1.154 . . . . 1.5 108.425 177.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 42.1 m -57.0 -38.78 73.56 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.303 0.483 . . . . 1.83 112.303 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 -62.87 -41.22 99.3 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 112.395 0.517 . . . . 1.85 112.395 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 69.5 mt -78.03 -30.23 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 123.377 0.671 . . . . 1.84 111.317 -179.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 18.0 mt -55.33 -39.48 70.04 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 121.075 -1.015 . . . . 1.65 113.287 172.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 44.5 mttt -64.44 -26.36 68.41 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 113.459 0.911 . . . . 1.95 113.459 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -90.46 -35.36 15.17 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 126.823 2.049 . . . . 2.25 114.926 -177.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -74.68 -22.7 58.72 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 119.05 -1.06 . . . . 3.43 111.788 168.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -130.95 55.54 19.65 Favored Pre-proline 0 CA--C 1.552 1.052 0 N-CA-C 116.817 2.154 . . . . 2.74 116.817 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -68.31 -18.94 44.43 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 124.675 3.583 . . . . 0.85 115.225 177.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -81.96 -9.93 59.42 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 121.069 -1.019 . . . . 5.74 113.514 170.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.26 144.44 46.23 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 114.637 1.347 . . . . 1.72 114.637 -173.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 74.1 p -95.42 -29.64 14.31 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.769 1.628 . . . . 1.68 111.05 175.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -126.71 141.74 51.75 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.711 1.205 . . . . 1.35 111.265 165.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.1 pt -158.69 104.01 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 127.546 2.338 . . . . 1.73 109.434 174.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.0 ptpt -149.67 148.6 29.47 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.67 1.188 . . . . 2.34 112.86 -177.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.2 t -133.26 147.08 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 126.285 1.834 . . . . 1.69 111.246 -170.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 93.7 m -141.77 127.85 19.62 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 118.406 0.548 . . . . 1.54 111.538 170.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -68.41 135.86 52.4 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 122.174 0.988 . . . . 1.81 110.062 165.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . 0.255 1.6 pt -127.33 25.2 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.887 0 C-N-CA 125.647 1.579 . . . . 1.67 111.082 177.506 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 11.3 p -143.34 53.75 1.35 Allowed 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 128.98 2.912 . . . . 3.42 114.38 -171.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -55.98 -18.41 18.99 Favored Glycine 0 CA--C 1.546 2.022 0 O-C-N 120.403 -1.435 . . . . 1.31 116.678 -177.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -96.29 -5.84 59.07 Favored Glycine 0 CA--C 1.541 1.693 0 CA-C-N 119.658 1.729 . . . . 1.07 116.132 176.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 11.9 t -147.27 -31.75 0.31 Allowed 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 119.275 1.538 . . . . 2.2 114.301 -173.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 58.68 34.82 78.54 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 129.093 3.235 . . . . 0.66 114.361 -171.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -100.09 3.51 44.04 Favored 'General case' 0 CA--C 1.552 1.021 0 N-CA-C 115.223 1.564 . . . . 1.59 115.223 -177.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 2.1 mtp -131.36 138.43 49.16 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 127.396 2.279 . . . . 2.73 112.865 175.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -145.13 143.11 30.19 Favored 'General case' 0 C--O 1.227 -0.092 0 CA-C-O 122.645 1.212 . . . . 3.21 113.933 174.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -82.09 133.0 35.25 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 125.09 1.356 . . . . 1.74 110.021 165.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 82.7 mt -133.65 127.08 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 CA-C-N 119.816 1.189 . . . . 1.82 110.116 175.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 74.1 mttt -123.16 117.94 26.52 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.811 1.244 . . . . 3.52 110.232 178.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.3 mt -122.71 160.77 24.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 126.305 1.842 . . . . 1.51 109.046 -179.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -155.41 131.6 10.19 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 126.266 1.826 . . . . 1.94 107.219 162.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.9 t -154.07 137.66 16.01 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 118.678 0.672 . . . . 0.32 111.704 -177.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -55.11 -16.0 2.66 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 127.223 2.209 . . . . 4.22 114.567 176.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -76.66 -21.81 54.92 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 114.021 1.119 . . . . 1.71 114.021 175.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -79.97 11.85 3.11 Favored 'General case' 0 CA--C 1.556 1.192 0 N-CA-C 115.446 1.647 . . . . 2.86 115.446 -166.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -75.74 -36.4 59.91 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 117.777 2.51 . . . . 3.08 117.777 -163.293 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -80.75 -25.85 37.72 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 120.723 1.601 . . . . 5.36 111.429 173.258 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 43.1 mmtt -65.95 133.89 51.81 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.67 1.188 . . . . 2.76 113.289 -173.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 46.2 mtt-85 -63.75 160.73 16.55 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 125.451 1.5 . . . . 4.64 110.928 163.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 41.3 m -35.69 -57.77 0.64 Allowed 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 125.377 1.471 . . . . 1.76 114.094 167.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.0 p -65.79 -39.54 85.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 125.29 1.436 . . . . 1.98 112.674 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -70.21 -26.82 64.05 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 118.487 -0.768 . . . . 1.03 112.907 177.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -70.25 -52.75 20.71 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 119.112 0.869 . . . . 0.93 110.359 167.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 39.2 m170 -53.35 -49.18 67.66 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 118.911 0.778 . . . . 0.58 112.553 -178.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 33.0 tp60 -48.99 -43.52 40.22 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.844 1.258 . . . . 1.36 113.097 177.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 86.3 mtp -59.89 -44.5 94.2 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 121.179 -0.951 . . . . 1.87 112.026 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.1 t -73.17 -31.51 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 125.753 1.621 . . . . 1.52 111.608 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -67.51 -49.81 61.71 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 126.644 1.978 . . . . 0.46 110.237 175.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 39.8 tp60 -69.27 -20.82 63.92 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 120.513 -1.367 . . . . 2.83 113.708 -176.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.26 -46.87 88.31 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.253 1.421 . . . . 1.56 111.658 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.28 -5.09 14.19 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.975 1.102 . . . . 1.71 113.975 -175.327 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 11.7 ttmt -47.72 -35.96 10.6 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.187 1.395 . . . . 3.89 113.103 169.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -76.31 -0.16 21.49 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 114.294 1.22 . . . . 2.48 114.294 -178.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -120.27 -49.18 2.29 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 127.94 2.496 . . . . 3.22 111.222 175.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 37.2 mt -138.76 118.9 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 127.136 2.174 . . . . 1.92 107.224 176.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 37.2 mtpt -86.57 -10.93 52.93 Favored 'General case' 0 N--CA 1.478 0.973 0 O-C-N 120.455 -1.403 . . . . 3.09 113.509 -175.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 -77.92 47.81 0.66 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 128.052 2.541 . . . . 3.48 115.688 -158.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 3.3 mpp? -65.24 1.97 0.93 Allowed 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 115.391 1.626 . . . . 2.18 115.391 -178.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -64.49 -23.52 67.31 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 114.214 1.19 . . . . 4.6 114.214 160.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -90.21 -22.46 35.06 Favored Glycine 0 N--CA 1.475 1.256 0 C-N-CA 126.082 1.801 . . . . 0.54 114.916 173.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.9 mp -85.51 145.45 27.39 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.165 0.986 . . . . 2.7 112.85 -169.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 -123.48 101.83 7.55 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 126.385 1.874 . . . . 4.29 109.73 176.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 2.3 mt -105.61 146.57 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 CA-C-O 123.515 1.626 . . . . 1.51 113.619 -173.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -140.36 131.6 26.57 Favored 'General case' 0 N--CA 1.439 -1.004 0 C-N-CA 128.814 2.845 . . . . 3.26 108.952 -172.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 19.6 p -146.55 148.71 32.43 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.756 2.022 . . . . 1.59 109.489 -177.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.7 p -147.77 171.47 15.63 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.566 -1.197 . . . . 0.72 111.027 173.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 13.4 p -136.37 128.61 17.34 Favored Pre-proline 0 N--CA 1.47 0.55 0 C-N-CA 123.799 0.84 . . . . 1.61 110.332 173.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -73.28 127.23 11.74 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 121.966 1.777 . . . . 0.86 109.751 176.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 3.2 tmtp? -139.3 22.44 2.57 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 114.67 1.359 . . . . 3.72 114.67 -160.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 55.4 mtt-85 . . . . . 0 C--O 1.252 1.186 0 C-N-CA 127.304 2.242 . . . . 9.62 113.132 176.651 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.942 0 N-CA-C 110.331 -0.248 . . . . 7.53 110.331 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.59 176.96 11.95 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.005 1.322 . . . . 5.26 111.736 -165.259 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.1 mp0 -103.09 150.29 23.76 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.669 0.747 . . . . 3.12 111.39 142.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 30.6 p -129.14 173.06 10.81 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.98 1.712 . . . . 2.02 109.32 161.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -72.34 -26.88 62.1 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 120.286 -1.509 . . . . 4.65 111.19 177.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -66.51 -35.66 90.34 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 125.492 1.52 . . . . 0.45 113.282 170.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.69 -50.77 42.46 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.187 1.395 . . . . 1.37 111.563 173.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.8 mt -68.92 -48.81 62.38 Favored 'General case' 0 C--O 1.223 -0.292 0 C-N-CA 124.897 1.279 . . . . 1.55 110.973 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.39 -47.2 69.7 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.792 1.237 . . . . 4.6 111.416 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.3 t -67.74 -46.97 81.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 O-C-N 124.156 0.91 . . . . 1.85 108.716 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 89.6 m -52.82 -44.48 66.72 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.463 0.705 . . . . 1.63 112.005 175.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -62.42 -32.68 73.56 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.038 0.935 . . . . 2.93 113.126 -177.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 35.2 mt -82.27 -35.5 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 CA-C-N 118.798 0.727 . . . . 1.77 111.662 172.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 20.2 mt -53.74 -38.9 64.83 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 120.907 -1.121 . . . . 1.73 113.488 175.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 40.7 mttt -76.29 -9.64 58.8 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 114.8 1.407 . . . . 2.66 114.8 -178.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -90.26 -40.83 11.92 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 126.363 1.865 . . . . 3.02 113.214 167.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 65.0 mmtt -74.16 -30.12 62.1 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 119.1 -1.04 . . . . 2.16 111.777 177.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -132.98 53.15 10.13 Favored Pre-proline 0 CA--C 1.549 0.933 0 N-CA-C 117.285 2.328 . . . . 2.81 117.285 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -61.58 -26.38 80.44 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 123.975 3.117 . . . . 1.35 114.436 178.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 10.9 mmt180 -91.72 -3.79 55.83 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 114.344 1.238 . . . . 6.67 114.344 -176.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -55.07 149.5 11.95 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.03 1.732 . . . . 1.69 114.707 176.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 74.0 p -100.87 -9.88 21.2 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 126.172 1.789 . . . . 1.45 112.878 178.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -135.39 141.94 45.58 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.121 0.968 . . . . 1.41 110.52 150.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -154.19 108.14 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 C-N-CA 125.838 1.655 . . . . 1.95 110.799 171.517 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.4 ptpt -154.9 156.63 36.46 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.042 1.337 . . . . 2.09 113.11 176.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 25.3 t -122.34 151.65 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 127.37 2.268 . . . . 1.85 109.458 177.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 63.3 m -138.26 116.65 11.97 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 109.682 -0.488 . . . . 1.75 109.682 168.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -65.58 133.02 50.3 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 122.18 0.991 . . . . 2.12 109.11 166.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.1 pt -126.59 32.23 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 124.721 1.208 . . . . 1.71 109.533 178.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.6 t -146.6 45.83 1.2 Allowed 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 126.793 2.037 . . . . 1.87 113.257 -169.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -49.59 -31.89 15.56 Favored Glycine 0 CA--C 1.543 1.802 0 O-C-N 120.112 -1.618 . . . . 1.43 115.887 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -77.18 -12.81 84.26 Favored Glycine 0 CA--C 1.541 1.673 0 N-CA-C 116.248 1.259 . . . . 1.52 116.248 176.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 4.7 t -147.75 -44.14 0.17 Allowed 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 119.891 1.845 . . . . 2.63 114.384 -173.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 73.97 47.73 18.21 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 128.921 3.153 . . . . 0.93 112.434 -168.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -96.05 -29.64 14.0 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.545 1.538 . . . . 2.09 114.252 174.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -113.09 142.13 46.09 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 125.267 1.427 . . . . 2.3 113.811 -177.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -143.2 142.42 31.41 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 122.282 1.039 . . . . 3.24 112.824 172.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -83.58 139.98 32.52 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 125.862 1.665 . . . . 2.32 109.529 163.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 90.4 mt -135.94 129.59 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-N 119.335 0.97 . . . . 1.85 109.185 172.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 77.4 mttt -126.27 113.73 17.34 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.708 1.203 . . . . 3.45 109.768 -177.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.2 mt -125.11 157.82 33.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 126.333 1.853 . . . . 1.48 109.109 -178.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 48.2 tt0 -157.76 129.34 6.83 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 126.103 1.761 . . . . 1.84 107.415 167.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 18.2 t -160.14 145.28 14.97 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 120.131 1.332 . . . . 0.35 113.091 -171.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -59.42 -16.9 26.35 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.964 2.105 . . . . 3.69 114.583 -176.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -77.36 -20.21 55.14 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.733 1.613 . . . . 1.73 115.03 173.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -80.72 5.67 15.08 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 114.861 1.43 . . . . 2.89 114.861 -167.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 22.8 pttt -73.33 -49.64 26.34 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 114.7 1.37 . . . . 4.1 114.7 -171.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . 0.278 15.2 pm0 -80.89 25.35 0.45 Allowed 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 119.658 1.117 . . . . 4.08 113.855 -177.336 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 42.1 mmtt -119.03 141.39 48.75 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 127.393 2.277 . . . . 2.02 110.854 -177.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 40.1 mtt180 -67.82 166.15 16.05 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 123.003 0.521 . . . . 4.45 111.213 158.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 52.6 m -47.4 -53.35 14.18 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 114.384 1.253 . . . . 1.69 114.384 170.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 13.6 p -61.11 -37.81 78.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 123.215 0.606 . . . . 1.83 112.594 175.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -74.45 -27.59 60.66 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 118.53 -0.748 . . . . 1.14 112.553 179.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -64.28 -56.02 17.45 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.279 1.032 . . . . 0.85 109.872 166.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 35.7 m170 -53.0 -48.33 67.59 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.703 0.801 . . . . 0.58 112.255 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 30.8 tp60 -52.64 -40.54 62.9 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.471 1.108 . . . . 1.38 113.221 178.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -63.67 -37.65 88.15 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 120.3 1.409 . . . . 2.18 111.221 179.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.3 t -76.76 -31.08 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 125.192 1.397 . . . . 1.71 111.689 179.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -67.63 -48.07 67.77 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.597 1.559 . . . . 0.47 110.195 173.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -61.55 -27.53 68.68 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 120.713 -1.242 . . . . 3.62 113.202 178.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.64 -35.74 74.99 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.614 1.165 . . . . 1.48 112.399 -177.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.18 -3.03 8.53 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 113.927 1.084 . . . . 1.78 113.927 -178.177 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 26.1 ttpt -49.26 -37.63 24.14 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.141 1.376 . . . . 3.56 112.82 177.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -78.13 -12.64 60.01 Favored 'General case' 0 CA--C 1.552 1.043 0 CA-C-O 121.68 0.753 . . . . 2.62 111.863 -173.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -109.56 -51.04 2.92 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 128.98 2.912 . . . . 3.14 110.681 -171.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.3 mm -129.68 123.62 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 127.851 2.46 . . . . 2.82 106.579 164.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -97.01 -9.21 28.64 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 119.873 -1.767 . . . . 4.37 114.876 -178.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -81.94 50.77 1.61 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 127.631 2.372 . . . . 2.98 114.356 -166.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 5.2 mpp? -64.92 -2.21 2.49 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 114.998 1.481 . . . . 2.42 114.998 -175.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 19.4 p-80 -63.79 -14.87 56.51 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 114.28 1.215 . . . . 6.19 114.28 165.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -92.75 -17.55 44.26 Favored Glycine 0 CA--C 1.537 1.431 0 O-C-N 121.13 -0.981 . . . . 0.65 114.451 167.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.8 mp -89.07 146.49 24.8 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 121.283 -1.127 . . . . 2.68 112.685 -170.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 21.3 ttt85 -131.63 99.6 4.85 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.853 2.061 . . . . 3.92 110.049 -173.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 4.0 mt -107.96 145.82 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 CA-C-O 123.461 1.6 . . . . 1.76 113.943 -169.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -135.31 127.89 30.74 Favored 'General case' 0 N--CA 1.438 -1.051 0 C-N-CA 128.446 2.698 . . . . 3.18 107.975 -171.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 23.7 p -143.28 160.61 40.18 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 126.466 1.907 . . . . 1.51 110.207 -175.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -171.28 175.69 4.14 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 124.953 1.301 . . . . 1.26 109.735 179.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.5 p -136.68 135.66 20.67 Favored Pre-proline 0 N--CA 1.471 0.581 0 C-N-CA 123.855 0.862 . . . . 1.74 110.936 175.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -75.44 129.34 11.87 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 123.561 2.84 . . . . 0.67 109.584 173.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? -140.8 24.64 2.2 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.265 1.026 . . . . 3.79 113.696 -159.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.316 0 C-N-CA 126.878 2.071 . . . . 8.03 113.042 -175.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.709 0 CA-C-O 118.319 -0.848 . . . . 5.9 110.378 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . 0.31 3.1 t 54.57 19.15 2.28 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 117.58 2.437 . . . . 4.6 117.58 169.209 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 18.0 mp0 -44.27 143.75 1.16 Allowed 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 115.734 1.753 . . . . 2.95 115.734 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 80.9 p -103.42 169.98 8.22 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.054 0.942 . . . . 1.58 109.309 150.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -70.81 -21.74 62.43 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 120.844 -1.16 . . . . 2.9 112.662 169.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.21 -41.62 96.76 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 125.533 1.54 . . . . 0.49 113.264 169.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.68 -47.81 29.4 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.769 1.627 . . . . 1.27 111.708 172.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.4 mt -68.46 -50.68 50.71 Favored 'General case' 0 C--O 1.231 0.095 0 C-N-CA 125.456 1.502 . . . . 1.67 111.444 -178.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -57.83 -49.74 75.63 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 126.119 1.768 . . . . 5.12 111.145 -179.251 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 36.3 t -60.59 -47.54 92.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 108.223 -1.029 . . . . 1.56 108.223 176.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 88.8 m -57.1 -37.58 72.15 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 112.539 0.57 . . . . 1.86 112.539 178.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 7.9 mm-40 -64.47 -41.64 96.39 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 113.178 0.807 . . . . 2.08 113.178 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 27.7 mt -76.04 -29.83 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-N 118.195 0.452 . . . . 2.01 110.561 177.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 23.5 mt -57.42 -39.13 75.53 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 120.865 -1.147 . . . . 1.72 113.594 170.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 39.5 mttt -64.45 -17.96 64.31 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 113.935 1.087 . . . . 2.18 113.935 177.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -104.36 -35.56 7.9 Favored 'General case' 0 N--CA 1.433 -1.325 0 C-N-CA 126.894 2.078 . . . . 1.86 114.021 -177.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -74.15 -23.33 59.25 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 119.607 -0.837 . . . . 2.06 111.777 167.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -132.86 51.4 7.0 Favored Pre-proline 0 CA--C 1.548 0.871 0 N-CA-C 117.748 2.499 . . . . 3.62 117.748 -178.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -64.82 -24.76 61.03 Favored 'Trans proline' 0 C--O 1.238 0.489 0 C-N-CA 123.89 3.06 . . . . 0.76 114.352 174.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 15.5 mmp_? -76.94 -1.08 26.76 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.593 0.96 . . . . 6.74 113.593 173.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.15 154.55 30.81 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 115.176 1.547 . . . . 1.63 115.176 177.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 70.6 p -107.96 -27.81 9.96 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.022 1.329 . . . . 1.91 112.568 165.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -117.67 133.73 55.64 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.745 0.818 . . . . 1.46 111.14 163.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.3 pt -152.63 99.44 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 125.955 1.702 . . . . 1.73 109.689 169.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.2 ptpt -146.67 149.05 32.71 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.194 1.398 . . . . 2.02 111.809 -176.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.5 t -133.71 152.31 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 125.947 1.699 . . . . 1.66 110.221 -172.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 81.4 m -141.56 135.29 29.94 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.356 0.663 . . . . 1.65 110.607 167.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -75.86 130.28 38.31 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 122.108 0.956 . . . . 2.06 110.315 166.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . 0.273 3.7 pt -123.0 29.1 2.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 125.533 1.533 . . . . 1.62 110.33 177.067 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.1 p -135.17 62.85 1.63 Allowed 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 127.897 2.479 . . . . 3.52 114.005 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.36 2.27 1.71 Allowed Glycine 0 CA--C 1.539 1.562 0 N-CA-C 117.252 1.661 . . . . 1.3 117.252 178.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -122.73 -5.6 8.26 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-N 119.84 1.82 . . . . 0.99 115.943 172.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 1.7 m -151.79 -18.68 0.19 Allowed 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 115.066 1.506 . . . . 3.3 115.066 -175.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 52.53 43.96 59.08 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 126.254 1.883 . . . . 0.8 114.209 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -112.55 2.68 16.37 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 125.303 1.441 . . . . 1.91 114.097 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 13.9 ttm -132.85 120.92 22.18 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 128.93 2.892 . . . . 1.92 109.498 -166.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -140.95 143.95 34.85 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.709 0.766 . . . . 3.19 112.824 -175.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -82.75 135.59 34.95 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 125.217 1.407 . . . . 2.57 108.985 164.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 88.3 mt -135.93 127.71 44.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-N 119.457 1.026 . . . . 1.64 110.081 172.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -121.01 114.2 21.17 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.9 1.28 . . . . 3.24 109.923 176.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.2 mt -121.55 153.37 25.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 126.011 1.724 . . . . 1.79 108.99 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -157.58 124.13 4.92 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 125.132 1.373 . . . . 1.86 107.711 168.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 43.2 t -153.95 144.32 22.25 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.723 1.147 . . . . 0.44 113.02 -169.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -55.88 -21.88 22.54 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.78 1.632 . . . . 3.73 114.589 -178.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -75.52 -21.71 57.75 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 113.692 0.997 . . . . 1.78 113.692 177.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -77.67 13.29 1.34 Allowed 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 114.111 1.152 . . . . 3.52 114.111 -167.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -83.49 -43.1 16.14 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.888 0.699 . . . . 2.89 112.888 -176.581 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -83.12 46.24 1.1 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 125.332 1.453 . . . . 3.42 110.765 179.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 54.0 mmtt -148.04 144.17 27.72 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 128.316 2.647 . . . . 2.5 111.82 -176.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 17.6 mtt85 -70.05 171.12 10.08 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.17 0.988 . . . . 5.08 111.341 155.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 87.3 m -57.98 -48.26 80.51 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 113.758 1.021 . . . . 2.35 113.758 174.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 13.6 p -59.72 -37.3 70.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 O-C-N 121.805 -0.56 . . . . 1.71 112.186 172.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -74.55 -26.38 59.92 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 118.609 -0.71 . . . . 1.0 111.996 179.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -64.79 -54.09 36.78 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.712 1.142 . . . . 0.96 109.911 165.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 37.2 m170 -54.29 -49.14 70.3 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.256 1.023 . . . . 0.82 113.307 -178.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 56.5 tp60 -48.54 -43.3 35.3 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.667 1.987 . . . . 1.44 113.528 177.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 83.2 mtp -63.28 -46.39 86.99 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.681 0.792 . . . . 1.78 111.648 179.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.9 t -66.5 -30.99 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 125.191 1.396 . . . . 1.72 111.383 178.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -68.37 -54.45 17.19 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.161 1.785 . . . . 0.51 110.726 175.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.7 -22.12 66.59 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.678 0.791 . . . . 2.96 112.973 -178.077 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.06 -41.1 78.12 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 125.482 1.513 . . . . 1.75 112.608 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.22 2.24 9.18 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 114.646 1.35 . . . . 1.64 114.646 -176.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 11.7 ttpp -51.65 -37.61 51.17 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 124.819 1.248 . . . . 3.9 112.131 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -83.21 -7.11 59.66 Favored 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 113.392 0.886 . . . . 2.02 113.392 -175.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -98.21 -51.1 4.11 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 127.027 2.131 . . . . 3.41 110.917 174.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 21.4 mt -143.21 104.57 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 126.585 1.954 . . . . 1.87 107.642 176.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -79.01 -2.09 38.63 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 115.313 1.597 . . . . 3.08 115.313 -174.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -74.26 36.69 0.1 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 129.335 3.054 . . . . 3.95 116.046 -165.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 5.6 mpp? -63.13 1.89 0.41 Allowed 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 116.053 1.871 . . . . 2.43 116.053 -176.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 7.6 p80 -58.16 -29.46 65.62 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 120.602 -1.311 . . . . 4.89 112.036 156.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -78.58 -29.81 51.15 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 126.496 1.998 . . . . 0.55 115.595 176.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.2 mp -91.33 122.17 33.71 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.368 -1.077 . . . . 2.77 113.07 -158.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 47.1 ttt180 -99.1 100.73 11.91 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 127.386 2.274 . . . . 3.84 109.785 -179.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 2.1 mt -108.04 143.06 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 CA-C-O 123.18 1.467 . . . . 2.02 113.506 -170.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -133.97 123.27 24.34 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 128.277 2.631 . . . . 3.28 108.49 -173.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 33.3 p -137.68 156.29 48.19 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 125.62 1.568 . . . . 1.74 112.158 -176.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.1 p -167.09 177.31 6.32 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.651 1.58 . . . . 0.68 110.476 178.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.5 p -136.87 132.0 18.22 Favored Pre-proline 0 N--CA 1.479 1.01 0 O-C-N 121.033 -1.042 . . . . 1.78 111.328 175.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -76.29 100.02 1.35 Allowed 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 123.11 2.54 . . . . 1.25 111.379 -176.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -146.97 89.16 1.79 Allowed 'General case' 0 C--O 1.238 0.468 0 C-N-CA 126.373 1.869 . . . . 5.18 109.447 -173.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 28.7 ptt-85 . . . . . 0 C--O 1.251 1.154 0 N-CA-C 115.208 1.558 . . . . 8.81 115.208 -173.437 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.824 0 N-CA-C 113.153 0.798 . . . . 8.42 113.153 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 14.8 t -154.32 167.38 30.16 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.546 1.139 . . . . 4.55 112.572 -169.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 14.0 mp0 -62.65 152.14 36.15 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.438 1.495 . . . . 4.28 114.796 -176.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 33.8 p -118.83 171.88 7.91 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.688 1.595 . . . . 1.96 111.375 166.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -64.04 -32.96 74.69 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 121.474 -0.766 . . . . 2.98 111.106 169.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.92 -34.6 71.42 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 124.902 1.239 . . . . 0.61 113.821 179.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.19 -47.32 54.67 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.133 1.373 . . . . 1.26 111.634 173.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 12.3 mt -68.07 -49.99 57.87 Favored 'General case' 0 CA--C 1.523 -0.095 0 C-N-CA 124.94 1.296 . . . . 1.65 111.064 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -57.99 -46.74 84.71 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.218 1.407 . . . . 7.88 111.227 -179.487 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 39.5 t -61.91 -46.44 96.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 108.108 -1.071 . . . . 1.78 108.108 177.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 29.8 m -57.89 -35.92 71.68 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 112.693 0.627 . . . . 1.55 112.693 177.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -67.32 -44.57 78.81 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 113.112 0.782 . . . . 2.02 113.112 179.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 28.7 mt -74.89 -28.23 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-N 118.652 0.66 . . . . 1.76 110.555 -179.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 23.6 mt -58.52 -36.81 74.4 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 120.945 -1.097 . . . . 1.7 113.448 170.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 58.0 mttt -58.42 -31.96 68.22 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 113.055 0.761 . . . . 3.08 113.055 175.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -95.67 -34.59 11.9 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 127.069 2.148 . . . . 2.1 114.213 -172.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -77.73 -20.67 53.11 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 120.11 -0.636 . . . . 1.98 112.468 168.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -130.38 52.14 8.86 Favored Pre-proline 0 CA--C 1.55 0.972 0 N-CA-C 118.052 2.612 . . . . 2.68 118.052 178.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -63.51 -22.28 70.89 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.966 3.111 . . . . 0.82 114.409 174.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 21.8 mmt180 -87.48 -1.58 58.03 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 113.889 1.07 . . . . 5.92 113.889 177.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.37 151.82 46.34 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.897 1.279 . . . . 1.86 113.731 178.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 81.8 p -113.23 -9.0 13.5 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.594 1.558 . . . . 1.92 113.527 174.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -135.37 142.65 45.77 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 120.028 1.285 . . . . 1.86 111.107 153.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.4 pt -151.29 120.07 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 125.492 1.517 . . . . 1.9 111.959 170.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -159.2 158.6 32.99 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.386 1.475 . . . . 3.27 113.247 178.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.0 t -138.74 150.96 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 126.364 1.866 . . . . 1.61 109.952 -174.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 55.0 m -140.88 125.78 18.19 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 118.58 0.627 . . . . 1.61 109.865 168.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -69.68 130.17 41.62 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 121.53 -0.731 . . . . 2.53 109.273 167.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.9 pt -127.36 32.85 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 125.562 1.545 . . . . 1.6 110.485 178.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 44.8 t -138.91 69.67 1.37 Allowed 'General case' 0 C--N 1.343 0.307 0 C-N-CA 127.938 2.495 . . . . 1.91 111.209 -177.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -42.47 -36.67 2.32 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 126.16 1.838 . . . . 1.34 116.129 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -100.02 -14.27 34.29 Favored Glycine 0 CA--C 1.539 1.539 0 N-CA-C 115.981 1.153 . . . . 1.5 115.981 -173.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 8.2 t -138.12 -29.08 0.84 Allowed 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 119.18 1.49 . . . . 2.89 114.484 -174.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 55.86 47.68 77.49 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 124.263 0.935 . . . . 0.87 112.22 -161.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -93.39 -25.52 17.65 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.948 1.299 . . . . 1.56 113.175 173.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 23.0 mtm -106.02 135.16 47.97 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 125.268 1.427 . . . . 2.1 111.776 172.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -138.13 143.51 40.39 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 121.959 0.885 . . . . 3.25 112.179 169.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -81.08 139.08 35.89 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 125.931 1.692 . . . . 2.39 109.156 162.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 93.6 mt -137.39 129.05 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 CA-C-N 119.68 1.127 . . . . 1.74 110.018 171.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 79.7 mttt -123.08 117.38 25.28 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.814 1.246 . . . . 3.32 109.858 177.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.2 mt -126.1 157.06 36.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 126.371 1.868 . . . . 1.58 109.338 -179.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -154.6 126.11 7.45 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 120.441 -1.412 . . . . 2.17 108.326 170.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 17.8 t -157.31 146.41 19.96 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-N 119.637 1.108 . . . . 0.37 112.937 -172.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -57.7 -26.21 61.41 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 126.389 1.876 . . . . 4.04 112.653 -177.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -73.08 -11.95 60.73 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.714 1.606 . . . . 1.88 114.96 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -91.2 6.09 46.49 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 116.408 2.003 . . . . 3.45 116.408 -171.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.47 -37.3 63.26 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 115.84 1.793 . . . . 3.67 115.84 -172.52 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -87.36 28.36 0.97 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 124.739 1.216 . . . . 4.12 112.669 -177.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 55.6 mmtt -131.08 132.99 45.26 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.929 1.292 . . . . 3.15 113.335 -164.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 23.9 mtt85 -65.09 169.83 5.08 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.889 1.276 . . . . 4.87 110.971 164.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 27.5 m -51.53 -53.86 33.33 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 113.384 0.883 . . . . 1.75 113.384 174.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.4 p -61.61 -38.05 79.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 123.377 0.671 . . . . 1.74 111.569 175.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -75.04 -20.67 59.47 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 113.727 1.01 . . . . 1.39 113.727 -178.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -75.13 -55.35 5.82 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 119.054 0.843 . . . . 0.89 110.116 164.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 40.8 m170 -56.42 -46.45 80.22 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.912 0.885 . . . . 0.92 113.24 -175.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 29.7 tp60 -47.88 -41.79 25.17 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.287 1.435 . . . . 1.25 113.088 177.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 3.7 mtm -64.17 -40.68 96.63 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 121.491 -0.756 . . . . 2.2 111.668 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.8 t -75.78 -23.99 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 126.07 1.748 . . . . 1.51 111.235 179.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -76.16 -48.44 20.53 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.911 1.684 . . . . 0.45 109.273 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 19.5 mm-40 -65.74 -23.68 66.79 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.622 1.169 . . . . 3.71 114.081 178.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.49 -38.49 84.47 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.119 0.968 . . . . 1.45 112.688 -177.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.22 3.41 10.36 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 114.605 1.335 . . . . 1.88 114.605 -178.58 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.9 ttmt -53.25 -39.94 64.23 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.674 1.189 . . . . 3.93 112.576 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -82.47 -5.83 58.93 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 123.311 0.644 . . . . 2.14 112.629 -175.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -95.83 -49.16 5.44 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 127.412 2.285 . . . . 2.77 111.592 167.682 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 21.2 mt -148.38 110.36 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 128.133 2.573 . . . . 2.12 109.024 178.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt -85.52 0.38 52.58 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 117.852 2.538 . . . . 5.06 117.852 -173.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -77.19 48.42 0.62 Allowed 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 129.557 3.143 . . . . 2.86 115.845 -160.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . 0.267 1.4 mpt? -70.63 3.51 3.07 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 119.709 -1.869 . . . . 3.11 115.42 -177.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 17.5 p-80 -66.92 -13.62 61.94 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 114.491 1.293 . . . . 5.95 114.491 156.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -108.64 -25.39 5.74 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 125.914 1.721 . . . . 0.57 115.103 171.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.2 mp -78.27 141.25 38.67 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 121.009 -1.289 . . . . 2.67 113.577 -174.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 34.8 ttt180 -125.9 101.76 6.97 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 127.316 2.246 . . . . 3.76 109.933 -177.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 4.0 mt -108.21 149.77 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-O 123.59 1.662 . . . . 1.62 113.593 -171.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -139.77 119.56 13.35 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 111.356 -2.657 . . . . 3.2 108.631 -171.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.8 p -136.85 145.02 43.92 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 125.285 1.434 . . . . 1.73 111.253 -177.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.8 p -148.08 178.58 8.42 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.283 -1.326 . . . . 0.87 111.404 176.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 6.8 p -145.0 135.82 12.25 Favored Pre-proline 0 N--CA 1.47 0.575 0 O-C-N 121.759 -0.588 . . . . 1.62 112.385 -178.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -80.85 105.66 1.71 Allowed 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 123.298 2.665 . . . . 0.77 110.999 176.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -135.41 25.14 3.48 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.396 1.478 . . . . 4.74 113.997 -162.219 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 20.8 ttt180 . . . . . 0 N--CA 1.48 1.043 0 C-N-CA 125.346 1.458 . . . . 8.53 111.6 176.471 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.074 0 N-CA-C 112.106 0.41 . . . . 6.31 112.106 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -138.32 -178.39 5.27 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 125.651 1.58 . . . . 4.62 111.272 173.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -135.46 136.17 41.09 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 126.003 1.721 . . . . 3.0 111.304 169.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 70.1 p -100.4 -178.89 3.94 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 126.069 1.748 . . . . 2.16 110.13 160.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -73.24 -25.71 60.83 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 120.264 -1.522 . . . . 2.88 112.208 160.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.73 -40.27 98.56 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 125.453 1.501 . . . . 0.52 113.244 173.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -52.22 -42.19 63.37 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.588 1.555 . . . . 1.24 113.016 177.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 14.0 mt -75.06 -48.44 23.9 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 126.543 1.937 . . . . 1.89 110.549 -179.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -53.81 -49.09 69.12 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.333 1.453 . . . . 3.78 111.149 175.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 29.8 t -62.46 -52.04 64.79 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 C-N-CA 125.457 1.503 . . . . 1.55 107.576 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 99.3 m -52.24 -43.13 64.15 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.479 0.712 . . . . 1.5 111.848 178.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -65.33 -42.21 93.15 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 118.267 -0.873 . . . . 2.35 112.406 -178.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 38.6 mt -72.4 -32.0 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 CA-C-N 119.754 1.161 . . . . 1.68 110.494 178.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 20.6 mt -54.36 -44.06 71.87 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 121.344 -0.848 . . . . 1.7 112.904 173.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 34.9 mttt -65.91 -23.88 66.72 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 113.69 0.996 . . . . 3.14 113.69 -178.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -93.03 -33.83 13.95 Favored 'General case' 0 N--CA 1.435 -1.211 0 C-N-CA 126.694 1.998 . . . . 2.34 114.357 -177.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -75.64 -21.43 57.71 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 120.292 -0.563 . . . . 2.12 111.947 166.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -131.12 58.2 37.16 Favored Pre-proline 0 CA--C 1.549 0.927 0 N-CA-C 117.254 2.316 . . . . 2.76 117.254 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -67.18 -13.38 39.43 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 124.241 3.294 . . . . 1.11 114.428 168.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.97 -12.72 60.19 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 115.274 1.583 . . . . 8.7 115.274 171.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.94 153.79 42.69 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 116.37 1.989 . . . . 1.62 116.37 -162.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 39.8 p -107.83 -25.28 11.31 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.521 1.528 . . . . 1.71 112.466 166.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -125.9 141.24 52.07 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.297 0.953 . . . . 1.47 111.62 164.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.2 pt -157.4 112.06 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 126.589 1.956 . . . . 1.99 109.598 174.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.8 ptpt -153.38 149.9 28.3 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.239 1.416 . . . . 2.73 112.221 -177.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.5 t -133.63 151.58 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 126.081 1.753 . . . . 1.82 110.574 -176.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 88.0 m -146.6 122.73 10.82 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 121.046 -1.034 . . . . 1.65 111.903 167.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -65.94 129.04 38.42 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.634 0.731 . . . . 1.99 109.314 162.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.9 pt -129.26 28.62 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 C-N-CA 126.364 1.865 . . . . 1.75 110.009 179.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.5 t -132.99 59.25 1.74 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 127.547 2.339 . . . . 1.8 112.271 -165.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -66.5 14.33 0.36 Allowed Glycine 0 CA--C 1.539 1.562 0 C-N-CA 126.126 1.822 . . . . 1.82 117.295 -175.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -154.07 16.99 0.61 Allowed Glycine 0 CA--C 1.533 1.171 0 C-N-CA 125.568 1.556 . . . . 1.82 113.853 -177.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.6 t -161.52 -27.88 0.05 Allowed 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.363 1.465 . . . . 3.09 112.49 177.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 54.47 40.53 69.65 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 125.642 1.591 . . . . 0.78 113.898 -171.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -109.96 -37.07 5.71 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 127.372 2.269 . . . . 1.53 113.959 -176.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 30.0 mtm -84.03 130.94 34.86 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 124.283 1.033 . . . . 2.06 110.669 175.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -141.32 141.87 33.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 122.147 0.975 . . . . 3.2 112.313 172.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -81.23 137.22 35.87 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 124.905 1.282 . . . . 1.97 109.748 162.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.9 mt -136.76 131.94 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 108.213 -1.032 . . . . 1.87 108.213 171.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 8.0 tmtm? -128.42 128.61 44.78 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 118.992 0.815 . . . . 8.51 112.095 169.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.2 mt -124.51 162.44 26.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 125.772 1.629 . . . . 1.52 108.869 -179.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -156.7 131.14 8.69 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 126.652 1.981 . . . . 2.08 106.829 164.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 32.9 t -158.04 143.92 17.17 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 119.558 1.072 . . . . 0.36 111.776 -172.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -55.9 -23.56 32.12 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 113.821 1.045 . . . . 3.03 113.821 179.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -70.67 -19.14 62.82 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 114.9 1.444 . . . . 1.83 114.9 178.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -83.14 10.72 7.6 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 114.545 1.313 . . . . 2.85 114.545 -169.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.6 pttt -72.35 -44.92 61.91 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.979 1.711 . . . . 4.02 113.527 -175.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -83.9 20.36 1.52 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.997 1.719 . . . . 3.71 112.489 -175.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 64.4 mmtt -130.47 132.55 45.73 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 126.469 1.907 . . . . 2.62 111.984 -166.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 47.6 mtt180 -69.5 168.25 15.0 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.965 1.306 . . . . 4.16 111.694 163.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 56.6 m -46.2 -55.41 7.15 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.058 1.343 . . . . 1.68 113.533 170.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.7 p -57.55 -44.24 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 124.501 1.12 . . . . 1.93 112.464 174.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -72.04 -27.87 62.98 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 118.378 -0.82 . . . . 1.27 112.85 -178.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -69.97 -51.84 29.28 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 119.451 1.023 . . . . 0.86 109.921 169.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 44.1 m170 -52.17 -53.07 47.66 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.075 0.95 . . . . 0.69 112.24 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 28.0 tp60 -46.59 -43.67 17.5 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.1 1.36 . . . . 1.93 113.411 177.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 61.6 mtp -64.18 -36.22 83.36 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 120.998 -1.064 . . . . 1.66 113.069 -178.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.0 t -79.05 -36.07 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 125.613 1.565 . . . . 1.49 110.56 177.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -61.22 -50.29 73.68 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.986 1.314 . . . . 0.47 110.221 174.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 63.7 tp60 -57.45 -29.82 64.51 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 120.246 -1.534 . . . . 2.84 113.553 178.073 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.54 -37.22 82.98 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.119 0.968 . . . . 1.54 112.058 -177.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.59 0.88 8.84 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 115.06 1.504 . . . . 1.86 115.06 -179.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 30.2 ttpt -47.41 -36.76 10.27 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 125.85 1.66 . . . . 3.77 112.618 175.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -88.85 7.55 33.68 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 112.403 0.52 . . . . 2.07 112.403 -172.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -121.11 -61.13 1.58 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 128.625 2.77 . . . . 2.73 110.449 175.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 7.2 mm -115.77 90.33 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 125.046 1.338 . . . . 2.84 109.018 171.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 8.0 ptpp? -76.15 -18.56 59.06 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 114.348 1.24 . . . . 5.4 114.348 -173.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -67.08 46.19 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 131.258 3.823 . . . . 3.39 114.429 -178.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 61.2 mtm -71.58 10.25 0.68 Allowed 'General case' 0 CA--C 1.54 0.56 0 O-C-N 119.393 -2.067 . . . . 2.4 114.933 -172.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -69.59 -20.59 63.63 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.315 0.857 . . . . 4.38 113.315 161.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -84.45 -32.88 21.25 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 123.904 0.764 . . . . 0.62 112.212 174.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.0 mp -71.91 144.31 49.03 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 122.515 1.15 . . . . 2.69 112.795 -173.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 45.1 ttt180 -128.48 99.67 5.48 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 126.547 1.939 . . . . 3.47 109.126 -176.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 4.9 mt -108.78 141.75 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 123.697 1.713 . . . . 2.01 112.953 -170.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -130.51 132.79 45.8 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 111.495 -2.593 . . . . 3.18 107.542 -172.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 17.2 p -151.85 151.85 31.85 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.788 1.235 . . . . 1.55 109.945 -173.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.1 p -161.83 -179.53 7.27 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.506 -1.224 . . . . 0.71 110.243 178.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 6.3 p -135.15 136.14 24.15 Favored Pre-proline 0 C--N 1.325 -0.481 0 C-N-CA 124.267 1.027 . . . . 1.68 109.782 177.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -76.35 122.2 6.45 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 123.377 2.718 . . . . 0.79 108.791 175.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 6.8 mmtt -146.76 17.21 1.27 Allowed 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 114.351 1.241 . . . . 3.9 114.351 -157.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 29.4 ttt-85 . . . . . 0 C--O 1.254 1.297 0 C-N-CA 127.562 2.345 . . . . 9.4 111.806 -173.078 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.964 0 CA-C-O 118.907 -0.568 . . . . 5.5 112.018 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.9 t -128.54 173.65 10.07 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 119.391 0.996 . . . . 3.83 111.806 176.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 16.4 mp0 -120.8 158.71 26.97 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.179 1.391 . . . . 3.05 113.445 -168.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 80.9 p -127.06 166.87 16.79 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.774 2.03 . . . . 1.6 108.291 159.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -62.68 -26.66 68.77 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 119.986 1.267 . . . . 3.27 111.951 169.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.43 -43.47 94.82 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 126.01 1.767 . . . . 0.44 113.063 172.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.88 -45.6 60.14 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 119.321 1.56 . . . . 2.03 111.44 173.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.7 mt -69.52 -52.22 28.43 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 124.912 1.285 . . . . 1.6 111.264 178.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -53.62 -48.28 69.46 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.915 1.286 . . . . 3.72 110.695 179.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 67.6 t -63.99 -49.24 82.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 108.25 -1.019 . . . . 1.53 108.25 179.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 98.3 m -56.18 -43.01 77.99 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.15 0.58 . . . . 1.72 112.4 178.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.74 -37.02 85.78 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.479 1.112 . . . . 2.76 111.911 -179.089 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 64.1 mt -79.82 -30.63 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 CA-C-N 118.775 0.716 . . . . 1.94 110.855 176.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.2 mt -59.81 -36.09 76.05 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 120.694 -1.254 . . . . 1.62 112.687 170.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 27.2 mttt -65.84 -19.05 65.74 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 113.429 0.9 . . . . 2.06 113.429 175.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -98.43 -39.2 8.89 Favored 'General case' 0 N--CA 1.434 -1.254 0 C-N-CA 126.079 1.752 . . . . 2.17 113.946 179.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 29.5 mmtt -78.17 -21.69 49.81 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 112.675 0.62 . . . . 3.03 112.675 172.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -136.24 52.4 6.31 Favored Pre-proline 0 CA--C 1.55 0.98 0 N-CA-C 118.126 2.639 . . . . 3.66 118.126 178.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -69.47 -22.07 33.94 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 123.659 2.906 . . . . 1.09 114.395 173.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 13.4 mmp_? -82.7 -18.37 41.13 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 120.861 -1.149 . . . . 7.82 112.485 177.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -55.5 145.87 21.71 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 125.868 1.667 . . . . 1.92 113.559 176.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 81.9 p -86.44 -28.97 23.19 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.247 1.019 . . . . 1.88 110.938 176.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -121.69 143.73 49.18 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.001 0.921 . . . . 1.75 112.615 164.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.5 pt -155.41 111.53 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 128.123 2.569 . . . . 1.97 110.167 169.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 6.4 ptpt -153.28 156.0 37.59 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.885 1.274 . . . . 1.94 113.062 176.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.7 t -133.77 145.94 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 126.314 1.846 . . . . 1.66 110.281 -177.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 28.4 m -132.69 128.02 36.05 Favored 'General case' 0 CA--C 1.512 -0.482 0 C-N-CA 123.706 0.802 . . . . 1.63 111.521 171.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -74.04 125.3 27.99 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 122.209 1.004 . . . . 1.8 109.586 165.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.4 pt -124.72 30.5 2.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 125.273 1.429 . . . . 1.6 109.96 178.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 32.4 t -138.98 62.73 1.53 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 127.509 2.324 . . . . 1.88 111.998 -175.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -65.63 10.62 0.47 Allowed Glycine 0 CA--C 1.541 1.696 0 O-C-N 120.256 -1.528 . . . . 1.51 116.689 178.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -121.49 -4.28 9.92 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 125.749 1.642 . . . . 1.06 114.709 171.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 9.2 t -156.97 -31.59 0.08 Allowed 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 119.386 1.593 . . . . 3.45 114.832 -176.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 59.93 48.93 83.67 Favored Glycine 0 CA--C 1.538 1.516 0 C-N-CA 126.036 1.779 . . . . 0.62 113.051 -161.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -105.88 -17.47 14.35 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 126.299 1.839 . . . . 1.68 114.625 178.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 6.6 mtm -110.9 140.43 45.38 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 126.11 1.764 . . . . 2.48 111.954 168.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -142.99 148.93 37.62 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.725 0.81 . . . . 3.26 112.795 172.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -85.84 138.45 32.04 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.858 1.663 . . . . 1.96 109.356 163.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 84.2 mt -134.75 131.01 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 CA-C-N 120.057 1.299 . . . . 1.8 109.965 171.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 66.9 mttt -128.2 118.59 23.61 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.637 1.175 . . . . 3.61 111.329 179.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.2 mt -128.5 157.36 41.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 C-N-CA 126.586 1.954 . . . . 1.51 109.633 -178.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -157.39 126.9 6.03 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 120.353 -1.467 . . . . 1.84 109.248 170.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 16.4 t -160.1 144.29 14.43 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 120.599 1.545 . . . . 0.46 112.815 -169.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -55.32 -29.69 58.76 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.902 1.281 . . . . 4.87 112.562 -177.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -66.43 -19.25 65.75 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 115.166 1.543 . . . . 1.75 115.166 178.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -82.56 -2.78 54.66 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 120.824 -1.172 . . . . 3.5 114.106 -172.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 55.3 pttt -67.09 -25.45 66.23 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.752 1.621 . . . . 3.85 114.432 -176.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -109.05 26.61 10.41 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.976 1.71 . . . . 4.56 111.415 -169.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 38.9 mmtt -131.79 141.4 49.46 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 126.535 1.934 . . . . 2.36 111.319 -172.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 31.0 mtt180 -64.04 165.38 9.11 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 118.975 -0.535 . . . . 5.65 110.906 165.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 66.7 m -48.24 -54.53 13.27 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 113.154 0.798 . . . . 1.78 113.154 170.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.2 p -60.34 -39.38 80.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 124.656 1.182 . . . . 1.84 112.717 176.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -69.88 -35.37 74.6 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 112.841 0.682 . . . . 1.33 112.841 176.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -60.87 -52.33 65.52 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 119.507 1.049 . . . . 0.79 109.911 170.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 38.3 m170 -54.8 -51.6 65.27 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.292 0.637 . . . . 0.57 111.81 176.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 41.3 tp60 -48.76 -44.02 38.36 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.933 1.693 . . . . 1.4 113.161 178.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 1.4 mtm -63.46 -40.36 96.92 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 119.628 1.104 . . . . 2.14 111.868 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.2 t -74.83 -31.17 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 124.556 1.142 . . . . 1.6 111.145 178.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -66.88 -52.82 38.75 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.571 1.549 . . . . 0.45 110.697 176.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 43.7 tp60 -64.09 -23.91 67.5 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 119.993 -1.692 . . . . 2.63 113.15 -177.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -54.19 -45.82 72.25 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.9 1.28 . . . . 1.61 111.254 177.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -119.91 1.47 10.96 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 114.994 1.479 . . . . 1.49 114.994 -175.062 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 29.8 ttpt -51.28 -36.8 43.95 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 125.226 1.41 . . . . 3.16 112.13 -177.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -85.15 -9.09 58.25 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 112.781 0.66 . . . . 2.21 112.781 -174.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -94.91 -62.05 1.38 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 127.128 2.171 . . . . 3.01 110.428 174.418 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 8.6 mm -121.61 88.93 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 125.631 1.572 . . . . 2.52 109.044 176.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -72.76 -16.68 61.64 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 115.378 1.621 . . . . 3.36 115.378 -174.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.9 mp0 -63.18 39.08 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 130.946 3.699 . . . . 3.1 115.903 -177.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 64.2 mtm -69.46 2.55 2.98 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 119.669 -1.894 . . . . 2.52 115.412 -170.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 10.9 p-80 -65.85 -22.7 66.56 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.611 0.764 . . . . 5.98 112.668 160.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -84.57 -14.79 69.88 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 125.995 1.76 . . . . 0.52 114.27 171.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.6 mp -97.47 127.01 43.08 Favored 'General case' 0 C--O 1.236 0.37 0 O-C-N 121.553 -0.969 . . . . 2.75 111.877 -168.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 59.2 ttt180 -106.11 101.05 10.56 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.734 2.014 . . . . 4.61 109.735 178.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 4.8 mt -107.59 141.08 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-O 123.183 1.468 . . . . 1.8 112.02 -173.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -129.74 130.99 46.13 Favored 'General case' 0 N--CA 1.433 -1.31 0 C-N-CA 128.35 2.66 . . . . 3.43 108.628 -174.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 13.6 p -143.1 152.94 42.4 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 126.006 1.722 . . . . 1.55 109.036 -178.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 2.8 p -163.03 -179.48 6.75 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.617 -1.174 . . . . 0.63 109.671 177.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.2 p -144.19 135.26 12.46 Favored Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 112.909 0.707 . . . . 1.92 112.909 -175.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -80.7 133.28 9.21 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 124.157 3.238 . . . . 0.73 112.024 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 31.6 mmtt -141.41 59.34 1.51 Allowed 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 115.443 -0.799 . . . . 3.51 112.5 -149.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 52.8 ttp180 . . . . . 0 C--O 1.253 1.254 0 C-N-CA 126.684 1.994 . . . . 11.56 111.951 172.976 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.896 0 N-CA-C 110.346 -0.242 . . . . 5.19 110.346 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 57.9 m 64.04 137.69 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 127.607 2.363 . . . . 3.9 115.894 -179.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -128.39 -178.74 4.68 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.855 1.262 . . . . 3.52 111.093 178.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 55.2 p -127.69 -175.87 3.6 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 126.257 1.823 . . . . 1.73 109.795 168.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -62.21 -39.55 93.14 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 120.646 1.566 . . . . 4.61 110.764 160.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.48 -43.78 96.16 Favored Glycine 0 C--N 1.34 0.789 0 C-N-CA 126.045 1.783 . . . . 0.73 113.21 -177.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.12 -48.35 73.77 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 118.974 1.387 . . . . 1.31 112.565 -178.317 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 46.0 mt -66.32 -50.31 64.07 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 125.807 1.643 . . . . 1.82 110.882 178.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -54.99 -50.03 70.0 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.779 2.032 . . . . 4.05 111.428 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.2 t -64.36 -47.12 90.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 124.418 1.087 . . . . 1.78 108.127 177.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 89.7 m -57.65 -38.3 74.83 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 118.035 0.38 . . . . 1.66 111.998 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -62.39 -40.67 97.24 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 112.629 0.603 . . . . 1.69 112.629 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 24.3 mt -79.4 -29.46 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 O-C-N 123.314 0.384 . . . . 2.02 111.013 179.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.1 mt -56.13 -41.54 75.48 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 120.833 -1.167 . . . . 1.81 113.534 169.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 38.5 mttt -60.89 -28.61 69.01 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 113.262 0.838 . . . . 2.97 113.262 178.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -93.48 -37.96 11.67 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 127.294 2.238 . . . . 2.04 114.497 -175.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -73.87 -26.91 60.8 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-O 117.999 -1.0 . . . . 2.03 111.489 171.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -132.06 52.01 8.33 Favored Pre-proline 0 CA--C 1.547 0.865 0 N-CA-C 117.811 2.523 . . . . 2.7 117.811 -177.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -62.48 -22.6 74.24 Favored 'Trans proline' 0 C--O 1.236 0.403 0 C-N-CA 123.758 2.972 . . . . 0.74 114.194 174.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.41 -18.44 64.45 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 113.953 1.094 . . . . 8.52 113.953 174.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -56.36 150.67 14.35 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 115.552 1.686 . . . . 1.55 115.552 -167.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 61.1 p -90.26 -35.66 15.17 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 114.702 -1.135 . . . . 1.76 111.672 166.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -125.09 136.13 53.36 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.53 1.132 . . . . 1.39 111.176 173.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.5 pt -153.89 114.08 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 124.381 1.073 . . . . 1.52 112.876 171.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -157.14 154.62 29.64 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.569 1.548 . . . . 2.42 113.297 -179.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.8 t -131.77 142.66 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 127.673 2.389 . . . . 1.88 108.604 177.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 59.2 m -135.77 120.72 18.67 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.948 1.299 . . . . 1.82 110.484 175.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -70.52 128.74 37.19 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.95 0.881 . . . . 1.91 109.839 168.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.7 pt -130.47 31.19 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 C-N-CA 126.566 1.946 . . . . 2.05 109.597 178.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.7 t -139.87 61.91 1.52 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 128.319 2.648 . . . . 2.06 110.436 -170.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.6 -3.47 5.63 Favored Glycine 0 CA--C 1.538 1.504 0 N-CA-C 118.128 2.011 . . . . 1.25 118.128 -168.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -140.37 12.41 3.01 Favored Glycine 0 N--CA 1.475 1.24 0 CA-C-N 119.632 1.716 . . . . 1.35 115.222 175.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 16.7 m -143.55 -34.15 0.41 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.746 1.618 . . . . 3.95 111.865 -176.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 52.84 42.96 60.41 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 126.69 2.091 . . . . 0.71 113.194 -177.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -107.34 -29.86 9.04 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.446 1.898 . . . . 2.31 112.357 -177.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 1.8 mtm -102.97 126.53 50.18 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 126.501 1.92 . . . . 2.54 109.96 -179.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -139.05 150.51 45.84 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.157 0.983 . . . . 3.27 110.487 178.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -104.72 124.28 49.11 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.856 1.662 . . . . 2.04 109.448 171.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 53.8 mt -124.61 135.5 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 125.314 1.446 . . . . 1.8 110.645 -176.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 62.0 tttt -126.74 120.71 30.07 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.177 0.991 . . . . 6.07 110.455 174.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.1 mt -125.31 154.0 33.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 126.453 1.901 . . . . 1.76 108.974 176.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -156.02 130.3 8.79 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 120.561 -1.337 . . . . 1.63 108.393 166.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.4 t -162.64 147.22 11.89 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 118.881 0.764 . . . . 0.76 112.369 -174.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -55.21 -24.15 25.83 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.303 1.841 . . . . 2.95 114.553 -175.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -70.07 -18.26 63.27 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 115.155 1.539 . . . . 2.51 115.155 175.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -78.56 15.86 0.94 Allowed 'General case' 0 CA--C 1.559 1.32 0 N-CA-C 114.854 1.427 . . . . 2.84 114.854 -173.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 38.4 pttt -79.1 -35.7 41.86 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 128.215 2.606 . . . . 3.25 117.275 -165.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -119.45 32.27 6.17 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.455 1.102 . . . . 3.69 112.301 -179.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 67.8 mmtt -112.13 142.21 44.86 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 128.043 2.537 . . . . 2.12 111.214 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 8.2 mmt180 -66.19 161.87 21.09 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.141 0.976 . . . . 4.12 111.002 163.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 96.4 m -47.42 -55.74 8.36 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.334 1.054 . . . . 1.92 113.616 169.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.6 p -56.9 -37.61 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 124.809 1.243 . . . . 1.82 112.644 178.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.4 mm100 -77.14 -32.33 56.28 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.444 1.098 . . . . 2.3 113.048 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -62.92 -53.57 51.97 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.156 0.889 . . . . 0.78 109.832 168.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 39.2 m170 -53.15 -50.87 63.68 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.914 0.886 . . . . 0.51 111.626 177.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 34.7 tp60 -48.28 -44.27 33.46 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.922 1.289 . . . . 1.29 112.875 178.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 4.1 mtm -61.59 -43.41 98.92 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 119.977 1.262 . . . . 2.24 111.297 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.8 t -71.83 -29.08 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.87 1.268 . . . . 1.5 111.471 178.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -71.91 -44.67 63.31 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.102 1.361 . . . . 0.62 110.481 175.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.7 -22.83 66.06 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 120.647 -1.283 . . . . 2.84 113.379 178.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.45 -38.98 78.64 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.784 1.234 . . . . 1.66 112.48 176.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.04 -2.31 9.2 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 114.772 1.397 . . . . 1.8 114.772 -173.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 11.0 ttpp -49.49 -35.73 20.77 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 126.086 1.754 . . . . 4.83 113.323 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -88.76 -11.19 45.7 Favored 'General case' 0 CA--C 1.552 1.044 0 N-CA-C 112.307 0.484 . . . . 2.09 112.307 -174.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -95.45 -49.79 5.27 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 127.338 2.255 . . . . 3.75 112.045 174.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 34.2 mt -135.41 113.07 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 127.525 2.33 . . . . 2.28 106.302 172.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.86 -17.78 34.65 Favored 'General case' 0 N--CA 1.48 1.075 0 O-C-N 120.703 -1.248 . . . . 4.21 114.22 -169.54 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -88.33 63.9 7.34 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.33 1.852 . . . . 4.21 112.798 -164.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 5.3 mpp? -69.14 8.04 0.63 Allowed 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 115.16 1.541 . . . . 2.31 115.16 -178.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 28.3 p80 -53.18 -36.42 60.92 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 120.978 -1.076 . . . . 5.22 113.377 171.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -85.43 -9.25 79.55 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 125.673 1.606 . . . . 0.62 114.635 -179.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.9 mp -96.68 107.36 19.8 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 121.311 -1.111 . . . . 2.77 112.44 -166.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 10.4 ttt180 -81.05 117.39 21.59 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 112.818 -1.992 . . . . 3.94 108.467 171.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 4.3 mt -125.29 135.07 65.18 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.679 0 CA-C-O 123.448 1.594 . . . . 1.75 112.491 -175.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -121.69 122.67 40.1 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 111.539 -2.573 . . . . 3.85 107.611 -175.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 15.6 p -132.92 152.5 51.89 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.103 1.361 . . . . 1.52 110.21 179.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.8 p -158.2 175.57 13.6 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 124.639 1.176 . . . . 0.64 110.367 176.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 9.0 p -141.94 127.82 10.86 Favored Pre-proline 0 N--CA 1.472 0.661 0 C-N-CA 123.132 0.573 . . . . 1.57 111.77 -177.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -83.69 119.19 2.56 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 123.447 2.765 . . . . 0.66 111.957 -176.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -151.45 95.57 2.16 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.139 1.376 . . . . 5.16 110.776 179.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 60.5 ttt180 . . . . . 0 C--O 1.251 1.133 0 C-N-CA 125.547 1.539 . . . . 8.4 111.325 -179.636 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.469 0.484 0 CA-C-O 120.914 0.387 . . . . 2.27 111.897 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 80.0 p -107.11 164.5 12.11 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.008 0.923 . . . . 0.81000000000000005 109.414 156.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 21.9 mp0 -64.32 -22.13 66.85 Favored 'General case' 0 CA--C 1.549 0.941 0 O-C-N 121.454 -0.778 . . . . 3.7200000000000002 111.716 162.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.45 -39.61 95.81 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 126.72 2.105 . . . . 0.42999999999999999 114.08 170.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.87 -43.99 73.64 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.486 1.643 . . . . 2.1000000000000001 111.29 174.078 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 11.7 mt -66.28 -55.37 16.38 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 125.399 1.48 . . . . 0.34999999999999998 109.867 178.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.3 tpm_? -49.69 -51.46 38.16 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.632 1.573 . . . . 7.1900000000000004 113.351 176.172 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 26.0 t -65.21 -43.33 95.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 106.945 -1.502 . . . . 0.32000000000000001 106.945 -175.44 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 36.1 m -58.7 -38.21 77.78 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 118.525 -0.75 . . . . 0.40999999999999998 112.056 175.026 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 14.3 mm-40 -60.97 -49.67 76.49 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 119.448 1.022 . . . . 1.73 112.219 -179.211 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 18.3 mt -75.34 -30.96 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 CA-C-N 118.343 0.519 . . . . 0.52000000000000002 110.027 -175.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 29.9 mt -56.49 -38.33 71.61 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 114.459 1.281 . . . . 0.57999999999999996 114.459 171.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 31.2 mttt -58.94 -36.76 75.32 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 119.122 0.874 . . . . 2.96 112.347 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.03 -36.31 15.87 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 128.651 2.78 . . . . 4.9199999999999999 114.493 -173.427 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 48.6 mmtt -71.27 -20.84 62.17 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 118.262 -0.875 . . . . 1.26 112.397 167.126 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -134.09 59.12 35.8 Favored Pre-proline 0 CA--C 1.558 1.275 0 N-CA-C 117.756 2.502 . . . . 2.0899999999999999 117.756 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.35 -19.81 32.86 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 124.62 3.547 . . . . 0.93999999999999995 114.983 171.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 40.8 mmt180 -78.79 -0.12 29.19 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 120.836 -1.165 . . . . 4.8200000000000003 113.775 170.63 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.26 149.1 50.86 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 115.675 1.731 . . . . 0.53000000000000003 115.675 -176.38 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 16.3 p -108.15 -27.97 9.77 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 127.048 2.139 . . . . 0.68999999999999995 112.842 170.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -119.57 138.63 53.08 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.376 1.071 . . . . 0.54000000000000004 110.881 163.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.2 pt -153.92 118.87 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 124.788 1.235 . . . . 0.67000000000000004 111.663 166.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.4 ptpt -158.11 154.39 27.43 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 126.032 1.733 . . . . 1.27 112.3 173.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.4 t -132.66 149.98 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 126.465 1.906 . . . . 0.35999999999999999 109.712 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 92.5 m -140.0 131.18 26.51 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.613 0.765 . . . . 0.46999999999999997 111.427 169.35 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -73.91 121.96 21.78 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.513 0.725 . . . . 1.8 109.978 163.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . 0.255 5.5 pt -117.11 25.52 4.35 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 C-N-CA 125.495 1.518 . . . . 0.68999999999999995 111.039 179.034 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 31.9 t -137.91 58.99 1.67 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 128.564 2.746 . . . . 1.3500000000000001 111.223 -173.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -55.53 -6.53 1.1 Allowed Glycine 0 CA--C 1.544 1.878 0 N-CA-C 119.003 2.361 . . . . 1.3 119.003 -173.126 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -133.04 16.39 4.7 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 126.247 1.879 . . . . 1.03 114.653 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 15.4 t -153.17 -39.7 0.1 Allowed 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.778 1.231 . . . . 1.52 111.776 170.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 64.67 44.18 95.31 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 125.699 1.618 . . . . 0.88 112.707 -167.118 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -90.08 -31.39 17.16 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.911 1.284 . . . . 1.21 113.667 173.371 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 9.0 mtm -104.43 138.01 41.46 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.866 1.266 . . . . 1.53 112.576 174.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -137.46 147.34 45.25 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.995 0.918 . . . . 1.97 111.225 169.36 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -83.32 138.49 33.53 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 124.904 1.282 . . . . 2.4399999999999999 109.531 161.516 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 97.5 mt -134.48 129.0 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 CA-C-N 119.344 0.975 . . . . 0.59999999999999998 109.474 168.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 71.6 mttt -126.06 115.99 20.71 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.688 1.195 . . . . 2.6800000000000002 110.347 178.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.1 mt -127.02 156.62 38.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 126.442 1.897 . . . . 0.25 109.423 -177.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -152.87 133.3 13.67 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.252 1.821 . . . . 2.02 106.584 162.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 28.0 t -155.91 143.37 19.39 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 120.132 1.333 . . . . 0.41999999999999998 112.883 -173.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -57.51 -20.62 32.62 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.923 1.289 . . . . 3.25 114.149 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -75.69 -15.12 60.34 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 114.27 1.211 . . . . 1.8600000000000001 114.27 177.011 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -83.5 16.72 2.46 Favored 'General case' 0 CA--C 1.55 0.964 0 N-CA-C 113.689 0.996 . . . . 1.6200000000000001 113.689 -174.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -71.05 -44.35 65.94 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.677 1.591 . . . . 3.0 112.654 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -91.85 35.85 0.97 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.206 1.402 . . . . 4.1100000000000003 113.115 -174.237 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 62.6 mmtt -144.78 141.32 29.11 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.684 1.594 . . . . 1.54 113.115 -167.406 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 22.6 mmt180 -73.03 170.62 14.48 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 126.596 1.959 . . . . 4.4900000000000002 112.223 162.05 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 84.2 m -50.95 -54.71 21.9 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.816 1.043 . . . . 1.1000000000000001 113.816 168.37 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.1 p -59.9 -35.88 63.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 123.776 0.83 . . . . 0.81999999999999995 112.974 178.177 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -76.4 -37.07 57.65 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.722 0.809 . . . . 1.2 112.029 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -59.83 -54.07 50.52 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.962 0.905 . . . . 0.68999999999999995 109.889 168.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 47.8 m170 -50.13 -52.76 32.45 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.256 1.022 . . . . 0.54000000000000004 111.878 177.405 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 39.9 tp60 -47.07 -44.28 20.82 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.592 1.557 . . . . 1.26 112.847 179.399 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 81.2 mtp -62.97 -43.43 98.81 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 121.166 -0.959 . . . . 0.98999999999999999 112.255 178.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.2 t -71.22 -25.83 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 125.657 1.583 . . . . 0.25 111.735 177.211 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -76.8 -44.41 32.74 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.621 1.568 . . . . 0.51000000000000001 109.69 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -64.76 -27.39 68.86 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 125.104 1.362 . . . . 3.4399999999999999 113.99 175.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.94 -29.99 71.22 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.501 1.52 . . . . 0.47999999999999998 112.916 -175.646 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.0 -8.19 8.85 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 115.124 1.527 . . . . 0.40000000000000002 115.124 176.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -44.37 -43.58 7.68 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.081 1.352 . . . . 2.02 112.847 176.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -85.78 6.01 29.88 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-O 122.505 1.145 . . . . 2.4500000000000002 111.759 -165.133 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -124.54 -56.27 1.61 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 129.946 3.299 . . . . 2.98 108.377 -177.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.0 mm -126.38 132.9 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 127.573 2.349 . . . . 1.9399999999999999 108.923 169.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -92.77 -10.89 35.34 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 116.274 1.953 . . . . 2.6299999999999999 116.274 -174.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -78.66 36.65 0.27 Allowed 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 117.702 2.482 . . . . 3.0499999999999998 117.702 -153.445 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 4.6 mpp? -64.06 9.42 0.07 Allowed 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 116.259 1.948 . . . . 1.3200000000000001 116.259 -175.332 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 49.3 t60 -65.07 -38.82 92.05 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 120.946 -1.096 . . . . 4.3700000000000001 111.81 160.433 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -84.61 -17.79 63.23 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 126.355 1.931 . . . . 0.41999999999999998 114.045 -178.42 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.5 mp -87.61 118.77 27.31 Favored 'General case' 0 C--N 1.332 -0.179 0 O-C-N 121.674 -0.898 . . . . 1.71 112.265 -170.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 28.7 ttm180 -98.02 102.06 13.71 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 127.453 2.301 . . . . 4.8700000000000001 109.885 -177.42 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 4.1 mt -111.7 143.91 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-O 123.903 1.811 . . . . 0.42999999999999999 113.14 -169.418 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -136.0 125.6 25.32 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 111.543 -2.571 . . . . 1.8400000000000001 108.005 -171.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 28.3 p -144.86 153.55 41.72 Favored 'General case' 0 CA--C 1.509 -0.607 0 C-N-CA 125.837 1.655 . . . . 0.40000000000000002 109.791 -171.508 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -163.35 175.55 10.73 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.239 -1.346 . . . . 0.70999999999999996 109.379 176.324 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.4 p -122.97 139.65 31.87 Favored Pre-proline 0 C--N 1.325 -0.488 0 O-C-N 121.289 -0.882 . . . . 0.64000000000000001 109.531 170.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo . . . . . 0 N--CA 1.45 -1.062 0 C-N-CA 123.207 2.605 . . . . 0.87 108.463 172.847 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 . . . . . 0 N--CA 1.47 0.565 0 N-CA-C 115.443 1.646 . . . . 2.27 115.443 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 38.9 p -117.0 179.9 3.89 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.877 1.671 . . . . 0.90000000000000002 111.041 169.12 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -70.45 -35.25 73.23 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 120.633 -1.292 . . . . 3.0499999999999998 111.959 168.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -67.42 -37.59 90.33 Favored Glycine 0 CA--C 1.529 0.948 0 CA-C-O 118.572 -1.127 . . . . 0.44 112.901 178.122 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -46.08 -50.24 15.49 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.51 1.524 . . . . 1.3799999999999999 112.713 173.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 15.1 mt -69.95 -50.73 39.03 Favored 'General case' 0 CA--C 1.528 0.098 0 C-N-CA 124.957 1.303 . . . . 0.40999999999999998 111.132 -178.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.54 -48.36 77.43 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.578 1.151 . . . . 3.0099999999999998 110.85 -179.027 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.0 t -63.12 -41.93 94.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 108.496 -0.927 . . . . 0.28999999999999998 108.496 177.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 74.2 m -59.09 -42.08 89.61 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 118.761 0.709 . . . . 0.46999999999999997 111.28 178.067 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -69.48 -33.37 72.79 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 114.011 1.115 . . . . 3.1099999999999999 114.011 -175.344 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 30.5 mt -79.53 -30.69 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 CA-C-N 119.099 0.863 . . . . 0.47999999999999998 110.694 173.107 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 33.1 mt -58.19 -36.74 73.54 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 120.74 -1.225 . . . . 0.51000000000000001 113.233 171.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 38.0 mttt -59.78 -24.6 64.23 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 114.21 1.189 . . . . 1.3300000000000001 114.21 173.527 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -101.25 -34.73 9.54 Favored 'General case' 0 N--CA 1.427 -1.575 0 C-N-CA 125.494 1.518 . . . . 2.0800000000000001 113.87 -175.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -75.26 -24.66 57.63 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 118.646 -1.221 . . . . 1.1000000000000001 111.79 169.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -130.6 54.55 14.99 Favored Pre-proline 0 CA--C 1.548 0.865 0 N-CA-C 117.049 2.24 . . . . 2.21 117.049 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -62.49 -30.79 80.26 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 123.573 2.849 . . . . 0.73999999999999999 113.688 174.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 28.0 mmt85 -75.95 -11.89 60.04 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 120.352 1.433 . . . . 4.7000000000000002 114.519 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -55.21 146.67 18.26 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.157 1.783 . . . . 0.40999999999999998 114.524 -174.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 66.7 p -88.09 -30.74 19.65 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.905 0.882 . . . . 0.70999999999999996 111.111 170.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -129.77 138.67 51.19 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.005 0.922 . . . . 0.45000000000000001 111.734 170.405 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.6 pt -150.46 117.74 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 125.572 1.549 . . . . 0.73999999999999999 111.419 165.323 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.79 157.79 37.06 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.705 1.202 . . . . 2.4199999999999999 113.46 169.217 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.0 t -125.08 144.13 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 128.215 2.606 . . . . 0.37 110.492 -173.584 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 80.7 m -128.86 126.37 39.64 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.388 1.475 . . . . 0.51000000000000001 109.518 166.479 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -73.41 139.2 45.72 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 122.023 0.916 . . . . 2.4700000000000002 110.344 165.204 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.7 pt -134.31 32.8 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 C-N-CA 126.411 1.884 . . . . 0.83999999999999997 110.397 177.297 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.44 ' HB2' ' H ' ' A' ' 62' ' ' MET . 23.2 t -141.01 62.31 1.48 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 128.13 2.572 . . . . 1.4399999999999999 112.779 -171.261 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.08 -30.11 60.27 Favored Glycine 0 CA--C 1.54 1.619 0 O-C-N 119.989 -1.694 . . . . 1.8 114.649 179.05 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -85.81 -9.46 77.86 Favored Glycine 0 CA--C 1.539 1.549 0 N-CA-C 116.421 1.328 . . . . 1.45 116.421 -179.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 19.6 t -148.52 -38.83 0.17 Allowed 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 119.493 1.646 . . . . 2.75 114.319 -175.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 66.82 43.52 91.41 Favored Glycine 0 CA--C 1.536 1.375 0 C-N-CA 126.854 2.168 . . . . 1.1599999999999999 112.581 -165.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -94.06 -37.98 11.36 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.13 1.372 . . . . 1.76 113.594 172.501 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.459 ' HG3' ' CA ' ' A' ' 97' ' ' GLY . 4.0 mpp? -94.99 140.29 30.16 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 124.373 1.069 . . . . 2.8199999999999998 112.962 -175.252 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -145.38 143.5 30.15 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 122.393 1.092 . . . . 1.8999999999999999 113.805 175.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -100.07 119.51 38.41 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.364 1.866 . . . . 2.6699999999999999 109.911 170.264 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 61.6 mt -132.48 130.54 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.784 1.234 . . . . 0.84999999999999998 110.747 -161.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -117.67 125.95 51.63 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.304 1.442 . . . . 2.98 110.683 177.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.445 ' CD1' HG13 ' A' ' 84' ' ' VAL . 1.2 mt -129.35 156.37 41.79 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 C-N-CA 127.347 2.259 . . . . 0.25 109.703 174.37 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -155.37 133.67 11.67 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.678 1.591 . . . . 1.8200000000000001 108.704 164.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 16.9 t -159.55 140.49 12.51 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 119.811 1.187 . . . . 0.33000000000000002 112.865 -175.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -61.48 -3.6 1.05 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 127.609 2.364 . . . . 3.73 115.084 179.411 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -84.8 -23.6 29.07 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.901 1.68 . . . . 1.6599999999999999 113.725 173.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -79.92 9.93 4.79 Favored 'General case' 0 CA--C 1.555 1.16 0 N-CA-C 116.052 1.871 . . . . 1.6699999999999999 116.052 -165.385 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.89 -37.17 35.35 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 117.613 2.449 . . . . 2.8799999999999999 117.613 -163.033 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -88.63 40.53 0.97 Allowed 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 121.046 1.748 . . . . 4.3300000000000001 111.993 178.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.9 mmtp -139.71 137.16 34.93 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 125.437 1.495 . . . . 1.8400000000000001 111.823 -168.239 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 46.2 mtt180 -68.75 172.03 6.97 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.856 1.662 . . . . 3.6600000000000001 111.741 164.005 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 87.0 m -47.6 -58.34 4.37 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 125.357 1.463 . . . . 0.78000000000000003 113.425 170.446 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.2 p -59.48 -36.13 62.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.351 1.061 . . . . 0.54000000000000004 112.775 176.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 11.1 mt-30 -77.08 -27.34 54.22 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 113.446 0.906 . . . . 1.3600000000000001 113.446 -177.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -71.42 -54.1 11.81 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.012 0.925 . . . . 0.71999999999999997 110.33 166.258 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 52.6 m170 -55.08 -42.58 73.0 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.543 0.737 . . . . 0.46999999999999997 112.414 -177.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 31.0 tp60 -47.43 -42.0 21.44 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 126.201 1.801 . . . . 1.1499999999999999 113.032 177.527 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 63.8 mtp -66.36 -43.47 85.9 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 123.568 0.747 . . . . 1.1499999999999999 111.234 -177.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.445 HG13 ' CD1' ' A' ' 67' ' ' ILE . 2.5 t -72.27 -34.31 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 127.058 2.143 . . . . 0.22 111.654 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -63.16 -53.15 57.76 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 127.169 2.188 . . . . 0.56000000000000005 109.524 173.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.8 tm0? -65.27 -30.19 71.04 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.234 -0.916 . . . . 3.21 112.235 -177.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -55.89 -34.22 65.34 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 125.631 1.573 . . . . 0.39000000000000001 112.72 -172.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.41 -2.81 9.45 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 115.053 1.501 . . . . 0.40999999999999998 115.053 177.53 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 26.8 ttpt -51.15 -36.3 40.17 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.957 0.903 . . . . 1.9399999999999999 112.475 178.466 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -74.92 -13.73 60.57 Favored 'General case' 0 N--CA 1.439 -1.022 0 O-C-N 121.578 -0.701 . . . . 2.2400000000000002 112.269 -176.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -94.86 -49.49 5.56 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 128.466 2.706 . . . . 3.0 113.448 172.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 30.6 mt -141.02 129.35 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 127.738 2.415 . . . . 1.1299999999999999 107.938 177.085 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 45.7 mttp -97.66 -14.66 20.8 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 116.21 1.93 . . . . 3.2999999999999998 116.21 -170.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -79.35 68.41 5.34 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 115.354 1.613 . . . . 4.96 115.354 -160.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -70.39 1.58 4.84 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 116.471 2.026 . . . . 1.77 116.471 -178.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 22.4 t60 -54.57 -32.66 58.91 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.924 0.868 . . . . 4.4800000000000004 112.064 153.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.459 ' CA ' ' HG3' ' A' ' 62' ' ' MET . . . -83.39 -18.01 65.28 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 126.175 1.845 . . . . 0.5 116.544 -176.028 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 10.1 mt -93.62 139.56 30.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 118.517 1.158 . . . . 2.27 110.746 -168.329 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 35.5 ttt180 -123.55 95.76 4.71 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.552 1.541 . . . . 3.3999999999999999 107.91 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -114.32 135.34 54.39 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.475 0 CA-C-O 123.115 1.436 . . . . 0.46999999999999997 112.444 -161.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -127.83 114.24 16.97 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 112.178 -2.283 . . . . 2.0600000000000001 107.764 -168.488 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 23.4 p -127.13 150.31 49.55 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.293 1.437 . . . . 0.29999999999999999 110.566 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 2.2 p -150.7 172.73 15.11 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.222 -1.354 . . . . 0.64000000000000001 111.123 173.257 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.9 p -140.24 129.58 13.42 Favored Pre-proline 0 N--CA 1.472 0.628 0 C-N-CA 123.172 0.589 . . . . 0.52000000000000002 111.6 178.614 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo . . . . . 0 CA--C 1.538 0.714 0 C-N-CA 123.751 2.967 . . . . 0.68000000000000005 111.418 -177.441 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 96.7 mm-40 . . . . . 0 C--O 1.238 0.463 0 CA-C-O 122.638 1.208 . . . . 2.9900000000000002 113.018 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 62.6 p -121.06 161.63 21.38 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 112.532 -2.122 . . . . 0.60999999999999999 108.46 149.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -63.88 -21.15 66.32 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 120.586 -1.321 . . . . 2.7000000000000002 112.044 164.534 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -67.38 -39.24 91.61 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 126.875 2.179 . . . . 0.56999999999999995 113.572 173.084 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.25 -44.31 68.04 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.512 1.525 . . . . 1.29 111.233 173.03 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.4 mt -68.79 -53.92 18.87 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 125.801 1.64 . . . . 0.40000000000000002 110.935 176.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.5 ttp-105 -49.8 -50.06 46.41 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 126.617 1.967 . . . . 3.6000000000000001 111.162 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 52.0 t -68.27 -46.94 80.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 123.992 0.917 . . . . 0.28999999999999998 108.538 -178.575 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 98.3 m -57.93 -42.63 85.23 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 118.497 0.589 . . . . 0.39000000000000001 111.903 178.443 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -62.39 -35.9 80.62 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.888 0.875 . . . . 2.9300000000000002 112.449 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 62.4 mt -80.86 -31.81 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-N 118.845 0.748 . . . . 0.46000000000000002 111.019 175.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 29.6 mt -58.09 -37.58 74.78 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 120.945 -1.097 . . . . 0.40000000000000002 112.34 171.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 23.9 mttt -63.38 -22.36 66.83 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 113.539 0.94 . . . . 1.78 113.539 174.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -96.41 -36.15 10.93 Favored 'General case' 0 N--CA 1.434 -1.255 0 C-N-CA 125.994 1.717 . . . . 2.1299999999999999 114.694 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 64.9 mmtt -74.84 -28.01 60.51 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 119.668 -0.813 . . . . 1.55 111.8 171.321 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -130.33 50.29 5.83 Favored Pre-proline 0 CA--C 1.55 0.952 0 N-CA-C 117.65 2.463 . . . . 2.0499999999999998 117.65 -178.072 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -61.51 -25.47 79.63 Favored 'Trans proline' 0 C--O 1.237 0.468 0 C-N-CA 123.949 3.099 . . . . 0.94999999999999996 114.428 177.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 12.5 mmt85 -80.78 -11.35 59.62 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 114.148 1.166 . . . . 5.04 114.148 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -51.85 151.33 3.55 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 126.245 1.818 . . . . 0.44 114.725 -173.215 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 68.9 p -93.04 -32.21 14.57 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.976 1.31 . . . . 0.59999999999999998 111.033 169.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -124.82 139.01 54.23 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.212 1.005 . . . . 0.47999999999999998 111.992 170.358 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.4 pt -156.16 112.49 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 126.433 1.893 . . . . 0.56000000000000005 111.316 166.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.5 ptpt -151.88 148.3 27.64 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.916 1.286 . . . . 1.01 112.888 172.49 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 29.0 t -124.39 144.2 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 127.1 2.16 . . . . 0.34000000000000002 108.872 -178.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 98.9 m -132.07 127.34 35.9 Favored 'General case' 0 CA--C 1.512 -0.507 0 C-N-CA 124.732 1.213 . . . . 0.55000000000000004 109.931 172.003 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.82 130.44 41.07 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 124.25 1.02 . . . . 2.5800000000000001 111.009 174.31 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.3 pt -132.64 26.61 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 C-N-CA 126.234 1.814 . . . . 0.79000000000000004 110.77 174.457 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.5 t -138.14 107.97 6.3 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.931 1.293 . . . . 1.55 113.519 164.31 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -83.43 -18.06 65.12 Favored Glycine 0 N--CA 1.474 1.203 0 C-N-CA 124.228 0.918 . . . . 2.3999999999999999 113.821 162.048 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -77.36 -39.69 25.71 Favored Glycine 0 N--CA 1.467 0.746 0 C-N-CA 124.548 1.071 . . . . 1.8200000000000001 113.368 -175.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 20.8 m -145.9 -17.89 0.46 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.755 1.222 . . . . 1.73 113.284 -170.322 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 63.06 37.8 95.54 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 126.374 1.94 . . . . 0.97999999999999998 113.948 -178.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -101.61 -8.96 21.37 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.67 1.188 . . . . 1.6100000000000001 113.074 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 7.8 ttm -119.35 122.12 41.11 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 125.824 1.65 . . . . 1.6299999999999999 109.803 -162.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.42 ' H ' HD23 ' A' ' 98' ' ' LEU . 76.5 m-85 -146.06 147.26 31.43 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 121.859 0.838 . . . . 2.0499999999999998 112.989 -177.151 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -101.52 124.29 46.95 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.705 1.602 . . . . 2.48 109.692 173.473 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 95.5 mt -134.54 130.84 53.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 O-C-N 120.866 -1.146 . . . . 1.01 111.44 -165.279 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.5 mptt -119.8 130.45 54.93 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.529 0.732 . . . . 3.29 111.618 171.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.452 ' CD1' HG13 ' A' ' 84' ' ' VAL . 1.3 mt -129.67 159.46 41.69 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 C-N-CA 126.566 1.947 . . . . 0.29999999999999999 109.279 176.252 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -159.42 135.4 8.78 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 126.347 1.859 . . . . 1.8600000000000001 108.628 165.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.3 t -162.98 146.7 11.03 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 118.494 0.588 . . . . 0.42999999999999999 111.491 -176.31 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -51.38 -32.53 26.29 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.858 1.663 . . . . 3.6600000000000001 113.759 178.133 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -63.39 -20.08 65.22 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 114.838 1.422 . . . . 1.6799999999999999 114.838 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -81.45 10.96 4.96 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 114.984 1.476 . . . . 1.6299999999999999 114.984 -169.228 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.5 pttt -74.63 -43.84 53.45 Favored 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 115.002 1.482 . . . . 2.3300000000000001 115.002 -172.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -91.15 27.64 1.83 Allowed 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 124.894 1.278 . . . . 4.2300000000000004 111.803 -174.008 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -123.09 140.14 53.34 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 127.47 2.308 . . . . 1.45 111.451 -171.41 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 13.1 mmt85 -69.37 165.94 19.67 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.057 1.343 . . . . 2.7599999999999998 110.629 161.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 28.2 m -52.09 -53.55 41.06 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.718 1.207 . . . . 0.85999999999999999 112.986 171.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.1 p -59.55 -35.64 60.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 124.252 1.021 . . . . 0.88 113.161 175.255 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -74.79 -35.89 62.51 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.676 0.621 . . . . 1.21 112.676 177.188 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -60.26 -51.6 68.86 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 119.462 1.028 . . . . 0.69999999999999996 109.192 169.2 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 36.7 m170 -55.62 -46.08 77.44 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.603 0.761 . . . . 0.71999999999999997 112.982 177.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 40.1 tp60 -48.43 -45.5 36.4 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.511 1.525 . . . . 1.23 112.625 176.091 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 67.0 mtp -63.71 -34.73 78.53 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 119.407 1.003 . . . . 0.97999999999999998 112.792 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.452 HG13 ' CD1' ' A' ' 67' ' ' ILE . 2.8 t -78.24 -30.34 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 125.689 1.596 . . . . 0.39000000000000001 111.752 177.396 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -71.27 -50.9 27.95 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.266 1.826 . . . . 0.71999999999999997 110.965 174.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 27.3 tp60 -69.78 -15.01 63.05 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 125.327 1.451 . . . . 3.1499999999999999 113.784 -178.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.15 -39.93 88.05 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.575 1.15 . . . . 0.41999999999999998 112.539 173.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.86 -0.07 8.54 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 115.764 1.764 . . . . 0.35999999999999999 115.764 -177.207 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 27.0 ttmt -43.57 -45.24 6.59 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 125.631 1.572 . . . . 2.2000000000000002 113.147 177.122 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -83.19 -7.02 59.68 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-O 121.294 0.569 . . . . 2.0899999999999999 112.201 -169.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 23.6 tp10 -103.59 -41.49 5.95 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 129.55 3.14 . . . . 2.21 111.011 -176.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 44.6 mt -150.61 115.21 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 129.806 3.242 . . . . 1.1200000000000001 107.029 175.107 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -92.26 -4.62 53.79 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 117.336 2.347 . . . . 3.46 117.336 -169.32 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -82.13 33.55 0.4 Allowed 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 127.97 2.508 . . . . 2.9900000000000002 115.503 -161.537 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 4.4 mpp? -68.53 6.16 0.88 Allowed 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 117.639 2.459 . . . . 1.3600000000000001 117.639 -165.175 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 34.2 t60 -42.62 -38.67 2.09 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 121.218 -0.926 . . . . 4.2599999999999998 112.113 152.112 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -69.14 -16.15 70.57 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 126.294 1.902 . . . . 0.51000000000000001 117.03 -179.175 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.42 HD23 ' H ' ' A' ' 63' ' ' TYR . 12.4 mt -96.7 129.47 44.1 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 119.057 1.428 . . . . 2.2799999999999998 112.715 -163.191 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 35.9 ttt180 -111.03 87.64 2.59 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 126.912 2.085 . . . . 3.6099999999999999 107.906 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 1.7 mt -106.23 144.61 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-O 122.879 1.323 . . . . 0.47999999999999998 112.31 -166.199 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -137.11 132.02 33.48 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 111.748 -2.478 . . . . 2.25 108.756 -173.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 21.1 p -146.24 152.78 39.74 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 126.449 1.899 . . . . 0.32000000000000001 110.198 -173.068 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 2.6 p -159.51 177.92 10.43 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 124.405 1.082 . . . . 0.65000000000000002 110.97 176.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.2 p -136.86 138.8 27.04 Favored Pre-proline 0 N--CA 1.47 0.567 0 C-N-CA 124.089 0.956 . . . . 0.46000000000000002 110.412 175.48 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo . . . . . 0 CA--C 1.533 0.47 0 C-N-CA 122.828 2.352 . . . . 0.66000000000000003 110.723 174.352 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 . . . . . 0 C--O 1.236 0.385 0 N-CA-C 112.924 0.713 . . . . 6.2199999999999998 112.924 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 79.2 p -110.38 -179.44 3.77 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.203 -1.036 . . . . 0.79000000000000004 108.203 140.21 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -71.63 -30.94 66.33 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 119.797 -1.815 . . . . 3.5 112.396 162.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.73 -41.21 99.57 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 124.279 0.943 . . . . 0.68999999999999995 113.281 173.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -54.14 -42.07 69.12 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.176 1.39 . . . . 1.52 112.919 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 22.5 mt -69.16 -50.67 45.59 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 125.519 1.527 . . . . 0.84999999999999998 111.323 177.477 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.98 -50.3 73.1 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 126.004 1.722 . . . . 2.96 110.61 -179.148 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 56.2 t -60.42 -47.4 92.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 108.292 -1.003 . . . . 0.31 108.292 177.39 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 93.0 m -58.53 -38.63 78.17 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.646 0.61 . . . . 0.65000000000000002 112.646 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.3 mm-40 -63.54 -40.23 96.49 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 118.412 0.551 . . . . 1.7 112.313 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 35.7 mt -82.02 -28.4 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 122.759 0.424 . . . . 0.67000000000000004 110.77 -175.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 11.8 mt -54.23 -37.75 64.96 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.473 -0.767 . . . . 0.71999999999999997 112.832 168.051 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.7 mttt -62.49 -25.27 67.92 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 114.237 1.199 . . . . 2.1299999999999999 114.237 178.429 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -106.14 -31.83 8.51 Favored 'General case' 0 N--CA 1.435 -1.22 0 C-N-CA 126.775 2.03 . . . . 2.4900000000000002 113.728 -167.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 53.1 mmtt -77.57 -24.84 49.71 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 118.729 -0.653 . . . . 1.46 111.713 164.522 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -131.71 49.54 4.77 Favored Pre-proline 0 CA--C 1.556 1.191 0 N-CA-C 118.435 2.754 . . . . 1.55 118.435 -178.335 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -68.07 -12.97 36.84 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 125.056 3.837 . . . . 0.82999999999999996 114.948 176.133 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 38.8 mtt180 -99.58 -6.73 26.88 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.195 0.998 . . . . 4.9100000000000001 113.444 175.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.41 139.91 58.56 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 125.025 1.33 . . . . 0.69999999999999996 113.141 176.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 44.2 p -75.46 -35.52 60.86 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.249 1.42 . . . . 0.89000000000000001 109.395 176.571 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -124.29 138.26 54.41 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.562 1.145 . . . . 0.34999999999999998 111.736 171.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.8 pt -150.22 118.46 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 125.577 1.551 . . . . 0.80000000000000004 112.522 163.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 7.8 ptpt -158.88 158.26 33.06 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.744 1.218 . . . . 1.76 114.016 177.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.7 t -126.11 155.93 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 127.766 2.426 . . . . 0.46999999999999997 111.028 -174.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 88.4 m -147.14 127.35 13.83 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 120.996 -1.065 . . . . 0.35999999999999999 111.817 162.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -69.63 126.91 31.16 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.889 0.852 . . . . 1.8600000000000001 110.568 165.509 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.5 pt -126.08 25.14 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 C-N-CA 126.047 1.739 . . . . 0.63 111.387 -178.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 34.9 t -132.5 62.74 1.64 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 128.308 2.643 . . . . 1.5900000000000001 109.032 176.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -54.29 -13.3 3.7 Favored Glycine 0 CA--C 1.54 1.643 0 N-CA-C 117.642 1.817 . . . . 1.73 117.642 -169.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -123.55 -6.71 7.2 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 126.31 1.91 . . . . 1.6399999999999999 115.828 -179.067 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -138.74 -21.75 0.99 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.212 1.405 . . . . 2.4300000000000002 114.399 -176.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 55.0 39.06 67.3 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 128.054 2.74 . . . . 0.94999999999999996 115.477 -178.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -88.05 -32.47 18.74 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.131 1.372 . . . . 1.3400000000000001 114.094 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 8.5 mtm -106.9 142.25 36.82 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.648 1.579 . . . . 1.49 112.842 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -142.46 144.09 32.88 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 122.181 0.991 . . . . 2.0099999999999998 112.539 172.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -83.05 139.46 33.24 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 126.604 1.961 . . . . 2.0699999999999998 110.076 165.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 90.6 mt -138.01 128.45 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 CA-C-N 119.39 0.996 . . . . 0.64000000000000001 110.606 170.092 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 77.9 mttt -113.73 126.78 55.61 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.118 1.367 . . . . 2.9500000000000002 110.943 171.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.434 ' CD1' HG13 ' A' ' 84' ' ' VAL . 1.3 mt -130.55 156.95 42.89 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 126.863 2.065 . . . . 0.31 109.938 174.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -156.8 130.86 8.43 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.332 1.453 . . . . 1.6499999999999999 109.583 166.167 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 32.6 t -158.26 143.6 16.66 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 119.994 1.27 . . . . 0.56999999999999995 112.019 -176.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -51.77 -24.86 6.49 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.206 1.402 . . . . 3.1000000000000001 113.52 173.305 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -69.51 -14.59 62.94 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 114.182 1.179 . . . . 1.73 114.182 -178.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -92.33 13.85 18.17 Favored 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 125.163 1.385 . . . . 1.71 114.266 -175.494 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.414 ' HB3' HG21 ' A' ' 104' ' ' VAL . 0.3 OUTLIER -79.27 -15.05 58.58 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 115.769 1.766 . . . . 3.3199999999999998 115.769 -167.717 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -123.17 29.95 6.53 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.082 1.753 . . . . 4.54 110.867 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -122.35 129.85 52.54 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 126.299 1.84 . . . . 1.27 111.053 -172.226 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 38.3 mtt-85 -63.52 164.41 9.47 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.852 1.261 . . . . 3.25 111.064 168.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 86.7 m -44.53 -55.89 4.76 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.933 0.893 . . . . 0.75 112.985 170.214 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.2 p -61.57 -37.25 77.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 124.987 1.315 . . . . 0.56999999999999995 113.164 178.384 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -75.66 -29.85 59.22 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 112.917 0.71 . . . . 1.0600000000000001 112.917 179.451 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 60.5 mt-30 -65.09 -54.8 24.44 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 119.007 0.821 . . . . 1.51 109.03 168.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 45.1 m170 -54.46 -45.31 73.09 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.952 0.901 . . . . 0.54000000000000004 112.859 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 50.5 tp60 -48.36 -43.46 33.58 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.363 1.465 . . . . 1.3899999999999999 112.912 178.697 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 45.5 mtp -66.32 -42.03 88.81 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 121.43 -0.794 . . . . 0.93999999999999995 111.717 -178.457 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.434 HG13 ' CD1' ' A' ' 67' ' ' ILE . 3.1 t -72.22 -29.7 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 125.267 1.427 . . . . 0.32000000000000001 111.773 176.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -69.23 -51.72 34.9 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 126.185 1.794 . . . . 0.89000000000000001 108.276 179.302 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -69.0 -19.89 64.15 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 113.748 1.018 . . . . 2.5600000000000001 113.748 -176.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.4 -41.77 80.94 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.031 0.932 . . . . 0.39000000000000001 111.652 178.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.86 -4.16 9.67 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 115.386 1.625 . . . . 0.32000000000000001 115.386 -176.282 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 21.9 tttt -53.32 -34.68 58.43 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 125.048 1.339 . . . . 1.95 113.45 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 67.2 mt-10 -87.27 -2.58 58.72 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 123.166 0.587 . . . . 2.3199999999999998 111.638 -174.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -100.98 -45.55 5.38 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 128.147 2.579 . . . . 3.0899999999999999 112.17 167.225 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 30.2 mt -145.78 110.6 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 128.003 2.521 . . . . 0.94999999999999996 107.676 178.334 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -86.17 -1.43 57.43 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 116.185 1.92 . . . . 2.3500000000000001 116.185 -173.283 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -77.19 43.39 0.37 Allowed 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 128.728 2.811 . . . . 3.5899999999999999 115.948 -164.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 4.7 mpp? -62.95 1.89 0.37 Allowed 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 114.952 1.464 . . . . 1.28 114.952 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 22.0 t60 -59.78 -26.51 65.77 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.513 1.125 . . . . 4.1399999999999997 113.21 163.165 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -106.37 -8.15 33.67 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 126.893 2.187 . . . . 0.46000000000000002 114.855 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.7 mp -96.38 123.52 40.05 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 118.374 1.087 . . . . 1.5900000000000001 111.55 -173.593 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 54.0 ttt180 -105.68 100.01 9.59 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 126.956 2.102 . . . . 3.0499999999999998 109.08 -174.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 3.6 mt -108.28 141.17 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-O 122.969 1.366 . . . . 0.42999999999999999 111.795 -169.319 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -130.91 123.27 28.56 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 111.695 -2.502 . . . . 1.8500000000000001 107.363 -173.431 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 16.2 p -136.94 140.45 42.26 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.058 1.343 . . . . 0.31 109.697 -176.556 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.6 t -138.01 -177.6 4.89 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 122.585 1.183 . . . . 2.2400000000000002 110.922 167.497 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.414 HG21 ' HB3' ' A' ' 73' ' ' LYS . 7.2 p -147.65 135.78 10.96 Favored Pre-proline 0 C--N 1.317 -0.827 0 C-N-CA 126.085 1.754 . . . . 0.55000000000000004 108.662 177.142 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo . . . . . 0 CA--C 1.538 0.676 0 C-N-CA 123.018 2.478 . . . . 1.1699999999999999 110.646 175.102 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 . . . . . 0 N--CA 1.469 0.517 0 N-CA-C 115.534 1.679 . . . . 2.54 115.534 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 72.3 p -128.19 169.28 14.32 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 126.751 2.02 . . . . 0.55000000000000004 108.614 160.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -68.37 -16.93 64.11 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 121.027 -1.046 . . . . 2.79 113.004 165.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.99 -42.88 67.32 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 124.62 1.105 . . . . 0.46000000000000002 113.295 169.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.08 -48.88 43.91 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.488 1.915 . . . . 1.3600000000000001 111.892 173.304 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 24.0 mt -67.04 -51.85 49.55 Favored 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 125.755 1.622 . . . . 0.45000000000000001 111.353 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.5 ttp180 -50.45 -49.93 53.74 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 126.936 2.094 . . . . 4.5899999999999999 110.667 178.348 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.7 t -67.92 -46.98 80.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 108.874 -0.787 . . . . 0.34999999999999998 108.874 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 57.5 m -55.48 -40.35 71.56 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 118.324 0.511 . . . . 0.34999999999999998 112.326 178.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -61.71 -42.47 98.98 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 112.349 0.499 . . . . 1.6299999999999999 112.349 -177.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 18.5 mt -79.65 -29.37 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 CA-C-N 118.345 0.52 . . . . 0.52000000000000002 111.514 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 22.9 mt -55.55 -40.4 71.86 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 120.98 -1.075 . . . . 0.39000000000000001 113.759 172.4 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 42.4 mttt -59.45 -27.82 66.43 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 113.832 1.049 . . . . 1.3100000000000001 113.832 178.614 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -97.4 -34.22 11.12 Favored 'General case' 0 N--CA 1.431 -1.382 0 C-N-CA 127.423 2.289 . . . . 2.2200000000000002 114.233 -172.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 63.1 mmtt -74.27 -23.52 59.13 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 119.089 -1.044 . . . . 1.28 111.919 167.239 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -127.84 54.97 14.4 Favored Pre-proline 0 CA--C 1.554 1.101 0 N-CA-C 117.874 2.546 . . . . 1.51 117.874 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -66.87 -17.99 52.25 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 124.935 3.757 . . . . 0.81999999999999995 114.99 173.422 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 25.1 mmt85 -85.29 -1.18 56.69 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 113.89 1.07 . . . . 4.6600000000000001 113.89 171.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.19 149.36 50.05 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 114.3 1.222 . . . . 0.46999999999999997 114.3 -176.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 72.4 p -114.98 -4.15 12.59 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.94 1.696 . . . . 0.89000000000000001 113.418 173.094 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -140.73 146.31 37.59 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.422 1.089 . . . . 0.37 111.391 147.607 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.3 pt -154.58 117.54 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 126.381 1.872 . . . . 0.53000000000000003 111.918 169.582 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.4 ptpt -158.66 148.43 19.41 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.918 1.287 . . . . 1.04 114.041 178.016 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.2 t -126.52 150.48 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 C-N-CA 126.834 2.053 . . . . 0.29999999999999999 111.287 -173.184 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 98.1 m -143.57 135.41 26.51 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.502 0.721 . . . . 0.40000000000000002 112.371 171.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -77.62 126.0 30.2 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 122.131 0.967 . . . . 1.9199999999999999 111.012 168.26 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.0 pt -124.05 29.47 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 C-N-CA 126.151 1.781 . . . . 0.55000000000000004 110.978 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.528 ' HB2' ' H ' ' A' ' 62' ' ' MET . 29.8 t -135.69 58.53 1.75 Allowed 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 128.214 2.606 . . . . 1.28 111.453 -174.541 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -65.27 14.77 0.21 Allowed Glycine 0 CA--C 1.537 1.444 0 N-CA-C 117.794 1.877 . . . . 2.1200000000000001 117.794 -174.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -135.81 0.3 3.33 Favored Glycine 0 CA--C 1.537 1.407 0 C-N-CA 125.803 1.668 . . . . 1.1799999999999999 114.085 175.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 36.7 t -151.61 -38.62 0.12 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.958 1.303 . . . . 1.5700000000000001 113.568 -177.23 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 67.19 38.5 92.02 Favored Glycine 0 CA--C 1.541 1.678 0 C-N-CA 126.37 1.938 . . . . 0.77000000000000002 114.67 -165.518 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -93.71 -20.32 20.25 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 127.242 2.217 . . . . 0.95999999999999996 115.382 176.573 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.528 ' H ' ' HB2' ' A' ' 56' ' ' SER . 6.1 mtm -111.38 139.91 46.4 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.643 1.577 . . . . 1.3 112.862 172.651 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -139.96 150.0 43.97 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.875 0.87 . . . . 1.8600000000000001 112.376 172.317 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -86.74 139.87 30.3 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 125.363 1.465 . . . . 2.3100000000000001 110.126 163.121 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 90.1 mt -134.34 127.34 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 124.242 1.017 . . . . 0.63 109.606 168.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -117.34 122.74 44.72 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.522 1.129 . . . . 2.46 109.259 171.016 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.408 ' CD1' HG13 ' A' ' 84' ' ' VAL . 1.2 mt -126.81 157.63 37.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 127.089 2.155 . . . . 0.26000000000000001 109.196 177.679 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -155.27 131.42 10.2 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 125.706 1.602 . . . . 1.9299999999999999 107.69 168.365 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 28.7 t -156.82 143.05 18.12 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 120.304 1.411 . . . . 0.41999999999999998 112.327 -173.039 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -63.91 -10.43 20.89 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 114.767 1.395 . . . . 2.9399999999999999 114.767 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -79.51 -17.52 53.91 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 113.953 1.094 . . . . 1.8300000000000001 113.953 174.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -84.19 1.23 45.48 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 114.556 1.317 . . . . 1.95 114.556 -167.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.417 ' HB3' HG21 ' A' ' 104' ' ' VAL . 30.1 pttt -79.77 -22.97 42.53 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 115.306 1.595 . . . . 3.8599999999999999 115.306 -171.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -97.89 19.25 14.15 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-O 121.987 0.899 . . . . 4.0 111.794 178.165 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 44.1 mmtt -120.48 139.66 52.55 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 128.079 2.552 . . . . 1.4299999999999999 111.16 -175.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 17.0 mtm180 -66.15 164.48 15.53 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.335 1.054 . . . . 5.2000000000000002 111.197 161.199 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.1 m -46.66 -54.19 10.08 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 113.781 1.03 . . . . 0.68000000000000005 113.781 170.222 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 9.4 p -59.5 -37.01 67.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 123.685 0.794 . . . . 0.57999999999999996 112.053 176.522 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -77.65 -16.81 58.28 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 114.104 1.15 . . . . 1.01 114.104 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -77.87 -55.12 5.58 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 119.45 1.023 . . . . 0.63 109.658 166.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 44.7 m170 -54.12 -46.62 72.22 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.328 1.051 . . . . 0.53000000000000003 113.178 -177.312 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 53.2 tp60 -47.79 -40.61 21.36 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.426 1.89 . . . . 1.3600000000000001 113.165 177.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 64.5 mtp -66.78 -44.27 81.79 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.468 1.107 . . . . 0.95999999999999996 111.596 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.408 HG13 ' CD1' ' A' ' 67' ' ' ILE . 2.9 t -69.49 -31.0 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 126.162 1.785 . . . . 0.27000000000000002 110.955 178.714 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -68.87 -52.27 31.48 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.058 1.743 . . . . 0.5 110.176 174.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.04 -28.37 62.48 Favored 'General case' 0 CA--C 1.546 0.808 0 O-C-N 120.679 -1.263 . . . . 2.1899999999999999 111.848 178.514 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.66 -33.83 76.5 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.741 1.216 . . . . 0.37 112.892 -173.144 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.46 -7.88 8.63 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 114.473 1.286 . . . . 0.44 114.473 177.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 32.0 ttpt -46.47 -43.51 16.73 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 124.454 1.102 . . . . 2.5299999999999998 112.369 176.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -77.96 -4.05 45.03 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-O 121.645 0.736 . . . . 2.3799999999999999 112.055 -169.187 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -111.79 -45.41 3.35 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 129.991 3.317 . . . . 2.2599999999999998 111.154 -176.318 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 40.3 mt -144.85 124.95 7.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 129.001 2.92 . . . . 1.1499999999999999 107.283 177.064 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -96.09 -10.93 27.15 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 115.317 1.599 . . . . 3.3999999999999999 115.317 -174.198 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . 0.27 19.0 pt-20 -77.12 43.31 0.36 Allowed 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 116.38 1.993 . . . . 4.6399999999999997 116.38 -162.624 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 59.1 mtm -71.32 -1.61 13.44 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.65 1.98 . . . . 1.53 115.948 -167.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 6.9 p-80 -60.19 -20.36 58.3 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 121.335 -0.853 . . . . 4.8399999999999999 112.904 159.086 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -87.63 -12.94 65.98 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 125.43 1.491 . . . . 0.59999999999999998 115.176 169.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.6 mp -100.08 116.47 32.18 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 118.381 1.091 . . . . 1.72 112.268 -168.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 17.6 ttm180 -98.13 103.55 15.51 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 126.505 1.922 . . . . 4.8799999999999999 110.081 -175.349 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 2.9 mt -108.56 145.48 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 123.548 1.642 . . . . 0.39000000000000001 112.933 -171.144 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -139.43 120.97 15.15 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 111.048 -2.796 . . . . 1.95 107.825 -171.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 21.2 p -133.6 152.03 51.81 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 126.242 1.817 . . . . 0.27000000000000002 110.025 -177.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 10.4 p -157.41 179.3 9.38 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.931 -1.031 . . . . 0.64000000000000001 111.187 173.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.417 HG21 ' HB3' ' A' ' 73' ' ' LYS . 7.4 p -144.21 133.73 11.56 Favored Pre-proline 0 N--CA 1.47 0.572 0 N-CA-C 113.197 0.814 . . . . 0.51000000000000001 113.197 -177.64 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo . . . . . 0 N--CA 1.455 -0.774 0 C-N-CA 122.773 2.315 . . . . 0.59999999999999998 109.456 173.011 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 . . . . . 0 CA--C 1.537 0.455 0 N-CA-C 109.759 -0.46 . . . . 1.96 109.759 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 23.1 p -115.55 164.24 14.6 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.517 1.127 . . . . 0.89000000000000001 110.662 170.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -65.42 -32.77 74.58 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 120.77 -1.206 . . . . 2.8900000000000001 111.377 174.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.02 -35.12 90.97 Favored Glycine 0 C--O 1.218 -0.875 0 CA-C-O 118.578 -1.123 . . . . 0.41999999999999998 112.251 172.127 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.38 -50.93 64.07 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 119.94 1.87 . . . . 1.26 111.825 174.392 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 15.2 mt -69.8 -50.37 43.66 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 125.657 1.583 . . . . 0.57999999999999996 110.615 -176.539 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.38 -48.35 79.28 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 126.135 1.774 . . . . 3.1499999999999999 111.533 177.651 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 29.6 t -62.84 -44.03 99.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 107.875 -1.157 . . . . 0.35999999999999999 107.875 178.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 47.2 m -58.05 -40.38 80.8 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 118.575 0.625 . . . . 0.41999999999999998 112.084 177.069 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 9.9 mm-40 -64.42 -45.2 88.59 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.634 0.605 . . . . 1.8999999999999999 112.634 -179.072 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 41.1 mt -72.04 -30.95 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-N 118.143 0.429 . . . . 0.63 109.866 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 37.5 mt -60.48 -37.73 81.98 Favored 'General case' 0 CA--C 1.531 0.237 0 O-C-N 120.925 -1.109 . . . . 0.47999999999999998 113.487 173.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 34.3 mttt -64.68 -25.88 68.14 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 113.596 0.961 . . . . 1.45 113.596 175.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -87.08 -39.91 15.16 Favored 'General case' 0 N--CA 1.433 -1.325 0 C-N-CA 125.769 1.627 . . . . 2.21 113.404 176.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 62.4 mmtt -74.95 -25.51 58.93 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 119.342 -0.943 . . . . 1.48 112.067 175.27 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -128.11 49.69 4.71 Favored Pre-proline 0 CA--C 1.55 0.975 0 N-CA-C 119.112 3.004 . . . . 2.1099999999999999 119.112 -179.036 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -67.72 -12.84 36.86 Favored 'Trans proline' 0 CA--C 1.534 0.489 0 C-N-CA 124.718 3.612 . . . . 0.72999999999999998 115.268 175.079 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 12.3 mmm180 -76.18 -16.49 59.84 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 114.124 1.157 . . . . 7.0099999999999998 114.124 169.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.94 152.48 43.1 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 115.892 1.812 . . . . 0.41999999999999998 115.892 -166.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 30.9 p -100.24 -22.95 14.95 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 118.019 -0.991 . . . . 0.63 112.374 168.185 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -126.11 141.41 51.95 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 119.932 1.242 . . . . 0.31 111.53 161.307 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.4 pt -157.6 103.31 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 127.23 2.212 . . . . 0.56000000000000005 110.337 171.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.5 ptpt -152.3 157.21 41.04 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.163 1.385 . . . . 1.1399999999999999 113.097 -175.406 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 23.7 t -137.72 144.57 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 126.639 1.976 . . . . 0.40999999999999998 110.548 -169.561 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.405 ' HB ' ' HB3' ' A' ' 64' ' ' GLU . 88.6 m -134.67 126.29 28.81 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 108.989 -0.745 . . . . 0.40999999999999998 108.989 165.571 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -70.67 133.83 46.99 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.474 0.654 . . . . 2.1499999999999999 109.755 167.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . 0.261 2.9 pt -127.7 34.9 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 C-N-CA 126.373 1.869 . . . . 0.85999999999999999 109.188 173.585 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 36.4 p -144.72 42.57 1.35 Allowed 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 128.281 2.632 . . . . 2.77 116.766 -174.232 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -51.26 -22.42 7.06 Favored Glycine 0 CA--C 1.546 2.02 0 N-CA-C 118.399 2.119 . . . . 2.0299999999999998 118.399 -176.582 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -110.28 -0.02 29.68 Favored Glycine 0 CA--C 1.541 1.7 0 C-N-CA 126.406 1.955 . . . . 1.28 115.37 177.487 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 7.8 t -132.99 -40.79 0.92 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.544 1.138 . . . . 1.8799999999999999 113.756 -176.098 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 57.88 47.83 86.29 Favored Glycine 0 CA--C 1.536 1.396 0 C-N-CA 128.348 2.88 . . . . 1.1799999999999999 113.535 -167.168 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -124.41 18.02 8.95 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.794 1.238 . . . . 1.04 114.024 -179.234 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 8.5 ttm -153.07 122.77 6.83 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.757 1.223 . . . . 1.78 112.097 -170.511 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -141.97 148.21 38.21 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.989 0.899 . . . . 1.8700000000000001 113.413 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.405 ' HB3' ' HB ' ' A' ' 53' ' ' THR . 7.8 tt0 -93.18 114.3 26.75 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.627 1.971 . . . . 2.3799999999999999 109.732 168.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 83.0 mt -125.46 123.78 65.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 CA-C-N 120.125 1.33 . . . . 0.70999999999999996 110.625 -170.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 71.7 mttt -125.26 119.52 28.67 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.871 1.269 . . . . 2.6400000000000001 111.011 -172.15 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.449 ' CD1' HG13 ' A' ' 84' ' ' VAL . 1.3 mt -130.02 153.33 38.74 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 127.158 2.183 . . . . 0.26000000000000001 109.93 -176.401 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -154.22 127.96 8.75 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.125 1.37 . . . . 1.8500000000000001 108.733 166.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 23.0 t -159.33 142.26 14.21 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 120.383 1.447 . . . . 0.29999999999999999 112.657 -172.07 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -50.65 -31.41 16.12 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.544 1.137 . . . . 2.73 112.522 178.345 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -66.98 -10.73 52.63 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 114.644 1.35 . . . . 1.6599999999999999 114.644 -175.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -95.71 10.28 37.47 Favored 'General case' 0 CA--C 1.557 1.217 0 N-CA-C 116.194 1.924 . . . . 2.0899999999999999 116.194 -175.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.443 ' HA ' HG11 ' A' ' 104' ' ' VAL . 0.1 OUTLIER -71.8 -37.15 70.45 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-N 120.775 1.625 . . . . 2.8799999999999999 115.139 -172.073 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -86.19 13.29 8.14 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.575 1.55 . . . . 3.3599999999999999 112.266 -174.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 51.4 mmtt -127.67 131.21 49.84 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.586 1.554 . . . . 2.23 112.951 -159.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 19.1 mmt180 -63.53 163.33 11.27 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.351 1.46 . . . . 5.2699999999999996 111.561 166.106 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 41.3 m -43.5 -55.52 4.17 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 125.498 1.519 . . . . 1.03 114.167 168.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 9.9 p -59.85 -38.35 75.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 N-CA-C 113.579 0.955 . . . . 0.51000000000000001 113.579 175.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -74.83 -32.45 61.94 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.308 0.643 . . . . 1.05 112.277 -177.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -66.44 -54.29 25.9 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.314 1.046 . . . . 0.64000000000000001 109.81 168.403 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 46.6 m170 -52.83 -44.77 66.95 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.886 1.274 . . . . 0.51000000000000001 112.951 -178.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 41.3 tp60 -53.34 -39.76 64.37 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.801 1.24 . . . . 1.2 112.821 178.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 4.7 mtm -66.38 -41.44 89.38 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 121.262 -0.899 . . . . 1.51 111.302 179.176 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.449 HG13 ' CD1' ' A' ' 67' ' ' ILE . 2.3 t -72.39 -26.45 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 125.243 1.417 . . . . 0.28999999999999998 111.914 178.136 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -70.1 -56.16 7.61 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 126.046 1.739 . . . . 0.82999999999999996 109.148 175.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.98 -6.42 42.0 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.101 1.149 . . . . 2.79 114.101 -178.246 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.02 -33.83 76.99 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 120.945 -1.097 . . . . 0.47999999999999998 112.738 169.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.24 -0.64 2.01 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 115.489 1.663 . . . . 0.40000000000000002 115.489 -176.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 34.9 tttt -50.26 -38.36 40.45 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 125.175 1.39 . . . . 2.2000000000000002 113.016 177.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -75.31 -18.44 60.03 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-O 121.514 0.673 . . . . 1.8899999999999999 111.413 -177.252 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -88.72 -51.98 5.38 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 129.126 2.971 . . . . 2.4300000000000002 110.991 177.359 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 32.9 mt -147.61 114.48 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 128.467 2.707 . . . . 1.02 108.327 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.4 tmtp? -92.28 -7.62 47.55 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 114.87 1.433 . . . . 4.0999999999999996 114.87 -163.231 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -70.43 57.42 0.17 Allowed 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 129.681 3.192 . . . . 3.1299999999999999 115.477 -164.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . 0.273 1.3 mpt? -75.84 3.63 9.62 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 119.311 -2.118 . . . . 1.8400000000000001 116.483 -178.593 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 73.2 t60 -59.21 -30.28 68.11 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 121.235 -0.916 . . . . 4.6900000000000004 112.371 151.387 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -83.56 -30.44 29.97 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 127.886 2.66 . . . . 0.5 116.457 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.0 mt -89.31 120.62 30.82 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 122.856 1.312 . . . . 2.1800000000000002 111.415 -164.576 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 14.6 ttm180 -106.82 99.23 8.82 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 112.797 -2.001 . . . . 5.2800000000000002 106.502 -179.251 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 1.4 mt -113.3 140.41 33.59 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.457 0 CA-C-O 122.845 1.307 . . . . 0.57999999999999996 111.105 -165.4 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -135.14 117.21 15.37 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 111.907 -2.406 . . . . 1.99 107.445 -166.161 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 18.5 p -134.89 147.52 49.87 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.221 1.808 . . . . 0.27000000000000002 110.145 -175.293 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.9 p -153.42 179.02 9.16 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.052 -1.431 . . . . 0.58999999999999997 110.319 174.241 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.443 HG11 ' HA ' ' A' ' 73' ' ' LYS . 6.5 p -145.82 133.26 10.26 Favored Pre-proline 0 N--CA 1.469 0.481 0 O-C-N 121.572 -0.705 . . . . 0.38 111.801 -178.511 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo . . . . . 0 N--CA 1.448 -1.205 0 C-N-CA 122.721 2.281 . . . . 1.01 108.911 166.173 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.8 mp0 . . . . . 0 C--O 1.238 0.478 0 N-CA-C 115.228 1.566 . . . . 2.3300000000000001 115.228 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 59.2 p -87.13 165.35 15.81 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 114.863 -1.062 . . . . 0.60999999999999999 110.492 156.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -64.54 -27.68 69.13 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 120.936 -1.103 . . . . 4.29 111.875 168.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.54 -38.68 96.04 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 126.119 1.818 . . . . 0.45000000000000001 113.379 170.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.79 -43.18 72.62 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.291 1.546 . . . . 2.1299999999999999 112.014 174.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 11.7 mt -69.17 -52.04 31.97 Favored 'General case' 0 N--CA 1.462 0.129 0 C-N-CA 125.573 1.549 . . . . 0.35999999999999999 111.005 178.329 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -53.48 -49.75 66.82 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 126.923 2.089 . . . . 3.4199999999999999 110.874 178.463 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 38.1 t -67.4 -45.04 86.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 108.75 -0.833 . . . . 0.31 108.75 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 68.4 m -53.98 -43.55 70.05 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 118.511 0.596 . . . . 0.37 112.392 175.415 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -62.89 -43.65 98.21 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 118.593 0.633 . . . . 1.8 111.734 -176.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 53.2 mt -71.6 -29.86 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 123.312 0.645 . . . . 0.78000000000000003 110.323 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 53.2 mt -64.93 -41.44 95.52 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 120.655 -1.278 . . . . 0.62 113.269 171.431 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 38.7 mttt -62.19 -19.43 63.11 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-N 119.544 1.066 . . . . 1.77 113.852 174.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -95.91 -37.95 10.48 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 126.315 1.846 . . . . 2.3100000000000001 114.832 -178.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -78.38 -22.1 48.38 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 118.675 -0.678 . . . . 1.1100000000000001 112.492 170.257 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -133.07 50.07 5.13 Favored Pre-proline 0 CA--C 1.548 0.902 0 N-CA-C 118.854 2.909 . . . . 1.54 118.854 -179.073 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -62.98 -26.42 74.08 Favored 'Trans proline' 0 CA--C 1.534 0.516 0 C-N-CA 123.48 2.786 . . . . 1.0 115.842 177.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 27.0 mmm180 -76.97 -12.85 60.0 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 120.387 1.449 . . . . 7.3499999999999996 114.61 176.254 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -53.8 144.92 17.08 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.925 1.29 . . . . 0.62 114.159 -175.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 44.3 p -97.4 -22.5 16.57 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.473 1.109 . . . . 0.56999999999999995 111.984 176.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -123.4 138.39 54.61 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.942 0.897 . . . . 0.40999999999999998 110.321 157.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -154.35 105.97 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 124.841 1.256 . . . . 0.62 110.361 169.417 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.9 ptpt -150.05 154.75 38.68 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.025 1.33 . . . . 1.21 112.814 -179.252 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.9 t -129.95 148.27 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 126.785 2.034 . . . . 0.44 109.632 -178.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 55.2 m -135.42 132.91 38.06 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 118.465 0.575 . . . . 0.48999999999999999 110.244 161.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -72.51 134.34 45.24 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 122.037 0.922 . . . . 1.79 109.767 167.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . 0.257 1.8 pt -127.7 33.39 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 125.57 1.548 . . . . 0.53000000000000003 109.787 174.482 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.2 p -141.55 63.93 1.42 Allowed 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 127.087 2.155 . . . . 2.4399999999999999 114.362 -177.54 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -58.03 -19.05 36.32 Favored Glycine 0 CA--C 1.543 1.819 0 N-CA-C 116.326 1.29 . . . . 1.25 116.326 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -108.86 -5.55 31.03 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 125.74 1.638 . . . . 0.95999999999999996 116.63 -178.008 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 1.3 m -152.11 -15.86 0.18 Allowed 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 115.2 1.555 . . . . 1.77 115.2 -177.06 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 51.75 38.93 45.88 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 127.246 2.355 . . . . 0.81000000000000005 114.995 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -110.76 6.5 21.53 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.116 1.366 . . . . 1.21 113.236 -175.376 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 15.0 ttm -140.48 121.07 14.22 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.714 2.006 . . . . 1.9199999999999999 110.497 -161.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.418 ' HB2' HD22 ' A' ' 98' ' ' LEU . 78.2 m-85 -143.36 146.33 33.43 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 113.815 1.043 . . . . 1.9199999999999999 113.815 -174.502 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -90.88 114.15 26.52 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.901 1.68 . . . . 2.6299999999999999 109.417 167.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 95.9 mt -120.55 123.66 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 O-C-N 120.762 -1.211 . . . . 0.63 109.565 -175.318 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 75.7 mttt -124.28 111.23 15.58 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.78 1.232 . . . . 2.6499999999999999 110.254 -174.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.3 mt -120.46 155.26 23.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 127.445 2.298 . . . . 0.23999999999999999 109.052 -178.077 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -153.66 130.49 10.89 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.186 1.394 . . . . 1.8500000000000001 107.291 162.476 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.6 t -155.3 140.75 17.78 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 120.107 1.321 . . . . 0.32000000000000001 112.352 -173.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -61.91 -6.6 2.91 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.621 1.568 . . . . 3.8900000000000001 115.111 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -84.68 -14.58 48.06 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.733 1.613 . . . . 1.77 114.207 175.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -87.13 12.03 12.51 Favored 'General case' 0 CA--C 1.559 1.302 0 N-CA-C 114.37 1.248 . . . . 2.0299999999999998 114.37 -175.404 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.412 ' HB3' HG21 ' A' ' 104' ' ' VAL 0.252 0.0 OUTLIER -76.83 -14.62 59.89 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 117.225 2.305 . . . . 2.54 117.225 -166.476 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -118.29 25.33 10.38 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.341 1.456 . . . . 4.8799999999999999 111.253 169.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 52.3 mmtt -112.61 131.36 55.66 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.544 1.538 . . . . 1.3799999999999999 111.868 177.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 36.1 mtt180 -65.71 161.69 20.16 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.667 1.187 . . . . 3.77 111.071 163.257 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 54.1 m -38.04 -55.56 1.24 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 126.356 1.862 . . . . 0.92000000000000004 113.799 168.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.5 p -63.86 -40.34 88.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 125.212 1.405 . . . . 0.85999999999999999 113.598 178.329 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -71.92 -32.3 67.22 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 121.619 -0.675 . . . . 1.01 111.573 178.036 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -63.79 -53.45 50.62 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.568 0.747 . . . . 0.64000000000000001 109.885 169.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 62.8 m170 -49.94 -52.35 34.06 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.796 0.838 . . . . 0.75 111.968 178.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 23.4 tp60 -46.9 -44.33 19.62 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.037 1.735 . . . . 1.23 113.134 178.363 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 85.0 mtp -62.33 -43.51 98.66 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 119.159 0.89 . . . . 0.92000000000000004 112.516 178.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.6 t -71.7 -27.41 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 C-N-CA 125.647 1.579 . . . . 0.23000000000000001 112.146 178.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -74.31 -50.67 17.87 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.525 1.93 . . . . 0.46999999999999997 109.381 177.268 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 12.5 mm-40 -65.56 -18.66 65.49 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.378 1.471 . . . . 2.54 113.635 178.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.69 -44.67 85.99 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 119.337 0.971 . . . . 0.78000000000000003 111.056 179.03 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.11 5.66 9.22 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 115.513 1.672 . . . . 0.67000000000000004 115.513 -174.204 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.5 ttmt -51.67 -40.23 59.66 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 125.037 1.335 . . . . 3.1699999999999999 113.136 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -81.68 10.32 6.31 Favored 'General case' 0 CA--C 1.554 1.126 0 CA-C-O 122.121 0.962 . . . . 2.3999999999999999 113.347 -174.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -126.84 -56.26 1.37 Allowed 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 129.443 3.097 . . . . 3.1200000000000001 108.652 -176.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -128.57 120.97 53.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 126.872 2.069 . . . . 1.54 108.371 165.782 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -105.75 1.69 27.28 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 119.919 -1.738 . . . . 2.6299999999999999 114.812 -179.103 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.3 mp0 -71.88 47.01 0.14 Allowed 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 130.573 3.549 . . . . 3.25 115.332 -173.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . 0.254 2.1 mpt? -72.35 12.75 0.41 Allowed 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 116.703 2.112 . . . . 1.78 116.703 -173.632 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 39.8 p-80 -63.39 -28.4 69.96 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.366 -0.834 . . . . 4.1100000000000003 112.083 154.409 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -77.94 -22.61 68.44 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 115.916 1.126 . . . . 0.45000000000000001 115.916 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.418 HD22 ' HB2' ' A' ' 63' ' ' TYR . 10.1 mt -92.06 136.02 33.51 Favored 'General case' 0 C--O 1.238 0.463 0 O-C-N 120.813 -1.404 . . . . 2.1499999999999999 111.222 -164.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 15.3 ttt180 -114.63 105.49 13.12 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.686 1.594 . . . . 3.73 106.896 169.055 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 1.5 mt -114.41 137.47 47.64 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.648 0 CA-C-O 123.098 1.427 . . . . 0.44 111.005 -169.198 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -130.54 123.72 30.24 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-N 111.769 -2.468 . . . . 1.8799999999999999 106.628 -169.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 17.3 p -140.86 152.68 45.29 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 126.237 1.815 . . . . 0.28999999999999998 109.217 -175.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -161.05 173.88 14.56 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.296 -0.866 . . . . 0.69999999999999996 110.481 176.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.412 HG21 ' HB3' ' A' ' 73' ' ' LYS . 12.5 p -141.84 133.71 13.54 Favored Pre-proline 0 N--CA 1.468 0.467 0 O-C-N 121.329 -0.857 . . . . 0.59999999999999998 111.962 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo . . . . . 0 N--CA 1.453 -0.874 0 C-N-CA 122.081 1.854 . . . . 0.85999999999999999 110.615 174.698 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 . . . . . 0 CA--C 1.544 0.743 0 N-CA-C 115.128 1.529 . . . . 2.4900000000000002 115.128 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 66.9 p -100.93 170.18 8.47 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 121.128 -0.982 . . . . 0.59999999999999998 109.897 159.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 -70.07 -29.48 66.49 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 120.436 -1.415 . . . . 3.8599999999999999 111.902 163.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -66.54 -38.14 93.15 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 124.282 0.944 . . . . 0.35999999999999999 113.139 177.052 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.94 -44.27 50.39 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.449 1.499 . . . . 1.98 111.539 172.569 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.4 mt -70.26 -51.87 27.32 Favored 'General case' 0 C--N 1.337 0.046 0 C-N-CA 125.479 1.512 . . . . 0.40000000000000002 110.747 -178.258 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.87 -48.93 76.97 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.904 1.682 . . . . 3.0600000000000001 110.865 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.8 t -65.54 -45.25 93.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 108.435 -0.95 . . . . 0.34000000000000002 108.435 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 98.7 m -56.92 -41.32 77.96 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 118.687 0.676 . . . . 0.38 112.411 176.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -63.86 -42.52 97.52 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 112.753 0.649 . . . . 2.04 112.753 -178.247 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 32.2 mt -75.45 -30.25 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 CA-C-N 118.629 0.649 . . . . 0.47999999999999998 110.462 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 44.0 mt -60.14 -40.35 89.48 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 120.779 -1.2 . . . . 0.67000000000000004 113.34 171.379 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 27.2 mttt -60.73 -24.95 66.09 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 119.338 0.972 . . . . 1.8500000000000001 113.391 176.266 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -94.62 -35.38 12.24 Favored 'General case' 0 N--CA 1.434 -1.236 0 C-N-CA 126.895 2.078 . . . . 1.96 115.066 -178.064 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 56.8 mmtt -75.89 -22.77 55.79 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 119.735 -0.786 . . . . 1.3100000000000001 111.856 170.037 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -130.19 51.39 7.45 Favored Pre-proline 0 CA--C 1.551 1.002 0 N-CA-C 118.428 2.751 . . . . 1.6200000000000001 118.428 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -67.66 -18.88 48.28 Favored 'Trans proline' 0 CA--C 1.534 0.507 0 C-N-CA 124.457 3.438 . . . . 0.62 115.099 176.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.96 -5.01 58.9 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 114.861 1.43 . . . . 5.6600000000000001 114.861 172.029 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.09 146.73 52.63 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 113.615 0.968 . . . . 0.40999999999999998 113.615 -178.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 60.9 p -93.34 -32.76 14.16 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.331 -0.849 . . . . 0.68000000000000005 111.06 172.107 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -117.63 137.88 52.34 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.046 0.938 . . . . 0.31 111.527 165.27 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -156.03 108.16 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 126.685 1.994 . . . . 0.60999999999999999 109.919 171.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.1 ptpt -152.37 157.83 41.84 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.813 1.645 . . . . 1.05 113.618 178.362 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.3 t -132.67 151.68 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 126.051 1.74 . . . . 0.34999999999999998 110.763 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 89.8 m -141.1 125.22 17.3 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 120.31 -1.493 . . . . 0.40999999999999998 110.846 169.259 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -67.44 135.3 52.91 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.809 0.814 . . . . 1.77 109.838 168.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.3 pt -134.34 19.93 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 124.909 1.284 . . . . 0.64000000000000001 111.76 178.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.3 t -123.05 83.42 2.12 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 127.316 2.246 . . . . 1.3400000000000001 111.399 176.246 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -73.2 9.22 7.39 Favored Glycine 0 N--CA 1.476 1.363 0 O-C-N 120.325 -1.484 . . . . 1.8500000000000001 115.212 -177.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -129.12 -12.98 2.48 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 126.452 1.977 . . . . 1.23 114.046 -175.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 7.2 t -151.41 -18.04 0.2 Allowed 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 118.575 1.187 . . . . 1.99 114.055 175.405 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 54.93 37.55 62.76 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 124.686 1.136 . . . . 0.90000000000000002 111.984 -163.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -91.97 1.83 56.94 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.295 1.438 . . . . 0.92000000000000004 113.184 178.377 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 1.4 mtp -134.31 141.46 46.94 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 126.179 1.792 . . . . 2.0099999999999998 112.396 175.342 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.436 ' H ' HD23 ' A' ' 98' ' ' LEU . 95.4 m-85 -142.62 145.37 33.43 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 122.021 0.915 . . . . 2.0099999999999998 112.363 173.438 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -80.86 133.74 35.64 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 125.897 1.679 . . . . 1.8200000000000001 108.573 161.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.5 mt -137.34 122.7 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 CA-C-N 119.464 1.029 . . . . 0.59999999999999998 108.911 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 70.3 mttt -124.73 112.05 16.28 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.29 1.036 . . . . 2.7599999999999998 110.183 -175.313 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.3 mt -121.96 155.93 26.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 126.858 2.063 . . . . 0.28000000000000003 109.061 -177.481 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -156.06 126.72 6.8 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.453 1.501 . . . . 2.0600000000000001 107.598 165.154 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.4 t -156.84 147.93 22.0 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 119.932 1.242 . . . . 0.38 112.417 -173.402 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -57.48 -28.11 63.1 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.245 1.418 . . . . 4.0199999999999996 113.019 -174.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -69.78 -18.22 63.47 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 115.039 1.496 . . . . 1.75 115.039 177.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -80.94 13.84 2.5 Favored 'General case' 0 CA--C 1.545 0.759 0 O-C-N 121.102 -0.999 . . . . 1.6299999999999999 113.215 -176.092 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 50.7 pttt -78.74 -27.68 44.79 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.157 1.383 . . . . 2.7599999999999998 113.348 176.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -109.11 33.7 4.13 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.12 1.768 . . . . 4.8300000000000001 111.875 -167.527 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 65.4 mmtt -139.56 141.64 37.2 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 126.897 2.079 . . . . 1.78 111.407 -169.54 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 6.6 mmt180 -65.88 168.78 7.49 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.668 1.187 . . . . 3.8300000000000001 110.872 162.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 94.7 m -54.97 -53.91 49.62 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 113.036 0.754 . . . . 1.22 113.036 170.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 10.1 p -57.4 -40.46 74.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 123.216 0.606 . . . . 0.92000000000000004 111.681 176.612 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -68.64 -32.36 72.16 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.2 0.815 . . . . 2.0600000000000001 113.2 178.107 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 -62.41 -52.08 65.0 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.556 1.071 . . . . 1.9199999999999999 109.924 170.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 33.1 m170 -58.21 -50.08 74.8 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 118.944 0.793 . . . . 0.78000000000000003 112.64 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -54.15 -40.95 67.9 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 124.706 1.202 . . . . 4.25 113.937 178.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 1.1 mmm -61.97 -34.6 76.44 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 120.403 1.456 . . . . 1.55 111.657 -178.174 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.1 t -79.32 -32.04 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 127.122 2.169 . . . . 0.31 111.347 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -67.7 -46.51 72.03 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.347 1.459 . . . . 0.89000000000000001 111.312 170.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 55.0 tp60 -65.73 -25.76 67.44 Favored 'General case' 0 N--CA 1.445 -0.687 0 O-C-N 120.373 -1.454 . . . . 2.6099999999999999 113.847 -177.239 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.87 -30.99 69.36 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.451 1.5 . . . . 0.34999999999999998 112.521 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -127.13 1.14 6.48 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 115.492 1.664 . . . . 0.60999999999999999 115.492 177.677 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 31.2 ttmt -46.54 -43.3 16.93 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.443 1.497 . . . . 2.1200000000000001 112.413 175.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -81.74 -18.86 42.79 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-O 121.362 0.601 . . . . 2.1699999999999999 111.509 -171.378 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -88.9 -49.52 6.75 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 127.995 2.518 . . . . 2.3399999999999999 111.197 -178.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 51.0 mt -147.36 101.06 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 127.544 2.338 . . . . 1.3600000000000001 108.115 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.3 ptmm? -79.21 -7.57 58.34 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 116.551 2.056 . . . . 2.7400000000000002 116.551 -166.143 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -79.19 44.03 0.56 Allowed 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 130.074 3.35 . . . . 3.5299999999999998 115.594 -165.553 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 4.2 mpp? -73.86 12.45 0.67 Allowed 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 117.651 2.463 . . . . 1.48 117.651 -168.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 68.6 t60 -53.78 -32.6 53.1 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 120.516 1.507 . . . . 4.4500000000000002 112.337 168.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -75.65 -12.23 83.93 Favored Glycine 0 CA--C 1.522 0.475 0 N-CA-C 117.364 1.706 . . . . 0.51000000000000001 117.364 -178.087 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.436 HD23 ' H ' ' A' ' 63' ' ' TYR . 13.2 mt -88.25 133.71 33.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 122.787 1.279 . . . . 2.0899999999999999 111.369 -162.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 19.9 ttm180 -120.0 85.49 2.39 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 126.901 2.081 . . . . 5.7000000000000002 106.9 -172.462 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 1.6 mt -106.67 141.39 22.01 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 CA-C-O 123.905 1.812 . . . . 0.42999999999999999 112.038 -163.427 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -135.87 125.43 25.21 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 111.515 -2.584 . . . . 2.0899999999999999 107.513 -170.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 26.2 p -140.99 157.74 44.91 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 125.834 1.654 . . . . 0.26000000000000001 109.077 -176.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 2.5 p -168.55 178.58 4.7 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.583 -1.189 . . . . 0.58999999999999997 109.837 176.084 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.3 p -138.65 129.4 15.17 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 124.106 0.962 . . . . 0.38 112.022 -178.236 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo . . . . . 0 C--N 1.348 0.529 0 C-N-CA 124.079 3.186 . . . . 0.75 111.957 -175.617 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 12.0 mp0 . . . . . 0 CA--C 1.536 0.424 0 CA-C-O 121.551 0.691 . . . . 2.3399999999999999 111.305 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 80.4 p -120.49 170.59 9.25 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 107.947 -1.131 . . . . 0.56999999999999995 107.947 144.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -69.5 -22.6 63.59 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 120.919 -1.113 . . . . 2.8700000000000001 112.068 166.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.36 -41.38 98.15 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 124.309 0.956 . . . . 0.35999999999999999 112.574 169.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.72 -46.22 40.47 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.681 1.593 . . . . 1.3200000000000001 111.681 171.099 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.6 mt -68.6 -52.47 31.26 Favored 'General case' 0 C--N 1.339 0.113 0 C-N-CA 125.085 1.354 . . . . 0.38 111.225 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -56.59 -50.18 72.71 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.375 1.47 . . . . 3.1299999999999999 110.824 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.7 t -60.3 -46.74 94.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 107.757 -1.201 . . . . 0.29999999999999999 107.757 179.119 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 63.3 m -57.92 -41.22 82.24 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 118.417 0.553 . . . . 0.37 112.358 177.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 -60.55 -45.62 93.23 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 123.28 0.632 . . . . 1.77 111.396 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 42.9 mt -76.87 -27.29 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 117.871 0.305 . . . . 0.65000000000000002 110.433 -175.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 19.0 mt -58.73 -39.0 79.6 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.077 -1.014 . . . . 0.41999999999999998 112.831 168.525 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 37.6 mttt -65.35 -19.9 66.15 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 113.794 1.035 . . . . 1.48 113.794 175.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -102.39 -34.83 9.03 Favored 'General case' 0 N--CA 1.436 -1.166 0 C-N-CA 126.776 2.03 . . . . 2.2400000000000002 114.532 -174.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 26.6 mmtp -75.97 -30.79 58.73 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 120.038 -0.665 . . . . 2.7999999999999998 111.039 167.486 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -128.14 50.57 5.74 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 118.351 2.722 . . . . 1.55 118.351 -176.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -60.47 -27.61 85.16 Favored 'Trans proline' 0 C--O 1.236 0.409 0 C-N-CA 123.134 2.556 . . . . 0.81999999999999995 114.297 174.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 31.7 mmt180 -74.86 -9.24 58.36 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 114.079 1.14 . . . . 4.9800000000000004 114.079 179.03 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.59 152.37 15.19 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 115.579 1.696 . . . . 0.40999999999999998 115.579 -173.11 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 42.8 p -104.27 -5.68 21.63 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 127.259 2.223 . . . . 1.0700000000000001 113.148 168.181 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -143.16 143.88 31.98 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 119.932 1.242 . . . . 0.40999999999999998 111.814 153.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.9 pt -155.15 116.14 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 126.753 2.021 . . . . 0.52000000000000002 111.069 169.079 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 7.9 ptpt -161.03 153.5 20.49 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.481 1.512 . . . . 1.1100000000000001 112.782 179.091 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.5 t -134.54 143.49 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 126.218 1.807 . . . . 0.34999999999999998 110.483 -175.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 64.2 m -133.76 125.14 27.9 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.839 1.656 . . . . 0.46000000000000002 110.805 173.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -75.27 132.86 41.33 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 122.304 1.05 . . . . 1.8200000000000001 111.526 171.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.4 pt -133.84 26.8 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 C-N-CA 126.295 1.838 . . . . 0.59999999999999998 110.898 178.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 46.8 t -134.2 69.91 1.46 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 126.879 2.072 . . . . 1.3500000000000001 112.696 176.177 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -54.06 -25.13 30.53 Favored Glycine 0 CA--C 1.54 1.609 0 N-CA-C 116.074 1.19 . . . . 1.5 116.074 -179.158 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -88.35 -17.67 56.79 Favored Glycine 0 CA--C 1.534 1.28 0 CA-C-N 119.118 1.459 . . . . 1.5 116.194 -176.112 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 9.8 m -154.86 -32.46 0.1 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.792 1.237 . . . . 1.72 114.127 -164.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 64.99 47.1 86.35 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 125.426 1.489 . . . . 0.80000000000000004 112.987 -166.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -98.15 -1.6 41.87 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 126.402 1.881 . . . . 0.91000000000000003 114.098 176.648 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 15.6 mtm -136.96 138.8 40.97 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 126.151 1.781 . . . . 1.45 110.88 177.071 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -143.75 146.51 33.19 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.701 0.8 . . . . 1.8700000000000001 111.781 172.105 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -94.91 130.08 41.68 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.61 1.564 . . . . 2.3900000000000001 109.561 169.405 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 80.4 mt -137.65 129.33 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.879 0.872 . . . . 0.79000000000000004 110.636 -167.032 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 60.0 mttt -115.75 125.12 52.37 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.94 0.896 . . . . 3.77 110.272 173.531 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.455 HD12 HG13 ' A' ' 84' ' ' VAL . 1.2 mt -129.21 155.18 41.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 C-N-CA 125.482 1.513 . . . . 0.41999999999999998 109.877 173.376 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -158.35 133.23 8.4 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 120.059 -1.651 . . . . 2.0099999999999998 109.31 171.062 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 19.6 t -162.4 147.1 12.26 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 119.911 1.232 . . . . 0.45000000000000001 112.21 -174.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -53.91 -28.83 39.21 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.382 1.473 . . . . 4.7699999999999996 113.014 -179.018 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -65.7 -20.32 66.24 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 115.237 1.569 . . . . 1.8200000000000001 115.237 177.502 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -84.43 2.1 42.32 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 115.104 1.52 . . . . 1.99 115.104 -168.215 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 16.4 pttm -69.34 -47.35 64.63 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-O 121.819 0.819 . . . . 2.9100000000000001 112.079 -176.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -84.2 35.29 0.53 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 128.842 2.857 . . . . 4.1799999999999997 111.455 -170.532 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 49.0 mmtt -140.11 140.35 36.02 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 127.892 2.477 . . . . 1.3 110.754 -172.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 49.5 mtt180 -68.13 172.42 5.74 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.537 0.735 . . . . 3.7200000000000002 111.404 163.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 37.3 m -51.41 -54.41 26.93 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.671 0.789 . . . . 0.93000000000000005 112.852 168.558 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 10.9 p -57.23 -37.68 57.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 124.312 1.045 . . . . 0.68000000000000005 112.701 176.487 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -80.59 -32.3 36.52 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 113.128 0.788 . . . . 1.1899999999999999 113.128 -177.512 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -61.94 -50.26 72.84 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 119.904 1.229 . . . . 0.64000000000000001 109.846 168.149 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 50.8 m170 -55.75 -49.73 72.32 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 122.912 0.485 . . . . 0.68999999999999995 111.629 177.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 47.4 tp60 -46.88 -45.1 20.2 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.706 2.002 . . . . 1.3700000000000001 112.937 -178.046 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 71.9 mtp -62.34 -43.26 99.24 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.998 0.919 . . . . 1.1299999999999999 112.189 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.455 HG13 HD12 ' A' ' 67' ' ' ILE . 6.0 t -74.03 -27.23 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 126.612 1.965 . . . . 0.23999999999999999 112.097 178.466 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -71.98 -50.04 32.08 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 126.003 1.721 . . . . 0.56000000000000005 108.751 176.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 15.3 mm-40 -65.88 -24.38 66.84 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.621 1.168 . . . . 2.3799999999999999 112.806 179.1 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -56.44 -37.17 69.87 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.398 1.079 . . . . 0.45000000000000001 112.568 -176.238 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -127.79 4.62 6.04 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 115.236 1.569 . . . . 0.47999999999999998 115.236 -179.054 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 16.4 ttmt -50.73 -34.9 28.84 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.827 1.251 . . . . 2.9900000000000002 113.309 -178.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -74.05 -29.92 62.14 Favored 'General case' 0 N--CA 1.439 -1.025 0 O-C-N 121.484 -0.76 . . . . 2.5800000000000001 111.78 -177.21 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.23 -58.42 3.29 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 127.944 2.498 . . . . 2.71 111.995 175.185 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 34.7 mt -136.97 123.88 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 125.778 1.631 . . . . 1.0700000000000001 107.868 178.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -90.75 -12.04 37.73 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 115.005 1.483 . . . . 2.8799999999999999 115.005 -166.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -85.77 67.19 9.96 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 126.182 1.793 . . . . 3.5299999999999998 113.752 -156.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . 0.272 0.8 OUTLIER -74.35 -4.0 33.7 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 115.71 1.745 . . . . 1.8400000000000001 115.71 176.844 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 67.2 t60 -55.76 -24.52 35.86 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 121.61 -0.681 . . . . 4.3399999999999999 112.786 153.407 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -88.2 -27.0 26.84 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 127.424 2.44 . . . . 0.54000000000000004 116.146 177.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.0 mt -90.5 134.5 34.32 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 121.895 -0.768 . . . . 2.3300000000000001 111.622 -166.303 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 27.0 ttt180 -117.08 92.68 3.92 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.837 1.655 . . . . 3.2999999999999998 108.527 -176.234 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -114.03 135.12 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-O 123.094 1.426 . . . . 0.46999999999999997 113.198 -159.65 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -131.36 91.22 2.98 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 112.897 -1.956 . . . . 2.0 109.917 -164.558 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.1 p -99.64 152.34 20.16 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.988 1.715 . . . . 0.31 111.895 178.293 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.2 p -156.39 -179.42 8.15 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 125.716 1.606 . . . . 0.64000000000000001 110.614 174.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.5 p -143.27 132.04 11.43 Favored Pre-proline 0 N--CA 1.476 0.834 0 O-C-N 121.5 -0.75 . . . . 0.46000000000000002 112.725 -179.186 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo . . . . . 0 C--N 1.351 0.685 0 C-N-CA 124.327 3.351 . . . . 0.68999999999999995 112.294 -176.511 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 . . . . . 0 N--CA 1.469 0.501 0 CA-C-O 120.794 0.331 . . . . 2.4399999999999999 111.255 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 69.3 p -110.7 179.05 4.17 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.764 1.226 . . . . 0.65000000000000002 109.957 160.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -71.02 -30.27 66.43 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 120.86 -1.15 . . . . 3.3700000000000001 111.951 161.155 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.21 -38.14 82.0 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 124.8 1.191 . . . . 0.40000000000000002 114.119 -178.543 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.53 -45.28 37.19 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.638 1.575 . . . . 1.22 111.575 174.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 15.0 mt -69.42 -52.82 23.25 Favored 'General case' 0 CA--C 1.522 -0.125 0 C-N-CA 125.68 1.592 . . . . 0.41999999999999998 110.945 -178.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.482 ' HE ' ' CD ' ' A' ' 91' ' ' GLU . 5.9 tpt180 -56.38 -49.64 73.88 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 125.419 1.487 . . . . 4.9800000000000004 111.585 -178.726 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 37.1 t -65.57 -42.17 92.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 107.827 -1.175 . . . . 0.51000000000000001 107.827 -179.021 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 87.1 m -57.99 -38.49 76.2 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 118.547 0.612 . . . . 0.47999999999999998 112.318 174.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 -63.06 -40.86 98.95 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 113.498 0.925 . . . . 1.74 113.498 -177.053 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 16.4 mt -81.32 -30.79 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 118.363 0.529 . . . . 0.68999999999999995 110.34 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 45.5 mt -51.95 -38.33 56.08 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 114.372 1.249 . . . . 0.72999999999999998 114.372 169.095 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 57.0 mttt -59.65 -31.05 69.17 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 124.962 1.305 . . . . 2.6200000000000001 113.912 178.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -93.69 -32.02 14.21 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 127.616 2.366 . . . . 2.3999999999999999 113.794 -174.349 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 59.9 mmtt -75.32 -26.55 58.74 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 119.805 -0.758 . . . . 1.6200000000000001 111.086 168.317 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -128.45 55.47 17.52 Favored Pre-proline 0 CA--C 1.55 0.959 0 N-CA-C 117.897 2.554 . . . . 1.6200000000000001 117.897 -177.221 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -68.83 -19.28 41.0 Favored 'Trans proline' 0 CA--C 1.534 0.489 0 C-N-CA 123.947 3.098 . . . . 0.81000000000000005 113.993 168.118 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 76.4 mtt180 -79.46 -2.61 42.75 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 114.601 1.334 . . . . 6.0899999999999999 114.601 174.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.25 158.38 33.46 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 115.727 1.751 . . . . 0.71999999999999997 115.727 -170.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 64.2 p -118.09 -15.77 9.85 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.97 1.308 . . . . 0.57999999999999996 112.651 168.301 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -131.66 141.72 49.67 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.914 0.885 . . . . 0.32000000000000001 111.727 152.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.0 pt -149.79 117.96 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 126.084 1.754 . . . . 0.77000000000000002 110.661 161.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 11.4 ptpt -152.8 155.01 36.31 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.86 1.264 . . . . 1.3999999999999999 112.285 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.7 t -135.78 144.88 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 126.281 1.833 . . . . 0.28999999999999998 110.398 -176.606 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 94.4 m -136.77 128.61 29.1 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.317 0.647 . . . . 0.32000000000000001 110.646 171.311 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -73.14 123.74 24.21 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.589 0.756 . . . . 2.0099999999999998 109.604 165.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.3 pt -122.18 27.2 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 125.001 1.321 . . . . 0.71999999999999997 110.574 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 36.6 t -136.32 65.55 1.52 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 127.189 2.196 . . . . 1.5700000000000001 111.001 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.37 0.6 2.66 Favored Glycine 0 CA--C 1.54 1.607 0 N-CA-C 117.227 1.651 . . . . 1.6000000000000001 117.227 -176.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -131.72 4.13 5.4 Favored Glycine 0 CA--C 1.538 1.521 0 C-N-CA 125.687 1.613 . . . . 1.4299999999999999 115.131 176.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 4.4 t -147.97 -27.35 0.34 Allowed 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 118.614 1.207 . . . . 1.5600000000000001 113.979 175.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 59.09 33.14 73.19 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 127.138 2.304 . . . . 1.0 114.316 -170.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -84.31 -28.27 27.23 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 118.291 1.046 . . . . 1.28 113.516 178.249 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -106.49 140.54 39.23 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 125.052 1.341 . . . . 1.6200000000000001 113.017 -179.201 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -142.64 145.68 33.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.751 -1.113 . . . . 1.8200000000000001 111.605 170.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -83.58 138.66 33.28 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 125.101 1.36 . . . . 1.78 109.288 162.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 93.9 mt -133.95 126.83 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.189 0.996 . . . . 0.56000000000000005 108.939 169.186 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 67.8 mttt -124.59 122.22 36.94 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.555 1.142 . . . . 2.6200000000000001 110.127 178.147 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.416 ' CD1' HG13 ' A' ' 84' ' ' VAL . 1.6 mt -126.25 158.66 35.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 125.869 1.668 . . . . 0.40000000000000002 109.296 -179.173 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -151.89 130.17 12.02 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 126.293 1.837 . . . . 1.8600000000000001 106.257 160.407 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 21.2 t -154.35 139.55 17.51 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 118.745 0.702 . . . . 0.35999999999999999 110.683 -176.06 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -58.32 -18.3 26.23 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.32 1.448 . . . . 3.1699999999999999 114.525 -177.228 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -74.23 -19.72 60.42 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.311 1.444 . . . . 1.6899999999999999 114.529 177.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -82.84 10.91 6.74 Favored 'General case' 0 CA--C 1.555 1.17 0 N-CA-C 116.123 1.898 . . . . 1.6299999999999999 116.123 -169.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.782 ' HA ' HG11 ' A' ' 104' ' ' VAL . 22.6 pttt -65.26 -46.85 78.85 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 127.059 2.144 . . . . 2.1200000000000001 115.754 -165.064 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -92.4 -20.7 20.76 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 126.799 2.04 . . . . 5.1100000000000003 112.353 -175.501 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 66.7 mmtt -58.82 142.91 49.05 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.567 1.147 . . . . 1.24 113.083 177.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 9.8 mmp_? -69.12 168.82 13.16 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 125.52 1.528 . . . . 6.4800000000000004 111.148 163.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.6 m -46.76 -56.86 5.52 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.424 0.69 . . . . 1.23 112.606 170.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.7 p -58.8 -41.73 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 125.235 1.414 . . . . 0.96999999999999997 112.633 178.026 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -76.0 -23.08 55.22 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 118.703 -0.665 . . . . 1.1200000000000001 112.496 -177.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -68.63 -58.05 4.83 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 119.634 1.107 . . . . 0.59999999999999998 109.925 164.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 32.5 m170 -56.14 -43.87 78.66 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.618 0.767 . . . . 0.48999999999999999 112.788 -177.082 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 50.9 tp60 -53.31 -40.6 64.9 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.325 1.45 . . . . 1.27 113.086 178.179 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 2.6 mtm -64.04 -39.57 94.38 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 119.649 1.113 . . . . 1.26 111.283 178.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.416 HG13 ' CD1' ' A' ' 67' ' ' ILE . 2.3 t -73.18 -28.42 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 125.497 1.519 . . . . 0.28000000000000003 111.775 177.71 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -71.58 -48.2 49.93 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.644 1.578 . . . . 0.59999999999999998 110.812 174.027 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.14 -22.32 66.89 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 120.736 -1.227 . . . . 2.77 112.384 177.03 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.28 -22.07 66.82 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 113.704 1.001 . . . . 0.94999999999999996 113.704 -177.611 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -132.69 -1.95 3.39 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 114.604 1.335 . . . . 0.58999999999999997 114.604 173.55 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 36.3 tttt -47.02 -41.74 17.02 Favored 'General case' 0 C--N 1.344 0.327 0 C-N-CA 124.682 1.193 . . . . 3.48 111.62 173.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -76.29 -3.15 35.12 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 123.913 0.885 . . . . 3.0800000000000001 112.761 -173.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.482 ' CD ' ' HE ' ' A' ' 35' ' ' ARG . 11.7 mm-40 -105.89 -51.54 2.97 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 128.288 2.635 . . . . 3.27 111.677 170.306 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 5.6 mt -143.33 126.88 13.61 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.371 0 C-N-CA 128.575 2.75 . . . . 1.9099999999999999 106.648 -178.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -94.63 -22.46 18.15 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.174 -0.954 . . . . 3.8599999999999999 113.196 -175.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -74.61 78.56 1.99 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.463 1.505 . . . . 3.75 113.018 -174.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 4.2 mpp? -82.38 13.46 3.58 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.936 1.295 . . . . 1.24 114.368 177.009 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 80.8 t60 -63.8 -34.29 77.59 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 120.624 -1.297 . . . . 4.3700000000000001 114.082 -177.259 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -84.5 -11.94 76.56 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 126.218 1.866 . . . . 0.57999999999999996 113.901 174.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.3 mp -86.47 139.13 31.18 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.427 1.091 . . . . 1.8500000000000001 111.917 -172.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 16.7 ttm180 -126.99 99.36 5.69 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 126.272 1.829 . . . . 5.3200000000000003 109.85 -169.283 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 3.6 mt -108.94 145.62 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-O 122.945 1.355 . . . . 0.37 113.306 -167.175 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -144.39 134.6 24.27 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 127.93 2.492 . . . . 2.1600000000000001 109.31 -170.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 16.4 p -150.8 153.14 34.88 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 127.847 2.459 . . . . 0.26000000000000001 109.397 -170.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.67 172.34 18.69 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 124.922 1.289 . . . . 0.62 110.045 175.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.782 HG11 ' HA ' ' A' ' 73' ' ' LYS . 8.9 p -136.97 125.87 15.16 Favored Pre-proline 0 N--CA 1.473 0.679 0 N-CA-C 113.661 0.985 . . . . 0.52000000000000002 113.661 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo . . . . . 0 N--CA 1.449 -1.101 0 C-N-CA 123.211 2.607 . . . . 0.77000000000000002 110.763 170.962 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 . . . . . 0 N--CA 1.471 0.595 0 N-CA-C 112.09 0.404 . . . . 2.6200000000000001 112.09 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 80.8 p -120.92 176.14 5.7 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.526 1.53 . . . . 0.77000000000000002 111.324 165.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 -66.04 -31.12 71.82 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 120.169 -1.582 . . . . 4.1699999999999999 112.048 160.339 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.14 -46.13 95.13 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 125.565 1.555 . . . . 0.52000000000000002 112.603 177.069 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.34 -47.24 47.42 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.469 1.507 . . . . 1.28 112.179 177.858 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 11.7 mt -72.24 -47.65 48.7 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.075 1.35 . . . . 0.44 111.716 -179.135 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -56.03 -50.44 70.9 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 126.381 1.873 . . . . 2.96 111.117 177.439 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 50.2 t -60.1 -46.21 94.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 107.945 -1.132 . . . . 0.32000000000000001 107.945 178.057 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 37.6 m -59.41 -39.14 82.5 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 118.974 -0.536 . . . . 0.40000000000000002 112.438 179.036 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 7.9 mm-40 -60.48 -40.96 93.19 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 118.88 0.764 . . . . 2.0 112.43 178.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 49.0 mt -81.63 -28.16 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 123.129 0.572 . . . . 0.45000000000000001 110.63 -177.559 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 18.0 mt -59.66 -40.31 87.32 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 120.722 -1.236 . . . . 0.53000000000000003 112.83 168.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 46.5 mttt -63.55 -23.31 67.33 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 119.423 1.01 . . . . 1.3400000000000001 113.383 177.343 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -96.4 -35.51 11.15 Favored 'General case' 0 N--CA 1.434 -1.265 0 C-N-CA 126.937 2.095 . . . . 2.0899999999999999 114.803 -177.154 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 64.3 mmtt -74.17 -27.75 60.97 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 118.176 -0.916 . . . . 1.24 111.125 167.363 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -127.29 51.44 6.63 Favored Pre-proline 0 CA--C 1.551 0.995 0 N-CA-C 117.347 2.351 . . . . 1.53 117.347 -178.478 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -64.75 -14.0 42.39 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 125.171 3.914 . . . . 0.76000000000000001 115.04 176.356 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 32.5 mmt180 -83.31 -14.98 51.83 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.955 1.465 . . . . 4.8399999999999999 114.955 170.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.62 143.14 47.32 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 116.728 2.122 . . . . 0.65000000000000002 116.728 -166.22 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 77.8 p -96.89 -24.85 15.67 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.922 0.889 . . . . 0.60999999999999999 112.64 175.462 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -126.28 140.42 52.54 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.838 0.855 . . . . 0.51000000000000001 111.743 161.287 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.3 pt -155.77 117.8 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 126.292 1.837 . . . . 0.69999999999999996 110.582 173.472 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.2 ptpt -152.44 155.84 38.32 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.459 1.504 . . . . 1.3600000000000001 112.408 173.573 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.1 t -132.15 143.24 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 125.98 1.712 . . . . 0.47999999999999998 109.9 177.341 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 74.6 m -136.53 123.64 21.65 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 118.46 0.573 . . . . 0.46000000000000002 111.72 173.053 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -65.59 128.05 34.37 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 108.528 -0.916 . . . . 1.97 108.528 165.485 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.9 pt -127.53 33.1 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 125.859 1.663 . . . . 0.46000000000000002 109.499 178.61 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.6 t -145.98 57.46 1.21 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 128.138 2.575 . . . . 1.27 110.828 -173.46 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.21 -0.85 0.33 Allowed Glycine 0 CA--C 1.541 1.711 0 C-N-CA 126.681 2.086 . . . . 1.3100000000000001 117.889 -178.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -144.54 24.25 2.0 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 126.488 1.994 . . . . 1.4299999999999999 113.505 -178.357 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -162.99 -27.77 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.565 1.546 . . . . 1.52 112.901 172.633 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 53.41 39.87 60.32 Favored Glycine 0 CA--C 1.536 1.362 0 C-N-CA 127.277 2.37 . . . . 0.63 114.707 -173.198 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -96.7 -34.79 11.23 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.976 1.31 . . . . 0.81000000000000005 113.716 178.374 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 8.9 mtm -96.23 138.42 33.86 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 124.183 0.993 . . . . 1.29 111.525 177.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -142.63 144.88 32.99 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.019 0.928 . . . . 1.9199999999999999 112.759 172.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -82.29 137.99 34.68 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 126.289 1.836 . . . . 2.3399999999999999 109.215 165.095 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 92.2 mt -136.19 125.15 38.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.017 0.927 . . . . 0.62 109.507 169.508 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 64.4 mttt -123.89 114.62 20.07 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.47 1.108 . . . . 2.8500000000000001 109.957 177.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.2 mt -122.92 157.56 28.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 126.535 1.934 . . . . 0.34999999999999998 109.653 -177.212 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -154.93 132.91 11.57 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.756 1.623 . . . . 1.73 108.265 163.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 33.2 t -158.6 140.53 13.79 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 119.277 0.944 . . . . 0.38 110.515 -174.585 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -58.16 -19.81 35.88 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 114.311 1.226 . . . . 2.7799999999999998 114.311 -177.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -72.01 -19.65 61.83 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.052 1.341 . . . . 1.75 114.387 179.362 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -79.44 13.28 2.04 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 114.165 1.172 . . . . 1.79 114.165 -171.342 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 42.6 pttt -77.69 -42.13 35.59 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 113.226 0.825 . . . . 2.4199999999999999 113.226 -172.763 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -81.4 38.8 0.5 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.342 1.057 . . . . 3.7799999999999998 112.739 -177.365 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 61.5 mmtt -138.44 144.75 40.28 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 126.164 1.786 . . . . 1.54 111.886 -171.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 55.4 mtt180 -71.98 167.24 20.55 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 124.226 1.01 . . . . 3.8100000000000001 111.144 154.304 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 95.6 m -43.39 -56.03 3.8 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 126.136 1.774 . . . . 0.66000000000000003 113.216 166.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.5 p -59.07 -42.63 87.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.92 1.288 . . . . 0.51000000000000001 113.264 175.552 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -74.68 -23.31 58.61 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 118.578 -0.725 . . . . 1.3100000000000001 112.381 -177.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -67.78 -54.69 17.14 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 119.728 1.149 . . . . 0.71999999999999997 110.241 163.617 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 36.6 m170 -49.94 -51.29 42.32 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.068 0.947 . . . . 0.57999999999999996 112.102 -179.069 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 15.5 tp60 -47.37 -44.17 23.9 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.082 1.353 . . . . 1.4199999999999999 113.541 178.17 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 76.5 mtp -61.91 -43.92 97.85 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 119.334 0.97 . . . . 1.1599999999999999 111.467 -177.611 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.1 t -72.62 -28.28 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 126.579 1.952 . . . . 0.22 111.226 179.339 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -72.5 -50.07 28.51 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.924 1.69 . . . . 0.47999999999999998 109.679 176.461 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.8 mm-40 -65.01 -20.13 66.35 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.738 1.215 . . . . 2.2400000000000002 113.355 178.418 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.94 -43.53 86.39 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 118.707 0.685 . . . . 0.40999999999999998 111.398 178.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.55 5.65 9.54 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 115.132 1.53 . . . . 0.34000000000000002 115.132 -174.245 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.9 ttmt -52.43 -38.18 58.53 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 125.034 1.333 . . . . 2.98 112.89 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -76.2 -26.08 55.79 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 112.92 0.711 . . . . 3.02 112.92 -178.174 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -78.9 -60.73 2.26 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.502 1.921 . . . . 3.3900000000000001 110.647 175.152 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 42.5 mt -135.22 103.44 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 126.393 1.877 . . . . 1.04 108.361 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 14.1 ptpt -79.61 -17.38 53.97 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 115.428 1.64 . . . . 2.4199999999999999 115.428 -169.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 19.7 mp0 -67.14 47.78 0.04 OUTLIER 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 130.227 3.411 . . . . 3.3199999999999998 116.269 -171.613 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 4.2 mpp? -62.65 -2.1 1.02 Allowed 'General case' 0 N--CA 1.476 0.865 0 O-C-N 119.31 -2.118 . . . . 1.3100000000000001 115.21 177.539 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 2.6 p80 -58.05 -29.82 65.69 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 119.419 1.009 . . . . 3.2799999999999998 113.34 162.45 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -85.49 -23.39 47.44 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 124.862 1.22 . . . . 0.51000000000000001 113.495 177.746 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.6 mp -83.19 143.3 30.57 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 122.401 1.096 . . . . 1.55 112.386 -169.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 24.1 ttt180 -118.88 95.93 5.03 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 127.258 2.223 . . . . 2.9500000000000002 108.511 -175.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 2.7 mt -110.14 138.31 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 CA-C-O 123.66 1.695 . . . . 0.34999999999999998 113.528 -168.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -137.76 127.09 24.71 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-N 111.116 -2.765 . . . . 1.97 108.494 -169.379 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 12.4 p -145.51 154.44 42.2 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.123 1.769 . . . . 0.28999999999999998 108.955 -173.026 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.2 p -160.94 173.24 15.57 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.475 -1.238 . . . . 0.56999999999999995 110.309 176.567 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.4 p -138.9 123.74 11.71 Favored Pre-proline 0 C--O 1.237 0.445 0 N-CA-C 112.649 0.611 . . . . 0.56999999999999995 112.649 -177.463 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo . . . . . 0 N--CA 1.448 -1.205 0 C-N-CA 122.934 2.422 . . . . 0.88 108.431 169.569 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 . . . . . 0 CA--C 1.542 0.667 0 CA-C-O 122.583 1.182 . . . . 2.6099999999999999 113.177 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 56.6 p -121.32 178.79 4.64 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.053 1.741 . . . . 0.62 110.022 169.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -70.08 -27.92 65.01 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.046 -1.033 . . . . 3.2599999999999998 111.491 160.726 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -71.79 -39.8 59.17 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 125.622 1.582 . . . . 0.38 114.105 -178.237 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.29 -44.18 43.87 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 119.449 1.625 . . . . 2.0 111.334 174.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 8.9 mt -68.52 -56.18 9.21 Favored 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 125.987 1.715 . . . . 0.35999999999999999 110.67 178.058 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.58 -46.65 77.22 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.235 1.014 . . . . 2.8999999999999999 111.555 -178.675 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.8 t -61.65 -48.01 90.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 107.972 -1.122 . . . . 0.41999999999999998 107.972 178.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 52.9 m -57.31 -43.97 83.73 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 118.645 0.657 . . . . 0.44 112.059 176.644 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -61.99 -28.81 69.83 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.339 1.456 . . . . 2.8500000000000001 113.262 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 64.4 mt -90.49 -29.19 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 124.532 1.133 . . . . 0.52000000000000002 111.702 173.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.6 mt -56.94 -36.69 70.54 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 120.321 -1.487 . . . . 0.77000000000000002 112.754 172.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 38.0 mttt -63.67 -17.33 62.84 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 115.004 1.483 . . . . 1.6499999999999999 115.004 177.138 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -106.56 -37.73 6.37 Favored 'General case' 0 N--CA 1.429 -1.508 0 C-N-CA 125.987 1.715 . . . . 1.9399999999999999 113.576 -172.221 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -77.34 -23.62 50.9 Favored 'General case' 0 N--CA 1.453 -0.311 0 O-C-N 123.538 0.524 . . . . 1.23 111.99 166.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -133.99 52.4 8.01 Favored Pre-proline 0 CA--C 1.546 0.795 0 N-CA-C 117.702 2.482 . . . . 1.55 117.702 -179.361 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -61.73 -22.68 74.94 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 123.585 2.857 . . . . 0.73999999999999999 113.547 166.601 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 19.1 mtm180 -67.91 -15.04 63.43 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 114.654 1.353 . . . . 7.5300000000000002 114.654 174.289 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.84 144.74 47.36 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 114.45 1.278 . . . . 0.47999999999999998 114.45 -164.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 65.3 p -96.27 -19.66 19.12 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.938 0.895 . . . . 0.51000000000000001 112.551 174.083 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -130.77 142.23 50.4 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.202 1.001 . . . . 0.32000000000000001 111.975 159.28 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.4 pt -155.5 111.4 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 126.662 1.985 . . . . 0.46999999999999997 111.359 172.572 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.6 ptpt -154.22 150.14 27.75 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.006 1.322 . . . . 1.1699999999999999 112.71 -178.46 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.4 t -131.88 143.25 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 C-N-CA 125.818 1.647 . . . . 0.37 110.512 -173.683 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 77.6 m -135.34 129.71 33.87 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.825 1.25 . . . . 0.34000000000000002 112.1 172.667 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -78.94 132.68 36.81 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.11 0.964 . . . . 1.76 110.457 170.176 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.7 pt -130.58 28.24 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 125.843 1.657 . . . . 0.56999999999999995 111.285 179.211 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 41.6 t -139.13 63.72 1.5 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 127.625 2.37 . . . . 1.3200000000000001 110.981 -176.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.98 -9.06 12.19 Favored Glycine 0 CA--C 1.54 1.641 0 N-CA-C 117.086 1.594 . . . . 1.1899999999999999 117.086 -176.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -115.9 3.67 20.98 Favored Glycine 0 CA--C 1.537 1.456 0 C-N-CA 126.363 1.935 . . . . 1.0600000000000001 115.331 179.278 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 37.0 t -155.32 -38.37 0.09 Allowed 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 118.631 1.215 . . . . 1.99 113.087 -176.492 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 64.58 36.45 93.17 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 127.026 2.251 . . . . 0.68999999999999995 113.754 -169.406 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -85.02 -23.05 28.81 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 114.007 1.114 . . . . 0.88 114.007 173.264 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 1.2 mpp? -112.82 140.41 47.63 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.176 0.99 . . . . 1.8500000000000001 113.56 -176.302 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -143.52 144.99 32.21 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 122.154 0.978 . . . . 1.8700000000000001 113.144 173.035 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -98.46 120.15 38.39 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.009 1.724 . . . . 2.52 109.653 169.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 68.2 mt -132.07 129.54 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 124.684 1.194 . . . . 1.0 109.833 -163.5 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 67.9 mttt -125.45 125.66 43.69 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.62 0.768 . . . . 2.5299999999999998 110.628 179.068 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.421 ' CD1' HG13 ' A' ' 84' ' ' VAL . 1.2 mt -129.49 157.95 42.14 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 127.589 2.356 . . . . 0.25 108.774 178.273 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 71.5 tt0 -157.14 128.61 6.95 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.774 1.63 . . . . 1.6499999999999999 108.325 168.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 9.1 t -162.54 147.74 12.31 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 120.301 1.41 . . . . 0.40999999999999998 114.05 -169.635 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -59.07 -24.6 63.04 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 126.049 1.74 . . . . 4.5499999999999998 113.929 -172.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -73.57 -16.18 61.26 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.56 1.544 . . . . 1.8 115.086 177.362 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -83.51 -2.59 56.31 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 114.509 1.3 . . . . 2.04 114.509 -171.599 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.401 ' HB3' HG21 ' A' ' 104' ' ' VAL . 21.2 pttm -69.75 -42.09 74.35 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 113.505 0.928 . . . . 2.8500000000000001 113.505 -178.084 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -91.58 41.44 1.07 Allowed 'General case' 0 CA--C 1.547 0.847 0 CA-C-O 123.018 1.389 . . . . 4.0899999999999999 111.143 -170.065 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.9 mmtp -146.31 142.49 28.35 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 128.225 2.61 . . . . 2.9199999999999999 109.572 -166.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.423 ' HG2' ' H ' ' A' ' 76' ' ' ARG . 10.7 mmt85 -64.39 166.91 7.54 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.697 1.199 . . . . 3.4199999999999999 110.583 158.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 55.0 m -53.19 -51.09 63.2 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 113.801 1.038 . . . . 0.71999999999999997 113.801 168.407 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 14.7 p -63.47 -34.67 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 112.616 0.598 . . . . 0.62 112.616 177.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -65.22 -44.98 86.53 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 118.117 -0.945 . . . . 2.6099999999999999 111.667 173.067 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -58.04 -51.42 69.73 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 119.291 0.95 . . . . 0.60999999999999999 110.202 174.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 40.0 m170 -56.08 -50.01 72.21 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 123.405 0.682 . . . . 0.46999999999999997 111.371 178.23 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 32.6 tp60 -53.07 -39.84 63.59 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.771 1.228 . . . . 1.53 112.875 -177.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 85.4 mtp -59.36 -47.11 86.67 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 119.752 1.16 . . . . 1.0900000000000001 111.973 177.274 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.421 HG13 ' CD1' ' A' ' 67' ' ' ILE . 5.7 t -70.21 -32.19 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 126.009 1.723 . . . . 0.23000000000000001 111.41 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -65.55 -52.29 53.52 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.128 1.771 . . . . 0.57999999999999996 109.942 173.386 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 8.2 tm0? -66.98 -26.44 66.81 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.328 1.051 . . . . 3.1499999999999999 113.161 -176.256 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -56.73 -39.09 73.32 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.712 1.605 . . . . 0.39000000000000001 112.27 -179.038 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.64 -0.57 10.21 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 114.315 1.228 . . . . 0.44 114.315 -178.342 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 25.6 ttpt -52.5 -33.26 44.19 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.549 1.139 . . . . 1.8899999999999999 112.805 175.355 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -81.81 -3.14 53.21 Favored 'General case' 0 CA--C 1.553 1.067 0 O-C-N 121.335 -0.853 . . . . 1.8999999999999999 112.564 -178.269 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -104.61 -54.76 2.46 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 127.496 2.318 . . . . 3.1800000000000002 111.435 169.551 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 32.6 mt -138.31 119.9 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 126.775 2.03 . . . . 0.94999999999999996 108.494 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 41.5 mtmt -90.97 -1.43 57.83 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 115.012 1.486 . . . . 2.7599999999999998 115.012 -169.686 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -81.58 58.61 3.78 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.379 1.872 . . . . 3.04 114.676 -158.143 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . 0.3 1.3 mpt? -75.28 9.52 2.04 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 119.779 -1.826 . . . . 1.79 115.477 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 13.7 p80 -65.01 -26.4 68.27 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.46 0.541 . . . . 3.96 112.46 153.134 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -94.77 -17.98 36.49 Favored Glycine 0 C--N 1.333 0.414 0 C-N-CA 126.455 1.979 . . . . 0.5 115.986 -175.613 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.8 mt -93.33 124.1 37.08 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 117.732 0.766 . . . . 2.1699999999999999 110.875 -165.597 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 22.0 ttt180 -110.14 89.13 2.93 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 126.363 1.865 . . . . 3.3199999999999998 107.347 -177.209 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 1.1 mt -108.69 139.99 29.05 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.565 0 CA-C-O 123.037 1.399 . . . . 0.46999999999999997 111.743 -163.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -131.5 121.08 23.89 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 111.777 -2.465 . . . . 1.98 108.115 -169.026 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 24.4 p -131.93 153.96 49.76 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 126.268 1.827 . . . . 0.28000000000000003 110.196 -179.059 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -160.49 179.76 8.34 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 126.114 1.766 . . . . 0.64000000000000001 109.135 171.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.401 HG21 ' HB3' ' A' ' 73' ' ' LYS . 3.7 p -136.73 135.91 20.91 Favored Pre-proline 0 N--CA 1.474 0.748 0 O-C-N 120.897 -1.127 . . . . 0.48999999999999999 111.98 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo . . . . . 0 C--N 1.351 0.676 0 C-N-CA 124.52 3.48 . . . . 0.81000000000000005 111.402 -179.262 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.8 mp0 . . . . . 0 N--CA 1.471 0.602 0 N-CA-C 114.439 1.274 . . . . 2.48 114.439 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 72.8 p -121.04 179.51 4.36 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 126.257 1.823 . . . . 0.53000000000000003 110.278 157.494 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.41 -32.7 71.87 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 120.941 -1.1 . . . . 3.6800000000000002 112.357 164.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.14 -38.4 96.47 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 125.183 1.373 . . . . 0.35999999999999999 112.949 174.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.71 -45.66 63.64 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.879 1.272 . . . . 1.49 112.369 176.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 13.1 mt -71.21 -49.87 38.98 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 125.008 1.323 . . . . 0.38 111.491 -178.607 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -54.26 -50.65 66.72 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 127.358 2.263 . . . . 3.9900000000000002 110.991 178.355 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.8 t -63.86 -45.68 96.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 108.312 -0.996 . . . . 0.25 108.312 178.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 51.6 m -55.7 -36.52 67.27 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.243 0.46 . . . . 0.34999999999999998 112.243 177.189 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -69.21 -43.47 74.03 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 114.123 1.157 . . . . 2.04 114.123 -178.326 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 26.7 mt -75.67 -28.29 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-N 118.689 0.677 . . . . 0.53000000000000003 110.403 -179.278 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 21.5 mt -55.75 -37.7 68.84 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.569 0.951 . . . . 0.40000000000000002 113.569 169.134 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 38.3 mttt -62.84 -32.92 74.24 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 118.563 0.62 . . . . 1.3999999999999999 112.561 179.516 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -90.57 -35.48 15.0 Favored 'General case' 0 N--CA 1.438 -1.054 0 C-N-CA 128.362 2.665 . . . . 2.25 114.779 -175.717 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -77.17 -17.43 58.56 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 120.159 -0.616 . . . . 1.3799999999999999 112.525 169.099 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -132.16 60.96 54.8 Favored Pre-proline 0 CA--C 1.551 1.017 0 N-CA-C 116.914 2.19 . . . . 2.1099999999999999 116.914 175.707 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -68.68 -24.09 35.49 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 124.658 3.572 . . . . 0.90000000000000002 114.759 170.152 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -80.27 0.13 34.05 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 114.495 1.295 . . . . 6.25 114.495 171.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.53 147.99 52.51 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 114.654 1.353 . . . . 0.52000000000000002 114.654 -175.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 25.8 p -103.82 -18.69 14.55 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.525 1.13 . . . . 0.56000000000000005 112.671 167.013 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -133.41 144.2 49.38 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 119.568 1.076 . . . . 0.40999999999999998 112.149 159.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.9 pt -157.04 110.51 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 127.425 2.29 . . . . 0.56000000000000005 110.815 171.014 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.5 ptpt -151.61 155.99 39.53 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.602 1.561 . . . . 1.1899999999999999 113.024 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.9 t -136.04 145.57 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 126.016 1.726 . . . . 0.34999999999999998 111.628 -172.518 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 94.3 m -138.82 126.67 22.24 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.233 0.613 . . . . 0.34999999999999998 111.695 172.44 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -71.51 126.82 30.66 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.787 0.803 . . . . 1.8200000000000001 110.451 168.572 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.2 pt -125.84 22.06 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 C-N-CA 125.524 1.529 . . . . 0.5 111.147 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.401 ' CB ' ' H ' ' A' ' 62' ' ' MET . 38.1 t -131.65 62.37 1.63 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 128.709 2.803 . . . . 1.3600000000000001 110.896 179.198 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.01 -10.1 18.16 Favored Glycine 0 CA--C 1.539 1.562 0 N-CA-C 117.261 1.664 . . . . 1.1499999999999999 117.261 -174.746 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -103.38 -19.62 12.17 Favored Glycine 0 N--CA 1.471 1.019 0 C-N-CA 126.534 2.016 . . . . 0.96999999999999997 115.28 179.054 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 33.1 m -145.34 -29.56 0.44 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.29 1.036 . . . . 2.5899999999999999 113.345 -163.579 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 60.42 41.41 98.55 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 128.201 2.81 . . . . 0.72999999999999998 113.735 -175.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -98.39 -16.86 19.12 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.265 1.826 . . . . 0.90000000000000002 112.955 -178.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.415 ' HG3' ' CA ' ' A' ' 97' ' ' GLY . 4.3 mpp? -117.8 141.49 48.35 Favored 'General case' 0 CA--C 1.52 -0.175 0 C-N-CA 126.627 1.971 . . . . 1.99 112.809 175.24 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -144.39 147.02 32.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.863 -1.062 . . . . 1.8500000000000001 111.241 171.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -83.7 137.24 33.86 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 125.185 1.394 . . . . 2.23 109.193 163.504 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 97.5 mt -133.72 129.16 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 123.869 0.868 . . . . 0.65000000000000002 109.345 170.541 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 70.0 mttt -124.56 116.97 23.31 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.673 1.189 . . . . 2.73 110.624 177.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.3 mt -122.29 162.62 21.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 C-N-CA 126.361 1.865 . . . . 0.46999999999999997 109.271 -177.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -156.67 131.32 8.83 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.696 1.999 . . . . 1.77 107.111 162.251 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.7 t -157.28 140.14 15.13 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 120.402 1.456 . . . . 0.34000000000000002 111.767 -173.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -58.26 -21.64 49.36 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.241 1.016 . . . . 3.4100000000000001 113.543 -178.485 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -71.01 -15.4 62.56 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 115.274 1.583 . . . . 1.8 115.274 179.288 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -88.0 10.26 19.58 Favored 'General case' 0 CA--C 1.553 1.068 0 N-CA-C 115.537 1.68 . . . . 1.6200000000000001 115.537 -171.696 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.58 ' HA ' HG11 ' A' ' 104' ' ' VAL . 14.9 pttt -63.07 -46.35 87.87 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 126.251 1.82 . . . . 2.3300000000000001 115.569 -165.626 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -100.69 -11.03 20.29 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.385 1.474 . . . . 4.4100000000000001 111.692 -168.69 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 32.9 mmtt -64.76 142.88 58.28 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 126.81 2.044 . . . . 1.52 112.561 174.483 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 16.6 mtt-85 -67.58 166.49 14.82 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 122.9 0.48 . . . . 3.2200000000000002 111.092 159.538 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.8 m -50.31 -50.56 50.32 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 113.873 1.064 . . . . 0.73999999999999999 113.873 172.643 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 10.4 p -62.71 -38.44 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 123.474 0.71 . . . . 0.67000000000000004 112.783 174.154 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -75.34 -19.79 59.41 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.736 0.643 . . . . 1.4299999999999999 112.736 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -70.34 -53.94 14.63 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.397 -0.814 . . . . 0.66000000000000003 109.807 163.311 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 49.7 m170 -53.05 -48.28 67.79 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.82 0.848 . . . . 0.66000000000000003 113.062 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 47.0 tp60 -47.79 -43.28 27.52 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.796 1.638 . . . . 1.1799999999999999 113.477 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 3.6 mtm -67.07 -39.82 86.91 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 118.93 0.786 . . . . 1.3100000000000001 111.768 -178.714 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.2 t -73.14 -33.83 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 125.616 1.567 . . . . 0.34999999999999998 110.644 179.387 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -63.42 -50.64 69.0 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.111 1.764 . . . . 0.45000000000000001 110.536 173.168 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 35.5 tp60 -66.05 -21.7 66.39 Favored 'General case' 0 N--CA 1.45 -0.474 0 O-C-N 119.849 -1.782 . . . . 2.3799999999999999 114.118 -178.024 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.17 -40.55 85.97 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.379 0.672 . . . . 0.44 111.589 177.214 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.66 3.78 9.54 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 115.372 1.619 . . . . 0.34999999999999998 115.372 -176.02 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 26.3 ttmt -43.8 -45.55 7.36 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 125.405 1.482 . . . . 1.9299999999999999 111.877 174.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -84.27 -6.0 59.34 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 113.225 0.824 . . . . 3.0499999999999998 113.225 -172.033 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -98.51 -56.15 2.54 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 127.226 2.211 . . . . 2.21 111.867 174.527 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 23.3 mt -132.96 92.61 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.57 1.548 . . . . 1.1799999999999999 107.76 176.488 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -69.8 -19.08 63.5 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 114.094 1.146 . . . . 2.6299999999999999 114.094 -172.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . 0.295 16.3 pt-20 -73.97 43.75 0.17 Allowed 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 116.359 1.985 . . . . 3.9700000000000002 116.359 -169.09 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 64.3 mtm -66.21 0.75 1.85 Allowed 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 126.52 1.928 . . . . 1.3600000000000001 116.023 -172.473 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 21.0 p-80 -61.6 -5.52 1.91 Allowed 'General case' 0 CA--C 1.55 0.959 0 N-CA-C 113.836 1.05 . . . . 4.8300000000000001 113.836 157.621 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.415 ' CA ' ' HG3' ' A' ' 62' ' ' MET . . . -104.17 -14.99 22.98 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 125.468 1.509 . . . . 0.40000000000000002 115.807 167.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.9 mp -89.68 124.97 35.06 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 118.904 1.352 . . . . 1.5600000000000001 111.753 -169.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 50.3 ttt180 -103.26 100.87 10.79 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 127.072 2.149 . . . . 3.1200000000000001 110.063 -178.225 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 5.4 mt -108.97 144.39 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-O 123.822 1.772 . . . . 0.45000000000000001 112.853 -170.706 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -136.89 135.93 38.25 Favored 'General case' 0 N--CA 1.433 -1.298 0 C-N-CA 128.944 2.897 . . . . 1.97 109.248 -175.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.4 p -145.66 157.7 43.93 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 126.792 2.037 . . . . 0.56000000000000005 108.176 -175.756 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -155.81 175.25 14.18 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 124.77 1.228 . . . . 0.71999999999999997 108.959 172.386 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.58 HG11 ' HA ' ' A' ' 73' ' ' LYS . 7.1 p -142.8 126.33 9.38 Favored Pre-proline 0 N--CA 1.467 0.395 0 O-C-N 121.386 -0.821 . . . . 0.48999999999999999 112.198 -179.531 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo . . . . . 0 N--CA 1.449 -1.116 0 C-N-CA 122.953 2.435 . . . . 0.68999999999999995 110.894 176.201 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 . . . . . 0 C--O 1.234 0.255 0 N-CA-C 113.103 0.779 . . . . 2.0800000000000001 113.103 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 58.7 p -102.02 176.46 5.19 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 126.115 1.766 . . . . 0.60999999999999999 111.674 177.614 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -67.72 -34.03 76.06 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 120.486 -1.384 . . . . 4.1299999999999999 112.115 164.298 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.4 -38.34 80.3 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 125.044 1.307 . . . . 0.46000000000000002 114.229 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.87 -48.66 66.96 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 118.926 1.363 . . . . 1.3899999999999999 112.551 -179.082 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 16.2 mt -70.11 -48.48 57.4 Favored 'General case' 0 CA--C 1.527 0.082 0 C-N-CA 125.375 1.47 . . . . 0.52000000000000002 110.822 -178.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -53.32 -51.18 63.2 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 127.584 2.354 . . . . 3.8799999999999999 111.319 179.251 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 39.3 t -62.83 -48.37 88.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 124.584 1.154 . . . . 0.23000000000000001 108.425 177.573 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 42.1 m -57.0 -38.78 73.56 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.303 0.483 . . . . 0.42999999999999999 112.303 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 -62.87 -41.22 99.3 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 112.395 0.517 . . . . 1.8500000000000001 112.395 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 69.5 mt -78.03 -30.23 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 123.377 0.671 . . . . 0.48999999999999999 111.317 -179.61 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 18.0 mt -55.33 -39.48 70.04 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 121.075 -1.015 . . . . 0.44 113.287 172.556 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 44.5 mttt -64.44 -26.36 68.41 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 113.459 0.911 . . . . 1.3200000000000001 113.459 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -90.46 -35.36 15.17 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 126.823 2.049 . . . . 2.25 114.926 -177.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -74.68 -22.7 58.72 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 119.05 -1.06 . . . . 2.23 111.788 168.165 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -130.95 55.54 19.65 Favored Pre-proline 0 CA--C 1.552 1.052 0 N-CA-C 116.817 2.154 . . . . 1.5900000000000001 116.817 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -68.31 -18.94 44.43 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 124.675 3.583 . . . . 0.79000000000000004 115.225 177.577 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -81.96 -9.93 59.42 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 121.069 -1.019 . . . . 4.8600000000000003 113.514 170.634 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.26 144.44 46.23 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 114.637 1.347 . . . . 0.53000000000000003 114.637 -173.03 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 74.1 p -95.42 -29.64 14.31 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.769 1.628 . . . . 0.63 111.05 175.16 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -126.71 141.74 51.75 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.711 1.205 . . . . 0.31 111.265 165.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.1 pt -158.69 104.01 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 127.546 2.338 . . . . 0.47999999999999998 109.434 174.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.0 ptpt -149.67 148.6 29.47 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.67 1.188 . . . . 1.3100000000000001 112.86 -177.628 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.2 t -133.26 147.08 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 126.285 1.834 . . . . 0.35999999999999999 111.246 -170.378 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 93.7 m -141.77 127.85 19.62 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 118.406 0.548 . . . . 0.34000000000000002 111.538 170.739 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -68.41 135.86 52.4 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 122.174 0.988 . . . . 1.8100000000000001 110.062 165.584 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . 0.255 1.6 pt -127.33 25.2 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.887 0 C-N-CA 125.647 1.579 . . . . 0.56000000000000005 111.082 177.506 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 11.3 p -143.34 53.75 1.35 Allowed 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 128.98 2.912 . . . . 2.1200000000000001 114.38 -171.467 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -55.98 -18.41 18.99 Favored Glycine 0 CA--C 1.546 2.022 0 O-C-N 120.403 -1.435 . . . . 1.3100000000000001 116.678 -177.05 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -96.29 -5.84 59.07 Favored Glycine 0 CA--C 1.541 1.693 0 CA-C-N 119.658 1.729 . . . . 1.0 116.132 176.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 11.9 t -147.27 -31.75 0.31 Allowed 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 119.275 1.538 . . . . 1.48 114.301 -173.322 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 58.68 34.82 78.54 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 129.093 3.235 . . . . 0.66000000000000003 114.361 -171.089 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -100.09 3.51 44.04 Favored 'General case' 0 CA--C 1.552 1.021 0 N-CA-C 115.223 1.564 . . . . 0.97999999999999998 115.223 -177.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 2.1 mtp -131.36 138.43 49.16 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 127.396 2.279 . . . . 1.5700000000000001 112.865 175.249 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -145.13 143.11 30.19 Favored 'General case' 0 C--O 1.227 -0.092 0 CA-C-O 122.645 1.212 . . . . 1.8500000000000001 113.933 174.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -82.09 133.0 35.25 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 125.09 1.356 . . . . 1.74 110.021 165.276 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 82.7 mt -133.65 127.08 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 CA-C-N 119.816 1.189 . . . . 0.56000000000000005 110.116 175.468 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 74.1 mttt -123.16 117.94 26.52 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.811 1.244 . . . . 2.5699999999999998 110.232 178.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.3 mt -122.71 160.77 24.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 126.305 1.842 . . . . 0.29999999999999999 109.046 -179.111 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -155.41 131.6 10.19 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 126.266 1.826 . . . . 1.9399999999999999 107.219 162.649 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.9 t -154.07 137.66 16.01 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 118.678 0.672 . . . . 0.29999999999999999 111.704 -177.061 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -55.11 -16.0 2.66 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 127.223 2.209 . . . . 4.2199999999999998 114.567 176.202 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -76.66 -21.81 54.92 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 114.021 1.119 . . . . 1.71 114.021 175.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -79.97 11.85 3.11 Favored 'General case' 0 CA--C 1.556 1.192 0 N-CA-C 115.446 1.647 . . . . 1.6499999999999999 115.446 -166.085 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.403 ' HA ' HG11 ' A' ' 104' ' ' VAL . 1.0 OUTLIER -75.74 -36.4 59.91 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 117.777 2.51 . . . . 2.4199999999999999 117.777 -163.293 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -80.75 -25.85 37.72 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 120.723 1.601 . . . . 5.3600000000000003 111.429 173.258 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 43.1 mmtt -65.95 133.89 51.81 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.67 1.188 . . . . 1.78 113.289 -173.273 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 46.2 mtt-85 -63.75 160.73 16.55 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 125.451 1.5 . . . . 3.5699999999999998 110.928 163.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 41.3 m -35.69 -57.77 0.64 Allowed 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 125.377 1.471 . . . . 0.69999999999999996 114.094 167.282 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.0 p -65.79 -39.54 85.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 125.29 1.436 . . . . 0.58999999999999997 112.674 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -70.21 -26.82 64.05 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 118.487 -0.768 . . . . 0.98999999999999999 112.907 177.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -70.25 -52.75 20.71 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 119.112 0.869 . . . . 0.79000000000000004 110.359 167.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 39.2 m170 -53.35 -49.18 67.66 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 118.911 0.778 . . . . 0.48999999999999999 112.553 -178.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 33.0 tp60 -48.99 -43.52 40.22 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.844 1.258 . . . . 1.3 113.097 177.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 86.3 mtp -59.89 -44.5 94.2 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 121.179 -0.951 . . . . 0.94999999999999996 112.026 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.1 t -73.17 -31.51 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 125.753 1.621 . . . . 0.22 111.608 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -67.51 -49.81 61.71 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 126.644 1.978 . . . . 0.46000000000000002 110.237 175.055 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 39.8 tp60 -69.27 -20.82 63.92 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 120.513 -1.367 . . . . 2.8300000000000001 113.708 -176.167 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.26 -46.87 88.31 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.253 1.421 . . . . 0.51000000000000001 111.658 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.28 -5.09 14.19 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.975 1.102 . . . . 0.38 113.975 -175.327 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 11.7 ttmt -47.72 -35.96 10.6 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.187 1.395 . . . . 2.8300000000000001 113.103 169.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -76.31 -0.16 21.49 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 114.294 1.22 . . . . 2.48 114.294 -178.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -120.27 -49.18 2.29 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 127.94 2.496 . . . . 3.2200000000000002 111.222 175.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 37.2 mt -138.76 118.9 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 127.136 2.174 . . . . 0.94999999999999996 107.224 176.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 37.2 mtpt -86.57 -10.93 52.93 Favored 'General case' 0 N--CA 1.478 0.973 0 O-C-N 120.455 -1.403 . . . . 2.4500000000000002 113.509 -175.198 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 -77.92 47.81 0.66 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 128.052 2.541 . . . . 3.48 115.688 -158.464 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 3.3 mpp? -65.24 1.97 0.93 Allowed 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 115.391 1.626 . . . . 1.6200000000000001 115.391 -178.653 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -64.49 -23.52 67.31 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 114.214 1.19 . . . . 3.48 114.214 160.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -90.21 -22.46 35.06 Favored Glycine 0 N--CA 1.475 1.256 0 C-N-CA 126.082 1.801 . . . . 0.53000000000000003 114.916 173.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.9 mp -85.51 145.45 27.39 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.165 0.986 . . . . 1.55 112.85 -169.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 -123.48 101.83 7.55 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 126.385 1.874 . . . . 3.75 109.73 176.287 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 2.3 mt -105.61 146.57 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 CA-C-O 123.515 1.626 . . . . 0.34999999999999998 113.619 -173.527 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -140.36 131.6 26.57 Favored 'General case' 0 N--CA 1.439 -1.004 0 C-N-CA 128.814 2.845 . . . . 1.8799999999999999 108.952 -172.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 19.6 p -146.55 148.71 32.43 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.756 2.022 . . . . 0.34999999999999998 109.489 -177.003 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.7 p -147.77 171.47 15.63 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.566 -1.197 . . . . 0.63 111.027 173.296 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.403 HG11 ' HA ' ' A' ' 73' ' ' LYS . 13.4 p -136.37 128.61 17.34 Favored Pre-proline 0 N--CA 1.47 0.55 0 C-N-CA 123.799 0.84 . . . . 0.48999999999999999 110.332 173.681 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo . . . . . 0 N--CA 1.457 -0.651 0 C-N-CA 121.966 1.777 . . . . 0.72999999999999998 109.751 176.961 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.1 mp0 . . . . . 0 N--CA 1.468 0.466 0 CA-C-O 121.669 0.747 . . . . 2.5299999999999998 111.39 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 30.6 p -129.14 173.06 10.81 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.98 1.712 . . . . 0.85999999999999999 109.32 161.592 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -72.34 -26.88 62.1 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 120.286 -1.509 . . . . 4.6500000000000004 111.19 177.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -66.51 -35.66 90.34 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 125.492 1.52 . . . . 0.40999999999999998 113.282 170.666 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.69 -50.77 42.46 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.187 1.395 . . . . 1.3700000000000001 111.563 173.71 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.8 mt -68.92 -48.81 62.38 Favored 'General case' 0 C--O 1.223 -0.292 0 C-N-CA 124.897 1.279 . . . . 0.42999999999999999 110.973 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.39 -47.2 69.7 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.792 1.237 . . . . 3.6299999999999999 111.416 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.3 t -67.74 -46.97 81.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 O-C-N 124.156 0.91 . . . . 0.47999999999999998 108.716 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 89.6 m -52.82 -44.48 66.72 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.463 0.705 . . . . 0.53000000000000003 112.005 175.482 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -62.42 -32.68 73.56 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.038 0.935 . . . . 2.9300000000000002 113.126 -177.487 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 35.2 mt -82.27 -35.5 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 CA-C-N 118.798 0.727 . . . . 0.53000000000000003 111.662 172.682 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 20.2 mt -53.74 -38.9 64.83 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 120.907 -1.121 . . . . 0.40000000000000002 113.488 175.561 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 40.7 mttt -76.29 -9.64 58.8 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 114.8 1.407 . . . . 1.8600000000000001 114.8 -178.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -90.26 -40.83 11.92 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 126.363 1.865 . . . . 3.02 113.214 167.006 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 65.0 mmtt -74.16 -30.12 62.1 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 119.1 -1.04 . . . . 1.29 111.777 177.428 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -132.98 53.15 10.13 Favored Pre-proline 0 CA--C 1.549 0.933 0 N-CA-C 117.285 2.328 . . . . 1.6599999999999999 117.285 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -61.58 -26.38 80.44 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 123.975 3.117 . . . . 1.3500000000000001 114.436 178.229 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 10.9 mmt180 -91.72 -3.79 55.83 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 114.344 1.238 . . . . 5.7599999999999998 114.344 -176.14 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -55.07 149.5 11.95 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.03 1.732 . . . . 0.59999999999999998 114.707 176.173 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 74.0 p -100.87 -9.88 21.2 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 126.172 1.789 . . . . 0.91000000000000003 112.878 178.1 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -135.39 141.94 45.58 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.121 0.968 . . . . 0.34000000000000002 110.52 150.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -154.19 108.14 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 C-N-CA 125.838 1.655 . . . . 0.73999999999999999 110.799 171.517 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.4 ptpt -154.9 156.63 36.46 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.042 1.337 . . . . 1.1299999999999999 113.11 176.801 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 25.3 t -122.34 151.65 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 127.37 2.268 . . . . 0.48999999999999999 109.458 177.56 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 63.3 m -138.26 116.65 11.97 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 109.682 -0.488 . . . . 0.66000000000000003 109.682 168.11 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -65.58 133.02 50.3 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 122.18 0.991 . . . . 2.1200000000000001 109.11 166.655 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.1 pt -126.59 32.23 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 124.721 1.208 . . . . 0.60999999999999999 109.533 178.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.6 t -146.6 45.83 1.2 Allowed 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 126.793 2.037 . . . . 1.27 113.257 -169.247 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -49.59 -31.89 15.56 Favored Glycine 0 CA--C 1.543 1.802 0 O-C-N 120.112 -1.618 . . . . 1.4299999999999999 115.887 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -77.18 -12.81 84.26 Favored Glycine 0 CA--C 1.541 1.673 0 N-CA-C 116.248 1.259 . . . . 1.49 116.248 176.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 4.7 t -147.75 -44.14 0.17 Allowed 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 119.891 1.845 . . . . 1.51 114.384 -173.229 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 73.97 47.73 18.21 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 128.921 3.153 . . . . 0.93000000000000005 112.434 -168.534 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -96.05 -29.64 14.0 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.545 1.538 . . . . 1.1899999999999999 114.252 174.665 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -113.09 142.13 46.09 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 125.267 1.427 . . . . 1.8700000000000001 113.811 -177.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -143.2 142.42 31.41 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 122.282 1.039 . . . . 1.8799999999999999 112.824 172.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -83.58 139.98 32.52 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 125.862 1.665 . . . . 2.3199999999999998 109.529 163.277 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 90.4 mt -135.94 129.59 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-N 119.335 0.97 . . . . 0.67000000000000004 109.185 172.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 77.4 mttt -126.27 113.73 17.34 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.708 1.203 . . . . 2.73 109.768 -177.769 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.2 mt -125.11 157.82 33.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 126.333 1.853 . . . . 0.23000000000000001 109.109 -178.297 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 48.2 tt0 -157.76 129.34 6.83 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 126.103 1.761 . . . . 1.8400000000000001 107.415 167.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 18.2 t -160.14 145.28 14.97 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 120.131 1.332 . . . . 0.34999999999999998 113.091 -171.647 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -59.42 -16.9 26.35 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.964 2.105 . . . . 3.6899999999999999 114.583 -176.594 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -77.36 -20.21 55.14 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.733 1.613 . . . . 1.73 115.03 173.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -80.72 5.67 15.08 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 114.861 1.43 . . . . 1.6699999999999999 114.861 -167.246 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 22.8 pttt -73.33 -49.64 26.34 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 114.7 1.37 . . . . 2.9700000000000002 114.7 -171.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . 0.278 15.2 pm0 -80.89 25.35 0.45 Allowed 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 119.658 1.117 . . . . 4.0800000000000001 113.855 -177.336 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 42.1 mmtt -119.03 141.39 48.75 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 127.393 2.277 . . . . 1.23 110.854 -177.569 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 40.1 mtt180 -67.82 166.15 16.05 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 123.003 0.521 . . . . 3.5499999999999998 111.213 158.63 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 52.6 m -47.4 -53.35 14.18 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 114.384 1.253 . . . . 0.79000000000000004 114.384 170.739 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 13.6 p -61.11 -37.81 78.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 123.215 0.606 . . . . 0.63 112.594 175.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -74.45 -27.59 60.66 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 118.53 -0.748 . . . . 1.1399999999999999 112.553 179.469 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -64.28 -56.02 17.45 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.279 1.032 . . . . 0.65000000000000002 109.872 166.548 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 35.7 m170 -53.0 -48.33 67.59 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.703 0.801 . . . . 0.48999999999999999 112.255 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 30.8 tp60 -52.64 -40.54 62.9 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.471 1.108 . . . . 1.3799999999999999 113.221 178.278 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -63.67 -37.65 88.15 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 120.3 1.409 . . . . 1.0 111.221 179.449 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.3 t -76.76 -31.08 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 125.192 1.397 . . . . 0.26000000000000001 111.689 179.107 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -67.63 -48.07 67.77 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.597 1.559 . . . . 0.46999999999999997 110.195 173.775 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -61.55 -27.53 68.68 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 120.713 -1.242 . . . . 3.6200000000000001 113.202 178.633 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.64 -35.74 74.99 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.614 1.165 . . . . 0.37 112.399 -177.189 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.18 -3.03 8.53 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 113.927 1.084 . . . . 0.42999999999999999 113.927 -178.177 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 26.1 ttpt -49.26 -37.63 24.14 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.141 1.376 . . . . 2.79 112.82 177.385 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -78.13 -12.64 60.01 Favored 'General case' 0 CA--C 1.552 1.043 0 CA-C-O 121.68 0.753 . . . . 2.6200000000000001 111.863 -173.168 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -109.56 -51.04 2.92 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 128.98 2.912 . . . . 3.1400000000000001 110.681 -171.639 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.3 mm -129.68 123.62 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 127.851 2.46 . . . . 1.3799999999999999 106.579 164.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -97.01 -9.21 28.64 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 119.873 -1.767 . . . . 3.23 114.876 -178.372 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -81.94 50.77 1.61 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 127.631 2.372 . . . . 2.7599999999999998 114.356 -166.134 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 5.2 mpp? -64.92 -2.21 2.49 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 114.998 1.481 . . . . 1.3100000000000001 114.998 -175.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 19.4 p-80 -63.79 -14.87 56.51 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 114.28 1.215 . . . . 4.6299999999999999 114.28 165.485 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -92.75 -17.55 44.26 Favored Glycine 0 CA--C 1.537 1.431 0 O-C-N 121.13 -0.981 . . . . 0.54000000000000004 114.451 167.298 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.8 mp -89.07 146.49 24.8 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 121.283 -1.127 . . . . 1.5900000000000001 112.685 -170.495 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 21.3 ttt85 -131.63 99.6 4.85 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.853 2.061 . . . . 3.1299999999999999 110.049 -173.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 4.0 mt -107.96 145.82 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 CA-C-O 123.461 1.6 . . . . 0.46999999999999997 113.943 -169.294 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -135.31 127.89 30.74 Favored 'General case' 0 N--CA 1.438 -1.051 0 C-N-CA 128.446 2.698 . . . . 1.8600000000000001 107.975 -171.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 23.7 p -143.28 160.61 40.18 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 126.466 1.907 . . . . 0.34000000000000002 110.207 -175.074 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -171.28 175.69 4.14 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 124.953 1.301 . . . . 0.64000000000000001 109.735 179.139 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.5 p -136.68 135.66 20.67 Favored Pre-proline 0 N--CA 1.471 0.581 0 C-N-CA 123.855 0.862 . . . . 0.44 110.936 175.508 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo . . . . . 0 N--CA 1.458 -0.594 0 C-N-CA 123.561 2.84 . . . . 0.67000000000000004 109.584 173.356 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 18.0 mp0 . . . . . 0 N--CA 1.476 0.843 0 N-CA-C 115.734 1.753 . . . . 2.3199999999999998 115.734 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 80.9 p -103.42 169.98 8.22 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.054 0.942 . . . . 0.58999999999999997 109.309 150.72 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -70.81 -21.74 62.43 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 120.844 -1.16 . . . . 2.8999999999999999 112.662 169.169 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.21 -41.62 96.76 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 125.533 1.54 . . . . 0.44 113.264 169.079 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.68 -47.81 29.4 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.769 1.627 . . . . 1.27 111.708 172.567 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.4 mt -68.46 -50.68 50.71 Favored 'General case' 0 C--O 1.231 0.095 0 C-N-CA 125.456 1.502 . . . . 0.38 111.444 -178.698 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -57.83 -49.74 75.63 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 126.119 1.768 . . . . 4.3200000000000003 111.145 -179.251 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 36.3 t -60.59 -47.54 92.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 108.223 -1.029 . . . . 0.26000000000000001 108.223 176.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 88.8 m -57.1 -37.58 72.15 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 112.539 0.57 . . . . 0.42999999999999999 112.539 178.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 7.9 mm-40 -64.47 -41.64 96.39 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 113.178 0.807 . . . . 2.0800000000000001 113.178 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 27.7 mt -76.04 -29.83 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-N 118.195 0.452 . . . . 0.65000000000000002 110.561 177.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 23.5 mt -57.42 -39.13 75.53 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 120.865 -1.147 . . . . 0.40000000000000002 113.594 170.406 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 39.5 mttt -64.45 -17.96 64.31 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 113.935 1.087 . . . . 1.45 113.935 177.411 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -104.36 -35.56 7.9 Favored 'General case' 0 N--CA 1.433 -1.325 0 C-N-CA 126.894 2.078 . . . . 1.8600000000000001 114.021 -177.28 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -74.15 -23.33 59.25 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 119.607 -0.837 . . . . 1.2 111.777 167.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -132.86 51.4 7.0 Favored Pre-proline 0 CA--C 1.548 0.871 0 N-CA-C 117.748 2.499 . . . . 2.0699999999999998 117.748 -178.728 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -64.82 -24.76 61.03 Favored 'Trans proline' 0 C--O 1.238 0.489 0 C-N-CA 123.89 3.06 . . . . 0.76000000000000001 114.352 174.589 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 15.5 mmp_? -76.94 -1.08 26.76 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.593 0.96 . . . . 5.7599999999999998 113.593 173.706 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.15 154.55 30.81 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 115.176 1.547 . . . . 0.45000000000000001 115.176 177.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 70.6 p -107.96 -27.81 9.96 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.022 1.329 . . . . 0.68000000000000005 112.568 165.631 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -117.67 133.73 55.64 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.745 0.818 . . . . 0.42999999999999999 111.14 163.139 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.3 pt -152.63 99.44 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 125.955 1.702 . . . . 0.53000000000000003 109.689 169.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.2 ptpt -146.67 149.05 32.71 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.194 1.398 . . . . 1.1499999999999999 111.809 -176.625 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.5 t -133.71 152.31 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 125.947 1.699 . . . . 0.39000000000000001 110.221 -172.525 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 81.4 m -141.56 135.29 29.94 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.356 0.663 . . . . 0.45000000000000001 110.607 167.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -75.86 130.28 38.31 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 122.108 0.956 . . . . 2.0600000000000001 110.315 166.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . 0.273 3.7 pt -123.0 29.1 2.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 125.533 1.533 . . . . 0.47999999999999998 110.33 177.067 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.1 p -135.17 62.85 1.63 Allowed 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 127.897 2.479 . . . . 2.1699999999999999 114.005 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.36 2.27 1.71 Allowed Glycine 0 CA--C 1.539 1.562 0 N-CA-C 117.252 1.661 . . . . 1.3 117.252 178.748 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -122.73 -5.6 8.26 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-N 119.84 1.82 . . . . 0.93000000000000005 115.943 172.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 1.7 m -151.79 -18.68 0.19 Allowed 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 115.066 1.506 . . . . 2.1200000000000001 115.066 -175.112 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 52.53 43.96 59.08 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 126.254 1.883 . . . . 0.80000000000000004 114.209 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -112.55 2.68 16.37 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 125.303 1.441 . . . . 1.1399999999999999 114.097 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 13.9 ttm -132.85 120.92 22.18 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 128.93 2.892 . . . . 1.8300000000000001 109.498 -166.412 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -140.95 143.95 34.85 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.709 0.766 . . . . 1.8300000000000001 112.824 -175.646 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -82.75 135.59 34.95 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 125.217 1.407 . . . . 2.5699999999999998 108.985 164.026 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 88.3 mt -135.93 127.71 44.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-N 119.457 1.026 . . . . 0.54000000000000004 110.081 172.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -121.01 114.2 21.17 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.9 1.28 . . . . 2.5299999999999998 109.923 176.413 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.446 ' CD1' HG13 ' A' ' 84' ' ' VAL . 1.2 mt -121.55 153.37 25.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 126.011 1.724 . . . . 0.34999999999999998 108.99 179.336 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -157.58 124.13 4.92 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 125.132 1.373 . . . . 1.8600000000000001 107.711 168.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 43.2 t -153.95 144.32 22.25 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.723 1.147 . . . . 0.40000000000000002 113.02 -169.518 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -55.88 -21.88 22.54 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.78 1.632 . . . . 3.73 114.589 -178.211 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -75.52 -21.71 57.75 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 113.692 0.997 . . . . 1.78 113.692 177.036 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -77.67 13.29 1.34 Allowed 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 114.111 1.152 . . . . 2.02 114.111 -167.004 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -83.49 -43.1 16.14 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.888 0.699 . . . . 2.2200000000000002 112.888 -176.581 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -83.12 46.24 1.1 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 125.332 1.453 . . . . 3.4199999999999999 110.765 179.231 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 54.0 mmtt -148.04 144.17 27.72 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 128.316 2.647 . . . . 1.6799999999999999 111.82 -176.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 17.6 mtt85 -70.05 171.12 10.08 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.17 0.988 . . . . 3.8999999999999999 111.341 155.525 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 87.3 m -57.98 -48.26 80.51 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 113.758 1.021 . . . . 1.2 113.758 174.45 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 13.6 p -59.72 -37.3 70.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 O-C-N 121.805 -0.56 . . . . 0.62 112.186 172.441 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -74.55 -26.38 59.92 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 118.609 -0.71 . . . . 1.0 111.996 179.136 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -64.79 -54.09 36.78 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.712 1.142 . . . . 0.73999999999999999 109.911 165.18 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 37.2 m170 -54.29 -49.14 70.3 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.256 1.023 . . . . 0.68999999999999995 113.307 -178.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 56.5 tp60 -48.54 -43.3 35.3 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.667 1.987 . . . . 1.4399999999999999 113.528 177.821 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 83.2 mtp -63.28 -46.39 86.99 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.681 0.792 . . . . 0.98999999999999999 111.648 179.453 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.446 HG13 ' CD1' ' A' ' 67' ' ' ILE . 2.9 t -66.5 -30.99 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 125.191 1.396 . . . . 0.40999999999999998 111.383 178.119 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -68.37 -54.45 17.19 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.161 1.785 . . . . 0.51000000000000001 110.726 175.196 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.7 -22.12 66.59 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.678 0.791 . . . . 2.96 112.973 -178.077 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.06 -41.1 78.12 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 125.482 1.513 . . . . 0.44 112.608 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.22 2.24 9.18 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 114.646 1.35 . . . . 0.33000000000000002 114.646 -176.533 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 11.7 ttpp -51.65 -37.61 51.17 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 124.819 1.248 . . . . 2.8900000000000001 112.131 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -83.21 -7.11 59.66 Favored 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 113.392 0.886 . . . . 2.02 113.392 -175.661 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -98.21 -51.1 4.11 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 127.027 2.131 . . . . 3.4100000000000001 110.917 174.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 21.4 mt -143.21 104.57 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 126.585 1.954 . . . . 0.95999999999999996 107.642 176.747 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -79.01 -2.09 38.63 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 115.313 1.597 . . . . 2.3100000000000001 115.313 -174.311 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -74.26 36.69 0.1 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 129.335 3.054 . . . . 3.9500000000000002 116.046 -165.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 5.6 mpp? -63.13 1.89 0.41 Allowed 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 116.053 1.871 . . . . 1.27 116.053 -176.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 7.6 p80 -58.16 -29.46 65.62 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 120.602 -1.311 . . . . 3.6800000000000002 112.036 156.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -78.58 -29.81 51.15 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 126.496 1.998 . . . . 0.40000000000000002 115.595 176.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.2 mp -91.33 122.17 33.71 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.368 -1.077 . . . . 1.6200000000000001 113.07 -158.006 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 47.1 ttt180 -99.1 100.73 11.91 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 127.386 2.274 . . . . 3.2799999999999998 109.785 -179.179 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 2.1 mt -108.04 143.06 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 CA-C-O 123.18 1.467 . . . . 0.59999999999999998 113.506 -170.267 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -133.97 123.27 24.34 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 128.277 2.631 . . . . 1.9199999999999999 108.49 -173.481 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 33.3 p -137.68 156.29 48.19 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 125.62 1.568 . . . . 0.53000000000000003 112.158 -176.714 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.1 p -167.09 177.31 6.32 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.651 1.58 . . . . 0.64000000000000001 110.476 178.674 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.5 p -136.87 132.0 18.22 Favored Pre-proline 0 N--CA 1.479 1.01 0 O-C-N 121.033 -1.042 . . . . 0.52000000000000002 111.328 175.343 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo . . . . . 0 N--CA 1.457 -0.62 0 C-N-CA 123.11 2.54 . . . . 1.25 111.379 -176.568 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 14.0 mp0 . . . . . 0 CA--C 1.542 0.65 0 N-CA-C 114.796 1.406 . . . . 3.5800000000000001 114.796 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 33.8 p -118.83 171.88 7.91 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.688 1.595 . . . . 0.60999999999999999 111.375 166.262 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -64.04 -32.96 74.69 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 121.474 -0.766 . . . . 2.98 111.106 169.462 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.92 -34.6 71.42 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 124.902 1.239 . . . . 0.46999999999999997 113.821 179.713 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.19 -47.32 54.67 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.133 1.373 . . . . 1.26 111.634 173.907 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 12.3 mt -68.07 -49.99 57.87 Favored 'General case' 0 CA--C 1.523 -0.095 0 C-N-CA 124.94 1.296 . . . . 0.58999999999999997 111.064 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -57.99 -46.74 84.71 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.218 1.407 . . . . 6.2400000000000002 111.227 -179.487 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.441 HG13 ' HG ' ' A' ' 88' ' ' LEU . 39.5 t -61.91 -46.44 96.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 108.108 -1.071 . . . . 0.35999999999999999 108.108 177.728 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 29.8 m -57.89 -35.92 71.68 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 112.693 0.627 . . . . 0.54000000000000004 112.693 177.552 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -67.32 -44.57 78.81 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 113.112 0.782 . . . . 2.02 113.112 179.507 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 28.7 mt -74.89 -28.23 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-N 118.652 0.66 . . . . 0.53000000000000003 110.555 -179.552 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 23.6 mt -58.52 -36.81 74.4 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 120.945 -1.097 . . . . 0.39000000000000001 113.448 170.28 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 58.0 mttt -58.42 -31.96 68.22 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 113.055 0.761 . . . . 1.8300000000000001 113.055 175.062 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -95.67 -34.59 11.9 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 127.069 2.148 . . . . 2.1000000000000001 114.213 -172.11 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -77.73 -20.67 53.11 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 120.11 -0.636 . . . . 1.1399999999999999 112.468 168.318 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -130.38 52.14 8.86 Favored Pre-proline 0 CA--C 1.55 0.972 0 N-CA-C 118.052 2.612 . . . . 1.54 118.052 178.567 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -63.51 -22.28 70.89 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.966 3.111 . . . . 0.78000000000000003 114.409 174.824 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 21.8 mmt180 -87.48 -1.58 58.03 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 113.889 1.07 . . . . 5.04 113.889 177.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.37 151.82 46.34 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.897 1.279 . . . . 0.68000000000000005 113.731 178.275 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 81.8 p -113.23 -9.0 13.5 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.594 1.558 . . . . 0.92000000000000004 113.527 174.297 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -135.37 142.65 45.77 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 120.028 1.285 . . . . 0.55000000000000004 111.107 153.008 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.4 pt -151.29 120.07 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 125.492 1.517 . . . . 0.52000000000000002 111.959 170.018 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -159.2 158.6 32.99 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.386 1.475 . . . . 2.04 113.247 178.904 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.0 t -138.74 150.96 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 126.364 1.866 . . . . 0.29999999999999999 109.952 -174.229 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 55.0 m -140.88 125.78 18.19 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 118.58 0.627 . . . . 0.40000000000000002 109.865 168.803 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -69.68 130.17 41.62 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 121.53 -0.731 . . . . 2.5299999999999998 109.273 167.053 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.9 pt -127.36 32.85 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 125.562 1.545 . . . . 0.53000000000000003 110.485 178.567 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.455 ' HB2' ' H ' ' A' ' 62' ' ' MET . 44.8 t -138.91 69.67 1.37 Allowed 'General case' 0 C--N 1.343 0.307 0 C-N-CA 127.938 2.495 . . . . 1.27 111.209 -177.302 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -42.47 -36.67 2.32 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 126.16 1.838 . . . . 1.3400000000000001 116.129 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -100.02 -14.27 34.29 Favored Glycine 0 CA--C 1.539 1.539 0 N-CA-C 115.981 1.153 . . . . 1.5 115.981 -173.768 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 8.2 t -138.12 -29.08 0.84 Allowed 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 119.18 1.49 . . . . 2.1600000000000001 114.484 -174.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 55.86 47.68 77.49 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 124.263 0.935 . . . . 0.70999999999999996 112.22 -161.803 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -93.39 -25.52 17.65 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.948 1.299 . . . . 0.77000000000000002 113.175 173.655 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.455 ' H ' ' HB2' ' A' ' 56' ' ' SER . 23.0 mtm -106.02 135.16 47.97 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 125.268 1.427 . . . . 1.29 111.776 172.624 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -138.13 143.51 40.39 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 121.959 0.885 . . . . 1.8899999999999999 112.179 169.255 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -81.08 139.08 35.89 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 125.931 1.692 . . . . 2.3900000000000001 109.156 162.044 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 93.6 mt -137.39 129.05 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 CA-C-N 119.68 1.127 . . . . 0.64000000000000001 110.018 171.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 79.7 mttt -123.08 117.38 25.28 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.814 1.246 . . . . 2.5299999999999998 109.858 177.306 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.2 mt -126.1 157.06 36.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 126.371 1.868 . . . . 0.29999999999999999 109.338 -179.241 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -154.6 126.11 7.45 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 120.441 -1.412 . . . . 2.1699999999999999 108.326 170.081 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 17.8 t -157.31 146.41 19.96 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-N 119.637 1.108 . . . . 0.35999999999999999 112.937 -172.089 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -57.7 -26.21 61.41 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 126.389 1.876 . . . . 4.04 112.653 -177.375 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -73.08 -11.95 60.73 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.714 1.606 . . . . 1.8799999999999999 114.96 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -91.2 6.09 46.49 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 116.408 2.003 . . . . 1.97 116.408 -171.275 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.47 -37.3 63.26 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 115.84 1.793 . . . . 2.5600000000000001 115.84 -172.52 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -87.36 28.36 0.97 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 124.739 1.216 . . . . 4.1200000000000001 112.669 -177.704 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 55.6 mmtt -131.08 132.99 45.26 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.929 1.292 . . . . 1.8400000000000001 113.335 -164.163 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 23.9 mtt85 -65.09 169.83 5.08 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.889 1.276 . . . . 3.7400000000000002 110.971 164.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 27.5 m -51.53 -53.86 33.33 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 113.384 0.883 . . . . 0.97999999999999998 113.384 174.249 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.4 p -61.61 -38.05 79.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 123.377 0.671 . . . . 0.60999999999999999 111.569 175.591 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -75.04 -20.67 59.47 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 113.727 1.01 . . . . 1.2 113.727 -178.135 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -75.13 -55.35 5.82 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 119.054 0.843 . . . . 0.70999999999999996 110.116 164.706 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 40.8 m170 -56.42 -46.45 80.22 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.912 0.885 . . . . 0.78000000000000003 113.24 -175.236 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 29.7 tp60 -47.88 -41.79 25.17 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.287 1.435 . . . . 1.25 113.088 177.627 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 3.7 mtm -64.17 -40.68 96.63 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 121.491 -0.756 . . . . 1.1599999999999999 111.668 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.8 t -75.78 -23.99 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 126.07 1.748 . . . . 0.23999999999999999 111.235 179.565 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -76.16 -48.44 20.53 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.911 1.684 . . . . 0.45000000000000001 109.273 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 19.5 mm-40 -65.74 -23.68 66.79 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.622 1.169 . . . . 2.52 114.081 178.547 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.49 -38.49 84.47 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.119 0.968 . . . . 0.38 112.688 -177.009 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.441 ' HG ' HG13 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -121.22 3.41 10.36 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 114.605 1.335 . . . . 0.5 114.605 -178.58 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.9 ttmt -53.25 -39.94 64.23 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.674 1.189 . . . . 2.98 112.576 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -82.47 -5.83 58.93 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 123.311 0.644 . . . . 2.1400000000000001 112.629 -175.8 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -95.83 -49.16 5.44 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 127.412 2.285 . . . . 2.77 111.592 167.682 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 21.2 mt -148.38 110.36 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 128.133 2.573 . . . . 1.0800000000000001 109.024 178.591 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt -85.52 0.38 52.58 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 117.852 2.538 . . . . 4.0099999999999998 117.852 -173.226 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -77.19 48.42 0.62 Allowed 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 129.557 3.143 . . . . 2.8599999999999999 115.845 -160.354 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . 0.267 1.4 mpt? -70.63 3.51 3.07 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 119.709 -1.869 . . . . 1.9099999999999999 115.42 -177.774 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 17.5 p-80 -66.92 -13.62 61.94 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 114.491 1.293 . . . . 4.4000000000000004 114.491 156.006 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -108.64 -25.39 5.74 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 125.914 1.721 . . . . 0.48999999999999999 115.103 171.594 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.2 mp -78.27 141.25 38.67 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 121.009 -1.289 . . . . 1.54 113.577 -174.052 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 34.8 ttt180 -125.9 101.76 6.97 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 127.316 2.246 . . . . 3.1600000000000001 109.933 -177.476 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 4.0 mt -108.21 149.77 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-O 123.59 1.662 . . . . 0.44 113.593 -171.405 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -139.77 119.56 13.35 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 111.356 -2.657 . . . . 1.8799999999999999 108.631 -171.355 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.8 p -136.85 145.02 43.92 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 125.285 1.434 . . . . 0.40999999999999998 111.253 -177.314 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.8 p -148.08 178.58 8.42 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.283 -1.326 . . . . 0.76000000000000001 111.404 176.707 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 6.8 p -145.0 135.82 12.25 Favored Pre-proline 0 N--CA 1.47 0.575 0 O-C-N 121.759 -0.588 . . . . 0.56000000000000005 112.385 -178.577 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo . . . . . 0 N--CA 1.454 -0.8 0 C-N-CA 123.298 2.665 . . . . 0.76000000000000001 110.999 176.654 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 . . . . . 0 N--CA 1.469 0.504 0 CA-C-O 121.542 0.687 . . . . 2.27 111.304 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 70.1 p -100.4 -178.89 3.94 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 126.069 1.748 . . . . 0.81999999999999995 110.13 160.368 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -73.24 -25.71 60.83 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 120.264 -1.522 . . . . 2.8799999999999999 112.208 160.109 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.73 -40.27 98.56 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 125.453 1.501 . . . . 0.48999999999999999 113.244 173.008 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -52.22 -42.19 63.37 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.588 1.555 . . . . 1.24 113.016 177.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 14.0 mt -75.06 -48.44 23.9 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 126.543 1.937 . . . . 0.46000000000000002 110.549 -179.409 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -53.81 -49.09 69.12 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.333 1.453 . . . . 2.9399999999999999 111.149 175.629 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 29.8 t -62.46 -52.04 64.79 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 C-N-CA 125.457 1.503 . . . . 0.34999999999999998 107.576 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 99.3 m -52.24 -43.13 64.15 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.479 0.712 . . . . 0.41999999999999998 111.848 178.036 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -65.33 -42.21 93.15 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 118.267 -0.873 . . . . 2.1899999999999999 112.406 -178.766 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 38.6 mt -72.4 -32.0 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 CA-C-N 119.754 1.161 . . . . 0.45000000000000001 110.494 178.076 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 20.6 mt -54.36 -44.06 71.87 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 121.344 -0.848 . . . . 0.41999999999999998 112.904 173.169 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 34.9 mttt -65.91 -23.88 66.72 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 113.69 0.996 . . . . 2.1499999999999999 113.69 -178.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -93.03 -33.83 13.95 Favored 'General case' 0 N--CA 1.435 -1.211 0 C-N-CA 126.694 1.998 . . . . 2.3399999999999999 114.357 -177.14 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -75.64 -21.43 57.71 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 120.292 -0.563 . . . . 1.1299999999999999 111.947 166.117 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -131.12 58.2 37.16 Favored Pre-proline 0 CA--C 1.549 0.927 0 N-CA-C 117.254 2.316 . . . . 1.6200000000000001 117.254 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -67.18 -13.38 39.43 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 124.241 3.294 . . . . 1.1100000000000001 114.428 168.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.97 -12.72 60.19 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 115.274 1.583 . . . . 7.5599999999999996 115.274 171.717 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.94 153.79 42.69 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 116.37 1.989 . . . . 0.65000000000000002 116.37 -162.782 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 39.8 p -107.83 -25.28 11.31 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.521 1.528 . . . . 0.56000000000000005 112.466 166.693 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -125.9 141.24 52.07 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.297 0.953 . . . . 0.40000000000000002 111.62 164.143 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.2 pt -157.4 112.06 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 126.589 1.956 . . . . 0.81999999999999995 109.598 174.555 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.8 ptpt -153.38 149.9 28.3 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.239 1.416 . . . . 1.5800000000000001 112.221 -177.514 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.5 t -133.63 151.58 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 126.081 1.753 . . . . 0.46000000000000002 110.574 -176.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 88.0 m -146.6 122.73 10.82 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 121.046 -1.034 . . . . 0.35999999999999999 111.903 167.027 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -65.94 129.04 38.42 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.634 0.731 . . . . 1.99 109.314 162.102 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.9 pt -129.26 28.62 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 C-N-CA 126.364 1.865 . . . . 0.53000000000000003 110.009 179.166 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.5 t -132.99 59.25 1.74 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 127.547 2.339 . . . . 1.22 112.271 -165.293 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -66.5 14.33 0.36 Allowed Glycine 0 CA--C 1.539 1.562 0 C-N-CA 126.126 1.822 . . . . 1.8200000000000001 117.295 -175.236 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -154.07 16.99 0.61 Allowed Glycine 0 CA--C 1.533 1.171 0 C-N-CA 125.568 1.556 . . . . 1.8200000000000001 113.853 -177.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.6 t -161.52 -27.88 0.05 Allowed 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.363 1.465 . . . . 1.8600000000000001 112.49 177.628 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 54.47 40.53 69.65 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 125.642 1.591 . . . . 0.78000000000000003 113.898 -171.807 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -109.96 -37.07 5.71 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 127.372 2.269 . . . . 1.2 113.959 -176.167 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 30.0 mtm -84.03 130.94 34.86 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 124.283 1.033 . . . . 1.3400000000000001 110.669 175.84 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -141.32 141.87 33.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 122.147 0.975 . . . . 1.8400000000000001 112.313 172.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -81.23 137.22 35.87 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 124.905 1.282 . . . . 1.97 109.748 162.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.9 mt -136.76 131.94 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 108.213 -1.032 . . . . 0.63 108.213 171.596 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 8.0 tmtm? -128.42 128.61 44.78 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 118.992 0.815 . . . . 7.54 112.095 169.391 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.2 mt -124.51 162.44 26.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 125.772 1.629 . . . . 0.28999999999999998 108.869 -179.674 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -156.7 131.14 8.69 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 126.652 1.981 . . . . 2.0800000000000001 106.829 164.605 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 32.9 t -158.04 143.92 17.17 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 119.558 1.072 . . . . 0.34999999999999998 111.776 -172.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -55.9 -23.56 32.12 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 113.821 1.045 . . . . 3.0299999999999998 113.821 179.263 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -70.67 -19.14 62.82 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 114.9 1.444 . . . . 1.8300000000000001 114.9 178.401 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -83.14 10.72 7.6 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 114.545 1.313 . . . . 1.6200000000000001 114.545 -169.783 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.6 pttt -72.35 -44.92 61.91 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.979 1.711 . . . . 2.8999999999999999 113.527 -175.729 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -83.9 20.36 1.52 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.997 1.719 . . . . 3.71 112.489 -175.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 64.4 mmtt -130.47 132.55 45.73 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 126.469 1.907 . . . . 1.4199999999999999 111.984 -166.061 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 47.6 mtt180 -69.5 168.25 15.0 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.965 1.306 . . . . 3.2999999999999998 111.694 163.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 56.6 m -46.2 -55.41 7.15 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.058 1.343 . . . . 0.89000000000000001 113.533 170.645 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.7 p -57.55 -44.24 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 124.501 1.12 . . . . 0.58999999999999997 112.464 174.233 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -72.04 -27.87 62.98 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 118.378 -0.82 . . . . 1.1000000000000001 112.85 -178.515 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -69.97 -51.84 29.28 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 119.451 1.023 . . . . 0.68000000000000005 109.921 169.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 44.1 m170 -52.17 -53.07 47.66 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.075 0.95 . . . . 0.57999999999999996 112.24 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 28.0 tp60 -46.59 -43.67 17.5 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.1 1.36 . . . . 1.4299999999999999 113.411 177.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 61.6 mtp -64.18 -36.22 83.36 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 120.998 -1.064 . . . . 1.0600000000000001 113.069 -178.526 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.0 t -79.05 -36.07 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 125.613 1.565 . . . . 0.39000000000000001 110.56 177.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -61.22 -50.29 73.68 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.986 1.314 . . . . 0.46999999999999997 110.221 174.565 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 63.7 tp60 -57.45 -29.82 64.51 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 120.246 -1.534 . . . . 2.3300000000000001 113.553 178.073 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.54 -37.22 82.98 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.119 0.968 . . . . 0.54000000000000004 112.058 -177.135 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.59 0.88 8.84 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 115.06 1.504 . . . . 0.62 115.06 -179.499 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 30.2 ttpt -47.41 -36.76 10.27 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 125.85 1.66 . . . . 2.6699999999999999 112.618 175.743 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -88.85 7.55 33.68 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 112.403 0.52 . . . . 2.0699999999999998 112.403 -172.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -121.11 -61.13 1.58 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 128.625 2.77 . . . . 2.73 110.449 175.086 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 7.2 mm -115.77 90.33 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 125.046 1.338 . . . . 1.6499999999999999 109.018 171.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 8.0 ptpp? -76.15 -18.56 59.06 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 114.348 1.24 . . . . 4.4000000000000004 114.348 -173.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -67.08 46.19 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 131.258 3.823 . . . . 3.3900000000000001 114.429 -178.677 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 61.2 mtm -71.58 10.25 0.68 Allowed 'General case' 0 CA--C 1.54 0.56 0 O-C-N 119.393 -2.067 . . . . 1.3700000000000001 114.933 -172.626 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -69.59 -20.59 63.63 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.315 0.857 . . . . 3.2200000000000002 113.315 161.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -84.45 -32.88 21.25 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 123.904 0.764 . . . . 0.62 112.212 174.502 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.0 mp -71.91 144.31 49.03 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 122.515 1.15 . . . . 1.6100000000000001 112.795 -173.684 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 45.1 ttt180 -128.48 99.67 5.48 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 126.547 1.939 . . . . 3.02 109.126 -176.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 4.9 mt -108.78 141.75 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 123.697 1.713 . . . . 0.62 112.953 -170.617 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -130.51 132.79 45.8 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 111.495 -2.593 . . . . 1.8500000000000001 107.542 -172.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 17.2 p -151.85 151.85 31.85 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.788 1.235 . . . . 0.33000000000000002 109.945 -173.626 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.1 p -161.83 -179.53 7.27 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.506 -1.224 . . . . 0.64000000000000001 110.243 178.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 6.3 p -135.15 136.14 24.15 Favored Pre-proline 0 C--N 1.325 -0.481 0 C-N-CA 124.267 1.027 . . . . 0.57999999999999996 109.782 177.115 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo . . . . . 0 N--CA 1.457 -0.653 0 C-N-CA 123.377 2.718 . . . . 0.68000000000000005 108.791 175.728 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 16.4 mp0 . . . . . 0 CA--C 1.537 0.444 0 N-CA-C 113.445 0.906 . . . . 2.2000000000000002 113.445 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 80.9 p -127.06 166.87 16.79 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.774 2.03 . . . . 0.67000000000000004 108.291 159.544 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -62.68 -26.66 68.77 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 119.986 1.267 . . . . 3.27 111.951 169.311 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.43 -43.47 94.82 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 126.01 1.767 . . . . 0.40999999999999998 113.063 172.423 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.88 -45.6 60.14 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 119.321 1.56 . . . . 2.0299999999999998 111.44 173.423 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.7 mt -69.52 -52.22 28.43 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 124.912 1.285 . . . . 0.45000000000000001 111.264 178.423 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -53.62 -48.28 69.46 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.915 1.286 . . . . 2.8999999999999999 110.695 179.378 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 67.6 t -63.99 -49.24 82.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 108.25 -1.019 . . . . 0.27000000000000002 108.25 179.573 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 98.3 m -56.18 -43.01 77.99 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.15 0.58 . . . . 0.34999999999999998 112.4 178.501 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.74 -37.02 85.78 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.479 1.112 . . . . 2.7599999999999998 111.911 -179.089 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 64.1 mt -79.82 -30.63 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 CA-C-N 118.775 0.716 . . . . 0.47999999999999998 110.855 176.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.2 mt -59.81 -36.09 76.05 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 120.694 -1.254 . . . . 0.52000000000000002 112.687 170.776 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 27.2 mttt -65.84 -19.05 65.74 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 113.429 0.9 . . . . 1.3799999999999999 113.429 175.624 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -98.43 -39.2 8.89 Favored 'General case' 0 N--CA 1.434 -1.254 0 C-N-CA 126.079 1.752 . . . . 2.1699999999999999 113.946 179.361 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 29.5 mmtt -78.17 -21.69 49.81 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 112.675 0.62 . . . . 1.8100000000000001 112.675 172.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -136.24 52.4 6.31 Favored Pre-proline 0 CA--C 1.55 0.98 0 N-CA-C 118.126 2.639 . . . . 2.1099999999999999 118.126 178.384 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -69.47 -22.07 33.94 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 123.659 2.906 . . . . 0.97999999999999998 114.395 173.077 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 13.4 mmp_? -82.7 -18.37 41.13 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 120.861 -1.149 . . . . 6.75 112.485 177.66 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -55.5 145.87 21.71 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 125.868 1.667 . . . . 0.58999999999999997 113.559 176.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 81.9 p -86.44 -28.97 23.19 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.247 1.019 . . . . 0.72999999999999998 110.938 176.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -121.69 143.73 49.18 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.001 0.921 . . . . 0.40999999999999998 112.615 164.551 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.5 pt -155.41 111.53 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 128.123 2.569 . . . . 0.56000000000000005 110.167 169.514 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 6.4 ptpt -153.28 156.0 37.59 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.885 1.274 . . . . 1.02 113.062 176.779 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.7 t -133.77 145.94 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 126.314 1.846 . . . . 0.51000000000000001 110.281 -177.665 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 28.4 m -132.69 128.02 36.05 Favored 'General case' 0 CA--C 1.512 -0.482 0 C-N-CA 123.706 0.802 . . . . 0.60999999999999999 111.521 171.687 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -74.04 125.3 27.99 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 122.209 1.004 . . . . 1.8 109.586 165.286 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.4 pt -124.72 30.5 2.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 125.273 1.429 . . . . 0.47999999999999998 109.96 178.809 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.465 ' HB2' ' H ' ' A' ' 62' ' ' MET . 32.4 t -138.98 62.73 1.53 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 127.509 2.324 . . . . 1.25 111.998 -175.843 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -65.63 10.62 0.47 Allowed Glycine 0 CA--C 1.541 1.696 0 O-C-N 120.256 -1.528 . . . . 1.51 116.689 178.284 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -121.49 -4.28 9.92 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 125.749 1.642 . . . . 0.91000000000000003 114.709 171.031 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 9.2 t -156.97 -31.59 0.08 Allowed 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 119.386 1.593 . . . . 1.8400000000000001 114.832 -176.27 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 59.93 48.93 83.67 Favored Glycine 0 CA--C 1.538 1.516 0 C-N-CA 126.036 1.779 . . . . 0.60999999999999999 113.051 -161.518 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -105.88 -17.47 14.35 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 126.299 1.839 . . . . 0.85999999999999999 114.625 178.079 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.465 ' H ' ' HB2' ' A' ' 56' ' ' SER . 6.6 mtm -110.9 140.43 45.38 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 126.11 1.764 . . . . 1.3500000000000001 111.954 168.298 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -142.99 148.93 37.62 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.725 0.81 . . . . 1.8999999999999999 112.795 172.134 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -85.84 138.45 32.04 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.858 1.663 . . . . 1.96 109.356 163.135 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 84.2 mt -134.75 131.01 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 CA-C-N 120.057 1.299 . . . . 0.63 109.965 171.346 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 66.9 mttt -128.2 118.59 23.61 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.637 1.175 . . . . 2.7599999999999998 111.329 179.297 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.401 ' CD1' HG13 ' A' ' 84' ' ' VAL . 1.2 mt -128.5 157.36 41.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 C-N-CA 126.586 1.954 . . . . 0.25 109.633 -178.368 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -157.39 126.9 6.03 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 120.353 -1.467 . . . . 1.8400000000000001 109.248 170.837 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 16.4 t -160.1 144.29 14.43 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 120.599 1.545 . . . . 0.41999999999999998 112.815 -169.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -55.32 -29.69 58.76 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.902 1.281 . . . . 4.8700000000000001 112.562 -177.355 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -66.43 -19.25 65.75 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 115.166 1.543 . . . . 1.75 115.166 178.124 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -82.56 -2.78 54.66 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 120.824 -1.172 . . . . 2.0099999999999998 114.106 -172.078 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.516 ' HB3' HG21 ' A' ' 104' ' ' VAL . 55.3 pttt -67.09 -25.45 66.23 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.752 1.621 . . . . 2.77 114.432 -176.18 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -109.05 26.61 10.41 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.976 1.71 . . . . 4.5599999999999996 111.415 -169.461 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 38.9 mmtt -131.79 141.4 49.46 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 126.535 1.934 . . . . 1.3999999999999999 111.319 -172.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 31.0 mtt180 -64.04 165.38 9.11 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 118.975 -0.535 . . . . 4.6299999999999999 110.906 165.359 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 66.7 m -48.24 -54.53 13.27 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 113.154 0.798 . . . . 1.0 113.154 170.19 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.2 p -60.34 -39.38 80.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 124.656 1.182 . . . . 0.65000000000000002 112.717 176.598 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -69.88 -35.37 74.6 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 112.841 0.682 . . . . 1.3300000000000001 112.841 176.233 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -60.87 -52.33 65.52 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 119.507 1.049 . . . . 0.62 109.911 170.539 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 38.3 m170 -54.8 -51.6 65.27 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.292 0.637 . . . . 0.48999999999999999 111.81 176.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 41.3 tp60 -48.76 -44.02 38.36 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.933 1.693 . . . . 1.24 113.161 178.432 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 1.4 mtm -63.46 -40.36 96.92 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 119.628 1.104 . . . . 1.1299999999999999 111.868 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.401 HG13 ' CD1' ' A' ' 67' ' ' ILE . 4.2 t -74.83 -31.17 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 124.556 1.142 . . . . 0.37 111.145 178.828 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -66.88 -52.82 38.75 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.571 1.549 . . . . 0.45000000000000001 110.697 176.41 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 43.7 tp60 -64.09 -23.91 67.5 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 119.993 -1.692 . . . . 2.6299999999999999 113.15 -177.401 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -54.19 -45.82 72.25 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.9 1.28 . . . . 0.48999999999999999 111.254 177.071 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -119.91 1.47 10.96 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 114.994 1.479 . . . . 0.47999999999999998 114.994 -175.062 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 29.8 ttpt -51.28 -36.8 43.95 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 125.226 1.41 . . . . 2.1899999999999999 112.13 -177.024 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -85.15 -9.09 58.25 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 112.781 0.66 . . . . 2.21 112.781 -174.803 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -94.91 -62.05 1.38 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 127.128 2.171 . . . . 3.0099999999999998 110.428 174.418 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 8.6 mm -121.61 88.93 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 125.631 1.572 . . . . 1.46 109.044 176.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -72.76 -16.68 61.64 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 115.378 1.621 . . . . 2.5899999999999999 115.378 -174.044 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.9 mp0 -63.18 39.08 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 130.946 3.699 . . . . 3.1000000000000001 115.903 -177.02 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 64.2 mtm -69.46 2.55 2.98 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 119.669 -1.894 . . . . 1.4199999999999999 115.412 -170.329 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 10.9 p-80 -65.85 -22.7 66.56 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.611 0.764 . . . . 4.4100000000000001 112.668 160.635 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -84.57 -14.79 69.88 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 125.995 1.76 . . . . 0.39000000000000001 114.27 171.179 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.6 mp -97.47 127.01 43.08 Favored 'General case' 0 C--O 1.236 0.37 0 O-C-N 121.553 -0.969 . . . . 1.6699999999999999 111.877 -168.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 59.2 ttt180 -106.11 101.05 10.56 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.734 2.014 . . . . 3.98 109.735 178.212 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 4.8 mt -107.59 141.08 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-O 123.183 1.468 . . . . 0.46000000000000002 112.02 -173.272 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -129.74 130.99 46.13 Favored 'General case' 0 N--CA 1.433 -1.31 0 C-N-CA 128.35 2.66 . . . . 2.0299999999999998 108.628 -174.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 13.6 p -143.1 152.94 42.4 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 126.006 1.722 . . . . 0.29999999999999999 109.036 -178.724 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 2.8 p -163.03 -179.48 6.75 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.617 -1.174 . . . . 0.60999999999999999 109.671 177.589 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.516 HG21 ' HB3' ' A' ' 73' ' ' LYS . 4.2 p -144.19 135.26 12.46 Favored Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 112.909 0.707 . . . . 0.58999999999999997 112.909 -175.641 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo . . . . . 0 C--N 1.35 0.654 0 C-N-CA 124.157 3.238 . . . . 0.72999999999999998 112.024 179.72 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 . . . . . 0 CA--C 1.548 0.868 0 CA-C-O 121.112 0.482 . . . . 2.8100000000000001 111.093 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 55.2 p -127.69 -175.87 3.6 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 126.257 1.823 . . . . 0.87 109.795 168.696 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -62.21 -39.55 93.14 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 120.646 1.566 . . . . 4.6100000000000003 110.764 160.219 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.48 -43.78 96.16 Favored Glycine 0 C--N 1.34 0.789 0 C-N-CA 126.045 1.783 . . . . 0.68000000000000005 113.21 -177.375 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.12 -48.35 73.77 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 118.974 1.387 . . . . 1.3100000000000001 112.565 -178.317 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 46.0 mt -66.32 -50.31 64.07 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 125.807 1.643 . . . . 0.52000000000000002 110.882 178.437 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -54.99 -50.03 70.0 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.779 2.032 . . . . 3.2200000000000002 111.428 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.2 t -64.36 -47.12 90.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 124.418 1.087 . . . . 0.34999999999999998 108.127 177.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 89.7 m -57.65 -38.3 74.83 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 118.035 0.38 . . . . 0.35999999999999999 111.998 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -62.39 -40.67 97.24 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 112.629 0.603 . . . . 1.6899999999999999 112.629 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 24.3 mt -79.4 -29.46 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 O-C-N 123.314 0.384 . . . . 0.66000000000000003 111.013 179.369 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.1 mt -56.13 -41.54 75.48 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 120.833 -1.167 . . . . 0.5 113.534 169.326 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 38.5 mttt -60.89 -28.61 69.01 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 113.262 0.838 . . . . 2.0499999999999998 113.262 178.264 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -93.48 -37.96 11.67 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 127.294 2.238 . . . . 2.04 114.497 -175.255 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -73.87 -26.91 60.8 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-O 117.999 -1.0 . . . . 1.1899999999999999 111.489 171.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -132.06 52.01 8.33 Favored Pre-proline 0 CA--C 1.547 0.865 0 N-CA-C 117.811 2.523 . . . . 1.5700000000000001 117.811 -177.767 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -62.48 -22.6 74.24 Favored 'Trans proline' 0 C--O 1.236 0.403 0 C-N-CA 123.758 2.972 . . . . 0.73999999999999999 114.194 174.331 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.41 -18.44 64.45 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 113.953 1.094 . . . . 7.2000000000000002 113.953 174.837 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -56.36 150.67 14.35 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 115.552 1.686 . . . . 0.51000000000000001 115.552 -167.716 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 61.1 p -90.26 -35.66 15.17 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 114.702 -1.135 . . . . 0.79000000000000004 111.672 166.351 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -125.09 136.13 53.36 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.53 1.132 . . . . 0.32000000000000001 111.176 173.197 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.5 pt -153.89 114.08 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 124.381 1.073 . . . . 0.46999999999999997 112.876 171.021 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -157.14 154.62 29.64 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.569 1.548 . . . . 1.25 113.297 -179.53 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.8 t -131.77 142.66 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 127.673 2.389 . . . . 0.67000000000000004 108.604 177.64 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 59.2 m -135.77 120.72 18.67 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.948 1.299 . . . . 0.51000000000000001 110.484 175.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -70.52 128.74 37.19 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.95 0.881 . . . . 1.9099999999999999 109.839 168.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.7 pt -130.47 31.19 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 C-N-CA 126.566 1.946 . . . . 0.73999999999999999 109.597 178.727 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.7 t -139.87 61.91 1.52 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 128.319 2.648 . . . . 1.3200000000000001 110.436 -170.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.6 -3.47 5.63 Favored Glycine 0 CA--C 1.538 1.504 0 N-CA-C 118.128 2.011 . . . . 1.25 118.128 -168.144 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -140.37 12.41 3.01 Favored Glycine 0 N--CA 1.475 1.24 0 CA-C-N 119.632 1.716 . . . . 0.93000000000000005 115.222 175.64 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 16.7 m -143.55 -34.15 0.41 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.746 1.618 . . . . 2.9100000000000001 111.865 -176.049 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 52.84 42.96 60.41 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 126.69 2.091 . . . . 0.70999999999999996 113.194 -177.154 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -107.34 -29.86 9.04 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.446 1.898 . . . . 0.93999999999999995 112.357 -177.814 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 1.8 mtm -102.97 126.53 50.18 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 126.501 1.92 . . . . 2.1699999999999999 109.96 -179.453 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -139.05 150.51 45.84 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.157 0.983 . . . . 1.9299999999999999 110.487 178.247 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -104.72 124.28 49.11 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.856 1.662 . . . . 2.04 109.448 171.371 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 53.8 mt -124.61 135.5 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 125.314 1.446 . . . . 0.65000000000000002 110.645 -176.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 62.0 tttt -126.74 120.71 30.07 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.177 0.991 . . . . 5.1200000000000001 110.455 174.077 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.409 ' CD1' HG13 ' A' ' 84' ' ' VAL . 1.1 mt -125.31 154.0 33.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 126.453 1.901 . . . . 0.28000000000000003 108.974 176.884 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -156.02 130.3 8.79 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 120.561 -1.337 . . . . 1.6299999999999999 108.393 166.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.4 t -162.64 147.22 11.89 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 118.881 0.764 . . . . 0.66000000000000003 112.369 -174.466 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -55.21 -24.15 25.83 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.303 1.841 . . . . 2.9500000000000002 114.553 -175.746 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -70.07 -18.26 63.27 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 115.155 1.539 . . . . 2.5099999999999998 115.155 175.466 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -78.56 15.86 0.94 Allowed 'General case' 0 CA--C 1.559 1.32 0 N-CA-C 114.854 1.427 . . . . 1.6299999999999999 114.854 -173.696 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.404 ' HG2' ' H ' ' A' ' 73' ' ' LYS . 38.4 pttt -79.1 -35.7 41.86 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 128.215 2.606 . . . . 2.4300000000000002 117.275 -165.5 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -119.45 32.27 6.17 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.455 1.102 . . . . 3.6899999999999999 112.301 -179.248 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 67.8 mmtt -112.13 142.21 44.86 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 128.043 2.537 . . . . 1.3600000000000001 111.214 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 8.2 mmt180 -66.19 161.87 21.09 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.141 0.976 . . . . 3.29 111.002 163.647 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 96.4 m -47.42 -55.74 8.36 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.334 1.054 . . . . 0.77000000000000002 113.616 169.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.6 p -56.9 -37.61 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 124.809 1.243 . . . . 0.58999999999999997 112.644 178.012 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.4 mm100 -77.14 -32.33 56.28 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.444 1.098 . . . . 1.8400000000000001 113.048 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -62.92 -53.57 51.97 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.156 0.889 . . . . 0.59999999999999998 109.832 168.194 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 39.2 m170 -53.15 -50.87 63.68 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.914 0.886 . . . . 0.42999999999999999 111.626 177.217 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 34.7 tp60 -48.28 -44.27 33.46 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.922 1.289 . . . . 1.29 112.875 178.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 4.1 mtm -61.59 -43.41 98.92 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 119.977 1.262 . . . . 1.1599999999999999 111.297 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.409 HG13 ' CD1' ' A' ' 67' ' ' ILE . 5.8 t -71.83 -29.08 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.87 1.268 . . . . 0.23999999999999999 111.471 178.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -71.91 -44.67 63.31 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.102 1.361 . . . . 0.62 110.481 175.015 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.7 -22.83 66.06 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 120.647 -1.283 . . . . 2.8399999999999999 113.379 178.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.45 -38.98 78.64 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.784 1.234 . . . . 0.34999999999999998 112.48 176.899 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.04 -2.31 9.2 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 114.772 1.397 . . . . 0.40000000000000002 114.772 -173.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 11.0 ttpp -49.49 -35.73 20.77 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 126.086 1.754 . . . . 3.6499999999999999 113.323 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -88.76 -11.19 45.7 Favored 'General case' 0 CA--C 1.552 1.044 0 N-CA-C 112.307 0.484 . . . . 2.0899999999999999 112.307 -174.818 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -95.45 -49.79 5.27 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 127.338 2.255 . . . . 3.75 112.045 174.749 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 34.2 mt -135.41 113.07 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 127.525 2.33 . . . . 1.1200000000000001 106.302 172.504 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.86 -17.78 34.65 Favored 'General case' 0 N--CA 1.48 1.075 0 O-C-N 120.703 -1.248 . . . . 3.4500000000000002 114.22 -169.54 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -88.33 63.9 7.34 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.33 1.852 . . . . 4.21 112.798 -164.413 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' MET . . . . . 0.417 ' HA ' HD13 ' A' ' 98' ' ' LEU . 5.3 mpp? -69.14 8.04 0.63 Allowed 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 115.16 1.541 . . . . 1.28 115.16 -178.31 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 28.3 p80 -53.18 -36.42 60.92 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 120.978 -1.076 . . . . 3.9500000000000002 113.377 171.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -85.43 -9.25 79.55 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 125.673 1.606 . . . . 0.42999999999999999 114.635 -179.051 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.417 HD13 ' HA ' ' A' ' 95' ' ' MET . 4.9 mp -96.68 107.36 19.8 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 121.311 -1.111 . . . . 1.6599999999999999 112.44 -166.538 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 10.4 ttt180 -81.05 117.39 21.59 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 112.818 -1.992 . . . . 3.4399999999999999 108.467 171.108 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 4.3 mt -125.29 135.07 65.18 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.679 0 CA-C-O 123.448 1.594 . . . . 0.35999999999999999 112.491 -175.506 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -121.69 122.67 40.1 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 111.539 -2.573 . . . . 2.4300000000000002 107.611 -175.039 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 15.6 p -132.92 152.5 51.89 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.103 1.361 . . . . 0.25 110.21 179.023 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.8 p -158.2 175.57 13.6 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 124.639 1.176 . . . . 0.59999999999999998 110.367 176.846 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 9.0 p -141.94 127.82 10.86 Favored Pre-proline 0 N--CA 1.472 0.661 0 C-N-CA 123.132 0.573 . . . . 0.41999999999999998 111.77 -177.696 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo . . . . . 0 CA--C 1.537 0.64 0 C-N-CA 123.447 2.765 . . . . 0.66000000000000003 111.957 -176.367 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.856 0 CA-C-O 119.715 -0.183 . . . . 4.9800000000000004 110.805 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.7 m -146.44 175.32 10.64 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 125.645 1.578 . . . . 3.3900000000000001 110.289 177.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -127.51 154.91 44.55 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.658 1.183 . . . . 2.27 111.897 170.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 80.0 p -107.11 164.5 12.11 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.008 0.923 . . . . 0.81000000000000005 109.414 156.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 21.9 mp0 -64.32 -22.13 66.85 Favored 'General case' 0 CA--C 1.549 0.941 0 O-C-N 121.454 -0.778 . . . . 3.7200000000000002 111.716 162.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.45 -39.61 95.81 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 126.72 2.105 . . . . 0.42999999999999999 114.08 170.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.87 -43.99 73.64 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.486 1.643 . . . . 2.1000000000000001 111.29 174.078 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 11.7 mt -66.28 -55.37 16.38 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 125.399 1.48 . . . . 0.34999999999999998 109.867 178.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.3 tpm_? -49.69 -51.46 38.16 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.632 1.573 . . . . 7.1900000000000004 113.351 176.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 26.0 t -65.21 -43.33 95.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 106.945 -1.502 . . . . 0.32000000000000001 106.945 -175.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 36.1 m -58.7 -38.21 77.78 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 118.525 -0.75 . . . . 0.40999999999999998 112.056 175.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 14.3 mm-40 -60.97 -49.67 76.49 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 119.448 1.022 . . . . 1.73 112.219 -179.211 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 18.3 mt -75.34 -30.96 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 CA-C-N 118.343 0.519 . . . . 0.52000000000000002 110.027 -175.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 29.9 mt -56.49 -38.33 71.61 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 114.459 1.281 . . . . 0.57999999999999996 114.459 171.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 31.2 mttt -58.94 -36.76 75.32 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 119.122 0.874 . . . . 2.96 112.347 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.03 -36.31 15.87 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 128.651 2.78 . . . . 4.9199999999999999 114.493 -173.427 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 48.6 mmtt -71.27 -20.84 62.17 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 118.262 -0.875 . . . . 1.26 112.397 167.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -134.09 59.12 35.8 Favored Pre-proline 0 CA--C 1.558 1.275 0 N-CA-C 117.756 2.502 . . . . 2.0899999999999999 117.756 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.35 -19.81 32.86 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 124.62 3.547 . . . . 0.93999999999999995 114.983 171.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 40.8 mmt180 -78.79 -0.12 29.19 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 120.836 -1.165 . . . . 4.8200000000000003 113.775 170.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.26 149.1 50.86 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 115.675 1.731 . . . . 0.53000000000000003 115.675 -176.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 16.3 p -108.15 -27.97 9.77 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 127.048 2.139 . . . . 0.68999999999999995 112.842 170.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -119.57 138.63 53.08 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.376 1.071 . . . . 0.54000000000000004 110.881 163.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.2 pt -153.92 118.87 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 124.788 1.235 . . . . 0.67000000000000004 111.663 166.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.4 ptpt -158.11 154.39 27.43 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 126.032 1.733 . . . . 1.27 112.3 173.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.4 t -132.66 149.98 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 126.465 1.906 . . . . 0.35999999999999999 109.712 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 92.5 m -140.0 131.18 26.51 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.613 0.765 . . . . 0.46999999999999997 111.427 169.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -73.91 121.96 21.78 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.513 0.725 . . . . 1.8 109.978 163.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . 0.255 5.5 pt -117.11 25.52 4.35 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 C-N-CA 125.495 1.518 . . . . 0.68999999999999995 111.039 179.034 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 31.9 t -137.91 58.99 1.67 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 128.564 2.746 . . . . 1.3500000000000001 111.223 -173.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -55.53 -6.53 1.1 Allowed Glycine 0 CA--C 1.544 1.878 0 N-CA-C 119.003 2.361 . . . . 1.3 119.003 -173.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -133.04 16.39 4.7 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 126.247 1.879 . . . . 1.03 114.653 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 15.4 t -153.17 -39.7 0.1 Allowed 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.778 1.231 . . . . 1.52 111.776 170.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 64.67 44.18 95.31 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 125.699 1.618 . . . . 0.88 112.707 -167.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -90.08 -31.39 17.16 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.911 1.284 . . . . 1.21 113.667 173.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 9.0 mtm -104.43 138.01 41.46 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.866 1.266 . . . . 1.53 112.576 174.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -137.46 147.34 45.25 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.995 0.918 . . . . 1.97 111.225 169.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -83.32 138.49 33.53 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 124.904 1.282 . . . . 2.4399999999999999 109.531 161.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 97.5 mt -134.48 129.0 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 CA-C-N 119.344 0.975 . . . . 0.59999999999999998 109.474 168.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 71.6 mttt -126.06 115.99 20.71 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.688 1.195 . . . . 2.6800000000000002 110.347 178.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.1 mt -127.02 156.62 38.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 126.442 1.897 . . . . 0.25 109.423 -177.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -152.87 133.3 13.67 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.252 1.821 . . . . 2.02 106.584 162.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 28.0 t -155.91 143.37 19.39 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 120.132 1.333 . . . . 0.41999999999999998 112.883 -173.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -57.51 -20.62 32.62 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.923 1.289 . . . . 3.25 114.149 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -75.69 -15.12 60.34 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 114.27 1.211 . . . . 1.8600000000000001 114.27 177.011 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -83.5 16.72 2.46 Favored 'General case' 0 CA--C 1.55 0.964 0 N-CA-C 113.689 0.996 . . . . 1.6200000000000001 113.689 -174.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -71.05 -44.35 65.94 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.677 1.591 . . . . 3.0 112.654 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -91.85 35.85 0.97 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.206 1.402 . . . . 4.1100000000000003 113.115 -174.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 62.6 mmtt -144.78 141.32 29.11 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.684 1.594 . . . . 1.54 113.115 -167.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 22.6 mmt180 -73.03 170.62 14.48 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 126.596 1.959 . . . . 4.4900000000000002 112.223 162.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 84.2 m -50.95 -54.71 21.9 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.816 1.043 . . . . 1.1000000000000001 113.816 168.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.1 p -59.9 -35.88 63.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 123.776 0.83 . . . . 0.81999999999999995 112.974 178.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -76.4 -37.07 57.65 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.722 0.809 . . . . 1.2 112.029 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -59.83 -54.07 50.52 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.962 0.905 . . . . 0.68999999999999995 109.889 168.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 47.8 m170 -50.13 -52.76 32.45 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.256 1.022 . . . . 0.54000000000000004 111.878 177.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 39.9 tp60 -47.07 -44.28 20.82 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.592 1.557 . . . . 1.26 112.847 179.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 81.2 mtp -62.97 -43.43 98.81 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 121.166 -0.959 . . . . 0.98999999999999999 112.255 178.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.2 t -71.22 -25.83 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 125.657 1.583 . . . . 0.25 111.735 177.211 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -76.8 -44.41 32.74 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.621 1.568 . . . . 0.51000000000000001 109.69 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -64.76 -27.39 68.86 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 125.104 1.362 . . . . 3.4399999999999999 113.99 175.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.94 -29.99 71.22 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.501 1.52 . . . . 0.47999999999999998 112.916 -175.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.0 -8.19 8.85 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 115.124 1.527 . . . . 0.40000000000000002 115.124 176.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -44.37 -43.58 7.68 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.081 1.352 . . . . 2.02 112.847 176.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -85.78 6.01 29.88 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-O 122.505 1.145 . . . . 2.4500000000000002 111.759 -165.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -124.54 -56.27 1.61 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 129.946 3.299 . . . . 2.98 108.377 -177.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.0 mm -126.38 132.9 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 127.573 2.349 . . . . 1.9399999999999999 108.923 169.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -92.77 -10.89 35.34 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 116.274 1.953 . . . . 2.6299999999999999 116.274 -174.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -78.66 36.65 0.27 Allowed 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 117.702 2.482 . . . . 3.0499999999999998 117.702 -153.445 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 4.6 mpp? -64.06 9.42 0.07 Allowed 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 116.259 1.948 . . . . 1.3200000000000001 116.259 -175.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 49.3 t60 -65.07 -38.82 92.05 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 120.946 -1.096 . . . . 4.3700000000000001 111.81 160.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -84.61 -17.79 63.23 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 126.355 1.931 . . . . 0.41999999999999998 114.045 -178.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.5 mp -87.61 118.77 27.31 Favored 'General case' 0 C--N 1.332 -0.179 0 O-C-N 121.674 -0.898 . . . . 1.71 112.265 -170.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 28.7 ttm180 -98.02 102.06 13.71 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 127.453 2.301 . . . . 4.8700000000000001 109.885 -177.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 4.1 mt -111.7 143.91 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-O 123.903 1.811 . . . . 0.42999999999999999 113.14 -169.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -136.0 125.6 25.32 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 111.543 -2.571 . . . . 1.8400000000000001 108.005 -171.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 28.3 p -144.86 153.55 41.72 Favored 'General case' 0 CA--C 1.509 -0.607 0 C-N-CA 125.837 1.655 . . . . 0.40000000000000002 109.791 -171.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -163.35 175.55 10.73 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.239 -1.346 . . . . 0.70999999999999996 109.379 176.324 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.4 p -122.97 139.65 31.87 Favored Pre-proline 0 C--N 1.325 -0.488 0 O-C-N 121.289 -0.882 . . . . 0.64000000000000001 109.531 170.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -80.94 121.54 4.06 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 123.207 2.605 . . . . 0.87 108.463 172.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 10.2 mmtt -149.5 26.55 0.84 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.067 1.347 . . . . 3.2400000000000002 111.083 -160.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 63.6 mtm-85 . . . . . 0 C--O 1.257 1.475 0 C-N-CA 126.687 1.995 . . . . 10.15 113.788 -157.002 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.736 0 N-CA-C 109.588 -0.523 . . . . 6.5800000000000001 109.588 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 13.9 m -65.86 138.77 58.1 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.908 0.883 . . . . 3.77 111.777 -177.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -44.61 147.85 0.56 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.828 1.651 . . . . 2.27 115.443 -178.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 38.9 p -117.0 179.9 3.89 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.877 1.671 . . . . 0.90000000000000002 111.041 169.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -70.45 -35.25 73.23 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 120.633 -1.292 . . . . 3.0499999999999998 111.959 168.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -67.42 -37.59 90.33 Favored Glycine 0 CA--C 1.529 0.948 0 CA-C-O 118.572 -1.127 . . . . 0.44 112.901 178.122 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -46.08 -50.24 15.49 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.51 1.524 . . . . 1.3799999999999999 112.713 173.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 15.1 mt -69.95 -50.73 39.03 Favored 'General case' 0 CA--C 1.528 0.098 0 C-N-CA 124.957 1.303 . . . . 0.40999999999999998 111.132 -178.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.54 -48.36 77.43 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.578 1.151 . . . . 3.0099999999999998 110.85 -179.027 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.0 t -63.12 -41.93 94.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 108.496 -0.927 . . . . 0.28999999999999998 108.496 177.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 74.2 m -59.09 -42.08 89.61 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 118.761 0.709 . . . . 0.46999999999999997 111.28 178.067 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -69.48 -33.37 72.79 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 114.011 1.115 . . . . 3.1099999999999999 114.011 -175.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 30.5 mt -79.53 -30.69 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 CA-C-N 119.099 0.863 . . . . 0.47999999999999998 110.694 173.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 33.1 mt -58.19 -36.74 73.54 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 120.74 -1.225 . . . . 0.51000000000000001 113.233 171.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 38.0 mttt -59.78 -24.6 64.23 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 114.21 1.189 . . . . 1.3300000000000001 114.21 173.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -101.25 -34.73 9.54 Favored 'General case' 0 N--CA 1.427 -1.575 0 C-N-CA 125.494 1.518 . . . . 2.0800000000000001 113.87 -175.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -75.26 -24.66 57.63 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 118.646 -1.221 . . . . 1.1000000000000001 111.79 169.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -130.6 54.55 14.99 Favored Pre-proline 0 CA--C 1.548 0.865 0 N-CA-C 117.049 2.24 . . . . 2.21 117.049 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -62.49 -30.79 80.26 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 123.573 2.849 . . . . 0.73999999999999999 113.688 174.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 28.0 mmt85 -75.95 -11.89 60.04 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 120.352 1.433 . . . . 4.7000000000000002 114.519 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -55.21 146.67 18.26 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.157 1.783 . . . . 0.40999999999999998 114.524 -174.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 66.7 p -88.09 -30.74 19.65 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.905 0.882 . . . . 0.70999999999999996 111.111 170.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -129.77 138.67 51.19 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.005 0.922 . . . . 0.45000000000000001 111.734 170.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.6 pt -150.46 117.74 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 125.572 1.549 . . . . 0.73999999999999999 111.419 165.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.79 157.79 37.06 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.705 1.202 . . . . 2.4199999999999999 113.46 169.217 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.0 t -125.08 144.13 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 128.215 2.606 . . . . 0.37 110.492 -173.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 80.7 m -128.86 126.37 39.64 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.388 1.475 . . . . 0.51000000000000001 109.518 166.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -73.41 139.2 45.72 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 122.023 0.916 . . . . 2.4700000000000002 110.344 165.204 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.7 pt -134.31 32.8 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 C-N-CA 126.411 1.884 . . . . 0.83999999999999997 110.397 177.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.44 ' HB2' ' H ' ' A' ' 62' ' ' MET . 23.2 t -141.01 62.31 1.48 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 128.13 2.572 . . . . 1.4399999999999999 112.779 -171.261 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.08 -30.11 60.27 Favored Glycine 0 CA--C 1.54 1.619 0 O-C-N 119.989 -1.694 . . . . 1.8 114.649 179.05 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -85.81 -9.46 77.86 Favored Glycine 0 CA--C 1.539 1.549 0 N-CA-C 116.421 1.328 . . . . 1.45 116.421 -179.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 19.6 t -148.52 -38.83 0.17 Allowed 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 119.493 1.646 . . . . 2.75 114.319 -175.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 66.82 43.52 91.41 Favored Glycine 0 CA--C 1.536 1.375 0 C-N-CA 126.854 2.168 . . . . 1.1599999999999999 112.581 -165.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -94.06 -37.98 11.36 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.13 1.372 . . . . 1.76 113.594 172.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.459 ' HG3' ' CA ' ' A' ' 97' ' ' GLY . 4.0 mpp? -94.99 140.29 30.16 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 124.373 1.069 . . . . 2.8199999999999998 112.962 -175.252 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -145.38 143.5 30.15 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 122.393 1.092 . . . . 1.8999999999999999 113.805 175.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -100.07 119.51 38.41 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.364 1.866 . . . . 2.6699999999999999 109.911 170.264 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 61.6 mt -132.48 130.54 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.784 1.234 . . . . 0.84999999999999998 110.747 -161.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -117.67 125.95 51.63 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.304 1.442 . . . . 2.98 110.683 177.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.445 ' CD1' HG13 ' A' ' 84' ' ' VAL . 1.2 mt -129.35 156.37 41.79 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 C-N-CA 127.347 2.259 . . . . 0.25 109.703 174.37 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -155.37 133.67 11.67 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.678 1.591 . . . . 1.8200000000000001 108.704 164.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 16.9 t -159.55 140.49 12.51 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 119.811 1.187 . . . . 0.33000000000000002 112.865 -175.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -61.48 -3.6 1.05 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 127.609 2.364 . . . . 3.73 115.084 179.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -84.8 -23.6 29.07 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.901 1.68 . . . . 1.6599999999999999 113.725 173.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -79.92 9.93 4.79 Favored 'General case' 0 CA--C 1.555 1.16 0 N-CA-C 116.052 1.871 . . . . 1.6699999999999999 116.052 -165.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.89 -37.17 35.35 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 117.613 2.449 . . . . 2.8799999999999999 117.613 -163.033 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -88.63 40.53 0.97 Allowed 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 121.046 1.748 . . . . 4.3300000000000001 111.993 178.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.9 mmtp -139.71 137.16 34.93 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 125.437 1.495 . . . . 1.8400000000000001 111.823 -168.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 46.2 mtt180 -68.75 172.03 6.97 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.856 1.662 . . . . 3.6600000000000001 111.741 164.005 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 87.0 m -47.6 -58.34 4.37 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 125.357 1.463 . . . . 0.78000000000000003 113.425 170.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.2 p -59.48 -36.13 62.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.351 1.061 . . . . 0.54000000000000004 112.775 176.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 11.1 mt-30 -77.08 -27.34 54.22 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 113.446 0.906 . . . . 1.3600000000000001 113.446 -177.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -71.42 -54.1 11.81 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.012 0.925 . . . . 0.71999999999999997 110.33 166.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 52.6 m170 -55.08 -42.58 73.0 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.543 0.737 . . . . 0.46999999999999997 112.414 -177.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 31.0 tp60 -47.43 -42.0 21.44 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 126.201 1.801 . . . . 1.1499999999999999 113.032 177.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 63.8 mtp -66.36 -43.47 85.9 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 123.568 0.747 . . . . 1.1499999999999999 111.234 -177.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.445 HG13 ' CD1' ' A' ' 67' ' ' ILE . 2.5 t -72.27 -34.31 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 127.058 2.143 . . . . 0.22 111.654 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -63.16 -53.15 57.76 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 127.169 2.188 . . . . 0.56000000000000005 109.524 173.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.8 tm0? -65.27 -30.19 71.04 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.234 -0.916 . . . . 3.21 112.235 -177.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -55.89 -34.22 65.34 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 125.631 1.573 . . . . 0.39000000000000001 112.72 -172.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.41 -2.81 9.45 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 115.053 1.501 . . . . 0.40999999999999998 115.053 177.53 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 26.8 ttpt -51.15 -36.3 40.17 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.957 0.903 . . . . 1.9399999999999999 112.475 178.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -74.92 -13.73 60.57 Favored 'General case' 0 N--CA 1.439 -1.022 0 O-C-N 121.578 -0.701 . . . . 2.2400000000000002 112.269 -176.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -94.86 -49.49 5.56 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 128.466 2.706 . . . . 3.0 113.448 172.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 30.6 mt -141.02 129.35 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 127.738 2.415 . . . . 1.1299999999999999 107.938 177.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 45.7 mttp -97.66 -14.66 20.8 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 116.21 1.93 . . . . 3.2999999999999998 116.21 -170.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -79.35 68.41 5.34 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 115.354 1.613 . . . . 4.96 115.354 -160.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -70.39 1.58 4.84 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 116.471 2.026 . . . . 1.77 116.471 -178.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 22.4 t60 -54.57 -32.66 58.91 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.924 0.868 . . . . 4.4800000000000004 112.064 153.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.459 ' CA ' ' HG3' ' A' ' 62' ' ' MET . . . -83.39 -18.01 65.28 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 126.175 1.845 . . . . 0.5 116.544 -176.028 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 10.1 mt -93.62 139.56 30.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 118.517 1.158 . . . . 2.27 110.746 -168.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 35.5 ttt180 -123.55 95.76 4.71 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.552 1.541 . . . . 3.3999999999999999 107.91 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -114.32 135.34 54.39 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.475 0 CA-C-O 123.115 1.436 . . . . 0.46999999999999997 112.444 -161.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -127.83 114.24 16.97 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 112.178 -2.283 . . . . 2.0600000000000001 107.764 -168.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 23.4 p -127.13 150.31 49.55 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.293 1.437 . . . . 0.29999999999999999 110.566 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 2.2 p -150.7 172.73 15.11 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.222 -1.354 . . . . 0.64000000000000001 111.123 173.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.9 p -140.24 129.58 13.42 Favored Pre-proline 0 N--CA 1.472 0.628 0 C-N-CA 123.172 0.589 . . . . 0.52000000000000002 111.6 178.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -78.66 109.67 2.66 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 123.751 2.967 . . . . 0.68000000000000005 111.418 -177.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 71.7 tttt -140.98 46.7 1.75 Allowed 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.313 1.445 . . . . 3.8199999999999998 111.853 -157.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 48.0 ttp180 . . . . . 0 C--O 1.254 1.307 0 C-N-CA 127.064 2.145 . . . . 6.6699999999999999 113.331 -172.282 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.943 0 N-CA-C 110.12 -0.326 . . . . 4.9100000000000001 110.12 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.0 t -145.64 153.23 40.8 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.268 1.027 . . . . 3.3399999999999999 111.227 -177.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 96.7 mm-40 -129.96 152.99 48.82 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 122.638 1.208 . . . . 2.9900000000000002 113.018 171.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 62.6 p -121.06 161.63 21.38 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 112.532 -2.122 . . . . 0.60999999999999999 108.46 149.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -63.88 -21.15 66.32 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 120.586 -1.321 . . . . 2.7000000000000002 112.044 164.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -67.38 -39.24 91.61 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 126.875 2.179 . . . . 0.56999999999999995 113.572 173.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.25 -44.31 68.04 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.512 1.525 . . . . 1.29 111.233 173.03 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.4 mt -68.79 -53.92 18.87 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 125.801 1.64 . . . . 0.40000000000000002 110.935 176.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.5 ttp-105 -49.8 -50.06 46.41 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 126.617 1.967 . . . . 3.6000000000000001 111.162 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 52.0 t -68.27 -46.94 80.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 123.992 0.917 . . . . 0.28999999999999998 108.538 -178.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 98.3 m -57.93 -42.63 85.23 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 118.497 0.589 . . . . 0.39000000000000001 111.903 178.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -62.39 -35.9 80.62 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.888 0.875 . . . . 2.9300000000000002 112.449 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 62.4 mt -80.86 -31.81 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-N 118.845 0.748 . . . . 0.46000000000000002 111.019 175.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 29.6 mt -58.09 -37.58 74.78 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 120.945 -1.097 . . . . 0.40000000000000002 112.34 171.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 23.9 mttt -63.38 -22.36 66.83 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 113.539 0.94 . . . . 1.78 113.539 174.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -96.41 -36.15 10.93 Favored 'General case' 0 N--CA 1.434 -1.255 0 C-N-CA 125.994 1.717 . . . . 2.1299999999999999 114.694 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 64.9 mmtt -74.84 -28.01 60.51 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 119.668 -0.813 . . . . 1.55 111.8 171.321 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -130.33 50.29 5.83 Favored Pre-proline 0 CA--C 1.55 0.952 0 N-CA-C 117.65 2.463 . . . . 2.0499999999999998 117.65 -178.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -61.51 -25.47 79.63 Favored 'Trans proline' 0 C--O 1.237 0.468 0 C-N-CA 123.949 3.099 . . . . 0.94999999999999996 114.428 177.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 12.5 mmt85 -80.78 -11.35 59.62 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 114.148 1.166 . . . . 5.04 114.148 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -51.85 151.33 3.55 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 126.245 1.818 . . . . 0.44 114.725 -173.215 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 68.9 p -93.04 -32.21 14.57 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.976 1.31 . . . . 0.59999999999999998 111.033 169.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -124.82 139.01 54.23 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.212 1.005 . . . . 0.47999999999999998 111.992 170.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.4 pt -156.16 112.49 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 126.433 1.893 . . . . 0.56000000000000005 111.316 166.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.5 ptpt -151.88 148.3 27.64 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.916 1.286 . . . . 1.01 112.888 172.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 29.0 t -124.39 144.2 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 127.1 2.16 . . . . 0.34000000000000002 108.872 -178.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 98.9 m -132.07 127.34 35.9 Favored 'General case' 0 CA--C 1.512 -0.507 0 C-N-CA 124.732 1.213 . . . . 0.55000000000000004 109.931 172.003 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.82 130.44 41.07 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 124.25 1.02 . . . . 2.5800000000000001 111.009 174.31 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.3 pt -132.64 26.61 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 C-N-CA 126.234 1.814 . . . . 0.79000000000000004 110.77 174.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.5 t -138.14 107.97 6.3 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.931 1.293 . . . . 1.55 113.519 164.31 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -83.43 -18.06 65.12 Favored Glycine 0 N--CA 1.474 1.203 0 C-N-CA 124.228 0.918 . . . . 2.3999999999999999 113.821 162.048 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -77.36 -39.69 25.71 Favored Glycine 0 N--CA 1.467 0.746 0 C-N-CA 124.548 1.071 . . . . 1.8200000000000001 113.368 -175.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 20.8 m -145.9 -17.89 0.46 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.755 1.222 . . . . 1.73 113.284 -170.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 63.06 37.8 95.54 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 126.374 1.94 . . . . 0.97999999999999998 113.948 -178.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -101.61 -8.96 21.37 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.67 1.188 . . . . 1.6100000000000001 113.074 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 7.8 ttm -119.35 122.12 41.11 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 125.824 1.65 . . . . 1.6299999999999999 109.803 -162.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.42 ' H ' HD23 ' A' ' 98' ' ' LEU . 76.5 m-85 -146.06 147.26 31.43 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 121.859 0.838 . . . . 2.0499999999999998 112.989 -177.151 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -101.52 124.29 46.95 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.705 1.602 . . . . 2.48 109.692 173.473 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 95.5 mt -134.54 130.84 53.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 O-C-N 120.866 -1.146 . . . . 1.01 111.44 -165.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.5 mptt -119.8 130.45 54.93 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.529 0.732 . . . . 3.29 111.618 171.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.452 ' CD1' HG13 ' A' ' 84' ' ' VAL . 1.3 mt -129.67 159.46 41.69 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 C-N-CA 126.566 1.947 . . . . 0.29999999999999999 109.279 176.252 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -159.42 135.4 8.78 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 126.347 1.859 . . . . 1.8600000000000001 108.628 165.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.3 t -162.98 146.7 11.03 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 118.494 0.588 . . . . 0.42999999999999999 111.491 -176.31 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -51.38 -32.53 26.29 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.858 1.663 . . . . 3.6600000000000001 113.759 178.133 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -63.39 -20.08 65.22 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 114.838 1.422 . . . . 1.6799999999999999 114.838 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -81.45 10.96 4.96 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 114.984 1.476 . . . . 1.6299999999999999 114.984 -169.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.5 pttt -74.63 -43.84 53.45 Favored 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 115.002 1.482 . . . . 2.3300000000000001 115.002 -172.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -91.15 27.64 1.83 Allowed 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 124.894 1.278 . . . . 4.2300000000000004 111.803 -174.008 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -123.09 140.14 53.34 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 127.47 2.308 . . . . 1.45 111.451 -171.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 13.1 mmt85 -69.37 165.94 19.67 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.057 1.343 . . . . 2.7599999999999998 110.629 161.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 28.2 m -52.09 -53.55 41.06 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.718 1.207 . . . . 0.85999999999999999 112.986 171.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.1 p -59.55 -35.64 60.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 124.252 1.021 . . . . 0.88 113.161 175.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -74.79 -35.89 62.51 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.676 0.621 . . . . 1.21 112.676 177.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -60.26 -51.6 68.86 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 119.462 1.028 . . . . 0.69999999999999996 109.192 169.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 36.7 m170 -55.62 -46.08 77.44 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.603 0.761 . . . . 0.71999999999999997 112.982 177.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 40.1 tp60 -48.43 -45.5 36.4 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.511 1.525 . . . . 1.23 112.625 176.091 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 67.0 mtp -63.71 -34.73 78.53 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 119.407 1.003 . . . . 0.97999999999999998 112.792 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.452 HG13 ' CD1' ' A' ' 67' ' ' ILE . 2.8 t -78.24 -30.34 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 125.689 1.596 . . . . 0.39000000000000001 111.752 177.396 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -71.27 -50.9 27.95 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.266 1.826 . . . . 0.71999999999999997 110.965 174.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 27.3 tp60 -69.78 -15.01 63.05 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 125.327 1.451 . . . . 3.1499999999999999 113.784 -178.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.15 -39.93 88.05 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.575 1.15 . . . . 0.41999999999999998 112.539 173.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.86 -0.07 8.54 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 115.764 1.764 . . . . 0.35999999999999999 115.764 -177.207 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 27.0 ttmt -43.57 -45.24 6.59 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 125.631 1.572 . . . . 2.2000000000000002 113.147 177.122 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -83.19 -7.02 59.68 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-O 121.294 0.569 . . . . 2.0899999999999999 112.201 -169.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 23.6 tp10 -103.59 -41.49 5.95 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 129.55 3.14 . . . . 2.21 111.011 -176.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 44.6 mt -150.61 115.21 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 129.806 3.242 . . . . 1.1200000000000001 107.029 175.107 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -92.26 -4.62 53.79 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 117.336 2.347 . . . . 3.46 117.336 -169.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -82.13 33.55 0.4 Allowed 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 127.97 2.508 . . . . 2.9900000000000002 115.503 -161.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 4.4 mpp? -68.53 6.16 0.88 Allowed 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 117.639 2.459 . . . . 1.3600000000000001 117.639 -165.175 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 34.2 t60 -42.62 -38.67 2.09 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 121.218 -0.926 . . . . 4.2599999999999998 112.113 152.112 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -69.14 -16.15 70.57 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 126.294 1.902 . . . . 0.51000000000000001 117.03 -179.175 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.42 HD23 ' H ' ' A' ' 63' ' ' TYR . 12.4 mt -96.7 129.47 44.1 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 119.057 1.428 . . . . 2.2799999999999998 112.715 -163.191 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 35.9 ttt180 -111.03 87.64 2.59 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 126.912 2.085 . . . . 3.6099999999999999 107.906 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 1.7 mt -106.23 144.61 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-O 122.879 1.323 . . . . 0.47999999999999998 112.31 -166.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -137.11 132.02 33.48 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 111.748 -2.478 . . . . 2.25 108.756 -173.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 21.1 p -146.24 152.78 39.74 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 126.449 1.899 . . . . 0.32000000000000001 110.198 -173.068 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 2.6 p -159.51 177.92 10.43 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 124.405 1.082 . . . . 0.65000000000000002 110.97 176.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.2 p -136.86 138.8 27.04 Favored Pre-proline 0 N--CA 1.47 0.567 0 C-N-CA 124.089 0.956 . . . . 0.46000000000000002 110.412 175.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -79.04 118.02 3.98 Favored 'Trans proline' 0 CA--C 1.533 0.47 0 C-N-CA 122.828 2.352 . . . . 0.66000000000000003 110.723 174.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -153.04 31.15 0.49 Allowed 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 114.127 1.158 . . . . 2.7400000000000002 114.127 -159.617 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.318 0 C-N-CA 125.268 1.427 . . . . 8.2599999999999998 113.493 -178.312 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.734 0 N-CA-C 109.768 -0.456 . . . . 8.0600000000000005 109.768 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.1 m 54.0 48.92 20.06 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.13 1.372 . . . . 4.5300000000000002 112.901 -176.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -107.1 139.98 40.67 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 125.824 1.649 . . . . 6.2199999999999998 112.924 -175.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 79.2 p -110.38 -179.44 3.77 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.203 -1.036 . . . . 0.79000000000000004 108.203 140.21 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -71.63 -30.94 66.33 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 119.797 -1.815 . . . . 3.5 112.396 162.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.73 -41.21 99.57 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 124.279 0.943 . . . . 0.68999999999999995 113.281 173.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -54.14 -42.07 69.12 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.176 1.39 . . . . 1.52 112.919 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 22.5 mt -69.16 -50.67 45.59 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 125.519 1.527 . . . . 0.84999999999999998 111.323 177.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.98 -50.3 73.1 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 126.004 1.722 . . . . 2.96 110.61 -179.148 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 56.2 t -60.42 -47.4 92.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 108.292 -1.003 . . . . 0.31 108.292 177.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 93.0 m -58.53 -38.63 78.17 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.646 0.61 . . . . 0.65000000000000002 112.646 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.3 mm-40 -63.54 -40.23 96.49 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 118.412 0.551 . . . . 1.7 112.313 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 35.7 mt -82.02 -28.4 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 122.759 0.424 . . . . 0.67000000000000004 110.77 -175.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 11.8 mt -54.23 -37.75 64.96 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.473 -0.767 . . . . 0.71999999999999997 112.832 168.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.7 mttt -62.49 -25.27 67.92 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 114.237 1.199 . . . . 2.1299999999999999 114.237 178.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -106.14 -31.83 8.51 Favored 'General case' 0 N--CA 1.435 -1.22 0 C-N-CA 126.775 2.03 . . . . 2.4900000000000002 113.728 -167.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 53.1 mmtt -77.57 -24.84 49.71 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 118.729 -0.653 . . . . 1.46 111.713 164.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -131.71 49.54 4.77 Favored Pre-proline 0 CA--C 1.556 1.191 0 N-CA-C 118.435 2.754 . . . . 1.55 118.435 -178.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -68.07 -12.97 36.84 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 125.056 3.837 . . . . 0.82999999999999996 114.948 176.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 38.8 mtt180 -99.58 -6.73 26.88 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.195 0.998 . . . . 4.9100000000000001 113.444 175.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.41 139.91 58.56 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 125.025 1.33 . . . . 0.69999999999999996 113.141 176.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 44.2 p -75.46 -35.52 60.86 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.249 1.42 . . . . 0.89000000000000001 109.395 176.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -124.29 138.26 54.41 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.562 1.145 . . . . 0.34999999999999998 111.736 171.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.8 pt -150.22 118.46 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 125.577 1.551 . . . . 0.80000000000000004 112.522 163.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 7.8 ptpt -158.88 158.26 33.06 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.744 1.218 . . . . 1.76 114.016 177.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.7 t -126.11 155.93 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 127.766 2.426 . . . . 0.46999999999999997 111.028 -174.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 88.4 m -147.14 127.35 13.83 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 120.996 -1.065 . . . . 0.35999999999999999 111.817 162.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -69.63 126.91 31.16 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.889 0.852 . . . . 1.8600000000000001 110.568 165.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.5 pt -126.08 25.14 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 C-N-CA 126.047 1.739 . . . . 0.63 111.387 -178.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 34.9 t -132.5 62.74 1.64 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 128.308 2.643 . . . . 1.5900000000000001 109.032 176.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -54.29 -13.3 3.7 Favored Glycine 0 CA--C 1.54 1.643 0 N-CA-C 117.642 1.817 . . . . 1.73 117.642 -169.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -123.55 -6.71 7.2 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 126.31 1.91 . . . . 1.6399999999999999 115.828 -179.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -138.74 -21.75 0.99 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.212 1.405 . . . . 2.4300000000000002 114.399 -176.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 55.0 39.06 67.3 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 128.054 2.74 . . . . 0.94999999999999996 115.477 -178.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -88.05 -32.47 18.74 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.131 1.372 . . . . 1.3400000000000001 114.094 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 8.5 mtm -106.9 142.25 36.82 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.648 1.579 . . . . 1.49 112.842 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -142.46 144.09 32.88 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 122.181 0.991 . . . . 2.0099999999999998 112.539 172.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -83.05 139.46 33.24 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 126.604 1.961 . . . . 2.0699999999999998 110.076 165.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 90.6 mt -138.01 128.45 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 CA-C-N 119.39 0.996 . . . . 0.64000000000000001 110.606 170.092 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 77.9 mttt -113.73 126.78 55.61 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.118 1.367 . . . . 2.9500000000000002 110.943 171.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.434 ' CD1' HG13 ' A' ' 84' ' ' VAL . 1.3 mt -130.55 156.95 42.89 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 126.863 2.065 . . . . 0.31 109.938 174.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -156.8 130.86 8.43 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.332 1.453 . . . . 1.6499999999999999 109.583 166.167 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 32.6 t -158.26 143.6 16.66 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 119.994 1.27 . . . . 0.56999999999999995 112.019 -176.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -51.77 -24.86 6.49 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.206 1.402 . . . . 3.1000000000000001 113.52 173.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -69.51 -14.59 62.94 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 114.182 1.179 . . . . 1.73 114.182 -178.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -92.33 13.85 18.17 Favored 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 125.163 1.385 . . . . 1.71 114.266 -175.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.414 ' HB3' HG21 ' A' ' 104' ' ' VAL . 0.3 OUTLIER -79.27 -15.05 58.58 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 115.769 1.766 . . . . 3.3199999999999998 115.769 -167.717 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -123.17 29.95 6.53 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.082 1.753 . . . . 4.54 110.867 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -122.35 129.85 52.54 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 126.299 1.84 . . . . 1.27 111.053 -172.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 38.3 mtt-85 -63.52 164.41 9.47 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.852 1.261 . . . . 3.25 111.064 168.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 86.7 m -44.53 -55.89 4.76 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.933 0.893 . . . . 0.75 112.985 170.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.2 p -61.57 -37.25 77.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 124.987 1.315 . . . . 0.56999999999999995 113.164 178.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -75.66 -29.85 59.22 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 112.917 0.71 . . . . 1.0600000000000001 112.917 179.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 60.5 mt-30 -65.09 -54.8 24.44 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 119.007 0.821 . . . . 1.51 109.03 168.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 45.1 m170 -54.46 -45.31 73.09 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.952 0.901 . . . . 0.54000000000000004 112.859 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 50.5 tp60 -48.36 -43.46 33.58 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.363 1.465 . . . . 1.3899999999999999 112.912 178.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 45.5 mtp -66.32 -42.03 88.81 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 121.43 -0.794 . . . . 0.93999999999999995 111.717 -178.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.434 HG13 ' CD1' ' A' ' 67' ' ' ILE . 3.1 t -72.22 -29.7 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 125.267 1.427 . . . . 0.32000000000000001 111.773 176.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -69.23 -51.72 34.9 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 126.185 1.794 . . . . 0.89000000000000001 108.276 179.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -69.0 -19.89 64.15 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 113.748 1.018 . . . . 2.5600000000000001 113.748 -176.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.4 -41.77 80.94 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.031 0.932 . . . . 0.39000000000000001 111.652 178.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.86 -4.16 9.67 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 115.386 1.625 . . . . 0.32000000000000001 115.386 -176.282 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 21.9 tttt -53.32 -34.68 58.43 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 125.048 1.339 . . . . 1.95 113.45 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 67.2 mt-10 -87.27 -2.58 58.72 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 123.166 0.587 . . . . 2.3199999999999998 111.638 -174.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -100.98 -45.55 5.38 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 128.147 2.579 . . . . 3.0899999999999999 112.17 167.225 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 30.2 mt -145.78 110.6 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 128.003 2.521 . . . . 0.94999999999999996 107.676 178.334 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -86.17 -1.43 57.43 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 116.185 1.92 . . . . 2.3500000000000001 116.185 -173.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -77.19 43.39 0.37 Allowed 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 128.728 2.811 . . . . 3.5899999999999999 115.948 -164.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 4.7 mpp? -62.95 1.89 0.37 Allowed 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 114.952 1.464 . . . . 1.28 114.952 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 22.0 t60 -59.78 -26.51 65.77 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.513 1.125 . . . . 4.1399999999999997 113.21 163.165 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -106.37 -8.15 33.67 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 126.893 2.187 . . . . 0.46000000000000002 114.855 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.7 mp -96.38 123.52 40.05 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 118.374 1.087 . . . . 1.5900000000000001 111.55 -173.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 54.0 ttt180 -105.68 100.01 9.59 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 126.956 2.102 . . . . 3.0499999999999998 109.08 -174.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 3.6 mt -108.28 141.17 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-O 122.969 1.366 . . . . 0.42999999999999999 111.795 -169.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -130.91 123.27 28.56 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 111.695 -2.502 . . . . 1.8500000000000001 107.363 -173.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 16.2 p -136.94 140.45 42.26 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.058 1.343 . . . . 0.31 109.697 -176.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.6 t -138.01 -177.6 4.89 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 122.585 1.183 . . . . 2.2400000000000002 110.922 167.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.414 HG21 ' HB3' ' A' ' 73' ' ' LYS . 7.2 p -147.65 135.78 10.96 Favored Pre-proline 0 C--N 1.317 -0.827 0 C-N-CA 126.085 1.754 . . . . 0.55000000000000004 108.662 177.142 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -71.96 93.64 0.71 Allowed 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 123.018 2.478 . . . . 1.1699999999999999 110.646 175.102 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 56.2 tttt -150.49 79.42 1.34 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 128.564 2.746 . . . . 4.1600000000000001 107.941 -168.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 9.8 mmt180 . . . . . 0 C--O 1.254 1.312 0 C-N-CA 127.484 2.313 . . . . 12.720000000000001 111.74 -178.653 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.616 0 CA-C-O 118.515 -0.755 . . . . 6.2699999999999996 112.177 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.5 m -62.61 128.7 37.18 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-N 120.345 1.43 . . . . 3.3700000000000001 110.939 178.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -142.16 156.58 45.35 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 115.534 1.679 . . . . 2.54 115.534 -163.025 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 72.3 p -128.19 169.28 14.32 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 126.751 2.02 . . . . 0.55000000000000004 108.614 160.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -68.37 -16.93 64.11 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 121.027 -1.046 . . . . 2.79 113.004 165.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.99 -42.88 67.32 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 124.62 1.105 . . . . 0.46000000000000002 113.295 169.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.08 -48.88 43.91 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.488 1.915 . . . . 1.3600000000000001 111.892 173.304 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 24.0 mt -67.04 -51.85 49.55 Favored 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 125.755 1.622 . . . . 0.45000000000000001 111.353 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.5 ttp180 -50.45 -49.93 53.74 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 126.936 2.094 . . . . 4.5899999999999999 110.667 178.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.7 t -67.92 -46.98 80.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 108.874 -0.787 . . . . 0.34999999999999998 108.874 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 57.5 m -55.48 -40.35 71.56 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 118.324 0.511 . . . . 0.34999999999999998 112.326 178.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -61.71 -42.47 98.98 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 112.349 0.499 . . . . 1.6299999999999999 112.349 -177.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 18.5 mt -79.65 -29.37 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 CA-C-N 118.345 0.52 . . . . 0.52000000000000002 111.514 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 22.9 mt -55.55 -40.4 71.86 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 120.98 -1.075 . . . . 0.39000000000000001 113.759 172.4 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 42.4 mttt -59.45 -27.82 66.43 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 113.832 1.049 . . . . 1.3100000000000001 113.832 178.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -97.4 -34.22 11.12 Favored 'General case' 0 N--CA 1.431 -1.382 0 C-N-CA 127.423 2.289 . . . . 2.2200000000000002 114.233 -172.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 63.1 mmtt -74.27 -23.52 59.13 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 119.089 -1.044 . . . . 1.28 111.919 167.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -127.84 54.97 14.4 Favored Pre-proline 0 CA--C 1.554 1.101 0 N-CA-C 117.874 2.546 . . . . 1.51 117.874 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -66.87 -17.99 52.25 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 124.935 3.757 . . . . 0.81999999999999995 114.99 173.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 25.1 mmt85 -85.29 -1.18 56.69 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 113.89 1.07 . . . . 4.6600000000000001 113.89 171.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.19 149.36 50.05 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 114.3 1.222 . . . . 0.46999999999999997 114.3 -176.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 72.4 p -114.98 -4.15 12.59 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.94 1.696 . . . . 0.89000000000000001 113.418 173.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -140.73 146.31 37.59 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.422 1.089 . . . . 0.37 111.391 147.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.3 pt -154.58 117.54 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 126.381 1.872 . . . . 0.53000000000000003 111.918 169.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.4 ptpt -158.66 148.43 19.41 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.918 1.287 . . . . 1.04 114.041 178.016 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.2 t -126.52 150.48 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 C-N-CA 126.834 2.053 . . . . 0.29999999999999999 111.287 -173.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 98.1 m -143.57 135.41 26.51 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.502 0.721 . . . . 0.40000000000000002 112.371 171.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -77.62 126.0 30.2 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 122.131 0.967 . . . . 1.9199999999999999 111.012 168.26 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.0 pt -124.05 29.47 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 C-N-CA 126.151 1.781 . . . . 0.55000000000000004 110.978 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.528 ' HB2' ' H ' ' A' ' 62' ' ' MET . 29.8 t -135.69 58.53 1.75 Allowed 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 128.214 2.606 . . . . 1.28 111.453 -174.541 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -65.27 14.77 0.21 Allowed Glycine 0 CA--C 1.537 1.444 0 N-CA-C 117.794 1.877 . . . . 2.1200000000000001 117.794 -174.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -135.81 0.3 3.33 Favored Glycine 0 CA--C 1.537 1.407 0 C-N-CA 125.803 1.668 . . . . 1.1799999999999999 114.085 175.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 36.7 t -151.61 -38.62 0.12 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.958 1.303 . . . . 1.5700000000000001 113.568 -177.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 67.19 38.5 92.02 Favored Glycine 0 CA--C 1.541 1.678 0 C-N-CA 126.37 1.938 . . . . 0.77000000000000002 114.67 -165.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -93.71 -20.32 20.25 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 127.242 2.217 . . . . 0.95999999999999996 115.382 176.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.528 ' H ' ' HB2' ' A' ' 56' ' ' SER . 6.1 mtm -111.38 139.91 46.4 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.643 1.577 . . . . 1.3 112.862 172.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -139.96 150.0 43.97 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.875 0.87 . . . . 1.8600000000000001 112.376 172.317 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -86.74 139.87 30.3 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 125.363 1.465 . . . . 2.3100000000000001 110.126 163.121 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 90.1 mt -134.34 127.34 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 124.242 1.017 . . . . 0.63 109.606 168.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -117.34 122.74 44.72 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.522 1.129 . . . . 2.46 109.259 171.016 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.408 ' CD1' HG13 ' A' ' 84' ' ' VAL . 1.2 mt -126.81 157.63 37.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 127.089 2.155 . . . . 0.26000000000000001 109.196 177.679 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -155.27 131.42 10.2 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 125.706 1.602 . . . . 1.9299999999999999 107.69 168.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 28.7 t -156.82 143.05 18.12 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 120.304 1.411 . . . . 0.41999999999999998 112.327 -173.039 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -63.91 -10.43 20.89 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 114.767 1.395 . . . . 2.9399999999999999 114.767 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -79.51 -17.52 53.91 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 113.953 1.094 . . . . 1.8300000000000001 113.953 174.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -84.19 1.23 45.48 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 114.556 1.317 . . . . 1.95 114.556 -167.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.417 ' HB3' HG21 ' A' ' 104' ' ' VAL . 30.1 pttt -79.77 -22.97 42.53 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 115.306 1.595 . . . . 3.8599999999999999 115.306 -171.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -97.89 19.25 14.15 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-O 121.987 0.899 . . . . 4.0 111.794 178.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 44.1 mmtt -120.48 139.66 52.55 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 128.079 2.552 . . . . 1.4299999999999999 111.16 -175.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 17.0 mtm180 -66.15 164.48 15.53 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.335 1.054 . . . . 5.2000000000000002 111.197 161.199 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.1 m -46.66 -54.19 10.08 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 113.781 1.03 . . . . 0.68000000000000005 113.781 170.222 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 9.4 p -59.5 -37.01 67.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 123.685 0.794 . . . . 0.57999999999999996 112.053 176.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -77.65 -16.81 58.28 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 114.104 1.15 . . . . 1.01 114.104 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -77.87 -55.12 5.58 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 119.45 1.023 . . . . 0.63 109.658 166.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 44.7 m170 -54.12 -46.62 72.22 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.328 1.051 . . . . 0.53000000000000003 113.178 -177.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 53.2 tp60 -47.79 -40.61 21.36 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.426 1.89 . . . . 1.3600000000000001 113.165 177.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 64.5 mtp -66.78 -44.27 81.79 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.468 1.107 . . . . 0.95999999999999996 111.596 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.408 HG13 ' CD1' ' A' ' 67' ' ' ILE . 2.9 t -69.49 -31.0 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 126.162 1.785 . . . . 0.27000000000000002 110.955 178.714 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -68.87 -52.27 31.48 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.058 1.743 . . . . 0.5 110.176 174.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.04 -28.37 62.48 Favored 'General case' 0 CA--C 1.546 0.808 0 O-C-N 120.679 -1.263 . . . . 2.1899999999999999 111.848 178.514 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.66 -33.83 76.5 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.741 1.216 . . . . 0.37 112.892 -173.144 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.46 -7.88 8.63 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 114.473 1.286 . . . . 0.44 114.473 177.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 32.0 ttpt -46.47 -43.51 16.73 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 124.454 1.102 . . . . 2.5299999999999998 112.369 176.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -77.96 -4.05 45.03 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-O 121.645 0.736 . . . . 2.3799999999999999 112.055 -169.187 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -111.79 -45.41 3.35 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 129.991 3.317 . . . . 2.2599999999999998 111.154 -176.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 40.3 mt -144.85 124.95 7.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 129.001 2.92 . . . . 1.1499999999999999 107.283 177.064 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -96.09 -10.93 27.15 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 115.317 1.599 . . . . 3.3999999999999999 115.317 -174.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . 0.27 19.0 pt-20 -77.12 43.31 0.36 Allowed 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 116.38 1.993 . . . . 4.6399999999999997 116.38 -162.624 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 59.1 mtm -71.32 -1.61 13.44 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.65 1.98 . . . . 1.53 115.948 -167.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 6.9 p-80 -60.19 -20.36 58.3 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 121.335 -0.853 . . . . 4.8399999999999999 112.904 159.086 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -87.63 -12.94 65.98 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 125.43 1.491 . . . . 0.59999999999999998 115.176 169.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.6 mp -100.08 116.47 32.18 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 118.381 1.091 . . . . 1.72 112.268 -168.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 17.6 ttm180 -98.13 103.55 15.51 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 126.505 1.922 . . . . 4.8799999999999999 110.081 -175.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 2.9 mt -108.56 145.48 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 123.548 1.642 . . . . 0.39000000000000001 112.933 -171.144 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -139.43 120.97 15.15 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 111.048 -2.796 . . . . 1.95 107.825 -171.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 21.2 p -133.6 152.03 51.81 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 126.242 1.817 . . . . 0.27000000000000002 110.025 -177.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 10.4 p -157.41 179.3 9.38 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.931 -1.031 . . . . 0.64000000000000001 111.187 173.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.417 HG21 ' HB3' ' A' ' 73' ' ' LYS . 7.4 p -144.21 133.73 11.56 Favored Pre-proline 0 N--CA 1.47 0.572 0 N-CA-C 113.197 0.814 . . . . 0.51000000000000001 113.197 -177.64 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.98 112.28 3.48 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.773 2.315 . . . . 0.59999999999999998 109.456 173.011 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -135.98 97.29 3.59 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.935 1.694 . . . . 4.3099999999999996 109.098 -164.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 . . . . . 0 C--O 1.252 1.214 0 CA-C-O 115.888 -2.006 . . . . 10.68 115.7 -171.928 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.85 0 CA-C-O 118.054 -0.974 . . . . 4.8300000000000001 112.708 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . 0.299 3.2 t 54.29 175.77 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 127.147 2.179 . . . . 3.5 115.829 -174.556 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -151.9 150.63 30.29 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 127.088 2.155 . . . . 1.96 109.759 -177.254 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 23.1 p -115.55 164.24 14.6 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.517 1.127 . . . . 0.89000000000000001 110.662 170.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -65.42 -32.77 74.58 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 120.77 -1.206 . . . . 2.8900000000000001 111.377 174.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.02 -35.12 90.97 Favored Glycine 0 C--O 1.218 -0.875 0 CA-C-O 118.578 -1.123 . . . . 0.41999999999999998 112.251 172.127 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.38 -50.93 64.07 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 119.94 1.87 . . . . 1.26 111.825 174.392 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 15.2 mt -69.8 -50.37 43.66 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 125.657 1.583 . . . . 0.57999999999999996 110.615 -176.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.38 -48.35 79.28 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 126.135 1.774 . . . . 3.1499999999999999 111.533 177.651 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 29.6 t -62.84 -44.03 99.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 107.875 -1.157 . . . . 0.35999999999999999 107.875 178.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 47.2 m -58.05 -40.38 80.8 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 118.575 0.625 . . . . 0.41999999999999998 112.084 177.069 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 9.9 mm-40 -64.42 -45.2 88.59 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.634 0.605 . . . . 1.8999999999999999 112.634 -179.072 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 41.1 mt -72.04 -30.95 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-N 118.143 0.429 . . . . 0.63 109.866 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 37.5 mt -60.48 -37.73 81.98 Favored 'General case' 0 CA--C 1.531 0.237 0 O-C-N 120.925 -1.109 . . . . 0.47999999999999998 113.487 173.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 34.3 mttt -64.68 -25.88 68.14 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 113.596 0.961 . . . . 1.45 113.596 175.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -87.08 -39.91 15.16 Favored 'General case' 0 N--CA 1.433 -1.325 0 C-N-CA 125.769 1.627 . . . . 2.21 113.404 176.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 62.4 mmtt -74.95 -25.51 58.93 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 119.342 -0.943 . . . . 1.48 112.067 175.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -128.11 49.69 4.71 Favored Pre-proline 0 CA--C 1.55 0.975 0 N-CA-C 119.112 3.004 . . . . 2.1099999999999999 119.112 -179.036 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -67.72 -12.84 36.86 Favored 'Trans proline' 0 CA--C 1.534 0.489 0 C-N-CA 124.718 3.612 . . . . 0.72999999999999998 115.268 175.079 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 12.3 mmm180 -76.18 -16.49 59.84 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 114.124 1.157 . . . . 7.0099999999999998 114.124 169.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.94 152.48 43.1 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 115.892 1.812 . . . . 0.41999999999999998 115.892 -166.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 30.9 p -100.24 -22.95 14.95 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 118.019 -0.991 . . . . 0.63 112.374 168.185 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -126.11 141.41 51.95 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 119.932 1.242 . . . . 0.31 111.53 161.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.4 pt -157.6 103.31 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 127.23 2.212 . . . . 0.56000000000000005 110.337 171.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.5 ptpt -152.3 157.21 41.04 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.163 1.385 . . . . 1.1399999999999999 113.097 -175.406 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 23.7 t -137.72 144.57 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 126.639 1.976 . . . . 0.40999999999999998 110.548 -169.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.405 ' HB ' ' HB3' ' A' ' 64' ' ' GLU . 88.6 m -134.67 126.29 28.81 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 108.989 -0.745 . . . . 0.40999999999999998 108.989 165.571 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -70.67 133.83 46.99 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.474 0.654 . . . . 2.1499999999999999 109.755 167.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . 0.261 2.9 pt -127.7 34.9 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 C-N-CA 126.373 1.869 . . . . 0.85999999999999999 109.188 173.585 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 36.4 p -144.72 42.57 1.35 Allowed 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 128.281 2.632 . . . . 2.77 116.766 -174.232 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -51.26 -22.42 7.06 Favored Glycine 0 CA--C 1.546 2.02 0 N-CA-C 118.399 2.119 . . . . 2.0299999999999998 118.399 -176.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -110.28 -0.02 29.68 Favored Glycine 0 CA--C 1.541 1.7 0 C-N-CA 126.406 1.955 . . . . 1.28 115.37 177.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 7.8 t -132.99 -40.79 0.92 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.544 1.138 . . . . 1.8799999999999999 113.756 -176.098 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 57.88 47.83 86.29 Favored Glycine 0 CA--C 1.536 1.396 0 C-N-CA 128.348 2.88 . . . . 1.1799999999999999 113.535 -167.168 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -124.41 18.02 8.95 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.794 1.238 . . . . 1.04 114.024 -179.234 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 8.5 ttm -153.07 122.77 6.83 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.757 1.223 . . . . 1.78 112.097 -170.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -141.97 148.21 38.21 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.989 0.899 . . . . 1.8700000000000001 113.413 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.405 ' HB3' ' HB ' ' A' ' 53' ' ' THR . 7.8 tt0 -93.18 114.3 26.75 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.627 1.971 . . . . 2.3799999999999999 109.732 168.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 83.0 mt -125.46 123.78 65.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 CA-C-N 120.125 1.33 . . . . 0.70999999999999996 110.625 -170.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 71.7 mttt -125.26 119.52 28.67 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.871 1.269 . . . . 2.6400000000000001 111.011 -172.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.449 ' CD1' HG13 ' A' ' 84' ' ' VAL . 1.3 mt -130.02 153.33 38.74 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 127.158 2.183 . . . . 0.26000000000000001 109.93 -176.401 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -154.22 127.96 8.75 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.125 1.37 . . . . 1.8500000000000001 108.733 166.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 23.0 t -159.33 142.26 14.21 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 120.383 1.447 . . . . 0.29999999999999999 112.657 -172.07 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -50.65 -31.41 16.12 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.544 1.137 . . . . 2.73 112.522 178.345 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -66.98 -10.73 52.63 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 114.644 1.35 . . . . 1.6599999999999999 114.644 -175.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -95.71 10.28 37.47 Favored 'General case' 0 CA--C 1.557 1.217 0 N-CA-C 116.194 1.924 . . . . 2.0899999999999999 116.194 -175.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.443 ' HA ' HG11 ' A' ' 104' ' ' VAL . 0.1 OUTLIER -71.8 -37.15 70.45 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-N 120.775 1.625 . . . . 2.8799999999999999 115.139 -172.073 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -86.19 13.29 8.14 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.575 1.55 . . . . 3.3599999999999999 112.266 -174.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 51.4 mmtt -127.67 131.21 49.84 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.586 1.554 . . . . 2.23 112.951 -159.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 19.1 mmt180 -63.53 163.33 11.27 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.351 1.46 . . . . 5.2699999999999996 111.561 166.106 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 41.3 m -43.5 -55.52 4.17 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 125.498 1.519 . . . . 1.03 114.167 168.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 9.9 p -59.85 -38.35 75.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 N-CA-C 113.579 0.955 . . . . 0.51000000000000001 113.579 175.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -74.83 -32.45 61.94 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.308 0.643 . . . . 1.05 112.277 -177.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -66.44 -54.29 25.9 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.314 1.046 . . . . 0.64000000000000001 109.81 168.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 46.6 m170 -52.83 -44.77 66.95 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.886 1.274 . . . . 0.51000000000000001 112.951 -178.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 41.3 tp60 -53.34 -39.76 64.37 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.801 1.24 . . . . 1.2 112.821 178.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 4.7 mtm -66.38 -41.44 89.38 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 121.262 -0.899 . . . . 1.51 111.302 179.176 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.449 HG13 ' CD1' ' A' ' 67' ' ' ILE . 2.3 t -72.39 -26.45 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 125.243 1.417 . . . . 0.28999999999999998 111.914 178.136 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -70.1 -56.16 7.61 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 126.046 1.739 . . . . 0.82999999999999996 109.148 175.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.98 -6.42 42.0 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.101 1.149 . . . . 2.79 114.101 -178.246 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.02 -33.83 76.99 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 120.945 -1.097 . . . . 0.47999999999999998 112.738 169.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.24 -0.64 2.01 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 115.489 1.663 . . . . 0.40000000000000002 115.489 -176.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 34.9 tttt -50.26 -38.36 40.45 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 125.175 1.39 . . . . 2.2000000000000002 113.016 177.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -75.31 -18.44 60.03 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-O 121.514 0.673 . . . . 1.8899999999999999 111.413 -177.252 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -88.72 -51.98 5.38 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 129.126 2.971 . . . . 2.4300000000000002 110.991 177.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 32.9 mt -147.61 114.48 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 128.467 2.707 . . . . 1.02 108.327 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.4 tmtp? -92.28 -7.62 47.55 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 114.87 1.433 . . . . 4.0999999999999996 114.87 -163.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -70.43 57.42 0.17 Allowed 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 129.681 3.192 . . . . 3.1299999999999999 115.477 -164.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . 0.273 1.3 mpt? -75.84 3.63 9.62 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 119.311 -2.118 . . . . 1.8400000000000001 116.483 -178.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 73.2 t60 -59.21 -30.28 68.11 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 121.235 -0.916 . . . . 4.6900000000000004 112.371 151.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -83.56 -30.44 29.97 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 127.886 2.66 . . . . 0.5 116.457 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.0 mt -89.31 120.62 30.82 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 122.856 1.312 . . . . 2.1800000000000002 111.415 -164.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 14.6 ttm180 -106.82 99.23 8.82 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 112.797 -2.001 . . . . 5.2800000000000002 106.502 -179.251 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 1.4 mt -113.3 140.41 33.59 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.457 0 CA-C-O 122.845 1.307 . . . . 0.57999999999999996 111.105 -165.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -135.14 117.21 15.37 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 111.907 -2.406 . . . . 1.99 107.445 -166.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 18.5 p -134.89 147.52 49.87 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.221 1.808 . . . . 0.27000000000000002 110.145 -175.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.9 p -153.42 179.02 9.16 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.052 -1.431 . . . . 0.58999999999999997 110.319 174.241 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.443 HG11 ' HA ' ' A' ' 73' ' ' LYS . 6.5 p -145.82 133.26 10.26 Favored Pre-proline 0 N--CA 1.469 0.481 0 O-C-N 121.572 -0.705 . . . . 0.38 111.801 -178.511 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -77.71 123.98 6.67 Favored 'Trans proline' 0 N--CA 1.448 -1.205 0 C-N-CA 122.721 2.281 . . . . 1.01 108.911 166.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -141.88 64.93 1.38 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.673 1.589 . . . . 3.2200000000000002 108.693 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 63.1 ttt-85 . . . . . 0 C--O 1.254 1.297 0 C-N-CA 125.785 1.634 . . . . 7.1799999999999997 111.966 177.305 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.78 0 N-CA-C 111.935 0.346 . . . . 6.29 111.935 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . 0.32 1.0 OUTLIER 51.79 11.22 0.13 Allowed 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 128.797 2.839 . . . . 3.9500000000000002 117.593 179.647 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.8 mp0 -54.34 131.52 42.14 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 126.067 1.747 . . . . 2.3300000000000001 115.228 -177.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 59.2 p -87.13 165.35 15.81 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 114.863 -1.062 . . . . 0.60999999999999999 110.492 156.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -64.54 -27.68 69.13 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 120.936 -1.103 . . . . 4.29 111.875 168.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.54 -38.68 96.04 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 126.119 1.818 . . . . 0.45000000000000001 113.379 170.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.79 -43.18 72.62 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.291 1.546 . . . . 2.1299999999999999 112.014 174.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 11.7 mt -69.17 -52.04 31.97 Favored 'General case' 0 N--CA 1.462 0.129 0 C-N-CA 125.573 1.549 . . . . 0.35999999999999999 111.005 178.329 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -53.48 -49.75 66.82 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 126.923 2.089 . . . . 3.4199999999999999 110.874 178.463 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 38.1 t -67.4 -45.04 86.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 108.75 -0.833 . . . . 0.31 108.75 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 68.4 m -53.98 -43.55 70.05 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 118.511 0.596 . . . . 0.37 112.392 175.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -62.89 -43.65 98.21 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 118.593 0.633 . . . . 1.8 111.734 -176.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 53.2 mt -71.6 -29.86 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 123.312 0.645 . . . . 0.78000000000000003 110.323 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 53.2 mt -64.93 -41.44 95.52 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 120.655 -1.278 . . . . 0.62 113.269 171.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 38.7 mttt -62.19 -19.43 63.11 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-N 119.544 1.066 . . . . 1.77 113.852 174.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -95.91 -37.95 10.48 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 126.315 1.846 . . . . 2.3100000000000001 114.832 -178.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -78.38 -22.1 48.38 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 118.675 -0.678 . . . . 1.1100000000000001 112.492 170.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -133.07 50.07 5.13 Favored Pre-proline 0 CA--C 1.548 0.902 0 N-CA-C 118.854 2.909 . . . . 1.54 118.854 -179.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -62.98 -26.42 74.08 Favored 'Trans proline' 0 CA--C 1.534 0.516 0 C-N-CA 123.48 2.786 . . . . 1.0 115.842 177.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 27.0 mmm180 -76.97 -12.85 60.0 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 120.387 1.449 . . . . 7.3499999999999996 114.61 176.254 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -53.8 144.92 17.08 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.925 1.29 . . . . 0.62 114.159 -175.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 44.3 p -97.4 -22.5 16.57 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.473 1.109 . . . . 0.56999999999999995 111.984 176.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -123.4 138.39 54.61 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.942 0.897 . . . . 0.40999999999999998 110.321 157.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -154.35 105.97 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 124.841 1.256 . . . . 0.62 110.361 169.417 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.9 ptpt -150.05 154.75 38.68 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.025 1.33 . . . . 1.21 112.814 -179.252 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.9 t -129.95 148.27 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 126.785 2.034 . . . . 0.44 109.632 -178.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 55.2 m -135.42 132.91 38.06 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 118.465 0.575 . . . . 0.48999999999999999 110.244 161.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -72.51 134.34 45.24 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 122.037 0.922 . . . . 1.79 109.767 167.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . 0.257 1.8 pt -127.7 33.39 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 125.57 1.548 . . . . 0.53000000000000003 109.787 174.482 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.2 p -141.55 63.93 1.42 Allowed 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 127.087 2.155 . . . . 2.4399999999999999 114.362 -177.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -58.03 -19.05 36.32 Favored Glycine 0 CA--C 1.543 1.819 0 N-CA-C 116.326 1.29 . . . . 1.25 116.326 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -108.86 -5.55 31.03 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 125.74 1.638 . . . . 0.95999999999999996 116.63 -178.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 1.3 m -152.11 -15.86 0.18 Allowed 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 115.2 1.555 . . . . 1.77 115.2 -177.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 51.75 38.93 45.88 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 127.246 2.355 . . . . 0.81000000000000005 114.995 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -110.76 6.5 21.53 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.116 1.366 . . . . 1.21 113.236 -175.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 15.0 ttm -140.48 121.07 14.22 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.714 2.006 . . . . 1.9199999999999999 110.497 -161.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.418 ' HB2' HD22 ' A' ' 98' ' ' LEU . 78.2 m-85 -143.36 146.33 33.43 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 113.815 1.043 . . . . 1.9199999999999999 113.815 -174.502 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -90.88 114.15 26.52 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.901 1.68 . . . . 2.6299999999999999 109.417 167.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 95.9 mt -120.55 123.66 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 O-C-N 120.762 -1.211 . . . . 0.63 109.565 -175.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 75.7 mttt -124.28 111.23 15.58 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.78 1.232 . . . . 2.6499999999999999 110.254 -174.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.3 mt -120.46 155.26 23.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 127.445 2.298 . . . . 0.23999999999999999 109.052 -178.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -153.66 130.49 10.89 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.186 1.394 . . . . 1.8500000000000001 107.291 162.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.6 t -155.3 140.75 17.78 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 120.107 1.321 . . . . 0.32000000000000001 112.352 -173.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -61.91 -6.6 2.91 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.621 1.568 . . . . 3.8900000000000001 115.111 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -84.68 -14.58 48.06 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.733 1.613 . . . . 1.77 114.207 175.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -87.13 12.03 12.51 Favored 'General case' 0 CA--C 1.559 1.302 0 N-CA-C 114.37 1.248 . . . . 2.0299999999999998 114.37 -175.404 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.412 ' HB3' HG21 ' A' ' 104' ' ' VAL 0.252 0.0 OUTLIER -76.83 -14.62 59.89 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 117.225 2.305 . . . . 2.54 117.225 -166.476 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -118.29 25.33 10.38 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.341 1.456 . . . . 4.8799999999999999 111.253 169.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 52.3 mmtt -112.61 131.36 55.66 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.544 1.538 . . . . 1.3799999999999999 111.868 177.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 36.1 mtt180 -65.71 161.69 20.16 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.667 1.187 . . . . 3.77 111.071 163.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 54.1 m -38.04 -55.56 1.24 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 126.356 1.862 . . . . 0.92000000000000004 113.799 168.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.5 p -63.86 -40.34 88.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 125.212 1.405 . . . . 0.85999999999999999 113.598 178.329 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -71.92 -32.3 67.22 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 121.619 -0.675 . . . . 1.01 111.573 178.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -63.79 -53.45 50.62 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.568 0.747 . . . . 0.64000000000000001 109.885 169.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 62.8 m170 -49.94 -52.35 34.06 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.796 0.838 . . . . 0.75 111.968 178.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 23.4 tp60 -46.9 -44.33 19.62 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.037 1.735 . . . . 1.23 113.134 178.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 85.0 mtp -62.33 -43.51 98.66 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 119.159 0.89 . . . . 0.92000000000000004 112.516 178.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.6 t -71.7 -27.41 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 C-N-CA 125.647 1.579 . . . . 0.23000000000000001 112.146 178.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -74.31 -50.67 17.87 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.525 1.93 . . . . 0.46999999999999997 109.381 177.268 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 12.5 mm-40 -65.56 -18.66 65.49 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.378 1.471 . . . . 2.54 113.635 178.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.69 -44.67 85.99 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 119.337 0.971 . . . . 0.78000000000000003 111.056 179.03 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.11 5.66 9.22 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 115.513 1.672 . . . . 0.67000000000000004 115.513 -174.204 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.5 ttmt -51.67 -40.23 59.66 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 125.037 1.335 . . . . 3.1699999999999999 113.136 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -81.68 10.32 6.31 Favored 'General case' 0 CA--C 1.554 1.126 0 CA-C-O 122.121 0.962 . . . . 2.3999999999999999 113.347 -174.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -126.84 -56.26 1.37 Allowed 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 129.443 3.097 . . . . 3.1200000000000001 108.652 -176.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -128.57 120.97 53.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 126.872 2.069 . . . . 1.54 108.371 165.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -105.75 1.69 27.28 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 119.919 -1.738 . . . . 2.6299999999999999 114.812 -179.103 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.3 mp0 -71.88 47.01 0.14 Allowed 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 130.573 3.549 . . . . 3.25 115.332 -173.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . 0.254 2.1 mpt? -72.35 12.75 0.41 Allowed 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 116.703 2.112 . . . . 1.78 116.703 -173.632 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 39.8 p-80 -63.39 -28.4 69.96 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.366 -0.834 . . . . 4.1100000000000003 112.083 154.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -77.94 -22.61 68.44 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 115.916 1.126 . . . . 0.45000000000000001 115.916 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.418 HD22 ' HB2' ' A' ' 63' ' ' TYR . 10.1 mt -92.06 136.02 33.51 Favored 'General case' 0 C--O 1.238 0.463 0 O-C-N 120.813 -1.404 . . . . 2.1499999999999999 111.222 -164.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 15.3 ttt180 -114.63 105.49 13.12 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.686 1.594 . . . . 3.73 106.896 169.055 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 1.5 mt -114.41 137.47 47.64 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.648 0 CA-C-O 123.098 1.427 . . . . 0.44 111.005 -169.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -130.54 123.72 30.24 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-N 111.769 -2.468 . . . . 1.8799999999999999 106.628 -169.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 17.3 p -140.86 152.68 45.29 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 126.237 1.815 . . . . 0.28999999999999998 109.217 -175.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -161.05 173.88 14.56 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.296 -0.866 . . . . 0.69999999999999996 110.481 176.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.412 HG21 ' HB3' ' A' ' 73' ' ' LYS . 12.5 p -141.84 133.71 13.54 Favored Pre-proline 0 N--CA 1.468 0.467 0 O-C-N 121.329 -0.857 . . . . 0.59999999999999998 111.962 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -77.45 103.45 1.73 Allowed 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.081 1.854 . . . . 0.85999999999999999 110.615 174.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 71.4 tttt -146.87 93.81 2.33 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.428 1.891 . . . . 3.7200000000000002 110.515 -169.085 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 4.0 ptp180 . . . . . 0 C--O 1.253 1.251 0 C-N-CA 126.573 1.949 . . . . 6.6699999999999999 114.856 176.498 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.723 0 N-CA-C 110.194 -0.299 . . . . 4.46 110.194 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . 0.317 1.5 t 54.93 -4.62 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 117.924 2.565 . . . . 5.4400000000000004 117.924 -172.78 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 62.69 153.12 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 127.251 2.22 . . . . 2.4900000000000002 115.128 176.01 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 66.9 p -100.93 170.18 8.47 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 121.128 -0.982 . . . . 0.59999999999999998 109.897 159.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 -70.07 -29.48 66.49 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 120.436 -1.415 . . . . 3.8599999999999999 111.902 163.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -66.54 -38.14 93.15 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 124.282 0.944 . . . . 0.35999999999999999 113.139 177.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.94 -44.27 50.39 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.449 1.499 . . . . 1.98 111.539 172.569 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.4 mt -70.26 -51.87 27.32 Favored 'General case' 0 C--N 1.337 0.046 0 C-N-CA 125.479 1.512 . . . . 0.40000000000000002 110.747 -178.258 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.87 -48.93 76.97 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.904 1.682 . . . . 3.0600000000000001 110.865 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.8 t -65.54 -45.25 93.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 108.435 -0.95 . . . . 0.34000000000000002 108.435 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 98.7 m -56.92 -41.32 77.96 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 118.687 0.676 . . . . 0.38 112.411 176.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -63.86 -42.52 97.52 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 112.753 0.649 . . . . 2.04 112.753 -178.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 32.2 mt -75.45 -30.25 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 CA-C-N 118.629 0.649 . . . . 0.47999999999999998 110.462 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 44.0 mt -60.14 -40.35 89.48 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 120.779 -1.2 . . . . 0.67000000000000004 113.34 171.379 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 27.2 mttt -60.73 -24.95 66.09 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 119.338 0.972 . . . . 1.8500000000000001 113.391 176.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -94.62 -35.38 12.24 Favored 'General case' 0 N--CA 1.434 -1.236 0 C-N-CA 126.895 2.078 . . . . 1.96 115.066 -178.064 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 56.8 mmtt -75.89 -22.77 55.79 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 119.735 -0.786 . . . . 1.3100000000000001 111.856 170.037 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -130.19 51.39 7.45 Favored Pre-proline 0 CA--C 1.551 1.002 0 N-CA-C 118.428 2.751 . . . . 1.6200000000000001 118.428 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -67.66 -18.88 48.28 Favored 'Trans proline' 0 CA--C 1.534 0.507 0 C-N-CA 124.457 3.438 . . . . 0.62 115.099 176.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.96 -5.01 58.9 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 114.861 1.43 . . . . 5.6600000000000001 114.861 172.029 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.09 146.73 52.63 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 113.615 0.968 . . . . 0.40999999999999998 113.615 -178.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 60.9 p -93.34 -32.76 14.16 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.331 -0.849 . . . . 0.68000000000000005 111.06 172.107 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -117.63 137.88 52.34 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.046 0.938 . . . . 0.31 111.527 165.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -156.03 108.16 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 126.685 1.994 . . . . 0.60999999999999999 109.919 171.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.1 ptpt -152.37 157.83 41.84 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.813 1.645 . . . . 1.05 113.618 178.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.3 t -132.67 151.68 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 126.051 1.74 . . . . 0.34999999999999998 110.763 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 89.8 m -141.1 125.22 17.3 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 120.31 -1.493 . . . . 0.40999999999999998 110.846 169.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -67.44 135.3 52.91 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.809 0.814 . . . . 1.77 109.838 168.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.3 pt -134.34 19.93 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 124.909 1.284 . . . . 0.64000000000000001 111.76 178.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.3 t -123.05 83.42 2.12 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 127.316 2.246 . . . . 1.3400000000000001 111.399 176.246 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -73.2 9.22 7.39 Favored Glycine 0 N--CA 1.476 1.363 0 O-C-N 120.325 -1.484 . . . . 1.8500000000000001 115.212 -177.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -129.12 -12.98 2.48 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 126.452 1.977 . . . . 1.23 114.046 -175.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 7.2 t -151.41 -18.04 0.2 Allowed 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 118.575 1.187 . . . . 1.99 114.055 175.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 54.93 37.55 62.76 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 124.686 1.136 . . . . 0.90000000000000002 111.984 -163.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -91.97 1.83 56.94 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.295 1.438 . . . . 0.92000000000000004 113.184 178.377 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 1.4 mtp -134.31 141.46 46.94 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 126.179 1.792 . . . . 2.0099999999999998 112.396 175.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.436 ' H ' HD23 ' A' ' 98' ' ' LEU . 95.4 m-85 -142.62 145.37 33.43 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 122.021 0.915 . . . . 2.0099999999999998 112.363 173.438 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -80.86 133.74 35.64 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 125.897 1.679 . . . . 1.8200000000000001 108.573 161.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.5 mt -137.34 122.7 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 CA-C-N 119.464 1.029 . . . . 0.59999999999999998 108.911 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 70.3 mttt -124.73 112.05 16.28 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.29 1.036 . . . . 2.7599999999999998 110.183 -175.313 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.3 mt -121.96 155.93 26.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 126.858 2.063 . . . . 0.28000000000000003 109.061 -177.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -156.06 126.72 6.8 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.453 1.501 . . . . 2.0600000000000001 107.598 165.154 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.4 t -156.84 147.93 22.0 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 119.932 1.242 . . . . 0.38 112.417 -173.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -57.48 -28.11 63.1 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.245 1.418 . . . . 4.0199999999999996 113.019 -174.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -69.78 -18.22 63.47 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 115.039 1.496 . . . . 1.75 115.039 177.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -80.94 13.84 2.5 Favored 'General case' 0 CA--C 1.545 0.759 0 O-C-N 121.102 -0.999 . . . . 1.6299999999999999 113.215 -176.092 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 50.7 pttt -78.74 -27.68 44.79 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.157 1.383 . . . . 2.7599999999999998 113.348 176.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -109.11 33.7 4.13 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.12 1.768 . . . . 4.8300000000000001 111.875 -167.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 65.4 mmtt -139.56 141.64 37.2 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 126.897 2.079 . . . . 1.78 111.407 -169.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 6.6 mmt180 -65.88 168.78 7.49 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.668 1.187 . . . . 3.8300000000000001 110.872 162.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 94.7 m -54.97 -53.91 49.62 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 113.036 0.754 . . . . 1.22 113.036 170.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 10.1 p -57.4 -40.46 74.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 123.216 0.606 . . . . 0.92000000000000004 111.681 176.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -68.64 -32.36 72.16 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.2 0.815 . . . . 2.0600000000000001 113.2 178.107 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 -62.41 -52.08 65.0 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.556 1.071 . . . . 1.9199999999999999 109.924 170.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 33.1 m170 -58.21 -50.08 74.8 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 118.944 0.793 . . . . 0.78000000000000003 112.64 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -54.15 -40.95 67.9 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 124.706 1.202 . . . . 4.25 113.937 178.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 1.1 mmm -61.97 -34.6 76.44 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 120.403 1.456 . . . . 1.55 111.657 -178.174 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.1 t -79.32 -32.04 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 127.122 2.169 . . . . 0.31 111.347 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -67.7 -46.51 72.03 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.347 1.459 . . . . 0.89000000000000001 111.312 170.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 55.0 tp60 -65.73 -25.76 67.44 Favored 'General case' 0 N--CA 1.445 -0.687 0 O-C-N 120.373 -1.454 . . . . 2.6099999999999999 113.847 -177.239 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.87 -30.99 69.36 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.451 1.5 . . . . 0.34999999999999998 112.521 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -127.13 1.14 6.48 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 115.492 1.664 . . . . 0.60999999999999999 115.492 177.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 31.2 ttmt -46.54 -43.3 16.93 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.443 1.497 . . . . 2.1200000000000001 112.413 175.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -81.74 -18.86 42.79 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-O 121.362 0.601 . . . . 2.1699999999999999 111.509 -171.378 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -88.9 -49.52 6.75 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 127.995 2.518 . . . . 2.3399999999999999 111.197 -178.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 51.0 mt -147.36 101.06 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 127.544 2.338 . . . . 1.3600000000000001 108.115 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.3 ptmm? -79.21 -7.57 58.34 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 116.551 2.056 . . . . 2.7400000000000002 116.551 -166.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -79.19 44.03 0.56 Allowed 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 130.074 3.35 . . . . 3.5299999999999998 115.594 -165.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 4.2 mpp? -73.86 12.45 0.67 Allowed 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 117.651 2.463 . . . . 1.48 117.651 -168.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 68.6 t60 -53.78 -32.6 53.1 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 120.516 1.507 . . . . 4.4500000000000002 112.337 168.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -75.65 -12.23 83.93 Favored Glycine 0 CA--C 1.522 0.475 0 N-CA-C 117.364 1.706 . . . . 0.51000000000000001 117.364 -178.087 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.436 HD23 ' H ' ' A' ' 63' ' ' TYR . 13.2 mt -88.25 133.71 33.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 122.787 1.279 . . . . 2.0899999999999999 111.369 -162.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 19.9 ttm180 -120.0 85.49 2.39 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 126.901 2.081 . . . . 5.7000000000000002 106.9 -172.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 1.6 mt -106.67 141.39 22.01 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 CA-C-O 123.905 1.812 . . . . 0.42999999999999999 112.038 -163.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -135.87 125.43 25.21 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 111.515 -2.584 . . . . 2.0899999999999999 107.513 -170.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 26.2 p -140.99 157.74 44.91 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 125.834 1.654 . . . . 0.26000000000000001 109.077 -176.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 2.5 p -168.55 178.58 4.7 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.583 -1.189 . . . . 0.58999999999999997 109.837 176.084 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.3 p -138.65 129.4 15.17 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 124.106 0.962 . . . . 0.38 112.022 -178.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -82.06 125.39 4.67 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 124.079 3.186 . . . . 0.75 111.957 -175.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 2.7 mmtm -148.28 55.7 1.04 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.106 -0.952 . . . . 5.5999999999999996 112.728 -152.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 24.9 mmt180 . . . . . 0 C--O 1.257 1.481 0 C-N-CA 124.906 1.282 . . . . 7.79 112.982 173.536 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.761 0 N-CA-C 110.025 -0.361 . . . . 5.2999999999999998 110.025 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 80.1 m -127.6 140.82 51.87 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.463 0.705 . . . . 2.7799999999999998 111.704 -176.15 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 12.0 mp0 -114.22 166.57 11.51 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.187 1.795 . . . . 2.3399999999999999 111.305 178.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 80.4 p -120.49 170.59 9.25 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 107.947 -1.131 . . . . 0.56999999999999995 107.947 144.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -69.5 -22.6 63.59 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 120.919 -1.113 . . . . 2.8700000000000001 112.068 166.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.36 -41.38 98.15 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 124.309 0.956 . . . . 0.35999999999999999 112.574 169.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.72 -46.22 40.47 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.681 1.593 . . . . 1.3200000000000001 111.681 171.099 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.6 mt -68.6 -52.47 31.26 Favored 'General case' 0 C--N 1.339 0.113 0 C-N-CA 125.085 1.354 . . . . 0.38 111.225 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -56.59 -50.18 72.71 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.375 1.47 . . . . 3.1299999999999999 110.824 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.7 t -60.3 -46.74 94.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 107.757 -1.201 . . . . 0.29999999999999999 107.757 179.119 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 63.3 m -57.92 -41.22 82.24 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 118.417 0.553 . . . . 0.37 112.358 177.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 -60.55 -45.62 93.23 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 123.28 0.632 . . . . 1.77 111.396 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 42.9 mt -76.87 -27.29 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 117.871 0.305 . . . . 0.65000000000000002 110.433 -175.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 19.0 mt -58.73 -39.0 79.6 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.077 -1.014 . . . . 0.41999999999999998 112.831 168.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 37.6 mttt -65.35 -19.9 66.15 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 113.794 1.035 . . . . 1.48 113.794 175.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -102.39 -34.83 9.03 Favored 'General case' 0 N--CA 1.436 -1.166 0 C-N-CA 126.776 2.03 . . . . 2.2400000000000002 114.532 -174.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 26.6 mmtp -75.97 -30.79 58.73 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 120.038 -0.665 . . . . 2.7999999999999998 111.039 167.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -128.14 50.57 5.74 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 118.351 2.722 . . . . 1.55 118.351 -176.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -60.47 -27.61 85.16 Favored 'Trans proline' 0 C--O 1.236 0.409 0 C-N-CA 123.134 2.556 . . . . 0.81999999999999995 114.297 174.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 31.7 mmt180 -74.86 -9.24 58.36 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 114.079 1.14 . . . . 4.9800000000000004 114.079 179.03 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.59 152.37 15.19 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 115.579 1.696 . . . . 0.40999999999999998 115.579 -173.11 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 42.8 p -104.27 -5.68 21.63 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 127.259 2.223 . . . . 1.0700000000000001 113.148 168.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -143.16 143.88 31.98 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 119.932 1.242 . . . . 0.40999999999999998 111.814 153.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.9 pt -155.15 116.14 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 126.753 2.021 . . . . 0.52000000000000002 111.069 169.079 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 7.9 ptpt -161.03 153.5 20.49 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.481 1.512 . . . . 1.1100000000000001 112.782 179.091 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.5 t -134.54 143.49 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 126.218 1.807 . . . . 0.34999999999999998 110.483 -175.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 64.2 m -133.76 125.14 27.9 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.839 1.656 . . . . 0.46000000000000002 110.805 173.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -75.27 132.86 41.33 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 122.304 1.05 . . . . 1.8200000000000001 111.526 171.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.4 pt -133.84 26.8 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 C-N-CA 126.295 1.838 . . . . 0.59999999999999998 110.898 178.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 46.8 t -134.2 69.91 1.46 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 126.879 2.072 . . . . 1.3500000000000001 112.696 176.177 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -54.06 -25.13 30.53 Favored Glycine 0 CA--C 1.54 1.609 0 N-CA-C 116.074 1.19 . . . . 1.5 116.074 -179.158 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -88.35 -17.67 56.79 Favored Glycine 0 CA--C 1.534 1.28 0 CA-C-N 119.118 1.459 . . . . 1.5 116.194 -176.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 9.8 m -154.86 -32.46 0.1 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.792 1.237 . . . . 1.72 114.127 -164.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 64.99 47.1 86.35 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 125.426 1.489 . . . . 0.80000000000000004 112.987 -166.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -98.15 -1.6 41.87 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 126.402 1.881 . . . . 0.91000000000000003 114.098 176.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 15.6 mtm -136.96 138.8 40.97 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 126.151 1.781 . . . . 1.45 110.88 177.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -143.75 146.51 33.19 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.701 0.8 . . . . 1.8700000000000001 111.781 172.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -94.91 130.08 41.68 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.61 1.564 . . . . 2.3900000000000001 109.561 169.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 80.4 mt -137.65 129.33 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.879 0.872 . . . . 0.79000000000000004 110.636 -167.032 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 60.0 mttt -115.75 125.12 52.37 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.94 0.896 . . . . 3.77 110.272 173.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.455 HD12 HG13 ' A' ' 84' ' ' VAL . 1.2 mt -129.21 155.18 41.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 C-N-CA 125.482 1.513 . . . . 0.41999999999999998 109.877 173.376 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -158.35 133.23 8.4 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 120.059 -1.651 . . . . 2.0099999999999998 109.31 171.062 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 19.6 t -162.4 147.1 12.26 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 119.911 1.232 . . . . 0.45000000000000001 112.21 -174.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -53.91 -28.83 39.21 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.382 1.473 . . . . 4.7699999999999996 113.014 -179.018 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -65.7 -20.32 66.24 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 115.237 1.569 . . . . 1.8200000000000001 115.237 177.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -84.43 2.1 42.32 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 115.104 1.52 . . . . 1.99 115.104 -168.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 16.4 pttm -69.34 -47.35 64.63 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-O 121.819 0.819 . . . . 2.9100000000000001 112.079 -176.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -84.2 35.29 0.53 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 128.842 2.857 . . . . 4.1799999999999997 111.455 -170.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 49.0 mmtt -140.11 140.35 36.02 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 127.892 2.477 . . . . 1.3 110.754 -172.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 49.5 mtt180 -68.13 172.42 5.74 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.537 0.735 . . . . 3.7200000000000002 111.404 163.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 37.3 m -51.41 -54.41 26.93 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.671 0.789 . . . . 0.93000000000000005 112.852 168.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 10.9 p -57.23 -37.68 57.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 124.312 1.045 . . . . 0.68000000000000005 112.701 176.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -80.59 -32.3 36.52 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 113.128 0.788 . . . . 1.1899999999999999 113.128 -177.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -61.94 -50.26 72.84 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 119.904 1.229 . . . . 0.64000000000000001 109.846 168.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 50.8 m170 -55.75 -49.73 72.32 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 122.912 0.485 . . . . 0.68999999999999995 111.629 177.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 47.4 tp60 -46.88 -45.1 20.2 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.706 2.002 . . . . 1.3700000000000001 112.937 -178.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 71.9 mtp -62.34 -43.26 99.24 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.998 0.919 . . . . 1.1299999999999999 112.189 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.455 HG13 HD12 ' A' ' 67' ' ' ILE . 6.0 t -74.03 -27.23 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 126.612 1.965 . . . . 0.23999999999999999 112.097 178.466 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -71.98 -50.04 32.08 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 126.003 1.721 . . . . 0.56000000000000005 108.751 176.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 15.3 mm-40 -65.88 -24.38 66.84 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.621 1.168 . . . . 2.3799999999999999 112.806 179.1 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -56.44 -37.17 69.87 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.398 1.079 . . . . 0.45000000000000001 112.568 -176.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -127.79 4.62 6.04 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 115.236 1.569 . . . . 0.47999999999999998 115.236 -179.054 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 16.4 ttmt -50.73 -34.9 28.84 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.827 1.251 . . . . 2.9900000000000002 113.309 -178.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -74.05 -29.92 62.14 Favored 'General case' 0 N--CA 1.439 -1.025 0 O-C-N 121.484 -0.76 . . . . 2.5800000000000001 111.78 -177.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.23 -58.42 3.29 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 127.944 2.498 . . . . 2.71 111.995 175.185 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 34.7 mt -136.97 123.88 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 125.778 1.631 . . . . 1.0700000000000001 107.868 178.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -90.75 -12.04 37.73 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 115.005 1.483 . . . . 2.8799999999999999 115.005 -166.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -85.77 67.19 9.96 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 126.182 1.793 . . . . 3.5299999999999998 113.752 -156.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . 0.272 0.8 OUTLIER -74.35 -4.0 33.7 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 115.71 1.745 . . . . 1.8400000000000001 115.71 176.844 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 67.2 t60 -55.76 -24.52 35.86 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 121.61 -0.681 . . . . 4.3399999999999999 112.786 153.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -88.2 -27.0 26.84 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 127.424 2.44 . . . . 0.54000000000000004 116.146 177.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.0 mt -90.5 134.5 34.32 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 121.895 -0.768 . . . . 2.3300000000000001 111.622 -166.303 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 27.0 ttt180 -117.08 92.68 3.92 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.837 1.655 . . . . 3.2999999999999998 108.527 -176.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -114.03 135.12 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-O 123.094 1.426 . . . . 0.46999999999999997 113.198 -159.65 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -131.36 91.22 2.98 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 112.897 -1.956 . . . . 2.0 109.917 -164.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.1 p -99.64 152.34 20.16 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.988 1.715 . . . . 0.31 111.895 178.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.2 p -156.39 -179.42 8.15 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 125.716 1.606 . . . . 0.64000000000000001 110.614 174.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.5 p -143.27 132.04 11.43 Favored Pre-proline 0 N--CA 1.476 0.834 0 O-C-N 121.5 -0.75 . . . . 0.46000000000000002 112.725 -179.186 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -77.02 125.11 7.75 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 124.327 3.351 . . . . 0.68999999999999995 112.294 -176.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 38.2 mttt -149.7 100.68 3.0 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 113.017 -1.901 . . . . 3.98 111.52 -156.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 70.7 ttt-85 . . . . . 0 C--O 1.251 1.157 0 C-N-CA 127.849 2.46 . . . . 10.27 114.307 164.637 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.883 0 CA-C-O 121.211 0.529 . . . . 5.7599999999999998 111.054 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.22 159.81 21.31 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 126.493 1.917 . . . . 2.9300000000000002 111.272 -174.246 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -153.05 163.18 40.33 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 121.234 -0.916 . . . . 2.4399999999999999 111.255 164.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 69.3 p -110.7 179.05 4.17 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.764 1.226 . . . . 0.65000000000000002 109.957 160.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -71.02 -30.27 66.43 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 120.86 -1.15 . . . . 3.3700000000000001 111.951 161.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.21 -38.14 82.0 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 124.8 1.191 . . . . 0.40000000000000002 114.119 -178.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.53 -45.28 37.19 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.638 1.575 . . . . 1.22 111.575 174.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 15.0 mt -69.42 -52.82 23.25 Favored 'General case' 0 CA--C 1.522 -0.125 0 C-N-CA 125.68 1.592 . . . . 0.41999999999999998 110.945 -178.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.482 ' HE ' ' CD ' ' A' ' 91' ' ' GLU . 5.9 tpt180 -56.38 -49.64 73.88 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 125.419 1.487 . . . . 4.9800000000000004 111.585 -178.726 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 37.1 t -65.57 -42.17 92.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 107.827 -1.175 . . . . 0.51000000000000001 107.827 -179.021 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 87.1 m -57.99 -38.49 76.2 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 118.547 0.612 . . . . 0.47999999999999998 112.318 174.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 -63.06 -40.86 98.95 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 113.498 0.925 . . . . 1.74 113.498 -177.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 16.4 mt -81.32 -30.79 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 118.363 0.529 . . . . 0.68999999999999995 110.34 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 45.5 mt -51.95 -38.33 56.08 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 114.372 1.249 . . . . 0.72999999999999998 114.372 169.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 57.0 mttt -59.65 -31.05 69.17 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 124.962 1.305 . . . . 2.6200000000000001 113.912 178.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -93.69 -32.02 14.21 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 127.616 2.366 . . . . 2.3999999999999999 113.794 -174.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 59.9 mmtt -75.32 -26.55 58.74 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 119.805 -0.758 . . . . 1.6200000000000001 111.086 168.317 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -128.45 55.47 17.52 Favored Pre-proline 0 CA--C 1.55 0.959 0 N-CA-C 117.897 2.554 . . . . 1.6200000000000001 117.897 -177.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -68.83 -19.28 41.0 Favored 'Trans proline' 0 CA--C 1.534 0.489 0 C-N-CA 123.947 3.098 . . . . 0.81000000000000005 113.993 168.118 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 76.4 mtt180 -79.46 -2.61 42.75 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 114.601 1.334 . . . . 6.0899999999999999 114.601 174.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.25 158.38 33.46 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 115.727 1.751 . . . . 0.71999999999999997 115.727 -170.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 64.2 p -118.09 -15.77 9.85 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.97 1.308 . . . . 0.57999999999999996 112.651 168.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -131.66 141.72 49.67 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.914 0.885 . . . . 0.32000000000000001 111.727 152.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.0 pt -149.79 117.96 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 126.084 1.754 . . . . 0.77000000000000002 110.661 161.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 11.4 ptpt -152.8 155.01 36.31 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.86 1.264 . . . . 1.3999999999999999 112.285 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.7 t -135.78 144.88 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 126.281 1.833 . . . . 0.28999999999999998 110.398 -176.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 94.4 m -136.77 128.61 29.1 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.317 0.647 . . . . 0.32000000000000001 110.646 171.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -73.14 123.74 24.21 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.589 0.756 . . . . 2.0099999999999998 109.604 165.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.3 pt -122.18 27.2 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 125.001 1.321 . . . . 0.71999999999999997 110.574 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 36.6 t -136.32 65.55 1.52 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 127.189 2.196 . . . . 1.5700000000000001 111.001 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.37 0.6 2.66 Favored Glycine 0 CA--C 1.54 1.607 0 N-CA-C 117.227 1.651 . . . . 1.6000000000000001 117.227 -176.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -131.72 4.13 5.4 Favored Glycine 0 CA--C 1.538 1.521 0 C-N-CA 125.687 1.613 . . . . 1.4299999999999999 115.131 176.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 4.4 t -147.97 -27.35 0.34 Allowed 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 118.614 1.207 . . . . 1.5600000000000001 113.979 175.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 59.09 33.14 73.19 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 127.138 2.304 . . . . 1.0 114.316 -170.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -84.31 -28.27 27.23 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 118.291 1.046 . . . . 1.28 113.516 178.249 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -106.49 140.54 39.23 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 125.052 1.341 . . . . 1.6200000000000001 113.017 -179.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -142.64 145.68 33.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.751 -1.113 . . . . 1.8200000000000001 111.605 170.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -83.58 138.66 33.28 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 125.101 1.36 . . . . 1.78 109.288 162.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 93.9 mt -133.95 126.83 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.189 0.996 . . . . 0.56000000000000005 108.939 169.186 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 67.8 mttt -124.59 122.22 36.94 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.555 1.142 . . . . 2.6200000000000001 110.127 178.147 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.416 ' CD1' HG13 ' A' ' 84' ' ' VAL . 1.6 mt -126.25 158.66 35.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 125.869 1.668 . . . . 0.40000000000000002 109.296 -179.173 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -151.89 130.17 12.02 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 126.293 1.837 . . . . 1.8600000000000001 106.257 160.407 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 21.2 t -154.35 139.55 17.51 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 118.745 0.702 . . . . 0.35999999999999999 110.683 -176.06 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -58.32 -18.3 26.23 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.32 1.448 . . . . 3.1699999999999999 114.525 -177.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -74.23 -19.72 60.42 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.311 1.444 . . . . 1.6899999999999999 114.529 177.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -82.84 10.91 6.74 Favored 'General case' 0 CA--C 1.555 1.17 0 N-CA-C 116.123 1.898 . . . . 1.6299999999999999 116.123 -169.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.782 ' HA ' HG11 ' A' ' 104' ' ' VAL . 22.6 pttt -65.26 -46.85 78.85 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 127.059 2.144 . . . . 2.1200000000000001 115.754 -165.064 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -92.4 -20.7 20.76 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 126.799 2.04 . . . . 5.1100000000000003 112.353 -175.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 66.7 mmtt -58.82 142.91 49.05 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.567 1.147 . . . . 1.24 113.083 177.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 9.8 mmp_? -69.12 168.82 13.16 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 125.52 1.528 . . . . 6.4800000000000004 111.148 163.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.6 m -46.76 -56.86 5.52 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.424 0.69 . . . . 1.23 112.606 170.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.7 p -58.8 -41.73 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 125.235 1.414 . . . . 0.96999999999999997 112.633 178.026 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -76.0 -23.08 55.22 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 118.703 -0.665 . . . . 1.1200000000000001 112.496 -177.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -68.63 -58.05 4.83 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 119.634 1.107 . . . . 0.59999999999999998 109.925 164.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 32.5 m170 -56.14 -43.87 78.66 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.618 0.767 . . . . 0.48999999999999999 112.788 -177.082 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 50.9 tp60 -53.31 -40.6 64.9 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.325 1.45 . . . . 1.27 113.086 178.179 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 2.6 mtm -64.04 -39.57 94.38 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 119.649 1.113 . . . . 1.26 111.283 178.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.416 HG13 ' CD1' ' A' ' 67' ' ' ILE . 2.3 t -73.18 -28.42 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 125.497 1.519 . . . . 0.28000000000000003 111.775 177.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -71.58 -48.2 49.93 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.644 1.578 . . . . 0.59999999999999998 110.812 174.027 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.14 -22.32 66.89 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 120.736 -1.227 . . . . 2.77 112.384 177.03 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.28 -22.07 66.82 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 113.704 1.001 . . . . 0.94999999999999996 113.704 -177.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -132.69 -1.95 3.39 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 114.604 1.335 . . . . 0.58999999999999997 114.604 173.55 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 36.3 tttt -47.02 -41.74 17.02 Favored 'General case' 0 C--N 1.344 0.327 0 C-N-CA 124.682 1.193 . . . . 3.48 111.62 173.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -76.29 -3.15 35.12 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 123.913 0.885 . . . . 3.0800000000000001 112.761 -173.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.482 ' CD ' ' HE ' ' A' ' 35' ' ' ARG . 11.7 mm-40 -105.89 -51.54 2.97 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 128.288 2.635 . . . . 3.27 111.677 170.306 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 5.6 mt -143.33 126.88 13.61 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.371 0 C-N-CA 128.575 2.75 . . . . 1.9099999999999999 106.648 -178.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -94.63 -22.46 18.15 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.174 -0.954 . . . . 3.8599999999999999 113.196 -175.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -74.61 78.56 1.99 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.463 1.505 . . . . 3.75 113.018 -174.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 4.2 mpp? -82.38 13.46 3.58 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.936 1.295 . . . . 1.24 114.368 177.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 80.8 t60 -63.8 -34.29 77.59 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 120.624 -1.297 . . . . 4.3700000000000001 114.082 -177.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -84.5 -11.94 76.56 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 126.218 1.866 . . . . 0.57999999999999996 113.901 174.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.3 mp -86.47 139.13 31.18 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.427 1.091 . . . . 1.8500000000000001 111.917 -172.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 16.7 ttm180 -126.99 99.36 5.69 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 126.272 1.829 . . . . 5.3200000000000003 109.85 -169.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 3.6 mt -108.94 145.62 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-O 122.945 1.355 . . . . 0.37 113.306 -167.175 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -144.39 134.6 24.27 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 127.93 2.492 . . . . 2.1600000000000001 109.31 -170.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 16.4 p -150.8 153.14 34.88 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 127.847 2.459 . . . . 0.26000000000000001 109.397 -170.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.67 172.34 18.69 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 124.922 1.289 . . . . 0.62 110.045 175.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.782 HG11 ' HA ' ' A' ' 73' ' ' LYS . 8.9 p -136.97 125.87 15.16 Favored Pre-proline 0 N--CA 1.473 0.679 0 N-CA-C 113.661 0.985 . . . . 0.52000000000000002 113.661 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -78.24 134.39 12.79 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 123.211 2.607 . . . . 0.77000000000000002 110.763 170.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 25.1 ttmt -133.08 96.73 3.83 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.101 1.36 . . . . 2.6600000000000001 108.335 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 . . . . . 0 C--O 1.25 1.099 0 C-N-CA 127.319 2.248 . . . . 10.23 113.555 -171.206 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.779 0 N-CA-C 111.414 0.153 . . . . 4.9800000000000004 111.414 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.2 t -154.96 163.44 40.3 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.919 1.287 . . . . 3.7599999999999998 112.272 -177.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -137.03 151.58 49.1 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 126.072 1.749 . . . . 2.6200000000000001 112.09 173.058 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 80.8 p -120.92 176.14 5.7 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.526 1.53 . . . . 0.77000000000000002 111.324 165.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 -66.04 -31.12 71.82 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 120.169 -1.582 . . . . 4.1699999999999999 112.048 160.339 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.14 -46.13 95.13 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 125.565 1.555 . . . . 0.52000000000000002 112.603 177.069 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.34 -47.24 47.42 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.469 1.507 . . . . 1.28 112.179 177.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 11.7 mt -72.24 -47.65 48.7 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.075 1.35 . . . . 0.44 111.716 -179.135 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -56.03 -50.44 70.9 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 126.381 1.873 . . . . 2.96 111.117 177.439 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 50.2 t -60.1 -46.21 94.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 107.945 -1.132 . . . . 0.32000000000000001 107.945 178.057 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 37.6 m -59.41 -39.14 82.5 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 118.974 -0.536 . . . . 0.40000000000000002 112.438 179.036 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 7.9 mm-40 -60.48 -40.96 93.19 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 118.88 0.764 . . . . 2.0 112.43 178.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 49.0 mt -81.63 -28.16 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 123.129 0.572 . . . . 0.45000000000000001 110.63 -177.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 18.0 mt -59.66 -40.31 87.32 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 120.722 -1.236 . . . . 0.53000000000000003 112.83 168.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 46.5 mttt -63.55 -23.31 67.33 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 119.423 1.01 . . . . 1.3400000000000001 113.383 177.343 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -96.4 -35.51 11.15 Favored 'General case' 0 N--CA 1.434 -1.265 0 C-N-CA 126.937 2.095 . . . . 2.0899999999999999 114.803 -177.154 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 64.3 mmtt -74.17 -27.75 60.97 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 118.176 -0.916 . . . . 1.24 111.125 167.363 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -127.29 51.44 6.63 Favored Pre-proline 0 CA--C 1.551 0.995 0 N-CA-C 117.347 2.351 . . . . 1.53 117.347 -178.478 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -64.75 -14.0 42.39 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 125.171 3.914 . . . . 0.76000000000000001 115.04 176.356 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 32.5 mmt180 -83.31 -14.98 51.83 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.955 1.465 . . . . 4.8399999999999999 114.955 170.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.62 143.14 47.32 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 116.728 2.122 . . . . 0.65000000000000002 116.728 -166.22 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 77.8 p -96.89 -24.85 15.67 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.922 0.889 . . . . 0.60999999999999999 112.64 175.462 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -126.28 140.42 52.54 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.838 0.855 . . . . 0.51000000000000001 111.743 161.287 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.3 pt -155.77 117.8 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 126.292 1.837 . . . . 0.69999999999999996 110.582 173.472 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.2 ptpt -152.44 155.84 38.32 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.459 1.504 . . . . 1.3600000000000001 112.408 173.573 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.1 t -132.15 143.24 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 125.98 1.712 . . . . 0.47999999999999998 109.9 177.341 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 74.6 m -136.53 123.64 21.65 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 118.46 0.573 . . . . 0.46000000000000002 111.72 173.053 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -65.59 128.05 34.37 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 108.528 -0.916 . . . . 1.97 108.528 165.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.9 pt -127.53 33.1 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 125.859 1.663 . . . . 0.46000000000000002 109.499 178.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.6 t -145.98 57.46 1.21 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 128.138 2.575 . . . . 1.27 110.828 -173.46 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.21 -0.85 0.33 Allowed Glycine 0 CA--C 1.541 1.711 0 C-N-CA 126.681 2.086 . . . . 1.3100000000000001 117.889 -178.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -144.54 24.25 2.0 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 126.488 1.994 . . . . 1.4299999999999999 113.505 -178.357 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -162.99 -27.77 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.565 1.546 . . . . 1.52 112.901 172.633 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 53.41 39.87 60.32 Favored Glycine 0 CA--C 1.536 1.362 0 C-N-CA 127.277 2.37 . . . . 0.63 114.707 -173.198 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -96.7 -34.79 11.23 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.976 1.31 . . . . 0.81000000000000005 113.716 178.374 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 8.9 mtm -96.23 138.42 33.86 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 124.183 0.993 . . . . 1.29 111.525 177.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -142.63 144.88 32.99 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.019 0.928 . . . . 1.9199999999999999 112.759 172.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -82.29 137.99 34.68 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 126.289 1.836 . . . . 2.3399999999999999 109.215 165.095 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 92.2 mt -136.19 125.15 38.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.017 0.927 . . . . 0.62 109.507 169.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 64.4 mttt -123.89 114.62 20.07 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.47 1.108 . . . . 2.8500000000000001 109.957 177.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.2 mt -122.92 157.56 28.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 126.535 1.934 . . . . 0.34999999999999998 109.653 -177.212 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -154.93 132.91 11.57 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.756 1.623 . . . . 1.73 108.265 163.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 33.2 t -158.6 140.53 13.79 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 119.277 0.944 . . . . 0.38 110.515 -174.585 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -58.16 -19.81 35.88 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 114.311 1.226 . . . . 2.7799999999999998 114.311 -177.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -72.01 -19.65 61.83 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.052 1.341 . . . . 1.75 114.387 179.362 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -79.44 13.28 2.04 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 114.165 1.172 . . . . 1.79 114.165 -171.342 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 42.6 pttt -77.69 -42.13 35.59 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 113.226 0.825 . . . . 2.4199999999999999 113.226 -172.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -81.4 38.8 0.5 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.342 1.057 . . . . 3.7799999999999998 112.739 -177.365 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 61.5 mmtt -138.44 144.75 40.28 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 126.164 1.786 . . . . 1.54 111.886 -171.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 55.4 mtt180 -71.98 167.24 20.55 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 124.226 1.01 . . . . 3.8100000000000001 111.144 154.304 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 95.6 m -43.39 -56.03 3.8 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 126.136 1.774 . . . . 0.66000000000000003 113.216 166.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.5 p -59.07 -42.63 87.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.92 1.288 . . . . 0.51000000000000001 113.264 175.552 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -74.68 -23.31 58.61 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 118.578 -0.725 . . . . 1.3100000000000001 112.381 -177.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -67.78 -54.69 17.14 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 119.728 1.149 . . . . 0.71999999999999997 110.241 163.617 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 36.6 m170 -49.94 -51.29 42.32 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.068 0.947 . . . . 0.57999999999999996 112.102 -179.069 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 15.5 tp60 -47.37 -44.17 23.9 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.082 1.353 . . . . 1.4199999999999999 113.541 178.17 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 76.5 mtp -61.91 -43.92 97.85 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 119.334 0.97 . . . . 1.1599999999999999 111.467 -177.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.1 t -72.62 -28.28 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 126.579 1.952 . . . . 0.22 111.226 179.339 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -72.5 -50.07 28.51 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.924 1.69 . . . . 0.47999999999999998 109.679 176.461 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.8 mm-40 -65.01 -20.13 66.35 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.738 1.215 . . . . 2.2400000000000002 113.355 178.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.94 -43.53 86.39 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 118.707 0.685 . . . . 0.40999999999999998 111.398 178.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.55 5.65 9.54 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 115.132 1.53 . . . . 0.34000000000000002 115.132 -174.245 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.9 ttmt -52.43 -38.18 58.53 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 125.034 1.333 . . . . 2.98 112.89 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -76.2 -26.08 55.79 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 112.92 0.711 . . . . 3.02 112.92 -178.174 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -78.9 -60.73 2.26 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.502 1.921 . . . . 3.3900000000000001 110.647 175.152 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 42.5 mt -135.22 103.44 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 126.393 1.877 . . . . 1.04 108.361 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 14.1 ptpt -79.61 -17.38 53.97 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 115.428 1.64 . . . . 2.4199999999999999 115.428 -169.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 19.7 mp0 -67.14 47.78 0.04 OUTLIER 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 130.227 3.411 . . . . 3.3199999999999998 116.269 -171.613 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 4.2 mpp? -62.65 -2.1 1.02 Allowed 'General case' 0 N--CA 1.476 0.865 0 O-C-N 119.31 -2.118 . . . . 1.3100000000000001 115.21 177.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 2.6 p80 -58.05 -29.82 65.69 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 119.419 1.009 . . . . 3.2799999999999998 113.34 162.45 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -85.49 -23.39 47.44 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 124.862 1.22 . . . . 0.51000000000000001 113.495 177.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.6 mp -83.19 143.3 30.57 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 122.401 1.096 . . . . 1.55 112.386 -169.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 24.1 ttt180 -118.88 95.93 5.03 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 127.258 2.223 . . . . 2.9500000000000002 108.511 -175.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 2.7 mt -110.14 138.31 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 CA-C-O 123.66 1.695 . . . . 0.34999999999999998 113.528 -168.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -137.76 127.09 24.71 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-N 111.116 -2.765 . . . . 1.97 108.494 -169.379 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 12.4 p -145.51 154.44 42.2 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.123 1.769 . . . . 0.28999999999999998 108.955 -173.026 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.2 p -160.94 173.24 15.57 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.475 -1.238 . . . . 0.56999999999999995 110.309 176.567 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.4 p -138.9 123.74 11.71 Favored Pre-proline 0 C--O 1.237 0.445 0 N-CA-C 112.649 0.611 . . . . 0.56999999999999995 112.649 -177.463 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -74.73 126.63 10.27 Favored 'Trans proline' 0 N--CA 1.448 -1.205 0 C-N-CA 122.934 2.422 . . . . 0.88 108.431 169.569 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -124.14 74.79 1.32 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.721 1.608 . . . . 3.4500000000000002 109.109 -174.024 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 58.2 ttt-85 . . . . . 0 C--O 1.252 1.216 0 C-N-CA 127.563 2.345 . . . . 9.4600000000000009 112.851 -176.468 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.848 0 CA-C-O 120.474 0.178 . . . . 4.4500000000000002 111.232 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.6 m 65.98 144.54 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 127.614 2.365 . . . . 3.02 114.869 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -143.14 162.36 35.77 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 120.656 -1.278 . . . . 2.6099999999999999 113.177 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 56.6 p -121.32 178.79 4.64 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.053 1.741 . . . . 0.62 110.022 169.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -70.08 -27.92 65.01 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.046 -1.033 . . . . 3.2599999999999998 111.491 160.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -71.79 -39.8 59.17 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 125.622 1.582 . . . . 0.38 114.105 -178.237 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.29 -44.18 43.87 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 119.449 1.625 . . . . 2.0 111.334 174.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 8.9 mt -68.52 -56.18 9.21 Favored 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 125.987 1.715 . . . . 0.35999999999999999 110.67 178.058 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.58 -46.65 77.22 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.235 1.014 . . . . 2.8999999999999999 111.555 -178.675 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.8 t -61.65 -48.01 90.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 107.972 -1.122 . . . . 0.41999999999999998 107.972 178.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 52.9 m -57.31 -43.97 83.73 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 118.645 0.657 . . . . 0.44 112.059 176.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -61.99 -28.81 69.83 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.339 1.456 . . . . 2.8500000000000001 113.262 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 64.4 mt -90.49 -29.19 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 124.532 1.133 . . . . 0.52000000000000002 111.702 173.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.6 mt -56.94 -36.69 70.54 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 120.321 -1.487 . . . . 0.77000000000000002 112.754 172.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 38.0 mttt -63.67 -17.33 62.84 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 115.004 1.483 . . . . 1.6499999999999999 115.004 177.138 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -106.56 -37.73 6.37 Favored 'General case' 0 N--CA 1.429 -1.508 0 C-N-CA 125.987 1.715 . . . . 1.9399999999999999 113.576 -172.221 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -77.34 -23.62 50.9 Favored 'General case' 0 N--CA 1.453 -0.311 0 O-C-N 123.538 0.524 . . . . 1.23 111.99 166.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -133.99 52.4 8.01 Favored Pre-proline 0 CA--C 1.546 0.795 0 N-CA-C 117.702 2.482 . . . . 1.55 117.702 -179.361 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -61.73 -22.68 74.94 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 123.585 2.857 . . . . 0.73999999999999999 113.547 166.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 19.1 mtm180 -67.91 -15.04 63.43 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 114.654 1.353 . . . . 7.5300000000000002 114.654 174.289 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.84 144.74 47.36 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 114.45 1.278 . . . . 0.47999999999999998 114.45 -164.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 65.3 p -96.27 -19.66 19.12 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.938 0.895 . . . . 0.51000000000000001 112.551 174.083 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -130.77 142.23 50.4 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.202 1.001 . . . . 0.32000000000000001 111.975 159.28 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.4 pt -155.5 111.4 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 126.662 1.985 . . . . 0.46999999999999997 111.359 172.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.6 ptpt -154.22 150.14 27.75 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.006 1.322 . . . . 1.1699999999999999 112.71 -178.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.4 t -131.88 143.25 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 C-N-CA 125.818 1.647 . . . . 0.37 110.512 -173.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 77.6 m -135.34 129.71 33.87 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.825 1.25 . . . . 0.34000000000000002 112.1 172.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -78.94 132.68 36.81 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.11 0.964 . . . . 1.76 110.457 170.176 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.7 pt -130.58 28.24 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 125.843 1.657 . . . . 0.56999999999999995 111.285 179.211 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 41.6 t -139.13 63.72 1.5 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 127.625 2.37 . . . . 1.3200000000000001 110.981 -176.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.98 -9.06 12.19 Favored Glycine 0 CA--C 1.54 1.641 0 N-CA-C 117.086 1.594 . . . . 1.1899999999999999 117.086 -176.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -115.9 3.67 20.98 Favored Glycine 0 CA--C 1.537 1.456 0 C-N-CA 126.363 1.935 . . . . 1.0600000000000001 115.331 179.278 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 37.0 t -155.32 -38.37 0.09 Allowed 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 118.631 1.215 . . . . 1.99 113.087 -176.492 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 64.58 36.45 93.17 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 127.026 2.251 . . . . 0.68999999999999995 113.754 -169.406 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -85.02 -23.05 28.81 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 114.007 1.114 . . . . 0.88 114.007 173.264 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 1.2 mpp? -112.82 140.41 47.63 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.176 0.99 . . . . 1.8500000000000001 113.56 -176.302 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -143.52 144.99 32.21 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 122.154 0.978 . . . . 1.8700000000000001 113.144 173.035 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -98.46 120.15 38.39 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.009 1.724 . . . . 2.52 109.653 169.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 68.2 mt -132.07 129.54 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 124.684 1.194 . . . . 1.0 109.833 -163.5 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 67.9 mttt -125.45 125.66 43.69 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.62 0.768 . . . . 2.5299999999999998 110.628 179.068 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.421 ' CD1' HG13 ' A' ' 84' ' ' VAL . 1.2 mt -129.49 157.95 42.14 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 127.589 2.356 . . . . 0.25 108.774 178.273 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 71.5 tt0 -157.14 128.61 6.95 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.774 1.63 . . . . 1.6499999999999999 108.325 168.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 9.1 t -162.54 147.74 12.31 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 120.301 1.41 . . . . 0.40999999999999998 114.05 -169.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -59.07 -24.6 63.04 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 126.049 1.74 . . . . 4.5499999999999998 113.929 -172.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -73.57 -16.18 61.26 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.56 1.544 . . . . 1.8 115.086 177.362 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -83.51 -2.59 56.31 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 114.509 1.3 . . . . 2.04 114.509 -171.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.401 ' HB3' HG21 ' A' ' 104' ' ' VAL . 21.2 pttm -69.75 -42.09 74.35 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 113.505 0.928 . . . . 2.8500000000000001 113.505 -178.084 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -91.58 41.44 1.07 Allowed 'General case' 0 CA--C 1.547 0.847 0 CA-C-O 123.018 1.389 . . . . 4.0899999999999999 111.143 -170.065 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.9 mmtp -146.31 142.49 28.35 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 128.225 2.61 . . . . 2.9199999999999999 109.572 -166.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.423 ' HG2' ' H ' ' A' ' 76' ' ' ARG . 10.7 mmt85 -64.39 166.91 7.54 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.697 1.199 . . . . 3.4199999999999999 110.583 158.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 55.0 m -53.19 -51.09 63.2 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 113.801 1.038 . . . . 0.71999999999999997 113.801 168.407 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 14.7 p -63.47 -34.67 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 112.616 0.598 . . . . 0.62 112.616 177.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -65.22 -44.98 86.53 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 118.117 -0.945 . . . . 2.6099999999999999 111.667 173.067 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -58.04 -51.42 69.73 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 119.291 0.95 . . . . 0.60999999999999999 110.202 174.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 40.0 m170 -56.08 -50.01 72.21 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 123.405 0.682 . . . . 0.46999999999999997 111.371 178.23 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 32.6 tp60 -53.07 -39.84 63.59 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.771 1.228 . . . . 1.53 112.875 -177.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 85.4 mtp -59.36 -47.11 86.67 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 119.752 1.16 . . . . 1.0900000000000001 111.973 177.274 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.421 HG13 ' CD1' ' A' ' 67' ' ' ILE . 5.7 t -70.21 -32.19 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 126.009 1.723 . . . . 0.23000000000000001 111.41 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -65.55 -52.29 53.52 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.128 1.771 . . . . 0.57999999999999996 109.942 173.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 8.2 tm0? -66.98 -26.44 66.81 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.328 1.051 . . . . 3.1499999999999999 113.161 -176.256 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -56.73 -39.09 73.32 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.712 1.605 . . . . 0.39000000000000001 112.27 -179.038 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.64 -0.57 10.21 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 114.315 1.228 . . . . 0.44 114.315 -178.342 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 25.6 ttpt -52.5 -33.26 44.19 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.549 1.139 . . . . 1.8899999999999999 112.805 175.355 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -81.81 -3.14 53.21 Favored 'General case' 0 CA--C 1.553 1.067 0 O-C-N 121.335 -0.853 . . . . 1.8999999999999999 112.564 -178.269 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -104.61 -54.76 2.46 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 127.496 2.318 . . . . 3.1800000000000002 111.435 169.551 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 32.6 mt -138.31 119.9 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 126.775 2.03 . . . . 0.94999999999999996 108.494 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 41.5 mtmt -90.97 -1.43 57.83 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 115.012 1.486 . . . . 2.7599999999999998 115.012 -169.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -81.58 58.61 3.78 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.379 1.872 . . . . 3.04 114.676 -158.143 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . 0.3 1.3 mpt? -75.28 9.52 2.04 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 119.779 -1.826 . . . . 1.79 115.477 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 13.7 p80 -65.01 -26.4 68.27 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.46 0.541 . . . . 3.96 112.46 153.134 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -94.77 -17.98 36.49 Favored Glycine 0 C--N 1.333 0.414 0 C-N-CA 126.455 1.979 . . . . 0.5 115.986 -175.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.8 mt -93.33 124.1 37.08 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 117.732 0.766 . . . . 2.1699999999999999 110.875 -165.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 22.0 ttt180 -110.14 89.13 2.93 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 126.363 1.865 . . . . 3.3199999999999998 107.347 -177.209 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 1.1 mt -108.69 139.99 29.05 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.565 0 CA-C-O 123.037 1.399 . . . . 0.46999999999999997 111.743 -163.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -131.5 121.08 23.89 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 111.777 -2.465 . . . . 1.98 108.115 -169.026 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 24.4 p -131.93 153.96 49.76 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 126.268 1.827 . . . . 0.28000000000000003 110.196 -179.059 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -160.49 179.76 8.34 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 126.114 1.766 . . . . 0.64000000000000001 109.135 171.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.401 HG21 ' HB3' ' A' ' 73' ' ' LYS . 3.7 p -136.73 135.91 20.91 Favored Pre-proline 0 N--CA 1.474 0.748 0 O-C-N 120.897 -1.127 . . . . 0.48999999999999999 111.98 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -84.46 135.79 6.22 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 124.52 3.48 . . . . 0.81000000000000005 111.402 -179.262 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 7.0 mmtt -143.53 27.04 1.56 Allowed 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 114.182 1.179 . . . . 3.79 114.182 -161.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 71.1 mtm180 . . . . . 0 C--O 1.25 1.106 0 C-N-CA 126.182 1.793 . . . . 8.6300000000000008 114.212 -168.572 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.003 0 CA-C-O 120.289 0.09 . . . . 5.3300000000000001 111.203 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . 0.265 92.2 m 63.82 139.13 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 127.379 2.272 . . . . 2.9500000000000002 113.283 -167.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.8 mp0 -130.21 157.93 41.12 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 114.439 1.274 . . . . 2.48 114.439 -168.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 72.8 p -121.04 179.51 4.36 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 126.257 1.823 . . . . 0.53000000000000003 110.278 157.494 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.41 -32.7 71.87 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 120.941 -1.1 . . . . 3.6800000000000002 112.357 164.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.14 -38.4 96.47 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 125.183 1.373 . . . . 0.35999999999999999 112.949 174.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.71 -45.66 63.64 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.879 1.272 . . . . 1.49 112.369 176.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 13.1 mt -71.21 -49.87 38.98 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 125.008 1.323 . . . . 0.38 111.491 -178.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -54.26 -50.65 66.72 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 127.358 2.263 . . . . 3.9900000000000002 110.991 178.355 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.8 t -63.86 -45.68 96.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 108.312 -0.996 . . . . 0.25 108.312 178.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 51.6 m -55.7 -36.52 67.27 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.243 0.46 . . . . 0.34999999999999998 112.243 177.189 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -69.21 -43.47 74.03 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 114.123 1.157 . . . . 2.04 114.123 -178.326 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 26.7 mt -75.67 -28.29 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-N 118.689 0.677 . . . . 0.53000000000000003 110.403 -179.278 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 21.5 mt -55.75 -37.7 68.84 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.569 0.951 . . . . 0.40000000000000002 113.569 169.134 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 38.3 mttt -62.84 -32.92 74.24 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 118.563 0.62 . . . . 1.3999999999999999 112.561 179.516 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -90.57 -35.48 15.0 Favored 'General case' 0 N--CA 1.438 -1.054 0 C-N-CA 128.362 2.665 . . . . 2.25 114.779 -175.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -77.17 -17.43 58.56 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 120.159 -0.616 . . . . 1.3799999999999999 112.525 169.099 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -132.16 60.96 54.8 Favored Pre-proline 0 CA--C 1.551 1.017 0 N-CA-C 116.914 2.19 . . . . 2.1099999999999999 116.914 175.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -68.68 -24.09 35.49 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 124.658 3.572 . . . . 0.90000000000000002 114.759 170.152 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -80.27 0.13 34.05 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 114.495 1.295 . . . . 6.25 114.495 171.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.53 147.99 52.51 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 114.654 1.353 . . . . 0.52000000000000002 114.654 -175.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 25.8 p -103.82 -18.69 14.55 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.525 1.13 . . . . 0.56000000000000005 112.671 167.013 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -133.41 144.2 49.38 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 119.568 1.076 . . . . 0.40999999999999998 112.149 159.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.9 pt -157.04 110.51 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 127.425 2.29 . . . . 0.56000000000000005 110.815 171.014 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.5 ptpt -151.61 155.99 39.53 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.602 1.561 . . . . 1.1899999999999999 113.024 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.9 t -136.04 145.57 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 126.016 1.726 . . . . 0.34999999999999998 111.628 -172.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 94.3 m -138.82 126.67 22.24 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.233 0.613 . . . . 0.34999999999999998 111.695 172.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -71.51 126.82 30.66 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.787 0.803 . . . . 1.8200000000000001 110.451 168.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.2 pt -125.84 22.06 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 C-N-CA 125.524 1.529 . . . . 0.5 111.147 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.401 ' CB ' ' H ' ' A' ' 62' ' ' MET . 38.1 t -131.65 62.37 1.63 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 128.709 2.803 . . . . 1.3600000000000001 110.896 179.198 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.01 -10.1 18.16 Favored Glycine 0 CA--C 1.539 1.562 0 N-CA-C 117.261 1.664 . . . . 1.1499999999999999 117.261 -174.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -103.38 -19.62 12.17 Favored Glycine 0 N--CA 1.471 1.019 0 C-N-CA 126.534 2.016 . . . . 0.96999999999999997 115.28 179.054 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 33.1 m -145.34 -29.56 0.44 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.29 1.036 . . . . 2.5899999999999999 113.345 -163.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 60.42 41.41 98.55 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 128.201 2.81 . . . . 0.72999999999999998 113.735 -175.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -98.39 -16.86 19.12 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.265 1.826 . . . . 0.90000000000000002 112.955 -178.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.415 ' HG3' ' CA ' ' A' ' 97' ' ' GLY . 4.3 mpp? -117.8 141.49 48.35 Favored 'General case' 0 CA--C 1.52 -0.175 0 C-N-CA 126.627 1.971 . . . . 1.99 112.809 175.24 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -144.39 147.02 32.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.863 -1.062 . . . . 1.8500000000000001 111.241 171.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -83.7 137.24 33.86 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 125.185 1.394 . . . . 2.23 109.193 163.504 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 97.5 mt -133.72 129.16 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 123.869 0.868 . . . . 0.65000000000000002 109.345 170.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 70.0 mttt -124.56 116.97 23.31 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.673 1.189 . . . . 2.73 110.624 177.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.3 mt -122.29 162.62 21.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 C-N-CA 126.361 1.865 . . . . 0.46999999999999997 109.271 -177.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -156.67 131.32 8.83 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.696 1.999 . . . . 1.77 107.111 162.251 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.7 t -157.28 140.14 15.13 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 120.402 1.456 . . . . 0.34000000000000002 111.767 -173.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -58.26 -21.64 49.36 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.241 1.016 . . . . 3.4100000000000001 113.543 -178.485 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -71.01 -15.4 62.56 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 115.274 1.583 . . . . 1.8 115.274 179.288 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -88.0 10.26 19.58 Favored 'General case' 0 CA--C 1.553 1.068 0 N-CA-C 115.537 1.68 . . . . 1.6200000000000001 115.537 -171.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.58 ' HA ' HG11 ' A' ' 104' ' ' VAL . 14.9 pttt -63.07 -46.35 87.87 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 126.251 1.82 . . . . 2.3300000000000001 115.569 -165.626 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -100.69 -11.03 20.29 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.385 1.474 . . . . 4.4100000000000001 111.692 -168.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 32.9 mmtt -64.76 142.88 58.28 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 126.81 2.044 . . . . 1.52 112.561 174.483 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 16.6 mtt-85 -67.58 166.49 14.82 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 122.9 0.48 . . . . 3.2200000000000002 111.092 159.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.8 m -50.31 -50.56 50.32 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 113.873 1.064 . . . . 0.73999999999999999 113.873 172.643 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 10.4 p -62.71 -38.44 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 123.474 0.71 . . . . 0.67000000000000004 112.783 174.154 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -75.34 -19.79 59.41 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.736 0.643 . . . . 1.4299999999999999 112.736 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -70.34 -53.94 14.63 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.397 -0.814 . . . . 0.66000000000000003 109.807 163.311 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 49.7 m170 -53.05 -48.28 67.79 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.82 0.848 . . . . 0.66000000000000003 113.062 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 47.0 tp60 -47.79 -43.28 27.52 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.796 1.638 . . . . 1.1799999999999999 113.477 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 3.6 mtm -67.07 -39.82 86.91 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 118.93 0.786 . . . . 1.3100000000000001 111.768 -178.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.2 t -73.14 -33.83 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 125.616 1.567 . . . . 0.34999999999999998 110.644 179.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -63.42 -50.64 69.0 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.111 1.764 . . . . 0.45000000000000001 110.536 173.168 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 35.5 tp60 -66.05 -21.7 66.39 Favored 'General case' 0 N--CA 1.45 -0.474 0 O-C-N 119.849 -1.782 . . . . 2.3799999999999999 114.118 -178.024 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.17 -40.55 85.97 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.379 0.672 . . . . 0.44 111.589 177.214 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.66 3.78 9.54 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 115.372 1.619 . . . . 0.34999999999999998 115.372 -176.02 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 26.3 ttmt -43.8 -45.55 7.36 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 125.405 1.482 . . . . 1.9299999999999999 111.877 174.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -84.27 -6.0 59.34 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 113.225 0.824 . . . . 3.0499999999999998 113.225 -172.033 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -98.51 -56.15 2.54 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 127.226 2.211 . . . . 2.21 111.867 174.527 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 23.3 mt -132.96 92.61 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.57 1.548 . . . . 1.1799999999999999 107.76 176.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -69.8 -19.08 63.5 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 114.094 1.146 . . . . 2.6299999999999999 114.094 -172.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . 0.295 16.3 pt-20 -73.97 43.75 0.17 Allowed 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 116.359 1.985 . . . . 3.9700000000000002 116.359 -169.09 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 64.3 mtm -66.21 0.75 1.85 Allowed 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 126.52 1.928 . . . . 1.3600000000000001 116.023 -172.473 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 21.0 p-80 -61.6 -5.52 1.91 Allowed 'General case' 0 CA--C 1.55 0.959 0 N-CA-C 113.836 1.05 . . . . 4.8300000000000001 113.836 157.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.415 ' CA ' ' HG3' ' A' ' 62' ' ' MET . . . -104.17 -14.99 22.98 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 125.468 1.509 . . . . 0.40000000000000002 115.807 167.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.9 mp -89.68 124.97 35.06 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 118.904 1.352 . . . . 1.5600000000000001 111.753 -169.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 50.3 ttt180 -103.26 100.87 10.79 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 127.072 2.149 . . . . 3.1200000000000001 110.063 -178.225 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 5.4 mt -108.97 144.39 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-O 123.822 1.772 . . . . 0.45000000000000001 112.853 -170.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -136.89 135.93 38.25 Favored 'General case' 0 N--CA 1.433 -1.298 0 C-N-CA 128.944 2.897 . . . . 1.97 109.248 -175.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.4 p -145.66 157.7 43.93 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 126.792 2.037 . . . . 0.56000000000000005 108.176 -175.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -155.81 175.25 14.18 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 124.77 1.228 . . . . 0.71999999999999997 108.959 172.386 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.58 HG11 ' HA ' ' A' ' 73' ' ' LYS . 7.1 p -142.8 126.33 9.38 Favored Pre-proline 0 N--CA 1.467 0.395 0 O-C-N 121.386 -0.821 . . . . 0.48999999999999999 112.198 -179.531 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -73.82 102.41 1.5 Allowed 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 122.953 2.435 . . . . 0.68999999999999995 110.894 176.201 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 19.4 ttpp -139.58 70.5 1.37 Allowed 'General case' 0 C--O 1.236 0.347 0 C-N-CA 127.172 2.189 . . . . 3.0099999999999998 106.754 168.168 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 . . . . . 0 C--O 1.25 1.114 0 C-N-CA 127.293 2.237 . . . . 7.6200000000000001 110.798 -179.124 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.649 0 CA-C-O 119.858 -0.115 . . . . 8.0099999999999998 111.015 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 14.7 t -154.7 -22.03 0.12 Allowed 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 115.267 1.58 . . . . 4.9100000000000001 115.267 178.137 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -154.43 138.53 16.47 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 123.993 0.917 . . . . 2.0800000000000001 113.103 -175.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 58.7 p -102.02 176.46 5.19 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 126.115 1.766 . . . . 0.60999999999999999 111.674 177.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -67.72 -34.03 76.06 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 120.486 -1.384 . . . . 4.1299999999999999 112.115 164.298 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.4 -38.34 80.3 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 125.044 1.307 . . . . 0.46000000000000002 114.229 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.87 -48.66 66.96 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 118.926 1.363 . . . . 1.3899999999999999 112.551 -179.082 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 16.2 mt -70.11 -48.48 57.4 Favored 'General case' 0 CA--C 1.527 0.082 0 C-N-CA 125.375 1.47 . . . . 0.52000000000000002 110.822 -178.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -53.32 -51.18 63.2 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 127.584 2.354 . . . . 3.8799999999999999 111.319 179.251 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 39.3 t -62.83 -48.37 88.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 124.584 1.154 . . . . 0.23000000000000001 108.425 177.573 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 42.1 m -57.0 -38.78 73.56 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.303 0.483 . . . . 0.42999999999999999 112.303 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 -62.87 -41.22 99.3 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 112.395 0.517 . . . . 1.8500000000000001 112.395 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 69.5 mt -78.03 -30.23 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 123.377 0.671 . . . . 0.48999999999999999 111.317 -179.61 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 18.0 mt -55.33 -39.48 70.04 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 121.075 -1.015 . . . . 0.44 113.287 172.556 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 44.5 mttt -64.44 -26.36 68.41 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 113.459 0.911 . . . . 1.3200000000000001 113.459 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -90.46 -35.36 15.17 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 126.823 2.049 . . . . 2.25 114.926 -177.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -74.68 -22.7 58.72 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 119.05 -1.06 . . . . 2.23 111.788 168.165 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -130.95 55.54 19.65 Favored Pre-proline 0 CA--C 1.552 1.052 0 N-CA-C 116.817 2.154 . . . . 1.5900000000000001 116.817 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -68.31 -18.94 44.43 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 124.675 3.583 . . . . 0.79000000000000004 115.225 177.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -81.96 -9.93 59.42 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 121.069 -1.019 . . . . 4.8600000000000003 113.514 170.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.26 144.44 46.23 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 114.637 1.347 . . . . 0.53000000000000003 114.637 -173.03 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 74.1 p -95.42 -29.64 14.31 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.769 1.628 . . . . 0.63 111.05 175.16 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -126.71 141.74 51.75 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.711 1.205 . . . . 0.31 111.265 165.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.1 pt -158.69 104.01 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 127.546 2.338 . . . . 0.47999999999999998 109.434 174.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.0 ptpt -149.67 148.6 29.47 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.67 1.188 . . . . 1.3100000000000001 112.86 -177.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.2 t -133.26 147.08 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 126.285 1.834 . . . . 0.35999999999999999 111.246 -170.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 93.7 m -141.77 127.85 19.62 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 118.406 0.548 . . . . 0.34000000000000002 111.538 170.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -68.41 135.86 52.4 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 122.174 0.988 . . . . 1.8100000000000001 110.062 165.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . 0.255 1.6 pt -127.33 25.2 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.887 0 C-N-CA 125.647 1.579 . . . . 0.56000000000000005 111.082 177.506 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 11.3 p -143.34 53.75 1.35 Allowed 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 128.98 2.912 . . . . 2.1200000000000001 114.38 -171.467 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -55.98 -18.41 18.99 Favored Glycine 0 CA--C 1.546 2.022 0 O-C-N 120.403 -1.435 . . . . 1.3100000000000001 116.678 -177.05 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -96.29 -5.84 59.07 Favored Glycine 0 CA--C 1.541 1.693 0 CA-C-N 119.658 1.729 . . . . 1.0 116.132 176.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 11.9 t -147.27 -31.75 0.31 Allowed 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 119.275 1.538 . . . . 1.48 114.301 -173.322 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 58.68 34.82 78.54 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 129.093 3.235 . . . . 0.66000000000000003 114.361 -171.089 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -100.09 3.51 44.04 Favored 'General case' 0 CA--C 1.552 1.021 0 N-CA-C 115.223 1.564 . . . . 0.97999999999999998 115.223 -177.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 2.1 mtp -131.36 138.43 49.16 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 127.396 2.279 . . . . 1.5700000000000001 112.865 175.249 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -145.13 143.11 30.19 Favored 'General case' 0 C--O 1.227 -0.092 0 CA-C-O 122.645 1.212 . . . . 1.8500000000000001 113.933 174.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -82.09 133.0 35.25 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 125.09 1.356 . . . . 1.74 110.021 165.276 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 82.7 mt -133.65 127.08 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 CA-C-N 119.816 1.189 . . . . 0.56000000000000005 110.116 175.468 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 74.1 mttt -123.16 117.94 26.52 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.811 1.244 . . . . 2.5699999999999998 110.232 178.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.3 mt -122.71 160.77 24.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 126.305 1.842 . . . . 0.29999999999999999 109.046 -179.111 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -155.41 131.6 10.19 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 126.266 1.826 . . . . 1.9399999999999999 107.219 162.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.9 t -154.07 137.66 16.01 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 118.678 0.672 . . . . 0.29999999999999999 111.704 -177.061 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -55.11 -16.0 2.66 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 127.223 2.209 . . . . 4.2199999999999998 114.567 176.202 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -76.66 -21.81 54.92 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 114.021 1.119 . . . . 1.71 114.021 175.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -79.97 11.85 3.11 Favored 'General case' 0 CA--C 1.556 1.192 0 N-CA-C 115.446 1.647 . . . . 1.6499999999999999 115.446 -166.085 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.403 ' HA ' HG11 ' A' ' 104' ' ' VAL . 1.0 OUTLIER -75.74 -36.4 59.91 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 117.777 2.51 . . . . 2.4199999999999999 117.777 -163.293 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -80.75 -25.85 37.72 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 120.723 1.601 . . . . 5.3600000000000003 111.429 173.258 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 43.1 mmtt -65.95 133.89 51.81 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.67 1.188 . . . . 1.78 113.289 -173.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 46.2 mtt-85 -63.75 160.73 16.55 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 125.451 1.5 . . . . 3.5699999999999998 110.928 163.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 41.3 m -35.69 -57.77 0.64 Allowed 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 125.377 1.471 . . . . 0.69999999999999996 114.094 167.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.0 p -65.79 -39.54 85.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 125.29 1.436 . . . . 0.58999999999999997 112.674 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -70.21 -26.82 64.05 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 118.487 -0.768 . . . . 0.98999999999999999 112.907 177.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -70.25 -52.75 20.71 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 119.112 0.869 . . . . 0.79000000000000004 110.359 167.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 39.2 m170 -53.35 -49.18 67.66 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 118.911 0.778 . . . . 0.48999999999999999 112.553 -178.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 33.0 tp60 -48.99 -43.52 40.22 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.844 1.258 . . . . 1.3 113.097 177.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 86.3 mtp -59.89 -44.5 94.2 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 121.179 -0.951 . . . . 0.94999999999999996 112.026 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.1 t -73.17 -31.51 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 125.753 1.621 . . . . 0.22 111.608 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -67.51 -49.81 61.71 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 126.644 1.978 . . . . 0.46000000000000002 110.237 175.055 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 39.8 tp60 -69.27 -20.82 63.92 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 120.513 -1.367 . . . . 2.8300000000000001 113.708 -176.167 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.26 -46.87 88.31 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.253 1.421 . . . . 0.51000000000000001 111.658 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.28 -5.09 14.19 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.975 1.102 . . . . 0.38 113.975 -175.327 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 11.7 ttmt -47.72 -35.96 10.6 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.187 1.395 . . . . 2.8300000000000001 113.103 169.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -76.31 -0.16 21.49 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 114.294 1.22 . . . . 2.48 114.294 -178.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -120.27 -49.18 2.29 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 127.94 2.496 . . . . 3.2200000000000002 111.222 175.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 37.2 mt -138.76 118.9 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 127.136 2.174 . . . . 0.94999999999999996 107.224 176.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 37.2 mtpt -86.57 -10.93 52.93 Favored 'General case' 0 N--CA 1.478 0.973 0 O-C-N 120.455 -1.403 . . . . 2.4500000000000002 113.509 -175.198 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 -77.92 47.81 0.66 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 128.052 2.541 . . . . 3.48 115.688 -158.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 3.3 mpp? -65.24 1.97 0.93 Allowed 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 115.391 1.626 . . . . 1.6200000000000001 115.391 -178.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -64.49 -23.52 67.31 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 114.214 1.19 . . . . 3.48 114.214 160.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -90.21 -22.46 35.06 Favored Glycine 0 N--CA 1.475 1.256 0 C-N-CA 126.082 1.801 . . . . 0.53000000000000003 114.916 173.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.9 mp -85.51 145.45 27.39 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.165 0.986 . . . . 1.55 112.85 -169.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 -123.48 101.83 7.55 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 126.385 1.874 . . . . 3.75 109.73 176.287 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 2.3 mt -105.61 146.57 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 CA-C-O 123.515 1.626 . . . . 0.34999999999999998 113.619 -173.527 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -140.36 131.6 26.57 Favored 'General case' 0 N--CA 1.439 -1.004 0 C-N-CA 128.814 2.845 . . . . 1.8799999999999999 108.952 -172.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 19.6 p -146.55 148.71 32.43 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.756 2.022 . . . . 0.34999999999999998 109.489 -177.003 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.7 p -147.77 171.47 15.63 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.566 -1.197 . . . . 0.63 111.027 173.296 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.403 HG11 ' HA ' ' A' ' 73' ' ' LYS . 13.4 p -136.37 128.61 17.34 Favored Pre-proline 0 N--CA 1.47 0.55 0 C-N-CA 123.799 0.84 . . . . 0.48999999999999999 110.332 173.681 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -73.28 127.23 11.74 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 121.966 1.777 . . . . 0.72999999999999998 109.751 176.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 3.2 tmtp? -139.3 22.44 2.57 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 114.67 1.359 . . . . 2.8500000000000001 114.67 -160.518 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 55.4 mtt-85 . . . . . 0 C--O 1.252 1.186 0 C-N-CA 127.304 2.242 . . . . 8.7799999999999994 113.132 176.651 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.942 0 N-CA-C 110.331 -0.248 . . . . 6.6299999999999999 110.331 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.59 176.96 11.95 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.005 1.322 . . . . 4.3399999999999999 111.736 -165.259 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.1 mp0 -103.09 150.29 23.76 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.669 0.747 . . . . 2.5299999999999998 111.39 142.286 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 30.6 p -129.14 173.06 10.81 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.98 1.712 . . . . 0.85999999999999999 109.32 161.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -72.34 -26.88 62.1 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 120.286 -1.509 . . . . 4.6500000000000004 111.19 177.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -66.51 -35.66 90.34 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 125.492 1.52 . . . . 0.40999999999999998 113.282 170.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.69 -50.77 42.46 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.187 1.395 . . . . 1.3700000000000001 111.563 173.71 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.8 mt -68.92 -48.81 62.38 Favored 'General case' 0 C--O 1.223 -0.292 0 C-N-CA 124.897 1.279 . . . . 0.42999999999999999 110.973 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.39 -47.2 69.7 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.792 1.237 . . . . 3.6299999999999999 111.416 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.3 t -67.74 -46.97 81.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 O-C-N 124.156 0.91 . . . . 0.47999999999999998 108.716 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 89.6 m -52.82 -44.48 66.72 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.463 0.705 . . . . 0.53000000000000003 112.005 175.482 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -62.42 -32.68 73.56 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.038 0.935 . . . . 2.9300000000000002 113.126 -177.487 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 35.2 mt -82.27 -35.5 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 CA-C-N 118.798 0.727 . . . . 0.53000000000000003 111.662 172.682 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 20.2 mt -53.74 -38.9 64.83 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 120.907 -1.121 . . . . 0.40000000000000002 113.488 175.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 40.7 mttt -76.29 -9.64 58.8 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 114.8 1.407 . . . . 1.8600000000000001 114.8 -178.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -90.26 -40.83 11.92 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 126.363 1.865 . . . . 3.02 113.214 167.006 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 65.0 mmtt -74.16 -30.12 62.1 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 119.1 -1.04 . . . . 1.29 111.777 177.428 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -132.98 53.15 10.13 Favored Pre-proline 0 CA--C 1.549 0.933 0 N-CA-C 117.285 2.328 . . . . 1.6599999999999999 117.285 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -61.58 -26.38 80.44 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 123.975 3.117 . . . . 1.3500000000000001 114.436 178.229 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 10.9 mmt180 -91.72 -3.79 55.83 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 114.344 1.238 . . . . 5.7599999999999998 114.344 -176.14 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -55.07 149.5 11.95 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.03 1.732 . . . . 0.59999999999999998 114.707 176.173 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 74.0 p -100.87 -9.88 21.2 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 126.172 1.789 . . . . 0.91000000000000003 112.878 178.1 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -135.39 141.94 45.58 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.121 0.968 . . . . 0.34000000000000002 110.52 150.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -154.19 108.14 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 C-N-CA 125.838 1.655 . . . . 0.73999999999999999 110.799 171.517 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.4 ptpt -154.9 156.63 36.46 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.042 1.337 . . . . 1.1299999999999999 113.11 176.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 25.3 t -122.34 151.65 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 127.37 2.268 . . . . 0.48999999999999999 109.458 177.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 63.3 m -138.26 116.65 11.97 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 109.682 -0.488 . . . . 0.66000000000000003 109.682 168.11 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -65.58 133.02 50.3 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 122.18 0.991 . . . . 2.1200000000000001 109.11 166.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.1 pt -126.59 32.23 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 124.721 1.208 . . . . 0.60999999999999999 109.533 178.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.6 t -146.6 45.83 1.2 Allowed 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 126.793 2.037 . . . . 1.27 113.257 -169.247 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -49.59 -31.89 15.56 Favored Glycine 0 CA--C 1.543 1.802 0 O-C-N 120.112 -1.618 . . . . 1.4299999999999999 115.887 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -77.18 -12.81 84.26 Favored Glycine 0 CA--C 1.541 1.673 0 N-CA-C 116.248 1.259 . . . . 1.49 116.248 176.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 4.7 t -147.75 -44.14 0.17 Allowed 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 119.891 1.845 . . . . 1.51 114.384 -173.229 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 73.97 47.73 18.21 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 128.921 3.153 . . . . 0.93000000000000005 112.434 -168.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -96.05 -29.64 14.0 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.545 1.538 . . . . 1.1899999999999999 114.252 174.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -113.09 142.13 46.09 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 125.267 1.427 . . . . 1.8700000000000001 113.811 -177.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -143.2 142.42 31.41 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 122.282 1.039 . . . . 1.8799999999999999 112.824 172.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -83.58 139.98 32.52 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 125.862 1.665 . . . . 2.3199999999999998 109.529 163.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 90.4 mt -135.94 129.59 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-N 119.335 0.97 . . . . 0.67000000000000004 109.185 172.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 77.4 mttt -126.27 113.73 17.34 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.708 1.203 . . . . 2.73 109.768 -177.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.2 mt -125.11 157.82 33.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 126.333 1.853 . . . . 0.23000000000000001 109.109 -178.297 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 48.2 tt0 -157.76 129.34 6.83 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 126.103 1.761 . . . . 1.8400000000000001 107.415 167.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 18.2 t -160.14 145.28 14.97 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 120.131 1.332 . . . . 0.34999999999999998 113.091 -171.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -59.42 -16.9 26.35 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.964 2.105 . . . . 3.6899999999999999 114.583 -176.594 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -77.36 -20.21 55.14 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.733 1.613 . . . . 1.73 115.03 173.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -80.72 5.67 15.08 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 114.861 1.43 . . . . 1.6699999999999999 114.861 -167.246 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 22.8 pttt -73.33 -49.64 26.34 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 114.7 1.37 . . . . 2.9700000000000002 114.7 -171.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . 0.278 15.2 pm0 -80.89 25.35 0.45 Allowed 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 119.658 1.117 . . . . 4.0800000000000001 113.855 -177.336 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 42.1 mmtt -119.03 141.39 48.75 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 127.393 2.277 . . . . 1.23 110.854 -177.569 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 40.1 mtt180 -67.82 166.15 16.05 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 123.003 0.521 . . . . 3.5499999999999998 111.213 158.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 52.6 m -47.4 -53.35 14.18 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 114.384 1.253 . . . . 0.79000000000000004 114.384 170.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 13.6 p -61.11 -37.81 78.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 123.215 0.606 . . . . 0.63 112.594 175.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -74.45 -27.59 60.66 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 118.53 -0.748 . . . . 1.1399999999999999 112.553 179.469 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -64.28 -56.02 17.45 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.279 1.032 . . . . 0.65000000000000002 109.872 166.548 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 35.7 m170 -53.0 -48.33 67.59 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.703 0.801 . . . . 0.48999999999999999 112.255 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 30.8 tp60 -52.64 -40.54 62.9 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.471 1.108 . . . . 1.3799999999999999 113.221 178.278 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -63.67 -37.65 88.15 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 120.3 1.409 . . . . 1.0 111.221 179.449 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.3 t -76.76 -31.08 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 125.192 1.397 . . . . 0.26000000000000001 111.689 179.107 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -67.63 -48.07 67.77 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.597 1.559 . . . . 0.46999999999999997 110.195 173.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -61.55 -27.53 68.68 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 120.713 -1.242 . . . . 3.6200000000000001 113.202 178.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.64 -35.74 74.99 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.614 1.165 . . . . 0.37 112.399 -177.189 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.18 -3.03 8.53 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 113.927 1.084 . . . . 0.42999999999999999 113.927 -178.177 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 26.1 ttpt -49.26 -37.63 24.14 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.141 1.376 . . . . 2.79 112.82 177.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -78.13 -12.64 60.01 Favored 'General case' 0 CA--C 1.552 1.043 0 CA-C-O 121.68 0.753 . . . . 2.6200000000000001 111.863 -173.168 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -109.56 -51.04 2.92 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 128.98 2.912 . . . . 3.1400000000000001 110.681 -171.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.3 mm -129.68 123.62 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 127.851 2.46 . . . . 1.3799999999999999 106.579 164.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -97.01 -9.21 28.64 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 119.873 -1.767 . . . . 3.23 114.876 -178.372 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -81.94 50.77 1.61 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 127.631 2.372 . . . . 2.7599999999999998 114.356 -166.134 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 5.2 mpp? -64.92 -2.21 2.49 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 114.998 1.481 . . . . 1.3100000000000001 114.998 -175.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 19.4 p-80 -63.79 -14.87 56.51 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 114.28 1.215 . . . . 4.6299999999999999 114.28 165.485 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -92.75 -17.55 44.26 Favored Glycine 0 CA--C 1.537 1.431 0 O-C-N 121.13 -0.981 . . . . 0.54000000000000004 114.451 167.298 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.8 mp -89.07 146.49 24.8 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 121.283 -1.127 . . . . 1.5900000000000001 112.685 -170.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 21.3 ttt85 -131.63 99.6 4.85 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.853 2.061 . . . . 3.1299999999999999 110.049 -173.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 4.0 mt -107.96 145.82 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 CA-C-O 123.461 1.6 . . . . 0.46999999999999997 113.943 -169.294 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -135.31 127.89 30.74 Favored 'General case' 0 N--CA 1.438 -1.051 0 C-N-CA 128.446 2.698 . . . . 1.8600000000000001 107.975 -171.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 23.7 p -143.28 160.61 40.18 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 126.466 1.907 . . . . 0.34000000000000002 110.207 -175.074 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -171.28 175.69 4.14 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 124.953 1.301 . . . . 0.64000000000000001 109.735 179.139 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.5 p -136.68 135.66 20.67 Favored Pre-proline 0 N--CA 1.471 0.581 0 C-N-CA 123.855 0.862 . . . . 0.44 110.936 175.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -75.44 129.34 11.87 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 123.561 2.84 . . . . 0.67000000000000004 109.584 173.356 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? -140.8 24.64 2.2 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.265 1.026 . . . . 3.0099999999999998 113.696 -159.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.316 0 C-N-CA 126.878 2.071 . . . . 7.3399999999999999 113.042 -175.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.709 0 CA-C-O 118.319 -0.848 . . . . 5.0899999999999999 110.378 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . 0.31 3.1 t 54.57 19.15 2.28 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 117.58 2.437 . . . . 3.6499999999999999 117.58 169.209 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 18.0 mp0 -44.27 143.75 1.16 Allowed 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 115.734 1.753 . . . . 2.3199999999999998 115.734 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 80.9 p -103.42 169.98 8.22 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.054 0.942 . . . . 0.58999999999999997 109.309 150.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -70.81 -21.74 62.43 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 120.844 -1.16 . . . . 2.8999999999999999 112.662 169.169 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.21 -41.62 96.76 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 125.533 1.54 . . . . 0.44 113.264 169.079 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.68 -47.81 29.4 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.769 1.627 . . . . 1.27 111.708 172.567 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.4 mt -68.46 -50.68 50.71 Favored 'General case' 0 C--O 1.231 0.095 0 C-N-CA 125.456 1.502 . . . . 0.38 111.444 -178.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -57.83 -49.74 75.63 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 126.119 1.768 . . . . 4.3200000000000003 111.145 -179.251 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 36.3 t -60.59 -47.54 92.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 108.223 -1.029 . . . . 0.26000000000000001 108.223 176.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 88.8 m -57.1 -37.58 72.15 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 112.539 0.57 . . . . 0.42999999999999999 112.539 178.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 7.9 mm-40 -64.47 -41.64 96.39 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 113.178 0.807 . . . . 2.0800000000000001 113.178 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 27.7 mt -76.04 -29.83 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-N 118.195 0.452 . . . . 0.65000000000000002 110.561 177.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 23.5 mt -57.42 -39.13 75.53 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 120.865 -1.147 . . . . 0.40000000000000002 113.594 170.406 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 39.5 mttt -64.45 -17.96 64.31 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 113.935 1.087 . . . . 1.45 113.935 177.411 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -104.36 -35.56 7.9 Favored 'General case' 0 N--CA 1.433 -1.325 0 C-N-CA 126.894 2.078 . . . . 1.8600000000000001 114.021 -177.28 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -74.15 -23.33 59.25 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 119.607 -0.837 . . . . 1.2 111.777 167.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -132.86 51.4 7.0 Favored Pre-proline 0 CA--C 1.548 0.871 0 N-CA-C 117.748 2.499 . . . . 2.0699999999999998 117.748 -178.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -64.82 -24.76 61.03 Favored 'Trans proline' 0 C--O 1.238 0.489 0 C-N-CA 123.89 3.06 . . . . 0.76000000000000001 114.352 174.589 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 15.5 mmp_? -76.94 -1.08 26.76 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.593 0.96 . . . . 5.7599999999999998 113.593 173.706 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.15 154.55 30.81 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 115.176 1.547 . . . . 0.45000000000000001 115.176 177.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 70.6 p -107.96 -27.81 9.96 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.022 1.329 . . . . 0.68000000000000005 112.568 165.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -117.67 133.73 55.64 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.745 0.818 . . . . 0.42999999999999999 111.14 163.139 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.3 pt -152.63 99.44 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 125.955 1.702 . . . . 0.53000000000000003 109.689 169.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.2 ptpt -146.67 149.05 32.71 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.194 1.398 . . . . 1.1499999999999999 111.809 -176.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.5 t -133.71 152.31 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 125.947 1.699 . . . . 0.39000000000000001 110.221 -172.525 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 81.4 m -141.56 135.29 29.94 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.356 0.663 . . . . 0.45000000000000001 110.607 167.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -75.86 130.28 38.31 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 122.108 0.956 . . . . 2.0600000000000001 110.315 166.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . 0.273 3.7 pt -123.0 29.1 2.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 125.533 1.533 . . . . 0.47999999999999998 110.33 177.067 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.1 p -135.17 62.85 1.63 Allowed 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 127.897 2.479 . . . . 2.1699999999999999 114.005 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.36 2.27 1.71 Allowed Glycine 0 CA--C 1.539 1.562 0 N-CA-C 117.252 1.661 . . . . 1.3 117.252 178.748 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -122.73 -5.6 8.26 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-N 119.84 1.82 . . . . 0.93000000000000005 115.943 172.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 1.7 m -151.79 -18.68 0.19 Allowed 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 115.066 1.506 . . . . 2.1200000000000001 115.066 -175.112 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 52.53 43.96 59.08 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 126.254 1.883 . . . . 0.80000000000000004 114.209 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -112.55 2.68 16.37 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 125.303 1.441 . . . . 1.1399999999999999 114.097 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 13.9 ttm -132.85 120.92 22.18 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 128.93 2.892 . . . . 1.8300000000000001 109.498 -166.412 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -140.95 143.95 34.85 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.709 0.766 . . . . 1.8300000000000001 112.824 -175.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -82.75 135.59 34.95 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 125.217 1.407 . . . . 2.5699999999999998 108.985 164.026 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 88.3 mt -135.93 127.71 44.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-N 119.457 1.026 . . . . 0.54000000000000004 110.081 172.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -121.01 114.2 21.17 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.9 1.28 . . . . 2.5299999999999998 109.923 176.413 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.446 ' CD1' HG13 ' A' ' 84' ' ' VAL . 1.2 mt -121.55 153.37 25.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 126.011 1.724 . . . . 0.34999999999999998 108.99 179.336 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -157.58 124.13 4.92 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 125.132 1.373 . . . . 1.8600000000000001 107.711 168.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 43.2 t -153.95 144.32 22.25 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.723 1.147 . . . . 0.40000000000000002 113.02 -169.518 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -55.88 -21.88 22.54 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.78 1.632 . . . . 3.73 114.589 -178.211 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -75.52 -21.71 57.75 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 113.692 0.997 . . . . 1.78 113.692 177.036 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -77.67 13.29 1.34 Allowed 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 114.111 1.152 . . . . 2.02 114.111 -167.004 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -83.49 -43.1 16.14 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.888 0.699 . . . . 2.2200000000000002 112.888 -176.581 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -83.12 46.24 1.1 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 125.332 1.453 . . . . 3.4199999999999999 110.765 179.231 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 54.0 mmtt -148.04 144.17 27.72 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 128.316 2.647 . . . . 1.6799999999999999 111.82 -176.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 17.6 mtt85 -70.05 171.12 10.08 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.17 0.988 . . . . 3.8999999999999999 111.341 155.525 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 87.3 m -57.98 -48.26 80.51 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 113.758 1.021 . . . . 1.2 113.758 174.45 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 13.6 p -59.72 -37.3 70.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 O-C-N 121.805 -0.56 . . . . 0.62 112.186 172.441 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -74.55 -26.38 59.92 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 118.609 -0.71 . . . . 1.0 111.996 179.136 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -64.79 -54.09 36.78 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.712 1.142 . . . . 0.73999999999999999 109.911 165.18 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 37.2 m170 -54.29 -49.14 70.3 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.256 1.023 . . . . 0.68999999999999995 113.307 -178.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 56.5 tp60 -48.54 -43.3 35.3 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.667 1.987 . . . . 1.4399999999999999 113.528 177.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 83.2 mtp -63.28 -46.39 86.99 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.681 0.792 . . . . 0.98999999999999999 111.648 179.453 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.446 HG13 ' CD1' ' A' ' 67' ' ' ILE . 2.9 t -66.5 -30.99 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 125.191 1.396 . . . . 0.40999999999999998 111.383 178.119 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -68.37 -54.45 17.19 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.161 1.785 . . . . 0.51000000000000001 110.726 175.196 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.7 -22.12 66.59 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.678 0.791 . . . . 2.96 112.973 -178.077 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.06 -41.1 78.12 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 125.482 1.513 . . . . 0.44 112.608 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.22 2.24 9.18 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 114.646 1.35 . . . . 0.33000000000000002 114.646 -176.533 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 11.7 ttpp -51.65 -37.61 51.17 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 124.819 1.248 . . . . 2.8900000000000001 112.131 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -83.21 -7.11 59.66 Favored 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 113.392 0.886 . . . . 2.02 113.392 -175.661 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -98.21 -51.1 4.11 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 127.027 2.131 . . . . 3.4100000000000001 110.917 174.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 21.4 mt -143.21 104.57 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 126.585 1.954 . . . . 0.95999999999999996 107.642 176.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -79.01 -2.09 38.63 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 115.313 1.597 . . . . 2.3100000000000001 115.313 -174.311 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -74.26 36.69 0.1 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 129.335 3.054 . . . . 3.9500000000000002 116.046 -165.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 5.6 mpp? -63.13 1.89 0.41 Allowed 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 116.053 1.871 . . . . 1.27 116.053 -176.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 7.6 p80 -58.16 -29.46 65.62 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 120.602 -1.311 . . . . 3.6800000000000002 112.036 156.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -78.58 -29.81 51.15 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 126.496 1.998 . . . . 0.40000000000000002 115.595 176.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.2 mp -91.33 122.17 33.71 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.368 -1.077 . . . . 1.6200000000000001 113.07 -158.006 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 47.1 ttt180 -99.1 100.73 11.91 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 127.386 2.274 . . . . 3.2799999999999998 109.785 -179.179 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 2.1 mt -108.04 143.06 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 CA-C-O 123.18 1.467 . . . . 0.59999999999999998 113.506 -170.267 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -133.97 123.27 24.34 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 128.277 2.631 . . . . 1.9199999999999999 108.49 -173.481 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 33.3 p -137.68 156.29 48.19 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 125.62 1.568 . . . . 0.53000000000000003 112.158 -176.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.1 p -167.09 177.31 6.32 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.651 1.58 . . . . 0.64000000000000001 110.476 178.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.5 p -136.87 132.0 18.22 Favored Pre-proline 0 N--CA 1.479 1.01 0 O-C-N 121.033 -1.042 . . . . 0.52000000000000002 111.328 175.343 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -76.29 100.02 1.35 Allowed 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 123.11 2.54 . . . . 1.25 111.379 -176.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -146.97 89.16 1.79 Allowed 'General case' 0 C--O 1.238 0.468 0 C-N-CA 126.373 1.869 . . . . 4.2400000000000002 109.447 -173.598 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 28.7 ptt-85 . . . . . 0 C--O 1.251 1.154 0 N-CA-C 115.208 1.558 . . . . 7.6900000000000004 115.208 -173.437 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.824 0 N-CA-C 113.153 0.798 . . . . 7.4199999999999999 113.153 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 14.8 t -154.32 167.38 30.16 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.546 1.139 . . . . 3.4300000000000002 112.572 -169.522 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 14.0 mp0 -62.65 152.14 36.15 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.438 1.495 . . . . 3.5800000000000001 114.796 -176.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 33.8 p -118.83 171.88 7.91 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.688 1.595 . . . . 0.60999999999999999 111.375 166.262 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -64.04 -32.96 74.69 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 121.474 -0.766 . . . . 2.98 111.106 169.462 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.92 -34.6 71.42 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 124.902 1.239 . . . . 0.46999999999999997 113.821 179.713 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.19 -47.32 54.67 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.133 1.373 . . . . 1.26 111.634 173.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 12.3 mt -68.07 -49.99 57.87 Favored 'General case' 0 CA--C 1.523 -0.095 0 C-N-CA 124.94 1.296 . . . . 0.58999999999999997 111.064 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -57.99 -46.74 84.71 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.218 1.407 . . . . 6.2400000000000002 111.227 -179.487 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.441 HG13 ' HG ' ' A' ' 88' ' ' LEU . 39.5 t -61.91 -46.44 96.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 108.108 -1.071 . . . . 0.35999999999999999 108.108 177.728 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 29.8 m -57.89 -35.92 71.68 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 112.693 0.627 . . . . 0.54000000000000004 112.693 177.552 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -67.32 -44.57 78.81 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 113.112 0.782 . . . . 2.02 113.112 179.507 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 28.7 mt -74.89 -28.23 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-N 118.652 0.66 . . . . 0.53000000000000003 110.555 -179.552 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 23.6 mt -58.52 -36.81 74.4 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 120.945 -1.097 . . . . 0.39000000000000001 113.448 170.28 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 58.0 mttt -58.42 -31.96 68.22 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 113.055 0.761 . . . . 1.8300000000000001 113.055 175.062 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -95.67 -34.59 11.9 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 127.069 2.148 . . . . 2.1000000000000001 114.213 -172.11 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -77.73 -20.67 53.11 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 120.11 -0.636 . . . . 1.1399999999999999 112.468 168.318 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -130.38 52.14 8.86 Favored Pre-proline 0 CA--C 1.55 0.972 0 N-CA-C 118.052 2.612 . . . . 1.54 118.052 178.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -63.51 -22.28 70.89 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.966 3.111 . . . . 0.78000000000000003 114.409 174.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 21.8 mmt180 -87.48 -1.58 58.03 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 113.889 1.07 . . . . 5.04 113.889 177.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.37 151.82 46.34 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.897 1.279 . . . . 0.68000000000000005 113.731 178.275 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 81.8 p -113.23 -9.0 13.5 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.594 1.558 . . . . 0.92000000000000004 113.527 174.297 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -135.37 142.65 45.77 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 120.028 1.285 . . . . 0.55000000000000004 111.107 153.008 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.4 pt -151.29 120.07 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 125.492 1.517 . . . . 0.52000000000000002 111.959 170.018 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -159.2 158.6 32.99 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.386 1.475 . . . . 2.04 113.247 178.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.0 t -138.74 150.96 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 126.364 1.866 . . . . 0.29999999999999999 109.952 -174.229 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 55.0 m -140.88 125.78 18.19 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 118.58 0.627 . . . . 0.40000000000000002 109.865 168.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -69.68 130.17 41.62 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 121.53 -0.731 . . . . 2.5299999999999998 109.273 167.053 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.9 pt -127.36 32.85 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 125.562 1.545 . . . . 0.53000000000000003 110.485 178.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.455 ' HB2' ' H ' ' A' ' 62' ' ' MET . 44.8 t -138.91 69.67 1.37 Allowed 'General case' 0 C--N 1.343 0.307 0 C-N-CA 127.938 2.495 . . . . 1.27 111.209 -177.302 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -42.47 -36.67 2.32 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 126.16 1.838 . . . . 1.3400000000000001 116.129 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -100.02 -14.27 34.29 Favored Glycine 0 CA--C 1.539 1.539 0 N-CA-C 115.981 1.153 . . . . 1.5 115.981 -173.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 8.2 t -138.12 -29.08 0.84 Allowed 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 119.18 1.49 . . . . 2.1600000000000001 114.484 -174.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 55.86 47.68 77.49 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 124.263 0.935 . . . . 0.70999999999999996 112.22 -161.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -93.39 -25.52 17.65 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.948 1.299 . . . . 0.77000000000000002 113.175 173.655 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.455 ' H ' ' HB2' ' A' ' 56' ' ' SER . 23.0 mtm -106.02 135.16 47.97 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 125.268 1.427 . . . . 1.29 111.776 172.624 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -138.13 143.51 40.39 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 121.959 0.885 . . . . 1.8899999999999999 112.179 169.255 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -81.08 139.08 35.89 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 125.931 1.692 . . . . 2.3900000000000001 109.156 162.044 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 93.6 mt -137.39 129.05 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 CA-C-N 119.68 1.127 . . . . 0.64000000000000001 110.018 171.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 79.7 mttt -123.08 117.38 25.28 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.814 1.246 . . . . 2.5299999999999998 109.858 177.306 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.2 mt -126.1 157.06 36.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 126.371 1.868 . . . . 0.29999999999999999 109.338 -179.241 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -154.6 126.11 7.45 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 120.441 -1.412 . . . . 2.1699999999999999 108.326 170.081 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 17.8 t -157.31 146.41 19.96 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-N 119.637 1.108 . . . . 0.35999999999999999 112.937 -172.089 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -57.7 -26.21 61.41 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 126.389 1.876 . . . . 4.04 112.653 -177.375 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -73.08 -11.95 60.73 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.714 1.606 . . . . 1.8799999999999999 114.96 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -91.2 6.09 46.49 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 116.408 2.003 . . . . 1.97 116.408 -171.275 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.47 -37.3 63.26 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 115.84 1.793 . . . . 2.5600000000000001 115.84 -172.52 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -87.36 28.36 0.97 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 124.739 1.216 . . . . 4.1200000000000001 112.669 -177.704 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 55.6 mmtt -131.08 132.99 45.26 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.929 1.292 . . . . 1.8400000000000001 113.335 -164.163 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 23.9 mtt85 -65.09 169.83 5.08 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.889 1.276 . . . . 3.7400000000000002 110.971 164.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 27.5 m -51.53 -53.86 33.33 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 113.384 0.883 . . . . 0.97999999999999998 113.384 174.249 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.4 p -61.61 -38.05 79.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 123.377 0.671 . . . . 0.60999999999999999 111.569 175.591 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -75.04 -20.67 59.47 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 113.727 1.01 . . . . 1.2 113.727 -178.135 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -75.13 -55.35 5.82 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 119.054 0.843 . . . . 0.70999999999999996 110.116 164.706 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 40.8 m170 -56.42 -46.45 80.22 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.912 0.885 . . . . 0.78000000000000003 113.24 -175.236 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 29.7 tp60 -47.88 -41.79 25.17 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.287 1.435 . . . . 1.25 113.088 177.627 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 3.7 mtm -64.17 -40.68 96.63 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 121.491 -0.756 . . . . 1.1599999999999999 111.668 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.8 t -75.78 -23.99 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 126.07 1.748 . . . . 0.23999999999999999 111.235 179.565 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -76.16 -48.44 20.53 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.911 1.684 . . . . 0.45000000000000001 109.273 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 19.5 mm-40 -65.74 -23.68 66.79 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.622 1.169 . . . . 2.52 114.081 178.547 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.49 -38.49 84.47 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.119 0.968 . . . . 0.38 112.688 -177.009 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.441 ' HG ' HG13 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -121.22 3.41 10.36 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 114.605 1.335 . . . . 0.5 114.605 -178.58 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.9 ttmt -53.25 -39.94 64.23 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.674 1.189 . . . . 2.98 112.576 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -82.47 -5.83 58.93 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 123.311 0.644 . . . . 2.1400000000000001 112.629 -175.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -95.83 -49.16 5.44 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 127.412 2.285 . . . . 2.77 111.592 167.682 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 21.2 mt -148.38 110.36 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 128.133 2.573 . . . . 1.0800000000000001 109.024 178.591 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt -85.52 0.38 52.58 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 117.852 2.538 . . . . 4.0099999999999998 117.852 -173.226 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -77.19 48.42 0.62 Allowed 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 129.557 3.143 . . . . 2.8599999999999999 115.845 -160.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . 0.267 1.4 mpt? -70.63 3.51 3.07 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 119.709 -1.869 . . . . 1.9099999999999999 115.42 -177.774 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 17.5 p-80 -66.92 -13.62 61.94 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 114.491 1.293 . . . . 4.4000000000000004 114.491 156.006 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -108.64 -25.39 5.74 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 125.914 1.721 . . . . 0.48999999999999999 115.103 171.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.2 mp -78.27 141.25 38.67 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 121.009 -1.289 . . . . 1.54 113.577 -174.052 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 34.8 ttt180 -125.9 101.76 6.97 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 127.316 2.246 . . . . 3.1600000000000001 109.933 -177.476 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 4.0 mt -108.21 149.77 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-O 123.59 1.662 . . . . 0.44 113.593 -171.405 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -139.77 119.56 13.35 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 111.356 -2.657 . . . . 1.8799999999999999 108.631 -171.355 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.8 p -136.85 145.02 43.92 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 125.285 1.434 . . . . 0.40999999999999998 111.253 -177.314 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.8 p -148.08 178.58 8.42 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.283 -1.326 . . . . 0.76000000000000001 111.404 176.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 6.8 p -145.0 135.82 12.25 Favored Pre-proline 0 N--CA 1.47 0.575 0 O-C-N 121.759 -0.588 . . . . 0.56000000000000005 112.385 -178.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -80.85 105.66 1.71 Allowed 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 123.298 2.665 . . . . 0.76000000000000001 110.999 176.654 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -135.41 25.14 3.48 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.396 1.478 . . . . 3.9399999999999999 113.997 -162.219 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 20.8 ttt180 . . . . . 0 N--CA 1.48 1.043 0 C-N-CA 125.346 1.458 . . . . 7.5899999999999999 111.6 176.471 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.074 0 N-CA-C 112.106 0.41 . . . . 5.4299999999999997 112.106 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -138.32 -178.39 5.27 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 125.651 1.58 . . . . 3.5600000000000001 111.272 173.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -135.46 136.17 41.09 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 126.003 1.721 . . . . 2.27 111.304 169.332 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 70.1 p -100.4 -178.89 3.94 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 126.069 1.748 . . . . 0.81999999999999995 110.13 160.368 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -73.24 -25.71 60.83 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 120.264 -1.522 . . . . 2.8799999999999999 112.208 160.109 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.73 -40.27 98.56 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 125.453 1.501 . . . . 0.48999999999999999 113.244 173.008 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -52.22 -42.19 63.37 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.588 1.555 . . . . 1.24 113.016 177.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 14.0 mt -75.06 -48.44 23.9 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 126.543 1.937 . . . . 0.46000000000000002 110.549 -179.409 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -53.81 -49.09 69.12 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.333 1.453 . . . . 2.9399999999999999 111.149 175.629 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 29.8 t -62.46 -52.04 64.79 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 C-N-CA 125.457 1.503 . . . . 0.34999999999999998 107.576 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 99.3 m -52.24 -43.13 64.15 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.479 0.712 . . . . 0.41999999999999998 111.848 178.036 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -65.33 -42.21 93.15 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 118.267 -0.873 . . . . 2.1899999999999999 112.406 -178.766 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 38.6 mt -72.4 -32.0 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 CA-C-N 119.754 1.161 . . . . 0.45000000000000001 110.494 178.076 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 20.6 mt -54.36 -44.06 71.87 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 121.344 -0.848 . . . . 0.41999999999999998 112.904 173.169 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 34.9 mttt -65.91 -23.88 66.72 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 113.69 0.996 . . . . 2.1499999999999999 113.69 -178.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -93.03 -33.83 13.95 Favored 'General case' 0 N--CA 1.435 -1.211 0 C-N-CA 126.694 1.998 . . . . 2.3399999999999999 114.357 -177.14 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -75.64 -21.43 57.71 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 120.292 -0.563 . . . . 1.1299999999999999 111.947 166.117 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -131.12 58.2 37.16 Favored Pre-proline 0 CA--C 1.549 0.927 0 N-CA-C 117.254 2.316 . . . . 1.6200000000000001 117.254 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -67.18 -13.38 39.43 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 124.241 3.294 . . . . 1.1100000000000001 114.428 168.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.97 -12.72 60.19 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 115.274 1.583 . . . . 7.5599999999999996 115.274 171.717 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.94 153.79 42.69 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 116.37 1.989 . . . . 0.65000000000000002 116.37 -162.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 39.8 p -107.83 -25.28 11.31 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.521 1.528 . . . . 0.56000000000000005 112.466 166.693 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -125.9 141.24 52.07 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.297 0.953 . . . . 0.40000000000000002 111.62 164.143 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.2 pt -157.4 112.06 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 126.589 1.956 . . . . 0.81999999999999995 109.598 174.555 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.8 ptpt -153.38 149.9 28.3 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.239 1.416 . . . . 1.5800000000000001 112.221 -177.514 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.5 t -133.63 151.58 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 126.081 1.753 . . . . 0.46000000000000002 110.574 -176.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 88.0 m -146.6 122.73 10.82 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 121.046 -1.034 . . . . 0.35999999999999999 111.903 167.027 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -65.94 129.04 38.42 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.634 0.731 . . . . 1.99 109.314 162.102 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.9 pt -129.26 28.62 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 C-N-CA 126.364 1.865 . . . . 0.53000000000000003 110.009 179.166 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.5 t -132.99 59.25 1.74 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 127.547 2.339 . . . . 1.22 112.271 -165.293 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -66.5 14.33 0.36 Allowed Glycine 0 CA--C 1.539 1.562 0 C-N-CA 126.126 1.822 . . . . 1.8200000000000001 117.295 -175.236 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -154.07 16.99 0.61 Allowed Glycine 0 CA--C 1.533 1.171 0 C-N-CA 125.568 1.556 . . . . 1.8200000000000001 113.853 -177.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.6 t -161.52 -27.88 0.05 Allowed 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.363 1.465 . . . . 1.8600000000000001 112.49 177.628 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 54.47 40.53 69.65 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 125.642 1.591 . . . . 0.78000000000000003 113.898 -171.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -109.96 -37.07 5.71 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 127.372 2.269 . . . . 1.2 113.959 -176.167 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 30.0 mtm -84.03 130.94 34.86 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 124.283 1.033 . . . . 1.3400000000000001 110.669 175.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -141.32 141.87 33.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 122.147 0.975 . . . . 1.8400000000000001 112.313 172.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -81.23 137.22 35.87 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 124.905 1.282 . . . . 1.97 109.748 162.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.9 mt -136.76 131.94 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 108.213 -1.032 . . . . 0.63 108.213 171.596 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 8.0 tmtm? -128.42 128.61 44.78 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 118.992 0.815 . . . . 7.54 112.095 169.391 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.2 mt -124.51 162.44 26.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 125.772 1.629 . . . . 0.28999999999999998 108.869 -179.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -156.7 131.14 8.69 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 126.652 1.981 . . . . 2.0800000000000001 106.829 164.605 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 32.9 t -158.04 143.92 17.17 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 119.558 1.072 . . . . 0.34999999999999998 111.776 -172.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -55.9 -23.56 32.12 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 113.821 1.045 . . . . 3.0299999999999998 113.821 179.263 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -70.67 -19.14 62.82 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 114.9 1.444 . . . . 1.8300000000000001 114.9 178.401 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -83.14 10.72 7.6 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 114.545 1.313 . . . . 1.6200000000000001 114.545 -169.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.6 pttt -72.35 -44.92 61.91 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.979 1.711 . . . . 2.8999999999999999 113.527 -175.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -83.9 20.36 1.52 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.997 1.719 . . . . 3.71 112.489 -175.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 64.4 mmtt -130.47 132.55 45.73 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 126.469 1.907 . . . . 1.4199999999999999 111.984 -166.061 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 47.6 mtt180 -69.5 168.25 15.0 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.965 1.306 . . . . 3.2999999999999998 111.694 163.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 56.6 m -46.2 -55.41 7.15 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.058 1.343 . . . . 0.89000000000000001 113.533 170.645 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.7 p -57.55 -44.24 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 124.501 1.12 . . . . 0.58999999999999997 112.464 174.233 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -72.04 -27.87 62.98 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 118.378 -0.82 . . . . 1.1000000000000001 112.85 -178.515 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -69.97 -51.84 29.28 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 119.451 1.023 . . . . 0.68000000000000005 109.921 169.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 44.1 m170 -52.17 -53.07 47.66 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.075 0.95 . . . . 0.57999999999999996 112.24 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 28.0 tp60 -46.59 -43.67 17.5 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.1 1.36 . . . . 1.4299999999999999 113.411 177.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 61.6 mtp -64.18 -36.22 83.36 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 120.998 -1.064 . . . . 1.0600000000000001 113.069 -178.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.0 t -79.05 -36.07 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 125.613 1.565 . . . . 0.39000000000000001 110.56 177.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -61.22 -50.29 73.68 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.986 1.314 . . . . 0.46999999999999997 110.221 174.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 63.7 tp60 -57.45 -29.82 64.51 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 120.246 -1.534 . . . . 2.3300000000000001 113.553 178.073 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.54 -37.22 82.98 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.119 0.968 . . . . 0.54000000000000004 112.058 -177.135 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.59 0.88 8.84 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 115.06 1.504 . . . . 0.62 115.06 -179.499 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 30.2 ttpt -47.41 -36.76 10.27 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 125.85 1.66 . . . . 2.6699999999999999 112.618 175.743 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -88.85 7.55 33.68 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 112.403 0.52 . . . . 2.0699999999999998 112.403 -172.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -121.11 -61.13 1.58 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 128.625 2.77 . . . . 2.73 110.449 175.086 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 7.2 mm -115.77 90.33 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 125.046 1.338 . . . . 1.6499999999999999 109.018 171.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 8.0 ptpp? -76.15 -18.56 59.06 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 114.348 1.24 . . . . 4.4000000000000004 114.348 -173.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -67.08 46.19 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 131.258 3.823 . . . . 3.3900000000000001 114.429 -178.677 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 61.2 mtm -71.58 10.25 0.68 Allowed 'General case' 0 CA--C 1.54 0.56 0 O-C-N 119.393 -2.067 . . . . 1.3700000000000001 114.933 -172.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -69.59 -20.59 63.63 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.315 0.857 . . . . 3.2200000000000002 113.315 161.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -84.45 -32.88 21.25 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 123.904 0.764 . . . . 0.62 112.212 174.502 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.0 mp -71.91 144.31 49.03 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 122.515 1.15 . . . . 1.6100000000000001 112.795 -173.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 45.1 ttt180 -128.48 99.67 5.48 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 126.547 1.939 . . . . 3.02 109.126 -176.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 4.9 mt -108.78 141.75 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 123.697 1.713 . . . . 0.62 112.953 -170.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -130.51 132.79 45.8 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 111.495 -2.593 . . . . 1.8500000000000001 107.542 -172.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 17.2 p -151.85 151.85 31.85 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.788 1.235 . . . . 0.33000000000000002 109.945 -173.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.1 p -161.83 -179.53 7.27 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.506 -1.224 . . . . 0.64000000000000001 110.243 178.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 6.3 p -135.15 136.14 24.15 Favored Pre-proline 0 C--N 1.325 -0.481 0 C-N-CA 124.267 1.027 . . . . 0.57999999999999996 109.782 177.115 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -76.35 122.2 6.45 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 123.377 2.718 . . . . 0.68000000000000005 108.791 175.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 6.8 mmtt -146.76 17.21 1.27 Allowed 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 114.351 1.241 . . . . 2.9199999999999999 114.351 -157.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 29.4 ttt-85 . . . . . 0 C--O 1.254 1.297 0 C-N-CA 127.562 2.345 . . . . 8.7200000000000006 111.806 -173.078 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.964 0 CA-C-O 118.907 -0.568 . . . . 4.9100000000000001 112.018 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.9 t -128.54 173.65 10.07 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 119.391 0.996 . . . . 3.1499999999999999 111.806 176.397 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 16.4 mp0 -120.8 158.71 26.97 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.179 1.391 . . . . 2.2000000000000002 113.445 -168.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 80.9 p -127.06 166.87 16.79 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.774 2.03 . . . . 0.67000000000000004 108.291 159.544 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -62.68 -26.66 68.77 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 119.986 1.267 . . . . 3.27 111.951 169.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.43 -43.47 94.82 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 126.01 1.767 . . . . 0.40999999999999998 113.063 172.423 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.88 -45.6 60.14 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 119.321 1.56 . . . . 2.0299999999999998 111.44 173.423 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.7 mt -69.52 -52.22 28.43 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 124.912 1.285 . . . . 0.45000000000000001 111.264 178.423 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -53.62 -48.28 69.46 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.915 1.286 . . . . 2.8999999999999999 110.695 179.378 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 67.6 t -63.99 -49.24 82.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 108.25 -1.019 . . . . 0.27000000000000002 108.25 179.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 98.3 m -56.18 -43.01 77.99 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.15 0.58 . . . . 0.34999999999999998 112.4 178.501 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.74 -37.02 85.78 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.479 1.112 . . . . 2.7599999999999998 111.911 -179.089 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 64.1 mt -79.82 -30.63 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 CA-C-N 118.775 0.716 . . . . 0.47999999999999998 110.855 176.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.2 mt -59.81 -36.09 76.05 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 120.694 -1.254 . . . . 0.52000000000000002 112.687 170.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 27.2 mttt -65.84 -19.05 65.74 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 113.429 0.9 . . . . 1.3799999999999999 113.429 175.624 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -98.43 -39.2 8.89 Favored 'General case' 0 N--CA 1.434 -1.254 0 C-N-CA 126.079 1.752 . . . . 2.1699999999999999 113.946 179.361 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 29.5 mmtt -78.17 -21.69 49.81 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 112.675 0.62 . . . . 1.8100000000000001 112.675 172.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -136.24 52.4 6.31 Favored Pre-proline 0 CA--C 1.55 0.98 0 N-CA-C 118.126 2.639 . . . . 2.1099999999999999 118.126 178.384 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -69.47 -22.07 33.94 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 123.659 2.906 . . . . 0.97999999999999998 114.395 173.077 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 13.4 mmp_? -82.7 -18.37 41.13 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 120.861 -1.149 . . . . 6.75 112.485 177.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -55.5 145.87 21.71 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 125.868 1.667 . . . . 0.58999999999999997 113.559 176.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 81.9 p -86.44 -28.97 23.19 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.247 1.019 . . . . 0.72999999999999998 110.938 176.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -121.69 143.73 49.18 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.001 0.921 . . . . 0.40999999999999998 112.615 164.551 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.5 pt -155.41 111.53 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 128.123 2.569 . . . . 0.56000000000000005 110.167 169.514 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 6.4 ptpt -153.28 156.0 37.59 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.885 1.274 . . . . 1.02 113.062 176.779 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.7 t -133.77 145.94 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 126.314 1.846 . . . . 0.51000000000000001 110.281 -177.665 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 28.4 m -132.69 128.02 36.05 Favored 'General case' 0 CA--C 1.512 -0.482 0 C-N-CA 123.706 0.802 . . . . 0.60999999999999999 111.521 171.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -74.04 125.3 27.99 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 122.209 1.004 . . . . 1.8 109.586 165.286 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.4 pt -124.72 30.5 2.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 125.273 1.429 . . . . 0.47999999999999998 109.96 178.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.465 ' HB2' ' H ' ' A' ' 62' ' ' MET . 32.4 t -138.98 62.73 1.53 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 127.509 2.324 . . . . 1.25 111.998 -175.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -65.63 10.62 0.47 Allowed Glycine 0 CA--C 1.541 1.696 0 O-C-N 120.256 -1.528 . . . . 1.51 116.689 178.284 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -121.49 -4.28 9.92 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 125.749 1.642 . . . . 0.91000000000000003 114.709 171.031 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 9.2 t -156.97 -31.59 0.08 Allowed 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 119.386 1.593 . . . . 1.8400000000000001 114.832 -176.27 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 59.93 48.93 83.67 Favored Glycine 0 CA--C 1.538 1.516 0 C-N-CA 126.036 1.779 . . . . 0.60999999999999999 113.051 -161.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -105.88 -17.47 14.35 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 126.299 1.839 . . . . 0.85999999999999999 114.625 178.079 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.465 ' H ' ' HB2' ' A' ' 56' ' ' SER . 6.6 mtm -110.9 140.43 45.38 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 126.11 1.764 . . . . 1.3500000000000001 111.954 168.298 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -142.99 148.93 37.62 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.725 0.81 . . . . 1.8999999999999999 112.795 172.134 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -85.84 138.45 32.04 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.858 1.663 . . . . 1.96 109.356 163.135 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 84.2 mt -134.75 131.01 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 CA-C-N 120.057 1.299 . . . . 0.63 109.965 171.346 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 66.9 mttt -128.2 118.59 23.61 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.637 1.175 . . . . 2.7599999999999998 111.329 179.297 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.401 ' CD1' HG13 ' A' ' 84' ' ' VAL . 1.2 mt -128.5 157.36 41.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 C-N-CA 126.586 1.954 . . . . 0.25 109.633 -178.368 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -157.39 126.9 6.03 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 120.353 -1.467 . . . . 1.8400000000000001 109.248 170.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 16.4 t -160.1 144.29 14.43 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 120.599 1.545 . . . . 0.41999999999999998 112.815 -169.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -55.32 -29.69 58.76 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.902 1.281 . . . . 4.8700000000000001 112.562 -177.355 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -66.43 -19.25 65.75 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 115.166 1.543 . . . . 1.75 115.166 178.124 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -82.56 -2.78 54.66 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 120.824 -1.172 . . . . 2.0099999999999998 114.106 -172.078 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.516 ' HB3' HG21 ' A' ' 104' ' ' VAL . 55.3 pttt -67.09 -25.45 66.23 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.752 1.621 . . . . 2.77 114.432 -176.18 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -109.05 26.61 10.41 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.976 1.71 . . . . 4.5599999999999996 111.415 -169.461 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 38.9 mmtt -131.79 141.4 49.46 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 126.535 1.934 . . . . 1.3999999999999999 111.319 -172.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 31.0 mtt180 -64.04 165.38 9.11 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 118.975 -0.535 . . . . 4.6299999999999999 110.906 165.359 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 66.7 m -48.24 -54.53 13.27 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 113.154 0.798 . . . . 1.0 113.154 170.19 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.2 p -60.34 -39.38 80.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 124.656 1.182 . . . . 0.65000000000000002 112.717 176.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -69.88 -35.37 74.6 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 112.841 0.682 . . . . 1.3300000000000001 112.841 176.233 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -60.87 -52.33 65.52 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 119.507 1.049 . . . . 0.62 109.911 170.539 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 38.3 m170 -54.8 -51.6 65.27 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.292 0.637 . . . . 0.48999999999999999 111.81 176.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 41.3 tp60 -48.76 -44.02 38.36 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.933 1.693 . . . . 1.24 113.161 178.432 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 1.4 mtm -63.46 -40.36 96.92 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 119.628 1.104 . . . . 1.1299999999999999 111.868 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.401 HG13 ' CD1' ' A' ' 67' ' ' ILE . 4.2 t -74.83 -31.17 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 124.556 1.142 . . . . 0.37 111.145 178.828 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -66.88 -52.82 38.75 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.571 1.549 . . . . 0.45000000000000001 110.697 176.41 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 43.7 tp60 -64.09 -23.91 67.5 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 119.993 -1.692 . . . . 2.6299999999999999 113.15 -177.401 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -54.19 -45.82 72.25 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.9 1.28 . . . . 0.48999999999999999 111.254 177.071 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -119.91 1.47 10.96 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 114.994 1.479 . . . . 0.47999999999999998 114.994 -175.062 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 29.8 ttpt -51.28 -36.8 43.95 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 125.226 1.41 . . . . 2.1899999999999999 112.13 -177.024 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -85.15 -9.09 58.25 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 112.781 0.66 . . . . 2.21 112.781 -174.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -94.91 -62.05 1.38 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 127.128 2.171 . . . . 3.0099999999999998 110.428 174.418 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 8.6 mm -121.61 88.93 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 125.631 1.572 . . . . 1.46 109.044 176.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -72.76 -16.68 61.64 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 115.378 1.621 . . . . 2.5899999999999999 115.378 -174.044 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.9 mp0 -63.18 39.08 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 130.946 3.699 . . . . 3.1000000000000001 115.903 -177.02 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 64.2 mtm -69.46 2.55 2.98 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 119.669 -1.894 . . . . 1.4199999999999999 115.412 -170.329 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 10.9 p-80 -65.85 -22.7 66.56 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.611 0.764 . . . . 4.4100000000000001 112.668 160.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -84.57 -14.79 69.88 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 125.995 1.76 . . . . 0.39000000000000001 114.27 171.179 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.6 mp -97.47 127.01 43.08 Favored 'General case' 0 C--O 1.236 0.37 0 O-C-N 121.553 -0.969 . . . . 1.6699999999999999 111.877 -168.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 59.2 ttt180 -106.11 101.05 10.56 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.734 2.014 . . . . 3.98 109.735 178.212 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 4.8 mt -107.59 141.08 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-O 123.183 1.468 . . . . 0.46000000000000002 112.02 -173.272 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -129.74 130.99 46.13 Favored 'General case' 0 N--CA 1.433 -1.31 0 C-N-CA 128.35 2.66 . . . . 2.0299999999999998 108.628 -174.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 13.6 p -143.1 152.94 42.4 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 126.006 1.722 . . . . 0.29999999999999999 109.036 -178.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 2.8 p -163.03 -179.48 6.75 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.617 -1.174 . . . . 0.60999999999999999 109.671 177.589 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.516 HG21 ' HB3' ' A' ' 73' ' ' LYS . 4.2 p -144.19 135.26 12.46 Favored Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 112.909 0.707 . . . . 0.58999999999999997 112.909 -175.641 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -80.7 133.28 9.21 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 124.157 3.238 . . . . 0.72999999999999998 112.024 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 31.6 mmtt -141.41 59.34 1.51 Allowed 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 115.443 -0.799 . . . . 2.77 112.5 -149.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 52.8 ttp180 . . . . . 0 C--O 1.253 1.254 0 C-N-CA 126.684 1.994 . . . . 10.4 111.951 172.976 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.896 0 N-CA-C 110.346 -0.242 . . . . 4.6100000000000003 110.346 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 57.9 m 64.04 137.69 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 127.607 2.363 . . . . 2.8599999999999999 115.894 -179.368 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -128.39 -178.74 4.68 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.855 1.262 . . . . 2.8100000000000001 111.093 178.014 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 55.2 p -127.69 -175.87 3.6 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 126.257 1.823 . . . . 0.87 109.795 168.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -62.21 -39.55 93.14 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 120.646 1.566 . . . . 4.6100000000000003 110.764 160.219 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.48 -43.78 96.16 Favored Glycine 0 C--N 1.34 0.789 0 C-N-CA 126.045 1.783 . . . . 0.68000000000000005 113.21 -177.375 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.12 -48.35 73.77 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 118.974 1.387 . . . . 1.3100000000000001 112.565 -178.317 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 46.0 mt -66.32 -50.31 64.07 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 125.807 1.643 . . . . 0.52000000000000002 110.882 178.437 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -54.99 -50.03 70.0 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.779 2.032 . . . . 3.2200000000000002 111.428 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.2 t -64.36 -47.12 90.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 124.418 1.087 . . . . 0.34999999999999998 108.127 177.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 89.7 m -57.65 -38.3 74.83 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 118.035 0.38 . . . . 0.35999999999999999 111.998 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -62.39 -40.67 97.24 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 112.629 0.603 . . . . 1.6899999999999999 112.629 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 24.3 mt -79.4 -29.46 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 O-C-N 123.314 0.384 . . . . 0.66000000000000003 111.013 179.369 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.1 mt -56.13 -41.54 75.48 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 120.833 -1.167 . . . . 0.5 113.534 169.326 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 38.5 mttt -60.89 -28.61 69.01 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 113.262 0.838 . . . . 2.0499999999999998 113.262 178.264 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -93.48 -37.96 11.67 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 127.294 2.238 . . . . 2.04 114.497 -175.255 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -73.87 -26.91 60.8 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-O 117.999 -1.0 . . . . 1.1899999999999999 111.489 171.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -132.06 52.01 8.33 Favored Pre-proline 0 CA--C 1.547 0.865 0 N-CA-C 117.811 2.523 . . . . 1.5700000000000001 117.811 -177.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -62.48 -22.6 74.24 Favored 'Trans proline' 0 C--O 1.236 0.403 0 C-N-CA 123.758 2.972 . . . . 0.73999999999999999 114.194 174.331 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.41 -18.44 64.45 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 113.953 1.094 . . . . 7.2000000000000002 113.953 174.837 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -56.36 150.67 14.35 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 115.552 1.686 . . . . 0.51000000000000001 115.552 -167.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 61.1 p -90.26 -35.66 15.17 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 114.702 -1.135 . . . . 0.79000000000000004 111.672 166.351 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -125.09 136.13 53.36 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.53 1.132 . . . . 0.32000000000000001 111.176 173.197 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.5 pt -153.89 114.08 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 124.381 1.073 . . . . 0.46999999999999997 112.876 171.021 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -157.14 154.62 29.64 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.569 1.548 . . . . 1.25 113.297 -179.53 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.8 t -131.77 142.66 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 127.673 2.389 . . . . 0.67000000000000004 108.604 177.64 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 59.2 m -135.77 120.72 18.67 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.948 1.299 . . . . 0.51000000000000001 110.484 175.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -70.52 128.74 37.19 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.95 0.881 . . . . 1.9099999999999999 109.839 168.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.7 pt -130.47 31.19 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 C-N-CA 126.566 1.946 . . . . 0.73999999999999999 109.597 178.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.7 t -139.87 61.91 1.52 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 128.319 2.648 . . . . 1.3200000000000001 110.436 -170.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.6 -3.47 5.63 Favored Glycine 0 CA--C 1.538 1.504 0 N-CA-C 118.128 2.011 . . . . 1.25 118.128 -168.144 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -140.37 12.41 3.01 Favored Glycine 0 N--CA 1.475 1.24 0 CA-C-N 119.632 1.716 . . . . 0.93000000000000005 115.222 175.64 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 16.7 m -143.55 -34.15 0.41 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.746 1.618 . . . . 2.9100000000000001 111.865 -176.049 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 52.84 42.96 60.41 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 126.69 2.091 . . . . 0.70999999999999996 113.194 -177.154 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -107.34 -29.86 9.04 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.446 1.898 . . . . 0.93999999999999995 112.357 -177.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 1.8 mtm -102.97 126.53 50.18 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 126.501 1.92 . . . . 2.1699999999999999 109.96 -179.453 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -139.05 150.51 45.84 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.157 0.983 . . . . 1.9299999999999999 110.487 178.247 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -104.72 124.28 49.11 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.856 1.662 . . . . 2.04 109.448 171.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 53.8 mt -124.61 135.5 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 125.314 1.446 . . . . 0.65000000000000002 110.645 -176.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 62.0 tttt -126.74 120.71 30.07 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.177 0.991 . . . . 5.1200000000000001 110.455 174.077 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.409 ' CD1' HG13 ' A' ' 84' ' ' VAL . 1.1 mt -125.31 154.0 33.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 126.453 1.901 . . . . 0.28000000000000003 108.974 176.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -156.02 130.3 8.79 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 120.561 -1.337 . . . . 1.6299999999999999 108.393 166.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.4 t -162.64 147.22 11.89 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 118.881 0.764 . . . . 0.66000000000000003 112.369 -174.466 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -55.21 -24.15 25.83 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.303 1.841 . . . . 2.9500000000000002 114.553 -175.746 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -70.07 -18.26 63.27 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 115.155 1.539 . . . . 2.5099999999999998 115.155 175.466 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -78.56 15.86 0.94 Allowed 'General case' 0 CA--C 1.559 1.32 0 N-CA-C 114.854 1.427 . . . . 1.6299999999999999 114.854 -173.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.404 ' HG2' ' H ' ' A' ' 73' ' ' LYS . 38.4 pttt -79.1 -35.7 41.86 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 128.215 2.606 . . . . 2.4300000000000002 117.275 -165.5 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -119.45 32.27 6.17 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.455 1.102 . . . . 3.6899999999999999 112.301 -179.248 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 67.8 mmtt -112.13 142.21 44.86 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 128.043 2.537 . . . . 1.3600000000000001 111.214 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 8.2 mmt180 -66.19 161.87 21.09 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.141 0.976 . . . . 3.29 111.002 163.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 96.4 m -47.42 -55.74 8.36 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.334 1.054 . . . . 0.77000000000000002 113.616 169.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.6 p -56.9 -37.61 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 124.809 1.243 . . . . 0.58999999999999997 112.644 178.012 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.4 mm100 -77.14 -32.33 56.28 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.444 1.098 . . . . 1.8400000000000001 113.048 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -62.92 -53.57 51.97 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.156 0.889 . . . . 0.59999999999999998 109.832 168.194 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 39.2 m170 -53.15 -50.87 63.68 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.914 0.886 . . . . 0.42999999999999999 111.626 177.217 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 34.7 tp60 -48.28 -44.27 33.46 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.922 1.289 . . . . 1.29 112.875 178.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 4.1 mtm -61.59 -43.41 98.92 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 119.977 1.262 . . . . 1.1599999999999999 111.297 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.409 HG13 ' CD1' ' A' ' 67' ' ' ILE . 5.8 t -71.83 -29.08 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.87 1.268 . . . . 0.23999999999999999 111.471 178.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -71.91 -44.67 63.31 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.102 1.361 . . . . 0.62 110.481 175.015 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.7 -22.83 66.06 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 120.647 -1.283 . . . . 2.8399999999999999 113.379 178.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.45 -38.98 78.64 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.784 1.234 . . . . 0.34999999999999998 112.48 176.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.04 -2.31 9.2 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 114.772 1.397 . . . . 0.40000000000000002 114.772 -173.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 11.0 ttpp -49.49 -35.73 20.77 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 126.086 1.754 . . . . 3.6499999999999999 113.323 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -88.76 -11.19 45.7 Favored 'General case' 0 CA--C 1.552 1.044 0 N-CA-C 112.307 0.484 . . . . 2.0899999999999999 112.307 -174.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -95.45 -49.79 5.27 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 127.338 2.255 . . . . 3.75 112.045 174.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 34.2 mt -135.41 113.07 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 127.525 2.33 . . . . 1.1200000000000001 106.302 172.504 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.86 -17.78 34.65 Favored 'General case' 0 N--CA 1.48 1.075 0 O-C-N 120.703 -1.248 . . . . 3.4500000000000002 114.22 -169.54 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -88.33 63.9 7.34 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.33 1.852 . . . . 4.21 112.798 -164.413 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' MET . . . . . 0.417 ' HA ' HD13 ' A' ' 98' ' ' LEU . 5.3 mpp? -69.14 8.04 0.63 Allowed 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 115.16 1.541 . . . . 1.28 115.16 -178.31 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 28.3 p80 -53.18 -36.42 60.92 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 120.978 -1.076 . . . . 3.9500000000000002 113.377 171.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -85.43 -9.25 79.55 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 125.673 1.606 . . . . 0.42999999999999999 114.635 -179.051 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.417 HD13 ' HA ' ' A' ' 95' ' ' MET . 4.9 mp -96.68 107.36 19.8 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 121.311 -1.111 . . . . 1.6599999999999999 112.44 -166.538 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 10.4 ttt180 -81.05 117.39 21.59 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 112.818 -1.992 . . . . 3.4399999999999999 108.467 171.108 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 4.3 mt -125.29 135.07 65.18 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.679 0 CA-C-O 123.448 1.594 . . . . 0.35999999999999999 112.491 -175.506 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -121.69 122.67 40.1 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 111.539 -2.573 . . . . 2.4300000000000002 107.611 -175.039 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 15.6 p -132.92 152.5 51.89 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.103 1.361 . . . . 0.25 110.21 179.023 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.8 p -158.2 175.57 13.6 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 124.639 1.176 . . . . 0.59999999999999998 110.367 176.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 9.0 p -141.94 127.82 10.86 Favored Pre-proline 0 N--CA 1.472 0.661 0 C-N-CA 123.132 0.573 . . . . 0.41999999999999998 111.77 -177.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -83.69 119.19 2.56 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 123.447 2.765 . . . . 0.66000000000000003 111.957 -176.367 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -151.45 95.57 2.16 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.139 1.376 . . . . 4.1900000000000004 110.776 179.435 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 60.5 ttt180 . . . . . 0 C--O 1.251 1.133 0 C-N-CA 125.547 1.539 . . . . 7.5899999999999999 111.325 -179.636 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.469 0.484 0 CA-C-O 120.914 0.387 . . . . 2.27 111.897 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 80.0 p -107.11 164.5 12.11 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.008 0.923 . . . . 0.81000000000000005 109.414 156.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 21.9 mp0 -64.32 -22.13 66.85 Favored 'General case' 0 CA--C 1.549 0.941 0 O-C-N 121.454 -0.778 . . . . 3.7200000000000002 111.716 162.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.45 -39.61 95.81 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 126.72 2.105 . . . . 0.42999999999999999 114.08 170.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.87 -43.99 73.64 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.486 1.643 . . . . 2.1000000000000001 111.29 174.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 11.7 mt -66.28 -55.37 16.38 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 125.399 1.48 . . . . 0.34999999999999998 109.867 178.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.3 tpm_? -49.69 -51.46 38.16 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.632 1.573 . . . . 7.1900000000000004 113.351 176.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 26.0 t -65.21 -43.33 95.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 106.945 -1.502 . . . . 0.32000000000000001 106.945 -175.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 36.1 m -58.7 -38.21 77.78 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 118.525 -0.75 . . . . 0.40999999999999998 112.056 175.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 14.3 mm-40 -60.97 -49.67 76.49 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 119.448 1.022 . . . . 1.73 112.219 -179.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 18.3 mt -75.34 -30.96 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 CA-C-N 118.343 0.519 . . . . 0.52000000000000002 110.027 -175.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 29.9 mt -56.49 -38.33 71.61 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 114.459 1.281 . . . . 0.57999999999999996 114.459 171.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 31.2 mttt -58.94 -36.76 75.32 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 119.122 0.874 . . . . 2.96 112.347 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.03 -36.31 15.87 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 128.651 2.78 . . . . 4.9199999999999999 114.493 -173.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 48.6 mmtt -71.27 -20.84 62.17 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 118.262 -0.875 . . . . 1.26 112.397 167.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -134.09 59.12 35.8 Favored Pre-proline 0 CA--C 1.558 1.275 0 N-CA-C 117.756 2.502 . . . . 2.0899999999999999 117.756 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.35 -19.81 32.86 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 124.62 3.547 . . . . 0.93999999999999995 114.983 171.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 40.8 mmt180 -78.79 -0.12 29.19 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 120.836 -1.165 . . . . 4.8200000000000003 113.775 170.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.26 149.1 50.86 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 115.675 1.731 . . . . 0.53000000000000003 115.675 -176.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 16.3 p -108.15 -27.97 9.77 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 127.048 2.139 . . . . 0.68999999999999995 112.842 170.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -119.57 138.63 53.08 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.376 1.071 . . . . 0.54000000000000004 110.881 163.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.2 pt -153.92 118.87 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 124.788 1.235 . . . . 0.67000000000000004 111.663 166.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.4 ptpt -158.11 154.39 27.43 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 126.032 1.733 . . . . 1.27 112.3 173.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.4 t -132.66 149.98 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 126.465 1.906 . . . . 0.35999999999999999 109.712 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 92.5 m -140.0 131.18 26.51 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.613 0.765 . . . . 0.46999999999999997 111.427 169.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -73.91 121.96 21.78 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.513 0.725 . . . . 1.8 109.978 163.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . 0.255 5.5 pt -117.11 25.52 4.35 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 C-N-CA 125.495 1.518 . . . . 0.68999999999999995 111.039 179.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 31.9 t -137.91 58.99 1.67 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 128.564 2.746 . . . . 1.3500000000000001 111.223 -173.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -55.53 -6.53 1.1 Allowed Glycine 0 CA--C 1.544 1.878 0 N-CA-C 119.003 2.361 . . . . 1.3 119.003 -173.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -133.04 16.39 4.7 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 126.247 1.879 . . . . 1.03 114.653 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 15.4 t -153.17 -39.7 0.1 Allowed 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.778 1.231 . . . . 1.52 111.776 170.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 64.67 44.18 95.31 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 125.699 1.618 . . . . 0.88 112.707 -167.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -90.08 -31.39 17.16 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.911 1.284 . . . . 1.21 113.667 173.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 9.0 mtm -104.43 138.01 41.46 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.866 1.266 . . . . 1.53 112.576 174.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -137.46 147.34 45.25 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.995 0.918 . . . . 1.97 111.225 169.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -83.32 138.49 33.53 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 124.904 1.282 . . . . 2.4399999999999999 109.531 161.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 97.5 mt -134.48 129.0 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 CA-C-N 119.344 0.975 . . . . 0.59999999999999998 109.474 168.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 71.6 mttt -126.06 115.99 20.71 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.688 1.195 . . . . 2.6800000000000002 110.347 178.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.1 mt -127.02 156.62 38.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 126.442 1.897 . . . . 0.25 109.423 -177.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -152.87 133.3 13.67 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.252 1.821 . . . . 2.02 106.584 162.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 28.0 t -155.91 143.37 19.39 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 120.132 1.333 . . . . 0.41999999999999998 112.883 -173.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -57.51 -20.62 32.62 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.923 1.289 . . . . 3.25 114.149 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -75.69 -15.12 60.34 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 114.27 1.211 . . . . 1.8600000000000001 114.27 177.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -83.5 16.72 2.46 Favored 'General case' 0 CA--C 1.55 0.964 0 N-CA-C 113.689 0.996 . . . . 1.6200000000000001 113.689 -174.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -71.05 -44.35 65.94 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.677 1.591 . . . . 3.0 112.654 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -91.85 35.85 0.97 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.206 1.402 . . . . 4.1100000000000003 113.115 -174.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 62.6 mmtt -144.78 141.32 29.11 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.684 1.594 . . . . 1.54 113.115 -167.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 22.6 mmt180 -73.03 170.62 14.48 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 126.596 1.959 . . . . 4.4900000000000002 112.223 162.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 84.2 m -50.95 -54.71 21.9 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.816 1.043 . . . . 1.1000000000000001 113.816 168.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.1 p -59.9 -35.88 63.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 123.776 0.83 . . . . 0.81999999999999995 112.974 178.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -76.4 -37.07 57.65 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.722 0.809 . . . . 1.2 112.029 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -59.83 -54.07 50.52 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.962 0.905 . . . . 0.68999999999999995 109.889 168.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 47.8 m170 -50.13 -52.76 32.45 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.256 1.022 . . . . 0.54000000000000004 111.878 177.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 39.9 tp60 -47.07 -44.28 20.82 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.592 1.557 . . . . 1.26 112.847 179.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 81.2 mtp -62.97 -43.43 98.81 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 121.166 -0.959 . . . . 0.98999999999999999 112.255 178.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.2 t -71.22 -25.83 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 125.657 1.583 . . . . 0.25 111.735 177.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -76.8 -44.41 32.74 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.621 1.568 . . . . 0.51000000000000001 109.69 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -64.76 -27.39 68.86 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 125.104 1.362 . . . . 3.4399999999999999 113.99 175.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.94 -29.99 71.22 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.501 1.52 . . . . 0.47999999999999998 112.916 -175.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.0 -8.19 8.85 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 115.124 1.527 . . . . 0.40000000000000002 115.124 176.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -44.37 -43.58 7.68 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.081 1.352 . . . . 2.02 112.847 176.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -85.78 6.01 29.88 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-O 122.505 1.145 . . . . 2.4500000000000002 111.759 -165.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -124.54 -56.27 1.61 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 129.946 3.299 . . . . 2.98 108.377 -177.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.0 mm -126.38 132.9 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 127.573 2.349 . . . . 1.9399999999999999 108.923 169.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -92.77 -10.89 35.34 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 116.274 1.953 . . . . 2.6299999999999999 116.274 -174.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -78.66 36.65 0.27 Allowed 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 117.702 2.482 . . . . 3.0499999999999998 117.702 -153.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 4.6 mpp? -64.06 9.42 0.07 Allowed 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 116.259 1.948 . . . . 1.3200000000000001 116.259 -175.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 49.3 t60 -65.07 -38.82 92.05 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 120.946 -1.096 . . . . 4.3700000000000001 111.81 160.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -84.61 -17.79 63.23 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 126.355 1.931 . . . . 0.41999999999999998 114.045 -178.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.5 mp -87.61 118.77 27.31 Favored 'General case' 0 C--N 1.332 -0.179 0 O-C-N 121.674 -0.898 . . . . 1.71 112.265 -170.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 28.7 ttm180 -98.02 102.06 13.71 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 127.453 2.301 . . . . 4.8700000000000001 109.885 -177.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 4.1 mt -111.7 143.91 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-O 123.903 1.811 . . . . 0.42999999999999999 113.14 -169.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -136.0 125.6 25.32 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 111.543 -2.571 . . . . 1.8400000000000001 108.005 -171.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 28.3 p -144.86 153.55 41.72 Favored 'General case' 0 CA--C 1.509 -0.607 0 C-N-CA 125.837 1.655 . . . . 0.40000000000000002 109.791 -171.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -163.35 175.55 10.73 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.239 -1.346 . . . . 0.70999999999999996 109.379 176.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.4 p -122.97 139.65 31.87 Favored Pre-proline 0 C--N 1.325 -0.488 0 O-C-N 121.289 -0.882 . . . . 0.64000000000000001 109.531 170.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo . . . . . 0 N--CA 1.45 -1.062 0 C-N-CA 123.207 2.605 . . . . 0.87 108.463 172.847 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 . . . . . 0 N--CA 1.47 0.565 0 N-CA-C 115.443 1.646 . . . . 2.27 115.443 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 38.9 p -117.0 179.9 3.89 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.877 1.671 . . . . 0.90000000000000002 111.041 169.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -70.45 -35.25 73.23 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 120.633 -1.292 . . . . 3.0499999999999998 111.959 168.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -67.42 -37.59 90.33 Favored Glycine 0 CA--C 1.529 0.948 0 CA-C-O 118.572 -1.127 . . . . 0.44 112.901 178.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -46.08 -50.24 15.49 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.51 1.524 . . . . 1.3799999999999999 112.713 173.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 15.1 mt -69.95 -50.73 39.03 Favored 'General case' 0 CA--C 1.528 0.098 0 C-N-CA 124.957 1.303 . . . . 0.40999999999999998 111.132 -178.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.54 -48.36 77.43 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.578 1.151 . . . . 3.0099999999999998 110.85 -179.027 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.0 t -63.12 -41.93 94.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 108.496 -0.927 . . . . 0.28999999999999998 108.496 177.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 74.2 m -59.09 -42.08 89.61 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 118.761 0.709 . . . . 0.46999999999999997 111.28 178.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -69.48 -33.37 72.79 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 114.011 1.115 . . . . 3.1099999999999999 114.011 -175.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 30.5 mt -79.53 -30.69 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 CA-C-N 119.099 0.863 . . . . 0.47999999999999998 110.694 173.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 33.1 mt -58.19 -36.74 73.54 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 120.74 -1.225 . . . . 0.51000000000000001 113.233 171.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 38.0 mttt -59.78 -24.6 64.23 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 114.21 1.189 . . . . 1.3300000000000001 114.21 173.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -101.25 -34.73 9.54 Favored 'General case' 0 N--CA 1.427 -1.575 0 C-N-CA 125.494 1.518 . . . . 2.0800000000000001 113.87 -175.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -75.26 -24.66 57.63 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 118.646 -1.221 . . . . 1.1000000000000001 111.79 169.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -130.6 54.55 14.99 Favored Pre-proline 0 CA--C 1.548 0.865 0 N-CA-C 117.049 2.24 . . . . 2.21 117.049 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -62.49 -30.79 80.26 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 123.573 2.849 . . . . 0.73999999999999999 113.688 174.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 28.0 mmt85 -75.95 -11.89 60.04 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 120.352 1.433 . . . . 4.7000000000000002 114.519 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -55.21 146.67 18.26 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.157 1.783 . . . . 0.40999999999999998 114.524 -174.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 66.7 p -88.09 -30.74 19.65 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.905 0.882 . . . . 0.70999999999999996 111.111 170.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -129.77 138.67 51.19 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.005 0.922 . . . . 0.45000000000000001 111.734 170.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.6 pt -150.46 117.74 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 125.572 1.549 . . . . 0.73999999999999999 111.419 165.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.79 157.79 37.06 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.705 1.202 . . . . 2.4199999999999999 113.46 169.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.0 t -125.08 144.13 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 128.215 2.606 . . . . 0.37 110.492 -173.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 80.7 m -128.86 126.37 39.64 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.388 1.475 . . . . 0.51000000000000001 109.518 166.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -73.41 139.2 45.72 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 122.023 0.916 . . . . 2.4700000000000002 110.344 165.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.7 pt -134.31 32.8 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 C-N-CA 126.411 1.884 . . . . 0.83999999999999997 110.397 177.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.44 ' HB2' ' H ' ' A' ' 62' ' ' MET . 23.2 t -141.01 62.31 1.48 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 128.13 2.572 . . . . 1.4399999999999999 112.779 -171.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.08 -30.11 60.27 Favored Glycine 0 CA--C 1.54 1.619 0 O-C-N 119.989 -1.694 . . . . 1.8 114.649 179.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -85.81 -9.46 77.86 Favored Glycine 0 CA--C 1.539 1.549 0 N-CA-C 116.421 1.328 . . . . 1.45 116.421 -179.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 19.6 t -148.52 -38.83 0.17 Allowed 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 119.493 1.646 . . . . 2.75 114.319 -175.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 66.82 43.52 91.41 Favored Glycine 0 CA--C 1.536 1.375 0 C-N-CA 126.854 2.168 . . . . 1.1599999999999999 112.581 -165.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -94.06 -37.98 11.36 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.13 1.372 . . . . 1.76 113.594 172.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.459 ' HG3' ' CA ' ' A' ' 97' ' ' GLY . 4.0 mpp? -94.99 140.29 30.16 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 124.373 1.069 . . . . 2.8199999999999998 112.962 -175.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -145.38 143.5 30.15 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 122.393 1.092 . . . . 1.8999999999999999 113.805 175.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -100.07 119.51 38.41 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.364 1.866 . . . . 2.6699999999999999 109.911 170.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 61.6 mt -132.48 130.54 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.784 1.234 . . . . 0.84999999999999998 110.747 -161.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -117.67 125.95 51.63 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.304 1.442 . . . . 2.98 110.683 177.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.445 ' CD1' HG13 ' A' ' 84' ' ' VAL . 1.2 mt -129.35 156.37 41.79 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 C-N-CA 127.347 2.259 . . . . 0.25 109.703 174.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -155.37 133.67 11.67 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.678 1.591 . . . . 1.8200000000000001 108.704 164.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 16.9 t -159.55 140.49 12.51 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 119.811 1.187 . . . . 0.33000000000000002 112.865 -175.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -61.48 -3.6 1.05 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 127.609 2.364 . . . . 3.73 115.084 179.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -84.8 -23.6 29.07 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.901 1.68 . . . . 1.6599999999999999 113.725 173.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -79.92 9.93 4.79 Favored 'General case' 0 CA--C 1.555 1.16 0 N-CA-C 116.052 1.871 . . . . 1.6699999999999999 116.052 -165.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.89 -37.17 35.35 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 117.613 2.449 . . . . 2.8799999999999999 117.613 -163.033 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -88.63 40.53 0.97 Allowed 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 121.046 1.748 . . . . 4.3300000000000001 111.993 178.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.9 mmtp -139.71 137.16 34.93 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 125.437 1.495 . . . . 1.8400000000000001 111.823 -168.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 46.2 mtt180 -68.75 172.03 6.97 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.856 1.662 . . . . 3.6600000000000001 111.741 164.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 87.0 m -47.6 -58.34 4.37 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 125.357 1.463 . . . . 0.78000000000000003 113.425 170.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.2 p -59.48 -36.13 62.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.351 1.061 . . . . 0.54000000000000004 112.775 176.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 11.1 mt-30 -77.08 -27.34 54.22 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 113.446 0.906 . . . . 1.3600000000000001 113.446 -177.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -71.42 -54.1 11.81 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.012 0.925 . . . . 0.71999999999999997 110.33 166.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 52.6 m170 -55.08 -42.58 73.0 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.543 0.737 . . . . 0.46999999999999997 112.414 -177.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 31.0 tp60 -47.43 -42.0 21.44 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 126.201 1.801 . . . . 1.1499999999999999 113.032 177.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 63.8 mtp -66.36 -43.47 85.9 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 123.568 0.747 . . . . 1.1499999999999999 111.234 -177.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.445 HG13 ' CD1' ' A' ' 67' ' ' ILE . 2.5 t -72.27 -34.31 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 127.058 2.143 . . . . 0.22 111.654 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -63.16 -53.15 57.76 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 127.169 2.188 . . . . 0.56000000000000005 109.524 173.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.8 tm0? -65.27 -30.19 71.04 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.234 -0.916 . . . . 3.21 112.235 -177.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -55.89 -34.22 65.34 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 125.631 1.573 . . . . 0.39000000000000001 112.72 -172.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.41 -2.81 9.45 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 115.053 1.501 . . . . 0.40999999999999998 115.053 177.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 26.8 ttpt -51.15 -36.3 40.17 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.957 0.903 . . . . 1.9399999999999999 112.475 178.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -74.92 -13.73 60.57 Favored 'General case' 0 N--CA 1.439 -1.022 0 O-C-N 121.578 -0.701 . . . . 2.2400000000000002 112.269 -176.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -94.86 -49.49 5.56 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 128.466 2.706 . . . . 3.0 113.448 172.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 30.6 mt -141.02 129.35 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 127.738 2.415 . . . . 1.1299999999999999 107.938 177.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 45.7 mttp -97.66 -14.66 20.8 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 116.21 1.93 . . . . 3.2999999999999998 116.21 -170.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -79.35 68.41 5.34 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 115.354 1.613 . . . . 4.96 115.354 -160.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -70.39 1.58 4.84 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 116.471 2.026 . . . . 1.77 116.471 -178.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 22.4 t60 -54.57 -32.66 58.91 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.924 0.868 . . . . 4.4800000000000004 112.064 153.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.459 ' CA ' ' HG3' ' A' ' 62' ' ' MET . . . -83.39 -18.01 65.28 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 126.175 1.845 . . . . 0.5 116.544 -176.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 10.1 mt -93.62 139.56 30.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 118.517 1.158 . . . . 2.27 110.746 -168.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 35.5 ttt180 -123.55 95.76 4.71 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.552 1.541 . . . . 3.3999999999999999 107.91 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -114.32 135.34 54.39 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.475 0 CA-C-O 123.115 1.436 . . . . 0.46999999999999997 112.444 -161.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -127.83 114.24 16.97 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 112.178 -2.283 . . . . 2.0600000000000001 107.764 -168.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 23.4 p -127.13 150.31 49.55 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.293 1.437 . . . . 0.29999999999999999 110.566 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 2.2 p -150.7 172.73 15.11 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.222 -1.354 . . . . 0.64000000000000001 111.123 173.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.9 p -140.24 129.58 13.42 Favored Pre-proline 0 N--CA 1.472 0.628 0 C-N-CA 123.172 0.589 . . . . 0.52000000000000002 111.6 178.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo . . . . . 0 CA--C 1.538 0.714 0 C-N-CA 123.751 2.967 . . . . 0.68000000000000005 111.418 -177.441 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 96.7 mm-40 . . . . . 0 C--O 1.238 0.463 0 CA-C-O 122.638 1.208 . . . . 2.9900000000000002 113.018 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 62.6 p -121.06 161.63 21.38 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 112.532 -2.122 . . . . 0.60999999999999999 108.46 149.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -63.88 -21.15 66.32 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 120.586 -1.321 . . . . 2.7000000000000002 112.044 164.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -67.38 -39.24 91.61 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 126.875 2.179 . . . . 0.56999999999999995 113.572 173.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.25 -44.31 68.04 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.512 1.525 . . . . 1.29 111.233 173.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.4 mt -68.79 -53.92 18.87 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 125.801 1.64 . . . . 0.40000000000000002 110.935 176.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.5 ttp-105 -49.8 -50.06 46.41 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 126.617 1.967 . . . . 3.6000000000000001 111.162 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 52.0 t -68.27 -46.94 80.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 123.992 0.917 . . . . 0.28999999999999998 108.538 -178.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 98.3 m -57.93 -42.63 85.23 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 118.497 0.589 . . . . 0.39000000000000001 111.903 178.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -62.39 -35.9 80.62 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.888 0.875 . . . . 2.9300000000000002 112.449 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 62.4 mt -80.86 -31.81 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-N 118.845 0.748 . . . . 0.46000000000000002 111.019 175.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 29.6 mt -58.09 -37.58 74.78 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 120.945 -1.097 . . . . 0.40000000000000002 112.34 171.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 23.9 mttt -63.38 -22.36 66.83 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 113.539 0.94 . . . . 1.78 113.539 174.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -96.41 -36.15 10.93 Favored 'General case' 0 N--CA 1.434 -1.255 0 C-N-CA 125.994 1.717 . . . . 2.1299999999999999 114.694 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 64.9 mmtt -74.84 -28.01 60.51 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 119.668 -0.813 . . . . 1.55 111.8 171.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -130.33 50.29 5.83 Favored Pre-proline 0 CA--C 1.55 0.952 0 N-CA-C 117.65 2.463 . . . . 2.0499999999999998 117.65 -178.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -61.51 -25.47 79.63 Favored 'Trans proline' 0 C--O 1.237 0.468 0 C-N-CA 123.949 3.099 . . . . 0.94999999999999996 114.428 177.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 12.5 mmt85 -80.78 -11.35 59.62 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 114.148 1.166 . . . . 5.04 114.148 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -51.85 151.33 3.55 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 126.245 1.818 . . . . 0.44 114.725 -173.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 68.9 p -93.04 -32.21 14.57 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.976 1.31 . . . . 0.59999999999999998 111.033 169.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -124.82 139.01 54.23 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.212 1.005 . . . . 0.47999999999999998 111.992 170.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.4 pt -156.16 112.49 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 126.433 1.893 . . . . 0.56000000000000005 111.316 166.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.5 ptpt -151.88 148.3 27.64 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.916 1.286 . . . . 1.01 112.888 172.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 29.0 t -124.39 144.2 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 127.1 2.16 . . . . 0.34000000000000002 108.872 -178.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 98.9 m -132.07 127.34 35.9 Favored 'General case' 0 CA--C 1.512 -0.507 0 C-N-CA 124.732 1.213 . . . . 0.55000000000000004 109.931 172.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.82 130.44 41.07 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 124.25 1.02 . . . . 2.5800000000000001 111.009 174.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.3 pt -132.64 26.61 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 C-N-CA 126.234 1.814 . . . . 0.79000000000000004 110.77 174.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.5 t -138.14 107.97 6.3 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.931 1.293 . . . . 1.55 113.519 164.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -83.43 -18.06 65.12 Favored Glycine 0 N--CA 1.474 1.203 0 C-N-CA 124.228 0.918 . . . . 2.3999999999999999 113.821 162.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -77.36 -39.69 25.71 Favored Glycine 0 N--CA 1.467 0.746 0 C-N-CA 124.548 1.071 . . . . 1.8200000000000001 113.368 -175.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 20.8 m -145.9 -17.89 0.46 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.755 1.222 . . . . 1.73 113.284 -170.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 63.06 37.8 95.54 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 126.374 1.94 . . . . 0.97999999999999998 113.948 -178.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -101.61 -8.96 21.37 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.67 1.188 . . . . 1.6100000000000001 113.074 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 7.8 ttm -119.35 122.12 41.11 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 125.824 1.65 . . . . 1.6299999999999999 109.803 -162.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.42 ' H ' HD23 ' A' ' 98' ' ' LEU . 76.5 m-85 -146.06 147.26 31.43 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 121.859 0.838 . . . . 2.0499999999999998 112.989 -177.151 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -101.52 124.29 46.95 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.705 1.602 . . . . 2.48 109.692 173.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 95.5 mt -134.54 130.84 53.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 O-C-N 120.866 -1.146 . . . . 1.01 111.44 -165.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.5 mptt -119.8 130.45 54.93 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.529 0.732 . . . . 3.29 111.618 171.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.452 ' CD1' HG13 ' A' ' 84' ' ' VAL . 1.3 mt -129.67 159.46 41.69 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 C-N-CA 126.566 1.947 . . . . 0.29999999999999999 109.279 176.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -159.42 135.4 8.78 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 126.347 1.859 . . . . 1.8600000000000001 108.628 165.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.3 t -162.98 146.7 11.03 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 118.494 0.588 . . . . 0.42999999999999999 111.491 -176.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -51.38 -32.53 26.29 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.858 1.663 . . . . 3.6600000000000001 113.759 178.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -63.39 -20.08 65.22 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 114.838 1.422 . . . . 1.6799999999999999 114.838 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -81.45 10.96 4.96 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 114.984 1.476 . . . . 1.6299999999999999 114.984 -169.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.5 pttt -74.63 -43.84 53.45 Favored 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 115.002 1.482 . . . . 2.3300000000000001 115.002 -172.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -91.15 27.64 1.83 Allowed 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 124.894 1.278 . . . . 4.2300000000000004 111.803 -174.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -123.09 140.14 53.34 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 127.47 2.308 . . . . 1.45 111.451 -171.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 13.1 mmt85 -69.37 165.94 19.67 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.057 1.343 . . . . 2.7599999999999998 110.629 161.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 28.2 m -52.09 -53.55 41.06 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.718 1.207 . . . . 0.85999999999999999 112.986 171.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.1 p -59.55 -35.64 60.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 124.252 1.021 . . . . 0.88 113.161 175.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -74.79 -35.89 62.51 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.676 0.621 . . . . 1.21 112.676 177.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -60.26 -51.6 68.86 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 119.462 1.028 . . . . 0.69999999999999996 109.192 169.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 36.7 m170 -55.62 -46.08 77.44 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.603 0.761 . . . . 0.71999999999999997 112.982 177.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 40.1 tp60 -48.43 -45.5 36.4 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.511 1.525 . . . . 1.23 112.625 176.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 67.0 mtp -63.71 -34.73 78.53 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 119.407 1.003 . . . . 0.97999999999999998 112.792 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.452 HG13 ' CD1' ' A' ' 67' ' ' ILE . 2.8 t -78.24 -30.34 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 125.689 1.596 . . . . 0.39000000000000001 111.752 177.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -71.27 -50.9 27.95 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.266 1.826 . . . . 0.71999999999999997 110.965 174.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 27.3 tp60 -69.78 -15.01 63.05 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 125.327 1.451 . . . . 3.1499999999999999 113.784 -178.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.15 -39.93 88.05 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.575 1.15 . . . . 0.41999999999999998 112.539 173.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.86 -0.07 8.54 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 115.764 1.764 . . . . 0.35999999999999999 115.764 -177.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 27.0 ttmt -43.57 -45.24 6.59 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 125.631 1.572 . . . . 2.2000000000000002 113.147 177.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -83.19 -7.02 59.68 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-O 121.294 0.569 . . . . 2.0899999999999999 112.201 -169.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 23.6 tp10 -103.59 -41.49 5.95 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 129.55 3.14 . . . . 2.21 111.011 -176.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 44.6 mt -150.61 115.21 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 129.806 3.242 . . . . 1.1200000000000001 107.029 175.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -92.26 -4.62 53.79 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 117.336 2.347 . . . . 3.46 117.336 -169.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -82.13 33.55 0.4 Allowed 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 127.97 2.508 . . . . 2.9900000000000002 115.503 -161.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 4.4 mpp? -68.53 6.16 0.88 Allowed 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 117.639 2.459 . . . . 1.3600000000000001 117.639 -165.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 34.2 t60 -42.62 -38.67 2.09 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 121.218 -0.926 . . . . 4.2599999999999998 112.113 152.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -69.14 -16.15 70.57 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 126.294 1.902 . . . . 0.51000000000000001 117.03 -179.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.42 HD23 ' H ' ' A' ' 63' ' ' TYR . 12.4 mt -96.7 129.47 44.1 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 119.057 1.428 . . . . 2.2799999999999998 112.715 -163.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 35.9 ttt180 -111.03 87.64 2.59 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 126.912 2.085 . . . . 3.6099999999999999 107.906 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 1.7 mt -106.23 144.61 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-O 122.879 1.323 . . . . 0.47999999999999998 112.31 -166.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -137.11 132.02 33.48 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 111.748 -2.478 . . . . 2.25 108.756 -173.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 21.1 p -146.24 152.78 39.74 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 126.449 1.899 . . . . 0.32000000000000001 110.198 -173.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 2.6 p -159.51 177.92 10.43 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 124.405 1.082 . . . . 0.65000000000000002 110.97 176.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.2 p -136.86 138.8 27.04 Favored Pre-proline 0 N--CA 1.47 0.567 0 C-N-CA 124.089 0.956 . . . . 0.46000000000000002 110.412 175.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo . . . . . 0 CA--C 1.533 0.47 0 C-N-CA 122.828 2.352 . . . . 0.66000000000000003 110.723 174.352 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 . . . . . 0 C--O 1.236 0.385 0 N-CA-C 112.924 0.713 . . . . 6.2199999999999998 112.924 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 79.2 p -110.38 -179.44 3.77 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.203 -1.036 . . . . 0.79000000000000004 108.203 140.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -71.63 -30.94 66.33 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 119.797 -1.815 . . . . 3.5 112.396 162.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.73 -41.21 99.57 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 124.279 0.943 . . . . 0.68999999999999995 113.281 173.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -54.14 -42.07 69.12 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.176 1.39 . . . . 1.52 112.919 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 22.5 mt -69.16 -50.67 45.59 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 125.519 1.527 . . . . 0.84999999999999998 111.323 177.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.98 -50.3 73.1 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 126.004 1.722 . . . . 2.96 110.61 -179.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 56.2 t -60.42 -47.4 92.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 108.292 -1.003 . . . . 0.31 108.292 177.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 93.0 m -58.53 -38.63 78.17 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.646 0.61 . . . . 0.65000000000000002 112.646 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.3 mm-40 -63.54 -40.23 96.49 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 118.412 0.551 . . . . 1.7 112.313 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 35.7 mt -82.02 -28.4 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 122.759 0.424 . . . . 0.67000000000000004 110.77 -175.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 11.8 mt -54.23 -37.75 64.96 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.473 -0.767 . . . . 0.71999999999999997 112.832 168.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.7 mttt -62.49 -25.27 67.92 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 114.237 1.199 . . . . 2.1299999999999999 114.237 178.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -106.14 -31.83 8.51 Favored 'General case' 0 N--CA 1.435 -1.22 0 C-N-CA 126.775 2.03 . . . . 2.4900000000000002 113.728 -167.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 53.1 mmtt -77.57 -24.84 49.71 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 118.729 -0.653 . . . . 1.46 111.713 164.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -131.71 49.54 4.77 Favored Pre-proline 0 CA--C 1.556 1.191 0 N-CA-C 118.435 2.754 . . . . 1.55 118.435 -178.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -68.07 -12.97 36.84 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 125.056 3.837 . . . . 0.82999999999999996 114.948 176.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 38.8 mtt180 -99.58 -6.73 26.88 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.195 0.998 . . . . 4.9100000000000001 113.444 175.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.41 139.91 58.56 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 125.025 1.33 . . . . 0.69999999999999996 113.141 176.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 44.2 p -75.46 -35.52 60.86 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.249 1.42 . . . . 0.89000000000000001 109.395 176.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -124.29 138.26 54.41 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.562 1.145 . . . . 0.34999999999999998 111.736 171.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.8 pt -150.22 118.46 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 125.577 1.551 . . . . 0.80000000000000004 112.522 163.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 7.8 ptpt -158.88 158.26 33.06 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.744 1.218 . . . . 1.76 114.016 177.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.7 t -126.11 155.93 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 127.766 2.426 . . . . 0.46999999999999997 111.028 -174.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 88.4 m -147.14 127.35 13.83 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 120.996 -1.065 . . . . 0.35999999999999999 111.817 162.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -69.63 126.91 31.16 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.889 0.852 . . . . 1.8600000000000001 110.568 165.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.5 pt -126.08 25.14 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 C-N-CA 126.047 1.739 . . . . 0.63 111.387 -178.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 34.9 t -132.5 62.74 1.64 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 128.308 2.643 . . . . 1.5900000000000001 109.032 176.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -54.29 -13.3 3.7 Favored Glycine 0 CA--C 1.54 1.643 0 N-CA-C 117.642 1.817 . . . . 1.73 117.642 -169.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -123.55 -6.71 7.2 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 126.31 1.91 . . . . 1.6399999999999999 115.828 -179.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -138.74 -21.75 0.99 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.212 1.405 . . . . 2.4300000000000002 114.399 -176.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 55.0 39.06 67.3 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 128.054 2.74 . . . . 0.94999999999999996 115.477 -178.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -88.05 -32.47 18.74 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.131 1.372 . . . . 1.3400000000000001 114.094 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 8.5 mtm -106.9 142.25 36.82 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.648 1.579 . . . . 1.49 112.842 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -142.46 144.09 32.88 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 122.181 0.991 . . . . 2.0099999999999998 112.539 172.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -83.05 139.46 33.24 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 126.604 1.961 . . . . 2.0699999999999998 110.076 165.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 90.6 mt -138.01 128.45 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 CA-C-N 119.39 0.996 . . . . 0.64000000000000001 110.606 170.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 77.9 mttt -113.73 126.78 55.61 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.118 1.367 . . . . 2.9500000000000002 110.943 171.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.434 ' CD1' HG13 ' A' ' 84' ' ' VAL . 1.3 mt -130.55 156.95 42.89 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 126.863 2.065 . . . . 0.31 109.938 174.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -156.8 130.86 8.43 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.332 1.453 . . . . 1.6499999999999999 109.583 166.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 32.6 t -158.26 143.6 16.66 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 119.994 1.27 . . . . 0.56999999999999995 112.019 -176.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -51.77 -24.86 6.49 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.206 1.402 . . . . 3.1000000000000001 113.52 173.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -69.51 -14.59 62.94 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 114.182 1.179 . . . . 1.73 114.182 -178.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -92.33 13.85 18.17 Favored 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 125.163 1.385 . . . . 1.71 114.266 -175.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.414 ' HB3' HG21 ' A' ' 104' ' ' VAL . 0.3 OUTLIER -79.27 -15.05 58.58 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 115.769 1.766 . . . . 3.3199999999999998 115.769 -167.717 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -123.17 29.95 6.53 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.082 1.753 . . . . 4.54 110.867 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -122.35 129.85 52.54 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 126.299 1.84 . . . . 1.27 111.053 -172.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 38.3 mtt-85 -63.52 164.41 9.47 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.852 1.261 . . . . 3.25 111.064 168.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 86.7 m -44.53 -55.89 4.76 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.933 0.893 . . . . 0.75 112.985 170.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.2 p -61.57 -37.25 77.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 124.987 1.315 . . . . 0.56999999999999995 113.164 178.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -75.66 -29.85 59.22 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 112.917 0.71 . . . . 1.0600000000000001 112.917 179.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 60.5 mt-30 -65.09 -54.8 24.44 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 119.007 0.821 . . . . 1.51 109.03 168.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 45.1 m170 -54.46 -45.31 73.09 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.952 0.901 . . . . 0.54000000000000004 112.859 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 50.5 tp60 -48.36 -43.46 33.58 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.363 1.465 . . . . 1.3899999999999999 112.912 178.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 45.5 mtp -66.32 -42.03 88.81 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 121.43 -0.794 . . . . 0.93999999999999995 111.717 -178.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.434 HG13 ' CD1' ' A' ' 67' ' ' ILE . 3.1 t -72.22 -29.7 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 125.267 1.427 . . . . 0.32000000000000001 111.773 176.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -69.23 -51.72 34.9 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 126.185 1.794 . . . . 0.89000000000000001 108.276 179.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -69.0 -19.89 64.15 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 113.748 1.018 . . . . 2.5600000000000001 113.748 -176.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.4 -41.77 80.94 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.031 0.932 . . . . 0.39000000000000001 111.652 178.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.86 -4.16 9.67 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 115.386 1.625 . . . . 0.32000000000000001 115.386 -176.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 21.9 tttt -53.32 -34.68 58.43 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 125.048 1.339 . . . . 1.95 113.45 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 67.2 mt-10 -87.27 -2.58 58.72 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 123.166 0.587 . . . . 2.3199999999999998 111.638 -174.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -100.98 -45.55 5.38 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 128.147 2.579 . . . . 3.0899999999999999 112.17 167.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 30.2 mt -145.78 110.6 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 128.003 2.521 . . . . 0.94999999999999996 107.676 178.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -86.17 -1.43 57.43 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 116.185 1.92 . . . . 2.3500000000000001 116.185 -173.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -77.19 43.39 0.37 Allowed 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 128.728 2.811 . . . . 3.5899999999999999 115.948 -164.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 4.7 mpp? -62.95 1.89 0.37 Allowed 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 114.952 1.464 . . . . 1.28 114.952 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 22.0 t60 -59.78 -26.51 65.77 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.513 1.125 . . . . 4.1399999999999997 113.21 163.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -106.37 -8.15 33.67 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 126.893 2.187 . . . . 0.46000000000000002 114.855 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.7 mp -96.38 123.52 40.05 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 118.374 1.087 . . . . 1.5900000000000001 111.55 -173.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 54.0 ttt180 -105.68 100.01 9.59 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 126.956 2.102 . . . . 3.0499999999999998 109.08 -174.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 3.6 mt -108.28 141.17 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-O 122.969 1.366 . . . . 0.42999999999999999 111.795 -169.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -130.91 123.27 28.56 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 111.695 -2.502 . . . . 1.8500000000000001 107.363 -173.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 16.2 p -136.94 140.45 42.26 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.058 1.343 . . . . 0.31 109.697 -176.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.6 t -138.01 -177.6 4.89 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 122.585 1.183 . . . . 2.2400000000000002 110.922 167.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.414 HG21 ' HB3' ' A' ' 73' ' ' LYS . 7.2 p -147.65 135.78 10.96 Favored Pre-proline 0 C--N 1.317 -0.827 0 C-N-CA 126.085 1.754 . . . . 0.55000000000000004 108.662 177.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo . . . . . 0 CA--C 1.538 0.676 0 C-N-CA 123.018 2.478 . . . . 1.1699999999999999 110.646 175.102 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 . . . . . 0 N--CA 1.469 0.517 0 N-CA-C 115.534 1.679 . . . . 2.54 115.534 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 72.3 p -128.19 169.28 14.32 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 126.751 2.02 . . . . 0.55000000000000004 108.614 160.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -68.37 -16.93 64.11 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 121.027 -1.046 . . . . 2.79 113.004 165.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.99 -42.88 67.32 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 124.62 1.105 . . . . 0.46000000000000002 113.295 169.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.08 -48.88 43.91 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.488 1.915 . . . . 1.3600000000000001 111.892 173.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 24.0 mt -67.04 -51.85 49.55 Favored 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 125.755 1.622 . . . . 0.45000000000000001 111.353 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.5 ttp180 -50.45 -49.93 53.74 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 126.936 2.094 . . . . 4.5899999999999999 110.667 178.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.7 t -67.92 -46.98 80.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 108.874 -0.787 . . . . 0.34999999999999998 108.874 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 57.5 m -55.48 -40.35 71.56 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 118.324 0.511 . . . . 0.34999999999999998 112.326 178.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -61.71 -42.47 98.98 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 112.349 0.499 . . . . 1.6299999999999999 112.349 -177.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 18.5 mt -79.65 -29.37 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 CA-C-N 118.345 0.52 . . . . 0.52000000000000002 111.514 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 22.9 mt -55.55 -40.4 71.86 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 120.98 -1.075 . . . . 0.39000000000000001 113.759 172.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 42.4 mttt -59.45 -27.82 66.43 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 113.832 1.049 . . . . 1.3100000000000001 113.832 178.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -97.4 -34.22 11.12 Favored 'General case' 0 N--CA 1.431 -1.382 0 C-N-CA 127.423 2.289 . . . . 2.2200000000000002 114.233 -172.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 63.1 mmtt -74.27 -23.52 59.13 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 119.089 -1.044 . . . . 1.28 111.919 167.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -127.84 54.97 14.4 Favored Pre-proline 0 CA--C 1.554 1.101 0 N-CA-C 117.874 2.546 . . . . 1.51 117.874 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -66.87 -17.99 52.25 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 124.935 3.757 . . . . 0.81999999999999995 114.99 173.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 25.1 mmt85 -85.29 -1.18 56.69 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 113.89 1.07 . . . . 4.6600000000000001 113.89 171.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.19 149.36 50.05 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 114.3 1.222 . . . . 0.46999999999999997 114.3 -176.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 72.4 p -114.98 -4.15 12.59 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.94 1.696 . . . . 0.89000000000000001 113.418 173.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -140.73 146.31 37.59 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.422 1.089 . . . . 0.37 111.391 147.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.3 pt -154.58 117.54 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 126.381 1.872 . . . . 0.53000000000000003 111.918 169.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.4 ptpt -158.66 148.43 19.41 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.918 1.287 . . . . 1.04 114.041 178.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.2 t -126.52 150.48 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 C-N-CA 126.834 2.053 . . . . 0.29999999999999999 111.287 -173.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 98.1 m -143.57 135.41 26.51 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.502 0.721 . . . . 0.40000000000000002 112.371 171.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -77.62 126.0 30.2 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 122.131 0.967 . . . . 1.9199999999999999 111.012 168.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.0 pt -124.05 29.47 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 C-N-CA 126.151 1.781 . . . . 0.55000000000000004 110.978 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.528 ' HB2' ' H ' ' A' ' 62' ' ' MET . 29.8 t -135.69 58.53 1.75 Allowed 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 128.214 2.606 . . . . 1.28 111.453 -174.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -65.27 14.77 0.21 Allowed Glycine 0 CA--C 1.537 1.444 0 N-CA-C 117.794 1.877 . . . . 2.1200000000000001 117.794 -174.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -135.81 0.3 3.33 Favored Glycine 0 CA--C 1.537 1.407 0 C-N-CA 125.803 1.668 . . . . 1.1799999999999999 114.085 175.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 36.7 t -151.61 -38.62 0.12 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.958 1.303 . . . . 1.5700000000000001 113.568 -177.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 67.19 38.5 92.02 Favored Glycine 0 CA--C 1.541 1.678 0 C-N-CA 126.37 1.938 . . . . 0.77000000000000002 114.67 -165.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -93.71 -20.32 20.25 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 127.242 2.217 . . . . 0.95999999999999996 115.382 176.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.528 ' H ' ' HB2' ' A' ' 56' ' ' SER . 6.1 mtm -111.38 139.91 46.4 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.643 1.577 . . . . 1.3 112.862 172.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -139.96 150.0 43.97 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.875 0.87 . . . . 1.8600000000000001 112.376 172.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -86.74 139.87 30.3 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 125.363 1.465 . . . . 2.3100000000000001 110.126 163.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 90.1 mt -134.34 127.34 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 124.242 1.017 . . . . 0.63 109.606 168.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -117.34 122.74 44.72 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.522 1.129 . . . . 2.46 109.259 171.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.408 ' CD1' HG13 ' A' ' 84' ' ' VAL . 1.2 mt -126.81 157.63 37.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 127.089 2.155 . . . . 0.26000000000000001 109.196 177.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -155.27 131.42 10.2 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 125.706 1.602 . . . . 1.9299999999999999 107.69 168.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 28.7 t -156.82 143.05 18.12 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 120.304 1.411 . . . . 0.41999999999999998 112.327 -173.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -63.91 -10.43 20.89 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 114.767 1.395 . . . . 2.9399999999999999 114.767 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -79.51 -17.52 53.91 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 113.953 1.094 . . . . 1.8300000000000001 113.953 174.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -84.19 1.23 45.48 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 114.556 1.317 . . . . 1.95 114.556 -167.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.417 ' HB3' HG21 ' A' ' 104' ' ' VAL . 30.1 pttt -79.77 -22.97 42.53 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 115.306 1.595 . . . . 3.8599999999999999 115.306 -171.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -97.89 19.25 14.15 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-O 121.987 0.899 . . . . 4.0 111.794 178.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 44.1 mmtt -120.48 139.66 52.55 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 128.079 2.552 . . . . 1.4299999999999999 111.16 -175.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 17.0 mtm180 -66.15 164.48 15.53 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.335 1.054 . . . . 5.2000000000000002 111.197 161.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.1 m -46.66 -54.19 10.08 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 113.781 1.03 . . . . 0.68000000000000005 113.781 170.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 9.4 p -59.5 -37.01 67.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 123.685 0.794 . . . . 0.57999999999999996 112.053 176.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -77.65 -16.81 58.28 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 114.104 1.15 . . . . 1.01 114.104 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -77.87 -55.12 5.58 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 119.45 1.023 . . . . 0.63 109.658 166.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 44.7 m170 -54.12 -46.62 72.22 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.328 1.051 . . . . 0.53000000000000003 113.178 -177.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 53.2 tp60 -47.79 -40.61 21.36 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.426 1.89 . . . . 1.3600000000000001 113.165 177.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 64.5 mtp -66.78 -44.27 81.79 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.468 1.107 . . . . 0.95999999999999996 111.596 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.408 HG13 ' CD1' ' A' ' 67' ' ' ILE . 2.9 t -69.49 -31.0 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 126.162 1.785 . . . . 0.27000000000000002 110.955 178.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -68.87 -52.27 31.48 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.058 1.743 . . . . 0.5 110.176 174.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.04 -28.37 62.48 Favored 'General case' 0 CA--C 1.546 0.808 0 O-C-N 120.679 -1.263 . . . . 2.1899999999999999 111.848 178.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.66 -33.83 76.5 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.741 1.216 . . . . 0.37 112.892 -173.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.46 -7.88 8.63 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 114.473 1.286 . . . . 0.44 114.473 177.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 32.0 ttpt -46.47 -43.51 16.73 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 124.454 1.102 . . . . 2.5299999999999998 112.369 176.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -77.96 -4.05 45.03 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-O 121.645 0.736 . . . . 2.3799999999999999 112.055 -169.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -111.79 -45.41 3.35 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 129.991 3.317 . . . . 2.2599999999999998 111.154 -176.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 40.3 mt -144.85 124.95 7.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 129.001 2.92 . . . . 1.1499999999999999 107.283 177.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -96.09 -10.93 27.15 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 115.317 1.599 . . . . 3.3999999999999999 115.317 -174.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . 0.27 19.0 pt-20 -77.12 43.31 0.36 Allowed 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 116.38 1.993 . . . . 4.6399999999999997 116.38 -162.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 59.1 mtm -71.32 -1.61 13.44 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.65 1.98 . . . . 1.53 115.948 -167.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 6.9 p-80 -60.19 -20.36 58.3 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 121.335 -0.853 . . . . 4.8399999999999999 112.904 159.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -87.63 -12.94 65.98 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 125.43 1.491 . . . . 0.59999999999999998 115.176 169.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.6 mp -100.08 116.47 32.18 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 118.381 1.091 . . . . 1.72 112.268 -168.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 17.6 ttm180 -98.13 103.55 15.51 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 126.505 1.922 . . . . 4.8799999999999999 110.081 -175.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 2.9 mt -108.56 145.48 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 123.548 1.642 . . . . 0.39000000000000001 112.933 -171.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -139.43 120.97 15.15 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 111.048 -2.796 . . . . 1.95 107.825 -171.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 21.2 p -133.6 152.03 51.81 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 126.242 1.817 . . . . 0.27000000000000002 110.025 -177.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 10.4 p -157.41 179.3 9.38 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.931 -1.031 . . . . 0.64000000000000001 111.187 173.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.417 HG21 ' HB3' ' A' ' 73' ' ' LYS . 7.4 p -144.21 133.73 11.56 Favored Pre-proline 0 N--CA 1.47 0.572 0 N-CA-C 113.197 0.814 . . . . 0.51000000000000001 113.197 -177.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo . . . . . 0 N--CA 1.455 -0.774 0 C-N-CA 122.773 2.315 . . . . 0.59999999999999998 109.456 173.011 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 . . . . . 0 CA--C 1.537 0.455 0 N-CA-C 109.759 -0.46 . . . . 1.96 109.759 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 23.1 p -115.55 164.24 14.6 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.517 1.127 . . . . 0.89000000000000001 110.662 170.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -65.42 -32.77 74.58 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 120.77 -1.206 . . . . 2.8900000000000001 111.377 174.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.02 -35.12 90.97 Favored Glycine 0 C--O 1.218 -0.875 0 CA-C-O 118.578 -1.123 . . . . 0.41999999999999998 112.251 172.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.38 -50.93 64.07 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 119.94 1.87 . . . . 1.26 111.825 174.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 15.2 mt -69.8 -50.37 43.66 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 125.657 1.583 . . . . 0.57999999999999996 110.615 -176.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.38 -48.35 79.28 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 126.135 1.774 . . . . 3.1499999999999999 111.533 177.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 29.6 t -62.84 -44.03 99.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 107.875 -1.157 . . . . 0.35999999999999999 107.875 178.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 47.2 m -58.05 -40.38 80.8 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 118.575 0.625 . . . . 0.41999999999999998 112.084 177.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 9.9 mm-40 -64.42 -45.2 88.59 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.634 0.605 . . . . 1.8999999999999999 112.634 -179.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 41.1 mt -72.04 -30.95 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-N 118.143 0.429 . . . . 0.63 109.866 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 37.5 mt -60.48 -37.73 81.98 Favored 'General case' 0 CA--C 1.531 0.237 0 O-C-N 120.925 -1.109 . . . . 0.47999999999999998 113.487 173.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 34.3 mttt -64.68 -25.88 68.14 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 113.596 0.961 . . . . 1.45 113.596 175.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -87.08 -39.91 15.16 Favored 'General case' 0 N--CA 1.433 -1.325 0 C-N-CA 125.769 1.627 . . . . 2.21 113.404 176.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 62.4 mmtt -74.95 -25.51 58.93 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 119.342 -0.943 . . . . 1.48 112.067 175.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -128.11 49.69 4.71 Favored Pre-proline 0 CA--C 1.55 0.975 0 N-CA-C 119.112 3.004 . . . . 2.1099999999999999 119.112 -179.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -67.72 -12.84 36.86 Favored 'Trans proline' 0 CA--C 1.534 0.489 0 C-N-CA 124.718 3.612 . . . . 0.72999999999999998 115.268 175.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 12.3 mmm180 -76.18 -16.49 59.84 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 114.124 1.157 . . . . 7.0099999999999998 114.124 169.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.94 152.48 43.1 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 115.892 1.812 . . . . 0.41999999999999998 115.892 -166.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 30.9 p -100.24 -22.95 14.95 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 118.019 -0.991 . . . . 0.63 112.374 168.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -126.11 141.41 51.95 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 119.932 1.242 . . . . 0.31 111.53 161.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.4 pt -157.6 103.31 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 127.23 2.212 . . . . 0.56000000000000005 110.337 171.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.5 ptpt -152.3 157.21 41.04 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.163 1.385 . . . . 1.1399999999999999 113.097 -175.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 23.7 t -137.72 144.57 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 126.639 1.976 . . . . 0.40999999999999998 110.548 -169.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.405 ' HB ' ' HB3' ' A' ' 64' ' ' GLU . 88.6 m -134.67 126.29 28.81 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 108.989 -0.745 . . . . 0.40999999999999998 108.989 165.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -70.67 133.83 46.99 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.474 0.654 . . . . 2.1499999999999999 109.755 167.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . 0.261 2.9 pt -127.7 34.9 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 C-N-CA 126.373 1.869 . . . . 0.85999999999999999 109.188 173.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 36.4 p -144.72 42.57 1.35 Allowed 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 128.281 2.632 . . . . 2.77 116.766 -174.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -51.26 -22.42 7.06 Favored Glycine 0 CA--C 1.546 2.02 0 N-CA-C 118.399 2.119 . . . . 2.0299999999999998 118.399 -176.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -110.28 -0.02 29.68 Favored Glycine 0 CA--C 1.541 1.7 0 C-N-CA 126.406 1.955 . . . . 1.28 115.37 177.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 7.8 t -132.99 -40.79 0.92 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.544 1.138 . . . . 1.8799999999999999 113.756 -176.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 57.88 47.83 86.29 Favored Glycine 0 CA--C 1.536 1.396 0 C-N-CA 128.348 2.88 . . . . 1.1799999999999999 113.535 -167.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -124.41 18.02 8.95 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.794 1.238 . . . . 1.04 114.024 -179.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 8.5 ttm -153.07 122.77 6.83 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.757 1.223 . . . . 1.78 112.097 -170.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -141.97 148.21 38.21 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.989 0.899 . . . . 1.8700000000000001 113.413 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.405 ' HB3' ' HB ' ' A' ' 53' ' ' THR . 7.8 tt0 -93.18 114.3 26.75 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.627 1.971 . . . . 2.3799999999999999 109.732 168.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 83.0 mt -125.46 123.78 65.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 CA-C-N 120.125 1.33 . . . . 0.70999999999999996 110.625 -170.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 71.7 mttt -125.26 119.52 28.67 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.871 1.269 . . . . 2.6400000000000001 111.011 -172.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.449 ' CD1' HG13 ' A' ' 84' ' ' VAL . 1.3 mt -130.02 153.33 38.74 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 127.158 2.183 . . . . 0.26000000000000001 109.93 -176.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -154.22 127.96 8.75 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.125 1.37 . . . . 1.8500000000000001 108.733 166.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 23.0 t -159.33 142.26 14.21 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 120.383 1.447 . . . . 0.29999999999999999 112.657 -172.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -50.65 -31.41 16.12 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.544 1.137 . . . . 2.73 112.522 178.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -66.98 -10.73 52.63 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 114.644 1.35 . . . . 1.6599999999999999 114.644 -175.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -95.71 10.28 37.47 Favored 'General case' 0 CA--C 1.557 1.217 0 N-CA-C 116.194 1.924 . . . . 2.0899999999999999 116.194 -175.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.443 ' HA ' HG11 ' A' ' 104' ' ' VAL . 0.1 OUTLIER -71.8 -37.15 70.45 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-N 120.775 1.625 . . . . 2.8799999999999999 115.139 -172.073 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -86.19 13.29 8.14 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.575 1.55 . . . . 3.3599999999999999 112.266 -174.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 51.4 mmtt -127.67 131.21 49.84 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.586 1.554 . . . . 2.23 112.951 -159.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 19.1 mmt180 -63.53 163.33 11.27 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.351 1.46 . . . . 5.2699999999999996 111.561 166.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 41.3 m -43.5 -55.52 4.17 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 125.498 1.519 . . . . 1.03 114.167 168.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 9.9 p -59.85 -38.35 75.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 N-CA-C 113.579 0.955 . . . . 0.51000000000000001 113.579 175.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -74.83 -32.45 61.94 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.308 0.643 . . . . 1.05 112.277 -177.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -66.44 -54.29 25.9 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.314 1.046 . . . . 0.64000000000000001 109.81 168.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 46.6 m170 -52.83 -44.77 66.95 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.886 1.274 . . . . 0.51000000000000001 112.951 -178.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 41.3 tp60 -53.34 -39.76 64.37 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.801 1.24 . . . . 1.2 112.821 178.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 4.7 mtm -66.38 -41.44 89.38 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 121.262 -0.899 . . . . 1.51 111.302 179.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.449 HG13 ' CD1' ' A' ' 67' ' ' ILE . 2.3 t -72.39 -26.45 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 125.243 1.417 . . . . 0.28999999999999998 111.914 178.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -70.1 -56.16 7.61 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 126.046 1.739 . . . . 0.82999999999999996 109.148 175.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.98 -6.42 42.0 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.101 1.149 . . . . 2.79 114.101 -178.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.02 -33.83 76.99 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 120.945 -1.097 . . . . 0.47999999999999998 112.738 169.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.24 -0.64 2.01 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 115.489 1.663 . . . . 0.40000000000000002 115.489 -176.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 34.9 tttt -50.26 -38.36 40.45 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 125.175 1.39 . . . . 2.2000000000000002 113.016 177.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -75.31 -18.44 60.03 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-O 121.514 0.673 . . . . 1.8899999999999999 111.413 -177.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -88.72 -51.98 5.38 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 129.126 2.971 . . . . 2.4300000000000002 110.991 177.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 32.9 mt -147.61 114.48 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 128.467 2.707 . . . . 1.02 108.327 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.4 tmtp? -92.28 -7.62 47.55 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 114.87 1.433 . . . . 4.0999999999999996 114.87 -163.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -70.43 57.42 0.17 Allowed 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 129.681 3.192 . . . . 3.1299999999999999 115.477 -164.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . 0.273 1.3 mpt? -75.84 3.63 9.62 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 119.311 -2.118 . . . . 1.8400000000000001 116.483 -178.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 73.2 t60 -59.21 -30.28 68.11 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 121.235 -0.916 . . . . 4.6900000000000004 112.371 151.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -83.56 -30.44 29.97 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 127.886 2.66 . . . . 0.5 116.457 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.0 mt -89.31 120.62 30.82 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 122.856 1.312 . . . . 2.1800000000000002 111.415 -164.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 14.6 ttm180 -106.82 99.23 8.82 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 112.797 -2.001 . . . . 5.2800000000000002 106.502 -179.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 1.4 mt -113.3 140.41 33.59 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.457 0 CA-C-O 122.845 1.307 . . . . 0.57999999999999996 111.105 -165.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -135.14 117.21 15.37 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 111.907 -2.406 . . . . 1.99 107.445 -166.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 18.5 p -134.89 147.52 49.87 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.221 1.808 . . . . 0.27000000000000002 110.145 -175.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.9 p -153.42 179.02 9.16 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.052 -1.431 . . . . 0.58999999999999997 110.319 174.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.443 HG11 ' HA ' ' A' ' 73' ' ' LYS . 6.5 p -145.82 133.26 10.26 Favored Pre-proline 0 N--CA 1.469 0.481 0 O-C-N 121.572 -0.705 . . . . 0.38 111.801 -178.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo . . . . . 0 N--CA 1.448 -1.205 0 C-N-CA 122.721 2.281 . . . . 1.01 108.911 166.173 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.8 mp0 . . . . . 0 C--O 1.238 0.478 0 N-CA-C 115.228 1.566 . . . . 2.3300000000000001 115.228 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 59.2 p -87.13 165.35 15.81 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 114.863 -1.062 . . . . 0.60999999999999999 110.492 156.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -64.54 -27.68 69.13 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 120.936 -1.103 . . . . 4.29 111.875 168.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.54 -38.68 96.04 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 126.119 1.818 . . . . 0.45000000000000001 113.379 170.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.79 -43.18 72.62 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.291 1.546 . . . . 2.1299999999999999 112.014 174.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 11.7 mt -69.17 -52.04 31.97 Favored 'General case' 0 N--CA 1.462 0.129 0 C-N-CA 125.573 1.549 . . . . 0.35999999999999999 111.005 178.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -53.48 -49.75 66.82 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 126.923 2.089 . . . . 3.4199999999999999 110.874 178.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 38.1 t -67.4 -45.04 86.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 108.75 -0.833 . . . . 0.31 108.75 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 68.4 m -53.98 -43.55 70.05 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 118.511 0.596 . . . . 0.37 112.392 175.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -62.89 -43.65 98.21 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 118.593 0.633 . . . . 1.8 111.734 -176.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 53.2 mt -71.6 -29.86 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 123.312 0.645 . . . . 0.78000000000000003 110.323 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 53.2 mt -64.93 -41.44 95.52 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 120.655 -1.278 . . . . 0.62 113.269 171.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 38.7 mttt -62.19 -19.43 63.11 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-N 119.544 1.066 . . . . 1.77 113.852 174.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -95.91 -37.95 10.48 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 126.315 1.846 . . . . 2.3100000000000001 114.832 -178.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -78.38 -22.1 48.38 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 118.675 -0.678 . . . . 1.1100000000000001 112.492 170.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -133.07 50.07 5.13 Favored Pre-proline 0 CA--C 1.548 0.902 0 N-CA-C 118.854 2.909 . . . . 1.54 118.854 -179.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -62.98 -26.42 74.08 Favored 'Trans proline' 0 CA--C 1.534 0.516 0 C-N-CA 123.48 2.786 . . . . 1.0 115.842 177.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 27.0 mmm180 -76.97 -12.85 60.0 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 120.387 1.449 . . . . 7.3499999999999996 114.61 176.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -53.8 144.92 17.08 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.925 1.29 . . . . 0.62 114.159 -175.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 44.3 p -97.4 -22.5 16.57 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.473 1.109 . . . . 0.56999999999999995 111.984 176.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -123.4 138.39 54.61 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.942 0.897 . . . . 0.40999999999999998 110.321 157.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -154.35 105.97 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 124.841 1.256 . . . . 0.62 110.361 169.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.9 ptpt -150.05 154.75 38.68 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.025 1.33 . . . . 1.21 112.814 -179.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.9 t -129.95 148.27 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 126.785 2.034 . . . . 0.44 109.632 -178.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 55.2 m -135.42 132.91 38.06 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 118.465 0.575 . . . . 0.48999999999999999 110.244 161.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -72.51 134.34 45.24 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 122.037 0.922 . . . . 1.79 109.767 167.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . 0.257 1.8 pt -127.7 33.39 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 125.57 1.548 . . . . 0.53000000000000003 109.787 174.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.2 p -141.55 63.93 1.42 Allowed 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 127.087 2.155 . . . . 2.4399999999999999 114.362 -177.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -58.03 -19.05 36.32 Favored Glycine 0 CA--C 1.543 1.819 0 N-CA-C 116.326 1.29 . . . . 1.25 116.326 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -108.86 -5.55 31.03 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 125.74 1.638 . . . . 0.95999999999999996 116.63 -178.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 1.3 m -152.11 -15.86 0.18 Allowed 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 115.2 1.555 . . . . 1.77 115.2 -177.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 51.75 38.93 45.88 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 127.246 2.355 . . . . 0.81000000000000005 114.995 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -110.76 6.5 21.53 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.116 1.366 . . . . 1.21 113.236 -175.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 15.0 ttm -140.48 121.07 14.22 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.714 2.006 . . . . 1.9199999999999999 110.497 -161.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.418 ' HB2' HD22 ' A' ' 98' ' ' LEU . 78.2 m-85 -143.36 146.33 33.43 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 113.815 1.043 . . . . 1.9199999999999999 113.815 -174.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -90.88 114.15 26.52 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.901 1.68 . . . . 2.6299999999999999 109.417 167.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 95.9 mt -120.55 123.66 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 O-C-N 120.762 -1.211 . . . . 0.63 109.565 -175.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 75.7 mttt -124.28 111.23 15.58 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.78 1.232 . . . . 2.6499999999999999 110.254 -174.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.3 mt -120.46 155.26 23.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 127.445 2.298 . . . . 0.23999999999999999 109.052 -178.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -153.66 130.49 10.89 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.186 1.394 . . . . 1.8500000000000001 107.291 162.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.6 t -155.3 140.75 17.78 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 120.107 1.321 . . . . 0.32000000000000001 112.352 -173.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -61.91 -6.6 2.91 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.621 1.568 . . . . 3.8900000000000001 115.111 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -84.68 -14.58 48.06 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.733 1.613 . . . . 1.77 114.207 175.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -87.13 12.03 12.51 Favored 'General case' 0 CA--C 1.559 1.302 0 N-CA-C 114.37 1.248 . . . . 2.0299999999999998 114.37 -175.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.412 ' HB3' HG21 ' A' ' 104' ' ' VAL 0.252 0.0 OUTLIER -76.83 -14.62 59.89 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 117.225 2.305 . . . . 2.54 117.225 -166.476 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -118.29 25.33 10.38 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.341 1.456 . . . . 4.8799999999999999 111.253 169.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 52.3 mmtt -112.61 131.36 55.66 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.544 1.538 . . . . 1.3799999999999999 111.868 177.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 36.1 mtt180 -65.71 161.69 20.16 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.667 1.187 . . . . 3.77 111.071 163.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 54.1 m -38.04 -55.56 1.24 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 126.356 1.862 . . . . 0.92000000000000004 113.799 168.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.5 p -63.86 -40.34 88.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 125.212 1.405 . . . . 0.85999999999999999 113.598 178.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -71.92 -32.3 67.22 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 121.619 -0.675 . . . . 1.01 111.573 178.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -63.79 -53.45 50.62 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.568 0.747 . . . . 0.64000000000000001 109.885 169.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 62.8 m170 -49.94 -52.35 34.06 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.796 0.838 . . . . 0.75 111.968 178.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 23.4 tp60 -46.9 -44.33 19.62 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.037 1.735 . . . . 1.23 113.134 178.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 85.0 mtp -62.33 -43.51 98.66 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 119.159 0.89 . . . . 0.92000000000000004 112.516 178.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.6 t -71.7 -27.41 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 C-N-CA 125.647 1.579 . . . . 0.23000000000000001 112.146 178.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -74.31 -50.67 17.87 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.525 1.93 . . . . 0.46999999999999997 109.381 177.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 12.5 mm-40 -65.56 -18.66 65.49 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.378 1.471 . . . . 2.54 113.635 178.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.69 -44.67 85.99 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 119.337 0.971 . . . . 0.78000000000000003 111.056 179.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.11 5.66 9.22 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 115.513 1.672 . . . . 0.67000000000000004 115.513 -174.204 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.5 ttmt -51.67 -40.23 59.66 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 125.037 1.335 . . . . 3.1699999999999999 113.136 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -81.68 10.32 6.31 Favored 'General case' 0 CA--C 1.554 1.126 0 CA-C-O 122.121 0.962 . . . . 2.3999999999999999 113.347 -174.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -126.84 -56.26 1.37 Allowed 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 129.443 3.097 . . . . 3.1200000000000001 108.652 -176.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -128.57 120.97 53.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 126.872 2.069 . . . . 1.54 108.371 165.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -105.75 1.69 27.28 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 119.919 -1.738 . . . . 2.6299999999999999 114.812 -179.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.3 mp0 -71.88 47.01 0.14 Allowed 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 130.573 3.549 . . . . 3.25 115.332 -173.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . 0.254 2.1 mpt? -72.35 12.75 0.41 Allowed 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 116.703 2.112 . . . . 1.78 116.703 -173.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 39.8 p-80 -63.39 -28.4 69.96 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.366 -0.834 . . . . 4.1100000000000003 112.083 154.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -77.94 -22.61 68.44 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 115.916 1.126 . . . . 0.45000000000000001 115.916 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.418 HD22 ' HB2' ' A' ' 63' ' ' TYR . 10.1 mt -92.06 136.02 33.51 Favored 'General case' 0 C--O 1.238 0.463 0 O-C-N 120.813 -1.404 . . . . 2.1499999999999999 111.222 -164.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 15.3 ttt180 -114.63 105.49 13.12 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.686 1.594 . . . . 3.73 106.896 169.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 1.5 mt -114.41 137.47 47.64 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.648 0 CA-C-O 123.098 1.427 . . . . 0.44 111.005 -169.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -130.54 123.72 30.24 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-N 111.769 -2.468 . . . . 1.8799999999999999 106.628 -169.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 17.3 p -140.86 152.68 45.29 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 126.237 1.815 . . . . 0.28999999999999998 109.217 -175.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -161.05 173.88 14.56 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.296 -0.866 . . . . 0.69999999999999996 110.481 176.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.412 HG21 ' HB3' ' A' ' 73' ' ' LYS . 12.5 p -141.84 133.71 13.54 Favored Pre-proline 0 N--CA 1.468 0.467 0 O-C-N 121.329 -0.857 . . . . 0.59999999999999998 111.962 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo . . . . . 0 N--CA 1.453 -0.874 0 C-N-CA 122.081 1.854 . . . . 0.85999999999999999 110.615 174.698 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 . . . . . 0 CA--C 1.544 0.743 0 N-CA-C 115.128 1.529 . . . . 2.4900000000000002 115.128 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 66.9 p -100.93 170.18 8.47 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 121.128 -0.982 . . . . 0.59999999999999998 109.897 159.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 -70.07 -29.48 66.49 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 120.436 -1.415 . . . . 3.8599999999999999 111.902 163.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -66.54 -38.14 93.15 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 124.282 0.944 . . . . 0.35999999999999999 113.139 177.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.94 -44.27 50.39 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.449 1.499 . . . . 1.98 111.539 172.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.4 mt -70.26 -51.87 27.32 Favored 'General case' 0 C--N 1.337 0.046 0 C-N-CA 125.479 1.512 . . . . 0.40000000000000002 110.747 -178.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.87 -48.93 76.97 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.904 1.682 . . . . 3.0600000000000001 110.865 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.8 t -65.54 -45.25 93.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 108.435 -0.95 . . . . 0.34000000000000002 108.435 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 98.7 m -56.92 -41.32 77.96 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 118.687 0.676 . . . . 0.38 112.411 176.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -63.86 -42.52 97.52 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 112.753 0.649 . . . . 2.04 112.753 -178.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 32.2 mt -75.45 -30.25 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 CA-C-N 118.629 0.649 . . . . 0.47999999999999998 110.462 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 44.0 mt -60.14 -40.35 89.48 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 120.779 -1.2 . . . . 0.67000000000000004 113.34 171.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 27.2 mttt -60.73 -24.95 66.09 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 119.338 0.972 . . . . 1.8500000000000001 113.391 176.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -94.62 -35.38 12.24 Favored 'General case' 0 N--CA 1.434 -1.236 0 C-N-CA 126.895 2.078 . . . . 1.96 115.066 -178.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 56.8 mmtt -75.89 -22.77 55.79 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 119.735 -0.786 . . . . 1.3100000000000001 111.856 170.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -130.19 51.39 7.45 Favored Pre-proline 0 CA--C 1.551 1.002 0 N-CA-C 118.428 2.751 . . . . 1.6200000000000001 118.428 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -67.66 -18.88 48.28 Favored 'Trans proline' 0 CA--C 1.534 0.507 0 C-N-CA 124.457 3.438 . . . . 0.62 115.099 176.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.96 -5.01 58.9 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 114.861 1.43 . . . . 5.6600000000000001 114.861 172.029 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.09 146.73 52.63 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 113.615 0.968 . . . . 0.40999999999999998 113.615 -178.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 60.9 p -93.34 -32.76 14.16 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.331 -0.849 . . . . 0.68000000000000005 111.06 172.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -117.63 137.88 52.34 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.046 0.938 . . . . 0.31 111.527 165.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -156.03 108.16 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 126.685 1.994 . . . . 0.60999999999999999 109.919 171.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.1 ptpt -152.37 157.83 41.84 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.813 1.645 . . . . 1.05 113.618 178.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.3 t -132.67 151.68 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 126.051 1.74 . . . . 0.34999999999999998 110.763 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 89.8 m -141.1 125.22 17.3 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 120.31 -1.493 . . . . 0.40999999999999998 110.846 169.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -67.44 135.3 52.91 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.809 0.814 . . . . 1.77 109.838 168.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.3 pt -134.34 19.93 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 124.909 1.284 . . . . 0.64000000000000001 111.76 178.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.3 t -123.05 83.42 2.12 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 127.316 2.246 . . . . 1.3400000000000001 111.399 176.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -73.2 9.22 7.39 Favored Glycine 0 N--CA 1.476 1.363 0 O-C-N 120.325 -1.484 . . . . 1.8500000000000001 115.212 -177.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -129.12 -12.98 2.48 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 126.452 1.977 . . . . 1.23 114.046 -175.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 7.2 t -151.41 -18.04 0.2 Allowed 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 118.575 1.187 . . . . 1.99 114.055 175.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 54.93 37.55 62.76 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 124.686 1.136 . . . . 0.90000000000000002 111.984 -163.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -91.97 1.83 56.94 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.295 1.438 . . . . 0.92000000000000004 113.184 178.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 1.4 mtp -134.31 141.46 46.94 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 126.179 1.792 . . . . 2.0099999999999998 112.396 175.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.436 ' H ' HD23 ' A' ' 98' ' ' LEU . 95.4 m-85 -142.62 145.37 33.43 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 122.021 0.915 . . . . 2.0099999999999998 112.363 173.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -80.86 133.74 35.64 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 125.897 1.679 . . . . 1.8200000000000001 108.573 161.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.5 mt -137.34 122.7 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 CA-C-N 119.464 1.029 . . . . 0.59999999999999998 108.911 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 70.3 mttt -124.73 112.05 16.28 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.29 1.036 . . . . 2.7599999999999998 110.183 -175.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.3 mt -121.96 155.93 26.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 126.858 2.063 . . . . 0.28000000000000003 109.061 -177.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -156.06 126.72 6.8 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.453 1.501 . . . . 2.0600000000000001 107.598 165.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.4 t -156.84 147.93 22.0 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 119.932 1.242 . . . . 0.38 112.417 -173.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -57.48 -28.11 63.1 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.245 1.418 . . . . 4.0199999999999996 113.019 -174.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -69.78 -18.22 63.47 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 115.039 1.496 . . . . 1.75 115.039 177.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -80.94 13.84 2.5 Favored 'General case' 0 CA--C 1.545 0.759 0 O-C-N 121.102 -0.999 . . . . 1.6299999999999999 113.215 -176.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 50.7 pttt -78.74 -27.68 44.79 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.157 1.383 . . . . 2.7599999999999998 113.348 176.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -109.11 33.7 4.13 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.12 1.768 . . . . 4.8300000000000001 111.875 -167.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 65.4 mmtt -139.56 141.64 37.2 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 126.897 2.079 . . . . 1.78 111.407 -169.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 6.6 mmt180 -65.88 168.78 7.49 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.668 1.187 . . . . 3.8300000000000001 110.872 162.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 94.7 m -54.97 -53.91 49.62 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 113.036 0.754 . . . . 1.22 113.036 170.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 10.1 p -57.4 -40.46 74.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 123.216 0.606 . . . . 0.92000000000000004 111.681 176.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -68.64 -32.36 72.16 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.2 0.815 . . . . 2.0600000000000001 113.2 178.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 -62.41 -52.08 65.0 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.556 1.071 . . . . 1.9199999999999999 109.924 170.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 33.1 m170 -58.21 -50.08 74.8 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 118.944 0.793 . . . . 0.78000000000000003 112.64 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -54.15 -40.95 67.9 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 124.706 1.202 . . . . 4.25 113.937 178.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 1.1 mmm -61.97 -34.6 76.44 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 120.403 1.456 . . . . 1.55 111.657 -178.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.1 t -79.32 -32.04 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 127.122 2.169 . . . . 0.31 111.347 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -67.7 -46.51 72.03 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.347 1.459 . . . . 0.89000000000000001 111.312 170.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 55.0 tp60 -65.73 -25.76 67.44 Favored 'General case' 0 N--CA 1.445 -0.687 0 O-C-N 120.373 -1.454 . . . . 2.6099999999999999 113.847 -177.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.87 -30.99 69.36 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.451 1.5 . . . . 0.34999999999999998 112.521 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -127.13 1.14 6.48 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 115.492 1.664 . . . . 0.60999999999999999 115.492 177.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 31.2 ttmt -46.54 -43.3 16.93 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.443 1.497 . . . . 2.1200000000000001 112.413 175.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -81.74 -18.86 42.79 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-O 121.362 0.601 . . . . 2.1699999999999999 111.509 -171.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -88.9 -49.52 6.75 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 127.995 2.518 . . . . 2.3399999999999999 111.197 -178.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 51.0 mt -147.36 101.06 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 127.544 2.338 . . . . 1.3600000000000001 108.115 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.3 ptmm? -79.21 -7.57 58.34 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 116.551 2.056 . . . . 2.7400000000000002 116.551 -166.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -79.19 44.03 0.56 Allowed 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 130.074 3.35 . . . . 3.5299999999999998 115.594 -165.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 4.2 mpp? -73.86 12.45 0.67 Allowed 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 117.651 2.463 . . . . 1.48 117.651 -168.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 68.6 t60 -53.78 -32.6 53.1 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 120.516 1.507 . . . . 4.4500000000000002 112.337 168.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -75.65 -12.23 83.93 Favored Glycine 0 CA--C 1.522 0.475 0 N-CA-C 117.364 1.706 . . . . 0.51000000000000001 117.364 -178.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.436 HD23 ' H ' ' A' ' 63' ' ' TYR . 13.2 mt -88.25 133.71 33.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 122.787 1.279 . . . . 2.0899999999999999 111.369 -162.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 19.9 ttm180 -120.0 85.49 2.39 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 126.901 2.081 . . . . 5.7000000000000002 106.9 -172.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 1.6 mt -106.67 141.39 22.01 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 CA-C-O 123.905 1.812 . . . . 0.42999999999999999 112.038 -163.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -135.87 125.43 25.21 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 111.515 -2.584 . . . . 2.0899999999999999 107.513 -170.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 26.2 p -140.99 157.74 44.91 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 125.834 1.654 . . . . 0.26000000000000001 109.077 -176.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 2.5 p -168.55 178.58 4.7 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.583 -1.189 . . . . 0.58999999999999997 109.837 176.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.3 p -138.65 129.4 15.17 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 124.106 0.962 . . . . 0.38 112.022 -178.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo . . . . . 0 C--N 1.348 0.529 0 C-N-CA 124.079 3.186 . . . . 0.75 111.957 -175.617 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 12.0 mp0 . . . . . 0 CA--C 1.536 0.424 0 CA-C-O 121.551 0.691 . . . . 2.3399999999999999 111.305 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 80.4 p -120.49 170.59 9.25 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 107.947 -1.131 . . . . 0.56999999999999995 107.947 144.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -69.5 -22.6 63.59 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 120.919 -1.113 . . . . 2.8700000000000001 112.068 166.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.36 -41.38 98.15 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 124.309 0.956 . . . . 0.35999999999999999 112.574 169.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.72 -46.22 40.47 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.681 1.593 . . . . 1.3200000000000001 111.681 171.099 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.6 mt -68.6 -52.47 31.26 Favored 'General case' 0 C--N 1.339 0.113 0 C-N-CA 125.085 1.354 . . . . 0.38 111.225 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -56.59 -50.18 72.71 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.375 1.47 . . . . 3.1299999999999999 110.824 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.7 t -60.3 -46.74 94.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 107.757 -1.201 . . . . 0.29999999999999999 107.757 179.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 63.3 m -57.92 -41.22 82.24 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 118.417 0.553 . . . . 0.37 112.358 177.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 -60.55 -45.62 93.23 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 123.28 0.632 . . . . 1.77 111.396 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 42.9 mt -76.87 -27.29 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 117.871 0.305 . . . . 0.65000000000000002 110.433 -175.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 19.0 mt -58.73 -39.0 79.6 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.077 -1.014 . . . . 0.41999999999999998 112.831 168.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 37.6 mttt -65.35 -19.9 66.15 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 113.794 1.035 . . . . 1.48 113.794 175.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -102.39 -34.83 9.03 Favored 'General case' 0 N--CA 1.436 -1.166 0 C-N-CA 126.776 2.03 . . . . 2.2400000000000002 114.532 -174.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 26.6 mmtp -75.97 -30.79 58.73 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 120.038 -0.665 . . . . 2.7999999999999998 111.039 167.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -128.14 50.57 5.74 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 118.351 2.722 . . . . 1.55 118.351 -176.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -60.47 -27.61 85.16 Favored 'Trans proline' 0 C--O 1.236 0.409 0 C-N-CA 123.134 2.556 . . . . 0.81999999999999995 114.297 174.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 31.7 mmt180 -74.86 -9.24 58.36 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 114.079 1.14 . . . . 4.9800000000000004 114.079 179.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.59 152.37 15.19 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 115.579 1.696 . . . . 0.40999999999999998 115.579 -173.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 42.8 p -104.27 -5.68 21.63 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 127.259 2.223 . . . . 1.0700000000000001 113.148 168.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -143.16 143.88 31.98 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 119.932 1.242 . . . . 0.40999999999999998 111.814 153.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.9 pt -155.15 116.14 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 126.753 2.021 . . . . 0.52000000000000002 111.069 169.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 7.9 ptpt -161.03 153.5 20.49 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.481 1.512 . . . . 1.1100000000000001 112.782 179.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.5 t -134.54 143.49 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 126.218 1.807 . . . . 0.34999999999999998 110.483 -175.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 64.2 m -133.76 125.14 27.9 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.839 1.656 . . . . 0.46000000000000002 110.805 173.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -75.27 132.86 41.33 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 122.304 1.05 . . . . 1.8200000000000001 111.526 171.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.4 pt -133.84 26.8 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 C-N-CA 126.295 1.838 . . . . 0.59999999999999998 110.898 178.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 46.8 t -134.2 69.91 1.46 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 126.879 2.072 . . . . 1.3500000000000001 112.696 176.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -54.06 -25.13 30.53 Favored Glycine 0 CA--C 1.54 1.609 0 N-CA-C 116.074 1.19 . . . . 1.5 116.074 -179.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -88.35 -17.67 56.79 Favored Glycine 0 CA--C 1.534 1.28 0 CA-C-N 119.118 1.459 . . . . 1.5 116.194 -176.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 9.8 m -154.86 -32.46 0.1 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.792 1.237 . . . . 1.72 114.127 -164.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 64.99 47.1 86.35 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 125.426 1.489 . . . . 0.80000000000000004 112.987 -166.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -98.15 -1.6 41.87 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 126.402 1.881 . . . . 0.91000000000000003 114.098 176.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 15.6 mtm -136.96 138.8 40.97 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 126.151 1.781 . . . . 1.45 110.88 177.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -143.75 146.51 33.19 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.701 0.8 . . . . 1.8700000000000001 111.781 172.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -94.91 130.08 41.68 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.61 1.564 . . . . 2.3900000000000001 109.561 169.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 80.4 mt -137.65 129.33 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.879 0.872 . . . . 0.79000000000000004 110.636 -167.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 60.0 mttt -115.75 125.12 52.37 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.94 0.896 . . . . 3.77 110.272 173.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.455 HD12 HG13 ' A' ' 84' ' ' VAL . 1.2 mt -129.21 155.18 41.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 C-N-CA 125.482 1.513 . . . . 0.41999999999999998 109.877 173.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -158.35 133.23 8.4 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 120.059 -1.651 . . . . 2.0099999999999998 109.31 171.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 19.6 t -162.4 147.1 12.26 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 119.911 1.232 . . . . 0.45000000000000001 112.21 -174.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -53.91 -28.83 39.21 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.382 1.473 . . . . 4.7699999999999996 113.014 -179.018 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -65.7 -20.32 66.24 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 115.237 1.569 . . . . 1.8200000000000001 115.237 177.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -84.43 2.1 42.32 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 115.104 1.52 . . . . 1.99 115.104 -168.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 16.4 pttm -69.34 -47.35 64.63 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-O 121.819 0.819 . . . . 2.9100000000000001 112.079 -176.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -84.2 35.29 0.53 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 128.842 2.857 . . . . 4.1799999999999997 111.455 -170.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 49.0 mmtt -140.11 140.35 36.02 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 127.892 2.477 . . . . 1.3 110.754 -172.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 49.5 mtt180 -68.13 172.42 5.74 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.537 0.735 . . . . 3.7200000000000002 111.404 163.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 37.3 m -51.41 -54.41 26.93 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.671 0.789 . . . . 0.93000000000000005 112.852 168.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 10.9 p -57.23 -37.68 57.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 124.312 1.045 . . . . 0.68000000000000005 112.701 176.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -80.59 -32.3 36.52 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 113.128 0.788 . . . . 1.1899999999999999 113.128 -177.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -61.94 -50.26 72.84 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 119.904 1.229 . . . . 0.64000000000000001 109.846 168.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 50.8 m170 -55.75 -49.73 72.32 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 122.912 0.485 . . . . 0.68999999999999995 111.629 177.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 47.4 tp60 -46.88 -45.1 20.2 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.706 2.002 . . . . 1.3700000000000001 112.937 -178.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 71.9 mtp -62.34 -43.26 99.24 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.998 0.919 . . . . 1.1299999999999999 112.189 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.455 HG13 HD12 ' A' ' 67' ' ' ILE . 6.0 t -74.03 -27.23 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 126.612 1.965 . . . . 0.23999999999999999 112.097 178.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -71.98 -50.04 32.08 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 126.003 1.721 . . . . 0.56000000000000005 108.751 176.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 15.3 mm-40 -65.88 -24.38 66.84 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.621 1.168 . . . . 2.3799999999999999 112.806 179.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -56.44 -37.17 69.87 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.398 1.079 . . . . 0.45000000000000001 112.568 -176.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -127.79 4.62 6.04 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 115.236 1.569 . . . . 0.47999999999999998 115.236 -179.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 16.4 ttmt -50.73 -34.9 28.84 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.827 1.251 . . . . 2.9900000000000002 113.309 -178.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -74.05 -29.92 62.14 Favored 'General case' 0 N--CA 1.439 -1.025 0 O-C-N 121.484 -0.76 . . . . 2.5800000000000001 111.78 -177.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.23 -58.42 3.29 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 127.944 2.498 . . . . 2.71 111.995 175.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 34.7 mt -136.97 123.88 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 125.778 1.631 . . . . 1.0700000000000001 107.868 178.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -90.75 -12.04 37.73 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 115.005 1.483 . . . . 2.8799999999999999 115.005 -166.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -85.77 67.19 9.96 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 126.182 1.793 . . . . 3.5299999999999998 113.752 -156.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . 0.272 0.8 OUTLIER -74.35 -4.0 33.7 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 115.71 1.745 . . . . 1.8400000000000001 115.71 176.844 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 67.2 t60 -55.76 -24.52 35.86 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 121.61 -0.681 . . . . 4.3399999999999999 112.786 153.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -88.2 -27.0 26.84 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 127.424 2.44 . . . . 0.54000000000000004 116.146 177.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.0 mt -90.5 134.5 34.32 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 121.895 -0.768 . . . . 2.3300000000000001 111.622 -166.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 27.0 ttt180 -117.08 92.68 3.92 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.837 1.655 . . . . 3.2999999999999998 108.527 -176.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -114.03 135.12 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-O 123.094 1.426 . . . . 0.46999999999999997 113.198 -159.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -131.36 91.22 2.98 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 112.897 -1.956 . . . . 2.0 109.917 -164.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.1 p -99.64 152.34 20.16 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.988 1.715 . . . . 0.31 111.895 178.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.2 p -156.39 -179.42 8.15 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 125.716 1.606 . . . . 0.64000000000000001 110.614 174.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.5 p -143.27 132.04 11.43 Favored Pre-proline 0 N--CA 1.476 0.834 0 O-C-N 121.5 -0.75 . . . . 0.46000000000000002 112.725 -179.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo . . . . . 0 C--N 1.351 0.685 0 C-N-CA 124.327 3.351 . . . . 0.68999999999999995 112.294 -176.511 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 . . . . . 0 N--CA 1.469 0.501 0 CA-C-O 120.794 0.331 . . . . 2.4399999999999999 111.255 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 69.3 p -110.7 179.05 4.17 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.764 1.226 . . . . 0.65000000000000002 109.957 160.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -71.02 -30.27 66.43 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 120.86 -1.15 . . . . 3.3700000000000001 111.951 161.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.21 -38.14 82.0 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 124.8 1.191 . . . . 0.40000000000000002 114.119 -178.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.53 -45.28 37.19 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.638 1.575 . . . . 1.22 111.575 174.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 15.0 mt -69.42 -52.82 23.25 Favored 'General case' 0 CA--C 1.522 -0.125 0 C-N-CA 125.68 1.592 . . . . 0.41999999999999998 110.945 -178.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.482 ' HE ' ' CD ' ' A' ' 91' ' ' GLU . 5.9 tpt180 -56.38 -49.64 73.88 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 125.419 1.487 . . . . 4.9800000000000004 111.585 -178.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 37.1 t -65.57 -42.17 92.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 107.827 -1.175 . . . . 0.51000000000000001 107.827 -179.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 87.1 m -57.99 -38.49 76.2 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 118.547 0.612 . . . . 0.47999999999999998 112.318 174.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 -63.06 -40.86 98.95 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 113.498 0.925 . . . . 1.74 113.498 -177.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 16.4 mt -81.32 -30.79 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 118.363 0.529 . . . . 0.68999999999999995 110.34 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 45.5 mt -51.95 -38.33 56.08 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 114.372 1.249 . . . . 0.72999999999999998 114.372 169.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 57.0 mttt -59.65 -31.05 69.17 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 124.962 1.305 . . . . 2.6200000000000001 113.912 178.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -93.69 -32.02 14.21 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 127.616 2.366 . . . . 2.3999999999999999 113.794 -174.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 59.9 mmtt -75.32 -26.55 58.74 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 119.805 -0.758 . . . . 1.6200000000000001 111.086 168.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -128.45 55.47 17.52 Favored Pre-proline 0 CA--C 1.55 0.959 0 N-CA-C 117.897 2.554 . . . . 1.6200000000000001 117.897 -177.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -68.83 -19.28 41.0 Favored 'Trans proline' 0 CA--C 1.534 0.489 0 C-N-CA 123.947 3.098 . . . . 0.81000000000000005 113.993 168.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 76.4 mtt180 -79.46 -2.61 42.75 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 114.601 1.334 . . . . 6.0899999999999999 114.601 174.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.25 158.38 33.46 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 115.727 1.751 . . . . 0.71999999999999997 115.727 -170.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 64.2 p -118.09 -15.77 9.85 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.97 1.308 . . . . 0.57999999999999996 112.651 168.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -131.66 141.72 49.67 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.914 0.885 . . . . 0.32000000000000001 111.727 152.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.0 pt -149.79 117.96 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 126.084 1.754 . . . . 0.77000000000000002 110.661 161.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 11.4 ptpt -152.8 155.01 36.31 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.86 1.264 . . . . 1.3999999999999999 112.285 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.7 t -135.78 144.88 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 126.281 1.833 . . . . 0.28999999999999998 110.398 -176.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 94.4 m -136.77 128.61 29.1 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.317 0.647 . . . . 0.32000000000000001 110.646 171.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -73.14 123.74 24.21 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.589 0.756 . . . . 2.0099999999999998 109.604 165.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.3 pt -122.18 27.2 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 125.001 1.321 . . . . 0.71999999999999997 110.574 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 36.6 t -136.32 65.55 1.52 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 127.189 2.196 . . . . 1.5700000000000001 111.001 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.37 0.6 2.66 Favored Glycine 0 CA--C 1.54 1.607 0 N-CA-C 117.227 1.651 . . . . 1.6000000000000001 117.227 -176.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -131.72 4.13 5.4 Favored Glycine 0 CA--C 1.538 1.521 0 C-N-CA 125.687 1.613 . . . . 1.4299999999999999 115.131 176.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 4.4 t -147.97 -27.35 0.34 Allowed 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 118.614 1.207 . . . . 1.5600000000000001 113.979 175.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 59.09 33.14 73.19 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 127.138 2.304 . . . . 1.0 114.316 -170.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -84.31 -28.27 27.23 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 118.291 1.046 . . . . 1.28 113.516 178.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -106.49 140.54 39.23 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 125.052 1.341 . . . . 1.6200000000000001 113.017 -179.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -142.64 145.68 33.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.751 -1.113 . . . . 1.8200000000000001 111.605 170.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -83.58 138.66 33.28 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 125.101 1.36 . . . . 1.78 109.288 162.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 93.9 mt -133.95 126.83 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.189 0.996 . . . . 0.56000000000000005 108.939 169.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 67.8 mttt -124.59 122.22 36.94 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.555 1.142 . . . . 2.6200000000000001 110.127 178.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.416 ' CD1' HG13 ' A' ' 84' ' ' VAL . 1.6 mt -126.25 158.66 35.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 125.869 1.668 . . . . 0.40000000000000002 109.296 -179.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -151.89 130.17 12.02 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 126.293 1.837 . . . . 1.8600000000000001 106.257 160.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 21.2 t -154.35 139.55 17.51 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 118.745 0.702 . . . . 0.35999999999999999 110.683 -176.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -58.32 -18.3 26.23 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.32 1.448 . . . . 3.1699999999999999 114.525 -177.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -74.23 -19.72 60.42 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.311 1.444 . . . . 1.6899999999999999 114.529 177.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -82.84 10.91 6.74 Favored 'General case' 0 CA--C 1.555 1.17 0 N-CA-C 116.123 1.898 . . . . 1.6299999999999999 116.123 -169.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.782 ' HA ' HG11 ' A' ' 104' ' ' VAL . 22.6 pttt -65.26 -46.85 78.85 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 127.059 2.144 . . . . 2.1200000000000001 115.754 -165.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -92.4 -20.7 20.76 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 126.799 2.04 . . . . 5.1100000000000003 112.353 -175.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 66.7 mmtt -58.82 142.91 49.05 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.567 1.147 . . . . 1.24 113.083 177.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 9.8 mmp_? -69.12 168.82 13.16 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 125.52 1.528 . . . . 6.4800000000000004 111.148 163.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.6 m -46.76 -56.86 5.52 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.424 0.69 . . . . 1.23 112.606 170.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.7 p -58.8 -41.73 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 125.235 1.414 . . . . 0.96999999999999997 112.633 178.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -76.0 -23.08 55.22 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 118.703 -0.665 . . . . 1.1200000000000001 112.496 -177.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -68.63 -58.05 4.83 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 119.634 1.107 . . . . 0.59999999999999998 109.925 164.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 32.5 m170 -56.14 -43.87 78.66 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.618 0.767 . . . . 0.48999999999999999 112.788 -177.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 50.9 tp60 -53.31 -40.6 64.9 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.325 1.45 . . . . 1.27 113.086 178.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 2.6 mtm -64.04 -39.57 94.38 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 119.649 1.113 . . . . 1.26 111.283 178.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.416 HG13 ' CD1' ' A' ' 67' ' ' ILE . 2.3 t -73.18 -28.42 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 125.497 1.519 . . . . 0.28000000000000003 111.775 177.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -71.58 -48.2 49.93 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.644 1.578 . . . . 0.59999999999999998 110.812 174.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.14 -22.32 66.89 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 120.736 -1.227 . . . . 2.77 112.384 177.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.28 -22.07 66.82 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 113.704 1.001 . . . . 0.94999999999999996 113.704 -177.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -132.69 -1.95 3.39 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 114.604 1.335 . . . . 0.58999999999999997 114.604 173.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 36.3 tttt -47.02 -41.74 17.02 Favored 'General case' 0 C--N 1.344 0.327 0 C-N-CA 124.682 1.193 . . . . 3.48 111.62 173.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -76.29 -3.15 35.12 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 123.913 0.885 . . . . 3.0800000000000001 112.761 -173.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.482 ' CD ' ' HE ' ' A' ' 35' ' ' ARG . 11.7 mm-40 -105.89 -51.54 2.97 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 128.288 2.635 . . . . 3.27 111.677 170.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 5.6 mt -143.33 126.88 13.61 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.371 0 C-N-CA 128.575 2.75 . . . . 1.9099999999999999 106.648 -178.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -94.63 -22.46 18.15 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.174 -0.954 . . . . 3.8599999999999999 113.196 -175.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -74.61 78.56 1.99 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.463 1.505 . . . . 3.75 113.018 -174.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 4.2 mpp? -82.38 13.46 3.58 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.936 1.295 . . . . 1.24 114.368 177.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 80.8 t60 -63.8 -34.29 77.59 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 120.624 -1.297 . . . . 4.3700000000000001 114.082 -177.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -84.5 -11.94 76.56 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 126.218 1.866 . . . . 0.57999999999999996 113.901 174.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.3 mp -86.47 139.13 31.18 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.427 1.091 . . . . 1.8500000000000001 111.917 -172.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 16.7 ttm180 -126.99 99.36 5.69 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 126.272 1.829 . . . . 5.3200000000000003 109.85 -169.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 3.6 mt -108.94 145.62 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-O 122.945 1.355 . . . . 0.37 113.306 -167.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -144.39 134.6 24.27 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 127.93 2.492 . . . . 2.1600000000000001 109.31 -170.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 16.4 p -150.8 153.14 34.88 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 127.847 2.459 . . . . 0.26000000000000001 109.397 -170.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.67 172.34 18.69 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 124.922 1.289 . . . . 0.62 110.045 175.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.782 HG11 ' HA ' ' A' ' 73' ' ' LYS . 8.9 p -136.97 125.87 15.16 Favored Pre-proline 0 N--CA 1.473 0.679 0 N-CA-C 113.661 0.985 . . . . 0.52000000000000002 113.661 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo . . . . . 0 N--CA 1.449 -1.101 0 C-N-CA 123.211 2.607 . . . . 0.77000000000000002 110.763 170.962 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 . . . . . 0 N--CA 1.471 0.595 0 N-CA-C 112.09 0.404 . . . . 2.6200000000000001 112.09 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 80.8 p -120.92 176.14 5.7 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.526 1.53 . . . . 0.77000000000000002 111.324 165.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 -66.04 -31.12 71.82 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 120.169 -1.582 . . . . 4.1699999999999999 112.048 160.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.14 -46.13 95.13 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 125.565 1.555 . . . . 0.52000000000000002 112.603 177.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.34 -47.24 47.42 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.469 1.507 . . . . 1.28 112.179 177.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 11.7 mt -72.24 -47.65 48.7 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.075 1.35 . . . . 0.44 111.716 -179.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -56.03 -50.44 70.9 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 126.381 1.873 . . . . 2.96 111.117 177.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 50.2 t -60.1 -46.21 94.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 107.945 -1.132 . . . . 0.32000000000000001 107.945 178.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 37.6 m -59.41 -39.14 82.5 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 118.974 -0.536 . . . . 0.40000000000000002 112.438 179.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 7.9 mm-40 -60.48 -40.96 93.19 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 118.88 0.764 . . . . 2.0 112.43 178.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 49.0 mt -81.63 -28.16 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 123.129 0.572 . . . . 0.45000000000000001 110.63 -177.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 18.0 mt -59.66 -40.31 87.32 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 120.722 -1.236 . . . . 0.53000000000000003 112.83 168.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 46.5 mttt -63.55 -23.31 67.33 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 119.423 1.01 . . . . 1.3400000000000001 113.383 177.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -96.4 -35.51 11.15 Favored 'General case' 0 N--CA 1.434 -1.265 0 C-N-CA 126.937 2.095 . . . . 2.0899999999999999 114.803 -177.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 64.3 mmtt -74.17 -27.75 60.97 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 118.176 -0.916 . . . . 1.24 111.125 167.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -127.29 51.44 6.63 Favored Pre-proline 0 CA--C 1.551 0.995 0 N-CA-C 117.347 2.351 . . . . 1.53 117.347 -178.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -64.75 -14.0 42.39 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 125.171 3.914 . . . . 0.76000000000000001 115.04 176.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 32.5 mmt180 -83.31 -14.98 51.83 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.955 1.465 . . . . 4.8399999999999999 114.955 170.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.62 143.14 47.32 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 116.728 2.122 . . . . 0.65000000000000002 116.728 -166.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 77.8 p -96.89 -24.85 15.67 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.922 0.889 . . . . 0.60999999999999999 112.64 175.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -126.28 140.42 52.54 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.838 0.855 . . . . 0.51000000000000001 111.743 161.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.3 pt -155.77 117.8 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 126.292 1.837 . . . . 0.69999999999999996 110.582 173.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.2 ptpt -152.44 155.84 38.32 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.459 1.504 . . . . 1.3600000000000001 112.408 173.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.1 t -132.15 143.24 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 125.98 1.712 . . . . 0.47999999999999998 109.9 177.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 74.6 m -136.53 123.64 21.65 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 118.46 0.573 . . . . 0.46000000000000002 111.72 173.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -65.59 128.05 34.37 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 108.528 -0.916 . . . . 1.97 108.528 165.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.9 pt -127.53 33.1 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 125.859 1.663 . . . . 0.46000000000000002 109.499 178.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.6 t -145.98 57.46 1.21 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 128.138 2.575 . . . . 1.27 110.828 -173.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.21 -0.85 0.33 Allowed Glycine 0 CA--C 1.541 1.711 0 C-N-CA 126.681 2.086 . . . . 1.3100000000000001 117.889 -178.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -144.54 24.25 2.0 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 126.488 1.994 . . . . 1.4299999999999999 113.505 -178.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -162.99 -27.77 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.565 1.546 . . . . 1.52 112.901 172.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 53.41 39.87 60.32 Favored Glycine 0 CA--C 1.536 1.362 0 C-N-CA 127.277 2.37 . . . . 0.63 114.707 -173.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -96.7 -34.79 11.23 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.976 1.31 . . . . 0.81000000000000005 113.716 178.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 8.9 mtm -96.23 138.42 33.86 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 124.183 0.993 . . . . 1.29 111.525 177.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -142.63 144.88 32.99 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.019 0.928 . . . . 1.9199999999999999 112.759 172.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -82.29 137.99 34.68 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 126.289 1.836 . . . . 2.3399999999999999 109.215 165.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 92.2 mt -136.19 125.15 38.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.017 0.927 . . . . 0.62 109.507 169.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 64.4 mttt -123.89 114.62 20.07 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.47 1.108 . . . . 2.8500000000000001 109.957 177.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.2 mt -122.92 157.56 28.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 126.535 1.934 . . . . 0.34999999999999998 109.653 -177.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -154.93 132.91 11.57 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.756 1.623 . . . . 1.73 108.265 163.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 33.2 t -158.6 140.53 13.79 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 119.277 0.944 . . . . 0.38 110.515 -174.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -58.16 -19.81 35.88 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 114.311 1.226 . . . . 2.7799999999999998 114.311 -177.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -72.01 -19.65 61.83 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.052 1.341 . . . . 1.75 114.387 179.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -79.44 13.28 2.04 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 114.165 1.172 . . . . 1.79 114.165 -171.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 42.6 pttt -77.69 -42.13 35.59 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 113.226 0.825 . . . . 2.4199999999999999 113.226 -172.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -81.4 38.8 0.5 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.342 1.057 . . . . 3.7799999999999998 112.739 -177.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 61.5 mmtt -138.44 144.75 40.28 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 126.164 1.786 . . . . 1.54 111.886 -171.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 55.4 mtt180 -71.98 167.24 20.55 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 124.226 1.01 . . . . 3.8100000000000001 111.144 154.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 95.6 m -43.39 -56.03 3.8 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 126.136 1.774 . . . . 0.66000000000000003 113.216 166.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.5 p -59.07 -42.63 87.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.92 1.288 . . . . 0.51000000000000001 113.264 175.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -74.68 -23.31 58.61 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 118.578 -0.725 . . . . 1.3100000000000001 112.381 -177.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -67.78 -54.69 17.14 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 119.728 1.149 . . . . 0.71999999999999997 110.241 163.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 36.6 m170 -49.94 -51.29 42.32 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.068 0.947 . . . . 0.57999999999999996 112.102 -179.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 15.5 tp60 -47.37 -44.17 23.9 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.082 1.353 . . . . 1.4199999999999999 113.541 178.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 76.5 mtp -61.91 -43.92 97.85 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 119.334 0.97 . . . . 1.1599999999999999 111.467 -177.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.1 t -72.62 -28.28 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 126.579 1.952 . . . . 0.22 111.226 179.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -72.5 -50.07 28.51 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.924 1.69 . . . . 0.47999999999999998 109.679 176.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.8 mm-40 -65.01 -20.13 66.35 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.738 1.215 . . . . 2.2400000000000002 113.355 178.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.94 -43.53 86.39 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 118.707 0.685 . . . . 0.40999999999999998 111.398 178.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.55 5.65 9.54 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 115.132 1.53 . . . . 0.34000000000000002 115.132 -174.245 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.9 ttmt -52.43 -38.18 58.53 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 125.034 1.333 . . . . 2.98 112.89 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -76.2 -26.08 55.79 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 112.92 0.711 . . . . 3.02 112.92 -178.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -78.9 -60.73 2.26 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.502 1.921 . . . . 3.3900000000000001 110.647 175.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 42.5 mt -135.22 103.44 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 126.393 1.877 . . . . 1.04 108.361 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 14.1 ptpt -79.61 -17.38 53.97 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 115.428 1.64 . . . . 2.4199999999999999 115.428 -169.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 19.7 mp0 -67.14 47.78 0.04 OUTLIER 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 130.227 3.411 . . . . 3.3199999999999998 116.269 -171.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 4.2 mpp? -62.65 -2.1 1.02 Allowed 'General case' 0 N--CA 1.476 0.865 0 O-C-N 119.31 -2.118 . . . . 1.3100000000000001 115.21 177.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 2.6 p80 -58.05 -29.82 65.69 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 119.419 1.009 . . . . 3.2799999999999998 113.34 162.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -85.49 -23.39 47.44 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 124.862 1.22 . . . . 0.51000000000000001 113.495 177.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.6 mp -83.19 143.3 30.57 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 122.401 1.096 . . . . 1.55 112.386 -169.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 24.1 ttt180 -118.88 95.93 5.03 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 127.258 2.223 . . . . 2.9500000000000002 108.511 -175.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 2.7 mt -110.14 138.31 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 CA-C-O 123.66 1.695 . . . . 0.34999999999999998 113.528 -168.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -137.76 127.09 24.71 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-N 111.116 -2.765 . . . . 1.97 108.494 -169.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 12.4 p -145.51 154.44 42.2 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.123 1.769 . . . . 0.28999999999999998 108.955 -173.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.2 p -160.94 173.24 15.57 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.475 -1.238 . . . . 0.56999999999999995 110.309 176.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.4 p -138.9 123.74 11.71 Favored Pre-proline 0 C--O 1.237 0.445 0 N-CA-C 112.649 0.611 . . . . 0.56999999999999995 112.649 -177.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo . . . . . 0 N--CA 1.448 -1.205 0 C-N-CA 122.934 2.422 . . . . 0.88 108.431 169.569 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 . . . . . 0 CA--C 1.542 0.667 0 CA-C-O 122.583 1.182 . . . . 2.6099999999999999 113.177 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 56.6 p -121.32 178.79 4.64 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.053 1.741 . . . . 0.62 110.022 169.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -70.08 -27.92 65.01 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.046 -1.033 . . . . 3.2599999999999998 111.491 160.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -71.79 -39.8 59.17 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 125.622 1.582 . . . . 0.38 114.105 -178.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.29 -44.18 43.87 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 119.449 1.625 . . . . 2.0 111.334 174.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 8.9 mt -68.52 -56.18 9.21 Favored 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 125.987 1.715 . . . . 0.35999999999999999 110.67 178.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.58 -46.65 77.22 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.235 1.014 . . . . 2.8999999999999999 111.555 -178.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.8 t -61.65 -48.01 90.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 107.972 -1.122 . . . . 0.41999999999999998 107.972 178.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 52.9 m -57.31 -43.97 83.73 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 118.645 0.657 . . . . 0.44 112.059 176.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -61.99 -28.81 69.83 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.339 1.456 . . . . 2.8500000000000001 113.262 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 64.4 mt -90.49 -29.19 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 124.532 1.133 . . . . 0.52000000000000002 111.702 173.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.6 mt -56.94 -36.69 70.54 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 120.321 -1.487 . . . . 0.77000000000000002 112.754 172.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 38.0 mttt -63.67 -17.33 62.84 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 115.004 1.483 . . . . 1.6499999999999999 115.004 177.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -106.56 -37.73 6.37 Favored 'General case' 0 N--CA 1.429 -1.508 0 C-N-CA 125.987 1.715 . . . . 1.9399999999999999 113.576 -172.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -77.34 -23.62 50.9 Favored 'General case' 0 N--CA 1.453 -0.311 0 O-C-N 123.538 0.524 . . . . 1.23 111.99 166.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -133.99 52.4 8.01 Favored Pre-proline 0 CA--C 1.546 0.795 0 N-CA-C 117.702 2.482 . . . . 1.55 117.702 -179.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -61.73 -22.68 74.94 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 123.585 2.857 . . . . 0.73999999999999999 113.547 166.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 19.1 mtm180 -67.91 -15.04 63.43 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 114.654 1.353 . . . . 7.5300000000000002 114.654 174.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.84 144.74 47.36 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 114.45 1.278 . . . . 0.47999999999999998 114.45 -164.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 65.3 p -96.27 -19.66 19.12 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.938 0.895 . . . . 0.51000000000000001 112.551 174.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -130.77 142.23 50.4 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.202 1.001 . . . . 0.32000000000000001 111.975 159.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.4 pt -155.5 111.4 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 126.662 1.985 . . . . 0.46999999999999997 111.359 172.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.6 ptpt -154.22 150.14 27.75 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.006 1.322 . . . . 1.1699999999999999 112.71 -178.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.4 t -131.88 143.25 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 C-N-CA 125.818 1.647 . . . . 0.37 110.512 -173.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 77.6 m -135.34 129.71 33.87 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.825 1.25 . . . . 0.34000000000000002 112.1 172.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -78.94 132.68 36.81 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.11 0.964 . . . . 1.76 110.457 170.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.7 pt -130.58 28.24 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 125.843 1.657 . . . . 0.56999999999999995 111.285 179.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 41.6 t -139.13 63.72 1.5 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 127.625 2.37 . . . . 1.3200000000000001 110.981 -176.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.98 -9.06 12.19 Favored Glycine 0 CA--C 1.54 1.641 0 N-CA-C 117.086 1.594 . . . . 1.1899999999999999 117.086 -176.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -115.9 3.67 20.98 Favored Glycine 0 CA--C 1.537 1.456 0 C-N-CA 126.363 1.935 . . . . 1.0600000000000001 115.331 179.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 37.0 t -155.32 -38.37 0.09 Allowed 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 118.631 1.215 . . . . 1.99 113.087 -176.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 64.58 36.45 93.17 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 127.026 2.251 . . . . 0.68999999999999995 113.754 -169.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -85.02 -23.05 28.81 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 114.007 1.114 . . . . 0.88 114.007 173.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 1.2 mpp? -112.82 140.41 47.63 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.176 0.99 . . . . 1.8500000000000001 113.56 -176.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -143.52 144.99 32.21 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 122.154 0.978 . . . . 1.8700000000000001 113.144 173.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -98.46 120.15 38.39 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.009 1.724 . . . . 2.52 109.653 169.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 68.2 mt -132.07 129.54 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 124.684 1.194 . . . . 1.0 109.833 -163.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 67.9 mttt -125.45 125.66 43.69 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.62 0.768 . . . . 2.5299999999999998 110.628 179.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.421 ' CD1' HG13 ' A' ' 84' ' ' VAL . 1.2 mt -129.49 157.95 42.14 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 127.589 2.356 . . . . 0.25 108.774 178.273 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 71.5 tt0 -157.14 128.61 6.95 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.774 1.63 . . . . 1.6499999999999999 108.325 168.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 9.1 t -162.54 147.74 12.31 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 120.301 1.41 . . . . 0.40999999999999998 114.05 -169.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -59.07 -24.6 63.04 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 126.049 1.74 . . . . 4.5499999999999998 113.929 -172.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -73.57 -16.18 61.26 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.56 1.544 . . . . 1.8 115.086 177.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -83.51 -2.59 56.31 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 114.509 1.3 . . . . 2.04 114.509 -171.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.401 ' HB3' HG21 ' A' ' 104' ' ' VAL . 21.2 pttm -69.75 -42.09 74.35 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 113.505 0.928 . . . . 2.8500000000000001 113.505 -178.084 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -91.58 41.44 1.07 Allowed 'General case' 0 CA--C 1.547 0.847 0 CA-C-O 123.018 1.389 . . . . 4.0899999999999999 111.143 -170.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.9 mmtp -146.31 142.49 28.35 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 128.225 2.61 . . . . 2.9199999999999999 109.572 -166.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.423 ' HG2' ' H ' ' A' ' 76' ' ' ARG . 10.7 mmt85 -64.39 166.91 7.54 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.697 1.199 . . . . 3.4199999999999999 110.583 158.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 55.0 m -53.19 -51.09 63.2 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 113.801 1.038 . . . . 0.71999999999999997 113.801 168.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 14.7 p -63.47 -34.67 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 112.616 0.598 . . . . 0.62 112.616 177.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -65.22 -44.98 86.53 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 118.117 -0.945 . . . . 2.6099999999999999 111.667 173.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -58.04 -51.42 69.73 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 119.291 0.95 . . . . 0.60999999999999999 110.202 174.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 40.0 m170 -56.08 -50.01 72.21 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 123.405 0.682 . . . . 0.46999999999999997 111.371 178.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 32.6 tp60 -53.07 -39.84 63.59 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.771 1.228 . . . . 1.53 112.875 -177.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 85.4 mtp -59.36 -47.11 86.67 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 119.752 1.16 . . . . 1.0900000000000001 111.973 177.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.421 HG13 ' CD1' ' A' ' 67' ' ' ILE . 5.7 t -70.21 -32.19 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 126.009 1.723 . . . . 0.23000000000000001 111.41 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -65.55 -52.29 53.52 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.128 1.771 . . . . 0.57999999999999996 109.942 173.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 8.2 tm0? -66.98 -26.44 66.81 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.328 1.051 . . . . 3.1499999999999999 113.161 -176.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -56.73 -39.09 73.32 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.712 1.605 . . . . 0.39000000000000001 112.27 -179.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.64 -0.57 10.21 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 114.315 1.228 . . . . 0.44 114.315 -178.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 25.6 ttpt -52.5 -33.26 44.19 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.549 1.139 . . . . 1.8899999999999999 112.805 175.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -81.81 -3.14 53.21 Favored 'General case' 0 CA--C 1.553 1.067 0 O-C-N 121.335 -0.853 . . . . 1.8999999999999999 112.564 -178.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -104.61 -54.76 2.46 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 127.496 2.318 . . . . 3.1800000000000002 111.435 169.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 32.6 mt -138.31 119.9 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 126.775 2.03 . . . . 0.94999999999999996 108.494 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 41.5 mtmt -90.97 -1.43 57.83 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 115.012 1.486 . . . . 2.7599999999999998 115.012 -169.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -81.58 58.61 3.78 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.379 1.872 . . . . 3.04 114.676 -158.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . 0.3 1.3 mpt? -75.28 9.52 2.04 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 119.779 -1.826 . . . . 1.79 115.477 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 13.7 p80 -65.01 -26.4 68.27 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.46 0.541 . . . . 3.96 112.46 153.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -94.77 -17.98 36.49 Favored Glycine 0 C--N 1.333 0.414 0 C-N-CA 126.455 1.979 . . . . 0.5 115.986 -175.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.8 mt -93.33 124.1 37.08 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 117.732 0.766 . . . . 2.1699999999999999 110.875 -165.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 22.0 ttt180 -110.14 89.13 2.93 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 126.363 1.865 . . . . 3.3199999999999998 107.347 -177.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 1.1 mt -108.69 139.99 29.05 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.565 0 CA-C-O 123.037 1.399 . . . . 0.46999999999999997 111.743 -163.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -131.5 121.08 23.89 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 111.777 -2.465 . . . . 1.98 108.115 -169.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 24.4 p -131.93 153.96 49.76 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 126.268 1.827 . . . . 0.28000000000000003 110.196 -179.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -160.49 179.76 8.34 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 126.114 1.766 . . . . 0.64000000000000001 109.135 171.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.401 HG21 ' HB3' ' A' ' 73' ' ' LYS . 3.7 p -136.73 135.91 20.91 Favored Pre-proline 0 N--CA 1.474 0.748 0 O-C-N 120.897 -1.127 . . . . 0.48999999999999999 111.98 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo . . . . . 0 C--N 1.351 0.676 0 C-N-CA 124.52 3.48 . . . . 0.81000000000000005 111.402 -179.262 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.8 mp0 . . . . . 0 N--CA 1.471 0.602 0 N-CA-C 114.439 1.274 . . . . 2.48 114.439 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 72.8 p -121.04 179.51 4.36 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 126.257 1.823 . . . . 0.53000000000000003 110.278 157.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.41 -32.7 71.87 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 120.941 -1.1 . . . . 3.6800000000000002 112.357 164.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.14 -38.4 96.47 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 125.183 1.373 . . . . 0.35999999999999999 112.949 174.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.71 -45.66 63.64 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.879 1.272 . . . . 1.49 112.369 176.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 13.1 mt -71.21 -49.87 38.98 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 125.008 1.323 . . . . 0.38 111.491 -178.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -54.26 -50.65 66.72 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 127.358 2.263 . . . . 3.9900000000000002 110.991 178.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.8 t -63.86 -45.68 96.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 108.312 -0.996 . . . . 0.25 108.312 178.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 51.6 m -55.7 -36.52 67.27 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.243 0.46 . . . . 0.34999999999999998 112.243 177.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -69.21 -43.47 74.03 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 114.123 1.157 . . . . 2.04 114.123 -178.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 26.7 mt -75.67 -28.29 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-N 118.689 0.677 . . . . 0.53000000000000003 110.403 -179.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 21.5 mt -55.75 -37.7 68.84 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.569 0.951 . . . . 0.40000000000000002 113.569 169.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 38.3 mttt -62.84 -32.92 74.24 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 118.563 0.62 . . . . 1.3999999999999999 112.561 179.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -90.57 -35.48 15.0 Favored 'General case' 0 N--CA 1.438 -1.054 0 C-N-CA 128.362 2.665 . . . . 2.25 114.779 -175.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -77.17 -17.43 58.56 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 120.159 -0.616 . . . . 1.3799999999999999 112.525 169.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -132.16 60.96 54.8 Favored Pre-proline 0 CA--C 1.551 1.017 0 N-CA-C 116.914 2.19 . . . . 2.1099999999999999 116.914 175.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -68.68 -24.09 35.49 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 124.658 3.572 . . . . 0.90000000000000002 114.759 170.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -80.27 0.13 34.05 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 114.495 1.295 . . . . 6.25 114.495 171.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.53 147.99 52.51 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 114.654 1.353 . . . . 0.52000000000000002 114.654 -175.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 25.8 p -103.82 -18.69 14.55 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.525 1.13 . . . . 0.56000000000000005 112.671 167.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -133.41 144.2 49.38 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 119.568 1.076 . . . . 0.40999999999999998 112.149 159.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.9 pt -157.04 110.51 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 127.425 2.29 . . . . 0.56000000000000005 110.815 171.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.5 ptpt -151.61 155.99 39.53 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.602 1.561 . . . . 1.1899999999999999 113.024 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.9 t -136.04 145.57 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 126.016 1.726 . . . . 0.34999999999999998 111.628 -172.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 94.3 m -138.82 126.67 22.24 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.233 0.613 . . . . 0.34999999999999998 111.695 172.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -71.51 126.82 30.66 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.787 0.803 . . . . 1.8200000000000001 110.451 168.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.2 pt -125.84 22.06 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 C-N-CA 125.524 1.529 . . . . 0.5 111.147 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.401 ' CB ' ' H ' ' A' ' 62' ' ' MET . 38.1 t -131.65 62.37 1.63 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 128.709 2.803 . . . . 1.3600000000000001 110.896 179.198 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.01 -10.1 18.16 Favored Glycine 0 CA--C 1.539 1.562 0 N-CA-C 117.261 1.664 . . . . 1.1499999999999999 117.261 -174.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -103.38 -19.62 12.17 Favored Glycine 0 N--CA 1.471 1.019 0 C-N-CA 126.534 2.016 . . . . 0.96999999999999997 115.28 179.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 33.1 m -145.34 -29.56 0.44 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.29 1.036 . . . . 2.5899999999999999 113.345 -163.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 60.42 41.41 98.55 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 128.201 2.81 . . . . 0.72999999999999998 113.735 -175.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -98.39 -16.86 19.12 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.265 1.826 . . . . 0.90000000000000002 112.955 -178.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.415 ' HG3' ' CA ' ' A' ' 97' ' ' GLY . 4.3 mpp? -117.8 141.49 48.35 Favored 'General case' 0 CA--C 1.52 -0.175 0 C-N-CA 126.627 1.971 . . . . 1.99 112.809 175.24 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -144.39 147.02 32.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.863 -1.062 . . . . 1.8500000000000001 111.241 171.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -83.7 137.24 33.86 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 125.185 1.394 . . . . 2.23 109.193 163.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 97.5 mt -133.72 129.16 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 123.869 0.868 . . . . 0.65000000000000002 109.345 170.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 70.0 mttt -124.56 116.97 23.31 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.673 1.189 . . . . 2.73 110.624 177.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.3 mt -122.29 162.62 21.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 C-N-CA 126.361 1.865 . . . . 0.46999999999999997 109.271 -177.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -156.67 131.32 8.83 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.696 1.999 . . . . 1.77 107.111 162.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.7 t -157.28 140.14 15.13 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 120.402 1.456 . . . . 0.34000000000000002 111.767 -173.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -58.26 -21.64 49.36 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.241 1.016 . . . . 3.4100000000000001 113.543 -178.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -71.01 -15.4 62.56 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 115.274 1.583 . . . . 1.8 115.274 179.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -88.0 10.26 19.58 Favored 'General case' 0 CA--C 1.553 1.068 0 N-CA-C 115.537 1.68 . . . . 1.6200000000000001 115.537 -171.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.58 ' HA ' HG11 ' A' ' 104' ' ' VAL . 14.9 pttt -63.07 -46.35 87.87 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 126.251 1.82 . . . . 2.3300000000000001 115.569 -165.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -100.69 -11.03 20.29 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.385 1.474 . . . . 4.4100000000000001 111.692 -168.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 32.9 mmtt -64.76 142.88 58.28 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 126.81 2.044 . . . . 1.52 112.561 174.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 16.6 mtt-85 -67.58 166.49 14.82 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 122.9 0.48 . . . . 3.2200000000000002 111.092 159.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.8 m -50.31 -50.56 50.32 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 113.873 1.064 . . . . 0.73999999999999999 113.873 172.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 10.4 p -62.71 -38.44 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 123.474 0.71 . . . . 0.67000000000000004 112.783 174.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -75.34 -19.79 59.41 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.736 0.643 . . . . 1.4299999999999999 112.736 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -70.34 -53.94 14.63 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.397 -0.814 . . . . 0.66000000000000003 109.807 163.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 49.7 m170 -53.05 -48.28 67.79 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.82 0.848 . . . . 0.66000000000000003 113.062 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 47.0 tp60 -47.79 -43.28 27.52 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.796 1.638 . . . . 1.1799999999999999 113.477 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 3.6 mtm -67.07 -39.82 86.91 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 118.93 0.786 . . . . 1.3100000000000001 111.768 -178.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.2 t -73.14 -33.83 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 125.616 1.567 . . . . 0.34999999999999998 110.644 179.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -63.42 -50.64 69.0 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.111 1.764 . . . . 0.45000000000000001 110.536 173.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 35.5 tp60 -66.05 -21.7 66.39 Favored 'General case' 0 N--CA 1.45 -0.474 0 O-C-N 119.849 -1.782 . . . . 2.3799999999999999 114.118 -178.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.17 -40.55 85.97 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.379 0.672 . . . . 0.44 111.589 177.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.66 3.78 9.54 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 115.372 1.619 . . . . 0.34999999999999998 115.372 -176.02 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 26.3 ttmt -43.8 -45.55 7.36 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 125.405 1.482 . . . . 1.9299999999999999 111.877 174.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -84.27 -6.0 59.34 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 113.225 0.824 . . . . 3.0499999999999998 113.225 -172.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -98.51 -56.15 2.54 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 127.226 2.211 . . . . 2.21 111.867 174.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 23.3 mt -132.96 92.61 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.57 1.548 . . . . 1.1799999999999999 107.76 176.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -69.8 -19.08 63.5 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 114.094 1.146 . . . . 2.6299999999999999 114.094 -172.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . 0.295 16.3 pt-20 -73.97 43.75 0.17 Allowed 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 116.359 1.985 . . . . 3.9700000000000002 116.359 -169.09 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 64.3 mtm -66.21 0.75 1.85 Allowed 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 126.52 1.928 . . . . 1.3600000000000001 116.023 -172.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 21.0 p-80 -61.6 -5.52 1.91 Allowed 'General case' 0 CA--C 1.55 0.959 0 N-CA-C 113.836 1.05 . . . . 4.8300000000000001 113.836 157.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.415 ' CA ' ' HG3' ' A' ' 62' ' ' MET . . . -104.17 -14.99 22.98 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 125.468 1.509 . . . . 0.40000000000000002 115.807 167.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.9 mp -89.68 124.97 35.06 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 118.904 1.352 . . . . 1.5600000000000001 111.753 -169.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 50.3 ttt180 -103.26 100.87 10.79 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 127.072 2.149 . . . . 3.1200000000000001 110.063 -178.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 5.4 mt -108.97 144.39 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-O 123.822 1.772 . . . . 0.45000000000000001 112.853 -170.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -136.89 135.93 38.25 Favored 'General case' 0 N--CA 1.433 -1.298 0 C-N-CA 128.944 2.897 . . . . 1.97 109.248 -175.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.4 p -145.66 157.7 43.93 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 126.792 2.037 . . . . 0.56000000000000005 108.176 -175.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -155.81 175.25 14.18 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 124.77 1.228 . . . . 0.71999999999999997 108.959 172.386 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.58 HG11 ' HA ' ' A' ' 73' ' ' LYS . 7.1 p -142.8 126.33 9.38 Favored Pre-proline 0 N--CA 1.467 0.395 0 O-C-N 121.386 -0.821 . . . . 0.48999999999999999 112.198 -179.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo . . . . . 0 N--CA 1.449 -1.116 0 C-N-CA 122.953 2.435 . . . . 0.68999999999999995 110.894 176.201 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 . . . . . 0 C--O 1.234 0.255 0 N-CA-C 113.103 0.779 . . . . 2.0800000000000001 113.103 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 58.7 p -102.02 176.46 5.19 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 126.115 1.766 . . . . 0.60999999999999999 111.674 177.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -67.72 -34.03 76.06 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 120.486 -1.384 . . . . 4.1299999999999999 112.115 164.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.4 -38.34 80.3 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 125.044 1.307 . . . . 0.46000000000000002 114.229 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.87 -48.66 66.96 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 118.926 1.363 . . . . 1.3899999999999999 112.551 -179.082 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 16.2 mt -70.11 -48.48 57.4 Favored 'General case' 0 CA--C 1.527 0.082 0 C-N-CA 125.375 1.47 . . . . 0.52000000000000002 110.822 -178.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -53.32 -51.18 63.2 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 127.584 2.354 . . . . 3.8799999999999999 111.319 179.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 39.3 t -62.83 -48.37 88.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 124.584 1.154 . . . . 0.23000000000000001 108.425 177.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 42.1 m -57.0 -38.78 73.56 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.303 0.483 . . . . 0.42999999999999999 112.303 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 -62.87 -41.22 99.3 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 112.395 0.517 . . . . 1.8500000000000001 112.395 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 69.5 mt -78.03 -30.23 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 123.377 0.671 . . . . 0.48999999999999999 111.317 -179.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 18.0 mt -55.33 -39.48 70.04 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 121.075 -1.015 . . . . 0.44 113.287 172.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 44.5 mttt -64.44 -26.36 68.41 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 113.459 0.911 . . . . 1.3200000000000001 113.459 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -90.46 -35.36 15.17 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 126.823 2.049 . . . . 2.25 114.926 -177.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -74.68 -22.7 58.72 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 119.05 -1.06 . . . . 2.23 111.788 168.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -130.95 55.54 19.65 Favored Pre-proline 0 CA--C 1.552 1.052 0 N-CA-C 116.817 2.154 . . . . 1.5900000000000001 116.817 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -68.31 -18.94 44.43 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 124.675 3.583 . . . . 0.79000000000000004 115.225 177.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -81.96 -9.93 59.42 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 121.069 -1.019 . . . . 4.8600000000000003 113.514 170.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.26 144.44 46.23 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 114.637 1.347 . . . . 0.53000000000000003 114.637 -173.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 74.1 p -95.42 -29.64 14.31 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.769 1.628 . . . . 0.63 111.05 175.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -126.71 141.74 51.75 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.711 1.205 . . . . 0.31 111.265 165.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.1 pt -158.69 104.01 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 127.546 2.338 . . . . 0.47999999999999998 109.434 174.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.0 ptpt -149.67 148.6 29.47 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.67 1.188 . . . . 1.3100000000000001 112.86 -177.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.2 t -133.26 147.08 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 126.285 1.834 . . . . 0.35999999999999999 111.246 -170.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 93.7 m -141.77 127.85 19.62 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 118.406 0.548 . . . . 0.34000000000000002 111.538 170.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -68.41 135.86 52.4 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 122.174 0.988 . . . . 1.8100000000000001 110.062 165.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . 0.255 1.6 pt -127.33 25.2 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.887 0 C-N-CA 125.647 1.579 . . . . 0.56000000000000005 111.082 177.506 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 11.3 p -143.34 53.75 1.35 Allowed 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 128.98 2.912 . . . . 2.1200000000000001 114.38 -171.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -55.98 -18.41 18.99 Favored Glycine 0 CA--C 1.546 2.022 0 O-C-N 120.403 -1.435 . . . . 1.3100000000000001 116.678 -177.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -96.29 -5.84 59.07 Favored Glycine 0 CA--C 1.541 1.693 0 CA-C-N 119.658 1.729 . . . . 1.0 116.132 176.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 11.9 t -147.27 -31.75 0.31 Allowed 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 119.275 1.538 . . . . 1.48 114.301 -173.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 58.68 34.82 78.54 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 129.093 3.235 . . . . 0.66000000000000003 114.361 -171.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -100.09 3.51 44.04 Favored 'General case' 0 CA--C 1.552 1.021 0 N-CA-C 115.223 1.564 . . . . 0.97999999999999998 115.223 -177.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 2.1 mtp -131.36 138.43 49.16 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 127.396 2.279 . . . . 1.5700000000000001 112.865 175.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -145.13 143.11 30.19 Favored 'General case' 0 C--O 1.227 -0.092 0 CA-C-O 122.645 1.212 . . . . 1.8500000000000001 113.933 174.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -82.09 133.0 35.25 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 125.09 1.356 . . . . 1.74 110.021 165.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 82.7 mt -133.65 127.08 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 CA-C-N 119.816 1.189 . . . . 0.56000000000000005 110.116 175.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 74.1 mttt -123.16 117.94 26.52 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.811 1.244 . . . . 2.5699999999999998 110.232 178.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.3 mt -122.71 160.77 24.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 126.305 1.842 . . . . 0.29999999999999999 109.046 -179.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -155.41 131.6 10.19 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 126.266 1.826 . . . . 1.9399999999999999 107.219 162.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.9 t -154.07 137.66 16.01 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 118.678 0.672 . . . . 0.29999999999999999 111.704 -177.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -55.11 -16.0 2.66 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 127.223 2.209 . . . . 4.2199999999999998 114.567 176.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -76.66 -21.81 54.92 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 114.021 1.119 . . . . 1.71 114.021 175.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -79.97 11.85 3.11 Favored 'General case' 0 CA--C 1.556 1.192 0 N-CA-C 115.446 1.647 . . . . 1.6499999999999999 115.446 -166.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.403 ' HA ' HG11 ' A' ' 104' ' ' VAL . 1.0 OUTLIER -75.74 -36.4 59.91 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 117.777 2.51 . . . . 2.4199999999999999 117.777 -163.293 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -80.75 -25.85 37.72 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 120.723 1.601 . . . . 5.3600000000000003 111.429 173.258 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 43.1 mmtt -65.95 133.89 51.81 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.67 1.188 . . . . 1.78 113.289 -173.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 46.2 mtt-85 -63.75 160.73 16.55 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 125.451 1.5 . . . . 3.5699999999999998 110.928 163.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 41.3 m -35.69 -57.77 0.64 Allowed 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 125.377 1.471 . . . . 0.69999999999999996 114.094 167.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.0 p -65.79 -39.54 85.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 125.29 1.436 . . . . 0.58999999999999997 112.674 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -70.21 -26.82 64.05 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 118.487 -0.768 . . . . 0.98999999999999999 112.907 177.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -70.25 -52.75 20.71 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 119.112 0.869 . . . . 0.79000000000000004 110.359 167.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 39.2 m170 -53.35 -49.18 67.66 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 118.911 0.778 . . . . 0.48999999999999999 112.553 -178.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 33.0 tp60 -48.99 -43.52 40.22 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.844 1.258 . . . . 1.3 113.097 177.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 86.3 mtp -59.89 -44.5 94.2 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 121.179 -0.951 . . . . 0.94999999999999996 112.026 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.1 t -73.17 -31.51 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 125.753 1.621 . . . . 0.22 111.608 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -67.51 -49.81 61.71 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 126.644 1.978 . . . . 0.46000000000000002 110.237 175.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 39.8 tp60 -69.27 -20.82 63.92 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 120.513 -1.367 . . . . 2.8300000000000001 113.708 -176.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.26 -46.87 88.31 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.253 1.421 . . . . 0.51000000000000001 111.658 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.28 -5.09 14.19 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.975 1.102 . . . . 0.38 113.975 -175.327 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 11.7 ttmt -47.72 -35.96 10.6 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.187 1.395 . . . . 2.8300000000000001 113.103 169.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -76.31 -0.16 21.49 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 114.294 1.22 . . . . 2.48 114.294 -178.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -120.27 -49.18 2.29 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 127.94 2.496 . . . . 3.2200000000000002 111.222 175.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 37.2 mt -138.76 118.9 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 127.136 2.174 . . . . 0.94999999999999996 107.224 176.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 37.2 mtpt -86.57 -10.93 52.93 Favored 'General case' 0 N--CA 1.478 0.973 0 O-C-N 120.455 -1.403 . . . . 2.4500000000000002 113.509 -175.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 -77.92 47.81 0.66 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 128.052 2.541 . . . . 3.48 115.688 -158.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 3.3 mpp? -65.24 1.97 0.93 Allowed 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 115.391 1.626 . . . . 1.6200000000000001 115.391 -178.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -64.49 -23.52 67.31 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 114.214 1.19 . . . . 3.48 114.214 160.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -90.21 -22.46 35.06 Favored Glycine 0 N--CA 1.475 1.256 0 C-N-CA 126.082 1.801 . . . . 0.53000000000000003 114.916 173.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.9 mp -85.51 145.45 27.39 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.165 0.986 . . . . 1.55 112.85 -169.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 -123.48 101.83 7.55 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 126.385 1.874 . . . . 3.75 109.73 176.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 2.3 mt -105.61 146.57 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 CA-C-O 123.515 1.626 . . . . 0.34999999999999998 113.619 -173.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -140.36 131.6 26.57 Favored 'General case' 0 N--CA 1.439 -1.004 0 C-N-CA 128.814 2.845 . . . . 1.8799999999999999 108.952 -172.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 19.6 p -146.55 148.71 32.43 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.756 2.022 . . . . 0.34999999999999998 109.489 -177.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.7 p -147.77 171.47 15.63 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.566 -1.197 . . . . 0.63 111.027 173.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.403 HG11 ' HA ' ' A' ' 73' ' ' LYS . 13.4 p -136.37 128.61 17.34 Favored Pre-proline 0 N--CA 1.47 0.55 0 C-N-CA 123.799 0.84 . . . . 0.48999999999999999 110.332 173.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo . . . . . 0 N--CA 1.457 -0.651 0 C-N-CA 121.966 1.777 . . . . 0.72999999999999998 109.751 176.961 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.1 mp0 . . . . . 0 N--CA 1.468 0.466 0 CA-C-O 121.669 0.747 . . . . 2.5299999999999998 111.39 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 30.6 p -129.14 173.06 10.81 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.98 1.712 . . . . 0.85999999999999999 109.32 161.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -72.34 -26.88 62.1 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 120.286 -1.509 . . . . 4.6500000000000004 111.19 177.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -66.51 -35.66 90.34 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 125.492 1.52 . . . . 0.40999999999999998 113.282 170.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.69 -50.77 42.46 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.187 1.395 . . . . 1.3700000000000001 111.563 173.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.8 mt -68.92 -48.81 62.38 Favored 'General case' 0 C--O 1.223 -0.292 0 C-N-CA 124.897 1.279 . . . . 0.42999999999999999 110.973 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.39 -47.2 69.7 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.792 1.237 . . . . 3.6299999999999999 111.416 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.3 t -67.74 -46.97 81.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 O-C-N 124.156 0.91 . . . . 0.47999999999999998 108.716 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 89.6 m -52.82 -44.48 66.72 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.463 0.705 . . . . 0.53000000000000003 112.005 175.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -62.42 -32.68 73.56 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.038 0.935 . . . . 2.9300000000000002 113.126 -177.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 35.2 mt -82.27 -35.5 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 CA-C-N 118.798 0.727 . . . . 0.53000000000000003 111.662 172.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 20.2 mt -53.74 -38.9 64.83 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 120.907 -1.121 . . . . 0.40000000000000002 113.488 175.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 40.7 mttt -76.29 -9.64 58.8 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 114.8 1.407 . . . . 1.8600000000000001 114.8 -178.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -90.26 -40.83 11.92 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 126.363 1.865 . . . . 3.02 113.214 167.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 65.0 mmtt -74.16 -30.12 62.1 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 119.1 -1.04 . . . . 1.29 111.777 177.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -132.98 53.15 10.13 Favored Pre-proline 0 CA--C 1.549 0.933 0 N-CA-C 117.285 2.328 . . . . 1.6599999999999999 117.285 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -61.58 -26.38 80.44 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 123.975 3.117 . . . . 1.3500000000000001 114.436 178.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 10.9 mmt180 -91.72 -3.79 55.83 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 114.344 1.238 . . . . 5.7599999999999998 114.344 -176.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -55.07 149.5 11.95 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.03 1.732 . . . . 0.59999999999999998 114.707 176.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 74.0 p -100.87 -9.88 21.2 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 126.172 1.789 . . . . 0.91000000000000003 112.878 178.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -135.39 141.94 45.58 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.121 0.968 . . . . 0.34000000000000002 110.52 150.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -154.19 108.14 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 C-N-CA 125.838 1.655 . . . . 0.73999999999999999 110.799 171.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.4 ptpt -154.9 156.63 36.46 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.042 1.337 . . . . 1.1299999999999999 113.11 176.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 25.3 t -122.34 151.65 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 127.37 2.268 . . . . 0.48999999999999999 109.458 177.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 63.3 m -138.26 116.65 11.97 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 109.682 -0.488 . . . . 0.66000000000000003 109.682 168.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -65.58 133.02 50.3 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 122.18 0.991 . . . . 2.1200000000000001 109.11 166.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.1 pt -126.59 32.23 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 124.721 1.208 . . . . 0.60999999999999999 109.533 178.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.6 t -146.6 45.83 1.2 Allowed 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 126.793 2.037 . . . . 1.27 113.257 -169.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -49.59 -31.89 15.56 Favored Glycine 0 CA--C 1.543 1.802 0 O-C-N 120.112 -1.618 . . . . 1.4299999999999999 115.887 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -77.18 -12.81 84.26 Favored Glycine 0 CA--C 1.541 1.673 0 N-CA-C 116.248 1.259 . . . . 1.49 116.248 176.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 4.7 t -147.75 -44.14 0.17 Allowed 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 119.891 1.845 . . . . 1.51 114.384 -173.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 73.97 47.73 18.21 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 128.921 3.153 . . . . 0.93000000000000005 112.434 -168.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -96.05 -29.64 14.0 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.545 1.538 . . . . 1.1899999999999999 114.252 174.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -113.09 142.13 46.09 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 125.267 1.427 . . . . 1.8700000000000001 113.811 -177.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -143.2 142.42 31.41 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 122.282 1.039 . . . . 1.8799999999999999 112.824 172.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -83.58 139.98 32.52 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 125.862 1.665 . . . . 2.3199999999999998 109.529 163.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 90.4 mt -135.94 129.59 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-N 119.335 0.97 . . . . 0.67000000000000004 109.185 172.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 77.4 mttt -126.27 113.73 17.34 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.708 1.203 . . . . 2.73 109.768 -177.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.2 mt -125.11 157.82 33.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 126.333 1.853 . . . . 0.23000000000000001 109.109 -178.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 48.2 tt0 -157.76 129.34 6.83 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 126.103 1.761 . . . . 1.8400000000000001 107.415 167.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 18.2 t -160.14 145.28 14.97 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 120.131 1.332 . . . . 0.34999999999999998 113.091 -171.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -59.42 -16.9 26.35 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.964 2.105 . . . . 3.6899999999999999 114.583 -176.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -77.36 -20.21 55.14 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.733 1.613 . . . . 1.73 115.03 173.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -80.72 5.67 15.08 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 114.861 1.43 . . . . 1.6699999999999999 114.861 -167.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 22.8 pttt -73.33 -49.64 26.34 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 114.7 1.37 . . . . 2.9700000000000002 114.7 -171.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . 0.278 15.2 pm0 -80.89 25.35 0.45 Allowed 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 119.658 1.117 . . . . 4.0800000000000001 113.855 -177.336 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 42.1 mmtt -119.03 141.39 48.75 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 127.393 2.277 . . . . 1.23 110.854 -177.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 40.1 mtt180 -67.82 166.15 16.05 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 123.003 0.521 . . . . 3.5499999999999998 111.213 158.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 52.6 m -47.4 -53.35 14.18 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 114.384 1.253 . . . . 0.79000000000000004 114.384 170.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 13.6 p -61.11 -37.81 78.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 123.215 0.606 . . . . 0.63 112.594 175.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -74.45 -27.59 60.66 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 118.53 -0.748 . . . . 1.1399999999999999 112.553 179.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -64.28 -56.02 17.45 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.279 1.032 . . . . 0.65000000000000002 109.872 166.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 35.7 m170 -53.0 -48.33 67.59 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.703 0.801 . . . . 0.48999999999999999 112.255 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 30.8 tp60 -52.64 -40.54 62.9 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.471 1.108 . . . . 1.3799999999999999 113.221 178.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -63.67 -37.65 88.15 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 120.3 1.409 . . . . 1.0 111.221 179.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.3 t -76.76 -31.08 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 125.192 1.397 . . . . 0.26000000000000001 111.689 179.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -67.63 -48.07 67.77 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.597 1.559 . . . . 0.46999999999999997 110.195 173.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -61.55 -27.53 68.68 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 120.713 -1.242 . . . . 3.6200000000000001 113.202 178.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.64 -35.74 74.99 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.614 1.165 . . . . 0.37 112.399 -177.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.18 -3.03 8.53 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 113.927 1.084 . . . . 0.42999999999999999 113.927 -178.177 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 26.1 ttpt -49.26 -37.63 24.14 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.141 1.376 . . . . 2.79 112.82 177.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -78.13 -12.64 60.01 Favored 'General case' 0 CA--C 1.552 1.043 0 CA-C-O 121.68 0.753 . . . . 2.6200000000000001 111.863 -173.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -109.56 -51.04 2.92 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 128.98 2.912 . . . . 3.1400000000000001 110.681 -171.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.3 mm -129.68 123.62 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 127.851 2.46 . . . . 1.3799999999999999 106.579 164.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -97.01 -9.21 28.64 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 119.873 -1.767 . . . . 3.23 114.876 -178.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -81.94 50.77 1.61 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 127.631 2.372 . . . . 2.7599999999999998 114.356 -166.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 5.2 mpp? -64.92 -2.21 2.49 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 114.998 1.481 . . . . 1.3100000000000001 114.998 -175.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 19.4 p-80 -63.79 -14.87 56.51 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 114.28 1.215 . . . . 4.6299999999999999 114.28 165.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -92.75 -17.55 44.26 Favored Glycine 0 CA--C 1.537 1.431 0 O-C-N 121.13 -0.981 . . . . 0.54000000000000004 114.451 167.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.8 mp -89.07 146.49 24.8 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 121.283 -1.127 . . . . 1.5900000000000001 112.685 -170.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 21.3 ttt85 -131.63 99.6 4.85 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.853 2.061 . . . . 3.1299999999999999 110.049 -173.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 4.0 mt -107.96 145.82 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 CA-C-O 123.461 1.6 . . . . 0.46999999999999997 113.943 -169.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -135.31 127.89 30.74 Favored 'General case' 0 N--CA 1.438 -1.051 0 C-N-CA 128.446 2.698 . . . . 1.8600000000000001 107.975 -171.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 23.7 p -143.28 160.61 40.18 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 126.466 1.907 . . . . 0.34000000000000002 110.207 -175.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -171.28 175.69 4.14 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 124.953 1.301 . . . . 0.64000000000000001 109.735 179.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.5 p -136.68 135.66 20.67 Favored Pre-proline 0 N--CA 1.471 0.581 0 C-N-CA 123.855 0.862 . . . . 0.44 110.936 175.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo . . . . . 0 N--CA 1.458 -0.594 0 C-N-CA 123.561 2.84 . . . . 0.67000000000000004 109.584 173.356 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 18.0 mp0 . . . . . 0 N--CA 1.476 0.843 0 N-CA-C 115.734 1.753 . . . . 2.3199999999999998 115.734 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 80.9 p -103.42 169.98 8.22 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.054 0.942 . . . . 0.58999999999999997 109.309 150.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -70.81 -21.74 62.43 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 120.844 -1.16 . . . . 2.8999999999999999 112.662 169.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.21 -41.62 96.76 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 125.533 1.54 . . . . 0.44 113.264 169.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.68 -47.81 29.4 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.769 1.627 . . . . 1.27 111.708 172.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.4 mt -68.46 -50.68 50.71 Favored 'General case' 0 C--O 1.231 0.095 0 C-N-CA 125.456 1.502 . . . . 0.38 111.444 -178.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -57.83 -49.74 75.63 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 126.119 1.768 . . . . 4.3200000000000003 111.145 -179.251 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 36.3 t -60.59 -47.54 92.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 108.223 -1.029 . . . . 0.26000000000000001 108.223 176.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 88.8 m -57.1 -37.58 72.15 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 112.539 0.57 . . . . 0.42999999999999999 112.539 178.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 7.9 mm-40 -64.47 -41.64 96.39 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 113.178 0.807 . . . . 2.0800000000000001 113.178 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 27.7 mt -76.04 -29.83 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-N 118.195 0.452 . . . . 0.65000000000000002 110.561 177.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 23.5 mt -57.42 -39.13 75.53 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 120.865 -1.147 . . . . 0.40000000000000002 113.594 170.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 39.5 mttt -64.45 -17.96 64.31 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 113.935 1.087 . . . . 1.45 113.935 177.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -104.36 -35.56 7.9 Favored 'General case' 0 N--CA 1.433 -1.325 0 C-N-CA 126.894 2.078 . . . . 1.8600000000000001 114.021 -177.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -74.15 -23.33 59.25 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 119.607 -0.837 . . . . 1.2 111.777 167.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -132.86 51.4 7.0 Favored Pre-proline 0 CA--C 1.548 0.871 0 N-CA-C 117.748 2.499 . . . . 2.0699999999999998 117.748 -178.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -64.82 -24.76 61.03 Favored 'Trans proline' 0 C--O 1.238 0.489 0 C-N-CA 123.89 3.06 . . . . 0.76000000000000001 114.352 174.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 15.5 mmp_? -76.94 -1.08 26.76 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.593 0.96 . . . . 5.7599999999999998 113.593 173.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.15 154.55 30.81 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 115.176 1.547 . . . . 0.45000000000000001 115.176 177.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 70.6 p -107.96 -27.81 9.96 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.022 1.329 . . . . 0.68000000000000005 112.568 165.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -117.67 133.73 55.64 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.745 0.818 . . . . 0.42999999999999999 111.14 163.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.3 pt -152.63 99.44 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 125.955 1.702 . . . . 0.53000000000000003 109.689 169.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.2 ptpt -146.67 149.05 32.71 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.194 1.398 . . . . 1.1499999999999999 111.809 -176.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.5 t -133.71 152.31 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 125.947 1.699 . . . . 0.39000000000000001 110.221 -172.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 81.4 m -141.56 135.29 29.94 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.356 0.663 . . . . 0.45000000000000001 110.607 167.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -75.86 130.28 38.31 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 122.108 0.956 . . . . 2.0600000000000001 110.315 166.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . 0.273 3.7 pt -123.0 29.1 2.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 125.533 1.533 . . . . 0.47999999999999998 110.33 177.067 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.1 p -135.17 62.85 1.63 Allowed 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 127.897 2.479 . . . . 2.1699999999999999 114.005 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.36 2.27 1.71 Allowed Glycine 0 CA--C 1.539 1.562 0 N-CA-C 117.252 1.661 . . . . 1.3 117.252 178.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -122.73 -5.6 8.26 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-N 119.84 1.82 . . . . 0.93000000000000005 115.943 172.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 1.7 m -151.79 -18.68 0.19 Allowed 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 115.066 1.506 . . . . 2.1200000000000001 115.066 -175.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 52.53 43.96 59.08 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 126.254 1.883 . . . . 0.80000000000000004 114.209 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -112.55 2.68 16.37 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 125.303 1.441 . . . . 1.1399999999999999 114.097 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 13.9 ttm -132.85 120.92 22.18 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 128.93 2.892 . . . . 1.8300000000000001 109.498 -166.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -140.95 143.95 34.85 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.709 0.766 . . . . 1.8300000000000001 112.824 -175.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -82.75 135.59 34.95 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 125.217 1.407 . . . . 2.5699999999999998 108.985 164.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 88.3 mt -135.93 127.71 44.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-N 119.457 1.026 . . . . 0.54000000000000004 110.081 172.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -121.01 114.2 21.17 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.9 1.28 . . . . 2.5299999999999998 109.923 176.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.446 ' CD1' HG13 ' A' ' 84' ' ' VAL . 1.2 mt -121.55 153.37 25.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 126.011 1.724 . . . . 0.34999999999999998 108.99 179.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -157.58 124.13 4.92 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 125.132 1.373 . . . . 1.8600000000000001 107.711 168.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 43.2 t -153.95 144.32 22.25 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.723 1.147 . . . . 0.40000000000000002 113.02 -169.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -55.88 -21.88 22.54 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.78 1.632 . . . . 3.73 114.589 -178.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -75.52 -21.71 57.75 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 113.692 0.997 . . . . 1.78 113.692 177.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -77.67 13.29 1.34 Allowed 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 114.111 1.152 . . . . 2.02 114.111 -167.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -83.49 -43.1 16.14 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.888 0.699 . . . . 2.2200000000000002 112.888 -176.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -83.12 46.24 1.1 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 125.332 1.453 . . . . 3.4199999999999999 110.765 179.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 54.0 mmtt -148.04 144.17 27.72 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 128.316 2.647 . . . . 1.6799999999999999 111.82 -176.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 17.6 mtt85 -70.05 171.12 10.08 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.17 0.988 . . . . 3.8999999999999999 111.341 155.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 87.3 m -57.98 -48.26 80.51 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 113.758 1.021 . . . . 1.2 113.758 174.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 13.6 p -59.72 -37.3 70.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 O-C-N 121.805 -0.56 . . . . 0.62 112.186 172.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -74.55 -26.38 59.92 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 118.609 -0.71 . . . . 1.0 111.996 179.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -64.79 -54.09 36.78 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.712 1.142 . . . . 0.73999999999999999 109.911 165.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 37.2 m170 -54.29 -49.14 70.3 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.256 1.023 . . . . 0.68999999999999995 113.307 -178.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 56.5 tp60 -48.54 -43.3 35.3 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.667 1.987 . . . . 1.4399999999999999 113.528 177.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 83.2 mtp -63.28 -46.39 86.99 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.681 0.792 . . . . 0.98999999999999999 111.648 179.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.446 HG13 ' CD1' ' A' ' 67' ' ' ILE . 2.9 t -66.5 -30.99 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 125.191 1.396 . . . . 0.40999999999999998 111.383 178.119 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -68.37 -54.45 17.19 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.161 1.785 . . . . 0.51000000000000001 110.726 175.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.7 -22.12 66.59 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.678 0.791 . . . . 2.96 112.973 -178.077 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.06 -41.1 78.12 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 125.482 1.513 . . . . 0.44 112.608 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.22 2.24 9.18 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 114.646 1.35 . . . . 0.33000000000000002 114.646 -176.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 11.7 ttpp -51.65 -37.61 51.17 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 124.819 1.248 . . . . 2.8900000000000001 112.131 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -83.21 -7.11 59.66 Favored 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 113.392 0.886 . . . . 2.02 113.392 -175.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -98.21 -51.1 4.11 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 127.027 2.131 . . . . 3.4100000000000001 110.917 174.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 21.4 mt -143.21 104.57 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 126.585 1.954 . . . . 0.95999999999999996 107.642 176.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -79.01 -2.09 38.63 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 115.313 1.597 . . . . 2.3100000000000001 115.313 -174.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -74.26 36.69 0.1 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 129.335 3.054 . . . . 3.9500000000000002 116.046 -165.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 5.6 mpp? -63.13 1.89 0.41 Allowed 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 116.053 1.871 . . . . 1.27 116.053 -176.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 7.6 p80 -58.16 -29.46 65.62 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 120.602 -1.311 . . . . 3.6800000000000002 112.036 156.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -78.58 -29.81 51.15 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 126.496 1.998 . . . . 0.40000000000000002 115.595 176.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.2 mp -91.33 122.17 33.71 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.368 -1.077 . . . . 1.6200000000000001 113.07 -158.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 47.1 ttt180 -99.1 100.73 11.91 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 127.386 2.274 . . . . 3.2799999999999998 109.785 -179.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 2.1 mt -108.04 143.06 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 CA-C-O 123.18 1.467 . . . . 0.59999999999999998 113.506 -170.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -133.97 123.27 24.34 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 128.277 2.631 . . . . 1.9199999999999999 108.49 -173.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 33.3 p -137.68 156.29 48.19 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 125.62 1.568 . . . . 0.53000000000000003 112.158 -176.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.1 p -167.09 177.31 6.32 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.651 1.58 . . . . 0.64000000000000001 110.476 178.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.5 p -136.87 132.0 18.22 Favored Pre-proline 0 N--CA 1.479 1.01 0 O-C-N 121.033 -1.042 . . . . 0.52000000000000002 111.328 175.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo . . . . . 0 N--CA 1.457 -0.62 0 C-N-CA 123.11 2.54 . . . . 1.25 111.379 -176.568 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 14.0 mp0 . . . . . 0 CA--C 1.542 0.65 0 N-CA-C 114.796 1.406 . . . . 3.5800000000000001 114.796 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 33.8 p -118.83 171.88 7.91 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.688 1.595 . . . . 0.60999999999999999 111.375 166.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -64.04 -32.96 74.69 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 121.474 -0.766 . . . . 2.98 111.106 169.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.92 -34.6 71.42 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 124.902 1.239 . . . . 0.46999999999999997 113.821 179.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.19 -47.32 54.67 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.133 1.373 . . . . 1.26 111.634 173.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 12.3 mt -68.07 -49.99 57.87 Favored 'General case' 0 CA--C 1.523 -0.095 0 C-N-CA 124.94 1.296 . . . . 0.58999999999999997 111.064 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -57.99 -46.74 84.71 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.218 1.407 . . . . 6.2400000000000002 111.227 -179.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.441 HG13 ' HG ' ' A' ' 88' ' ' LEU . 39.5 t -61.91 -46.44 96.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 108.108 -1.071 . . . . 0.35999999999999999 108.108 177.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 29.8 m -57.89 -35.92 71.68 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 112.693 0.627 . . . . 0.54000000000000004 112.693 177.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -67.32 -44.57 78.81 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 113.112 0.782 . . . . 2.02 113.112 179.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 28.7 mt -74.89 -28.23 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-N 118.652 0.66 . . . . 0.53000000000000003 110.555 -179.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 23.6 mt -58.52 -36.81 74.4 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 120.945 -1.097 . . . . 0.39000000000000001 113.448 170.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 58.0 mttt -58.42 -31.96 68.22 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 113.055 0.761 . . . . 1.8300000000000001 113.055 175.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -95.67 -34.59 11.9 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 127.069 2.148 . . . . 2.1000000000000001 114.213 -172.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -77.73 -20.67 53.11 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 120.11 -0.636 . . . . 1.1399999999999999 112.468 168.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -130.38 52.14 8.86 Favored Pre-proline 0 CA--C 1.55 0.972 0 N-CA-C 118.052 2.612 . . . . 1.54 118.052 178.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -63.51 -22.28 70.89 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.966 3.111 . . . . 0.78000000000000003 114.409 174.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 21.8 mmt180 -87.48 -1.58 58.03 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 113.889 1.07 . . . . 5.04 113.889 177.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.37 151.82 46.34 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.897 1.279 . . . . 0.68000000000000005 113.731 178.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 81.8 p -113.23 -9.0 13.5 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.594 1.558 . . . . 0.92000000000000004 113.527 174.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -135.37 142.65 45.77 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 120.028 1.285 . . . . 0.55000000000000004 111.107 153.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.4 pt -151.29 120.07 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 125.492 1.517 . . . . 0.52000000000000002 111.959 170.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -159.2 158.6 32.99 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.386 1.475 . . . . 2.04 113.247 178.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.0 t -138.74 150.96 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 126.364 1.866 . . . . 0.29999999999999999 109.952 -174.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 55.0 m -140.88 125.78 18.19 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 118.58 0.627 . . . . 0.40000000000000002 109.865 168.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -69.68 130.17 41.62 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 121.53 -0.731 . . . . 2.5299999999999998 109.273 167.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.9 pt -127.36 32.85 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 125.562 1.545 . . . . 0.53000000000000003 110.485 178.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.455 ' HB2' ' H ' ' A' ' 62' ' ' MET . 44.8 t -138.91 69.67 1.37 Allowed 'General case' 0 C--N 1.343 0.307 0 C-N-CA 127.938 2.495 . . . . 1.27 111.209 -177.302 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -42.47 -36.67 2.32 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 126.16 1.838 . . . . 1.3400000000000001 116.129 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -100.02 -14.27 34.29 Favored Glycine 0 CA--C 1.539 1.539 0 N-CA-C 115.981 1.153 . . . . 1.5 115.981 -173.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 8.2 t -138.12 -29.08 0.84 Allowed 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 119.18 1.49 . . . . 2.1600000000000001 114.484 -174.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 55.86 47.68 77.49 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 124.263 0.935 . . . . 0.70999999999999996 112.22 -161.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -93.39 -25.52 17.65 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.948 1.299 . . . . 0.77000000000000002 113.175 173.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.455 ' H ' ' HB2' ' A' ' 56' ' ' SER . 23.0 mtm -106.02 135.16 47.97 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 125.268 1.427 . . . . 1.29 111.776 172.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -138.13 143.51 40.39 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 121.959 0.885 . . . . 1.8899999999999999 112.179 169.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -81.08 139.08 35.89 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 125.931 1.692 . . . . 2.3900000000000001 109.156 162.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 93.6 mt -137.39 129.05 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 CA-C-N 119.68 1.127 . . . . 0.64000000000000001 110.018 171.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 79.7 mttt -123.08 117.38 25.28 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.814 1.246 . . . . 2.5299999999999998 109.858 177.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.2 mt -126.1 157.06 36.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 126.371 1.868 . . . . 0.29999999999999999 109.338 -179.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -154.6 126.11 7.45 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 120.441 -1.412 . . . . 2.1699999999999999 108.326 170.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 17.8 t -157.31 146.41 19.96 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-N 119.637 1.108 . . . . 0.35999999999999999 112.937 -172.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -57.7 -26.21 61.41 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 126.389 1.876 . . . . 4.04 112.653 -177.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -73.08 -11.95 60.73 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.714 1.606 . . . . 1.8799999999999999 114.96 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -91.2 6.09 46.49 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 116.408 2.003 . . . . 1.97 116.408 -171.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.47 -37.3 63.26 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 115.84 1.793 . . . . 2.5600000000000001 115.84 -172.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -87.36 28.36 0.97 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 124.739 1.216 . . . . 4.1200000000000001 112.669 -177.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 55.6 mmtt -131.08 132.99 45.26 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.929 1.292 . . . . 1.8400000000000001 113.335 -164.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 23.9 mtt85 -65.09 169.83 5.08 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.889 1.276 . . . . 3.7400000000000002 110.971 164.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 27.5 m -51.53 -53.86 33.33 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 113.384 0.883 . . . . 0.97999999999999998 113.384 174.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.4 p -61.61 -38.05 79.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 123.377 0.671 . . . . 0.60999999999999999 111.569 175.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -75.04 -20.67 59.47 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 113.727 1.01 . . . . 1.2 113.727 -178.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -75.13 -55.35 5.82 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 119.054 0.843 . . . . 0.70999999999999996 110.116 164.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 40.8 m170 -56.42 -46.45 80.22 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.912 0.885 . . . . 0.78000000000000003 113.24 -175.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 29.7 tp60 -47.88 -41.79 25.17 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.287 1.435 . . . . 1.25 113.088 177.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 3.7 mtm -64.17 -40.68 96.63 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 121.491 -0.756 . . . . 1.1599999999999999 111.668 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.8 t -75.78 -23.99 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 126.07 1.748 . . . . 0.23999999999999999 111.235 179.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -76.16 -48.44 20.53 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.911 1.684 . . . . 0.45000000000000001 109.273 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 19.5 mm-40 -65.74 -23.68 66.79 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.622 1.169 . . . . 2.52 114.081 178.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.49 -38.49 84.47 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.119 0.968 . . . . 0.38 112.688 -177.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.441 ' HG ' HG13 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -121.22 3.41 10.36 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 114.605 1.335 . . . . 0.5 114.605 -178.58 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.9 ttmt -53.25 -39.94 64.23 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.674 1.189 . . . . 2.98 112.576 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -82.47 -5.83 58.93 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 123.311 0.644 . . . . 2.1400000000000001 112.629 -175.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -95.83 -49.16 5.44 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 127.412 2.285 . . . . 2.77 111.592 167.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 21.2 mt -148.38 110.36 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 128.133 2.573 . . . . 1.0800000000000001 109.024 178.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt -85.52 0.38 52.58 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 117.852 2.538 . . . . 4.0099999999999998 117.852 -173.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -77.19 48.42 0.62 Allowed 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 129.557 3.143 . . . . 2.8599999999999999 115.845 -160.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . 0.267 1.4 mpt? -70.63 3.51 3.07 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 119.709 -1.869 . . . . 1.9099999999999999 115.42 -177.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 17.5 p-80 -66.92 -13.62 61.94 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 114.491 1.293 . . . . 4.4000000000000004 114.491 156.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -108.64 -25.39 5.74 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 125.914 1.721 . . . . 0.48999999999999999 115.103 171.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.2 mp -78.27 141.25 38.67 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 121.009 -1.289 . . . . 1.54 113.577 -174.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 34.8 ttt180 -125.9 101.76 6.97 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 127.316 2.246 . . . . 3.1600000000000001 109.933 -177.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 4.0 mt -108.21 149.77 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-O 123.59 1.662 . . . . 0.44 113.593 -171.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -139.77 119.56 13.35 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 111.356 -2.657 . . . . 1.8799999999999999 108.631 -171.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.8 p -136.85 145.02 43.92 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 125.285 1.434 . . . . 0.40999999999999998 111.253 -177.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.8 p -148.08 178.58 8.42 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.283 -1.326 . . . . 0.76000000000000001 111.404 176.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 6.8 p -145.0 135.82 12.25 Favored Pre-proline 0 N--CA 1.47 0.575 0 O-C-N 121.759 -0.588 . . . . 0.56000000000000005 112.385 -178.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo . . . . . 0 N--CA 1.454 -0.8 0 C-N-CA 123.298 2.665 . . . . 0.76000000000000001 110.999 176.654 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 . . . . . 0 N--CA 1.469 0.504 0 CA-C-O 121.542 0.687 . . . . 2.27 111.304 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 70.1 p -100.4 -178.89 3.94 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 126.069 1.748 . . . . 0.81999999999999995 110.13 160.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -73.24 -25.71 60.83 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 120.264 -1.522 . . . . 2.8799999999999999 112.208 160.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.73 -40.27 98.56 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 125.453 1.501 . . . . 0.48999999999999999 113.244 173.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -52.22 -42.19 63.37 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.588 1.555 . . . . 1.24 113.016 177.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 14.0 mt -75.06 -48.44 23.9 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 126.543 1.937 . . . . 0.46000000000000002 110.549 -179.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -53.81 -49.09 69.12 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.333 1.453 . . . . 2.9399999999999999 111.149 175.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 29.8 t -62.46 -52.04 64.79 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 C-N-CA 125.457 1.503 . . . . 0.34999999999999998 107.576 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 99.3 m -52.24 -43.13 64.15 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.479 0.712 . . . . 0.41999999999999998 111.848 178.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -65.33 -42.21 93.15 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 118.267 -0.873 . . . . 2.1899999999999999 112.406 -178.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 38.6 mt -72.4 -32.0 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 CA-C-N 119.754 1.161 . . . . 0.45000000000000001 110.494 178.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 20.6 mt -54.36 -44.06 71.87 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 121.344 -0.848 . . . . 0.41999999999999998 112.904 173.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 34.9 mttt -65.91 -23.88 66.72 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 113.69 0.996 . . . . 2.1499999999999999 113.69 -178.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -93.03 -33.83 13.95 Favored 'General case' 0 N--CA 1.435 -1.211 0 C-N-CA 126.694 1.998 . . . . 2.3399999999999999 114.357 -177.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -75.64 -21.43 57.71 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 120.292 -0.563 . . . . 1.1299999999999999 111.947 166.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -131.12 58.2 37.16 Favored Pre-proline 0 CA--C 1.549 0.927 0 N-CA-C 117.254 2.316 . . . . 1.6200000000000001 117.254 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -67.18 -13.38 39.43 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 124.241 3.294 . . . . 1.1100000000000001 114.428 168.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.97 -12.72 60.19 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 115.274 1.583 . . . . 7.5599999999999996 115.274 171.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.94 153.79 42.69 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 116.37 1.989 . . . . 0.65000000000000002 116.37 -162.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 39.8 p -107.83 -25.28 11.31 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.521 1.528 . . . . 0.56000000000000005 112.466 166.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -125.9 141.24 52.07 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.297 0.953 . . . . 0.40000000000000002 111.62 164.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.2 pt -157.4 112.06 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 126.589 1.956 . . . . 0.81999999999999995 109.598 174.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.8 ptpt -153.38 149.9 28.3 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.239 1.416 . . . . 1.5800000000000001 112.221 -177.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.5 t -133.63 151.58 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 126.081 1.753 . . . . 0.46000000000000002 110.574 -176.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 88.0 m -146.6 122.73 10.82 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 121.046 -1.034 . . . . 0.35999999999999999 111.903 167.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -65.94 129.04 38.42 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.634 0.731 . . . . 1.99 109.314 162.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.9 pt -129.26 28.62 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 C-N-CA 126.364 1.865 . . . . 0.53000000000000003 110.009 179.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.5 t -132.99 59.25 1.74 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 127.547 2.339 . . . . 1.22 112.271 -165.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -66.5 14.33 0.36 Allowed Glycine 0 CA--C 1.539 1.562 0 C-N-CA 126.126 1.822 . . . . 1.8200000000000001 117.295 -175.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -154.07 16.99 0.61 Allowed Glycine 0 CA--C 1.533 1.171 0 C-N-CA 125.568 1.556 . . . . 1.8200000000000001 113.853 -177.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.6 t -161.52 -27.88 0.05 Allowed 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.363 1.465 . . . . 1.8600000000000001 112.49 177.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 54.47 40.53 69.65 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 125.642 1.591 . . . . 0.78000000000000003 113.898 -171.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -109.96 -37.07 5.71 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 127.372 2.269 . . . . 1.2 113.959 -176.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 30.0 mtm -84.03 130.94 34.86 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 124.283 1.033 . . . . 1.3400000000000001 110.669 175.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -141.32 141.87 33.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 122.147 0.975 . . . . 1.8400000000000001 112.313 172.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -81.23 137.22 35.87 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 124.905 1.282 . . . . 1.97 109.748 162.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.9 mt -136.76 131.94 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 108.213 -1.032 . . . . 0.63 108.213 171.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 8.0 tmtm? -128.42 128.61 44.78 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 118.992 0.815 . . . . 7.54 112.095 169.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.2 mt -124.51 162.44 26.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 125.772 1.629 . . . . 0.28999999999999998 108.869 -179.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -156.7 131.14 8.69 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 126.652 1.981 . . . . 2.0800000000000001 106.829 164.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 32.9 t -158.04 143.92 17.17 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 119.558 1.072 . . . . 0.34999999999999998 111.776 -172.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -55.9 -23.56 32.12 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 113.821 1.045 . . . . 3.0299999999999998 113.821 179.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -70.67 -19.14 62.82 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 114.9 1.444 . . . . 1.8300000000000001 114.9 178.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -83.14 10.72 7.6 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 114.545 1.313 . . . . 1.6200000000000001 114.545 -169.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.6 pttt -72.35 -44.92 61.91 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.979 1.711 . . . . 2.8999999999999999 113.527 -175.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -83.9 20.36 1.52 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.997 1.719 . . . . 3.71 112.489 -175.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 64.4 mmtt -130.47 132.55 45.73 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 126.469 1.907 . . . . 1.4199999999999999 111.984 -166.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 47.6 mtt180 -69.5 168.25 15.0 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.965 1.306 . . . . 3.2999999999999998 111.694 163.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 56.6 m -46.2 -55.41 7.15 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.058 1.343 . . . . 0.89000000000000001 113.533 170.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.7 p -57.55 -44.24 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 124.501 1.12 . . . . 0.58999999999999997 112.464 174.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -72.04 -27.87 62.98 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 118.378 -0.82 . . . . 1.1000000000000001 112.85 -178.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -69.97 -51.84 29.28 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 119.451 1.023 . . . . 0.68000000000000005 109.921 169.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 44.1 m170 -52.17 -53.07 47.66 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.075 0.95 . . . . 0.57999999999999996 112.24 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 28.0 tp60 -46.59 -43.67 17.5 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.1 1.36 . . . . 1.4299999999999999 113.411 177.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 61.6 mtp -64.18 -36.22 83.36 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 120.998 -1.064 . . . . 1.0600000000000001 113.069 -178.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.0 t -79.05 -36.07 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 125.613 1.565 . . . . 0.39000000000000001 110.56 177.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -61.22 -50.29 73.68 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.986 1.314 . . . . 0.46999999999999997 110.221 174.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 63.7 tp60 -57.45 -29.82 64.51 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 120.246 -1.534 . . . . 2.3300000000000001 113.553 178.073 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.54 -37.22 82.98 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.119 0.968 . . . . 0.54000000000000004 112.058 -177.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.59 0.88 8.84 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 115.06 1.504 . . . . 0.62 115.06 -179.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 30.2 ttpt -47.41 -36.76 10.27 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 125.85 1.66 . . . . 2.6699999999999999 112.618 175.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -88.85 7.55 33.68 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 112.403 0.52 . . . . 2.0699999999999998 112.403 -172.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -121.11 -61.13 1.58 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 128.625 2.77 . . . . 2.73 110.449 175.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 7.2 mm -115.77 90.33 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 125.046 1.338 . . . . 1.6499999999999999 109.018 171.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 8.0 ptpp? -76.15 -18.56 59.06 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 114.348 1.24 . . . . 4.4000000000000004 114.348 -173.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -67.08 46.19 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 131.258 3.823 . . . . 3.3900000000000001 114.429 -178.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 61.2 mtm -71.58 10.25 0.68 Allowed 'General case' 0 CA--C 1.54 0.56 0 O-C-N 119.393 -2.067 . . . . 1.3700000000000001 114.933 -172.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -69.59 -20.59 63.63 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.315 0.857 . . . . 3.2200000000000002 113.315 161.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -84.45 -32.88 21.25 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 123.904 0.764 . . . . 0.62 112.212 174.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.0 mp -71.91 144.31 49.03 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 122.515 1.15 . . . . 1.6100000000000001 112.795 -173.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 45.1 ttt180 -128.48 99.67 5.48 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 126.547 1.939 . . . . 3.02 109.126 -176.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 4.9 mt -108.78 141.75 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 123.697 1.713 . . . . 0.62 112.953 -170.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -130.51 132.79 45.8 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 111.495 -2.593 . . . . 1.8500000000000001 107.542 -172.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 17.2 p -151.85 151.85 31.85 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.788 1.235 . . . . 0.33000000000000002 109.945 -173.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.1 p -161.83 -179.53 7.27 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.506 -1.224 . . . . 0.64000000000000001 110.243 178.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 6.3 p -135.15 136.14 24.15 Favored Pre-proline 0 C--N 1.325 -0.481 0 C-N-CA 124.267 1.027 . . . . 0.57999999999999996 109.782 177.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo . . . . . 0 N--CA 1.457 -0.653 0 C-N-CA 123.377 2.718 . . . . 0.68000000000000005 108.791 175.728 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 16.4 mp0 . . . . . 0 CA--C 1.537 0.444 0 N-CA-C 113.445 0.906 . . . . 2.2000000000000002 113.445 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 80.9 p -127.06 166.87 16.79 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.774 2.03 . . . . 0.67000000000000004 108.291 159.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -62.68 -26.66 68.77 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 119.986 1.267 . . . . 3.27 111.951 169.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.43 -43.47 94.82 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 126.01 1.767 . . . . 0.40999999999999998 113.063 172.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.88 -45.6 60.14 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 119.321 1.56 . . . . 2.0299999999999998 111.44 173.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.7 mt -69.52 -52.22 28.43 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 124.912 1.285 . . . . 0.45000000000000001 111.264 178.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -53.62 -48.28 69.46 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.915 1.286 . . . . 2.8999999999999999 110.695 179.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 67.6 t -63.99 -49.24 82.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 108.25 -1.019 . . . . 0.27000000000000002 108.25 179.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 98.3 m -56.18 -43.01 77.99 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.15 0.58 . . . . 0.34999999999999998 112.4 178.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.74 -37.02 85.78 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.479 1.112 . . . . 2.7599999999999998 111.911 -179.089 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 64.1 mt -79.82 -30.63 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 CA-C-N 118.775 0.716 . . . . 0.47999999999999998 110.855 176.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.2 mt -59.81 -36.09 76.05 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 120.694 -1.254 . . . . 0.52000000000000002 112.687 170.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 27.2 mttt -65.84 -19.05 65.74 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 113.429 0.9 . . . . 1.3799999999999999 113.429 175.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -98.43 -39.2 8.89 Favored 'General case' 0 N--CA 1.434 -1.254 0 C-N-CA 126.079 1.752 . . . . 2.1699999999999999 113.946 179.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 29.5 mmtt -78.17 -21.69 49.81 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 112.675 0.62 . . . . 1.8100000000000001 112.675 172.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -136.24 52.4 6.31 Favored Pre-proline 0 CA--C 1.55 0.98 0 N-CA-C 118.126 2.639 . . . . 2.1099999999999999 118.126 178.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -69.47 -22.07 33.94 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 123.659 2.906 . . . . 0.97999999999999998 114.395 173.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 13.4 mmp_? -82.7 -18.37 41.13 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 120.861 -1.149 . . . . 6.75 112.485 177.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -55.5 145.87 21.71 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 125.868 1.667 . . . . 0.58999999999999997 113.559 176.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 81.9 p -86.44 -28.97 23.19 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.247 1.019 . . . . 0.72999999999999998 110.938 176.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -121.69 143.73 49.18 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.001 0.921 . . . . 0.40999999999999998 112.615 164.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.5 pt -155.41 111.53 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 128.123 2.569 . . . . 0.56000000000000005 110.167 169.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 6.4 ptpt -153.28 156.0 37.59 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.885 1.274 . . . . 1.02 113.062 176.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.7 t -133.77 145.94 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 126.314 1.846 . . . . 0.51000000000000001 110.281 -177.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 28.4 m -132.69 128.02 36.05 Favored 'General case' 0 CA--C 1.512 -0.482 0 C-N-CA 123.706 0.802 . . . . 0.60999999999999999 111.521 171.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -74.04 125.3 27.99 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 122.209 1.004 . . . . 1.8 109.586 165.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.4 pt -124.72 30.5 2.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 125.273 1.429 . . . . 0.47999999999999998 109.96 178.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.465 ' HB2' ' H ' ' A' ' 62' ' ' MET . 32.4 t -138.98 62.73 1.53 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 127.509 2.324 . . . . 1.25 111.998 -175.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -65.63 10.62 0.47 Allowed Glycine 0 CA--C 1.541 1.696 0 O-C-N 120.256 -1.528 . . . . 1.51 116.689 178.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -121.49 -4.28 9.92 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 125.749 1.642 . . . . 0.91000000000000003 114.709 171.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 9.2 t -156.97 -31.59 0.08 Allowed 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 119.386 1.593 . . . . 1.8400000000000001 114.832 -176.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 59.93 48.93 83.67 Favored Glycine 0 CA--C 1.538 1.516 0 C-N-CA 126.036 1.779 . . . . 0.60999999999999999 113.051 -161.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -105.88 -17.47 14.35 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 126.299 1.839 . . . . 0.85999999999999999 114.625 178.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.465 ' H ' ' HB2' ' A' ' 56' ' ' SER . 6.6 mtm -110.9 140.43 45.38 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 126.11 1.764 . . . . 1.3500000000000001 111.954 168.298 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -142.99 148.93 37.62 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.725 0.81 . . . . 1.8999999999999999 112.795 172.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -85.84 138.45 32.04 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.858 1.663 . . . . 1.96 109.356 163.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 84.2 mt -134.75 131.01 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 CA-C-N 120.057 1.299 . . . . 0.63 109.965 171.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 66.9 mttt -128.2 118.59 23.61 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.637 1.175 . . . . 2.7599999999999998 111.329 179.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.401 ' CD1' HG13 ' A' ' 84' ' ' VAL . 1.2 mt -128.5 157.36 41.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 C-N-CA 126.586 1.954 . . . . 0.25 109.633 -178.368 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -157.39 126.9 6.03 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 120.353 -1.467 . . . . 1.8400000000000001 109.248 170.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 16.4 t -160.1 144.29 14.43 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 120.599 1.545 . . . . 0.41999999999999998 112.815 -169.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -55.32 -29.69 58.76 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.902 1.281 . . . . 4.8700000000000001 112.562 -177.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -66.43 -19.25 65.75 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 115.166 1.543 . . . . 1.75 115.166 178.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -82.56 -2.78 54.66 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 120.824 -1.172 . . . . 2.0099999999999998 114.106 -172.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.516 ' HB3' HG21 ' A' ' 104' ' ' VAL . 55.3 pttt -67.09 -25.45 66.23 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.752 1.621 . . . . 2.77 114.432 -176.18 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -109.05 26.61 10.41 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.976 1.71 . . . . 4.5599999999999996 111.415 -169.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 38.9 mmtt -131.79 141.4 49.46 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 126.535 1.934 . . . . 1.3999999999999999 111.319 -172.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 31.0 mtt180 -64.04 165.38 9.11 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 118.975 -0.535 . . . . 4.6299999999999999 110.906 165.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 66.7 m -48.24 -54.53 13.27 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 113.154 0.798 . . . . 1.0 113.154 170.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.2 p -60.34 -39.38 80.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 124.656 1.182 . . . . 0.65000000000000002 112.717 176.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -69.88 -35.37 74.6 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 112.841 0.682 . . . . 1.3300000000000001 112.841 176.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -60.87 -52.33 65.52 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 119.507 1.049 . . . . 0.62 109.911 170.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 38.3 m170 -54.8 -51.6 65.27 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.292 0.637 . . . . 0.48999999999999999 111.81 176.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 41.3 tp60 -48.76 -44.02 38.36 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.933 1.693 . . . . 1.24 113.161 178.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 1.4 mtm -63.46 -40.36 96.92 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 119.628 1.104 . . . . 1.1299999999999999 111.868 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.401 HG13 ' CD1' ' A' ' 67' ' ' ILE . 4.2 t -74.83 -31.17 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 124.556 1.142 . . . . 0.37 111.145 178.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -66.88 -52.82 38.75 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.571 1.549 . . . . 0.45000000000000001 110.697 176.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 43.7 tp60 -64.09 -23.91 67.5 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 119.993 -1.692 . . . . 2.6299999999999999 113.15 -177.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -54.19 -45.82 72.25 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.9 1.28 . . . . 0.48999999999999999 111.254 177.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -119.91 1.47 10.96 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 114.994 1.479 . . . . 0.47999999999999998 114.994 -175.062 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 29.8 ttpt -51.28 -36.8 43.95 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 125.226 1.41 . . . . 2.1899999999999999 112.13 -177.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -85.15 -9.09 58.25 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 112.781 0.66 . . . . 2.21 112.781 -174.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -94.91 -62.05 1.38 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 127.128 2.171 . . . . 3.0099999999999998 110.428 174.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 8.6 mm -121.61 88.93 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 125.631 1.572 . . . . 1.46 109.044 176.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -72.76 -16.68 61.64 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 115.378 1.621 . . . . 2.5899999999999999 115.378 -174.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.9 mp0 -63.18 39.08 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 130.946 3.699 . . . . 3.1000000000000001 115.903 -177.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 64.2 mtm -69.46 2.55 2.98 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 119.669 -1.894 . . . . 1.4199999999999999 115.412 -170.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 10.9 p-80 -65.85 -22.7 66.56 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.611 0.764 . . . . 4.4100000000000001 112.668 160.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -84.57 -14.79 69.88 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 125.995 1.76 . . . . 0.39000000000000001 114.27 171.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.6 mp -97.47 127.01 43.08 Favored 'General case' 0 C--O 1.236 0.37 0 O-C-N 121.553 -0.969 . . . . 1.6699999999999999 111.877 -168.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 59.2 ttt180 -106.11 101.05 10.56 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.734 2.014 . . . . 3.98 109.735 178.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 4.8 mt -107.59 141.08 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-O 123.183 1.468 . . . . 0.46000000000000002 112.02 -173.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -129.74 130.99 46.13 Favored 'General case' 0 N--CA 1.433 -1.31 0 C-N-CA 128.35 2.66 . . . . 2.0299999999999998 108.628 -174.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 13.6 p -143.1 152.94 42.4 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 126.006 1.722 . . . . 0.29999999999999999 109.036 -178.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 2.8 p -163.03 -179.48 6.75 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.617 -1.174 . . . . 0.60999999999999999 109.671 177.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.516 HG21 ' HB3' ' A' ' 73' ' ' LYS . 4.2 p -144.19 135.26 12.46 Favored Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 112.909 0.707 . . . . 0.58999999999999997 112.909 -175.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo . . . . . 0 C--N 1.35 0.654 0 C-N-CA 124.157 3.238 . . . . 0.72999999999999998 112.024 179.72 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 . . . . . 0 CA--C 1.548 0.868 0 CA-C-O 121.112 0.482 . . . . 2.8100000000000001 111.093 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 55.2 p -127.69 -175.87 3.6 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 126.257 1.823 . . . . 0.87 109.795 168.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -62.21 -39.55 93.14 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 120.646 1.566 . . . . 4.6100000000000003 110.764 160.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.48 -43.78 96.16 Favored Glycine 0 C--N 1.34 0.789 0 C-N-CA 126.045 1.783 . . . . 0.68000000000000005 113.21 -177.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.12 -48.35 73.77 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 118.974 1.387 . . . . 1.3100000000000001 112.565 -178.317 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 46.0 mt -66.32 -50.31 64.07 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 125.807 1.643 . . . . 0.52000000000000002 110.882 178.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -54.99 -50.03 70.0 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.779 2.032 . . . . 3.2200000000000002 111.428 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.2 t -64.36 -47.12 90.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 124.418 1.087 . . . . 0.34999999999999998 108.127 177.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 89.7 m -57.65 -38.3 74.83 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 118.035 0.38 . . . . 0.35999999999999999 111.998 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -62.39 -40.67 97.24 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 112.629 0.603 . . . . 1.6899999999999999 112.629 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 24.3 mt -79.4 -29.46 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 O-C-N 123.314 0.384 . . . . 0.66000000000000003 111.013 179.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.1 mt -56.13 -41.54 75.48 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 120.833 -1.167 . . . . 0.5 113.534 169.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 38.5 mttt -60.89 -28.61 69.01 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 113.262 0.838 . . . . 2.0499999999999998 113.262 178.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -93.48 -37.96 11.67 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 127.294 2.238 . . . . 2.04 114.497 -175.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -73.87 -26.91 60.8 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-O 117.999 -1.0 . . . . 1.1899999999999999 111.489 171.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -132.06 52.01 8.33 Favored Pre-proline 0 CA--C 1.547 0.865 0 N-CA-C 117.811 2.523 . . . . 1.5700000000000001 117.811 -177.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -62.48 -22.6 74.24 Favored 'Trans proline' 0 C--O 1.236 0.403 0 C-N-CA 123.758 2.972 . . . . 0.73999999999999999 114.194 174.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.41 -18.44 64.45 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 113.953 1.094 . . . . 7.2000000000000002 113.953 174.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -56.36 150.67 14.35 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 115.552 1.686 . . . . 0.51000000000000001 115.552 -167.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 61.1 p -90.26 -35.66 15.17 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 114.702 -1.135 . . . . 0.79000000000000004 111.672 166.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -125.09 136.13 53.36 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.53 1.132 . . . . 0.32000000000000001 111.176 173.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.5 pt -153.89 114.08 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 124.381 1.073 . . . . 0.46999999999999997 112.876 171.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -157.14 154.62 29.64 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.569 1.548 . . . . 1.25 113.297 -179.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.8 t -131.77 142.66 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 127.673 2.389 . . . . 0.67000000000000004 108.604 177.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 59.2 m -135.77 120.72 18.67 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.948 1.299 . . . . 0.51000000000000001 110.484 175.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -70.52 128.74 37.19 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.95 0.881 . . . . 1.9099999999999999 109.839 168.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.7 pt -130.47 31.19 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 C-N-CA 126.566 1.946 . . . . 0.73999999999999999 109.597 178.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.7 t -139.87 61.91 1.52 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 128.319 2.648 . . . . 1.3200000000000001 110.436 -170.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.6 -3.47 5.63 Favored Glycine 0 CA--C 1.538 1.504 0 N-CA-C 118.128 2.011 . . . . 1.25 118.128 -168.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -140.37 12.41 3.01 Favored Glycine 0 N--CA 1.475 1.24 0 CA-C-N 119.632 1.716 . . . . 0.93000000000000005 115.222 175.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 16.7 m -143.55 -34.15 0.41 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.746 1.618 . . . . 2.9100000000000001 111.865 -176.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 52.84 42.96 60.41 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 126.69 2.091 . . . . 0.70999999999999996 113.194 -177.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -107.34 -29.86 9.04 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.446 1.898 . . . . 0.93999999999999995 112.357 -177.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 1.8 mtm -102.97 126.53 50.18 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 126.501 1.92 . . . . 2.1699999999999999 109.96 -179.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -139.05 150.51 45.84 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.157 0.983 . . . . 1.9299999999999999 110.487 178.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -104.72 124.28 49.11 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.856 1.662 . . . . 2.04 109.448 171.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 53.8 mt -124.61 135.5 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 125.314 1.446 . . . . 0.65000000000000002 110.645 -176.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 62.0 tttt -126.74 120.71 30.07 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.177 0.991 . . . . 5.1200000000000001 110.455 174.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.409 ' CD1' HG13 ' A' ' 84' ' ' VAL . 1.1 mt -125.31 154.0 33.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 126.453 1.901 . . . . 0.28000000000000003 108.974 176.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -156.02 130.3 8.79 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 120.561 -1.337 . . . . 1.6299999999999999 108.393 166.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.4 t -162.64 147.22 11.89 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 118.881 0.764 . . . . 0.66000000000000003 112.369 -174.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -55.21 -24.15 25.83 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.303 1.841 . . . . 2.9500000000000002 114.553 -175.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -70.07 -18.26 63.27 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 115.155 1.539 . . . . 2.5099999999999998 115.155 175.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -78.56 15.86 0.94 Allowed 'General case' 0 CA--C 1.559 1.32 0 N-CA-C 114.854 1.427 . . . . 1.6299999999999999 114.854 -173.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.404 ' HG2' ' H ' ' A' ' 73' ' ' LYS . 38.4 pttt -79.1 -35.7 41.86 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 128.215 2.606 . . . . 2.4300000000000002 117.275 -165.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -119.45 32.27 6.17 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.455 1.102 . . . . 3.6899999999999999 112.301 -179.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 67.8 mmtt -112.13 142.21 44.86 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 128.043 2.537 . . . . 1.3600000000000001 111.214 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 8.2 mmt180 -66.19 161.87 21.09 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.141 0.976 . . . . 3.29 111.002 163.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 96.4 m -47.42 -55.74 8.36 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.334 1.054 . . . . 0.77000000000000002 113.616 169.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.6 p -56.9 -37.61 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 124.809 1.243 . . . . 0.58999999999999997 112.644 178.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.4 mm100 -77.14 -32.33 56.28 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.444 1.098 . . . . 1.8400000000000001 113.048 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -62.92 -53.57 51.97 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.156 0.889 . . . . 0.59999999999999998 109.832 168.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 39.2 m170 -53.15 -50.87 63.68 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.914 0.886 . . . . 0.42999999999999999 111.626 177.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 34.7 tp60 -48.28 -44.27 33.46 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.922 1.289 . . . . 1.29 112.875 178.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 4.1 mtm -61.59 -43.41 98.92 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 119.977 1.262 . . . . 1.1599999999999999 111.297 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.409 HG13 ' CD1' ' A' ' 67' ' ' ILE . 5.8 t -71.83 -29.08 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.87 1.268 . . . . 0.23999999999999999 111.471 178.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -71.91 -44.67 63.31 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.102 1.361 . . . . 0.62 110.481 175.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.7 -22.83 66.06 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 120.647 -1.283 . . . . 2.8399999999999999 113.379 178.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.45 -38.98 78.64 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.784 1.234 . . . . 0.34999999999999998 112.48 176.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.04 -2.31 9.2 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 114.772 1.397 . . . . 0.40000000000000002 114.772 -173.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 11.0 ttpp -49.49 -35.73 20.77 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 126.086 1.754 . . . . 3.6499999999999999 113.323 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -88.76 -11.19 45.7 Favored 'General case' 0 CA--C 1.552 1.044 0 N-CA-C 112.307 0.484 . . . . 2.0899999999999999 112.307 -174.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -95.45 -49.79 5.27 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 127.338 2.255 . . . . 3.75 112.045 174.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 34.2 mt -135.41 113.07 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 127.525 2.33 . . . . 1.1200000000000001 106.302 172.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.86 -17.78 34.65 Favored 'General case' 0 N--CA 1.48 1.075 0 O-C-N 120.703 -1.248 . . . . 3.4500000000000002 114.22 -169.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -88.33 63.9 7.34 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.33 1.852 . . . . 4.21 112.798 -164.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . 0.417 ' HA ' HD13 ' A' ' 98' ' ' LEU . 5.3 mpp? -69.14 8.04 0.63 Allowed 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 115.16 1.541 . . . . 1.28 115.16 -178.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 28.3 p80 -53.18 -36.42 60.92 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 120.978 -1.076 . . . . 3.9500000000000002 113.377 171.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -85.43 -9.25 79.55 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 125.673 1.606 . . . . 0.42999999999999999 114.635 -179.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.417 HD13 ' HA ' ' A' ' 95' ' ' MET . 4.9 mp -96.68 107.36 19.8 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 121.311 -1.111 . . . . 1.6599999999999999 112.44 -166.538 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 10.4 ttt180 -81.05 117.39 21.59 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 112.818 -1.992 . . . . 3.4399999999999999 108.467 171.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 4.3 mt -125.29 135.07 65.18 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.679 0 CA-C-O 123.448 1.594 . . . . 0.35999999999999999 112.491 -175.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -121.69 122.67 40.1 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 111.539 -2.573 . . . . 2.4300000000000002 107.611 -175.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 15.6 p -132.92 152.5 51.89 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.103 1.361 . . . . 0.25 110.21 179.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.8 p -158.2 175.57 13.6 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 124.639 1.176 . . . . 0.59999999999999998 110.367 176.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 9.0 p -141.94 127.82 10.86 Favored Pre-proline 0 N--CA 1.472 0.661 0 C-N-CA 123.132 0.573 . . . . 0.41999999999999998 111.77 -177.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo . . . . . 0 CA--C 1.537 0.64 0 C-N-CA 123.447 2.765 . . . . 0.66000000000000003 111.957 -176.367 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.856 0 CA-C-O 119.715 -0.183 . . . . 4.9800000000000004 110.805 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.7 m -146.44 175.32 10.64 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 125.645 1.578 . . . . 3.3900000000000001 110.289 177.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -127.51 154.91 44.55 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.658 1.183 . . . . 2.27 111.897 170.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 80.0 p -107.11 164.5 12.11 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.008 0.923 . . . . 0.81000000000000005 109.414 156.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 21.9 mp0 -64.32 -22.13 66.85 Favored 'General case' 0 CA--C 1.549 0.941 0 O-C-N 121.454 -0.778 . . . . 3.7200000000000002 111.716 162.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.45 -39.61 95.81 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 126.72 2.105 . . . . 0.42999999999999999 114.08 170.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.87 -43.99 73.64 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.486 1.643 . . . . 2.1000000000000001 111.29 174.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 11.7 mt -66.28 -55.37 16.38 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 125.399 1.48 . . . . 0.34999999999999998 109.867 178.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.3 tpm_? -49.69 -51.46 38.16 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.632 1.573 . . . . 7.1900000000000004 113.351 176.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 26.0 t -65.21 -43.33 95.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 106.945 -1.502 . . . . 0.32000000000000001 106.945 -175.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 36.1 m -58.7 -38.21 77.78 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 118.525 -0.75 . . . . 0.40999999999999998 112.056 175.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 14.3 mm-40 -60.97 -49.67 76.49 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 119.448 1.022 . . . . 1.73 112.219 -179.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 18.3 mt -75.34 -30.96 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 CA-C-N 118.343 0.519 . . . . 0.52000000000000002 110.027 -175.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 29.9 mt -56.49 -38.33 71.61 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 114.459 1.281 . . . . 0.57999999999999996 114.459 171.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 31.2 mttt -58.94 -36.76 75.32 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 119.122 0.874 . . . . 2.96 112.347 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.03 -36.31 15.87 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 128.651 2.78 . . . . 4.9199999999999999 114.493 -173.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 48.6 mmtt -71.27 -20.84 62.17 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 118.262 -0.875 . . . . 1.26 112.397 167.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -134.09 59.12 35.8 Favored Pre-proline 0 CA--C 1.558 1.275 0 N-CA-C 117.756 2.502 . . . . 2.0899999999999999 117.756 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.35 -19.81 32.86 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 124.62 3.547 . . . . 0.93999999999999995 114.983 171.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 40.8 mmt180 -78.79 -0.12 29.19 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 120.836 -1.165 . . . . 4.8200000000000003 113.775 170.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.26 149.1 50.86 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 115.675 1.731 . . . . 0.53000000000000003 115.675 -176.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 16.3 p -108.15 -27.97 9.77 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 127.048 2.139 . . . . 0.68999999999999995 112.842 170.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -119.57 138.63 53.08 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.376 1.071 . . . . 0.54000000000000004 110.881 163.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.2 pt -153.92 118.87 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 124.788 1.235 . . . . 0.67000000000000004 111.663 166.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.4 ptpt -158.11 154.39 27.43 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 126.032 1.733 . . . . 1.27 112.3 173.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.4 t -132.66 149.98 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 126.465 1.906 . . . . 0.35999999999999999 109.712 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 92.5 m -140.0 131.18 26.51 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.613 0.765 . . . . 0.46999999999999997 111.427 169.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -73.91 121.96 21.78 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.513 0.725 . . . . 1.8 109.978 163.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . 0.255 5.5 pt -117.11 25.52 4.35 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 C-N-CA 125.495 1.518 . . . . 0.68999999999999995 111.039 179.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 31.9 t -137.91 58.99 1.67 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 128.564 2.746 . . . . 1.3500000000000001 111.223 -173.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -55.53 -6.53 1.1 Allowed Glycine 0 CA--C 1.544 1.878 0 N-CA-C 119.003 2.361 . . . . 1.3 119.003 -173.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -133.04 16.39 4.7 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 126.247 1.879 . . . . 1.03 114.653 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 15.4 t -153.17 -39.7 0.1 Allowed 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.778 1.231 . . . . 1.52 111.776 170.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 64.67 44.18 95.31 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 125.699 1.618 . . . . 0.88 112.707 -167.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -90.08 -31.39 17.16 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.911 1.284 . . . . 1.21 113.667 173.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 9.0 mtm -104.43 138.01 41.46 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.866 1.266 . . . . 1.53 112.576 174.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -137.46 147.34 45.25 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.995 0.918 . . . . 1.97 111.225 169.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -83.32 138.49 33.53 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 124.904 1.282 . . . . 2.4399999999999999 109.531 161.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 97.5 mt -134.48 129.0 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 CA-C-N 119.344 0.975 . . . . 0.59999999999999998 109.474 168.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 71.6 mttt -126.06 115.99 20.71 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.688 1.195 . . . . 2.6800000000000002 110.347 178.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.1 mt -127.02 156.62 38.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 126.442 1.897 . . . . 0.25 109.423 -177.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -152.87 133.3 13.67 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.252 1.821 . . . . 2.02 106.584 162.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 28.0 t -155.91 143.37 19.39 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 120.132 1.333 . . . . 0.41999999999999998 112.883 -173.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -57.51 -20.62 32.62 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.923 1.289 . . . . 3.25 114.149 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -75.69 -15.12 60.34 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 114.27 1.211 . . . . 1.8600000000000001 114.27 177.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -83.5 16.72 2.46 Favored 'General case' 0 CA--C 1.55 0.964 0 N-CA-C 113.689 0.996 . . . . 1.6200000000000001 113.689 -174.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -71.05 -44.35 65.94 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.677 1.591 . . . . 3.0 112.654 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -91.85 35.85 0.97 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.206 1.402 . . . . 4.1100000000000003 113.115 -174.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 62.6 mmtt -144.78 141.32 29.11 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.684 1.594 . . . . 1.54 113.115 -167.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 22.6 mmt180 -73.03 170.62 14.48 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 126.596 1.959 . . . . 4.4900000000000002 112.223 162.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 84.2 m -50.95 -54.71 21.9 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.816 1.043 . . . . 1.1000000000000001 113.816 168.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.1 p -59.9 -35.88 63.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 123.776 0.83 . . . . 0.81999999999999995 112.974 178.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -76.4 -37.07 57.65 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.722 0.809 . . . . 1.2 112.029 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -59.83 -54.07 50.52 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.962 0.905 . . . . 0.68999999999999995 109.889 168.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 47.8 m170 -50.13 -52.76 32.45 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.256 1.022 . . . . 0.54000000000000004 111.878 177.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 39.9 tp60 -47.07 -44.28 20.82 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.592 1.557 . . . . 1.26 112.847 179.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 81.2 mtp -62.97 -43.43 98.81 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 121.166 -0.959 . . . . 0.98999999999999999 112.255 178.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.2 t -71.22 -25.83 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 125.657 1.583 . . . . 0.25 111.735 177.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -76.8 -44.41 32.74 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.621 1.568 . . . . 0.51000000000000001 109.69 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -64.76 -27.39 68.86 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 125.104 1.362 . . . . 3.4399999999999999 113.99 175.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.94 -29.99 71.22 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.501 1.52 . . . . 0.47999999999999998 112.916 -175.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.0 -8.19 8.85 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 115.124 1.527 . . . . 0.40000000000000002 115.124 176.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -44.37 -43.58 7.68 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.081 1.352 . . . . 2.02 112.847 176.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -85.78 6.01 29.88 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-O 122.505 1.145 . . . . 2.4500000000000002 111.759 -165.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -124.54 -56.27 1.61 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 129.946 3.299 . . . . 2.98 108.377 -177.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.0 mm -126.38 132.9 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 127.573 2.349 . . . . 1.9399999999999999 108.923 169.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -92.77 -10.89 35.34 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 116.274 1.953 . . . . 2.6299999999999999 116.274 -174.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -78.66 36.65 0.27 Allowed 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 117.702 2.482 . . . . 3.0499999999999998 117.702 -153.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 4.6 mpp? -64.06 9.42 0.07 Allowed 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 116.259 1.948 . . . . 1.3200000000000001 116.259 -175.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 49.3 t60 -65.07 -38.82 92.05 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 120.946 -1.096 . . . . 4.3700000000000001 111.81 160.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -84.61 -17.79 63.23 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 126.355 1.931 . . . . 0.41999999999999998 114.045 -178.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.5 mp -87.61 118.77 27.31 Favored 'General case' 0 C--N 1.332 -0.179 0 O-C-N 121.674 -0.898 . . . . 1.71 112.265 -170.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 28.7 ttm180 -98.02 102.06 13.71 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 127.453 2.301 . . . . 4.8700000000000001 109.885 -177.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 4.1 mt -111.7 143.91 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-O 123.903 1.811 . . . . 0.42999999999999999 113.14 -169.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -136.0 125.6 25.32 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 111.543 -2.571 . . . . 1.8400000000000001 108.005 -171.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 28.3 p -144.86 153.55 41.72 Favored 'General case' 0 CA--C 1.509 -0.607 0 C-N-CA 125.837 1.655 . . . . 0.40000000000000002 109.791 -171.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -163.35 175.55 10.73 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.239 -1.346 . . . . 0.70999999999999996 109.379 176.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.4 p -122.97 139.65 31.87 Favored Pre-proline 0 C--N 1.325 -0.488 0 O-C-N 121.289 -0.882 . . . . 0.64000000000000001 109.531 170.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -80.94 121.54 4.06 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 123.207 2.605 . . . . 0.87 108.463 172.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 10.2 mmtt -149.5 26.55 0.84 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.067 1.347 . . . . 3.2400000000000002 111.083 -160.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 63.6 mtm-85 . . . . . 0 C--O 1.257 1.475 0 C-N-CA 126.687 1.995 . . . . 10.15 113.788 -157.002 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.736 0 N-CA-C 109.588 -0.523 . . . . 6.5800000000000001 109.588 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 13.9 m -65.86 138.77 58.1 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.908 0.883 . . . . 3.77 111.777 -177.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -44.61 147.85 0.56 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.828 1.651 . . . . 2.27 115.443 -178.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 38.9 p -117.0 179.9 3.89 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.877 1.671 . . . . 0.90000000000000002 111.041 169.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -70.45 -35.25 73.23 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 120.633 -1.292 . . . . 3.0499999999999998 111.959 168.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -67.42 -37.59 90.33 Favored Glycine 0 CA--C 1.529 0.948 0 CA-C-O 118.572 -1.127 . . . . 0.44 112.901 178.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -46.08 -50.24 15.49 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.51 1.524 . . . . 1.3799999999999999 112.713 173.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 15.1 mt -69.95 -50.73 39.03 Favored 'General case' 0 CA--C 1.528 0.098 0 C-N-CA 124.957 1.303 . . . . 0.40999999999999998 111.132 -178.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.54 -48.36 77.43 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.578 1.151 . . . . 3.0099999999999998 110.85 -179.027 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.0 t -63.12 -41.93 94.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 108.496 -0.927 . . . . 0.28999999999999998 108.496 177.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 74.2 m -59.09 -42.08 89.61 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 118.761 0.709 . . . . 0.46999999999999997 111.28 178.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -69.48 -33.37 72.79 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 114.011 1.115 . . . . 3.1099999999999999 114.011 -175.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 30.5 mt -79.53 -30.69 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 CA-C-N 119.099 0.863 . . . . 0.47999999999999998 110.694 173.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 33.1 mt -58.19 -36.74 73.54 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 120.74 -1.225 . . . . 0.51000000000000001 113.233 171.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 38.0 mttt -59.78 -24.6 64.23 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 114.21 1.189 . . . . 1.3300000000000001 114.21 173.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -101.25 -34.73 9.54 Favored 'General case' 0 N--CA 1.427 -1.575 0 C-N-CA 125.494 1.518 . . . . 2.0800000000000001 113.87 -175.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -75.26 -24.66 57.63 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 118.646 -1.221 . . . . 1.1000000000000001 111.79 169.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -130.6 54.55 14.99 Favored Pre-proline 0 CA--C 1.548 0.865 0 N-CA-C 117.049 2.24 . . . . 2.21 117.049 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -62.49 -30.79 80.26 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 123.573 2.849 . . . . 0.73999999999999999 113.688 174.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 28.0 mmt85 -75.95 -11.89 60.04 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 120.352 1.433 . . . . 4.7000000000000002 114.519 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -55.21 146.67 18.26 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.157 1.783 . . . . 0.40999999999999998 114.524 -174.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 66.7 p -88.09 -30.74 19.65 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.905 0.882 . . . . 0.70999999999999996 111.111 170.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -129.77 138.67 51.19 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.005 0.922 . . . . 0.45000000000000001 111.734 170.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.6 pt -150.46 117.74 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 125.572 1.549 . . . . 0.73999999999999999 111.419 165.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.79 157.79 37.06 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.705 1.202 . . . . 2.4199999999999999 113.46 169.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.0 t -125.08 144.13 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 128.215 2.606 . . . . 0.37 110.492 -173.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 80.7 m -128.86 126.37 39.64 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.388 1.475 . . . . 0.51000000000000001 109.518 166.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -73.41 139.2 45.72 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 122.023 0.916 . . . . 2.4700000000000002 110.344 165.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.7 pt -134.31 32.8 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 C-N-CA 126.411 1.884 . . . . 0.83999999999999997 110.397 177.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.44 ' HB2' ' H ' ' A' ' 62' ' ' MET . 23.2 t -141.01 62.31 1.48 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 128.13 2.572 . . . . 1.4399999999999999 112.779 -171.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.08 -30.11 60.27 Favored Glycine 0 CA--C 1.54 1.619 0 O-C-N 119.989 -1.694 . . . . 1.8 114.649 179.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -85.81 -9.46 77.86 Favored Glycine 0 CA--C 1.539 1.549 0 N-CA-C 116.421 1.328 . . . . 1.45 116.421 -179.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 19.6 t -148.52 -38.83 0.17 Allowed 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 119.493 1.646 . . . . 2.75 114.319 -175.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 66.82 43.52 91.41 Favored Glycine 0 CA--C 1.536 1.375 0 C-N-CA 126.854 2.168 . . . . 1.1599999999999999 112.581 -165.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -94.06 -37.98 11.36 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.13 1.372 . . . . 1.76 113.594 172.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.459 ' HG3' ' CA ' ' A' ' 97' ' ' GLY . 4.0 mpp? -94.99 140.29 30.16 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 124.373 1.069 . . . . 2.8199999999999998 112.962 -175.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -145.38 143.5 30.15 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 122.393 1.092 . . . . 1.8999999999999999 113.805 175.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -100.07 119.51 38.41 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.364 1.866 . . . . 2.6699999999999999 109.911 170.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 61.6 mt -132.48 130.54 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.784 1.234 . . . . 0.84999999999999998 110.747 -161.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -117.67 125.95 51.63 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.304 1.442 . . . . 2.98 110.683 177.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.445 ' CD1' HG13 ' A' ' 84' ' ' VAL . 1.2 mt -129.35 156.37 41.79 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 C-N-CA 127.347 2.259 . . . . 0.25 109.703 174.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -155.37 133.67 11.67 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.678 1.591 . . . . 1.8200000000000001 108.704 164.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 16.9 t -159.55 140.49 12.51 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 119.811 1.187 . . . . 0.33000000000000002 112.865 -175.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -61.48 -3.6 1.05 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 127.609 2.364 . . . . 3.73 115.084 179.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -84.8 -23.6 29.07 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.901 1.68 . . . . 1.6599999999999999 113.725 173.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -79.92 9.93 4.79 Favored 'General case' 0 CA--C 1.555 1.16 0 N-CA-C 116.052 1.871 . . . . 1.6699999999999999 116.052 -165.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.89 -37.17 35.35 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 117.613 2.449 . . . . 2.8799999999999999 117.613 -163.033 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -88.63 40.53 0.97 Allowed 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 121.046 1.748 . . . . 4.3300000000000001 111.993 178.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.9 mmtp -139.71 137.16 34.93 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 125.437 1.495 . . . . 1.8400000000000001 111.823 -168.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 46.2 mtt180 -68.75 172.03 6.97 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.856 1.662 . . . . 3.6600000000000001 111.741 164.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 87.0 m -47.6 -58.34 4.37 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 125.357 1.463 . . . . 0.78000000000000003 113.425 170.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.2 p -59.48 -36.13 62.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.351 1.061 . . . . 0.54000000000000004 112.775 176.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 11.1 mt-30 -77.08 -27.34 54.22 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 113.446 0.906 . . . . 1.3600000000000001 113.446 -177.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -71.42 -54.1 11.81 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.012 0.925 . . . . 0.71999999999999997 110.33 166.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 52.6 m170 -55.08 -42.58 73.0 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.543 0.737 . . . . 0.46999999999999997 112.414 -177.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 31.0 tp60 -47.43 -42.0 21.44 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 126.201 1.801 . . . . 1.1499999999999999 113.032 177.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 63.8 mtp -66.36 -43.47 85.9 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 123.568 0.747 . . . . 1.1499999999999999 111.234 -177.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.445 HG13 ' CD1' ' A' ' 67' ' ' ILE . 2.5 t -72.27 -34.31 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 127.058 2.143 . . . . 0.22 111.654 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -63.16 -53.15 57.76 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 127.169 2.188 . . . . 0.56000000000000005 109.524 173.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.8 tm0? -65.27 -30.19 71.04 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.234 -0.916 . . . . 3.21 112.235 -177.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -55.89 -34.22 65.34 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 125.631 1.573 . . . . 0.39000000000000001 112.72 -172.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.41 -2.81 9.45 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 115.053 1.501 . . . . 0.40999999999999998 115.053 177.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 26.8 ttpt -51.15 -36.3 40.17 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.957 0.903 . . . . 1.9399999999999999 112.475 178.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -74.92 -13.73 60.57 Favored 'General case' 0 N--CA 1.439 -1.022 0 O-C-N 121.578 -0.701 . . . . 2.2400000000000002 112.269 -176.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -94.86 -49.49 5.56 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 128.466 2.706 . . . . 3.0 113.448 172.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 30.6 mt -141.02 129.35 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 127.738 2.415 . . . . 1.1299999999999999 107.938 177.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 45.7 mttp -97.66 -14.66 20.8 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 116.21 1.93 . . . . 3.2999999999999998 116.21 -170.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -79.35 68.41 5.34 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 115.354 1.613 . . . . 4.96 115.354 -160.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -70.39 1.58 4.84 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 116.471 2.026 . . . . 1.77 116.471 -178.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 22.4 t60 -54.57 -32.66 58.91 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.924 0.868 . . . . 4.4800000000000004 112.064 153.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.459 ' CA ' ' HG3' ' A' ' 62' ' ' MET . . . -83.39 -18.01 65.28 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 126.175 1.845 . . . . 0.5 116.544 -176.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 10.1 mt -93.62 139.56 30.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 118.517 1.158 . . . . 2.27 110.746 -168.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 35.5 ttt180 -123.55 95.76 4.71 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.552 1.541 . . . . 3.3999999999999999 107.91 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -114.32 135.34 54.39 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.475 0 CA-C-O 123.115 1.436 . . . . 0.46999999999999997 112.444 -161.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -127.83 114.24 16.97 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 112.178 -2.283 . . . . 2.0600000000000001 107.764 -168.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 23.4 p -127.13 150.31 49.55 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.293 1.437 . . . . 0.29999999999999999 110.566 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 2.2 p -150.7 172.73 15.11 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.222 -1.354 . . . . 0.64000000000000001 111.123 173.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.9 p -140.24 129.58 13.42 Favored Pre-proline 0 N--CA 1.472 0.628 0 C-N-CA 123.172 0.589 . . . . 0.52000000000000002 111.6 178.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -78.66 109.67 2.66 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 123.751 2.967 . . . . 0.68000000000000005 111.418 -177.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 71.7 tttt -140.98 46.7 1.75 Allowed 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.313 1.445 . . . . 3.8199999999999998 111.853 -157.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 48.0 ttp180 . . . . . 0 C--O 1.254 1.307 0 C-N-CA 127.064 2.145 . . . . 6.6699999999999999 113.331 -172.282 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.943 0 N-CA-C 110.12 -0.326 . . . . 4.9100000000000001 110.12 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.0 t -145.64 153.23 40.8 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.268 1.027 . . . . 3.3399999999999999 111.227 -177.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 96.7 mm-40 -129.96 152.99 48.82 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 122.638 1.208 . . . . 2.9900000000000002 113.018 171.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 62.6 p -121.06 161.63 21.38 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 112.532 -2.122 . . . . 0.60999999999999999 108.46 149.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -63.88 -21.15 66.32 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 120.586 -1.321 . . . . 2.7000000000000002 112.044 164.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -67.38 -39.24 91.61 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 126.875 2.179 . . . . 0.56999999999999995 113.572 173.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.25 -44.31 68.04 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.512 1.525 . . . . 1.29 111.233 173.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.4 mt -68.79 -53.92 18.87 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 125.801 1.64 . . . . 0.40000000000000002 110.935 176.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.5 ttp-105 -49.8 -50.06 46.41 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 126.617 1.967 . . . . 3.6000000000000001 111.162 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 52.0 t -68.27 -46.94 80.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 123.992 0.917 . . . . 0.28999999999999998 108.538 -178.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 98.3 m -57.93 -42.63 85.23 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 118.497 0.589 . . . . 0.39000000000000001 111.903 178.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -62.39 -35.9 80.62 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.888 0.875 . . . . 2.9300000000000002 112.449 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 62.4 mt -80.86 -31.81 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-N 118.845 0.748 . . . . 0.46000000000000002 111.019 175.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 29.6 mt -58.09 -37.58 74.78 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 120.945 -1.097 . . . . 0.40000000000000002 112.34 171.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 23.9 mttt -63.38 -22.36 66.83 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 113.539 0.94 . . . . 1.78 113.539 174.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -96.41 -36.15 10.93 Favored 'General case' 0 N--CA 1.434 -1.255 0 C-N-CA 125.994 1.717 . . . . 2.1299999999999999 114.694 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 64.9 mmtt -74.84 -28.01 60.51 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 119.668 -0.813 . . . . 1.55 111.8 171.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -130.33 50.29 5.83 Favored Pre-proline 0 CA--C 1.55 0.952 0 N-CA-C 117.65 2.463 . . . . 2.0499999999999998 117.65 -178.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -61.51 -25.47 79.63 Favored 'Trans proline' 0 C--O 1.237 0.468 0 C-N-CA 123.949 3.099 . . . . 0.94999999999999996 114.428 177.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 12.5 mmt85 -80.78 -11.35 59.62 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 114.148 1.166 . . . . 5.04 114.148 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -51.85 151.33 3.55 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 126.245 1.818 . . . . 0.44 114.725 -173.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 68.9 p -93.04 -32.21 14.57 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.976 1.31 . . . . 0.59999999999999998 111.033 169.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -124.82 139.01 54.23 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.212 1.005 . . . . 0.47999999999999998 111.992 170.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.4 pt -156.16 112.49 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 126.433 1.893 . . . . 0.56000000000000005 111.316 166.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.5 ptpt -151.88 148.3 27.64 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.916 1.286 . . . . 1.01 112.888 172.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 29.0 t -124.39 144.2 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 127.1 2.16 . . . . 0.34000000000000002 108.872 -178.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 98.9 m -132.07 127.34 35.9 Favored 'General case' 0 CA--C 1.512 -0.507 0 C-N-CA 124.732 1.213 . . . . 0.55000000000000004 109.931 172.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.82 130.44 41.07 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 124.25 1.02 . . . . 2.5800000000000001 111.009 174.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.3 pt -132.64 26.61 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 C-N-CA 126.234 1.814 . . . . 0.79000000000000004 110.77 174.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.5 t -138.14 107.97 6.3 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.931 1.293 . . . . 1.55 113.519 164.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -83.43 -18.06 65.12 Favored Glycine 0 N--CA 1.474 1.203 0 C-N-CA 124.228 0.918 . . . . 2.3999999999999999 113.821 162.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -77.36 -39.69 25.71 Favored Glycine 0 N--CA 1.467 0.746 0 C-N-CA 124.548 1.071 . . . . 1.8200000000000001 113.368 -175.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 20.8 m -145.9 -17.89 0.46 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.755 1.222 . . . . 1.73 113.284 -170.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 63.06 37.8 95.54 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 126.374 1.94 . . . . 0.97999999999999998 113.948 -178.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -101.61 -8.96 21.37 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.67 1.188 . . . . 1.6100000000000001 113.074 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 7.8 ttm -119.35 122.12 41.11 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 125.824 1.65 . . . . 1.6299999999999999 109.803 -162.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.42 ' H ' HD23 ' A' ' 98' ' ' LEU . 76.5 m-85 -146.06 147.26 31.43 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 121.859 0.838 . . . . 2.0499999999999998 112.989 -177.151 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -101.52 124.29 46.95 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.705 1.602 . . . . 2.48 109.692 173.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 95.5 mt -134.54 130.84 53.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 O-C-N 120.866 -1.146 . . . . 1.01 111.44 -165.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.5 mptt -119.8 130.45 54.93 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.529 0.732 . . . . 3.29 111.618 171.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.452 ' CD1' HG13 ' A' ' 84' ' ' VAL . 1.3 mt -129.67 159.46 41.69 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 C-N-CA 126.566 1.947 . . . . 0.29999999999999999 109.279 176.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -159.42 135.4 8.78 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 126.347 1.859 . . . . 1.8600000000000001 108.628 165.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.3 t -162.98 146.7 11.03 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 118.494 0.588 . . . . 0.42999999999999999 111.491 -176.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -51.38 -32.53 26.29 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.858 1.663 . . . . 3.6600000000000001 113.759 178.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -63.39 -20.08 65.22 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 114.838 1.422 . . . . 1.6799999999999999 114.838 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -81.45 10.96 4.96 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 114.984 1.476 . . . . 1.6299999999999999 114.984 -169.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.5 pttt -74.63 -43.84 53.45 Favored 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 115.002 1.482 . . . . 2.3300000000000001 115.002 -172.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -91.15 27.64 1.83 Allowed 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 124.894 1.278 . . . . 4.2300000000000004 111.803 -174.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -123.09 140.14 53.34 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 127.47 2.308 . . . . 1.45 111.451 -171.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 13.1 mmt85 -69.37 165.94 19.67 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.057 1.343 . . . . 2.7599999999999998 110.629 161.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 28.2 m -52.09 -53.55 41.06 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.718 1.207 . . . . 0.85999999999999999 112.986 171.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.1 p -59.55 -35.64 60.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 124.252 1.021 . . . . 0.88 113.161 175.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -74.79 -35.89 62.51 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.676 0.621 . . . . 1.21 112.676 177.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -60.26 -51.6 68.86 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 119.462 1.028 . . . . 0.69999999999999996 109.192 169.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 36.7 m170 -55.62 -46.08 77.44 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.603 0.761 . . . . 0.71999999999999997 112.982 177.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 40.1 tp60 -48.43 -45.5 36.4 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.511 1.525 . . . . 1.23 112.625 176.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 67.0 mtp -63.71 -34.73 78.53 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 119.407 1.003 . . . . 0.97999999999999998 112.792 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.452 HG13 ' CD1' ' A' ' 67' ' ' ILE . 2.8 t -78.24 -30.34 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 125.689 1.596 . . . . 0.39000000000000001 111.752 177.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -71.27 -50.9 27.95 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.266 1.826 . . . . 0.71999999999999997 110.965 174.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 27.3 tp60 -69.78 -15.01 63.05 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 125.327 1.451 . . . . 3.1499999999999999 113.784 -178.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.15 -39.93 88.05 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.575 1.15 . . . . 0.41999999999999998 112.539 173.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.86 -0.07 8.54 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 115.764 1.764 . . . . 0.35999999999999999 115.764 -177.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 27.0 ttmt -43.57 -45.24 6.59 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 125.631 1.572 . . . . 2.2000000000000002 113.147 177.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -83.19 -7.02 59.68 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-O 121.294 0.569 . . . . 2.0899999999999999 112.201 -169.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 23.6 tp10 -103.59 -41.49 5.95 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 129.55 3.14 . . . . 2.21 111.011 -176.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 44.6 mt -150.61 115.21 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 129.806 3.242 . . . . 1.1200000000000001 107.029 175.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -92.26 -4.62 53.79 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 117.336 2.347 . . . . 3.46 117.336 -169.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -82.13 33.55 0.4 Allowed 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 127.97 2.508 . . . . 2.9900000000000002 115.503 -161.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 4.4 mpp? -68.53 6.16 0.88 Allowed 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 117.639 2.459 . . . . 1.3600000000000001 117.639 -165.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 34.2 t60 -42.62 -38.67 2.09 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 121.218 -0.926 . . . . 4.2599999999999998 112.113 152.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -69.14 -16.15 70.57 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 126.294 1.902 . . . . 0.51000000000000001 117.03 -179.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.42 HD23 ' H ' ' A' ' 63' ' ' TYR . 12.4 mt -96.7 129.47 44.1 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 119.057 1.428 . . . . 2.2799999999999998 112.715 -163.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 35.9 ttt180 -111.03 87.64 2.59 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 126.912 2.085 . . . . 3.6099999999999999 107.906 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 1.7 mt -106.23 144.61 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-O 122.879 1.323 . . . . 0.47999999999999998 112.31 -166.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -137.11 132.02 33.48 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 111.748 -2.478 . . . . 2.25 108.756 -173.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 21.1 p -146.24 152.78 39.74 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 126.449 1.899 . . . . 0.32000000000000001 110.198 -173.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 2.6 p -159.51 177.92 10.43 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 124.405 1.082 . . . . 0.65000000000000002 110.97 176.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.2 p -136.86 138.8 27.04 Favored Pre-proline 0 N--CA 1.47 0.567 0 C-N-CA 124.089 0.956 . . . . 0.46000000000000002 110.412 175.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -79.04 118.02 3.98 Favored 'Trans proline' 0 CA--C 1.533 0.47 0 C-N-CA 122.828 2.352 . . . . 0.66000000000000003 110.723 174.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -153.04 31.15 0.49 Allowed 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 114.127 1.158 . . . . 2.7400000000000002 114.127 -159.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.318 0 C-N-CA 125.268 1.427 . . . . 8.2599999999999998 113.493 -178.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.734 0 N-CA-C 109.768 -0.456 . . . . 8.0600000000000005 109.768 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.1 m 54.0 48.92 20.06 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.13 1.372 . . . . 4.5300000000000002 112.901 -176.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -107.1 139.98 40.67 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 125.824 1.649 . . . . 6.2199999999999998 112.924 -175.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 79.2 p -110.38 -179.44 3.77 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.203 -1.036 . . . . 0.79000000000000004 108.203 140.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -71.63 -30.94 66.33 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 119.797 -1.815 . . . . 3.5 112.396 162.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.73 -41.21 99.57 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 124.279 0.943 . . . . 0.68999999999999995 113.281 173.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -54.14 -42.07 69.12 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.176 1.39 . . . . 1.52 112.919 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 22.5 mt -69.16 -50.67 45.59 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 125.519 1.527 . . . . 0.84999999999999998 111.323 177.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.98 -50.3 73.1 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 126.004 1.722 . . . . 2.96 110.61 -179.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 56.2 t -60.42 -47.4 92.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 108.292 -1.003 . . . . 0.31 108.292 177.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 93.0 m -58.53 -38.63 78.17 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.646 0.61 . . . . 0.65000000000000002 112.646 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.3 mm-40 -63.54 -40.23 96.49 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 118.412 0.551 . . . . 1.7 112.313 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 35.7 mt -82.02 -28.4 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 122.759 0.424 . . . . 0.67000000000000004 110.77 -175.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 11.8 mt -54.23 -37.75 64.96 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.473 -0.767 . . . . 0.71999999999999997 112.832 168.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.7 mttt -62.49 -25.27 67.92 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 114.237 1.199 . . . . 2.1299999999999999 114.237 178.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -106.14 -31.83 8.51 Favored 'General case' 0 N--CA 1.435 -1.22 0 C-N-CA 126.775 2.03 . . . . 2.4900000000000002 113.728 -167.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 53.1 mmtt -77.57 -24.84 49.71 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 118.729 -0.653 . . . . 1.46 111.713 164.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -131.71 49.54 4.77 Favored Pre-proline 0 CA--C 1.556 1.191 0 N-CA-C 118.435 2.754 . . . . 1.55 118.435 -178.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -68.07 -12.97 36.84 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 125.056 3.837 . . . . 0.82999999999999996 114.948 176.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 38.8 mtt180 -99.58 -6.73 26.88 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.195 0.998 . . . . 4.9100000000000001 113.444 175.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.41 139.91 58.56 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 125.025 1.33 . . . . 0.69999999999999996 113.141 176.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 44.2 p -75.46 -35.52 60.86 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.249 1.42 . . . . 0.89000000000000001 109.395 176.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -124.29 138.26 54.41 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.562 1.145 . . . . 0.34999999999999998 111.736 171.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.8 pt -150.22 118.46 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 125.577 1.551 . . . . 0.80000000000000004 112.522 163.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 7.8 ptpt -158.88 158.26 33.06 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.744 1.218 . . . . 1.76 114.016 177.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.7 t -126.11 155.93 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 127.766 2.426 . . . . 0.46999999999999997 111.028 -174.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 88.4 m -147.14 127.35 13.83 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 120.996 -1.065 . . . . 0.35999999999999999 111.817 162.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -69.63 126.91 31.16 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.889 0.852 . . . . 1.8600000000000001 110.568 165.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.5 pt -126.08 25.14 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 C-N-CA 126.047 1.739 . . . . 0.63 111.387 -178.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 34.9 t -132.5 62.74 1.64 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 128.308 2.643 . . . . 1.5900000000000001 109.032 176.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -54.29 -13.3 3.7 Favored Glycine 0 CA--C 1.54 1.643 0 N-CA-C 117.642 1.817 . . . . 1.73 117.642 -169.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -123.55 -6.71 7.2 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 126.31 1.91 . . . . 1.6399999999999999 115.828 -179.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -138.74 -21.75 0.99 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.212 1.405 . . . . 2.4300000000000002 114.399 -176.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 55.0 39.06 67.3 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 128.054 2.74 . . . . 0.94999999999999996 115.477 -178.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -88.05 -32.47 18.74 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.131 1.372 . . . . 1.3400000000000001 114.094 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 8.5 mtm -106.9 142.25 36.82 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.648 1.579 . . . . 1.49 112.842 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -142.46 144.09 32.88 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 122.181 0.991 . . . . 2.0099999999999998 112.539 172.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -83.05 139.46 33.24 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 126.604 1.961 . . . . 2.0699999999999998 110.076 165.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 90.6 mt -138.01 128.45 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 CA-C-N 119.39 0.996 . . . . 0.64000000000000001 110.606 170.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 77.9 mttt -113.73 126.78 55.61 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.118 1.367 . . . . 2.9500000000000002 110.943 171.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.434 ' CD1' HG13 ' A' ' 84' ' ' VAL . 1.3 mt -130.55 156.95 42.89 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 126.863 2.065 . . . . 0.31 109.938 174.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -156.8 130.86 8.43 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.332 1.453 . . . . 1.6499999999999999 109.583 166.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 32.6 t -158.26 143.6 16.66 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 119.994 1.27 . . . . 0.56999999999999995 112.019 -176.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -51.77 -24.86 6.49 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.206 1.402 . . . . 3.1000000000000001 113.52 173.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -69.51 -14.59 62.94 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 114.182 1.179 . . . . 1.73 114.182 -178.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -92.33 13.85 18.17 Favored 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 125.163 1.385 . . . . 1.71 114.266 -175.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.414 ' HB3' HG21 ' A' ' 104' ' ' VAL . 0.3 OUTLIER -79.27 -15.05 58.58 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 115.769 1.766 . . . . 3.3199999999999998 115.769 -167.717 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -123.17 29.95 6.53 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.082 1.753 . . . . 4.54 110.867 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -122.35 129.85 52.54 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 126.299 1.84 . . . . 1.27 111.053 -172.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 38.3 mtt-85 -63.52 164.41 9.47 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.852 1.261 . . . . 3.25 111.064 168.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 86.7 m -44.53 -55.89 4.76 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.933 0.893 . . . . 0.75 112.985 170.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.2 p -61.57 -37.25 77.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 124.987 1.315 . . . . 0.56999999999999995 113.164 178.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -75.66 -29.85 59.22 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 112.917 0.71 . . . . 1.0600000000000001 112.917 179.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 60.5 mt-30 -65.09 -54.8 24.44 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 119.007 0.821 . . . . 1.51 109.03 168.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 45.1 m170 -54.46 -45.31 73.09 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.952 0.901 . . . . 0.54000000000000004 112.859 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 50.5 tp60 -48.36 -43.46 33.58 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.363 1.465 . . . . 1.3899999999999999 112.912 178.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 45.5 mtp -66.32 -42.03 88.81 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 121.43 -0.794 . . . . 0.93999999999999995 111.717 -178.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.434 HG13 ' CD1' ' A' ' 67' ' ' ILE . 3.1 t -72.22 -29.7 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 125.267 1.427 . . . . 0.32000000000000001 111.773 176.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -69.23 -51.72 34.9 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 126.185 1.794 . . . . 0.89000000000000001 108.276 179.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -69.0 -19.89 64.15 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 113.748 1.018 . . . . 2.5600000000000001 113.748 -176.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.4 -41.77 80.94 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.031 0.932 . . . . 0.39000000000000001 111.652 178.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.86 -4.16 9.67 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 115.386 1.625 . . . . 0.32000000000000001 115.386 -176.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 21.9 tttt -53.32 -34.68 58.43 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 125.048 1.339 . . . . 1.95 113.45 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 67.2 mt-10 -87.27 -2.58 58.72 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 123.166 0.587 . . . . 2.3199999999999998 111.638 -174.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -100.98 -45.55 5.38 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 128.147 2.579 . . . . 3.0899999999999999 112.17 167.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 30.2 mt -145.78 110.6 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 128.003 2.521 . . . . 0.94999999999999996 107.676 178.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -86.17 -1.43 57.43 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 116.185 1.92 . . . . 2.3500000000000001 116.185 -173.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -77.19 43.39 0.37 Allowed 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 128.728 2.811 . . . . 3.5899999999999999 115.948 -164.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 4.7 mpp? -62.95 1.89 0.37 Allowed 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 114.952 1.464 . . . . 1.28 114.952 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 22.0 t60 -59.78 -26.51 65.77 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.513 1.125 . . . . 4.1399999999999997 113.21 163.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -106.37 -8.15 33.67 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 126.893 2.187 . . . . 0.46000000000000002 114.855 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.7 mp -96.38 123.52 40.05 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 118.374 1.087 . . . . 1.5900000000000001 111.55 -173.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 54.0 ttt180 -105.68 100.01 9.59 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 126.956 2.102 . . . . 3.0499999999999998 109.08 -174.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 3.6 mt -108.28 141.17 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-O 122.969 1.366 . . . . 0.42999999999999999 111.795 -169.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -130.91 123.27 28.56 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 111.695 -2.502 . . . . 1.8500000000000001 107.363 -173.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 16.2 p -136.94 140.45 42.26 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.058 1.343 . . . . 0.31 109.697 -176.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.6 t -138.01 -177.6 4.89 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 122.585 1.183 . . . . 2.2400000000000002 110.922 167.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.414 HG21 ' HB3' ' A' ' 73' ' ' LYS . 7.2 p -147.65 135.78 10.96 Favored Pre-proline 0 C--N 1.317 -0.827 0 C-N-CA 126.085 1.754 . . . . 0.55000000000000004 108.662 177.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -71.96 93.64 0.71 Allowed 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 123.018 2.478 . . . . 1.1699999999999999 110.646 175.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 56.2 tttt -150.49 79.42 1.34 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 128.564 2.746 . . . . 4.1600000000000001 107.941 -168.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 9.8 mmt180 . . . . . 0 C--O 1.254 1.312 0 C-N-CA 127.484 2.313 . . . . 12.720000000000001 111.74 -178.653 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.616 0 CA-C-O 118.515 -0.755 . . . . 6.2699999999999996 112.177 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.5 m -62.61 128.7 37.18 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-N 120.345 1.43 . . . . 3.3700000000000001 110.939 178.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -142.16 156.58 45.35 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 115.534 1.679 . . . . 2.54 115.534 -163.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 72.3 p -128.19 169.28 14.32 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 126.751 2.02 . . . . 0.55000000000000004 108.614 160.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -68.37 -16.93 64.11 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 121.027 -1.046 . . . . 2.79 113.004 165.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.99 -42.88 67.32 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 124.62 1.105 . . . . 0.46000000000000002 113.295 169.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.08 -48.88 43.91 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.488 1.915 . . . . 1.3600000000000001 111.892 173.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 24.0 mt -67.04 -51.85 49.55 Favored 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 125.755 1.622 . . . . 0.45000000000000001 111.353 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.5 ttp180 -50.45 -49.93 53.74 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 126.936 2.094 . . . . 4.5899999999999999 110.667 178.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.7 t -67.92 -46.98 80.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 108.874 -0.787 . . . . 0.34999999999999998 108.874 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 57.5 m -55.48 -40.35 71.56 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 118.324 0.511 . . . . 0.34999999999999998 112.326 178.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -61.71 -42.47 98.98 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 112.349 0.499 . . . . 1.6299999999999999 112.349 -177.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 18.5 mt -79.65 -29.37 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 CA-C-N 118.345 0.52 . . . . 0.52000000000000002 111.514 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 22.9 mt -55.55 -40.4 71.86 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 120.98 -1.075 . . . . 0.39000000000000001 113.759 172.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 42.4 mttt -59.45 -27.82 66.43 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 113.832 1.049 . . . . 1.3100000000000001 113.832 178.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -97.4 -34.22 11.12 Favored 'General case' 0 N--CA 1.431 -1.382 0 C-N-CA 127.423 2.289 . . . . 2.2200000000000002 114.233 -172.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 63.1 mmtt -74.27 -23.52 59.13 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 119.089 -1.044 . . . . 1.28 111.919 167.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -127.84 54.97 14.4 Favored Pre-proline 0 CA--C 1.554 1.101 0 N-CA-C 117.874 2.546 . . . . 1.51 117.874 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -66.87 -17.99 52.25 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 124.935 3.757 . . . . 0.81999999999999995 114.99 173.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 25.1 mmt85 -85.29 -1.18 56.69 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 113.89 1.07 . . . . 4.6600000000000001 113.89 171.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.19 149.36 50.05 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 114.3 1.222 . . . . 0.46999999999999997 114.3 -176.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 72.4 p -114.98 -4.15 12.59 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.94 1.696 . . . . 0.89000000000000001 113.418 173.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -140.73 146.31 37.59 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.422 1.089 . . . . 0.37 111.391 147.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.3 pt -154.58 117.54 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 126.381 1.872 . . . . 0.53000000000000003 111.918 169.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.4 ptpt -158.66 148.43 19.41 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.918 1.287 . . . . 1.04 114.041 178.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.2 t -126.52 150.48 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 C-N-CA 126.834 2.053 . . . . 0.29999999999999999 111.287 -173.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 98.1 m -143.57 135.41 26.51 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.502 0.721 . . . . 0.40000000000000002 112.371 171.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -77.62 126.0 30.2 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 122.131 0.967 . . . . 1.9199999999999999 111.012 168.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.0 pt -124.05 29.47 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 C-N-CA 126.151 1.781 . . . . 0.55000000000000004 110.978 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.528 ' HB2' ' H ' ' A' ' 62' ' ' MET . 29.8 t -135.69 58.53 1.75 Allowed 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 128.214 2.606 . . . . 1.28 111.453 -174.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -65.27 14.77 0.21 Allowed Glycine 0 CA--C 1.537 1.444 0 N-CA-C 117.794 1.877 . . . . 2.1200000000000001 117.794 -174.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -135.81 0.3 3.33 Favored Glycine 0 CA--C 1.537 1.407 0 C-N-CA 125.803 1.668 . . . . 1.1799999999999999 114.085 175.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 36.7 t -151.61 -38.62 0.12 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.958 1.303 . . . . 1.5700000000000001 113.568 -177.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 67.19 38.5 92.02 Favored Glycine 0 CA--C 1.541 1.678 0 C-N-CA 126.37 1.938 . . . . 0.77000000000000002 114.67 -165.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -93.71 -20.32 20.25 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 127.242 2.217 . . . . 0.95999999999999996 115.382 176.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.528 ' H ' ' HB2' ' A' ' 56' ' ' SER . 6.1 mtm -111.38 139.91 46.4 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.643 1.577 . . . . 1.3 112.862 172.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -139.96 150.0 43.97 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.875 0.87 . . . . 1.8600000000000001 112.376 172.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -86.74 139.87 30.3 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 125.363 1.465 . . . . 2.3100000000000001 110.126 163.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 90.1 mt -134.34 127.34 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 124.242 1.017 . . . . 0.63 109.606 168.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -117.34 122.74 44.72 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.522 1.129 . . . . 2.46 109.259 171.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.408 ' CD1' HG13 ' A' ' 84' ' ' VAL . 1.2 mt -126.81 157.63 37.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 127.089 2.155 . . . . 0.26000000000000001 109.196 177.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -155.27 131.42 10.2 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 125.706 1.602 . . . . 1.9299999999999999 107.69 168.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 28.7 t -156.82 143.05 18.12 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 120.304 1.411 . . . . 0.41999999999999998 112.327 -173.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -63.91 -10.43 20.89 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 114.767 1.395 . . . . 2.9399999999999999 114.767 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -79.51 -17.52 53.91 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 113.953 1.094 . . . . 1.8300000000000001 113.953 174.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -84.19 1.23 45.48 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 114.556 1.317 . . . . 1.95 114.556 -167.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.417 ' HB3' HG21 ' A' ' 104' ' ' VAL . 30.1 pttt -79.77 -22.97 42.53 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 115.306 1.595 . . . . 3.8599999999999999 115.306 -171.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -97.89 19.25 14.15 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-O 121.987 0.899 . . . . 4.0 111.794 178.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 44.1 mmtt -120.48 139.66 52.55 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 128.079 2.552 . . . . 1.4299999999999999 111.16 -175.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 17.0 mtm180 -66.15 164.48 15.53 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.335 1.054 . . . . 5.2000000000000002 111.197 161.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.1 m -46.66 -54.19 10.08 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 113.781 1.03 . . . . 0.68000000000000005 113.781 170.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 9.4 p -59.5 -37.01 67.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 123.685 0.794 . . . . 0.57999999999999996 112.053 176.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -77.65 -16.81 58.28 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 114.104 1.15 . . . . 1.01 114.104 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -77.87 -55.12 5.58 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 119.45 1.023 . . . . 0.63 109.658 166.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 44.7 m170 -54.12 -46.62 72.22 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.328 1.051 . . . . 0.53000000000000003 113.178 -177.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 53.2 tp60 -47.79 -40.61 21.36 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.426 1.89 . . . . 1.3600000000000001 113.165 177.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 64.5 mtp -66.78 -44.27 81.79 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.468 1.107 . . . . 0.95999999999999996 111.596 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.408 HG13 ' CD1' ' A' ' 67' ' ' ILE . 2.9 t -69.49 -31.0 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 126.162 1.785 . . . . 0.27000000000000002 110.955 178.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -68.87 -52.27 31.48 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.058 1.743 . . . . 0.5 110.176 174.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.04 -28.37 62.48 Favored 'General case' 0 CA--C 1.546 0.808 0 O-C-N 120.679 -1.263 . . . . 2.1899999999999999 111.848 178.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.66 -33.83 76.5 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.741 1.216 . . . . 0.37 112.892 -173.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.46 -7.88 8.63 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 114.473 1.286 . . . . 0.44 114.473 177.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 32.0 ttpt -46.47 -43.51 16.73 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 124.454 1.102 . . . . 2.5299999999999998 112.369 176.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -77.96 -4.05 45.03 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-O 121.645 0.736 . . . . 2.3799999999999999 112.055 -169.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -111.79 -45.41 3.35 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 129.991 3.317 . . . . 2.2599999999999998 111.154 -176.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 40.3 mt -144.85 124.95 7.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 129.001 2.92 . . . . 1.1499999999999999 107.283 177.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -96.09 -10.93 27.15 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 115.317 1.599 . . . . 3.3999999999999999 115.317 -174.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . 0.27 19.0 pt-20 -77.12 43.31 0.36 Allowed 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 116.38 1.993 . . . . 4.6399999999999997 116.38 -162.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 59.1 mtm -71.32 -1.61 13.44 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.65 1.98 . . . . 1.53 115.948 -167.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 6.9 p-80 -60.19 -20.36 58.3 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 121.335 -0.853 . . . . 4.8399999999999999 112.904 159.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -87.63 -12.94 65.98 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 125.43 1.491 . . . . 0.59999999999999998 115.176 169.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.6 mp -100.08 116.47 32.18 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 118.381 1.091 . . . . 1.72 112.268 -168.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 17.6 ttm180 -98.13 103.55 15.51 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 126.505 1.922 . . . . 4.8799999999999999 110.081 -175.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 2.9 mt -108.56 145.48 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 123.548 1.642 . . . . 0.39000000000000001 112.933 -171.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -139.43 120.97 15.15 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 111.048 -2.796 . . . . 1.95 107.825 -171.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 21.2 p -133.6 152.03 51.81 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 126.242 1.817 . . . . 0.27000000000000002 110.025 -177.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 10.4 p -157.41 179.3 9.38 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.931 -1.031 . . . . 0.64000000000000001 111.187 173.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.417 HG21 ' HB3' ' A' ' 73' ' ' LYS . 7.4 p -144.21 133.73 11.56 Favored Pre-proline 0 N--CA 1.47 0.572 0 N-CA-C 113.197 0.814 . . . . 0.51000000000000001 113.197 -177.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.98 112.28 3.48 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.773 2.315 . . . . 0.59999999999999998 109.456 173.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -135.98 97.29 3.59 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.935 1.694 . . . . 4.3099999999999996 109.098 -164.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 . . . . . 0 C--O 1.252 1.214 0 CA-C-O 115.888 -2.006 . . . . 10.68 115.7 -171.928 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.85 0 CA-C-O 118.054 -0.974 . . . . 4.8300000000000001 112.708 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . 0.299 3.2 t 54.29 175.77 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 127.147 2.179 . . . . 3.5 115.829 -174.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -151.9 150.63 30.29 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 127.088 2.155 . . . . 1.96 109.759 -177.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 23.1 p -115.55 164.24 14.6 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.517 1.127 . . . . 0.89000000000000001 110.662 170.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -65.42 -32.77 74.58 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 120.77 -1.206 . . . . 2.8900000000000001 111.377 174.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.02 -35.12 90.97 Favored Glycine 0 C--O 1.218 -0.875 0 CA-C-O 118.578 -1.123 . . . . 0.41999999999999998 112.251 172.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.38 -50.93 64.07 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 119.94 1.87 . . . . 1.26 111.825 174.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 15.2 mt -69.8 -50.37 43.66 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 125.657 1.583 . . . . 0.57999999999999996 110.615 -176.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.38 -48.35 79.28 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 126.135 1.774 . . . . 3.1499999999999999 111.533 177.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 29.6 t -62.84 -44.03 99.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 107.875 -1.157 . . . . 0.35999999999999999 107.875 178.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 47.2 m -58.05 -40.38 80.8 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 118.575 0.625 . . . . 0.41999999999999998 112.084 177.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 9.9 mm-40 -64.42 -45.2 88.59 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.634 0.605 . . . . 1.8999999999999999 112.634 -179.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 41.1 mt -72.04 -30.95 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-N 118.143 0.429 . . . . 0.63 109.866 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 37.5 mt -60.48 -37.73 81.98 Favored 'General case' 0 CA--C 1.531 0.237 0 O-C-N 120.925 -1.109 . . . . 0.47999999999999998 113.487 173.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 34.3 mttt -64.68 -25.88 68.14 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 113.596 0.961 . . . . 1.45 113.596 175.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -87.08 -39.91 15.16 Favored 'General case' 0 N--CA 1.433 -1.325 0 C-N-CA 125.769 1.627 . . . . 2.21 113.404 176.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 62.4 mmtt -74.95 -25.51 58.93 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 119.342 -0.943 . . . . 1.48 112.067 175.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -128.11 49.69 4.71 Favored Pre-proline 0 CA--C 1.55 0.975 0 N-CA-C 119.112 3.004 . . . . 2.1099999999999999 119.112 -179.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -67.72 -12.84 36.86 Favored 'Trans proline' 0 CA--C 1.534 0.489 0 C-N-CA 124.718 3.612 . . . . 0.72999999999999998 115.268 175.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 12.3 mmm180 -76.18 -16.49 59.84 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 114.124 1.157 . . . . 7.0099999999999998 114.124 169.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.94 152.48 43.1 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 115.892 1.812 . . . . 0.41999999999999998 115.892 -166.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 30.9 p -100.24 -22.95 14.95 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 118.019 -0.991 . . . . 0.63 112.374 168.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -126.11 141.41 51.95 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 119.932 1.242 . . . . 0.31 111.53 161.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.4 pt -157.6 103.31 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 127.23 2.212 . . . . 0.56000000000000005 110.337 171.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.5 ptpt -152.3 157.21 41.04 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.163 1.385 . . . . 1.1399999999999999 113.097 -175.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 23.7 t -137.72 144.57 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 126.639 1.976 . . . . 0.40999999999999998 110.548 -169.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.405 ' HB ' ' HB3' ' A' ' 64' ' ' GLU . 88.6 m -134.67 126.29 28.81 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 108.989 -0.745 . . . . 0.40999999999999998 108.989 165.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -70.67 133.83 46.99 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.474 0.654 . . . . 2.1499999999999999 109.755 167.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . 0.261 2.9 pt -127.7 34.9 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 C-N-CA 126.373 1.869 . . . . 0.85999999999999999 109.188 173.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 36.4 p -144.72 42.57 1.35 Allowed 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 128.281 2.632 . . . . 2.77 116.766 -174.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -51.26 -22.42 7.06 Favored Glycine 0 CA--C 1.546 2.02 0 N-CA-C 118.399 2.119 . . . . 2.0299999999999998 118.399 -176.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -110.28 -0.02 29.68 Favored Glycine 0 CA--C 1.541 1.7 0 C-N-CA 126.406 1.955 . . . . 1.28 115.37 177.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 7.8 t -132.99 -40.79 0.92 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.544 1.138 . . . . 1.8799999999999999 113.756 -176.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 57.88 47.83 86.29 Favored Glycine 0 CA--C 1.536 1.396 0 C-N-CA 128.348 2.88 . . . . 1.1799999999999999 113.535 -167.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -124.41 18.02 8.95 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.794 1.238 . . . . 1.04 114.024 -179.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 8.5 ttm -153.07 122.77 6.83 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.757 1.223 . . . . 1.78 112.097 -170.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -141.97 148.21 38.21 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.989 0.899 . . . . 1.8700000000000001 113.413 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.405 ' HB3' ' HB ' ' A' ' 53' ' ' THR . 7.8 tt0 -93.18 114.3 26.75 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.627 1.971 . . . . 2.3799999999999999 109.732 168.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 83.0 mt -125.46 123.78 65.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 CA-C-N 120.125 1.33 . . . . 0.70999999999999996 110.625 -170.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 71.7 mttt -125.26 119.52 28.67 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.871 1.269 . . . . 2.6400000000000001 111.011 -172.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.449 ' CD1' HG13 ' A' ' 84' ' ' VAL . 1.3 mt -130.02 153.33 38.74 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 127.158 2.183 . . . . 0.26000000000000001 109.93 -176.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -154.22 127.96 8.75 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.125 1.37 . . . . 1.8500000000000001 108.733 166.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 23.0 t -159.33 142.26 14.21 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 120.383 1.447 . . . . 0.29999999999999999 112.657 -172.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -50.65 -31.41 16.12 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.544 1.137 . . . . 2.73 112.522 178.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -66.98 -10.73 52.63 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 114.644 1.35 . . . . 1.6599999999999999 114.644 -175.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -95.71 10.28 37.47 Favored 'General case' 0 CA--C 1.557 1.217 0 N-CA-C 116.194 1.924 . . . . 2.0899999999999999 116.194 -175.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.443 ' HA ' HG11 ' A' ' 104' ' ' VAL . 0.1 OUTLIER -71.8 -37.15 70.45 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-N 120.775 1.625 . . . . 2.8799999999999999 115.139 -172.073 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -86.19 13.29 8.14 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.575 1.55 . . . . 3.3599999999999999 112.266 -174.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 51.4 mmtt -127.67 131.21 49.84 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.586 1.554 . . . . 2.23 112.951 -159.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 19.1 mmt180 -63.53 163.33 11.27 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.351 1.46 . . . . 5.2699999999999996 111.561 166.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 41.3 m -43.5 -55.52 4.17 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 125.498 1.519 . . . . 1.03 114.167 168.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 9.9 p -59.85 -38.35 75.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 N-CA-C 113.579 0.955 . . . . 0.51000000000000001 113.579 175.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -74.83 -32.45 61.94 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.308 0.643 . . . . 1.05 112.277 -177.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -66.44 -54.29 25.9 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.314 1.046 . . . . 0.64000000000000001 109.81 168.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 46.6 m170 -52.83 -44.77 66.95 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.886 1.274 . . . . 0.51000000000000001 112.951 -178.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 41.3 tp60 -53.34 -39.76 64.37 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.801 1.24 . . . . 1.2 112.821 178.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 4.7 mtm -66.38 -41.44 89.38 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 121.262 -0.899 . . . . 1.51 111.302 179.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.449 HG13 ' CD1' ' A' ' 67' ' ' ILE . 2.3 t -72.39 -26.45 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 125.243 1.417 . . . . 0.28999999999999998 111.914 178.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -70.1 -56.16 7.61 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 126.046 1.739 . . . . 0.82999999999999996 109.148 175.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.98 -6.42 42.0 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.101 1.149 . . . . 2.79 114.101 -178.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.02 -33.83 76.99 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 120.945 -1.097 . . . . 0.47999999999999998 112.738 169.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.24 -0.64 2.01 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 115.489 1.663 . . . . 0.40000000000000002 115.489 -176.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 34.9 tttt -50.26 -38.36 40.45 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 125.175 1.39 . . . . 2.2000000000000002 113.016 177.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -75.31 -18.44 60.03 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-O 121.514 0.673 . . . . 1.8899999999999999 111.413 -177.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -88.72 -51.98 5.38 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 129.126 2.971 . . . . 2.4300000000000002 110.991 177.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 32.9 mt -147.61 114.48 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 128.467 2.707 . . . . 1.02 108.327 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.4 tmtp? -92.28 -7.62 47.55 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 114.87 1.433 . . . . 4.0999999999999996 114.87 -163.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -70.43 57.42 0.17 Allowed 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 129.681 3.192 . . . . 3.1299999999999999 115.477 -164.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . 0.273 1.3 mpt? -75.84 3.63 9.62 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 119.311 -2.118 . . . . 1.8400000000000001 116.483 -178.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 73.2 t60 -59.21 -30.28 68.11 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 121.235 -0.916 . . . . 4.6900000000000004 112.371 151.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -83.56 -30.44 29.97 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 127.886 2.66 . . . . 0.5 116.457 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.0 mt -89.31 120.62 30.82 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 122.856 1.312 . . . . 2.1800000000000002 111.415 -164.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 14.6 ttm180 -106.82 99.23 8.82 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 112.797 -2.001 . . . . 5.2800000000000002 106.502 -179.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 1.4 mt -113.3 140.41 33.59 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.457 0 CA-C-O 122.845 1.307 . . . . 0.57999999999999996 111.105 -165.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -135.14 117.21 15.37 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 111.907 -2.406 . . . . 1.99 107.445 -166.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 18.5 p -134.89 147.52 49.87 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.221 1.808 . . . . 0.27000000000000002 110.145 -175.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.9 p -153.42 179.02 9.16 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.052 -1.431 . . . . 0.58999999999999997 110.319 174.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.443 HG11 ' HA ' ' A' ' 73' ' ' LYS . 6.5 p -145.82 133.26 10.26 Favored Pre-proline 0 N--CA 1.469 0.481 0 O-C-N 121.572 -0.705 . . . . 0.38 111.801 -178.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -77.71 123.98 6.67 Favored 'Trans proline' 0 N--CA 1.448 -1.205 0 C-N-CA 122.721 2.281 . . . . 1.01 108.911 166.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -141.88 64.93 1.38 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.673 1.589 . . . . 3.2200000000000002 108.693 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 63.1 ttt-85 . . . . . 0 C--O 1.254 1.297 0 C-N-CA 125.785 1.634 . . . . 7.1799999999999997 111.966 177.305 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.78 0 N-CA-C 111.935 0.346 . . . . 6.29 111.935 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . 0.32 1.0 OUTLIER 51.79 11.22 0.13 Allowed 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 128.797 2.839 . . . . 3.9500000000000002 117.593 179.647 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.8 mp0 -54.34 131.52 42.14 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 126.067 1.747 . . . . 2.3300000000000001 115.228 -177.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 59.2 p -87.13 165.35 15.81 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 114.863 -1.062 . . . . 0.60999999999999999 110.492 156.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -64.54 -27.68 69.13 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 120.936 -1.103 . . . . 4.29 111.875 168.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.54 -38.68 96.04 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 126.119 1.818 . . . . 0.45000000000000001 113.379 170.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.79 -43.18 72.62 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.291 1.546 . . . . 2.1299999999999999 112.014 174.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 11.7 mt -69.17 -52.04 31.97 Favored 'General case' 0 N--CA 1.462 0.129 0 C-N-CA 125.573 1.549 . . . . 0.35999999999999999 111.005 178.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -53.48 -49.75 66.82 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 126.923 2.089 . . . . 3.4199999999999999 110.874 178.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 38.1 t -67.4 -45.04 86.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 108.75 -0.833 . . . . 0.31 108.75 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 68.4 m -53.98 -43.55 70.05 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 118.511 0.596 . . . . 0.37 112.392 175.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -62.89 -43.65 98.21 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 118.593 0.633 . . . . 1.8 111.734 -176.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 53.2 mt -71.6 -29.86 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 123.312 0.645 . . . . 0.78000000000000003 110.323 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 53.2 mt -64.93 -41.44 95.52 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 120.655 -1.278 . . . . 0.62 113.269 171.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 38.7 mttt -62.19 -19.43 63.11 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-N 119.544 1.066 . . . . 1.77 113.852 174.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -95.91 -37.95 10.48 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 126.315 1.846 . . . . 2.3100000000000001 114.832 -178.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -78.38 -22.1 48.38 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 118.675 -0.678 . . . . 1.1100000000000001 112.492 170.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -133.07 50.07 5.13 Favored Pre-proline 0 CA--C 1.548 0.902 0 N-CA-C 118.854 2.909 . . . . 1.54 118.854 -179.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -62.98 -26.42 74.08 Favored 'Trans proline' 0 CA--C 1.534 0.516 0 C-N-CA 123.48 2.786 . . . . 1.0 115.842 177.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 27.0 mmm180 -76.97 -12.85 60.0 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 120.387 1.449 . . . . 7.3499999999999996 114.61 176.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -53.8 144.92 17.08 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.925 1.29 . . . . 0.62 114.159 -175.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 44.3 p -97.4 -22.5 16.57 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.473 1.109 . . . . 0.56999999999999995 111.984 176.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -123.4 138.39 54.61 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.942 0.897 . . . . 0.40999999999999998 110.321 157.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -154.35 105.97 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 124.841 1.256 . . . . 0.62 110.361 169.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.9 ptpt -150.05 154.75 38.68 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.025 1.33 . . . . 1.21 112.814 -179.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.9 t -129.95 148.27 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 126.785 2.034 . . . . 0.44 109.632 -178.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 55.2 m -135.42 132.91 38.06 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 118.465 0.575 . . . . 0.48999999999999999 110.244 161.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -72.51 134.34 45.24 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 122.037 0.922 . . . . 1.79 109.767 167.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . 0.257 1.8 pt -127.7 33.39 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 125.57 1.548 . . . . 0.53000000000000003 109.787 174.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.2 p -141.55 63.93 1.42 Allowed 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 127.087 2.155 . . . . 2.4399999999999999 114.362 -177.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -58.03 -19.05 36.32 Favored Glycine 0 CA--C 1.543 1.819 0 N-CA-C 116.326 1.29 . . . . 1.25 116.326 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -108.86 -5.55 31.03 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 125.74 1.638 . . . . 0.95999999999999996 116.63 -178.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 1.3 m -152.11 -15.86 0.18 Allowed 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 115.2 1.555 . . . . 1.77 115.2 -177.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 51.75 38.93 45.88 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 127.246 2.355 . . . . 0.81000000000000005 114.995 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -110.76 6.5 21.53 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.116 1.366 . . . . 1.21 113.236 -175.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 15.0 ttm -140.48 121.07 14.22 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.714 2.006 . . . . 1.9199999999999999 110.497 -161.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.418 ' HB2' HD22 ' A' ' 98' ' ' LEU . 78.2 m-85 -143.36 146.33 33.43 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 113.815 1.043 . . . . 1.9199999999999999 113.815 -174.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -90.88 114.15 26.52 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.901 1.68 . . . . 2.6299999999999999 109.417 167.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 95.9 mt -120.55 123.66 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 O-C-N 120.762 -1.211 . . . . 0.63 109.565 -175.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 75.7 mttt -124.28 111.23 15.58 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.78 1.232 . . . . 2.6499999999999999 110.254 -174.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.3 mt -120.46 155.26 23.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 127.445 2.298 . . . . 0.23999999999999999 109.052 -178.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -153.66 130.49 10.89 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.186 1.394 . . . . 1.8500000000000001 107.291 162.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.6 t -155.3 140.75 17.78 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 120.107 1.321 . . . . 0.32000000000000001 112.352 -173.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -61.91 -6.6 2.91 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.621 1.568 . . . . 3.8900000000000001 115.111 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -84.68 -14.58 48.06 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.733 1.613 . . . . 1.77 114.207 175.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -87.13 12.03 12.51 Favored 'General case' 0 CA--C 1.559 1.302 0 N-CA-C 114.37 1.248 . . . . 2.0299999999999998 114.37 -175.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.412 ' HB3' HG21 ' A' ' 104' ' ' VAL 0.252 0.0 OUTLIER -76.83 -14.62 59.89 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 117.225 2.305 . . . . 2.54 117.225 -166.476 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -118.29 25.33 10.38 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.341 1.456 . . . . 4.8799999999999999 111.253 169.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 52.3 mmtt -112.61 131.36 55.66 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.544 1.538 . . . . 1.3799999999999999 111.868 177.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 36.1 mtt180 -65.71 161.69 20.16 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.667 1.187 . . . . 3.77 111.071 163.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 54.1 m -38.04 -55.56 1.24 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 126.356 1.862 . . . . 0.92000000000000004 113.799 168.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.5 p -63.86 -40.34 88.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 125.212 1.405 . . . . 0.85999999999999999 113.598 178.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -71.92 -32.3 67.22 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 121.619 -0.675 . . . . 1.01 111.573 178.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -63.79 -53.45 50.62 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.568 0.747 . . . . 0.64000000000000001 109.885 169.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 62.8 m170 -49.94 -52.35 34.06 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.796 0.838 . . . . 0.75 111.968 178.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 23.4 tp60 -46.9 -44.33 19.62 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.037 1.735 . . . . 1.23 113.134 178.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 85.0 mtp -62.33 -43.51 98.66 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 119.159 0.89 . . . . 0.92000000000000004 112.516 178.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.6 t -71.7 -27.41 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 C-N-CA 125.647 1.579 . . . . 0.23000000000000001 112.146 178.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -74.31 -50.67 17.87 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.525 1.93 . . . . 0.46999999999999997 109.381 177.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 12.5 mm-40 -65.56 -18.66 65.49 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.378 1.471 . . . . 2.54 113.635 178.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.69 -44.67 85.99 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 119.337 0.971 . . . . 0.78000000000000003 111.056 179.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.11 5.66 9.22 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 115.513 1.672 . . . . 0.67000000000000004 115.513 -174.204 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.5 ttmt -51.67 -40.23 59.66 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 125.037 1.335 . . . . 3.1699999999999999 113.136 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -81.68 10.32 6.31 Favored 'General case' 0 CA--C 1.554 1.126 0 CA-C-O 122.121 0.962 . . . . 2.3999999999999999 113.347 -174.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -126.84 -56.26 1.37 Allowed 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 129.443 3.097 . . . . 3.1200000000000001 108.652 -176.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -128.57 120.97 53.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 126.872 2.069 . . . . 1.54 108.371 165.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -105.75 1.69 27.28 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 119.919 -1.738 . . . . 2.6299999999999999 114.812 -179.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.3 mp0 -71.88 47.01 0.14 Allowed 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 130.573 3.549 . . . . 3.25 115.332 -173.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . 0.254 2.1 mpt? -72.35 12.75 0.41 Allowed 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 116.703 2.112 . . . . 1.78 116.703 -173.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 39.8 p-80 -63.39 -28.4 69.96 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.366 -0.834 . . . . 4.1100000000000003 112.083 154.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -77.94 -22.61 68.44 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 115.916 1.126 . . . . 0.45000000000000001 115.916 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.418 HD22 ' HB2' ' A' ' 63' ' ' TYR . 10.1 mt -92.06 136.02 33.51 Favored 'General case' 0 C--O 1.238 0.463 0 O-C-N 120.813 -1.404 . . . . 2.1499999999999999 111.222 -164.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 15.3 ttt180 -114.63 105.49 13.12 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.686 1.594 . . . . 3.73 106.896 169.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 1.5 mt -114.41 137.47 47.64 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.648 0 CA-C-O 123.098 1.427 . . . . 0.44 111.005 -169.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -130.54 123.72 30.24 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-N 111.769 -2.468 . . . . 1.8799999999999999 106.628 -169.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 17.3 p -140.86 152.68 45.29 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 126.237 1.815 . . . . 0.28999999999999998 109.217 -175.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -161.05 173.88 14.56 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.296 -0.866 . . . . 0.69999999999999996 110.481 176.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.412 HG21 ' HB3' ' A' ' 73' ' ' LYS . 12.5 p -141.84 133.71 13.54 Favored Pre-proline 0 N--CA 1.468 0.467 0 O-C-N 121.329 -0.857 . . . . 0.59999999999999998 111.962 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -77.45 103.45 1.73 Allowed 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.081 1.854 . . . . 0.85999999999999999 110.615 174.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 71.4 tttt -146.87 93.81 2.33 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.428 1.891 . . . . 3.7200000000000002 110.515 -169.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 4.0 ptp180 . . . . . 0 C--O 1.253 1.251 0 C-N-CA 126.573 1.949 . . . . 6.6699999999999999 114.856 176.498 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.723 0 N-CA-C 110.194 -0.299 . . . . 4.46 110.194 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . 0.317 1.5 t 54.93 -4.62 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 117.924 2.565 . . . . 5.4400000000000004 117.924 -172.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 62.69 153.12 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 127.251 2.22 . . . . 2.4900000000000002 115.128 176.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 66.9 p -100.93 170.18 8.47 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 121.128 -0.982 . . . . 0.59999999999999998 109.897 159.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 -70.07 -29.48 66.49 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 120.436 -1.415 . . . . 3.8599999999999999 111.902 163.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -66.54 -38.14 93.15 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 124.282 0.944 . . . . 0.35999999999999999 113.139 177.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.94 -44.27 50.39 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.449 1.499 . . . . 1.98 111.539 172.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.4 mt -70.26 -51.87 27.32 Favored 'General case' 0 C--N 1.337 0.046 0 C-N-CA 125.479 1.512 . . . . 0.40000000000000002 110.747 -178.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.87 -48.93 76.97 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.904 1.682 . . . . 3.0600000000000001 110.865 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.8 t -65.54 -45.25 93.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 108.435 -0.95 . . . . 0.34000000000000002 108.435 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 98.7 m -56.92 -41.32 77.96 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 118.687 0.676 . . . . 0.38 112.411 176.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -63.86 -42.52 97.52 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 112.753 0.649 . . . . 2.04 112.753 -178.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 32.2 mt -75.45 -30.25 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 CA-C-N 118.629 0.649 . . . . 0.47999999999999998 110.462 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 44.0 mt -60.14 -40.35 89.48 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 120.779 -1.2 . . . . 0.67000000000000004 113.34 171.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 27.2 mttt -60.73 -24.95 66.09 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 119.338 0.972 . . . . 1.8500000000000001 113.391 176.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -94.62 -35.38 12.24 Favored 'General case' 0 N--CA 1.434 -1.236 0 C-N-CA 126.895 2.078 . . . . 1.96 115.066 -178.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 56.8 mmtt -75.89 -22.77 55.79 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 119.735 -0.786 . . . . 1.3100000000000001 111.856 170.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -130.19 51.39 7.45 Favored Pre-proline 0 CA--C 1.551 1.002 0 N-CA-C 118.428 2.751 . . . . 1.6200000000000001 118.428 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -67.66 -18.88 48.28 Favored 'Trans proline' 0 CA--C 1.534 0.507 0 C-N-CA 124.457 3.438 . . . . 0.62 115.099 176.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.96 -5.01 58.9 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 114.861 1.43 . . . . 5.6600000000000001 114.861 172.029 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.09 146.73 52.63 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 113.615 0.968 . . . . 0.40999999999999998 113.615 -178.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 60.9 p -93.34 -32.76 14.16 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.331 -0.849 . . . . 0.68000000000000005 111.06 172.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -117.63 137.88 52.34 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.046 0.938 . . . . 0.31 111.527 165.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -156.03 108.16 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 126.685 1.994 . . . . 0.60999999999999999 109.919 171.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.1 ptpt -152.37 157.83 41.84 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.813 1.645 . . . . 1.05 113.618 178.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.3 t -132.67 151.68 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 126.051 1.74 . . . . 0.34999999999999998 110.763 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 89.8 m -141.1 125.22 17.3 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 120.31 -1.493 . . . . 0.40999999999999998 110.846 169.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -67.44 135.3 52.91 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.809 0.814 . . . . 1.77 109.838 168.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.3 pt -134.34 19.93 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 124.909 1.284 . . . . 0.64000000000000001 111.76 178.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.3 t -123.05 83.42 2.12 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 127.316 2.246 . . . . 1.3400000000000001 111.399 176.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -73.2 9.22 7.39 Favored Glycine 0 N--CA 1.476 1.363 0 O-C-N 120.325 -1.484 . . . . 1.8500000000000001 115.212 -177.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -129.12 -12.98 2.48 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 126.452 1.977 . . . . 1.23 114.046 -175.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 7.2 t -151.41 -18.04 0.2 Allowed 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 118.575 1.187 . . . . 1.99 114.055 175.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 54.93 37.55 62.76 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 124.686 1.136 . . . . 0.90000000000000002 111.984 -163.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -91.97 1.83 56.94 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.295 1.438 . . . . 0.92000000000000004 113.184 178.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 1.4 mtp -134.31 141.46 46.94 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 126.179 1.792 . . . . 2.0099999999999998 112.396 175.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.436 ' H ' HD23 ' A' ' 98' ' ' LEU . 95.4 m-85 -142.62 145.37 33.43 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 122.021 0.915 . . . . 2.0099999999999998 112.363 173.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -80.86 133.74 35.64 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 125.897 1.679 . . . . 1.8200000000000001 108.573 161.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.5 mt -137.34 122.7 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 CA-C-N 119.464 1.029 . . . . 0.59999999999999998 108.911 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 70.3 mttt -124.73 112.05 16.28 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.29 1.036 . . . . 2.7599999999999998 110.183 -175.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.3 mt -121.96 155.93 26.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 126.858 2.063 . . . . 0.28000000000000003 109.061 -177.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -156.06 126.72 6.8 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.453 1.501 . . . . 2.0600000000000001 107.598 165.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.4 t -156.84 147.93 22.0 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 119.932 1.242 . . . . 0.38 112.417 -173.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -57.48 -28.11 63.1 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.245 1.418 . . . . 4.0199999999999996 113.019 -174.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -69.78 -18.22 63.47 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 115.039 1.496 . . . . 1.75 115.039 177.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -80.94 13.84 2.5 Favored 'General case' 0 CA--C 1.545 0.759 0 O-C-N 121.102 -0.999 . . . . 1.6299999999999999 113.215 -176.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 50.7 pttt -78.74 -27.68 44.79 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.157 1.383 . . . . 2.7599999999999998 113.348 176.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -109.11 33.7 4.13 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.12 1.768 . . . . 4.8300000000000001 111.875 -167.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 65.4 mmtt -139.56 141.64 37.2 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 126.897 2.079 . . . . 1.78 111.407 -169.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 6.6 mmt180 -65.88 168.78 7.49 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.668 1.187 . . . . 3.8300000000000001 110.872 162.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 94.7 m -54.97 -53.91 49.62 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 113.036 0.754 . . . . 1.22 113.036 170.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 10.1 p -57.4 -40.46 74.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 123.216 0.606 . . . . 0.92000000000000004 111.681 176.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -68.64 -32.36 72.16 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.2 0.815 . . . . 2.0600000000000001 113.2 178.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 -62.41 -52.08 65.0 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.556 1.071 . . . . 1.9199999999999999 109.924 170.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 33.1 m170 -58.21 -50.08 74.8 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 118.944 0.793 . . . . 0.78000000000000003 112.64 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -54.15 -40.95 67.9 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 124.706 1.202 . . . . 4.25 113.937 178.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 1.1 mmm -61.97 -34.6 76.44 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 120.403 1.456 . . . . 1.55 111.657 -178.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.1 t -79.32 -32.04 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 127.122 2.169 . . . . 0.31 111.347 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -67.7 -46.51 72.03 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.347 1.459 . . . . 0.89000000000000001 111.312 170.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 55.0 tp60 -65.73 -25.76 67.44 Favored 'General case' 0 N--CA 1.445 -0.687 0 O-C-N 120.373 -1.454 . . . . 2.6099999999999999 113.847 -177.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.87 -30.99 69.36 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.451 1.5 . . . . 0.34999999999999998 112.521 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -127.13 1.14 6.48 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 115.492 1.664 . . . . 0.60999999999999999 115.492 177.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 31.2 ttmt -46.54 -43.3 16.93 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.443 1.497 . . . . 2.1200000000000001 112.413 175.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -81.74 -18.86 42.79 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-O 121.362 0.601 . . . . 2.1699999999999999 111.509 -171.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -88.9 -49.52 6.75 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 127.995 2.518 . . . . 2.3399999999999999 111.197 -178.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 51.0 mt -147.36 101.06 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 127.544 2.338 . . . . 1.3600000000000001 108.115 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.3 ptmm? -79.21 -7.57 58.34 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 116.551 2.056 . . . . 2.7400000000000002 116.551 -166.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -79.19 44.03 0.56 Allowed 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 130.074 3.35 . . . . 3.5299999999999998 115.594 -165.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 4.2 mpp? -73.86 12.45 0.67 Allowed 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 117.651 2.463 . . . . 1.48 117.651 -168.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 68.6 t60 -53.78 -32.6 53.1 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 120.516 1.507 . . . . 4.4500000000000002 112.337 168.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -75.65 -12.23 83.93 Favored Glycine 0 CA--C 1.522 0.475 0 N-CA-C 117.364 1.706 . . . . 0.51000000000000001 117.364 -178.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.436 HD23 ' H ' ' A' ' 63' ' ' TYR . 13.2 mt -88.25 133.71 33.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 122.787 1.279 . . . . 2.0899999999999999 111.369 -162.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 19.9 ttm180 -120.0 85.49 2.39 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 126.901 2.081 . . . . 5.7000000000000002 106.9 -172.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 1.6 mt -106.67 141.39 22.01 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 CA-C-O 123.905 1.812 . . . . 0.42999999999999999 112.038 -163.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -135.87 125.43 25.21 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 111.515 -2.584 . . . . 2.0899999999999999 107.513 -170.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 26.2 p -140.99 157.74 44.91 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 125.834 1.654 . . . . 0.26000000000000001 109.077 -176.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 2.5 p -168.55 178.58 4.7 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.583 -1.189 . . . . 0.58999999999999997 109.837 176.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.3 p -138.65 129.4 15.17 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 124.106 0.962 . . . . 0.38 112.022 -178.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -82.06 125.39 4.67 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 124.079 3.186 . . . . 0.75 111.957 -175.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 2.7 mmtm -148.28 55.7 1.04 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.106 -0.952 . . . . 5.5999999999999996 112.728 -152.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 24.9 mmt180 . . . . . 0 C--O 1.257 1.481 0 C-N-CA 124.906 1.282 . . . . 7.79 112.982 173.536 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.761 0 N-CA-C 110.025 -0.361 . . . . 5.2999999999999998 110.025 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 80.1 m -127.6 140.82 51.87 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.463 0.705 . . . . 2.7799999999999998 111.704 -176.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 12.0 mp0 -114.22 166.57 11.51 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.187 1.795 . . . . 2.3399999999999999 111.305 178.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 80.4 p -120.49 170.59 9.25 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 107.947 -1.131 . . . . 0.56999999999999995 107.947 144.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -69.5 -22.6 63.59 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 120.919 -1.113 . . . . 2.8700000000000001 112.068 166.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.36 -41.38 98.15 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 124.309 0.956 . . . . 0.35999999999999999 112.574 169.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.72 -46.22 40.47 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.681 1.593 . . . . 1.3200000000000001 111.681 171.099 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.6 mt -68.6 -52.47 31.26 Favored 'General case' 0 C--N 1.339 0.113 0 C-N-CA 125.085 1.354 . . . . 0.38 111.225 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -56.59 -50.18 72.71 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.375 1.47 . . . . 3.1299999999999999 110.824 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.7 t -60.3 -46.74 94.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 107.757 -1.201 . . . . 0.29999999999999999 107.757 179.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 63.3 m -57.92 -41.22 82.24 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 118.417 0.553 . . . . 0.37 112.358 177.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 -60.55 -45.62 93.23 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 123.28 0.632 . . . . 1.77 111.396 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 42.9 mt -76.87 -27.29 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 117.871 0.305 . . . . 0.65000000000000002 110.433 -175.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 19.0 mt -58.73 -39.0 79.6 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.077 -1.014 . . . . 0.41999999999999998 112.831 168.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 37.6 mttt -65.35 -19.9 66.15 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 113.794 1.035 . . . . 1.48 113.794 175.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -102.39 -34.83 9.03 Favored 'General case' 0 N--CA 1.436 -1.166 0 C-N-CA 126.776 2.03 . . . . 2.2400000000000002 114.532 -174.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 26.6 mmtp -75.97 -30.79 58.73 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 120.038 -0.665 . . . . 2.7999999999999998 111.039 167.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -128.14 50.57 5.74 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 118.351 2.722 . . . . 1.55 118.351 -176.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -60.47 -27.61 85.16 Favored 'Trans proline' 0 C--O 1.236 0.409 0 C-N-CA 123.134 2.556 . . . . 0.81999999999999995 114.297 174.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 31.7 mmt180 -74.86 -9.24 58.36 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 114.079 1.14 . . . . 4.9800000000000004 114.079 179.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.59 152.37 15.19 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 115.579 1.696 . . . . 0.40999999999999998 115.579 -173.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 42.8 p -104.27 -5.68 21.63 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 127.259 2.223 . . . . 1.0700000000000001 113.148 168.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -143.16 143.88 31.98 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 119.932 1.242 . . . . 0.40999999999999998 111.814 153.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.9 pt -155.15 116.14 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 126.753 2.021 . . . . 0.52000000000000002 111.069 169.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 7.9 ptpt -161.03 153.5 20.49 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.481 1.512 . . . . 1.1100000000000001 112.782 179.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.5 t -134.54 143.49 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 126.218 1.807 . . . . 0.34999999999999998 110.483 -175.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 64.2 m -133.76 125.14 27.9 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.839 1.656 . . . . 0.46000000000000002 110.805 173.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -75.27 132.86 41.33 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 122.304 1.05 . . . . 1.8200000000000001 111.526 171.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.4 pt -133.84 26.8 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 C-N-CA 126.295 1.838 . . . . 0.59999999999999998 110.898 178.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 46.8 t -134.2 69.91 1.46 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 126.879 2.072 . . . . 1.3500000000000001 112.696 176.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -54.06 -25.13 30.53 Favored Glycine 0 CA--C 1.54 1.609 0 N-CA-C 116.074 1.19 . . . . 1.5 116.074 -179.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -88.35 -17.67 56.79 Favored Glycine 0 CA--C 1.534 1.28 0 CA-C-N 119.118 1.459 . . . . 1.5 116.194 -176.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 9.8 m -154.86 -32.46 0.1 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.792 1.237 . . . . 1.72 114.127 -164.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 64.99 47.1 86.35 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 125.426 1.489 . . . . 0.80000000000000004 112.987 -166.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -98.15 -1.6 41.87 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 126.402 1.881 . . . . 0.91000000000000003 114.098 176.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 15.6 mtm -136.96 138.8 40.97 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 126.151 1.781 . . . . 1.45 110.88 177.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -143.75 146.51 33.19 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.701 0.8 . . . . 1.8700000000000001 111.781 172.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -94.91 130.08 41.68 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.61 1.564 . . . . 2.3900000000000001 109.561 169.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 80.4 mt -137.65 129.33 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.879 0.872 . . . . 0.79000000000000004 110.636 -167.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 60.0 mttt -115.75 125.12 52.37 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.94 0.896 . . . . 3.77 110.272 173.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.455 HD12 HG13 ' A' ' 84' ' ' VAL . 1.2 mt -129.21 155.18 41.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 C-N-CA 125.482 1.513 . . . . 0.41999999999999998 109.877 173.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -158.35 133.23 8.4 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 120.059 -1.651 . . . . 2.0099999999999998 109.31 171.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 19.6 t -162.4 147.1 12.26 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 119.911 1.232 . . . . 0.45000000000000001 112.21 -174.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -53.91 -28.83 39.21 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.382 1.473 . . . . 4.7699999999999996 113.014 -179.018 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -65.7 -20.32 66.24 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 115.237 1.569 . . . . 1.8200000000000001 115.237 177.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -84.43 2.1 42.32 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 115.104 1.52 . . . . 1.99 115.104 -168.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 16.4 pttm -69.34 -47.35 64.63 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-O 121.819 0.819 . . . . 2.9100000000000001 112.079 -176.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -84.2 35.29 0.53 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 128.842 2.857 . . . . 4.1799999999999997 111.455 -170.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 49.0 mmtt -140.11 140.35 36.02 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 127.892 2.477 . . . . 1.3 110.754 -172.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 49.5 mtt180 -68.13 172.42 5.74 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.537 0.735 . . . . 3.7200000000000002 111.404 163.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 37.3 m -51.41 -54.41 26.93 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.671 0.789 . . . . 0.93000000000000005 112.852 168.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 10.9 p -57.23 -37.68 57.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 124.312 1.045 . . . . 0.68000000000000005 112.701 176.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -80.59 -32.3 36.52 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 113.128 0.788 . . . . 1.1899999999999999 113.128 -177.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -61.94 -50.26 72.84 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 119.904 1.229 . . . . 0.64000000000000001 109.846 168.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 50.8 m170 -55.75 -49.73 72.32 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 122.912 0.485 . . . . 0.68999999999999995 111.629 177.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 47.4 tp60 -46.88 -45.1 20.2 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.706 2.002 . . . . 1.3700000000000001 112.937 -178.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 71.9 mtp -62.34 -43.26 99.24 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.998 0.919 . . . . 1.1299999999999999 112.189 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.455 HG13 HD12 ' A' ' 67' ' ' ILE . 6.0 t -74.03 -27.23 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 126.612 1.965 . . . . 0.23999999999999999 112.097 178.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -71.98 -50.04 32.08 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 126.003 1.721 . . . . 0.56000000000000005 108.751 176.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 15.3 mm-40 -65.88 -24.38 66.84 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.621 1.168 . . . . 2.3799999999999999 112.806 179.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -56.44 -37.17 69.87 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.398 1.079 . . . . 0.45000000000000001 112.568 -176.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -127.79 4.62 6.04 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 115.236 1.569 . . . . 0.47999999999999998 115.236 -179.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 16.4 ttmt -50.73 -34.9 28.84 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.827 1.251 . . . . 2.9900000000000002 113.309 -178.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -74.05 -29.92 62.14 Favored 'General case' 0 N--CA 1.439 -1.025 0 O-C-N 121.484 -0.76 . . . . 2.5800000000000001 111.78 -177.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.23 -58.42 3.29 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 127.944 2.498 . . . . 2.71 111.995 175.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 34.7 mt -136.97 123.88 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 125.778 1.631 . . . . 1.0700000000000001 107.868 178.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -90.75 -12.04 37.73 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 115.005 1.483 . . . . 2.8799999999999999 115.005 -166.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -85.77 67.19 9.96 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 126.182 1.793 . . . . 3.5299999999999998 113.752 -156.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . 0.272 0.8 OUTLIER -74.35 -4.0 33.7 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 115.71 1.745 . . . . 1.8400000000000001 115.71 176.844 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 67.2 t60 -55.76 -24.52 35.86 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 121.61 -0.681 . . . . 4.3399999999999999 112.786 153.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -88.2 -27.0 26.84 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 127.424 2.44 . . . . 0.54000000000000004 116.146 177.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.0 mt -90.5 134.5 34.32 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 121.895 -0.768 . . . . 2.3300000000000001 111.622 -166.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 27.0 ttt180 -117.08 92.68 3.92 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.837 1.655 . . . . 3.2999999999999998 108.527 -176.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -114.03 135.12 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-O 123.094 1.426 . . . . 0.46999999999999997 113.198 -159.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -131.36 91.22 2.98 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 112.897 -1.956 . . . . 2.0 109.917 -164.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.1 p -99.64 152.34 20.16 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.988 1.715 . . . . 0.31 111.895 178.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.2 p -156.39 -179.42 8.15 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 125.716 1.606 . . . . 0.64000000000000001 110.614 174.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.5 p -143.27 132.04 11.43 Favored Pre-proline 0 N--CA 1.476 0.834 0 O-C-N 121.5 -0.75 . . . . 0.46000000000000002 112.725 -179.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -77.02 125.11 7.75 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 124.327 3.351 . . . . 0.68999999999999995 112.294 -176.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 38.2 mttt -149.7 100.68 3.0 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 113.017 -1.901 . . . . 3.98 111.52 -156.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 70.7 ttt-85 . . . . . 0 C--O 1.251 1.157 0 C-N-CA 127.849 2.46 . . . . 10.27 114.307 164.637 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.883 0 CA-C-O 121.211 0.529 . . . . 5.7599999999999998 111.054 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.22 159.81 21.31 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 126.493 1.917 . . . . 2.9300000000000002 111.272 -174.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -153.05 163.18 40.33 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 121.234 -0.916 . . . . 2.4399999999999999 111.255 164.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 69.3 p -110.7 179.05 4.17 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.764 1.226 . . . . 0.65000000000000002 109.957 160.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -71.02 -30.27 66.43 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 120.86 -1.15 . . . . 3.3700000000000001 111.951 161.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.21 -38.14 82.0 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 124.8 1.191 . . . . 0.40000000000000002 114.119 -178.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.53 -45.28 37.19 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.638 1.575 . . . . 1.22 111.575 174.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 15.0 mt -69.42 -52.82 23.25 Favored 'General case' 0 CA--C 1.522 -0.125 0 C-N-CA 125.68 1.592 . . . . 0.41999999999999998 110.945 -178.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.482 ' HE ' ' CD ' ' A' ' 91' ' ' GLU . 5.9 tpt180 -56.38 -49.64 73.88 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 125.419 1.487 . . . . 4.9800000000000004 111.585 -178.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 37.1 t -65.57 -42.17 92.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 107.827 -1.175 . . . . 0.51000000000000001 107.827 -179.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 87.1 m -57.99 -38.49 76.2 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 118.547 0.612 . . . . 0.47999999999999998 112.318 174.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 -63.06 -40.86 98.95 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 113.498 0.925 . . . . 1.74 113.498 -177.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 16.4 mt -81.32 -30.79 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 118.363 0.529 . . . . 0.68999999999999995 110.34 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 45.5 mt -51.95 -38.33 56.08 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 114.372 1.249 . . . . 0.72999999999999998 114.372 169.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 57.0 mttt -59.65 -31.05 69.17 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 124.962 1.305 . . . . 2.6200000000000001 113.912 178.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -93.69 -32.02 14.21 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 127.616 2.366 . . . . 2.3999999999999999 113.794 -174.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 59.9 mmtt -75.32 -26.55 58.74 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 119.805 -0.758 . . . . 1.6200000000000001 111.086 168.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -128.45 55.47 17.52 Favored Pre-proline 0 CA--C 1.55 0.959 0 N-CA-C 117.897 2.554 . . . . 1.6200000000000001 117.897 -177.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -68.83 -19.28 41.0 Favored 'Trans proline' 0 CA--C 1.534 0.489 0 C-N-CA 123.947 3.098 . . . . 0.81000000000000005 113.993 168.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 76.4 mtt180 -79.46 -2.61 42.75 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 114.601 1.334 . . . . 6.0899999999999999 114.601 174.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.25 158.38 33.46 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 115.727 1.751 . . . . 0.71999999999999997 115.727 -170.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 64.2 p -118.09 -15.77 9.85 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.97 1.308 . . . . 0.57999999999999996 112.651 168.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -131.66 141.72 49.67 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.914 0.885 . . . . 0.32000000000000001 111.727 152.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.0 pt -149.79 117.96 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 126.084 1.754 . . . . 0.77000000000000002 110.661 161.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 11.4 ptpt -152.8 155.01 36.31 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.86 1.264 . . . . 1.3999999999999999 112.285 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.7 t -135.78 144.88 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 126.281 1.833 . . . . 0.28999999999999998 110.398 -176.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 94.4 m -136.77 128.61 29.1 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.317 0.647 . . . . 0.32000000000000001 110.646 171.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -73.14 123.74 24.21 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.589 0.756 . . . . 2.0099999999999998 109.604 165.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.3 pt -122.18 27.2 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 125.001 1.321 . . . . 0.71999999999999997 110.574 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 36.6 t -136.32 65.55 1.52 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 127.189 2.196 . . . . 1.5700000000000001 111.001 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.37 0.6 2.66 Favored Glycine 0 CA--C 1.54 1.607 0 N-CA-C 117.227 1.651 . . . . 1.6000000000000001 117.227 -176.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -131.72 4.13 5.4 Favored Glycine 0 CA--C 1.538 1.521 0 C-N-CA 125.687 1.613 . . . . 1.4299999999999999 115.131 176.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 4.4 t -147.97 -27.35 0.34 Allowed 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 118.614 1.207 . . . . 1.5600000000000001 113.979 175.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 59.09 33.14 73.19 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 127.138 2.304 . . . . 1.0 114.316 -170.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -84.31 -28.27 27.23 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 118.291 1.046 . . . . 1.28 113.516 178.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -106.49 140.54 39.23 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 125.052 1.341 . . . . 1.6200000000000001 113.017 -179.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -142.64 145.68 33.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.751 -1.113 . . . . 1.8200000000000001 111.605 170.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -83.58 138.66 33.28 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 125.101 1.36 . . . . 1.78 109.288 162.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 93.9 mt -133.95 126.83 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.189 0.996 . . . . 0.56000000000000005 108.939 169.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 67.8 mttt -124.59 122.22 36.94 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.555 1.142 . . . . 2.6200000000000001 110.127 178.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.416 ' CD1' HG13 ' A' ' 84' ' ' VAL . 1.6 mt -126.25 158.66 35.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 125.869 1.668 . . . . 0.40000000000000002 109.296 -179.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -151.89 130.17 12.02 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 126.293 1.837 . . . . 1.8600000000000001 106.257 160.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 21.2 t -154.35 139.55 17.51 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 118.745 0.702 . . . . 0.35999999999999999 110.683 -176.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -58.32 -18.3 26.23 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.32 1.448 . . . . 3.1699999999999999 114.525 -177.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -74.23 -19.72 60.42 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.311 1.444 . . . . 1.6899999999999999 114.529 177.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -82.84 10.91 6.74 Favored 'General case' 0 CA--C 1.555 1.17 0 N-CA-C 116.123 1.898 . . . . 1.6299999999999999 116.123 -169.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.782 ' HA ' HG11 ' A' ' 104' ' ' VAL . 22.6 pttt -65.26 -46.85 78.85 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 127.059 2.144 . . . . 2.1200000000000001 115.754 -165.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -92.4 -20.7 20.76 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 126.799 2.04 . . . . 5.1100000000000003 112.353 -175.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 66.7 mmtt -58.82 142.91 49.05 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.567 1.147 . . . . 1.24 113.083 177.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 9.8 mmp_? -69.12 168.82 13.16 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 125.52 1.528 . . . . 6.4800000000000004 111.148 163.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.6 m -46.76 -56.86 5.52 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.424 0.69 . . . . 1.23 112.606 170.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.7 p -58.8 -41.73 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 125.235 1.414 . . . . 0.96999999999999997 112.633 178.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -76.0 -23.08 55.22 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 118.703 -0.665 . . . . 1.1200000000000001 112.496 -177.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -68.63 -58.05 4.83 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 119.634 1.107 . . . . 0.59999999999999998 109.925 164.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 32.5 m170 -56.14 -43.87 78.66 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.618 0.767 . . . . 0.48999999999999999 112.788 -177.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 50.9 tp60 -53.31 -40.6 64.9 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.325 1.45 . . . . 1.27 113.086 178.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 2.6 mtm -64.04 -39.57 94.38 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 119.649 1.113 . . . . 1.26 111.283 178.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.416 HG13 ' CD1' ' A' ' 67' ' ' ILE . 2.3 t -73.18 -28.42 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 125.497 1.519 . . . . 0.28000000000000003 111.775 177.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -71.58 -48.2 49.93 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.644 1.578 . . . . 0.59999999999999998 110.812 174.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.14 -22.32 66.89 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 120.736 -1.227 . . . . 2.77 112.384 177.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.28 -22.07 66.82 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 113.704 1.001 . . . . 0.94999999999999996 113.704 -177.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -132.69 -1.95 3.39 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 114.604 1.335 . . . . 0.58999999999999997 114.604 173.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 36.3 tttt -47.02 -41.74 17.02 Favored 'General case' 0 C--N 1.344 0.327 0 C-N-CA 124.682 1.193 . . . . 3.48 111.62 173.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -76.29 -3.15 35.12 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 123.913 0.885 . . . . 3.0800000000000001 112.761 -173.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.482 ' CD ' ' HE ' ' A' ' 35' ' ' ARG . 11.7 mm-40 -105.89 -51.54 2.97 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 128.288 2.635 . . . . 3.27 111.677 170.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 5.6 mt -143.33 126.88 13.61 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.371 0 C-N-CA 128.575 2.75 . . . . 1.9099999999999999 106.648 -178.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -94.63 -22.46 18.15 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.174 -0.954 . . . . 3.8599999999999999 113.196 -175.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -74.61 78.56 1.99 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.463 1.505 . . . . 3.75 113.018 -174.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 4.2 mpp? -82.38 13.46 3.58 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.936 1.295 . . . . 1.24 114.368 177.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 80.8 t60 -63.8 -34.29 77.59 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 120.624 -1.297 . . . . 4.3700000000000001 114.082 -177.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -84.5 -11.94 76.56 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 126.218 1.866 . . . . 0.57999999999999996 113.901 174.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.3 mp -86.47 139.13 31.18 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.427 1.091 . . . . 1.8500000000000001 111.917 -172.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 16.7 ttm180 -126.99 99.36 5.69 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 126.272 1.829 . . . . 5.3200000000000003 109.85 -169.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 3.6 mt -108.94 145.62 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-O 122.945 1.355 . . . . 0.37 113.306 -167.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -144.39 134.6 24.27 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 127.93 2.492 . . . . 2.1600000000000001 109.31 -170.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 16.4 p -150.8 153.14 34.88 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 127.847 2.459 . . . . 0.26000000000000001 109.397 -170.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.67 172.34 18.69 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 124.922 1.289 . . . . 0.62 110.045 175.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.782 HG11 ' HA ' ' A' ' 73' ' ' LYS . 8.9 p -136.97 125.87 15.16 Favored Pre-proline 0 N--CA 1.473 0.679 0 N-CA-C 113.661 0.985 . . . . 0.52000000000000002 113.661 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -78.24 134.39 12.79 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 123.211 2.607 . . . . 0.77000000000000002 110.763 170.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 25.1 ttmt -133.08 96.73 3.83 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.101 1.36 . . . . 2.6600000000000001 108.335 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 . . . . . 0 C--O 1.25 1.099 0 C-N-CA 127.319 2.248 . . . . 10.23 113.555 -171.206 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.779 0 N-CA-C 111.414 0.153 . . . . 4.9800000000000004 111.414 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.2 t -154.96 163.44 40.3 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.919 1.287 . . . . 3.7599999999999998 112.272 -177.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -137.03 151.58 49.1 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 126.072 1.749 . . . . 2.6200000000000001 112.09 173.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 80.8 p -120.92 176.14 5.7 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.526 1.53 . . . . 0.77000000000000002 111.324 165.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 -66.04 -31.12 71.82 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 120.169 -1.582 . . . . 4.1699999999999999 112.048 160.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.14 -46.13 95.13 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 125.565 1.555 . . . . 0.52000000000000002 112.603 177.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.34 -47.24 47.42 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.469 1.507 . . . . 1.28 112.179 177.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 11.7 mt -72.24 -47.65 48.7 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.075 1.35 . . . . 0.44 111.716 -179.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -56.03 -50.44 70.9 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 126.381 1.873 . . . . 2.96 111.117 177.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 50.2 t -60.1 -46.21 94.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 107.945 -1.132 . . . . 0.32000000000000001 107.945 178.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 37.6 m -59.41 -39.14 82.5 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 118.974 -0.536 . . . . 0.40000000000000002 112.438 179.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 7.9 mm-40 -60.48 -40.96 93.19 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 118.88 0.764 . . . . 2.0 112.43 178.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 49.0 mt -81.63 -28.16 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 123.129 0.572 . . . . 0.45000000000000001 110.63 -177.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 18.0 mt -59.66 -40.31 87.32 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 120.722 -1.236 . . . . 0.53000000000000003 112.83 168.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 46.5 mttt -63.55 -23.31 67.33 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 119.423 1.01 . . . . 1.3400000000000001 113.383 177.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -96.4 -35.51 11.15 Favored 'General case' 0 N--CA 1.434 -1.265 0 C-N-CA 126.937 2.095 . . . . 2.0899999999999999 114.803 -177.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 64.3 mmtt -74.17 -27.75 60.97 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 118.176 -0.916 . . . . 1.24 111.125 167.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -127.29 51.44 6.63 Favored Pre-proline 0 CA--C 1.551 0.995 0 N-CA-C 117.347 2.351 . . . . 1.53 117.347 -178.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -64.75 -14.0 42.39 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 125.171 3.914 . . . . 0.76000000000000001 115.04 176.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 32.5 mmt180 -83.31 -14.98 51.83 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.955 1.465 . . . . 4.8399999999999999 114.955 170.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.62 143.14 47.32 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 116.728 2.122 . . . . 0.65000000000000002 116.728 -166.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 77.8 p -96.89 -24.85 15.67 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.922 0.889 . . . . 0.60999999999999999 112.64 175.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -126.28 140.42 52.54 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.838 0.855 . . . . 0.51000000000000001 111.743 161.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.3 pt -155.77 117.8 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 126.292 1.837 . . . . 0.69999999999999996 110.582 173.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.2 ptpt -152.44 155.84 38.32 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.459 1.504 . . . . 1.3600000000000001 112.408 173.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.1 t -132.15 143.24 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 125.98 1.712 . . . . 0.47999999999999998 109.9 177.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 74.6 m -136.53 123.64 21.65 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 118.46 0.573 . . . . 0.46000000000000002 111.72 173.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -65.59 128.05 34.37 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 108.528 -0.916 . . . . 1.97 108.528 165.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.9 pt -127.53 33.1 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 125.859 1.663 . . . . 0.46000000000000002 109.499 178.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.6 t -145.98 57.46 1.21 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 128.138 2.575 . . . . 1.27 110.828 -173.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.21 -0.85 0.33 Allowed Glycine 0 CA--C 1.541 1.711 0 C-N-CA 126.681 2.086 . . . . 1.3100000000000001 117.889 -178.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -144.54 24.25 2.0 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 126.488 1.994 . . . . 1.4299999999999999 113.505 -178.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -162.99 -27.77 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.565 1.546 . . . . 1.52 112.901 172.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 53.41 39.87 60.32 Favored Glycine 0 CA--C 1.536 1.362 0 C-N-CA 127.277 2.37 . . . . 0.63 114.707 -173.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -96.7 -34.79 11.23 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.976 1.31 . . . . 0.81000000000000005 113.716 178.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 8.9 mtm -96.23 138.42 33.86 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 124.183 0.993 . . . . 1.29 111.525 177.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -142.63 144.88 32.99 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.019 0.928 . . . . 1.9199999999999999 112.759 172.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -82.29 137.99 34.68 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 126.289 1.836 . . . . 2.3399999999999999 109.215 165.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 92.2 mt -136.19 125.15 38.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.017 0.927 . . . . 0.62 109.507 169.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 64.4 mttt -123.89 114.62 20.07 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.47 1.108 . . . . 2.8500000000000001 109.957 177.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.2 mt -122.92 157.56 28.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 126.535 1.934 . . . . 0.34999999999999998 109.653 -177.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -154.93 132.91 11.57 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.756 1.623 . . . . 1.73 108.265 163.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 33.2 t -158.6 140.53 13.79 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 119.277 0.944 . . . . 0.38 110.515 -174.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -58.16 -19.81 35.88 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 114.311 1.226 . . . . 2.7799999999999998 114.311 -177.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -72.01 -19.65 61.83 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.052 1.341 . . . . 1.75 114.387 179.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -79.44 13.28 2.04 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 114.165 1.172 . . . . 1.79 114.165 -171.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 42.6 pttt -77.69 -42.13 35.59 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 113.226 0.825 . . . . 2.4199999999999999 113.226 -172.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -81.4 38.8 0.5 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.342 1.057 . . . . 3.7799999999999998 112.739 -177.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 61.5 mmtt -138.44 144.75 40.28 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 126.164 1.786 . . . . 1.54 111.886 -171.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 55.4 mtt180 -71.98 167.24 20.55 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 124.226 1.01 . . . . 3.8100000000000001 111.144 154.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 95.6 m -43.39 -56.03 3.8 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 126.136 1.774 . . . . 0.66000000000000003 113.216 166.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.5 p -59.07 -42.63 87.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.92 1.288 . . . . 0.51000000000000001 113.264 175.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -74.68 -23.31 58.61 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 118.578 -0.725 . . . . 1.3100000000000001 112.381 -177.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -67.78 -54.69 17.14 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 119.728 1.149 . . . . 0.71999999999999997 110.241 163.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 36.6 m170 -49.94 -51.29 42.32 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.068 0.947 . . . . 0.57999999999999996 112.102 -179.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 15.5 tp60 -47.37 -44.17 23.9 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.082 1.353 . . . . 1.4199999999999999 113.541 178.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 76.5 mtp -61.91 -43.92 97.85 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 119.334 0.97 . . . . 1.1599999999999999 111.467 -177.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.1 t -72.62 -28.28 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 126.579 1.952 . . . . 0.22 111.226 179.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -72.5 -50.07 28.51 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.924 1.69 . . . . 0.47999999999999998 109.679 176.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.8 mm-40 -65.01 -20.13 66.35 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.738 1.215 . . . . 2.2400000000000002 113.355 178.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.94 -43.53 86.39 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 118.707 0.685 . . . . 0.40999999999999998 111.398 178.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.55 5.65 9.54 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 115.132 1.53 . . . . 0.34000000000000002 115.132 -174.245 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.9 ttmt -52.43 -38.18 58.53 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 125.034 1.333 . . . . 2.98 112.89 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -76.2 -26.08 55.79 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 112.92 0.711 . . . . 3.02 112.92 -178.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -78.9 -60.73 2.26 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.502 1.921 . . . . 3.3900000000000001 110.647 175.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 42.5 mt -135.22 103.44 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 126.393 1.877 . . . . 1.04 108.361 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 14.1 ptpt -79.61 -17.38 53.97 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 115.428 1.64 . . . . 2.4199999999999999 115.428 -169.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 19.7 mp0 -67.14 47.78 0.04 OUTLIER 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 130.227 3.411 . . . . 3.3199999999999998 116.269 -171.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 4.2 mpp? -62.65 -2.1 1.02 Allowed 'General case' 0 N--CA 1.476 0.865 0 O-C-N 119.31 -2.118 . . . . 1.3100000000000001 115.21 177.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 2.6 p80 -58.05 -29.82 65.69 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 119.419 1.009 . . . . 3.2799999999999998 113.34 162.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -85.49 -23.39 47.44 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 124.862 1.22 . . . . 0.51000000000000001 113.495 177.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.6 mp -83.19 143.3 30.57 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 122.401 1.096 . . . . 1.55 112.386 -169.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 24.1 ttt180 -118.88 95.93 5.03 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 127.258 2.223 . . . . 2.9500000000000002 108.511 -175.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 2.7 mt -110.14 138.31 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 CA-C-O 123.66 1.695 . . . . 0.34999999999999998 113.528 -168.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -137.76 127.09 24.71 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-N 111.116 -2.765 . . . . 1.97 108.494 -169.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 12.4 p -145.51 154.44 42.2 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.123 1.769 . . . . 0.28999999999999998 108.955 -173.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.2 p -160.94 173.24 15.57 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.475 -1.238 . . . . 0.56999999999999995 110.309 176.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.4 p -138.9 123.74 11.71 Favored Pre-proline 0 C--O 1.237 0.445 0 N-CA-C 112.649 0.611 . . . . 0.56999999999999995 112.649 -177.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -74.73 126.63 10.27 Favored 'Trans proline' 0 N--CA 1.448 -1.205 0 C-N-CA 122.934 2.422 . . . . 0.88 108.431 169.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -124.14 74.79 1.32 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.721 1.608 . . . . 3.4500000000000002 109.109 -174.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 58.2 ttt-85 . . . . . 0 C--O 1.252 1.216 0 C-N-CA 127.563 2.345 . . . . 9.4600000000000009 112.851 -176.468 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.848 0 CA-C-O 120.474 0.178 . . . . 4.4500000000000002 111.232 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.6 m 65.98 144.54 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 127.614 2.365 . . . . 3.02 114.869 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -143.14 162.36 35.77 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 120.656 -1.278 . . . . 2.6099999999999999 113.177 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 56.6 p -121.32 178.79 4.64 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.053 1.741 . . . . 0.62 110.022 169.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -70.08 -27.92 65.01 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.046 -1.033 . . . . 3.2599999999999998 111.491 160.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -71.79 -39.8 59.17 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 125.622 1.582 . . . . 0.38 114.105 -178.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.29 -44.18 43.87 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 119.449 1.625 . . . . 2.0 111.334 174.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 8.9 mt -68.52 -56.18 9.21 Favored 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 125.987 1.715 . . . . 0.35999999999999999 110.67 178.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.58 -46.65 77.22 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.235 1.014 . . . . 2.8999999999999999 111.555 -178.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.8 t -61.65 -48.01 90.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 107.972 -1.122 . . . . 0.41999999999999998 107.972 178.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 52.9 m -57.31 -43.97 83.73 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 118.645 0.657 . . . . 0.44 112.059 176.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -61.99 -28.81 69.83 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.339 1.456 . . . . 2.8500000000000001 113.262 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 64.4 mt -90.49 -29.19 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 124.532 1.133 . . . . 0.52000000000000002 111.702 173.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.6 mt -56.94 -36.69 70.54 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 120.321 -1.487 . . . . 0.77000000000000002 112.754 172.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 38.0 mttt -63.67 -17.33 62.84 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 115.004 1.483 . . . . 1.6499999999999999 115.004 177.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -106.56 -37.73 6.37 Favored 'General case' 0 N--CA 1.429 -1.508 0 C-N-CA 125.987 1.715 . . . . 1.9399999999999999 113.576 -172.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -77.34 -23.62 50.9 Favored 'General case' 0 N--CA 1.453 -0.311 0 O-C-N 123.538 0.524 . . . . 1.23 111.99 166.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -133.99 52.4 8.01 Favored Pre-proline 0 CA--C 1.546 0.795 0 N-CA-C 117.702 2.482 . . . . 1.55 117.702 -179.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -61.73 -22.68 74.94 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 123.585 2.857 . . . . 0.73999999999999999 113.547 166.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 19.1 mtm180 -67.91 -15.04 63.43 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 114.654 1.353 . . . . 7.5300000000000002 114.654 174.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.84 144.74 47.36 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 114.45 1.278 . . . . 0.47999999999999998 114.45 -164.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 65.3 p -96.27 -19.66 19.12 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.938 0.895 . . . . 0.51000000000000001 112.551 174.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -130.77 142.23 50.4 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.202 1.001 . . . . 0.32000000000000001 111.975 159.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.4 pt -155.5 111.4 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 126.662 1.985 . . . . 0.46999999999999997 111.359 172.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.6 ptpt -154.22 150.14 27.75 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.006 1.322 . . . . 1.1699999999999999 112.71 -178.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.4 t -131.88 143.25 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 C-N-CA 125.818 1.647 . . . . 0.37 110.512 -173.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 77.6 m -135.34 129.71 33.87 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.825 1.25 . . . . 0.34000000000000002 112.1 172.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -78.94 132.68 36.81 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.11 0.964 . . . . 1.76 110.457 170.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.7 pt -130.58 28.24 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 125.843 1.657 . . . . 0.56999999999999995 111.285 179.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 41.6 t -139.13 63.72 1.5 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 127.625 2.37 . . . . 1.3200000000000001 110.981 -176.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.98 -9.06 12.19 Favored Glycine 0 CA--C 1.54 1.641 0 N-CA-C 117.086 1.594 . . . . 1.1899999999999999 117.086 -176.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -115.9 3.67 20.98 Favored Glycine 0 CA--C 1.537 1.456 0 C-N-CA 126.363 1.935 . . . . 1.0600000000000001 115.331 179.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 37.0 t -155.32 -38.37 0.09 Allowed 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 118.631 1.215 . . . . 1.99 113.087 -176.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 64.58 36.45 93.17 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 127.026 2.251 . . . . 0.68999999999999995 113.754 -169.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -85.02 -23.05 28.81 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 114.007 1.114 . . . . 0.88 114.007 173.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 1.2 mpp? -112.82 140.41 47.63 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.176 0.99 . . . . 1.8500000000000001 113.56 -176.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -143.52 144.99 32.21 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 122.154 0.978 . . . . 1.8700000000000001 113.144 173.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -98.46 120.15 38.39 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.009 1.724 . . . . 2.52 109.653 169.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 68.2 mt -132.07 129.54 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 124.684 1.194 . . . . 1.0 109.833 -163.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 67.9 mttt -125.45 125.66 43.69 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.62 0.768 . . . . 2.5299999999999998 110.628 179.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.421 ' CD1' HG13 ' A' ' 84' ' ' VAL . 1.2 mt -129.49 157.95 42.14 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 127.589 2.356 . . . . 0.25 108.774 178.273 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 71.5 tt0 -157.14 128.61 6.95 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.774 1.63 . . . . 1.6499999999999999 108.325 168.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 9.1 t -162.54 147.74 12.31 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 120.301 1.41 . . . . 0.40999999999999998 114.05 -169.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -59.07 -24.6 63.04 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 126.049 1.74 . . . . 4.5499999999999998 113.929 -172.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -73.57 -16.18 61.26 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.56 1.544 . . . . 1.8 115.086 177.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -83.51 -2.59 56.31 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 114.509 1.3 . . . . 2.04 114.509 -171.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.401 ' HB3' HG21 ' A' ' 104' ' ' VAL . 21.2 pttm -69.75 -42.09 74.35 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 113.505 0.928 . . . . 2.8500000000000001 113.505 -178.084 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -91.58 41.44 1.07 Allowed 'General case' 0 CA--C 1.547 0.847 0 CA-C-O 123.018 1.389 . . . . 4.0899999999999999 111.143 -170.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.9 mmtp -146.31 142.49 28.35 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 128.225 2.61 . . . . 2.9199999999999999 109.572 -166.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.423 ' HG2' ' H ' ' A' ' 76' ' ' ARG . 10.7 mmt85 -64.39 166.91 7.54 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.697 1.199 . . . . 3.4199999999999999 110.583 158.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 55.0 m -53.19 -51.09 63.2 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 113.801 1.038 . . . . 0.71999999999999997 113.801 168.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 14.7 p -63.47 -34.67 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 112.616 0.598 . . . . 0.62 112.616 177.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -65.22 -44.98 86.53 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 118.117 -0.945 . . . . 2.6099999999999999 111.667 173.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -58.04 -51.42 69.73 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 119.291 0.95 . . . . 0.60999999999999999 110.202 174.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 40.0 m170 -56.08 -50.01 72.21 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 123.405 0.682 . . . . 0.46999999999999997 111.371 178.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 32.6 tp60 -53.07 -39.84 63.59 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.771 1.228 . . . . 1.53 112.875 -177.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 85.4 mtp -59.36 -47.11 86.67 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 119.752 1.16 . . . . 1.0900000000000001 111.973 177.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.421 HG13 ' CD1' ' A' ' 67' ' ' ILE . 5.7 t -70.21 -32.19 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 126.009 1.723 . . . . 0.23000000000000001 111.41 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -65.55 -52.29 53.52 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.128 1.771 . . . . 0.57999999999999996 109.942 173.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 8.2 tm0? -66.98 -26.44 66.81 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.328 1.051 . . . . 3.1499999999999999 113.161 -176.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -56.73 -39.09 73.32 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.712 1.605 . . . . 0.39000000000000001 112.27 -179.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.64 -0.57 10.21 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 114.315 1.228 . . . . 0.44 114.315 -178.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 25.6 ttpt -52.5 -33.26 44.19 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.549 1.139 . . . . 1.8899999999999999 112.805 175.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -81.81 -3.14 53.21 Favored 'General case' 0 CA--C 1.553 1.067 0 O-C-N 121.335 -0.853 . . . . 1.8999999999999999 112.564 -178.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -104.61 -54.76 2.46 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 127.496 2.318 . . . . 3.1800000000000002 111.435 169.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 32.6 mt -138.31 119.9 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 126.775 2.03 . . . . 0.94999999999999996 108.494 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 41.5 mtmt -90.97 -1.43 57.83 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 115.012 1.486 . . . . 2.7599999999999998 115.012 -169.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -81.58 58.61 3.78 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.379 1.872 . . . . 3.04 114.676 -158.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . 0.3 1.3 mpt? -75.28 9.52 2.04 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 119.779 -1.826 . . . . 1.79 115.477 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 13.7 p80 -65.01 -26.4 68.27 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.46 0.541 . . . . 3.96 112.46 153.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -94.77 -17.98 36.49 Favored Glycine 0 C--N 1.333 0.414 0 C-N-CA 126.455 1.979 . . . . 0.5 115.986 -175.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.8 mt -93.33 124.1 37.08 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 117.732 0.766 . . . . 2.1699999999999999 110.875 -165.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 22.0 ttt180 -110.14 89.13 2.93 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 126.363 1.865 . . . . 3.3199999999999998 107.347 -177.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 1.1 mt -108.69 139.99 29.05 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.565 0 CA-C-O 123.037 1.399 . . . . 0.46999999999999997 111.743 -163.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -131.5 121.08 23.89 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 111.777 -2.465 . . . . 1.98 108.115 -169.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 24.4 p -131.93 153.96 49.76 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 126.268 1.827 . . . . 0.28000000000000003 110.196 -179.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -160.49 179.76 8.34 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 126.114 1.766 . . . . 0.64000000000000001 109.135 171.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.401 HG21 ' HB3' ' A' ' 73' ' ' LYS . 3.7 p -136.73 135.91 20.91 Favored Pre-proline 0 N--CA 1.474 0.748 0 O-C-N 120.897 -1.127 . . . . 0.48999999999999999 111.98 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -84.46 135.79 6.22 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 124.52 3.48 . . . . 0.81000000000000005 111.402 -179.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 7.0 mmtt -143.53 27.04 1.56 Allowed 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 114.182 1.179 . . . . 3.79 114.182 -161.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 71.1 mtm180 . . . . . 0 C--O 1.25 1.106 0 C-N-CA 126.182 1.793 . . . . 8.6300000000000008 114.212 -168.572 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.003 0 CA-C-O 120.289 0.09 . . . . 5.3300000000000001 111.203 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . 0.265 92.2 m 63.82 139.13 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 127.379 2.272 . . . . 2.9500000000000002 113.283 -167.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.8 mp0 -130.21 157.93 41.12 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 114.439 1.274 . . . . 2.48 114.439 -168.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 72.8 p -121.04 179.51 4.36 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 126.257 1.823 . . . . 0.53000000000000003 110.278 157.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.41 -32.7 71.87 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 120.941 -1.1 . . . . 3.6800000000000002 112.357 164.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.14 -38.4 96.47 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 125.183 1.373 . . . . 0.35999999999999999 112.949 174.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.71 -45.66 63.64 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.879 1.272 . . . . 1.49 112.369 176.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 13.1 mt -71.21 -49.87 38.98 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 125.008 1.323 . . . . 0.38 111.491 -178.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -54.26 -50.65 66.72 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 127.358 2.263 . . . . 3.9900000000000002 110.991 178.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.8 t -63.86 -45.68 96.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 108.312 -0.996 . . . . 0.25 108.312 178.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 51.6 m -55.7 -36.52 67.27 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.243 0.46 . . . . 0.34999999999999998 112.243 177.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -69.21 -43.47 74.03 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 114.123 1.157 . . . . 2.04 114.123 -178.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 26.7 mt -75.67 -28.29 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-N 118.689 0.677 . . . . 0.53000000000000003 110.403 -179.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 21.5 mt -55.75 -37.7 68.84 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.569 0.951 . . . . 0.40000000000000002 113.569 169.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 38.3 mttt -62.84 -32.92 74.24 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 118.563 0.62 . . . . 1.3999999999999999 112.561 179.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -90.57 -35.48 15.0 Favored 'General case' 0 N--CA 1.438 -1.054 0 C-N-CA 128.362 2.665 . . . . 2.25 114.779 -175.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -77.17 -17.43 58.56 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 120.159 -0.616 . . . . 1.3799999999999999 112.525 169.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -132.16 60.96 54.8 Favored Pre-proline 0 CA--C 1.551 1.017 0 N-CA-C 116.914 2.19 . . . . 2.1099999999999999 116.914 175.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -68.68 -24.09 35.49 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 124.658 3.572 . . . . 0.90000000000000002 114.759 170.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -80.27 0.13 34.05 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 114.495 1.295 . . . . 6.25 114.495 171.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.53 147.99 52.51 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 114.654 1.353 . . . . 0.52000000000000002 114.654 -175.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 25.8 p -103.82 -18.69 14.55 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.525 1.13 . . . . 0.56000000000000005 112.671 167.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -133.41 144.2 49.38 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 119.568 1.076 . . . . 0.40999999999999998 112.149 159.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.9 pt -157.04 110.51 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 127.425 2.29 . . . . 0.56000000000000005 110.815 171.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.5 ptpt -151.61 155.99 39.53 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.602 1.561 . . . . 1.1899999999999999 113.024 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.9 t -136.04 145.57 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 126.016 1.726 . . . . 0.34999999999999998 111.628 -172.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 94.3 m -138.82 126.67 22.24 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.233 0.613 . . . . 0.34999999999999998 111.695 172.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -71.51 126.82 30.66 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.787 0.803 . . . . 1.8200000000000001 110.451 168.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.2 pt -125.84 22.06 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 C-N-CA 125.524 1.529 . . . . 0.5 111.147 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.401 ' CB ' ' H ' ' A' ' 62' ' ' MET . 38.1 t -131.65 62.37 1.63 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 128.709 2.803 . . . . 1.3600000000000001 110.896 179.198 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.01 -10.1 18.16 Favored Glycine 0 CA--C 1.539 1.562 0 N-CA-C 117.261 1.664 . . . . 1.1499999999999999 117.261 -174.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -103.38 -19.62 12.17 Favored Glycine 0 N--CA 1.471 1.019 0 C-N-CA 126.534 2.016 . . . . 0.96999999999999997 115.28 179.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 33.1 m -145.34 -29.56 0.44 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.29 1.036 . . . . 2.5899999999999999 113.345 -163.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 60.42 41.41 98.55 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 128.201 2.81 . . . . 0.72999999999999998 113.735 -175.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -98.39 -16.86 19.12 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.265 1.826 . . . . 0.90000000000000002 112.955 -178.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.415 ' HG3' ' CA ' ' A' ' 97' ' ' GLY . 4.3 mpp? -117.8 141.49 48.35 Favored 'General case' 0 CA--C 1.52 -0.175 0 C-N-CA 126.627 1.971 . . . . 1.99 112.809 175.24 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -144.39 147.02 32.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.863 -1.062 . . . . 1.8500000000000001 111.241 171.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -83.7 137.24 33.86 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 125.185 1.394 . . . . 2.23 109.193 163.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 97.5 mt -133.72 129.16 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 123.869 0.868 . . . . 0.65000000000000002 109.345 170.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 70.0 mttt -124.56 116.97 23.31 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.673 1.189 . . . . 2.73 110.624 177.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.3 mt -122.29 162.62 21.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 C-N-CA 126.361 1.865 . . . . 0.46999999999999997 109.271 -177.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -156.67 131.32 8.83 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.696 1.999 . . . . 1.77 107.111 162.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.7 t -157.28 140.14 15.13 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 120.402 1.456 . . . . 0.34000000000000002 111.767 -173.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -58.26 -21.64 49.36 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.241 1.016 . . . . 3.4100000000000001 113.543 -178.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -71.01 -15.4 62.56 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 115.274 1.583 . . . . 1.8 115.274 179.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -88.0 10.26 19.58 Favored 'General case' 0 CA--C 1.553 1.068 0 N-CA-C 115.537 1.68 . . . . 1.6200000000000001 115.537 -171.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.58 ' HA ' HG11 ' A' ' 104' ' ' VAL . 14.9 pttt -63.07 -46.35 87.87 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 126.251 1.82 . . . . 2.3300000000000001 115.569 -165.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -100.69 -11.03 20.29 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.385 1.474 . . . . 4.4100000000000001 111.692 -168.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 32.9 mmtt -64.76 142.88 58.28 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 126.81 2.044 . . . . 1.52 112.561 174.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 16.6 mtt-85 -67.58 166.49 14.82 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 122.9 0.48 . . . . 3.2200000000000002 111.092 159.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.8 m -50.31 -50.56 50.32 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 113.873 1.064 . . . . 0.73999999999999999 113.873 172.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 10.4 p -62.71 -38.44 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 123.474 0.71 . . . . 0.67000000000000004 112.783 174.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -75.34 -19.79 59.41 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.736 0.643 . . . . 1.4299999999999999 112.736 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -70.34 -53.94 14.63 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.397 -0.814 . . . . 0.66000000000000003 109.807 163.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 49.7 m170 -53.05 -48.28 67.79 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.82 0.848 . . . . 0.66000000000000003 113.062 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 47.0 tp60 -47.79 -43.28 27.52 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.796 1.638 . . . . 1.1799999999999999 113.477 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 3.6 mtm -67.07 -39.82 86.91 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 118.93 0.786 . . . . 1.3100000000000001 111.768 -178.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.2 t -73.14 -33.83 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 125.616 1.567 . . . . 0.34999999999999998 110.644 179.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -63.42 -50.64 69.0 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.111 1.764 . . . . 0.45000000000000001 110.536 173.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 35.5 tp60 -66.05 -21.7 66.39 Favored 'General case' 0 N--CA 1.45 -0.474 0 O-C-N 119.849 -1.782 . . . . 2.3799999999999999 114.118 -178.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.17 -40.55 85.97 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.379 0.672 . . . . 0.44 111.589 177.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.66 3.78 9.54 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 115.372 1.619 . . . . 0.34999999999999998 115.372 -176.02 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 26.3 ttmt -43.8 -45.55 7.36 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 125.405 1.482 . . . . 1.9299999999999999 111.877 174.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -84.27 -6.0 59.34 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 113.225 0.824 . . . . 3.0499999999999998 113.225 -172.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -98.51 -56.15 2.54 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 127.226 2.211 . . . . 2.21 111.867 174.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 23.3 mt -132.96 92.61 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.57 1.548 . . . . 1.1799999999999999 107.76 176.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -69.8 -19.08 63.5 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 114.094 1.146 . . . . 2.6299999999999999 114.094 -172.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . 0.295 16.3 pt-20 -73.97 43.75 0.17 Allowed 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 116.359 1.985 . . . . 3.9700000000000002 116.359 -169.09 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 64.3 mtm -66.21 0.75 1.85 Allowed 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 126.52 1.928 . . . . 1.3600000000000001 116.023 -172.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 21.0 p-80 -61.6 -5.52 1.91 Allowed 'General case' 0 CA--C 1.55 0.959 0 N-CA-C 113.836 1.05 . . . . 4.8300000000000001 113.836 157.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.415 ' CA ' ' HG3' ' A' ' 62' ' ' MET . . . -104.17 -14.99 22.98 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 125.468 1.509 . . . . 0.40000000000000002 115.807 167.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.9 mp -89.68 124.97 35.06 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 118.904 1.352 . . . . 1.5600000000000001 111.753 -169.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 50.3 ttt180 -103.26 100.87 10.79 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 127.072 2.149 . . . . 3.1200000000000001 110.063 -178.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 5.4 mt -108.97 144.39 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-O 123.822 1.772 . . . . 0.45000000000000001 112.853 -170.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -136.89 135.93 38.25 Favored 'General case' 0 N--CA 1.433 -1.298 0 C-N-CA 128.944 2.897 . . . . 1.97 109.248 -175.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.4 p -145.66 157.7 43.93 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 126.792 2.037 . . . . 0.56000000000000005 108.176 -175.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -155.81 175.25 14.18 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 124.77 1.228 . . . . 0.71999999999999997 108.959 172.386 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.58 HG11 ' HA ' ' A' ' 73' ' ' LYS . 7.1 p -142.8 126.33 9.38 Favored Pre-proline 0 N--CA 1.467 0.395 0 O-C-N 121.386 -0.821 . . . . 0.48999999999999999 112.198 -179.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -73.82 102.41 1.5 Allowed 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 122.953 2.435 . . . . 0.68999999999999995 110.894 176.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 19.4 ttpp -139.58 70.5 1.37 Allowed 'General case' 0 C--O 1.236 0.347 0 C-N-CA 127.172 2.189 . . . . 3.0099999999999998 106.754 168.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 . . . . . 0 C--O 1.25 1.114 0 C-N-CA 127.293 2.237 . . . . 7.6200000000000001 110.798 -179.124 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.649 0 CA-C-O 119.858 -0.115 . . . . 8.0099999999999998 111.015 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 14.7 t -154.7 -22.03 0.12 Allowed 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 115.267 1.58 . . . . 4.9100000000000001 115.267 178.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -154.43 138.53 16.47 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 123.993 0.917 . . . . 2.0800000000000001 113.103 -175.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 58.7 p -102.02 176.46 5.19 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 126.115 1.766 . . . . 0.60999999999999999 111.674 177.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -67.72 -34.03 76.06 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 120.486 -1.384 . . . . 4.1299999999999999 112.115 164.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.4 -38.34 80.3 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 125.044 1.307 . . . . 0.46000000000000002 114.229 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.87 -48.66 66.96 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 118.926 1.363 . . . . 1.3899999999999999 112.551 -179.082 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 16.2 mt -70.11 -48.48 57.4 Favored 'General case' 0 CA--C 1.527 0.082 0 C-N-CA 125.375 1.47 . . . . 0.52000000000000002 110.822 -178.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -53.32 -51.18 63.2 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 127.584 2.354 . . . . 3.8799999999999999 111.319 179.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 39.3 t -62.83 -48.37 88.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 124.584 1.154 . . . . 0.23000000000000001 108.425 177.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 42.1 m -57.0 -38.78 73.56 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.303 0.483 . . . . 0.42999999999999999 112.303 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 -62.87 -41.22 99.3 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 112.395 0.517 . . . . 1.8500000000000001 112.395 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 69.5 mt -78.03 -30.23 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 123.377 0.671 . . . . 0.48999999999999999 111.317 -179.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 18.0 mt -55.33 -39.48 70.04 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 121.075 -1.015 . . . . 0.44 113.287 172.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 44.5 mttt -64.44 -26.36 68.41 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 113.459 0.911 . . . . 1.3200000000000001 113.459 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -90.46 -35.36 15.17 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 126.823 2.049 . . . . 2.25 114.926 -177.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -74.68 -22.7 58.72 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 119.05 -1.06 . . . . 2.23 111.788 168.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -130.95 55.54 19.65 Favored Pre-proline 0 CA--C 1.552 1.052 0 N-CA-C 116.817 2.154 . . . . 1.5900000000000001 116.817 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -68.31 -18.94 44.43 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 124.675 3.583 . . . . 0.79000000000000004 115.225 177.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -81.96 -9.93 59.42 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 121.069 -1.019 . . . . 4.8600000000000003 113.514 170.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.26 144.44 46.23 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 114.637 1.347 . . . . 0.53000000000000003 114.637 -173.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 74.1 p -95.42 -29.64 14.31 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.769 1.628 . . . . 0.63 111.05 175.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -126.71 141.74 51.75 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.711 1.205 . . . . 0.31 111.265 165.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.1 pt -158.69 104.01 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 127.546 2.338 . . . . 0.47999999999999998 109.434 174.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.0 ptpt -149.67 148.6 29.47 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.67 1.188 . . . . 1.3100000000000001 112.86 -177.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.2 t -133.26 147.08 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 126.285 1.834 . . . . 0.35999999999999999 111.246 -170.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 93.7 m -141.77 127.85 19.62 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 118.406 0.548 . . . . 0.34000000000000002 111.538 170.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -68.41 135.86 52.4 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 122.174 0.988 . . . . 1.8100000000000001 110.062 165.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . 0.255 1.6 pt -127.33 25.2 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.887 0 C-N-CA 125.647 1.579 . . . . 0.56000000000000005 111.082 177.506 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 11.3 p -143.34 53.75 1.35 Allowed 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 128.98 2.912 . . . . 2.1200000000000001 114.38 -171.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -55.98 -18.41 18.99 Favored Glycine 0 CA--C 1.546 2.022 0 O-C-N 120.403 -1.435 . . . . 1.3100000000000001 116.678 -177.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -96.29 -5.84 59.07 Favored Glycine 0 CA--C 1.541 1.693 0 CA-C-N 119.658 1.729 . . . . 1.0 116.132 176.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 11.9 t -147.27 -31.75 0.31 Allowed 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 119.275 1.538 . . . . 1.48 114.301 -173.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 58.68 34.82 78.54 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 129.093 3.235 . . . . 0.66000000000000003 114.361 -171.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -100.09 3.51 44.04 Favored 'General case' 0 CA--C 1.552 1.021 0 N-CA-C 115.223 1.564 . . . . 0.97999999999999998 115.223 -177.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 2.1 mtp -131.36 138.43 49.16 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 127.396 2.279 . . . . 1.5700000000000001 112.865 175.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -145.13 143.11 30.19 Favored 'General case' 0 C--O 1.227 -0.092 0 CA-C-O 122.645 1.212 . . . . 1.8500000000000001 113.933 174.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -82.09 133.0 35.25 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 125.09 1.356 . . . . 1.74 110.021 165.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 82.7 mt -133.65 127.08 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 CA-C-N 119.816 1.189 . . . . 0.56000000000000005 110.116 175.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 74.1 mttt -123.16 117.94 26.52 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.811 1.244 . . . . 2.5699999999999998 110.232 178.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.3 mt -122.71 160.77 24.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 126.305 1.842 . . . . 0.29999999999999999 109.046 -179.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -155.41 131.6 10.19 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 126.266 1.826 . . . . 1.9399999999999999 107.219 162.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.9 t -154.07 137.66 16.01 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 118.678 0.672 . . . . 0.29999999999999999 111.704 -177.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -55.11 -16.0 2.66 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 127.223 2.209 . . . . 4.2199999999999998 114.567 176.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -76.66 -21.81 54.92 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 114.021 1.119 . . . . 1.71 114.021 175.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -79.97 11.85 3.11 Favored 'General case' 0 CA--C 1.556 1.192 0 N-CA-C 115.446 1.647 . . . . 1.6499999999999999 115.446 -166.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.403 ' HA ' HG11 ' A' ' 104' ' ' VAL . 1.0 OUTLIER -75.74 -36.4 59.91 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 117.777 2.51 . . . . 2.4199999999999999 117.777 -163.293 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -80.75 -25.85 37.72 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 120.723 1.601 . . . . 5.3600000000000003 111.429 173.258 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 43.1 mmtt -65.95 133.89 51.81 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.67 1.188 . . . . 1.78 113.289 -173.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 46.2 mtt-85 -63.75 160.73 16.55 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 125.451 1.5 . . . . 3.5699999999999998 110.928 163.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 41.3 m -35.69 -57.77 0.64 Allowed 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 125.377 1.471 . . . . 0.69999999999999996 114.094 167.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.0 p -65.79 -39.54 85.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 125.29 1.436 . . . . 0.58999999999999997 112.674 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -70.21 -26.82 64.05 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 118.487 -0.768 . . . . 0.98999999999999999 112.907 177.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -70.25 -52.75 20.71 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 119.112 0.869 . . . . 0.79000000000000004 110.359 167.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 39.2 m170 -53.35 -49.18 67.66 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 118.911 0.778 . . . . 0.48999999999999999 112.553 -178.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 33.0 tp60 -48.99 -43.52 40.22 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.844 1.258 . . . . 1.3 113.097 177.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 86.3 mtp -59.89 -44.5 94.2 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 121.179 -0.951 . . . . 0.94999999999999996 112.026 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.1 t -73.17 -31.51 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 125.753 1.621 . . . . 0.22 111.608 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -67.51 -49.81 61.71 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 126.644 1.978 . . . . 0.46000000000000002 110.237 175.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 39.8 tp60 -69.27 -20.82 63.92 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 120.513 -1.367 . . . . 2.8300000000000001 113.708 -176.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.26 -46.87 88.31 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.253 1.421 . . . . 0.51000000000000001 111.658 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.28 -5.09 14.19 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.975 1.102 . . . . 0.38 113.975 -175.327 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 11.7 ttmt -47.72 -35.96 10.6 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.187 1.395 . . . . 2.8300000000000001 113.103 169.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -76.31 -0.16 21.49 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 114.294 1.22 . . . . 2.48 114.294 -178.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -120.27 -49.18 2.29 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 127.94 2.496 . . . . 3.2200000000000002 111.222 175.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 37.2 mt -138.76 118.9 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 127.136 2.174 . . . . 0.94999999999999996 107.224 176.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 37.2 mtpt -86.57 -10.93 52.93 Favored 'General case' 0 N--CA 1.478 0.973 0 O-C-N 120.455 -1.403 . . . . 2.4500000000000002 113.509 -175.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 -77.92 47.81 0.66 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 128.052 2.541 . . . . 3.48 115.688 -158.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 3.3 mpp? -65.24 1.97 0.93 Allowed 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 115.391 1.626 . . . . 1.6200000000000001 115.391 -178.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -64.49 -23.52 67.31 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 114.214 1.19 . . . . 3.48 114.214 160.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -90.21 -22.46 35.06 Favored Glycine 0 N--CA 1.475 1.256 0 C-N-CA 126.082 1.801 . . . . 0.53000000000000003 114.916 173.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.9 mp -85.51 145.45 27.39 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.165 0.986 . . . . 1.55 112.85 -169.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 -123.48 101.83 7.55 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 126.385 1.874 . . . . 3.75 109.73 176.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 2.3 mt -105.61 146.57 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 CA-C-O 123.515 1.626 . . . . 0.34999999999999998 113.619 -173.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -140.36 131.6 26.57 Favored 'General case' 0 N--CA 1.439 -1.004 0 C-N-CA 128.814 2.845 . . . . 1.8799999999999999 108.952 -172.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 19.6 p -146.55 148.71 32.43 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.756 2.022 . . . . 0.34999999999999998 109.489 -177.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.7 p -147.77 171.47 15.63 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.566 -1.197 . . . . 0.63 111.027 173.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.403 HG11 ' HA ' ' A' ' 73' ' ' LYS . 13.4 p -136.37 128.61 17.34 Favored Pre-proline 0 N--CA 1.47 0.55 0 C-N-CA 123.799 0.84 . . . . 0.48999999999999999 110.332 173.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -73.28 127.23 11.74 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 121.966 1.777 . . . . 0.72999999999999998 109.751 176.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 3.2 tmtp? -139.3 22.44 2.57 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 114.67 1.359 . . . . 2.8500000000000001 114.67 -160.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 55.4 mtt-85 . . . . . 0 C--O 1.252 1.186 0 C-N-CA 127.304 2.242 . . . . 8.7799999999999994 113.132 176.651 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.942 0 N-CA-C 110.331 -0.248 . . . . 6.6299999999999999 110.331 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.59 176.96 11.95 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.005 1.322 . . . . 4.3399999999999999 111.736 -165.259 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.1 mp0 -103.09 150.29 23.76 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.669 0.747 . . . . 2.5299999999999998 111.39 142.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 30.6 p -129.14 173.06 10.81 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.98 1.712 . . . . 0.85999999999999999 109.32 161.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -72.34 -26.88 62.1 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 120.286 -1.509 . . . . 4.6500000000000004 111.19 177.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -66.51 -35.66 90.34 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 125.492 1.52 . . . . 0.40999999999999998 113.282 170.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.69 -50.77 42.46 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.187 1.395 . . . . 1.3700000000000001 111.563 173.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.8 mt -68.92 -48.81 62.38 Favored 'General case' 0 C--O 1.223 -0.292 0 C-N-CA 124.897 1.279 . . . . 0.42999999999999999 110.973 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.39 -47.2 69.7 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.792 1.237 . . . . 3.6299999999999999 111.416 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.3 t -67.74 -46.97 81.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 O-C-N 124.156 0.91 . . . . 0.47999999999999998 108.716 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 89.6 m -52.82 -44.48 66.72 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.463 0.705 . . . . 0.53000000000000003 112.005 175.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -62.42 -32.68 73.56 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.038 0.935 . . . . 2.9300000000000002 113.126 -177.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 35.2 mt -82.27 -35.5 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 CA-C-N 118.798 0.727 . . . . 0.53000000000000003 111.662 172.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 20.2 mt -53.74 -38.9 64.83 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 120.907 -1.121 . . . . 0.40000000000000002 113.488 175.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 40.7 mttt -76.29 -9.64 58.8 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 114.8 1.407 . . . . 1.8600000000000001 114.8 -178.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -90.26 -40.83 11.92 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 126.363 1.865 . . . . 3.02 113.214 167.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 65.0 mmtt -74.16 -30.12 62.1 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 119.1 -1.04 . . . . 1.29 111.777 177.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -132.98 53.15 10.13 Favored Pre-proline 0 CA--C 1.549 0.933 0 N-CA-C 117.285 2.328 . . . . 1.6599999999999999 117.285 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -61.58 -26.38 80.44 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 123.975 3.117 . . . . 1.3500000000000001 114.436 178.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 10.9 mmt180 -91.72 -3.79 55.83 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 114.344 1.238 . . . . 5.7599999999999998 114.344 -176.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -55.07 149.5 11.95 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.03 1.732 . . . . 0.59999999999999998 114.707 176.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 74.0 p -100.87 -9.88 21.2 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 126.172 1.789 . . . . 0.91000000000000003 112.878 178.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -135.39 141.94 45.58 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.121 0.968 . . . . 0.34000000000000002 110.52 150.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -154.19 108.14 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 C-N-CA 125.838 1.655 . . . . 0.73999999999999999 110.799 171.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.4 ptpt -154.9 156.63 36.46 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.042 1.337 . . . . 1.1299999999999999 113.11 176.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 25.3 t -122.34 151.65 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 127.37 2.268 . . . . 0.48999999999999999 109.458 177.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 63.3 m -138.26 116.65 11.97 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 109.682 -0.488 . . . . 0.66000000000000003 109.682 168.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -65.58 133.02 50.3 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 122.18 0.991 . . . . 2.1200000000000001 109.11 166.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.1 pt -126.59 32.23 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 124.721 1.208 . . . . 0.60999999999999999 109.533 178.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.6 t -146.6 45.83 1.2 Allowed 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 126.793 2.037 . . . . 1.27 113.257 -169.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -49.59 -31.89 15.56 Favored Glycine 0 CA--C 1.543 1.802 0 O-C-N 120.112 -1.618 . . . . 1.4299999999999999 115.887 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -77.18 -12.81 84.26 Favored Glycine 0 CA--C 1.541 1.673 0 N-CA-C 116.248 1.259 . . . . 1.49 116.248 176.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 4.7 t -147.75 -44.14 0.17 Allowed 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 119.891 1.845 . . . . 1.51 114.384 -173.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 73.97 47.73 18.21 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 128.921 3.153 . . . . 0.93000000000000005 112.434 -168.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -96.05 -29.64 14.0 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.545 1.538 . . . . 1.1899999999999999 114.252 174.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -113.09 142.13 46.09 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 125.267 1.427 . . . . 1.8700000000000001 113.811 -177.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -143.2 142.42 31.41 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 122.282 1.039 . . . . 1.8799999999999999 112.824 172.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -83.58 139.98 32.52 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 125.862 1.665 . . . . 2.3199999999999998 109.529 163.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 90.4 mt -135.94 129.59 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-N 119.335 0.97 . . . . 0.67000000000000004 109.185 172.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 77.4 mttt -126.27 113.73 17.34 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.708 1.203 . . . . 2.73 109.768 -177.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.2 mt -125.11 157.82 33.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 126.333 1.853 . . . . 0.23000000000000001 109.109 -178.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 48.2 tt0 -157.76 129.34 6.83 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 126.103 1.761 . . . . 1.8400000000000001 107.415 167.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 18.2 t -160.14 145.28 14.97 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 120.131 1.332 . . . . 0.34999999999999998 113.091 -171.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -59.42 -16.9 26.35 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.964 2.105 . . . . 3.6899999999999999 114.583 -176.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -77.36 -20.21 55.14 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.733 1.613 . . . . 1.73 115.03 173.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -80.72 5.67 15.08 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 114.861 1.43 . . . . 1.6699999999999999 114.861 -167.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 22.8 pttt -73.33 -49.64 26.34 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 114.7 1.37 . . . . 2.9700000000000002 114.7 -171.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . 0.278 15.2 pm0 -80.89 25.35 0.45 Allowed 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 119.658 1.117 . . . . 4.0800000000000001 113.855 -177.336 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 42.1 mmtt -119.03 141.39 48.75 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 127.393 2.277 . . . . 1.23 110.854 -177.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 40.1 mtt180 -67.82 166.15 16.05 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 123.003 0.521 . . . . 3.5499999999999998 111.213 158.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 52.6 m -47.4 -53.35 14.18 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 114.384 1.253 . . . . 0.79000000000000004 114.384 170.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 13.6 p -61.11 -37.81 78.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 123.215 0.606 . . . . 0.63 112.594 175.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -74.45 -27.59 60.66 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 118.53 -0.748 . . . . 1.1399999999999999 112.553 179.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -64.28 -56.02 17.45 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.279 1.032 . . . . 0.65000000000000002 109.872 166.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 35.7 m170 -53.0 -48.33 67.59 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.703 0.801 . . . . 0.48999999999999999 112.255 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 30.8 tp60 -52.64 -40.54 62.9 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.471 1.108 . . . . 1.3799999999999999 113.221 178.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -63.67 -37.65 88.15 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 120.3 1.409 . . . . 1.0 111.221 179.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.3 t -76.76 -31.08 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 125.192 1.397 . . . . 0.26000000000000001 111.689 179.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -67.63 -48.07 67.77 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.597 1.559 . . . . 0.46999999999999997 110.195 173.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -61.55 -27.53 68.68 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 120.713 -1.242 . . . . 3.6200000000000001 113.202 178.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.64 -35.74 74.99 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.614 1.165 . . . . 0.37 112.399 -177.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.18 -3.03 8.53 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 113.927 1.084 . . . . 0.42999999999999999 113.927 -178.177 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 26.1 ttpt -49.26 -37.63 24.14 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.141 1.376 . . . . 2.79 112.82 177.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -78.13 -12.64 60.01 Favored 'General case' 0 CA--C 1.552 1.043 0 CA-C-O 121.68 0.753 . . . . 2.6200000000000001 111.863 -173.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -109.56 -51.04 2.92 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 128.98 2.912 . . . . 3.1400000000000001 110.681 -171.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.3 mm -129.68 123.62 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 127.851 2.46 . . . . 1.3799999999999999 106.579 164.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -97.01 -9.21 28.64 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 119.873 -1.767 . . . . 3.23 114.876 -178.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -81.94 50.77 1.61 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 127.631 2.372 . . . . 2.7599999999999998 114.356 -166.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 5.2 mpp? -64.92 -2.21 2.49 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 114.998 1.481 . . . . 1.3100000000000001 114.998 -175.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 19.4 p-80 -63.79 -14.87 56.51 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 114.28 1.215 . . . . 4.6299999999999999 114.28 165.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -92.75 -17.55 44.26 Favored Glycine 0 CA--C 1.537 1.431 0 O-C-N 121.13 -0.981 . . . . 0.54000000000000004 114.451 167.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.8 mp -89.07 146.49 24.8 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 121.283 -1.127 . . . . 1.5900000000000001 112.685 -170.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 21.3 ttt85 -131.63 99.6 4.85 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.853 2.061 . . . . 3.1299999999999999 110.049 -173.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 4.0 mt -107.96 145.82 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 CA-C-O 123.461 1.6 . . . . 0.46999999999999997 113.943 -169.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -135.31 127.89 30.74 Favored 'General case' 0 N--CA 1.438 -1.051 0 C-N-CA 128.446 2.698 . . . . 1.8600000000000001 107.975 -171.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 23.7 p -143.28 160.61 40.18 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 126.466 1.907 . . . . 0.34000000000000002 110.207 -175.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -171.28 175.69 4.14 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 124.953 1.301 . . . . 0.64000000000000001 109.735 179.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.5 p -136.68 135.66 20.67 Favored Pre-proline 0 N--CA 1.471 0.581 0 C-N-CA 123.855 0.862 . . . . 0.44 110.936 175.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -75.44 129.34 11.87 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 123.561 2.84 . . . . 0.67000000000000004 109.584 173.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? -140.8 24.64 2.2 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.265 1.026 . . . . 3.0099999999999998 113.696 -159.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.316 0 C-N-CA 126.878 2.071 . . . . 7.3399999999999999 113.042 -175.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.709 0 CA-C-O 118.319 -0.848 . . . . 5.0899999999999999 110.378 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . 0.31 3.1 t 54.57 19.15 2.28 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 117.58 2.437 . . . . 3.6499999999999999 117.58 169.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 18.0 mp0 -44.27 143.75 1.16 Allowed 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 115.734 1.753 . . . . 2.3199999999999998 115.734 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 80.9 p -103.42 169.98 8.22 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.054 0.942 . . . . 0.58999999999999997 109.309 150.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -70.81 -21.74 62.43 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 120.844 -1.16 . . . . 2.8999999999999999 112.662 169.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.21 -41.62 96.76 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 125.533 1.54 . . . . 0.44 113.264 169.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.68 -47.81 29.4 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.769 1.627 . . . . 1.27 111.708 172.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.4 mt -68.46 -50.68 50.71 Favored 'General case' 0 C--O 1.231 0.095 0 C-N-CA 125.456 1.502 . . . . 0.38 111.444 -178.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -57.83 -49.74 75.63 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 126.119 1.768 . . . . 4.3200000000000003 111.145 -179.251 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 36.3 t -60.59 -47.54 92.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 108.223 -1.029 . . . . 0.26000000000000001 108.223 176.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 88.8 m -57.1 -37.58 72.15 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 112.539 0.57 . . . . 0.42999999999999999 112.539 178.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 7.9 mm-40 -64.47 -41.64 96.39 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 113.178 0.807 . . . . 2.0800000000000001 113.178 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 27.7 mt -76.04 -29.83 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-N 118.195 0.452 . . . . 0.65000000000000002 110.561 177.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 23.5 mt -57.42 -39.13 75.53 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 120.865 -1.147 . . . . 0.40000000000000002 113.594 170.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 39.5 mttt -64.45 -17.96 64.31 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 113.935 1.087 . . . . 1.45 113.935 177.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -104.36 -35.56 7.9 Favored 'General case' 0 N--CA 1.433 -1.325 0 C-N-CA 126.894 2.078 . . . . 1.8600000000000001 114.021 -177.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -74.15 -23.33 59.25 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 119.607 -0.837 . . . . 1.2 111.777 167.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -132.86 51.4 7.0 Favored Pre-proline 0 CA--C 1.548 0.871 0 N-CA-C 117.748 2.499 . . . . 2.0699999999999998 117.748 -178.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -64.82 -24.76 61.03 Favored 'Trans proline' 0 C--O 1.238 0.489 0 C-N-CA 123.89 3.06 . . . . 0.76000000000000001 114.352 174.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 15.5 mmp_? -76.94 -1.08 26.76 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.593 0.96 . . . . 5.7599999999999998 113.593 173.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.15 154.55 30.81 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 115.176 1.547 . . . . 0.45000000000000001 115.176 177.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 70.6 p -107.96 -27.81 9.96 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.022 1.329 . . . . 0.68000000000000005 112.568 165.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -117.67 133.73 55.64 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.745 0.818 . . . . 0.42999999999999999 111.14 163.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.3 pt -152.63 99.44 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 125.955 1.702 . . . . 0.53000000000000003 109.689 169.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.2 ptpt -146.67 149.05 32.71 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.194 1.398 . . . . 1.1499999999999999 111.809 -176.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.5 t -133.71 152.31 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 125.947 1.699 . . . . 0.39000000000000001 110.221 -172.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 81.4 m -141.56 135.29 29.94 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.356 0.663 . . . . 0.45000000000000001 110.607 167.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -75.86 130.28 38.31 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 122.108 0.956 . . . . 2.0600000000000001 110.315 166.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . 0.273 3.7 pt -123.0 29.1 2.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 125.533 1.533 . . . . 0.47999999999999998 110.33 177.067 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.1 p -135.17 62.85 1.63 Allowed 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 127.897 2.479 . . . . 2.1699999999999999 114.005 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.36 2.27 1.71 Allowed Glycine 0 CA--C 1.539 1.562 0 N-CA-C 117.252 1.661 . . . . 1.3 117.252 178.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -122.73 -5.6 8.26 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-N 119.84 1.82 . . . . 0.93000000000000005 115.943 172.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 1.7 m -151.79 -18.68 0.19 Allowed 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 115.066 1.506 . . . . 2.1200000000000001 115.066 -175.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 52.53 43.96 59.08 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 126.254 1.883 . . . . 0.80000000000000004 114.209 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -112.55 2.68 16.37 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 125.303 1.441 . . . . 1.1399999999999999 114.097 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 13.9 ttm -132.85 120.92 22.18 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 128.93 2.892 . . . . 1.8300000000000001 109.498 -166.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -140.95 143.95 34.85 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.709 0.766 . . . . 1.8300000000000001 112.824 -175.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -82.75 135.59 34.95 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 125.217 1.407 . . . . 2.5699999999999998 108.985 164.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 88.3 mt -135.93 127.71 44.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-N 119.457 1.026 . . . . 0.54000000000000004 110.081 172.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -121.01 114.2 21.17 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.9 1.28 . . . . 2.5299999999999998 109.923 176.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.446 ' CD1' HG13 ' A' ' 84' ' ' VAL . 1.2 mt -121.55 153.37 25.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 126.011 1.724 . . . . 0.34999999999999998 108.99 179.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -157.58 124.13 4.92 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 125.132 1.373 . . . . 1.8600000000000001 107.711 168.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 43.2 t -153.95 144.32 22.25 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.723 1.147 . . . . 0.40000000000000002 113.02 -169.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -55.88 -21.88 22.54 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.78 1.632 . . . . 3.73 114.589 -178.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -75.52 -21.71 57.75 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 113.692 0.997 . . . . 1.78 113.692 177.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -77.67 13.29 1.34 Allowed 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 114.111 1.152 . . . . 2.02 114.111 -167.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -83.49 -43.1 16.14 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.888 0.699 . . . . 2.2200000000000002 112.888 -176.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -83.12 46.24 1.1 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 125.332 1.453 . . . . 3.4199999999999999 110.765 179.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 54.0 mmtt -148.04 144.17 27.72 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 128.316 2.647 . . . . 1.6799999999999999 111.82 -176.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 17.6 mtt85 -70.05 171.12 10.08 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.17 0.988 . . . . 3.8999999999999999 111.341 155.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 87.3 m -57.98 -48.26 80.51 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 113.758 1.021 . . . . 1.2 113.758 174.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 13.6 p -59.72 -37.3 70.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 O-C-N 121.805 -0.56 . . . . 0.62 112.186 172.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -74.55 -26.38 59.92 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 118.609 -0.71 . . . . 1.0 111.996 179.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -64.79 -54.09 36.78 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.712 1.142 . . . . 0.73999999999999999 109.911 165.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 37.2 m170 -54.29 -49.14 70.3 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.256 1.023 . . . . 0.68999999999999995 113.307 -178.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 56.5 tp60 -48.54 -43.3 35.3 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.667 1.987 . . . . 1.4399999999999999 113.528 177.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 83.2 mtp -63.28 -46.39 86.99 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.681 0.792 . . . . 0.98999999999999999 111.648 179.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.446 HG13 ' CD1' ' A' ' 67' ' ' ILE . 2.9 t -66.5 -30.99 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 125.191 1.396 . . . . 0.40999999999999998 111.383 178.119 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -68.37 -54.45 17.19 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.161 1.785 . . . . 0.51000000000000001 110.726 175.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.7 -22.12 66.59 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.678 0.791 . . . . 2.96 112.973 -178.077 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.06 -41.1 78.12 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 125.482 1.513 . . . . 0.44 112.608 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.22 2.24 9.18 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 114.646 1.35 . . . . 0.33000000000000002 114.646 -176.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 11.7 ttpp -51.65 -37.61 51.17 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 124.819 1.248 . . . . 2.8900000000000001 112.131 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -83.21 -7.11 59.66 Favored 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 113.392 0.886 . . . . 2.02 113.392 -175.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -98.21 -51.1 4.11 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 127.027 2.131 . . . . 3.4100000000000001 110.917 174.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 21.4 mt -143.21 104.57 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 126.585 1.954 . . . . 0.95999999999999996 107.642 176.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -79.01 -2.09 38.63 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 115.313 1.597 . . . . 2.3100000000000001 115.313 -174.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -74.26 36.69 0.1 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 129.335 3.054 . . . . 3.9500000000000002 116.046 -165.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 5.6 mpp? -63.13 1.89 0.41 Allowed 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 116.053 1.871 . . . . 1.27 116.053 -176.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 7.6 p80 -58.16 -29.46 65.62 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 120.602 -1.311 . . . . 3.6800000000000002 112.036 156.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -78.58 -29.81 51.15 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 126.496 1.998 . . . . 0.40000000000000002 115.595 176.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.2 mp -91.33 122.17 33.71 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.368 -1.077 . . . . 1.6200000000000001 113.07 -158.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 47.1 ttt180 -99.1 100.73 11.91 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 127.386 2.274 . . . . 3.2799999999999998 109.785 -179.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 2.1 mt -108.04 143.06 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 CA-C-O 123.18 1.467 . . . . 0.59999999999999998 113.506 -170.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -133.97 123.27 24.34 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 128.277 2.631 . . . . 1.9199999999999999 108.49 -173.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 33.3 p -137.68 156.29 48.19 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 125.62 1.568 . . . . 0.53000000000000003 112.158 -176.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.1 p -167.09 177.31 6.32 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.651 1.58 . . . . 0.64000000000000001 110.476 178.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.5 p -136.87 132.0 18.22 Favored Pre-proline 0 N--CA 1.479 1.01 0 O-C-N 121.033 -1.042 . . . . 0.52000000000000002 111.328 175.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -76.29 100.02 1.35 Allowed 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 123.11 2.54 . . . . 1.25 111.379 -176.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -146.97 89.16 1.79 Allowed 'General case' 0 C--O 1.238 0.468 0 C-N-CA 126.373 1.869 . . . . 4.2400000000000002 109.447 -173.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 28.7 ptt-85 . . . . . 0 C--O 1.251 1.154 0 N-CA-C 115.208 1.558 . . . . 7.6900000000000004 115.208 -173.437 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.824 0 N-CA-C 113.153 0.798 . . . . 7.4199999999999999 113.153 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 14.8 t -154.32 167.38 30.16 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.546 1.139 . . . . 3.4300000000000002 112.572 -169.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 14.0 mp0 -62.65 152.14 36.15 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.438 1.495 . . . . 3.5800000000000001 114.796 -176.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 33.8 p -118.83 171.88 7.91 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.688 1.595 . . . . 0.60999999999999999 111.375 166.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -64.04 -32.96 74.69 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 121.474 -0.766 . . . . 2.98 111.106 169.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.92 -34.6 71.42 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 124.902 1.239 . . . . 0.46999999999999997 113.821 179.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.19 -47.32 54.67 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.133 1.373 . . . . 1.26 111.634 173.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 12.3 mt -68.07 -49.99 57.87 Favored 'General case' 0 CA--C 1.523 -0.095 0 C-N-CA 124.94 1.296 . . . . 0.58999999999999997 111.064 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -57.99 -46.74 84.71 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.218 1.407 . . . . 6.2400000000000002 111.227 -179.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.441 HG13 ' HG ' ' A' ' 88' ' ' LEU . 39.5 t -61.91 -46.44 96.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 108.108 -1.071 . . . . 0.35999999999999999 108.108 177.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 29.8 m -57.89 -35.92 71.68 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 112.693 0.627 . . . . 0.54000000000000004 112.693 177.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -67.32 -44.57 78.81 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 113.112 0.782 . . . . 2.02 113.112 179.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 28.7 mt -74.89 -28.23 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-N 118.652 0.66 . . . . 0.53000000000000003 110.555 -179.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 23.6 mt -58.52 -36.81 74.4 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 120.945 -1.097 . . . . 0.39000000000000001 113.448 170.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 58.0 mttt -58.42 -31.96 68.22 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 113.055 0.761 . . . . 1.8300000000000001 113.055 175.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -95.67 -34.59 11.9 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 127.069 2.148 . . . . 2.1000000000000001 114.213 -172.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -77.73 -20.67 53.11 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 120.11 -0.636 . . . . 1.1399999999999999 112.468 168.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -130.38 52.14 8.86 Favored Pre-proline 0 CA--C 1.55 0.972 0 N-CA-C 118.052 2.612 . . . . 1.54 118.052 178.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -63.51 -22.28 70.89 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.966 3.111 . . . . 0.78000000000000003 114.409 174.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 21.8 mmt180 -87.48 -1.58 58.03 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 113.889 1.07 . . . . 5.04 113.889 177.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.37 151.82 46.34 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.897 1.279 . . . . 0.68000000000000005 113.731 178.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 81.8 p -113.23 -9.0 13.5 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.594 1.558 . . . . 0.92000000000000004 113.527 174.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -135.37 142.65 45.77 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 120.028 1.285 . . . . 0.55000000000000004 111.107 153.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.4 pt -151.29 120.07 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 125.492 1.517 . . . . 0.52000000000000002 111.959 170.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -159.2 158.6 32.99 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.386 1.475 . . . . 2.04 113.247 178.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.0 t -138.74 150.96 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 126.364 1.866 . . . . 0.29999999999999999 109.952 -174.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 55.0 m -140.88 125.78 18.19 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 118.58 0.627 . . . . 0.40000000000000002 109.865 168.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -69.68 130.17 41.62 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 121.53 -0.731 . . . . 2.5299999999999998 109.273 167.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.9 pt -127.36 32.85 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 125.562 1.545 . . . . 0.53000000000000003 110.485 178.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.455 ' HB2' ' H ' ' A' ' 62' ' ' MET . 44.8 t -138.91 69.67 1.37 Allowed 'General case' 0 C--N 1.343 0.307 0 C-N-CA 127.938 2.495 . . . . 1.27 111.209 -177.302 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -42.47 -36.67 2.32 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 126.16 1.838 . . . . 1.3400000000000001 116.129 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -100.02 -14.27 34.29 Favored Glycine 0 CA--C 1.539 1.539 0 N-CA-C 115.981 1.153 . . . . 1.5 115.981 -173.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 8.2 t -138.12 -29.08 0.84 Allowed 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 119.18 1.49 . . . . 2.1600000000000001 114.484 -174.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 55.86 47.68 77.49 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 124.263 0.935 . . . . 0.70999999999999996 112.22 -161.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -93.39 -25.52 17.65 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.948 1.299 . . . . 0.77000000000000002 113.175 173.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.455 ' H ' ' HB2' ' A' ' 56' ' ' SER . 23.0 mtm -106.02 135.16 47.97 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 125.268 1.427 . . . . 1.29 111.776 172.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -138.13 143.51 40.39 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 121.959 0.885 . . . . 1.8899999999999999 112.179 169.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -81.08 139.08 35.89 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 125.931 1.692 . . . . 2.3900000000000001 109.156 162.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 93.6 mt -137.39 129.05 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 CA-C-N 119.68 1.127 . . . . 0.64000000000000001 110.018 171.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 79.7 mttt -123.08 117.38 25.28 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.814 1.246 . . . . 2.5299999999999998 109.858 177.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.2 mt -126.1 157.06 36.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 126.371 1.868 . . . . 0.29999999999999999 109.338 -179.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -154.6 126.11 7.45 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 120.441 -1.412 . . . . 2.1699999999999999 108.326 170.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 17.8 t -157.31 146.41 19.96 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-N 119.637 1.108 . . . . 0.35999999999999999 112.937 -172.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -57.7 -26.21 61.41 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 126.389 1.876 . . . . 4.04 112.653 -177.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -73.08 -11.95 60.73 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.714 1.606 . . . . 1.8799999999999999 114.96 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -91.2 6.09 46.49 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 116.408 2.003 . . . . 1.97 116.408 -171.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.47 -37.3 63.26 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 115.84 1.793 . . . . 2.5600000000000001 115.84 -172.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -87.36 28.36 0.97 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 124.739 1.216 . . . . 4.1200000000000001 112.669 -177.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 55.6 mmtt -131.08 132.99 45.26 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.929 1.292 . . . . 1.8400000000000001 113.335 -164.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 23.9 mtt85 -65.09 169.83 5.08 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.889 1.276 . . . . 3.7400000000000002 110.971 164.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 27.5 m -51.53 -53.86 33.33 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 113.384 0.883 . . . . 0.97999999999999998 113.384 174.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.4 p -61.61 -38.05 79.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 123.377 0.671 . . . . 0.60999999999999999 111.569 175.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -75.04 -20.67 59.47 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 113.727 1.01 . . . . 1.2 113.727 -178.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -75.13 -55.35 5.82 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 119.054 0.843 . . . . 0.70999999999999996 110.116 164.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 40.8 m170 -56.42 -46.45 80.22 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.912 0.885 . . . . 0.78000000000000003 113.24 -175.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 29.7 tp60 -47.88 -41.79 25.17 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.287 1.435 . . . . 1.25 113.088 177.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 3.7 mtm -64.17 -40.68 96.63 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 121.491 -0.756 . . . . 1.1599999999999999 111.668 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.8 t -75.78 -23.99 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 126.07 1.748 . . . . 0.23999999999999999 111.235 179.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -76.16 -48.44 20.53 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.911 1.684 . . . . 0.45000000000000001 109.273 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 19.5 mm-40 -65.74 -23.68 66.79 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.622 1.169 . . . . 2.52 114.081 178.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.49 -38.49 84.47 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.119 0.968 . . . . 0.38 112.688 -177.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.441 ' HG ' HG13 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -121.22 3.41 10.36 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 114.605 1.335 . . . . 0.5 114.605 -178.58 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.9 ttmt -53.25 -39.94 64.23 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.674 1.189 . . . . 2.98 112.576 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -82.47 -5.83 58.93 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 123.311 0.644 . . . . 2.1400000000000001 112.629 -175.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -95.83 -49.16 5.44 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 127.412 2.285 . . . . 2.77 111.592 167.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 21.2 mt -148.38 110.36 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 128.133 2.573 . . . . 1.0800000000000001 109.024 178.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt -85.52 0.38 52.58 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 117.852 2.538 . . . . 4.0099999999999998 117.852 -173.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -77.19 48.42 0.62 Allowed 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 129.557 3.143 . . . . 2.8599999999999999 115.845 -160.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . 0.267 1.4 mpt? -70.63 3.51 3.07 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 119.709 -1.869 . . . . 1.9099999999999999 115.42 -177.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 17.5 p-80 -66.92 -13.62 61.94 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 114.491 1.293 . . . . 4.4000000000000004 114.491 156.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -108.64 -25.39 5.74 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 125.914 1.721 . . . . 0.48999999999999999 115.103 171.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.2 mp -78.27 141.25 38.67 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 121.009 -1.289 . . . . 1.54 113.577 -174.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 34.8 ttt180 -125.9 101.76 6.97 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 127.316 2.246 . . . . 3.1600000000000001 109.933 -177.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 4.0 mt -108.21 149.77 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-O 123.59 1.662 . . . . 0.44 113.593 -171.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -139.77 119.56 13.35 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 111.356 -2.657 . . . . 1.8799999999999999 108.631 -171.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.8 p -136.85 145.02 43.92 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 125.285 1.434 . . . . 0.40999999999999998 111.253 -177.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.8 p -148.08 178.58 8.42 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.283 -1.326 . . . . 0.76000000000000001 111.404 176.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 6.8 p -145.0 135.82 12.25 Favored Pre-proline 0 N--CA 1.47 0.575 0 O-C-N 121.759 -0.588 . . . . 0.56000000000000005 112.385 -178.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -80.85 105.66 1.71 Allowed 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 123.298 2.665 . . . . 0.76000000000000001 110.999 176.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -135.41 25.14 3.48 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.396 1.478 . . . . 3.9399999999999999 113.997 -162.219 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 20.8 ttt180 . . . . . 0 N--CA 1.48 1.043 0 C-N-CA 125.346 1.458 . . . . 7.5899999999999999 111.6 176.471 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.074 0 N-CA-C 112.106 0.41 . . . . 5.4299999999999997 112.106 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -138.32 -178.39 5.27 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 125.651 1.58 . . . . 3.5600000000000001 111.272 173.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -135.46 136.17 41.09 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 126.003 1.721 . . . . 2.27 111.304 169.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 70.1 p -100.4 -178.89 3.94 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 126.069 1.748 . . . . 0.81999999999999995 110.13 160.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -73.24 -25.71 60.83 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 120.264 -1.522 . . . . 2.8799999999999999 112.208 160.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.73 -40.27 98.56 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 125.453 1.501 . . . . 0.48999999999999999 113.244 173.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -52.22 -42.19 63.37 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.588 1.555 . . . . 1.24 113.016 177.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 14.0 mt -75.06 -48.44 23.9 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 126.543 1.937 . . . . 0.46000000000000002 110.549 -179.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -53.81 -49.09 69.12 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.333 1.453 . . . . 2.9399999999999999 111.149 175.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 29.8 t -62.46 -52.04 64.79 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 C-N-CA 125.457 1.503 . . . . 0.34999999999999998 107.576 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 99.3 m -52.24 -43.13 64.15 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.479 0.712 . . . . 0.41999999999999998 111.848 178.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -65.33 -42.21 93.15 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 118.267 -0.873 . . . . 2.1899999999999999 112.406 -178.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 38.6 mt -72.4 -32.0 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 CA-C-N 119.754 1.161 . . . . 0.45000000000000001 110.494 178.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 20.6 mt -54.36 -44.06 71.87 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 121.344 -0.848 . . . . 0.41999999999999998 112.904 173.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 34.9 mttt -65.91 -23.88 66.72 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 113.69 0.996 . . . . 2.1499999999999999 113.69 -178.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -93.03 -33.83 13.95 Favored 'General case' 0 N--CA 1.435 -1.211 0 C-N-CA 126.694 1.998 . . . . 2.3399999999999999 114.357 -177.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -75.64 -21.43 57.71 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 120.292 -0.563 . . . . 1.1299999999999999 111.947 166.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -131.12 58.2 37.16 Favored Pre-proline 0 CA--C 1.549 0.927 0 N-CA-C 117.254 2.316 . . . . 1.6200000000000001 117.254 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -67.18 -13.38 39.43 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 124.241 3.294 . . . . 1.1100000000000001 114.428 168.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.97 -12.72 60.19 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 115.274 1.583 . . . . 7.5599999999999996 115.274 171.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.94 153.79 42.69 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 116.37 1.989 . . . . 0.65000000000000002 116.37 -162.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 39.8 p -107.83 -25.28 11.31 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.521 1.528 . . . . 0.56000000000000005 112.466 166.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -125.9 141.24 52.07 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.297 0.953 . . . . 0.40000000000000002 111.62 164.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.2 pt -157.4 112.06 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 126.589 1.956 . . . . 0.81999999999999995 109.598 174.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.8 ptpt -153.38 149.9 28.3 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.239 1.416 . . . . 1.5800000000000001 112.221 -177.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.5 t -133.63 151.58 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 126.081 1.753 . . . . 0.46000000000000002 110.574 -176.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 88.0 m -146.6 122.73 10.82 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 121.046 -1.034 . . . . 0.35999999999999999 111.903 167.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -65.94 129.04 38.42 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.634 0.731 . . . . 1.99 109.314 162.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.9 pt -129.26 28.62 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 C-N-CA 126.364 1.865 . . . . 0.53000000000000003 110.009 179.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.5 t -132.99 59.25 1.74 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 127.547 2.339 . . . . 1.22 112.271 -165.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -66.5 14.33 0.36 Allowed Glycine 0 CA--C 1.539 1.562 0 C-N-CA 126.126 1.822 . . . . 1.8200000000000001 117.295 -175.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -154.07 16.99 0.61 Allowed Glycine 0 CA--C 1.533 1.171 0 C-N-CA 125.568 1.556 . . . . 1.8200000000000001 113.853 -177.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.6 t -161.52 -27.88 0.05 Allowed 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.363 1.465 . . . . 1.8600000000000001 112.49 177.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 54.47 40.53 69.65 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 125.642 1.591 . . . . 0.78000000000000003 113.898 -171.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -109.96 -37.07 5.71 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 127.372 2.269 . . . . 1.2 113.959 -176.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 30.0 mtm -84.03 130.94 34.86 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 124.283 1.033 . . . . 1.3400000000000001 110.669 175.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -141.32 141.87 33.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 122.147 0.975 . . . . 1.8400000000000001 112.313 172.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -81.23 137.22 35.87 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 124.905 1.282 . . . . 1.97 109.748 162.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.9 mt -136.76 131.94 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 108.213 -1.032 . . . . 0.63 108.213 171.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 8.0 tmtm? -128.42 128.61 44.78 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 118.992 0.815 . . . . 7.54 112.095 169.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.2 mt -124.51 162.44 26.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 125.772 1.629 . . . . 0.28999999999999998 108.869 -179.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -156.7 131.14 8.69 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 126.652 1.981 . . . . 2.0800000000000001 106.829 164.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 32.9 t -158.04 143.92 17.17 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 119.558 1.072 . . . . 0.34999999999999998 111.776 -172.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -55.9 -23.56 32.12 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 113.821 1.045 . . . . 3.0299999999999998 113.821 179.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -70.67 -19.14 62.82 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 114.9 1.444 . . . . 1.8300000000000001 114.9 178.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -83.14 10.72 7.6 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 114.545 1.313 . . . . 1.6200000000000001 114.545 -169.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.6 pttt -72.35 -44.92 61.91 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.979 1.711 . . . . 2.8999999999999999 113.527 -175.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -83.9 20.36 1.52 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.997 1.719 . . . . 3.71 112.489 -175.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 64.4 mmtt -130.47 132.55 45.73 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 126.469 1.907 . . . . 1.4199999999999999 111.984 -166.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 47.6 mtt180 -69.5 168.25 15.0 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.965 1.306 . . . . 3.2999999999999998 111.694 163.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 56.6 m -46.2 -55.41 7.15 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.058 1.343 . . . . 0.89000000000000001 113.533 170.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.7 p -57.55 -44.24 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 124.501 1.12 . . . . 0.58999999999999997 112.464 174.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -72.04 -27.87 62.98 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 118.378 -0.82 . . . . 1.1000000000000001 112.85 -178.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -69.97 -51.84 29.28 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 119.451 1.023 . . . . 0.68000000000000005 109.921 169.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 44.1 m170 -52.17 -53.07 47.66 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.075 0.95 . . . . 0.57999999999999996 112.24 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 28.0 tp60 -46.59 -43.67 17.5 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.1 1.36 . . . . 1.4299999999999999 113.411 177.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 61.6 mtp -64.18 -36.22 83.36 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 120.998 -1.064 . . . . 1.0600000000000001 113.069 -178.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.0 t -79.05 -36.07 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 125.613 1.565 . . . . 0.39000000000000001 110.56 177.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -61.22 -50.29 73.68 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.986 1.314 . . . . 0.46999999999999997 110.221 174.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 63.7 tp60 -57.45 -29.82 64.51 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 120.246 -1.534 . . . . 2.3300000000000001 113.553 178.073 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.54 -37.22 82.98 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.119 0.968 . . . . 0.54000000000000004 112.058 -177.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.59 0.88 8.84 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 115.06 1.504 . . . . 0.62 115.06 -179.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 30.2 ttpt -47.41 -36.76 10.27 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 125.85 1.66 . . . . 2.6699999999999999 112.618 175.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -88.85 7.55 33.68 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 112.403 0.52 . . . . 2.0699999999999998 112.403 -172.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -121.11 -61.13 1.58 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 128.625 2.77 . . . . 2.73 110.449 175.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 7.2 mm -115.77 90.33 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 125.046 1.338 . . . . 1.6499999999999999 109.018 171.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 8.0 ptpp? -76.15 -18.56 59.06 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 114.348 1.24 . . . . 4.4000000000000004 114.348 -173.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -67.08 46.19 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 131.258 3.823 . . . . 3.3900000000000001 114.429 -178.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 61.2 mtm -71.58 10.25 0.68 Allowed 'General case' 0 CA--C 1.54 0.56 0 O-C-N 119.393 -2.067 . . . . 1.3700000000000001 114.933 -172.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -69.59 -20.59 63.63 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.315 0.857 . . . . 3.2200000000000002 113.315 161.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -84.45 -32.88 21.25 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 123.904 0.764 . . . . 0.62 112.212 174.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.0 mp -71.91 144.31 49.03 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 122.515 1.15 . . . . 1.6100000000000001 112.795 -173.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 45.1 ttt180 -128.48 99.67 5.48 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 126.547 1.939 . . . . 3.02 109.126 -176.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 4.9 mt -108.78 141.75 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 123.697 1.713 . . . . 0.62 112.953 -170.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -130.51 132.79 45.8 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 111.495 -2.593 . . . . 1.8500000000000001 107.542 -172.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 17.2 p -151.85 151.85 31.85 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.788 1.235 . . . . 0.33000000000000002 109.945 -173.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.1 p -161.83 -179.53 7.27 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.506 -1.224 . . . . 0.64000000000000001 110.243 178.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 6.3 p -135.15 136.14 24.15 Favored Pre-proline 0 C--N 1.325 -0.481 0 C-N-CA 124.267 1.027 . . . . 0.57999999999999996 109.782 177.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -76.35 122.2 6.45 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 123.377 2.718 . . . . 0.68000000000000005 108.791 175.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 6.8 mmtt -146.76 17.21 1.27 Allowed 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 114.351 1.241 . . . . 2.9199999999999999 114.351 -157.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 29.4 ttt-85 . . . . . 0 C--O 1.254 1.297 0 C-N-CA 127.562 2.345 . . . . 8.7200000000000006 111.806 -173.078 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.964 0 CA-C-O 118.907 -0.568 . . . . 4.9100000000000001 112.018 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.9 t -128.54 173.65 10.07 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 119.391 0.996 . . . . 3.1499999999999999 111.806 176.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 16.4 mp0 -120.8 158.71 26.97 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.179 1.391 . . . . 2.2000000000000002 113.445 -168.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 80.9 p -127.06 166.87 16.79 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.774 2.03 . . . . 0.67000000000000004 108.291 159.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -62.68 -26.66 68.77 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 119.986 1.267 . . . . 3.27 111.951 169.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.43 -43.47 94.82 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 126.01 1.767 . . . . 0.40999999999999998 113.063 172.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.88 -45.6 60.14 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 119.321 1.56 . . . . 2.0299999999999998 111.44 173.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.7 mt -69.52 -52.22 28.43 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 124.912 1.285 . . . . 0.45000000000000001 111.264 178.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -53.62 -48.28 69.46 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.915 1.286 . . . . 2.8999999999999999 110.695 179.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 67.6 t -63.99 -49.24 82.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 108.25 -1.019 . . . . 0.27000000000000002 108.25 179.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 98.3 m -56.18 -43.01 77.99 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.15 0.58 . . . . 0.34999999999999998 112.4 178.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.74 -37.02 85.78 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.479 1.112 . . . . 2.7599999999999998 111.911 -179.089 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 64.1 mt -79.82 -30.63 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 CA-C-N 118.775 0.716 . . . . 0.47999999999999998 110.855 176.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.2 mt -59.81 -36.09 76.05 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 120.694 -1.254 . . . . 0.52000000000000002 112.687 170.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 27.2 mttt -65.84 -19.05 65.74 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 113.429 0.9 . . . . 1.3799999999999999 113.429 175.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -98.43 -39.2 8.89 Favored 'General case' 0 N--CA 1.434 -1.254 0 C-N-CA 126.079 1.752 . . . . 2.1699999999999999 113.946 179.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 29.5 mmtt -78.17 -21.69 49.81 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 112.675 0.62 . . . . 1.8100000000000001 112.675 172.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -136.24 52.4 6.31 Favored Pre-proline 0 CA--C 1.55 0.98 0 N-CA-C 118.126 2.639 . . . . 2.1099999999999999 118.126 178.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -69.47 -22.07 33.94 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 123.659 2.906 . . . . 0.97999999999999998 114.395 173.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 13.4 mmp_? -82.7 -18.37 41.13 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 120.861 -1.149 . . . . 6.75 112.485 177.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -55.5 145.87 21.71 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 125.868 1.667 . . . . 0.58999999999999997 113.559 176.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 81.9 p -86.44 -28.97 23.19 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.247 1.019 . . . . 0.72999999999999998 110.938 176.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -121.69 143.73 49.18 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.001 0.921 . . . . 0.40999999999999998 112.615 164.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.5 pt -155.41 111.53 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 128.123 2.569 . . . . 0.56000000000000005 110.167 169.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 6.4 ptpt -153.28 156.0 37.59 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.885 1.274 . . . . 1.02 113.062 176.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.7 t -133.77 145.94 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 126.314 1.846 . . . . 0.51000000000000001 110.281 -177.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 28.4 m -132.69 128.02 36.05 Favored 'General case' 0 CA--C 1.512 -0.482 0 C-N-CA 123.706 0.802 . . . . 0.60999999999999999 111.521 171.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -74.04 125.3 27.99 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 122.209 1.004 . . . . 1.8 109.586 165.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.4 pt -124.72 30.5 2.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 125.273 1.429 . . . . 0.47999999999999998 109.96 178.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.465 ' HB2' ' H ' ' A' ' 62' ' ' MET . 32.4 t -138.98 62.73 1.53 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 127.509 2.324 . . . . 1.25 111.998 -175.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -65.63 10.62 0.47 Allowed Glycine 0 CA--C 1.541 1.696 0 O-C-N 120.256 -1.528 . . . . 1.51 116.689 178.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -121.49 -4.28 9.92 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 125.749 1.642 . . . . 0.91000000000000003 114.709 171.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 9.2 t -156.97 -31.59 0.08 Allowed 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 119.386 1.593 . . . . 1.8400000000000001 114.832 -176.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 59.93 48.93 83.67 Favored Glycine 0 CA--C 1.538 1.516 0 C-N-CA 126.036 1.779 . . . . 0.60999999999999999 113.051 -161.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -105.88 -17.47 14.35 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 126.299 1.839 . . . . 0.85999999999999999 114.625 178.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.465 ' H ' ' HB2' ' A' ' 56' ' ' SER . 6.6 mtm -110.9 140.43 45.38 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 126.11 1.764 . . . . 1.3500000000000001 111.954 168.298 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -142.99 148.93 37.62 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.725 0.81 . . . . 1.8999999999999999 112.795 172.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -85.84 138.45 32.04 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.858 1.663 . . . . 1.96 109.356 163.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 84.2 mt -134.75 131.01 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 CA-C-N 120.057 1.299 . . . . 0.63 109.965 171.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 66.9 mttt -128.2 118.59 23.61 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.637 1.175 . . . . 2.7599999999999998 111.329 179.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.401 ' CD1' HG13 ' A' ' 84' ' ' VAL . 1.2 mt -128.5 157.36 41.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 C-N-CA 126.586 1.954 . . . . 0.25 109.633 -178.368 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -157.39 126.9 6.03 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 120.353 -1.467 . . . . 1.8400000000000001 109.248 170.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 16.4 t -160.1 144.29 14.43 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 120.599 1.545 . . . . 0.41999999999999998 112.815 -169.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -55.32 -29.69 58.76 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.902 1.281 . . . . 4.8700000000000001 112.562 -177.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -66.43 -19.25 65.75 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 115.166 1.543 . . . . 1.75 115.166 178.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -82.56 -2.78 54.66 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 120.824 -1.172 . . . . 2.0099999999999998 114.106 -172.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.516 ' HB3' HG21 ' A' ' 104' ' ' VAL . 55.3 pttt -67.09 -25.45 66.23 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.752 1.621 . . . . 2.77 114.432 -176.18 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -109.05 26.61 10.41 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.976 1.71 . . . . 4.5599999999999996 111.415 -169.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 38.9 mmtt -131.79 141.4 49.46 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 126.535 1.934 . . . . 1.3999999999999999 111.319 -172.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 31.0 mtt180 -64.04 165.38 9.11 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 118.975 -0.535 . . . . 4.6299999999999999 110.906 165.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 66.7 m -48.24 -54.53 13.27 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 113.154 0.798 . . . . 1.0 113.154 170.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.2 p -60.34 -39.38 80.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 124.656 1.182 . . . . 0.65000000000000002 112.717 176.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -69.88 -35.37 74.6 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 112.841 0.682 . . . . 1.3300000000000001 112.841 176.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -60.87 -52.33 65.52 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 119.507 1.049 . . . . 0.62 109.911 170.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 38.3 m170 -54.8 -51.6 65.27 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.292 0.637 . . . . 0.48999999999999999 111.81 176.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 41.3 tp60 -48.76 -44.02 38.36 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.933 1.693 . . . . 1.24 113.161 178.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 1.4 mtm -63.46 -40.36 96.92 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 119.628 1.104 . . . . 1.1299999999999999 111.868 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.401 HG13 ' CD1' ' A' ' 67' ' ' ILE . 4.2 t -74.83 -31.17 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 124.556 1.142 . . . . 0.37 111.145 178.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -66.88 -52.82 38.75 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.571 1.549 . . . . 0.45000000000000001 110.697 176.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 43.7 tp60 -64.09 -23.91 67.5 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 119.993 -1.692 . . . . 2.6299999999999999 113.15 -177.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -54.19 -45.82 72.25 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.9 1.28 . . . . 0.48999999999999999 111.254 177.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -119.91 1.47 10.96 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 114.994 1.479 . . . . 0.47999999999999998 114.994 -175.062 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 29.8 ttpt -51.28 -36.8 43.95 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 125.226 1.41 . . . . 2.1899999999999999 112.13 -177.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -85.15 -9.09 58.25 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 112.781 0.66 . . . . 2.21 112.781 -174.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -94.91 -62.05 1.38 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 127.128 2.171 . . . . 3.0099999999999998 110.428 174.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 8.6 mm -121.61 88.93 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 125.631 1.572 . . . . 1.46 109.044 176.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -72.76 -16.68 61.64 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 115.378 1.621 . . . . 2.5899999999999999 115.378 -174.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.9 mp0 -63.18 39.08 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 130.946 3.699 . . . . 3.1000000000000001 115.903 -177.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 64.2 mtm -69.46 2.55 2.98 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 119.669 -1.894 . . . . 1.4199999999999999 115.412 -170.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 10.9 p-80 -65.85 -22.7 66.56 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.611 0.764 . . . . 4.4100000000000001 112.668 160.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -84.57 -14.79 69.88 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 125.995 1.76 . . . . 0.39000000000000001 114.27 171.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.6 mp -97.47 127.01 43.08 Favored 'General case' 0 C--O 1.236 0.37 0 O-C-N 121.553 -0.969 . . . . 1.6699999999999999 111.877 -168.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 59.2 ttt180 -106.11 101.05 10.56 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.734 2.014 . . . . 3.98 109.735 178.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 4.8 mt -107.59 141.08 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-O 123.183 1.468 . . . . 0.46000000000000002 112.02 -173.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -129.74 130.99 46.13 Favored 'General case' 0 N--CA 1.433 -1.31 0 C-N-CA 128.35 2.66 . . . . 2.0299999999999998 108.628 -174.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 13.6 p -143.1 152.94 42.4 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 126.006 1.722 . . . . 0.29999999999999999 109.036 -178.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 2.8 p -163.03 -179.48 6.75 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.617 -1.174 . . . . 0.60999999999999999 109.671 177.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.516 HG21 ' HB3' ' A' ' 73' ' ' LYS . 4.2 p -144.19 135.26 12.46 Favored Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 112.909 0.707 . . . . 0.58999999999999997 112.909 -175.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -80.7 133.28 9.21 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 124.157 3.238 . . . . 0.72999999999999998 112.024 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 31.6 mmtt -141.41 59.34 1.51 Allowed 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 115.443 -0.799 . . . . 2.77 112.5 -149.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 52.8 ttp180 . . . . . 0 C--O 1.253 1.254 0 C-N-CA 126.684 1.994 . . . . 10.4 111.951 172.976 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.896 0 N-CA-C 110.346 -0.242 . . . . 4.6100000000000003 110.346 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 57.9 m 64.04 137.69 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 127.607 2.363 . . . . 2.8599999999999999 115.894 -179.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -128.39 -178.74 4.68 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.855 1.262 . . . . 2.8100000000000001 111.093 178.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 55.2 p -127.69 -175.87 3.6 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 126.257 1.823 . . . . 0.87 109.795 168.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -62.21 -39.55 93.14 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 120.646 1.566 . . . . 4.6100000000000003 110.764 160.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.48 -43.78 96.16 Favored Glycine 0 C--N 1.34 0.789 0 C-N-CA 126.045 1.783 . . . . 0.68000000000000005 113.21 -177.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.12 -48.35 73.77 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 118.974 1.387 . . . . 1.3100000000000001 112.565 -178.317 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 46.0 mt -66.32 -50.31 64.07 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 125.807 1.643 . . . . 0.52000000000000002 110.882 178.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -54.99 -50.03 70.0 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.779 2.032 . . . . 3.2200000000000002 111.428 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.2 t -64.36 -47.12 90.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 124.418 1.087 . . . . 0.34999999999999998 108.127 177.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 89.7 m -57.65 -38.3 74.83 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 118.035 0.38 . . . . 0.35999999999999999 111.998 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -62.39 -40.67 97.24 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 112.629 0.603 . . . . 1.6899999999999999 112.629 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 24.3 mt -79.4 -29.46 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 O-C-N 123.314 0.384 . . . . 0.66000000000000003 111.013 179.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.1 mt -56.13 -41.54 75.48 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 120.833 -1.167 . . . . 0.5 113.534 169.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 38.5 mttt -60.89 -28.61 69.01 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 113.262 0.838 . . . . 2.0499999999999998 113.262 178.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -93.48 -37.96 11.67 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 127.294 2.238 . . . . 2.04 114.497 -175.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -73.87 -26.91 60.8 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-O 117.999 -1.0 . . . . 1.1899999999999999 111.489 171.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -132.06 52.01 8.33 Favored Pre-proline 0 CA--C 1.547 0.865 0 N-CA-C 117.811 2.523 . . . . 1.5700000000000001 117.811 -177.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -62.48 -22.6 74.24 Favored 'Trans proline' 0 C--O 1.236 0.403 0 C-N-CA 123.758 2.972 . . . . 0.73999999999999999 114.194 174.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.41 -18.44 64.45 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 113.953 1.094 . . . . 7.2000000000000002 113.953 174.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -56.36 150.67 14.35 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 115.552 1.686 . . . . 0.51000000000000001 115.552 -167.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 61.1 p -90.26 -35.66 15.17 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 114.702 -1.135 . . . . 0.79000000000000004 111.672 166.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -125.09 136.13 53.36 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.53 1.132 . . . . 0.32000000000000001 111.176 173.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.5 pt -153.89 114.08 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 124.381 1.073 . . . . 0.46999999999999997 112.876 171.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -157.14 154.62 29.64 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.569 1.548 . . . . 1.25 113.297 -179.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.8 t -131.77 142.66 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 127.673 2.389 . . . . 0.67000000000000004 108.604 177.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 59.2 m -135.77 120.72 18.67 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.948 1.299 . . . . 0.51000000000000001 110.484 175.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -70.52 128.74 37.19 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.95 0.881 . . . . 1.9099999999999999 109.839 168.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.7 pt -130.47 31.19 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 C-N-CA 126.566 1.946 . . . . 0.73999999999999999 109.597 178.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.7 t -139.87 61.91 1.52 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 128.319 2.648 . . . . 1.3200000000000001 110.436 -170.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.6 -3.47 5.63 Favored Glycine 0 CA--C 1.538 1.504 0 N-CA-C 118.128 2.011 . . . . 1.25 118.128 -168.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -140.37 12.41 3.01 Favored Glycine 0 N--CA 1.475 1.24 0 CA-C-N 119.632 1.716 . . . . 0.93000000000000005 115.222 175.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 16.7 m -143.55 -34.15 0.41 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.746 1.618 . . . . 2.9100000000000001 111.865 -176.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 52.84 42.96 60.41 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 126.69 2.091 . . . . 0.70999999999999996 113.194 -177.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -107.34 -29.86 9.04 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.446 1.898 . . . . 0.93999999999999995 112.357 -177.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 1.8 mtm -102.97 126.53 50.18 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 126.501 1.92 . . . . 2.1699999999999999 109.96 -179.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -139.05 150.51 45.84 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.157 0.983 . . . . 1.9299999999999999 110.487 178.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -104.72 124.28 49.11 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.856 1.662 . . . . 2.04 109.448 171.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 53.8 mt -124.61 135.5 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 125.314 1.446 . . . . 0.65000000000000002 110.645 -176.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 62.0 tttt -126.74 120.71 30.07 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.177 0.991 . . . . 5.1200000000000001 110.455 174.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.409 ' CD1' HG13 ' A' ' 84' ' ' VAL . 1.1 mt -125.31 154.0 33.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 126.453 1.901 . . . . 0.28000000000000003 108.974 176.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -156.02 130.3 8.79 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 120.561 -1.337 . . . . 1.6299999999999999 108.393 166.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.4 t -162.64 147.22 11.89 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 118.881 0.764 . . . . 0.66000000000000003 112.369 -174.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -55.21 -24.15 25.83 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.303 1.841 . . . . 2.9500000000000002 114.553 -175.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -70.07 -18.26 63.27 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 115.155 1.539 . . . . 2.5099999999999998 115.155 175.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -78.56 15.86 0.94 Allowed 'General case' 0 CA--C 1.559 1.32 0 N-CA-C 114.854 1.427 . . . . 1.6299999999999999 114.854 -173.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.404 ' HG2' ' H ' ' A' ' 73' ' ' LYS . 38.4 pttt -79.1 -35.7 41.86 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 128.215 2.606 . . . . 2.4300000000000002 117.275 -165.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -119.45 32.27 6.17 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.455 1.102 . . . . 3.6899999999999999 112.301 -179.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 67.8 mmtt -112.13 142.21 44.86 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 128.043 2.537 . . . . 1.3600000000000001 111.214 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 8.2 mmt180 -66.19 161.87 21.09 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.141 0.976 . . . . 3.29 111.002 163.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 96.4 m -47.42 -55.74 8.36 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.334 1.054 . . . . 0.77000000000000002 113.616 169.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.6 p -56.9 -37.61 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 124.809 1.243 . . . . 0.58999999999999997 112.644 178.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.4 mm100 -77.14 -32.33 56.28 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.444 1.098 . . . . 1.8400000000000001 113.048 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -62.92 -53.57 51.97 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.156 0.889 . . . . 0.59999999999999998 109.832 168.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 39.2 m170 -53.15 -50.87 63.68 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.914 0.886 . . . . 0.42999999999999999 111.626 177.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 34.7 tp60 -48.28 -44.27 33.46 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.922 1.289 . . . . 1.29 112.875 178.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 4.1 mtm -61.59 -43.41 98.92 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 119.977 1.262 . . . . 1.1599999999999999 111.297 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.409 HG13 ' CD1' ' A' ' 67' ' ' ILE . 5.8 t -71.83 -29.08 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.87 1.268 . . . . 0.23999999999999999 111.471 178.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -71.91 -44.67 63.31 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.102 1.361 . . . . 0.62 110.481 175.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.7 -22.83 66.06 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 120.647 -1.283 . . . . 2.8399999999999999 113.379 178.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.45 -38.98 78.64 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.784 1.234 . . . . 0.34999999999999998 112.48 176.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.04 -2.31 9.2 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 114.772 1.397 . . . . 0.40000000000000002 114.772 -173.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 11.0 ttpp -49.49 -35.73 20.77 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 126.086 1.754 . . . . 3.6499999999999999 113.323 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -88.76 -11.19 45.7 Favored 'General case' 0 CA--C 1.552 1.044 0 N-CA-C 112.307 0.484 . . . . 2.0899999999999999 112.307 -174.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -95.45 -49.79 5.27 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 127.338 2.255 . . . . 3.75 112.045 174.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 34.2 mt -135.41 113.07 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 127.525 2.33 . . . . 1.1200000000000001 106.302 172.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.86 -17.78 34.65 Favored 'General case' 0 N--CA 1.48 1.075 0 O-C-N 120.703 -1.248 . . . . 3.4500000000000002 114.22 -169.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -88.33 63.9 7.34 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.33 1.852 . . . . 4.21 112.798 -164.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . 0.417 ' HA ' HD13 ' A' ' 98' ' ' LEU . 5.3 mpp? -69.14 8.04 0.63 Allowed 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 115.16 1.541 . . . . 1.28 115.16 -178.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 28.3 p80 -53.18 -36.42 60.92 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 120.978 -1.076 . . . . 3.9500000000000002 113.377 171.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -85.43 -9.25 79.55 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 125.673 1.606 . . . . 0.42999999999999999 114.635 -179.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.417 HD13 ' HA ' ' A' ' 95' ' ' MET . 4.9 mp -96.68 107.36 19.8 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 121.311 -1.111 . . . . 1.6599999999999999 112.44 -166.538 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 10.4 ttt180 -81.05 117.39 21.59 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 112.818 -1.992 . . . . 3.4399999999999999 108.467 171.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 4.3 mt -125.29 135.07 65.18 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.679 0 CA-C-O 123.448 1.594 . . . . 0.35999999999999999 112.491 -175.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -121.69 122.67 40.1 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 111.539 -2.573 . . . . 2.4300000000000002 107.611 -175.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 15.6 p -132.92 152.5 51.89 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.103 1.361 . . . . 0.25 110.21 179.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.8 p -158.2 175.57 13.6 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 124.639 1.176 . . . . 0.59999999999999998 110.367 176.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 9.0 p -141.94 127.82 10.86 Favored Pre-proline 0 N--CA 1.472 0.661 0 C-N-CA 123.132 0.573 . . . . 0.41999999999999998 111.77 -177.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -83.69 119.19 2.56 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 123.447 2.765 . . . . 0.66000000000000003 111.957 -176.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -151.45 95.57 2.16 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.139 1.376 . . . . 4.1900000000000004 110.776 179.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 60.5 ttt180 . . . . . 0 C--O 1.251 1.133 0 C-N-CA 125.547 1.539 . . . . 7.5899999999999999 111.325 -179.636 . . . . . . . . 0 0 . 1 stop_ save_